data_2gg1_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2gg1 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 303' ' ' THR . . . . . 0.456 ' O ' HG21 ' A' ' 303' ' ' THR . 8.8 t . . . . . 0 CA--C 1.537 0.455 0 CA-C-O 121.697 0.761 . . . . 0.0 111.734 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . 0.537 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 13.9 p90 -70.12 117.0 11.14 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' THR . . . . . 0.458 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 11.0 t 172.22 -166.83 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -168.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 39.1 t -64.5 109.55 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 171.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . 0.4 ' HB3' HG22 ' A' ' 335' ' ' THR . 0.4 OUTLIER -72.6 144.6 47.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.199 -173.788 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . 0.577 ' OD1' HG21 ' A' ' 310' ' ' THR . 16.4 t70 -70.9 127.2 31.78 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.546 0.689 . . . . 0.0 110.711 -177.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.507 ' HD3' ' HB2' ' A' ' 387' ' ' ASP . 0.0 OUTLIER -44.85 -18.52 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 116.123 1.897 . . . . 0.0 116.123 -173.465 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.577 HG21 ' OD1' ' A' ' 308' ' ' ASP . 10.9 t -108.29 5.68 25.84 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 119.761 1.164 . . . . 0.0 111.725 -171.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . 0.463 ' HB3' ' HE3' ' A' ' 311' ' ' LYS . 25.3 mtpp -86.26 -25.77 25.35 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -171.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.502 ' HA ' ' O ' ' A' ' 331' ' ' GLY . 0.0 OUTLIER -83.14 174.74 10.53 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.664 0.745 . . . . 0.0 111.269 178.369 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 32.0 p -139.33 156.87 46.73 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.867 -177.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . 0.658 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 26.8 m-90 -76.39 92.34 3.36 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.54 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 84.8 tttt -77.67 -52.04 9.63 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 119.909 -0.716 . . . . 0.0 109.09 170.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.519 ' HB3' ' HB3' ' A' ' 329' ' ' GLU . 9.2 ttp180 -143.66 121.15 11.72 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 172.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . 0.495 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -72.49 162.49 73.74 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.993 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . 0.625 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 5.7 Cg_exo -42.31 115.48 0.5 Allowed 'Trans proline' 0 C--N 1.358 1.072 0 C-N-CA 122.586 2.191 . . . . 0.0 112.846 -177.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' THR . . . . . 0.438 ' O ' HG21 ' A' ' 327' ' ' VAL . 45.6 m -131.08 136.95 48.87 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.532 -174.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -60.12 116.88 4.51 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 97.3 p -52.28 -53.57 42.34 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.185 0.517 . . . . 0.0 111.37 -167.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 141.88 -26.44 2.36 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.62 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 17.1 t60 -99.24 12.23 36.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.032 0.444 . . . . 0.0 110.039 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . 0.409 ' O ' HG23 ' A' ' 325' ' ' THR . 24.6 t70 86.86 53.74 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.878 175.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' THR . . . . . 0.409 HG23 ' O ' ' A' ' 324' ' ' ASP . 0.9 OUTLIER -158.58 -167.48 2.16 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 113.67 -1.605 . . . . 0.0 106.906 176.423 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . 0.721 ' HB ' ' HG3' ' A' ' 374' ' ' MET . 0.6 OUTLIER -125.72 145.89 32.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 119.704 1.138 . . . . 0.0 111.64 -178.689 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' VAL . . . . . 0.458 HG12 ' HG2' ' A' ' 373' ' ' GLU . 13.6 m -123.56 152.58 28.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.751 172.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' MET . . . . . 0.648 ' SD ' ' HB ' ' A' ' 372' ' ' ILE . 0.1 OUTLIER -142.4 149.69 39.68 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 173.152 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.54 ' HG2' ' HD3' ' A' ' 315' ' ' LYS . 46.6 tt0 -129.43 125.14 35.82 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.071 -175.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.51 HG12 HG13 ' A' ' 385' ' ' VAL . 2.8 m -129.97 146.84 33.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -174.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . 0.502 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -118.03 137.96 13.52 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.573 -176.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -89.43 156.33 18.75 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.894 0.854 . . . . 0.0 112.957 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 2.3 p -94.79 -19.56 20.23 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.496 -1.229 . . . . 0.0 113.813 171.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -176.23 -37.22 0.05 OUTLIER Glycine 0 CA--C 1.525 0.717 0 C-N-CA 118.979 -1.582 . . . . 0.0 114.991 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' THR . . . . . 0.691 ' HB ' ' SD ' ' A' ' 364' ' ' MET . 90.7 m -53.36 127.21 23.97 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.682 0.277 . . . . 0.0 111.192 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.537 ' HG3' ' HB3' ' A' ' 304' ' ' TYR . 2.0 ptm180 -91.69 179.67 1.34 Allowed Pre-proline 0 CA--C 1.534 0.333 0 CA-C-O 117.248 -1.358 . . . . 0.0 107.914 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . 0.557 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.2 OUTLIER -23.99 96.96 0.01 OUTLIER 'Trans proline' 0 C--N 1.375 1.935 0 C-N-CA 124.098 3.199 . . . . 0.0 114.501 -168.256 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 338' ' ' CYS . . . . . 0.776 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 2.2 p -111.17 -177.61 3.25 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 113.928 -1.487 . . . . 0.0 109.94 -172.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -109.93 99.84 8.9 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 176.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . 0.653 HG21 HG12 ' A' ' 342' ' ' VAL . 43.7 mt -74.42 118.78 72.65 Favored Pre-proline 0 C--N 1.327 -0.412 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.181 -168.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -76.89 80.53 2.82 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.373 2.049 . . . . 0.0 111.238 176.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.653 HG12 HG21 ' A' ' 340' ' ' ILE . 1.4 m -102.16 111.77 33.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 114.849 -1.068 . . . . 0.0 110.106 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -127.14 174.63 8.76 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 178.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 344' ' ' ALA . . . . . 0.6 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -146.53 145.63 30.21 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.474 176.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 11.5 m -117.72 145.46 23.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 177.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -66.51 119.2 11.25 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.375 175.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 347' ' ' HIS . . . . . 0.534 ' O ' HG21 ' A' ' 349' ' ' VAL . 20.7 t60 40.72 66.61 0.61 Allowed 'General case' 0 N--CA 1.474 0.775 0 O-C-N 124.491 1.119 . . . . 0.0 111.95 175.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . 0.575 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 47.32 34.17 8.57 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 115.271 0.869 . . . . 0.0 115.271 -178.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . 0.534 HG21 ' O ' ' A' ' 347' ' ' HIS . 63.7 t -135.7 102.81 10.27 Favored Pre-proline 0 C--O 1.233 0.235 0 CA-C-N 118.371 1.086 . . . . 0.0 108.685 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -74.54 62.35 5.42 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.866 2.377 . . . . 0.0 112.837 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -100.15 -56.26 2.41 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.5 p -120.65 128.9 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-N 115.113 -0.948 . . . . 0.0 110.36 173.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . 0.445 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 33.0 t30 -64.49 119.63 10.78 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.526 175.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.462 ' O ' ' HB2' ' A' ' 376' ' ' LEU . 29.1 m -98.32 6.22 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.94 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 355' ' ' ALA . . . . . 0.6 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -77.55 84.99 3.92 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.474 0.654 . . . . 0.0 111.142 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 356' ' ' MET . . . . . 0.573 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 21.4 ttt -99.3 100.11 11.15 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 106.16 -1.792 . . . . 0.0 106.16 171.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.609 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 47.1 mt -86.21 121.95 29.52 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.416 -160.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.678 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 3.2 mm -64.43 -28.98 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 108.137 -1.061 . . . . 0.0 108.137 174.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 86.4 m -123.46 84.52 52.64 Favored Pre-proline 0 N--CA 1.45 -0.438 0 CA-C-N 114.27 -1.332 . . . . 0.0 108.459 172.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -85.33 27.66 0.59 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.06 2.507 . . . . 0.0 114.287 -169.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 35.7 m-20 -149.2 66.31 8.48 Favored Pre-proline 0 C--N 1.315 -0.922 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.123 177.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . 0.868 ' HB3' HG21 ' A' ' 372' ' ' ILE . 75.9 Cg_endo -81.43 149.08 16.64 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.183 1.922 . . . . 0.0 112.666 178.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 363' ' ' THR . . . . . 0.466 HG21 ' O ' ' A' ' 338' ' ' CYS . 2.6 p -143.75 147.59 34.41 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.615 -174.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 364' ' ' MET . . . . . 0.776 ' HG2' ' SG ' ' A' ' 338' ' ' CYS . 10.3 ptp . . . . . 0 CA--C 1.497 -1.06 0 C-N-CA 119.444 -0.902 . . . . 0.0 108.911 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . 0.561 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -50.35 -42.01 41.32 Favored Glycine 0 CA--C 1.504 -0.611 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.04 172.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 82.33 -130.42 9.69 Favored Glycine 0 N--CA 1.436 -1.34 0 C-N-CA 120.11 -1.043 . . . . 0.0 110.76 -177.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -103.3 138.16 40.45 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.323 0.582 . . . . 0.0 111.25 -175.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 372' ' ' ILE . . . . . 0.868 HG21 ' HB3' ' A' ' 362' ' ' PRO . 0.1 OUTLIER -130.48 165.23 31.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.41 -0.814 . . . . 0.0 108.999 175.921 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . 0.678 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 43.2 mt-10 -132.96 128.69 37.0 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.096 0.474 . . . . 0.0 110.483 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 374' ' ' MET . . . . . 0.721 ' HG3' ' HB ' ' A' ' 326' ' ' VAL . 0.0 OUTLIER -133.95 165.67 24.48 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -178.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 375' ' ' GLN . . . . . 0.774 HE21 ' H ' ' A' ' 376' ' ' LEU . 14.2 tp60 -177.67 172.83 1.7 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.155 -0.684 . . . . 0.0 109.155 169.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 376' ' ' LEU . . . . . 0.774 ' H ' HE21 ' A' ' 375' ' ' GLN . 2.5 tm? -165.81 133.89 2.38 Favored Pre-proline 0 C--N 1.309 -1.163 0 N-CA-C 103.753 -2.684 . . . . 0.0 103.753 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 377' ' ' PRO . . . . . 0.75 ' HD2' HD22 ' A' ' 376' ' ' LEU . 34.6 Cg_exo -28.07 126.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.479 2.786 . . . . 0.0 112.586 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -35.12 134.03 0.18 Allowed 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 124.574 3.516 . . . . 0.0 113.358 -167.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 157.1 -170.62 34.38 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -162.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . 0.693 ' HA ' ' HA ' ' A' ' 393' ' ' PHE . 2.9 m-20 -89.85 120.02 30.73 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 117.509 0.654 . . . . 0.0 110.515 -177.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -125.28 166.78 15.9 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 176.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 0.965 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -160.57 139.83 3.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 169.694 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . 0.712 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 40.8 mt -99.64 125.06 53.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 C-N-CA 119.367 -0.933 . . . . 0.0 109.539 -175.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -101.07 92.36 4.97 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.29 171.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . 0.51 HG13 HG12 ' A' ' 330' ' ' VAL . 11.7 t -84.9 85.62 2.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 60.63 -112.57 4.71 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.508 -0.853 . . . . 0.0 111.329 -170.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 387' ' ' ASP . . . . . 0.507 ' HB2' ' HD3' ' A' ' 309' ' ' LYS . 3.5 t70 -83.18 -18.13 40.43 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.091 0.472 . . . . 0.0 110.512 177.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . 0.658 ' HG ' ' CE2' ' A' ' 314' ' ' TRP . 3.4 mp -72.06 156.58 39.05 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.894 177.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . 0.712 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 7.7 p30 -168.96 158.17 8.49 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.316 177.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . 0.625 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 37.5 t-80 -174.83 116.93 0.18 Allowed 'General case' 0 C--O 1.237 0.431 0 O-C-N 123.419 0.45 . . . . 0.0 110.011 175.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 391' ' ' GLN . . . . . 0.965 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 8.2 tt0 -77.6 153.27 33.4 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.019 0.438 . . . . 0.0 112.073 -179.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 392' ' ' TRP . . . . . 0.401 ' CD1' ' NE2' ' A' ' 394' ' ' GLN . 23.9 t-105 -179.49 115.27 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.873 178.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . 0.693 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 12.3 p90 -68.21 121.05 15.39 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.21 0.529 . . . . 0.0 110.249 172.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . 0.625 ' HG3' HE22 ' A' ' 375' ' ' GLN . 4.2 mm100 -84.27 119.09 24.64 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -172.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.496 ' HB3' ' HZ3' ' A' ' 395' ' ' LYS . 4.1 mmmp? . . . . . 0 C--O 1.246 0.919 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.393 -176.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' THR . . . . . 0.429 ' O ' HG21 ' A' ' 303' ' ' THR . 6.4 t . . . . . 0 CA--C 1.538 0.497 0 CA-C-O 121.602 0.715 . . . . 0.0 111.181 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . 0.529 ' HB3' ' NE ' ' A' ' 336' ' ' ARG . 33.5 p90 -76.75 126.46 31.03 Favored 'General case' 0 CA--C 1.516 -0.358 0 O-C-N 121.806 -0.558 . . . . 0.0 109.729 176.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' THR . . . . . 0.503 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 10.0 t -179.9 -173.91 0.25 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.245 -174.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.481 HG11 ' O ' ' A' ' 306' ' ' VAL . 7.5 p -63.09 111.54 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 167.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.67 144.25 51.12 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.377 -169.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . 0.471 ' OD2' HG21 ' A' ' 310' ' ' THR . 34.0 t70 -67.56 119.96 13.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.322 0.582 . . . . 0.0 110.448 -178.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.61 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -46.12 -12.17 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 -172.631 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.471 HG21 ' OD2' ' A' ' 308' ' ' ASP . 8.1 t -107.2 -0.67 22.52 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 119.079 0.854 . . . . 0.0 111.319 -175.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -83.85 -25.11 30.57 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -173.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.61 ' CZ ' ' HA ' ' A' ' 309' ' ' LYS . 0.1 OUTLIER -83.22 174.68 10.55 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.759 0.79 . . . . 0.0 111.155 176.882 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 14.7 t -149.78 159.67 44.16 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.542 -1.208 . . . . 0.0 108.769 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . 0.426 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 29.0 m-90 -69.17 117.64 11.07 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 121.353 0.597 . . . . 0.0 110.28 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.954 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 59.4 tttm -97.47 -47.81 5.53 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 173.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.535 HH21 HG23 ' A' ' 327' ' ' VAL . 41.1 ttp-105 -154.61 130.03 9.8 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.955 168.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . 0.572 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . . . -66.13 166.0 18.96 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.993 -178.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . 0.572 ' HD2' ' HB3' ' A' ' 317' ' ' ALA . 3.6 Cg_exo -44.3 116.27 0.99 Allowed 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.559 2.173 . . . . 0.0 112.368 178.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 55.0 m -128.7 132.18 48.0 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.466 -174.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.94 125.35 23.23 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 175.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' SER . . . . . 0.47 ' C ' ' H ' ' A' ' 323' ' ' HIS . 59.5 p -70.24 5.6 1.64 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 123.423 0.689 . . . . 0.0 112.489 -168.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 74.56 -25.58 1.12 Allowed Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.319 -169.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . 0.47 ' H ' ' C ' ' A' ' 321' ' ' SER . 2.2 t-160 -106.42 46.46 0.92 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.114 0.483 . . . . 0.0 109.98 -178.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 50.34 43.66 26.65 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 114.96 -1.018 . . . . 0.0 113.533 177.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' THR . . . . . 0.648 ' HA ' ' CG ' ' A' ' 375' ' ' GLN . 2.1 p -150.84 -168.12 3.01 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 174.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . 0.825 ' HB ' ' HG2' ' A' ' 374' ' ' MET . 0.2 OUTLIER -129.3 144.73 37.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 118.979 0.809 . . . . 0.0 111.019 179.707 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' VAL . . . . . 0.569 HG12 ' HG2' ' A' ' 373' ' ' GLU . 15.0 m -128.39 143.86 39.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.024 174.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' MET . . . . . 0.454 ' HE1' ' HD3' ' A' ' 318' ' ' PRO . 0.0 OUTLIER -135.04 149.46 50.13 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 178.297 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.954 ' HG2' ' HD3' ' A' ' 315' ' ' LYS . 7.7 tt0 -131.12 131.07 43.88 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 120.657 -0.417 . . . . 0.0 109.994 -173.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.651 HG13 HG13 ' A' ' 385' ' ' VAL . 0.0 OUTLIER -126.81 161.29 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -178.18 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . 0.53 ' HA2' ' CA ' ' A' ' 368' ' ' GLY . . . -127.69 137.8 10.05 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.729 175.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . 0.945 ' H ' ' HA2' ' A' ' 368' ' ' GLY . 0.2 OUTLIER -89.96 155.6 19.0 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.541 0.686 . . . . 0.0 111.807 179.185 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 2.6 p -95.84 -13.99 23.58 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 171.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -176.44 -40.72 0.05 OUTLIER Glycine 0 CA--C 1.528 0.859 0 C-N-CA 118.961 -1.59 . . . . 0.0 115.19 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' THR . . . . . 0.552 ' HB ' ' SD ' ' A' ' 364' ' ' MET . 82.8 m -52.78 132.84 37.11 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.823 0.344 . . . . 0.0 111.533 -177.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.854 HH21 ' HB2' ' A' ' 337' ' ' PRO . 0.2 OUTLIER -87.87 177.4 2.7 Favored Pre-proline 0 C--N 1.338 0.077 0 CA-C-O 117.389 -1.291 . . . . 0.0 107.875 -179.143 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . 0.854 ' HB2' HH21 ' A' ' 336' ' ' ARG . 1.0 OUTLIER -26.64 98.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.367 1.535 0 C-N-CA 123.723 2.949 . . . . 0.0 114.138 -174.432 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 338' ' ' CYS . . . . . 0.767 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 6.5 p -111.48 -176.19 2.88 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 113.559 -1.655 . . . . 0.0 110.376 -171.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -111.54 98.9 7.77 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 174.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . 0.764 ' HB ' ' HG2' ' A' ' 362' ' ' PRO . 68.5 mt -74.49 119.59 77.33 Favored Pre-proline 0 C--N 1.328 -0.338 0 O-C-N 123.416 0.448 . . . . 0.0 110.906 -171.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.2 82.32 2.4 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.928 2.419 . . . . 0.0 112.162 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.66 HG12 HG22 ' A' ' 340' ' ' ILE . 9.9 m -99.04 151.65 4.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.382 178.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 -162.34 171.34 17.37 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 176.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 344' ' ' ALA . . . . . 0.641 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -145.97 144.67 30.27 Favored 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.008 176.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.556 ' HB ' ' HA ' ' A' ' 350' ' ' PRO . 4.9 m -116.27 143.83 25.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 176.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -63.6 123.23 18.29 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 176.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 347' ' ' HIS . . . . . 0.502 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 37.2 t-80 42.52 62.97 1.55 Allowed 'General case' 0 N--CA 1.473 0.711 0 O-C-N 124.268 0.98 . . . . 0.0 112.749 170.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . 0.531 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 50.75 29.72 19.55 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 115.25 0.86 . . . . 0.0 115.25 -177.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . 0.5 HG21 ' O ' ' A' ' 347' ' ' HIS . 50.6 t -136.2 103.08 9.74 Favored Pre-proline 0 C--O 1.234 0.247 0 CA-C-N 118.267 1.033 . . . . 0.0 109.784 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 350' ' ' PRO . . . . . 0.556 ' HA ' ' HB ' ' A' ' 345' ' ' VAL . 17.1 Cg_exo -71.98 62.62 3.24 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 123.095 2.53 . . . . 0.0 112.884 178.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -100.12 -56.05 2.47 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 178.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 4.6 p -124.64 133.4 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.451 174.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -64.85 117.35 7.43 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.89 177.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.592 HG12 HD21 ' A' ' 376' ' ' LEU . 27.9 m -99.79 7.54 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.917 179.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 355' ' ' ALA . . . . . 0.641 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -78.62 82.94 4.83 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.029 0.443 . . . . 0.0 110.568 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 356' ' ' MET . . . . . 0.597 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 22.4 ttt -97.46 51.96 1.1 Allowed 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 175.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.76 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 11.7 mt -24.53 111.59 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 112.901 -1.954 . . . . 0.0 115.226 170.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.791 HD12 ' HB2' ' A' ' 375' ' ' GLN . 3.9 mm -60.36 -22.89 26.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 113.352 -1.749 . . . . 0.0 108.48 168.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 55.1 m -139.23 90.34 11.82 Favored Pre-proline 0 N--CA 1.451 -0.419 0 CA-C-N 114.265 -1.334 . . . . 0.0 108.648 177.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 360' ' ' PRO . . . . . 0.545 ' HA ' HD12 ' A' ' 357' ' ' LEU . 92.6 Cg_endo -82.17 45.34 1.91 Allowed 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 123.27 2.647 . . . . 0.0 114.445 -170.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -174.58 80.44 0.34 Allowed Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 120.958 0.408 . . . . 0.0 110.375 176.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . 0.764 ' HG2' ' HB ' ' A' ' 340' ' ' ILE . 95.3 Cg_endo -82.65 112.39 2.13 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.702 2.268 . . . . 0.0 111.932 176.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 363' ' ' THR . . . . . 0.412 HG21 ' O ' ' A' ' 338' ' ' CYS . 4.0 p -90.81 142.19 28.02 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.764 0.792 . . . . 0.0 112.5 173.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 364' ' ' MET . . . . . 0.845 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 5.2 ptp . . . . . 0 CA--C 1.504 -0.827 0 CA-C-N 114.067 -1.424 . . . . 0.0 109.457 178.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . 0.945 ' HA2' ' H ' ' A' ' 332' ' ' PHE . . . . . . . . 0 CA--C 1.504 -0.637 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . 0.593 ' HA3' HG21 ' A' ' 330' ' ' VAL . . . -104.37 3.27 43.37 Favored Glycine 0 C--N 1.317 -0.505 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 175.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 73.15 -93.38 0.68 Allowed Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 114.96 -0.62 . . . . 0.0 113.575 175.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -152.29 133.49 14.34 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.411 -0.395 . . . . 0.0 111.084 -170.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 372' ' ' ILE . . . . . 0.751 ' HB ' ' HE1' ' A' ' 374' ' ' MET . 0.7 OUTLIER -129.63 135.38 61.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 173.392 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . 0.569 ' HG2' HG12 ' A' ' 327' ' ' VAL . 40.9 mt-10 -122.43 126.72 48.53 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 374' ' ' MET . . . . . 0.825 ' HG2' ' HB ' ' A' ' 326' ' ' VAL . 0.1 OUTLIER -134.47 165.5 25.02 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 123.505 0.722 . . . . 0.0 110.718 -175.692 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 375' ' ' GLN . . . . . 0.864 HE21 ' HA ' ' A' ' 375' ' ' GLN . 0.0 OUTLIER -173.5 -173.81 0.93 Allowed 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.545 0.688 . . . . 0.0 111.668 162.835 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 376' ' ' LEU . . . . . 0.971 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 10.5 tp -166.15 166.97 9.04 Favored Pre-proline 0 N--CA 1.443 -0.79 0 N-CA-C 104.481 -2.415 . . . . 0.0 104.481 171.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 377' ' ' PRO . . . . . 0.971 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 2.9 Cg_endo -43.48 133.81 7.0 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 121.58 1.52 . . . . 0.0 110.684 167.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_exo -37.8 140.04 0.29 Allowed 'Trans proline' 0 C--N 1.358 1.077 0 C-N-CA 123.85 3.033 . . . . 0.0 112.371 -177.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 148.61 -169.45 29.16 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.122 -1.037 . . . . 0.0 110.565 -160.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . 0.502 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 2.2 m-20 -98.72 128.52 45.0 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 117.583 0.692 . . . . 0.0 111.29 -175.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -127.07 168.73 14.21 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 176.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 1.059 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -161.04 138.6 2.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 168.835 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . 0.735 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 17.3 mt -104.62 130.29 55.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 C-N-CA 119.928 -0.709 . . . . 0.0 109.418 -172.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 384' ' ' TYR . . . . . 0.53 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 3.5 m-85 -101.57 98.56 8.86 Favored 'General case' 0 N--CA 1.441 -0.884 0 O-C-N 124.318 1.011 . . . . 0.0 108.572 169.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . 0.651 HG13 HG13 ' A' ' 330' ' ' VAL . 25.9 t -86.63 84.71 2.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 175.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 62.15 -112.06 4.52 Favored Glycine 0 N--CA 1.439 -1.132 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 -169.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 387' ' ' ASP . . . . . 0.513 ' HB2' ' HD3' ' A' ' 309' ' ' LYS . 0.7 OUTLIER -85.03 -15.26 44.71 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.781 0.324 . . . . 0.0 110.947 177.426 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' A' ' 384' ' ' TYR . 3.3 mp -70.34 155.07 41.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.023 177.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . 0.735 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 6.4 p30 -167.12 157.01 10.97 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.808 -0.178 . . . . 0.0 110.898 175.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . 0.544 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 33.0 t-80 -175.03 123.19 0.24 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.852 175.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 391' ' ' GLN . . . . . 1.059 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 25.3 tt0 -78.52 153.61 31.15 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.066 0.46 . . . . 0.0 111.585 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 392' ' ' TRP . . . . . 0.485 ' N ' ' HG2' ' A' ' 391' ' ' GLN . 10.7 t-105 -166.36 145.87 5.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.605 174.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . 0.48 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 13.5 p90 -103.3 118.79 37.58 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . 0.785 ' HG3' HE22 ' A' ' 375' ' ' GLN . 3.0 mm100 -83.14 112.96 20.3 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -168.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.402 ' HE2' ' HB2' ' A' ' 395' ' ' LYS . 31.2 mtmm . . . . . 0 C--O 1.248 1.026 0 O-C-N 124.225 0.953 . . . . 0.0 111.462 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' THR . . . . . 0.604 HG21 HG23 ' A' ' 335' ' ' THR . 8.9 t . . . . . 0 CA--C 1.539 0.527 0 CA-C-O 121.575 0.702 . . . . 0.0 111.232 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -63.54 119.11 9.18 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 174.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' THR . . . . . 0.409 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 12.1 t 174.9 -168.33 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -172.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 36.4 t -65.22 106.95 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 169.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . 0.545 ' HB3' HG22 ' A' ' 335' ' ' THR . 0.5 OUTLIER -69.91 140.86 53.16 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.264 -167.892 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . 0.566 ' OD1' HG21 ' A' ' 310' ' ' THR . 14.0 t70 -63.41 132.68 52.23 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.953 -174.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.553 ' HD2' ' N ' ' A' ' 310' ' ' THR . 0.0 OUTLIER -41.5 -20.36 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 116.104 1.89 . . . . 0.0 116.104 -175.428 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.566 HG21 ' OD1' ' A' ' 308' ' ' ASP . 6.7 t -108.31 2.54 22.68 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 119.134 0.879 . . . . 0.0 112.196 -174.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 24.9 mmmt -74.01 -33.14 63.68 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -173.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.929 ' HD1' HD11 ' A' ' 388' ' ' LEU . 0.0 OUTLIER -86.08 175.18 8.69 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 122.006 0.908 . . . . 0.0 111.672 -175.992 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 11.1 t -144.3 155.45 43.83 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 113.871 -1.513 . . . . 0.0 107.755 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 16.4 m-90 -75.69 93.11 3.04 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.237 0.541 . . . . 0.0 109.598 178.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.437 ' HB3' ' C ' ' A' ' 329' ' ' GLU . 25.1 tptp -65.95 -43.82 86.84 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 170.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.461 ' NH2' HG22 ' A' ' 319' ' ' THR . 24.8 ttt180 -152.83 130.79 11.78 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.142 170.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . 0.438 ' HB2' ' CD2' ' A' ' 390' ' ' HIS . . . -69.5 159.04 85.26 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.649 -178.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . 0.773 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 78.7 Cg_exo -39.71 112.7 0.16 Allowed 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 122.65 2.234 . . . . 0.0 112.742 178.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' THR . . . . . 0.461 HG22 ' NH2' ' A' ' 316' ' ' ARG . 19.0 m -131.89 135.33 46.57 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.166 -173.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -57.38 124.13 17.86 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 84.5 p -62.16 -47.84 82.73 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.448 0.642 . . . . 0.0 110.014 -174.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 123.64 -14.62 8.09 Favored Glycine 0 N--CA 1.443 -0.892 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -111.86 53.09 0.73 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.284 0.564 . . . . 0.0 109.884 178.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 22.9 t70 57.28 33.94 24.04 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 114.746 -1.116 . . . . 0.0 112.464 177.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' THR . . . . . 0.53 ' HB ' HG13 ' A' ' 358' ' ' ILE . 10.0 p -152.5 -172.55 4.27 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . 0.405 HG12 ' HE3' ' A' ' 374' ' ' MET . 0.4 OUTLIER -132.12 145.45 34.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.338 0.59 . . . . 0.0 111.377 -177.216 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' VAL . . . . . 0.554 ' HA ' ' O ' ' A' ' 372' ' ' ILE . 15.8 m -127.11 155.94 38.34 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.895 176.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 5.0 ptm -142.09 159.43 42.24 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 167.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.535 ' HG3' ' O ' ' A' ' 370' ' ' GLY . 9.7 tt0 -124.45 129.39 50.57 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -176.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.561 HG21 ' HA3' ' A' ' 369' ' ' GLY . 3.1 m -125.55 146.19 31.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.88 -179.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . 0.685 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -124.47 140.42 12.55 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.116 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . 0.584 ' HD1' ' HA2' ' A' ' 368' ' ' GLY . 7.9 p90 -89.3 146.67 24.56 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.96 0.886 . . . . 0.0 111.69 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 28.2 t -86.84 -28.6 22.8 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.114 -1.403 . . . . 0.0 111.961 172.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -159.23 -44.58 0.02 OUTLIER Glycine 0 C--N 1.336 0.56 0 C-N-CA 119.605 -1.283 . . . . 0.0 113.917 -179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' THR . . . . . 0.604 HG23 HG21 ' A' ' 303' ' ' THR . 27.1 m -52.69 124.55 14.12 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 123.795 0.35 . . . . 0.0 110.949 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.573 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 33.3 ptt85 -87.29 -177.38 0.88 Allowed Pre-proline 0 CA--C 1.532 0.285 0 CA-C-O 117.089 -1.434 . . . . 0.0 108.37 -174.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . 0.774 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.1 OUTLIER -26.63 96.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 123.751 2.967 . . . . 0.0 114.151 -176.449 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 338' ' ' CYS . . . . . 0.493 ' SG ' ' HG3' ' A' ' 364' ' ' MET . 12.1 p -112.42 -176.83 3.01 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 113.515 -1.675 . . . . 0.0 110.074 -171.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 11.2 mpt_? -112.21 103.08 11.22 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 178.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . 0.805 HG23 HG12 ' A' ' 342' ' ' VAL . 29.7 mt -74.17 119.99 79.14 Favored Pre-proline 0 C--N 1.324 -0.508 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.486 -167.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.65 81.26 2.67 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.853 2.368 . . . . 0.0 111.561 177.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.805 HG12 HG23 ' A' ' 340' ' ' ILE . 4.6 m -102.41 155.38 5.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-O 121.747 0.784 . . . . 0.0 110.887 -178.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 22.4 ptt180 -166.31 174.94 8.63 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 344' ' ' ALA . . . . . 0.614 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -150.9 145.0 25.35 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.849 -0.74 . . . . 0.0 110.893 177.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 9.2 m -119.88 147.16 23.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -70.12 122.86 20.26 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 176.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 347' ' ' HIS . . . . . 0.504 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 47.2 t60 43.96 60.43 2.73 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 124.149 0.906 . . . . 0.0 111.413 174.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . 0.696 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 44.09 46.04 7.93 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 114.637 0.615 . . . . 0.0 114.637 -174.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . 0.417 HG21 ' O ' ' A' ' 347' ' ' HIS . 73.5 t -141.64 102.5 5.93 Favored Pre-proline 0 C--N 1.33 -0.251 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -76.15 49.7 2.64 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.603 2.202 . . . . 0.0 112.625 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -102.11 -5.54 24.36 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 2.6 p -169.8 106.31 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 114.561 -1.199 . . . . 0.0 110.055 -167.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . 0.451 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 38.1 t30 -64.74 111.78 2.93 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.688 178.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.524 ' HA ' HD22 ' A' ' 376' ' ' LEU . 31.5 m -91.2 -0.59 9.55 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.212 177.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 355' ' ' ALA . . . . . 0.614 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -74.25 84.55 1.89 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.213 0.53 . . . . 0.0 111.462 -176.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 356' ' ' MET . . . . . 0.654 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 47.6 ttp -97.9 101.14 12.56 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 168.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.513 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 27.6 mt -85.35 119.33 25.6 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.192 -163.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.709 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 2.5 mm -61.79 -28.98 45.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.506 175.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 22.4 m -130.14 90.08 43.2 Favored Pre-proline 0 N--CA 1.443 -0.8 0 CA-C-N 114.3 -1.318 . . . . 0.0 108.539 173.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -83.87 36.86 0.61 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.142 2.561 . . . . 0.0 113.055 -173.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -153.35 71.56 6.88 Favored Pre-proline 0 C--N 1.317 -0.83 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.257 175.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . 0.603 ' HB2' HD13 ' A' ' 340' ' ' ILE . 94.7 Cg_endo -81.43 145.02 14.68 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.568 2.179 . . . . 0.0 111.387 176.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 363' ' ' THR . . . . . 0.448 ' O ' ' HA2' ' A' ' 369' ' ' GLY . 0.5 OUTLIER -144.26 140.19 29.08 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 -173.008 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 364' ' ' MET . . . . . 0.774 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 41.4 mtm . . . . . 0 CA--C 1.492 -1.286 0 C-N-CA 119.398 -0.921 . . . . 0.0 109.198 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . 0.685 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . . . . . . 0 N--CA 1.449 -0.49 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . 0.585 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -46.84 -25.79 2.49 Favored Glycine 0 CA--C 1.522 0.504 0 CA-C-N 117.7 0.75 . . . . 0.0 114.517 174.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . 0.535 ' O ' ' HG3' ' A' ' 329' ' ' GLU . . . 77.35 -57.82 3.7 Favored Glycine 0 C--O 1.228 -0.228 0 C-N-CA 120.867 -0.682 . . . . 0.0 113.034 176.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -165.87 147.06 6.9 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.126 0.489 . . . . 0.0 111.431 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 372' ' ' ILE . . . . . 0.715 HD11 HG11 ' A' ' 342' ' ' VAL . 1.3 mt -131.6 140.03 49.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.448 170.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . 0.709 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 40.8 mt-10 -119.44 123.7 44.71 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.428 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 374' ' ' MET . . . . . 0.533 ' HG2' HD12 ' A' ' 383' ' ' ILE . 0.0 OUTLIER -138.63 164.38 29.64 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.817 -176.866 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 375' ' ' GLN . . . . . 0.943 HE21 ' HA ' ' A' ' 375' ' ' GLN . 0.0 OUTLIER 177.54 175.0 0.47 Allowed 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 173.585 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 376' ' ' LEU . . . . . 1.015 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 8.9 tp -166.88 173.59 3.05 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 177.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 377' ' ' PRO . . . . . 1.015 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 75.2 Cg_exo -41.08 127.61 2.8 Favored 'Trans proline' 0 C--N 1.348 0.5 0 CA-C-N 121.465 1.559 . . . . 0.0 111.225 166.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -41.67 148.16 0.34 Allowed 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 123.826 3.017 . . . . 0.0 112.568 -177.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 142.31 -163.75 27.06 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 119.763 -1.208 . . . . 0.0 111.07 -162.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . 0.584 ' C ' HD21 ' A' ' 381' ' ' ASN . 4.8 m-20 -89.44 115.87 27.2 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 117.32 0.56 . . . . 0.0 111.163 -176.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.584 HD21 ' C ' ' A' ' 380' ' ' ASP . 0.8 OUTLIER -126.62 147.55 49.89 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.039 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 1.001 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -148.71 137.73 15.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 176.609 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . 0.659 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 28.2 mt -99.49 132.69 44.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.206 -173.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 384' ' ' TYR . . . . . 0.611 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 1.8 m-85 -106.13 99.91 9.48 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.177 -1.374 . . . . 0.0 109.071 170.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . 0.743 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 2.8 t -84.83 86.61 2.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 174.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 60.42 -106.36 1.03 Allowed Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 120.003 -1.094 . . . . 0.0 110.718 -169.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 387' ' ' ASP . . . . . 0.436 ' HB2' ' HB2' ' A' ' 309' ' ' LYS . 17.8 t70 -89.97 -14.36 34.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.502 0.192 . . . . 0.0 111.325 176.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . 0.929 HD11 ' HD1' ' A' ' 312' ' ' PHE . 3.0 mp -67.67 153.82 42.85 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 176.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . 0.659 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 30.5 p-10 -163.75 154.42 15.78 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.017 176.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . 0.773 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 9.2 t60 -173.41 116.38 0.26 Allowed 'General case' 0 C--O 1.241 0.633 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 174.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 391' ' ' GLN . . . . . 1.001 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 8.6 tt0 -80.59 153.67 27.89 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.973 -177.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 392' ' ' TRP . . . . . 0.494 ' HD1' ' OE1' ' A' ' 394' ' ' GLN . 32.0 t-105 -166.09 153.15 9.77 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.964 -1.017 . . . . 0.0 109.208 -176.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -110.11 118.06 35.38 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . 0.902 ' HG3' HE22 ' A' ' 375' ' ' GLN . 4.0 mm100 -80.33 104.11 10.66 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -173.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.153 -0.927 . . . . 0.0 111.293 -174.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' THR . . . . . 0.475 ' O ' HG21 ' A' ' 303' ' ' THR . 10.2 t . . . . . 0 CA--C 1.536 0.416 0 CA-C-O 121.89 0.852 . . . . 0.0 111.374 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . 0.548 ' HB3' ' NE ' ' A' ' 336' ' ' ARG . 17.2 p90 -67.06 130.77 44.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.814 174.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' THR . . . . . 0.513 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 14.8 t 173.1 -169.17 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -175.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 41.3 t -66.43 112.42 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 169.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.0 140.41 57.71 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -172.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . 0.581 ' OD1' HG21 ' A' ' 310' ' ' THR . 12.5 t70 -62.24 130.92 47.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.538 0.685 . . . . 0.0 111.46 -170.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 18.3 pttm -38.47 -29.71 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 113.175 -1.829 . . . . 0.0 115.066 -177.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.581 HG21 ' OD1' ' A' ' 308' ' ' ASP . 12.0 t -108.37 0.28 21.07 Favored 'General case' 0 N--CA 1.443 -0.817 0 O-C-N 121.685 -0.634 . . . . 0.0 112.425 -170.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -84.87 -29.18 25.48 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -173.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.462 ' CD1' ' HE2' ' A' ' 364' ' ' MET . 0.1 OUTLIER -81.1 173.76 12.25 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.639 0.733 . . . . 0.0 111.012 -179.75 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 6.4 t -147.49 159.02 44.2 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.004 -178.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . 0.448 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 25.3 m-90 -71.03 122.02 19.28 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 178.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.712 ' HD3' ' HB3' ' A' ' 329' ' ' GLU . 70.8 tttt -102.52 -42.92 5.79 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 173.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.805 ' HB3' ' HB2' ' A' ' 329' ' ' GLU . 19.8 ttm-85 -149.39 128.15 12.5 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.85 169.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -71.52 158.73 87.32 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . 0.726 ' HD3' ' HE2' ' A' ' 328' ' ' MET . 3.3 Cg_exo -43.01 111.15 0.2 Allowed 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 122.65 2.233 . . . . 0.0 112.487 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' THR . . . . . 0.53 ' O ' HG21 ' A' ' 327' ' ' VAL . 32.2 m -129.26 131.27 46.98 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.624 -174.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -59.34 125.32 23.14 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 86.6 p -58.79 -45.08 90.67 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.832 -173.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 136.7 -3.52 3.52 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.363 176.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 6.3 t-80 -143.7 70.68 1.31 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.052 0.453 . . . . 0.0 110.304 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 58.31 30.14 19.11 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.01 -0.995 . . . . 0.0 113.666 175.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' THR . . . . . 0.622 ' HA ' ' CG ' ' A' ' 375' ' ' GLN . 11.1 p -153.48 179.2 9.02 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . 0.78 HG23 ' HG2' ' A' ' 375' ' ' GLN . 0.5 OUTLIER -134.03 144.76 34.57 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.404 0 CA-C-O 121.106 0.479 . . . . 0.0 111.142 -172.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' VAL . . . . . 0.573 HG12 ' HG3' ' A' ' 373' ' ' GLU . 14.1 m -118.86 155.52 21.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.662 175.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 328' ' ' MET . . . . . 0.726 ' HE2' ' HD3' ' A' ' 318' ' ' PRO . 0.0 OUTLIER -143.56 153.42 42.55 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 176.71 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.805 ' HB2' ' HB3' ' A' ' 316' ' ' ARG . 8.9 mt-10 -134.7 133.43 39.99 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.003 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.594 HG21 ' HA3' ' A' ' 369' ' ' GLY . 2.4 m -132.81 159.05 43.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.004 0.431 . . . . 0.0 111.853 -179.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . 0.464 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -129.27 136.21 8.86 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.19 -1.005 . . . . 0.0 112.582 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . 0.422 ' HD1' ' CA ' ' A' ' 368' ' ' GLY . 2.1 p90 -90.31 154.45 19.7 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.682 0.753 . . . . 0.0 111.807 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 27.6 p -119.1 30.69 7.02 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.528 -1.214 . . . . 0.0 112.515 173.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 164.65 -51.29 0.29 Allowed Glycine 0 C--O 1.225 -0.465 0 C-N-CA 119.388 -1.387 . . . . 0.0 114.122 169.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' THR . . . . . . . . . . . . . 2.8 m -55.79 124.47 17.63 Favored 'General case' 0 C--N 1.317 -0.827 0 O-C-N 123.695 0.291 . . . . 0.0 111.5 -178.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.711 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 5.5 ppt_? -80.66 -178.63 1.2 Allowed Pre-proline 0 N--CA 1.462 0.132 0 CA-C-O 116.921 -1.514 . . . . 0.0 107.843 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . 0.842 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.7 OUTLIER -24.35 96.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 123.566 2.844 . . . . 0.0 113.733 -179.083 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 338' ' ' CYS . . . . . 0.596 ' SG ' ' HB2' ' A' ' 364' ' ' MET . 18.3 p -117.76 -176.8 3.11 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.091 -1.868 . . . . 0.0 109.927 -168.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -110.35 103.76 12.46 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -178.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . 0.726 HG12 ' HG3' ' A' ' 364' ' ' MET . 55.4 mt -72.2 121.15 83.93 Favored Pre-proline 0 C--N 1.328 -0.364 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.48 -171.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 341' ' ' PRO . . . . . 0.456 ' O ' ' HA ' ' A' ' 385' ' ' VAL . 74.2 Cg_endo -79.83 77.9 3.9 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 121.556 1.504 . . . . 0.0 110.947 174.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.762 HG11 HG11 ' A' ' 385' ' ' VAL . 0.0 OUTLIER -105.08 117.66 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-O 122.238 1.018 . . . . 0.0 110.555 175.628 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.441 ' HG3' ' HB2' ' A' ' 384' ' ' TYR . 25.9 ptt180 -130.49 179.34 5.99 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 113.575 -1.648 . . . . 0.0 106.983 177.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 344' ' ' ALA . . . . . 0.563 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -149.29 147.66 28.62 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.963 175.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 10.5 m -119.52 141.7 38.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.53 116.68 7.05 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 347' ' ' HIS . . . . . 0.56 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 57.9 t-80 44.67 65.89 0.98 Allowed 'General case' 0 N--CA 1.472 0.626 0 O-C-N 124.345 1.028 . . . . 0.0 111.447 175.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . 0.5 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 42.97 41.14 4.47 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 115.096 0.799 . . . . 0.0 115.096 -175.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . 0.546 HG21 ' O ' ' A' ' 347' ' ' HIS . 87.6 t -140.5 102.49 6.58 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 118.112 0.956 . . . . 0.0 108.661 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -74.63 66.25 5.68 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 122.99 2.46 . . . . 0.0 113.376 -178.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -100.47 -57.79 2.04 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 174.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 5.9 p -116.98 130.69 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.641 174.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . 0.507 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 38.1 t30 -62.92 108.26 1.16 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.423 171.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.422 ' HB ' ' OD1' ' A' ' 381' ' ' ASN . 20.4 m -88.96 5.28 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.0 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 355' ' ' ALA . . . . . 0.563 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -77.46 82.03 3.92 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.317 0.58 . . . . 0.0 110.436 177.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 356' ' ' MET . . . . . 0.525 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 39.1 ttm -98.03 99.83 11.12 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 172.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.642 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 46.4 mt -85.15 146.71 26.98 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.38 -159.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.695 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 2.4 mm -90.81 -21.7 6.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 176.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 359' ' ' THR . . . . . 0.443 ' HG1' ' CD ' ' A' ' 373' ' ' GLU . 97.5 m -127.1 84.83 62.47 Favored Pre-proline 0 N--CA 1.446 -0.655 0 CA-C-N 113.216 -1.811 . . . . 0.0 108.257 172.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -80.62 27.6 0.56 Allowed 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.798 2.332 . . . . 0.0 112.758 -175.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -147.66 61.66 6.35 Favored Pre-proline 0 C--N 1.315 -0.901 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.512 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . 0.48 ' HB2' HD13 ' A' ' 340' ' ' ILE . 90.2 Cg_endo -85.11 102.39 0.78 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.124 1.883 . . . . 0.0 112.066 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 363' ' ' THR . . . . . 0.424 HG21 ' O ' ' A' ' 338' ' ' CYS . 1.3 p -93.04 168.87 10.84 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 122.05 0.929 . . . . 0.0 113.273 171.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 364' ' ' MET . . . . . 0.842 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 43.9 mtt . . . . . 0 CA--C 1.499 -0.989 0 CA-C-N 113.819 -1.537 . . . . 0.0 109.324 174.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . 0.464 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . . . . . . 0 N--CA 1.452 -0.271 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . 0.594 ' HA3' HG21 ' A' ' 330' ' ' VAL . . . -70.62 95.65 0.54 Allowed Glycine 0 CA--C 1.507 -0.425 0 C-N-CA 120.081 -1.057 . . . . 0.0 110.78 168.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -70.94 -27.17 72.67 Favored Glycine 0 C--N 1.313 -0.71 0 CA-C-N 115.166 -0.517 . . . . 0.0 112.939 -166.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -164.44 136.71 4.71 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.942 0.401 . . . . 0.0 110.685 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 372' ' ' ILE . . . . . 0.596 HG13 ' CG ' ' A' ' 328' ' ' MET . 0.4 OUTLIER -127.31 145.4 34.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 173.005 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . 0.695 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 3.8 mp0 -127.38 127.09 43.63 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 175.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 374' ' ' MET . . . . . 0.688 ' HG2' HD12 ' A' ' 383' ' ' ILE . 4.3 ppp? -138.3 166.83 23.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.926 -175.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 375' ' ' GLN . . . . . 0.78 ' HG2' HG23 ' A' ' 326' ' ' VAL . 0.0 OUTLIER -173.9 175.32 2.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.194 0.521 . . . . 0.0 110.59 165.945 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 376' ' ' LEU . . . . . 0.71 HD22 ' HD2' ' A' ' 377' ' ' PRO . 2.2 tm? -167.79 129.42 1.22 Allowed Pre-proline 0 C--N 1.315 -0.903 0 N-CA-C 105.11 -2.181 . . . . 0.0 105.11 176.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 377' ' ' PRO . . . . . 0.71 ' HD2' HD22 ' A' ' 376' ' ' LEU . 58.7 Cg_exo -24.97 125.79 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 124.503 3.469 . . . . 0.0 112.874 -179.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -35.51 134.42 0.22 Allowed 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 124.82 3.68 . . . . 0.0 113.019 -165.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 157.7 -171.79 34.88 Favored Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -159.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . 0.56 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 5.7 m-20 -97.07 127.46 43.06 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 117.494 0.647 . . . . 0.0 110.342 -178.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.52 HD21 ' HG2' ' A' ' 394' ' ' GLN . 25.5 m-80 -131.09 168.56 17.21 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 1.043 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -158.87 140.18 4.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 169.775 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . 0.688 HD12 ' HG2' ' A' ' 374' ' ' MET . 44.3 mt -99.82 130.44 48.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 C-N-CA 119.656 -0.818 . . . . 0.0 109.473 -175.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 384' ' ' TYR . . . . . 0.453 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 2.5 m-85 -100.95 136.6 40.55 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 169.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . 0.762 HG11 HG11 ' A' ' 342' ' ' VAL . 6.1 t -126.67 85.47 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 176.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 66.56 -109.75 3.09 Favored Glycine 0 N--CA 1.435 -1.432 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 -166.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -95.47 -7.52 37.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.856 0.328 . . . . 0.0 111.883 172.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . 0.477 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 1.4 mp -66.05 150.07 49.27 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 173.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . 0.532 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 7.7 p30 -166.05 154.78 11.22 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 121.275 -0.17 . . . . 0.0 110.669 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . 0.505 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 3.9 t60 -173.49 116.34 0.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.145 176.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 391' ' ' GLN . . . . . 1.043 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 6.3 tt0 -77.64 153.85 32.78 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.209 0.528 . . . . 0.0 112.364 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 392' ' ' TRP . . . . . 0.446 ' HD1' ' OE1' ' A' ' 394' ' ' GLN . 17.1 t-105 -169.53 147.71 3.61 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.054 176.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . 0.51 ' HB2' ' HE3' ' A' ' 395' ' ' LYS . 5.9 p90 -102.27 114.9 29.46 Favored 'General case' 0 C--N 1.313 -0.987 0 O-C-N 121.408 -0.807 . . . . 0.0 109.023 -178.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . 0.753 ' HG3' HE22 ' A' ' 375' ' ' GLN . 2.8 mm100 -83.23 107.17 15.59 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -171.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.51 ' HE3' ' HB2' ' A' ' 393' ' ' PHE . 33.7 mmtp . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.022 -0.989 . . . . 0.0 109.965 -172.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 2.4 t . . . . . 0 CA--C 1.534 0.362 0 CA-C-O 121.306 0.574 . . . . 0.0 111.753 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . 0.514 ' HB3' ' NE ' ' A' ' 336' ' ' ARG . 21.7 p90 -63.11 124.27 20.72 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.931 0.396 . . . . 0.0 110.563 172.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' THR . . . . . 0.584 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 9.7 t -179.85 -176.75 0.36 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -176.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 47.8 t -64.21 112.69 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 166.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . 0.678 ' HB2' ' CZ ' ' A' ' 332' ' ' PHE . 0.0 OUTLIER -68.16 138.55 55.76 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.032 0.444 . . . . 0.0 110.456 -171.088 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . 0.582 ' OD2' HG21 ' A' ' 310' ' ' THR . 14.7 t70 -61.32 133.12 55.51 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.01 -171.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.432 ' O ' ' CE1' ' A' ' 312' ' ' PHE . 22.1 pttp -38.59 -28.94 0.03 OUTLIER 'General case' 0 C--O 1.22 -0.5 0 CA-C-N 113.097 -1.865 . . . . 0.0 114.973 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.582 HG21 ' OD2' ' A' ' 308' ' ' ASP . 13.5 t -109.05 10.4 26.13 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 119.286 0.948 . . . . 0.0 113.192 -169.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . 0.488 ' HB2' ' CE2' ' A' ' 332' ' ' PHE . 28.6 mtpp -96.02 -19.76 19.22 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 -174.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.723 ' HD2' ' HE1' ' A' ' 332' ' ' PHE . 0.3 OUTLIER -86.43 173.0 9.95 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.937 0.875 . . . . 0.0 111.882 177.124 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 8.9 t -153.34 162.11 41.63 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 113.981 -1.463 . . . . 0.0 109.131 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 14.5 m-90 -76.17 95.47 3.69 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 120.884 0.373 . . . . 0.0 110.38 -177.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.544 ' HB3' ' HB3' ' A' ' 329' ' ' GLU . 59.4 tttm -65.68 -46.62 78.39 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 165.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.599 ' HB3' ' HB2' ' A' ' 329' ' ' GLU . 40.7 ttt180 -153.09 128.32 9.81 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 114.45 -1.25 . . . . 0.0 108.864 169.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . 0.502 ' HB3' ' CG ' ' A' ' 390' ' ' HIS . . . -74.45 160.93 80.09 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-O 118.757 -0.64 . . . . 0.0 109.871 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . 0.934 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 85.5 Cg_exo -36.87 108.87 0.06 OUTLIER 'Trans proline' 0 C--N 1.362 1.282 0 C-N-CA 123.149 2.566 . . . . 0.0 113.36 -178.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' THR . . . . . 0.442 ' O ' HG21 ' A' ' 327' ' ' VAL . 18.6 m -127.44 132.86 49.99 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.944 -175.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . 0.552 ' HB2' ' CZ2' ' A' ' 392' ' ' TRP . 13.5 t70 -55.61 124.95 19.06 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 60.0 p -62.98 -46.73 86.32 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.411 0.624 . . . . 0.0 110.116 -173.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 122.8 -7.94 9.38 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -124.47 56.79 1.27 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.141 -0.529 . . . . 0.0 110.703 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . 0.571 ' HA ' ' HD3' ' A' ' 395' ' ' LYS . 21.5 m-20 56.87 31.19 19.22 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.458 176.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' THR . . . . . 0.524 ' HB ' HG13 ' A' ' 358' ' ' ILE . 15.7 p -150.67 -179.26 7.1 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -178.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 1.3 t -129.57 144.42 38.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.178 0.513 . . . . 0.0 110.973 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 327' ' ' VAL . . . . . 0.559 HG12 ' HG2' ' A' ' 373' ' ' GLU . 16.7 m -120.06 154.48 23.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.336 176.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 328' ' ' MET . . . . . 0.489 ' SD ' HG11 ' A' ' 330' ' ' VAL . 0.0 OUTLIER -143.15 147.07 34.35 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 176.722 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.599 ' HB2' ' HB3' ' A' ' 316' ' ' ARG . 9.0 mt-10 -130.32 128.13 40.88 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 121.076 0.465 . . . . 0.0 110.957 -176.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.489 HG11 ' SD ' ' A' ' 328' ' ' MET . 0.0 OUTLIER -128.35 149.8 33.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.928 -175.971 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . 0.634 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -128.72 141.78 12.9 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.503 -0.856 . . . . 0.0 113.094 -179.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . 0.723 ' HE1' ' HD2' ' A' ' 312' ' ' PHE . 3.5 m-85 -112.81 178.03 4.43 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.358 0.663 . . . . 0.0 111.041 174.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 50.7 m -136.03 4.41 2.98 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 170.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -145.68 -62.93 0.01 OUTLIER Glycine 0 C--N 1.34 0.767 0 C-N-CA 119.029 -1.558 . . . . 0.0 114.768 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' THR . . . . . 0.467 HG21 ' HB3' ' A' ' 338' ' ' CYS . 13.9 m -53.95 132.46 42.16 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.122 0.487 . . . . 0.0 111.11 -175.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.868 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 2.8 ptm180 -82.29 -176.76 0.83 Allowed Pre-proline 0 C--O 1.226 -0.133 0 CA-C-O 117.981 -1.009 . . . . 0.0 108.952 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . 0.868 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.4 OUTLIER -31.7 98.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 123.264 2.643 . . . . 0.0 112.802 174.172 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 338' ' ' CYS . . . . . 0.592 ' O ' HG21 ' A' ' 363' ' ' THR . 26.3 p -119.91 -174.25 2.72 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 113.522 -1.672 . . . . 0.0 109.578 -170.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -108.96 107.12 17.37 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -178.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . 0.884 HD13 ' HB2' ' A' ' 362' ' ' PRO . 32.9 mt -73.26 120.12 79.37 Favored Pre-proline 0 C--N 1.329 -0.313 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.963 -173.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -77.11 80.36 2.89 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.187 1.925 . . . . 0.0 111.202 175.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.69 HG11 HG22 ' A' ' 340' ' ' ILE . 11.7 m -97.41 146.3 7.89 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.662 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.091 178.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.443 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 24.4 ptt180 -163.82 171.98 14.72 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 172.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 344' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -147.97 143.66 27.46 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.797 177.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.432 ' HB ' ' HA ' ' A' ' 350' ' ' PRO . 6.2 m -115.96 144.39 23.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -63.23 117.13 6.14 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.279 -0.418 . . . . 0.0 112.014 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 347' ' ' HIS . . . . . 0.722 ' HB3' ' CB ' ' A' ' 380' ' ' ASP . 11.6 p80 30.37 75.5 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 O-C-N 124.721 1.263 . . . . 0.0 113.671 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . 0.811 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 53.64 28.44 37.83 Favored Glycine 0 CA--C 1.519 0.337 0 N-CA-C 115.69 1.036 . . . . 0.0 115.69 178.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . 0.455 HG21 ' O ' ' A' ' 347' ' ' HIS . 46.9 t -137.15 101.79 9.2 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 118.948 1.374 . . . . 0.0 108.731 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 350' ' ' PRO . . . . . 0.432 ' HA ' ' HB ' ' A' ' 345' ' ' VAL . 15.2 Cg_exo -73.06 66.51 4.17 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 123.112 2.542 . . . . 0.0 112.865 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -99.87 -55.39 2.66 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.282 -1.006 . . . . 0.0 108.282 177.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 4.7 p -130.1 136.2 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.215 174.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . 0.464 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 52.1 t30 -63.18 117.82 7.07 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.187 177.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 30.5 m -95.25 5.1 8.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.844 176.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 355' ' ' ALA . . . . . 0.464 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -77.47 84.16 3.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.235 0.541 . . . . 0.0 111.405 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.94 102.9 14.77 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 170.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.55 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 32.3 mt -83.45 117.93 23.4 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.41 -162.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.664 HD12 ' HB3' ' A' ' 375' ' ' GLN . 4.4 mm -59.54 -29.12 41.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.358 173.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 12.6 m -131.91 94.12 25.55 Favored Pre-proline 0 N--CA 1.446 -0.672 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.573 172.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -81.83 34.6 0.55 Allowed 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 123.522 2.815 . . . . 0.0 112.899 -173.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -151.63 70.68 8.11 Favored Pre-proline 0 C--N 1.316 -0.889 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.98 177.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . 0.941 ' HB3' HG21 ' A' ' 372' ' ' ILE . 60.3 Cg_endo -80.88 141.02 13.1 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.313 2.008 . . . . 0.0 111.314 175.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 363' ' ' THR . . . . . 0.598 ' O ' ' HA2' ' A' ' 369' ' ' GLY . 1.0 OUTLIER -143.66 143.25 31.36 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -174.11 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 364' ' ' MET . . . . . 0.76 ' HA ' ' HA2' ' A' ' 369' ' ' GLY . 5.2 mmt . . . . . 0 CA--C 1.5 -0.954 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . 0.634 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . . . . . . 0 N--CA 1.453 -0.207 0 N-CA-C 112.257 -0.337 . . . . 0.0 112.257 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . 0.76 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -68.07 -24.99 74.58 Favored Glycine 0 C--N 1.333 0.368 0 N-CA-C 114.132 0.413 . . . . 0.0 114.132 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . 0.567 ' O ' ' HG2' ' A' ' 329' ' ' GLU . . . 85.37 -58.15 4.91 Favored Glycine 0 C--N 1.318 -0.417 0 C-N-CA 120.143 -1.027 . . . . 0.0 113.313 178.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -165.87 145.84 6.45 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.14 0.495 . . . . 0.0 112.173 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 372' ' ' ILE . . . . . 0.941 HG21 ' HB3' ' A' ' 362' ' ' PRO . 0.7 OUTLIER -136.13 156.25 36.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.451 171.441 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . 0.593 ' CB ' ' HB ' ' A' ' 358' ' ' ILE . 42.5 mt-10 -134.4 126.54 29.77 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -178.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 374' ' ' MET . . . . . 0.55 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 2.9 mtt -142.65 165.03 28.49 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -176.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 375' ' ' GLN . . . . . 0.775 HE21 ' HA ' ' A' ' 375' ' ' GLN . 0.0 OUTLIER -178.62 173.45 1.3 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.784 0.326 . . . . 0.0 110.296 176.981 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 376' ' ' LEU . . . . . 0.691 HD21 ' HD2' ' A' ' 377' ' ' PRO . 2.0 tm? -165.62 139.62 3.79 Favored Pre-proline 0 C--N 1.318 -0.785 0 N-CA-C 104.44 -2.43 . . . . 0.0 104.44 -177.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 377' ' ' PRO . . . . . 0.691 ' HD2' HD21 ' A' ' 376' ' ' LEU . 37.8 Cg_exo -33.89 129.63 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.761 2.307 . . . . 0.0 112.299 175.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . 0.699 ' HA ' HE22 ' A' ' 394' ' ' GLN . 75.8 Cg_exo -34.03 138.85 0.08 OUTLIER 'Trans proline' 0 C--N 1.362 1.243 0 C-N-CA 124.926 3.75 . . . . 0.0 113.932 -170.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 155.32 -158.38 28.38 Favored Glycine 0 N--CA 1.441 -0.975 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 -163.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . 0.722 ' CB ' ' HB3' ' A' ' 347' ' ' HIS . 8.9 m-20 -109.32 132.79 53.8 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 118.149 0.974 . . . . 0.0 111.522 175.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -126.25 168.7 13.73 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 176.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 1.053 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -160.05 138.49 2.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 168.048 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . 0.605 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 57.6 mt -99.16 128.81 50.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 C-N-CA 120.074 -0.65 . . . . 0.0 109.926 -173.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 384' ' ' TYR . . . . . 0.443 ' O ' ' HG2' ' A' ' 343' ' ' ARG . 0.2 OUTLIER -104.26 99.57 9.29 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 114.302 -1.317 . . . . 0.0 108.791 170.771 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . 0.49 ' O ' ' HB2' ' A' ' 388' ' ' LEU . 11.5 t -94.77 88.21 2.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 174.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 67.82 -116.99 8.24 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.123 -1.037 . . . . 0.0 110.851 -174.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -92.43 -4.26 53.98 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 117.783 0.792 . . . . 0.0 111.684 171.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . 0.686 HD12 ' HD1' ' A' ' 312' ' ' PHE . 2.5 mp -71.15 150.79 45.05 Favored 'General case' 0 CA--C 1.522 -0.113 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 172.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . 0.605 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 7.3 p30 -164.44 152.22 12.11 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.651 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . 0.934 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 30.5 t60 -175.56 119.5 0.17 Allowed 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.493 0.495 . . . . 0.0 110.4 176.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 391' ' ' GLN . . . . . 1.053 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 15.0 tt0 -78.03 153.24 32.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.404 0.621 . . . . 0.0 112.582 -179.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 392' ' ' TRP . . . . . 0.552 ' CZ2' ' HB2' ' A' ' 320' ' ' ASP . 52.7 t-105 -153.49 143.59 22.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.884 178.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -104.48 110.03 22.14 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 176.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . 0.699 HE22 ' HA ' ' A' ' 378' ' ' PRO . 0.0 OUTLIER -101.23 134.34 44.43 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 121.822 -0.549 . . . . 0.0 111.617 -164.847 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.571 ' HD3' ' HA ' ' A' ' 324' ' ' ASP . 13.2 mmmm . . . . . 0 C--O 1.245 0.824 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.794 -178.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 7.5 t . . . . . 0 CA--C 1.537 0.446 0 CA-C-O 121.12 0.486 . . . . 0.0 111.799 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . 0.619 ' HB2' ' O ' ' A' ' 337' ' ' PRO . 39.7 p90 -67.1 129.59 40.38 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' THR . . . . . 0.459 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 12.4 t 173.02 -167.18 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -170.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.467 HG11 ' O ' ' A' ' 306' ' ' VAL . 7.8 p -62.09 112.17 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 172.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -73.54 137.75 44.56 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.175 -173.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . 0.732 ' OD1' HG21 ' A' ' 310' ' ' THR . 9.4 t70 -60.36 119.9 8.84 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.034 177.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.444 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 29.0 pttt -42.09 -22.45 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 115.961 1.837 . . . . 0.0 115.961 -175.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.732 HG21 ' OD1' ' A' ' 308' ' ' ASP . 6.2 t -107.54 12.44 27.73 Favored 'General case' 0 C--N 1.314 -0.959 0 O-C-N 121.331 -0.856 . . . . 0.0 111.206 -170.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . 0.453 ' HE3' ' OG1' ' A' ' 335' ' ' THR . 19.9 mtmm -96.37 -22.94 16.87 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -174.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.546 ' HD2' ' HE3' ' A' ' 364' ' ' MET . 0.1 OUTLIER -85.86 174.62 9.17 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.517 0.675 . . . . 0.0 110.957 176.678 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 13.2 t -147.83 158.46 44.04 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.34 -177.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . 0.499 ' HZ3' ' HB2' ' A' ' 328' ' ' MET . 19.2 m95 -79.44 95.61 5.83 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-O 121.018 0.437 . . . . 0.0 110.775 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.546 ' HG2' ' OE1' ' A' ' 329' ' ' GLU . 4.3 ttpp -69.91 -43.49 71.6 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 169.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 3.8 ttm180 -153.04 101.85 2.6 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.634 174.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -41.49 154.77 0.23 Allowed Pre-proline 0 N--CA 1.476 0.83 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 171.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 3.8 Cg_exo -38.17 114.17 0.16 Allowed 'Trans proline' 0 C--N 1.366 1.493 0 C-N-CA 123.777 2.985 . . . . 0.0 113.228 -176.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' THR . . . . . 0.52 ' O ' HG21 ' A' ' 327' ' ' VAL . 16.9 m -134.38 137.39 44.07 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.32 -174.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -59.17 131.32 50.67 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -177.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' SER . . . . . 0.442 ' C ' ' H ' ' A' ' 323' ' ' HIS . 51.5 p -80.34 5.86 13.66 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 122.149 -0.344 . . . . 0.0 111.6 -175.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 74.0 -22.34 1.22 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.105 -175.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . 0.442 ' H ' ' C ' ' A' ' 321' ' ' SER . 94.7 m-70 -102.33 47.77 0.89 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.381 0.61 . . . . 0.0 110.328 -177.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . 0.453 ' O ' HG23 ' A' ' 325' ' ' THR . 4.9 t70 55.94 39.18 30.59 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 114.403 -1.272 . . . . 0.0 111.659 174.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 324' ' ' ASP . 4.0 p -160.29 -171.59 3.24 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . 0.767 ' HB ' ' SD ' ' A' ' 374' ' ' MET . 0.3 OUTLIER -132.57 146.2 33.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.546 0.689 . . . . 0.0 111.558 -175.125 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 327' ' ' VAL . . . . . 0.576 HG12 ' HG2' ' A' ' 373' ' ' GLU . 14.9 m -122.61 157.81 27.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.276 175.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 328' ' ' MET . . . . . 0.765 ' HE3' ' HB ' ' A' ' 372' ' ' ILE . 0.0 OUTLIER -135.62 146.67 48.14 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 173.223 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.546 ' OE1' ' HG2' ' A' ' 315' ' ' LYS . 9.5 tt0 -120.67 122.4 40.39 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -177.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 2.7 m -128.76 151.56 35.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.521 0.201 . . . . 0.0 111.301 -176.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . 0.792 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -126.84 139.4 11.22 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.478 -177.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . 0.438 ' H ' ' CA ' ' A' ' 368' ' ' GLY . 0.8 OUTLIER -89.37 152.88 21.27 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.367 0.603 . . . . 0.0 111.858 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 8.7 t -107.39 2.12 24.15 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 174.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -173.38 -63.6 0.05 OUTLIER Glycine 0 C--N 1.341 0.834 0 C-N-CA 118.676 -1.726 . . . . 0.0 115.144 175.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 335' ' ' THR . . . . . 0.453 ' OG1' ' HE3' ' A' ' 311' ' ' LYS . 51.5 m -52.46 134.13 34.96 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 123.805 0.356 . . . . 0.0 111.251 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.624 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 16.1 ptt180 -90.62 -175.95 0.58 Allowed Pre-proline 0 CA--C 1.536 0.429 0 CA-C-O 117.212 -1.375 . . . . 0.0 108.624 -175.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . 0.703 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.1 OUTLIER -24.07 96.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 124.061 3.174 . . . . 0.0 114.65 -170.869 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 338' ' ' CYS . . . . . 0.741 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 3.9 p -109.95 -176.05 2.9 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 113.719 -1.582 . . . . 0.0 110.32 -169.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -112.16 96.3 5.95 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 177.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . 0.744 ' HB ' ' HG2' ' A' ' 362' ' ' PRO . 61.9 mt -78.18 118.86 74.79 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.302 -169.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -79.65 82.46 2.49 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.837 2.358 . . . . 0.0 111.903 177.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.734 HG12 HG21 ' A' ' 340' ' ' ILE . 4.2 m -100.94 123.68 54.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.504 0.669 . . . . 0.0 110.669 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -132.07 173.97 10.67 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 176.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 344' ' ' ALA . . . . . 0.64 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -144.96 140.97 28.6 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.718 175.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.414 HG21 HG21 ' A' ' 382' ' ' ILE . 10.6 m -114.62 140.59 34.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . 0.539 ' HB2' HG13 ' A' ' 354' ' ' VAL . . . -67.62 121.4 15.81 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 347' ' ' HIS . . . . . 0.567 ' O ' HG21 ' A' ' 349' ' ' VAL . 6.9 t60 46.62 59.79 3.7 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 124.336 1.022 . . . . 0.0 111.038 174.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 45.86 39.16 8.4 Favored Glycine 0 C--N 1.335 0.515 0 N-CA-C 115.097 0.799 . . . . 0.0 115.097 -174.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . 0.567 HG21 ' O ' ' A' ' 347' ' ' HIS . 58.9 t -137.35 102.19 8.94 Favored Pre-proline 0 C--O 1.235 0.301 0 CA-C-N 118.219 1.009 . . . . 0.0 108.949 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 350' ' ' PRO . . . . . 0.413 ' HA ' ' HB ' ' A' ' 345' ' ' VAL . 9.0 Cg_exo -75.82 61.38 6.28 Favored 'Trans proline' 0 N--CA 1.464 -0.209 0 C-N-CA 122.802 2.334 . . . . 0.0 113.245 -178.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -100.51 -56.76 2.26 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 175.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 2.3 p -117.48 127.49 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.535 174.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -63.38 112.08 2.57 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.774 175.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.681 HG12 ' HG ' ' A' ' 376' ' ' LEU . 4.2 m -92.68 9.02 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.713 177.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 355' ' ' ALA . . . . . 0.64 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -79.17 82.97 5.28 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.147 0.498 . . . . 0.0 111.041 176.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 5.4 tmm? -92.92 100.5 12.95 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 169.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.447 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 22.2 mt -86.89 117.87 25.9 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.072 -163.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.705 ' HB ' ' CB ' ' A' ' 373' ' ' GLU . 2.7 mm -61.46 -25.03 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.632 175.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 19.5 m -138.91 93.72 10.41 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.828 173.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -88.61 41.1 0.57 Allowed 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 123.275 2.65 . . . . 0.0 114.063 -171.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -161.83 72.48 2.41 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-O 121.235 0.54 . . . . 0.0 109.779 175.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . 0.795 ' HB3' HG21 ' A' ' 372' ' ' ILE . 87.8 Cg_endo -82.58 108.57 1.71 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.79 2.327 . . . . 0.0 112.302 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 16.8 p -89.78 144.28 26.1 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.671 0.748 . . . . 0.0 112.326 171.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 364' ' ' MET . . . . . 0.741 ' HG2' ' SG ' ' A' ' 338' ' ' CYS . 5.7 ptp . . . . . 0 CA--C 1.499 -0.981 0 CA-C-N 114.387 -1.279 . . . . 0.0 108.153 174.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . 0.792 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . . . . . . 0 N--CA 1.444 -0.817 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . 0.434 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -48.23 -34.31 12.47 Favored Glycine 0 CA--C 1.519 0.313 0 CA-C-N 117.725 0.763 . . . . 0.0 113.303 172.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . 0.467 ' O ' ' HG3' ' A' ' 329' ' ' GLU . . . 81.53 -58.17 4.88 Favored Glycine 0 C--O 1.227 -0.314 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.584 176.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -165.19 137.82 4.42 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.043 0.449 . . . . 0.0 111.125 178.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 372' ' ' ILE . . . . . 0.795 HG21 ' HB3' ' A' ' 362' ' ' PRO . 0.9 OUTLIER -134.4 159.1 42.12 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 172.846 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . 0.705 ' CB ' ' HB ' ' A' ' 358' ' ' ILE . 36.5 mt-10 -128.21 125.92 39.94 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.581 -177.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 374' ' ' MET . . . . . 0.767 ' SD ' ' HB ' ' A' ' 326' ' ' VAL . 0.0 OUTLIER -136.43 160.37 38.97 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -179.083 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 375' ' ' GLN . . . . . 0.826 HE21 ' HA ' ' A' ' 375' ' ' GLN . 0.0 OUTLIER -177.91 170.11 1.93 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.918 0.39 . . . . 0.0 110.208 172.592 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 376' ' ' LEU . . . . . 0.722 HD21 ' HD2' ' A' ' 377' ' ' PRO . 2.3 tm? -166.93 131.81 1.66 Allowed Pre-proline 0 N--CA 1.439 -0.991 0 N-CA-C 104.537 -2.394 . . . . 0.0 104.537 -178.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 377' ' ' PRO . . . . . 0.722 ' HD2' HD21 ' A' ' 376' ' ' LEU . 35.7 Cg_exo -28.95 131.0 0.04 OUTLIER 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 123.788 2.992 . . . . 0.0 112.811 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -35.56 138.21 0.15 Allowed 'Trans proline' 0 C--N 1.359 1.106 0 C-N-CA 124.658 3.572 . . . . 0.0 113.582 -166.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 151.87 -165.07 30.56 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 -160.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . 0.46 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 15.8 m-20 -99.7 128.78 45.8 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 117.925 0.862 . . . . 0.0 111.23 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.411 HD22 ' HB3' ' A' ' 376' ' ' LEU . 9.5 m120 -128.43 159.79 34.3 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 174.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 1.054 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -150.55 139.1 14.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 170.313 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . 0.656 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 31.5 mt -99.51 127.02 52.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.44 -176.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 384' ' ' TYR . . . . . 0.426 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.2 OUTLIER -104.41 92.54 4.37 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.226 174.017 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . 0.521 ' O ' ' HB2' ' A' ' 388' ' ' LEU . 20.3 t -85.13 86.19 2.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 178.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 60.46 -112.57 4.66 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.287 -0.959 . . . . 0.0 111.341 -170.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 387' ' ' ASP . . . . . 0.402 ' N ' ' HB2' ' A' ' 309' ' ' LYS . 4.9 t70 -82.86 -17.05 45.23 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.008 0.432 . . . . 0.0 110.793 176.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . 0.521 ' HB2' ' O ' ' A' ' 385' ' ' VAL . 2.3 mp -69.38 151.83 45.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.209 177.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . 0.656 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 7.6 p30 -165.37 153.34 11.24 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.575 176.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . 0.446 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 35.5 t-80 -173.74 113.74 0.21 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.323 177.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 391' ' ' GLN . . . . . 1.054 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 13.6 tt0 -73.65 154.62 39.64 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.293 177.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 392' ' ' TRP . . . . . 0.555 ' HD1' ' OE1' ' A' ' 394' ' ' GLN . 17.8 t-105 -166.63 150.99 7.41 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.77 177.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -105.33 115.89 31.03 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . 0.746 ' HG3' HE22 ' A' ' 375' ' ' GLN . 3.5 mm100 -84.4 113.96 21.55 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -170.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 1.7 ptmm? . . . . . 0 C--O 1.251 1.172 0 CA-C-O 118.442 -0.79 . . . . 0.0 110.818 -178.252 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' THR . . . . . 0.501 HG21 HG23 ' A' ' 335' ' ' THR . 10.4 t . . . . . 0 CA--C 1.539 0.543 0 CA-C-O 121.949 0.881 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -69.84 116.38 10.16 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 175.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' THR . . . . . 0.574 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 13.0 t 177.38 -172.32 0.1 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -172.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 56.2 t -65.81 110.59 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 169.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . 1.015 ' HB3' HG22 ' A' ' 335' ' ' THR . 0.0 OUTLIER -68.37 135.83 52.41 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.966 0.413 . . . . 0.0 110.43 -169.886 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . 0.553 ' OD1' HG21 ' A' ' 310' ' ' THR . 17.1 t70 -64.32 126.16 26.91 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.31 -174.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.445 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -47.9 -17.74 0.13 Allowed 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 -168.85 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.553 HG21 ' OD1' ' A' ' 308' ' ' ASP . 11.8 t -108.92 3.28 22.12 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 119.88 1.218 . . . . 0.0 111.999 -173.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -78.51 -30.91 47.41 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -173.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.588 ' CD1' ' HE3' ' A' ' 364' ' ' MET . 0.0 OUTLIER -79.77 176.32 9.82 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-O 122.198 0.999 . . . . 0.0 111.821 -173.951 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 8.8 t -148.66 156.93 43.06 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 113.487 -1.688 . . . . 0.0 107.995 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 27.6 m-90 -68.66 121.19 15.93 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 54.4 tptt -103.13 -41.94 5.93 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 173.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -154.83 130.62 10.03 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.308 170.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -69.31 162.09 68.71 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.631 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . 0.725 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 53.8 Cg_exo -46.13 111.39 0.34 Allowed 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 122.311 2.007 . . . . 0.0 112.087 177.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' THR . . . . . 0.558 ' O ' HG21 ' A' ' 327' ' ' VAL . 17.2 m -130.08 132.7 46.27 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.655 -172.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -54.99 124.74 17.72 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 178.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' SER . . . . . 0.519 ' C ' ' H ' ' A' ' 323' ' ' HIS . 23.8 p -75.71 0.96 15.96 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.756 0.422 . . . . 0.0 111.848 -170.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 72.57 -26.91 0.73 Allowed Glycine 0 C--N 1.331 0.29 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.453 -169.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . 0.519 ' H ' ' C ' ' A' ' 321' ' ' SER . 30.4 t60 -95.87 44.6 1.08 Allowed 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 121.087 0.47 . . . . 0.0 109.789 -175.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 17.5 t70 59.12 31.51 21.35 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.001 175.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' THR . . . . . 0.813 ' HA ' ' HG3' ' A' ' 375' ' ' GLN . 4.6 p -152.05 -171.88 4.06 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -178.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . 0.403 HG13 ' C ' ' A' ' 319' ' ' THR . 48.2 t -137.71 129.17 39.65 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.611 0 CA-C-N 118.466 0.575 . . . . 0.0 111.085 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 327' ' ' VAL . . . . . 0.558 HG21 ' O ' ' A' ' 319' ' ' THR . 12.5 m -107.46 163.07 5.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.524 -178.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 328' ' ' MET . . . . . 0.534 ' HE3' ' HD3' ' A' ' 318' ' ' PRO . 0.0 OUTLIER -145.65 154.61 42.3 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 174.433 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' A' ' 370' ' ' GLY . 16.5 tt0 -133.28 130.53 39.07 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.387 -175.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.51 HG11 ' SD ' ' A' ' 328' ' ' MET . 0.2 OUTLIER -130.01 153.31 38.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.839 -178.277 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -121.18 137.12 11.62 Favored Glycine 0 CA--C 1.522 0.484 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.852 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . 0.459 ' HD2' ' N ' ' A' ' 335' ' ' THR . 1.3 p90 -88.05 155.85 19.6 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.673 0.749 . . . . 0.0 112.768 -178.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 28.3 p -115.69 20.93 14.32 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.76 -1.109 . . . . 0.0 112.764 169.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 164.24 -14.11 0.09 OUTLIER Glycine 0 N--CA 1.465 0.588 0 C-N-CA 120.112 -1.042 . . . . 0.0 113.846 173.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 335' ' ' THR . . . . . 1.015 HG22 ' HB3' ' A' ' 307' ' ' CYS . 0.2 OUTLIER -85.99 118.42 25.46 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 179.656 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 336' ' ' ARG . 4.8 ptp180 -100.22 178.94 1.12 Allowed Pre-proline 0 N--CA 1.451 -0.421 0 CA-C-O 116.549 -1.691 . . . . 0.0 106.475 174.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . 0.565 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.1 OUTLIER -23.26 91.04 0.0 OUTLIER 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 123.736 2.957 . . . . 0.0 114.387 -164.047 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 338' ' ' CYS . . . . . 0.574 ' HB2' ' O ' ' A' ' 305' ' ' THR . 14.2 p -115.41 -176.74 2.98 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 112.68 -2.055 . . . . 0.0 109.303 -170.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? -111.4 101.8 10.23 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . 0.723 HG12 ' HG3' ' A' ' 364' ' ' MET . 59.1 mt -72.95 118.78 71.32 Favored Pre-proline 0 C--N 1.325 -0.488 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.515 -170.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -74.18 79.24 2.44 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 121.969 1.78 . . . . 0.0 110.644 175.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.722 HG12 HG23 ' A' ' 340' ' ' ILE . 1.1 m -103.13 122.91 56.18 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.86 0 CA-C-O 121.874 0.845 . . . . 0.0 111.076 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.504 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 15.4 ptt180 -135.62 176.77 8.37 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 114.046 -1.434 . . . . 0.0 108.029 175.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 344' ' ' ALA . . . . . 0.587 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -148.66 144.31 27.07 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.554 175.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 11.6 m -117.09 144.9 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 176.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -68.66 116.08 8.77 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 178.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 347' ' ' HIS . . . . . 0.61 ' HB2' ' CB ' ' A' ' 380' ' ' ASP . 12.2 t60 40.64 67.68 0.49 Allowed 'General case' 0 N--CA 1.478 0.96 0 O-C-N 124.399 1.062 . . . . 0.0 111.519 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . 0.763 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 40.96 48.19 4.21 Favored Glycine 0 C--N 1.332 0.353 0 N-CA-C 115.206 0.842 . . . . 0.0 115.206 -174.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . 0.667 HG11 ' HG2' ' A' ' 351' ' ' GLU . 61.8 t -141.43 101.5 6.12 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 118.173 0.986 . . . . 0.0 108.457 176.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -80.53 72.3 6.6 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 123.131 2.554 . . . . 0.0 113.679 -176.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . 0.667 ' HG2' HG11 ' A' ' 349' ' ' VAL . 4.8 mm-40 -99.52 -58.04 2.02 Favored 'General case' 0 CA--C 1.502 -0.9 0 CA-C-O 122.6 1.191 . . . . 0.0 107.937 171.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . 0.454 HG11 ' HB2' ' A' ' 351' ' ' GLU . 1.1 p -125.47 127.17 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 112.644 -2.071 . . . . 0.0 110.127 -177.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -62.64 114.44 3.58 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.998 178.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.666 ' HB ' ' OD1' ' A' ' 381' ' ' ASN . 3.5 m -94.05 6.62 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.131 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 355' ' ' ALA . . . . . 0.587 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -74.67 83.13 2.08 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.886 0.374 . . . . 0.0 111.33 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 356' ' ' MET . . . . . 0.627 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 37.0 ttm -94.9 98.31 10.62 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 171.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.618 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 42.8 mt -87.46 123.92 32.89 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.802 -162.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.758 HD12 ' HB2' ' A' ' 375' ' ' GLN . 2.3 mm -62.88 -23.6 33.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.526 173.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 8.3 m -132.38 92.18 28.92 Favored Pre-proline 0 N--CA 1.447 -0.582 0 CA-C-N 114.499 -1.228 . . . . 0.0 108.547 170.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -86.41 28.77 0.53 Allowed 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.133 2.555 . . . . 0.0 112.466 -175.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -156.9 65.66 3.75 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 114.77 -1.104 . . . . 0.0 109.217 177.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . 0.699 ' HB2' HD12 ' A' ' 340' ' ' ILE . 87.2 Cg_endo -86.03 114.6 1.36 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.5 2.134 . . . . 0.0 111.991 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 363' ' ' THR . . . . . 0.408 HG21 ' O ' ' A' ' 338' ' ' CYS . 15.1 p -92.64 147.08 23.17 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 171.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 364' ' ' MET . . . . . 0.723 ' HG3' HG12 ' A' ' 340' ' ' ILE . 46.6 mtt . . . . . 0 CA--C 1.499 -1.009 0 CA-C-N 113.936 -1.484 . . . . 0.0 108.449 172.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . 0.694 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -46.64 -40.89 12.17 Favored Glycine 0 CA--C 1.519 0.305 0 CA-C-N 117.588 0.694 . . . . 0.0 113.476 173.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . 0.414 ' O ' ' HG3' ' A' ' 329' ' ' GLU . . . 83.28 -51.17 4.53 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.152 177.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -166.01 143.79 5.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.921 0.391 . . . . 0.0 111.616 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 372' ' ' ILE . . . . . 0.721 HD11 HG11 ' A' ' 342' ' ' VAL . 0.9 OUTLIER -134.71 151.46 31.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 170.398 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . 0.616 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 44.5 mt-10 -128.75 126.86 40.87 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.815 0.34 . . . . 0.0 110.355 -178.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 374' ' ' MET . . . . . 0.735 ' HG2' HD12 ' A' ' 383' ' ' ILE . 4.2 ppp? -137.3 165.1 26.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.589 -178.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 375' ' ' GLN . . . . . 0.813 ' HG3' ' HA ' ' A' ' 325' ' ' THR . 0.3 OUTLIER -177.32 -179.9 0.91 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.303 0.573 . . . . 0.0 111.692 168.954 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 376' ' ' LEU . . . . . 0.701 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 13.1 tp -167.96 155.0 7.68 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 178.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 377' ' ' PRO . . . . . 0.701 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 82.8 Cg_exo -45.53 131.67 12.49 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 121.287 1.325 . . . . 0.0 110.046 167.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . 0.544 ' HA ' ' NE2' ' A' ' 394' ' ' GLN . 4.0 Cg_exo -35.07 141.12 0.09 OUTLIER 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 125.103 3.869 . . . . 0.0 113.979 -171.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 152.64 -167.37 31.49 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 -163.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . 0.61 ' CB ' ' HB2' ' A' ' 347' ' ' HIS . 5.0 m-20 -99.4 124.31 44.43 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 117.548 0.674 . . . . 0.0 111.395 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.666 ' OD1' ' HB ' ' A' ' 354' ' ' VAL . 15.9 m-80 -134.19 141.64 47.12 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 0.997 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -142.58 137.05 28.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -179.837 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . 0.735 HD12 ' HG2' ' A' ' 374' ' ' MET . 47.6 mt -98.25 127.83 50.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.751 -172.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 384' ' ' TYR . . . . . 0.504 ' O ' ' HG2' ' A' ' 343' ' ' ARG . 0.3 OUTLIER -104.98 91.42 3.8 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.197 173.469 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . 0.416 HG13 HG13 ' A' ' 330' ' ' VAL . 9.3 t -83.34 90.27 2.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 61.45 -113.26 5.52 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.461 -0.876 . . . . 0.0 111.027 -170.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -88.11 -16.36 33.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.759 0.314 . . . . 0.0 110.883 175.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . 0.495 HD21 HG12 ' A' ' 330' ' ' VAL . 0.9 OUTLIER -69.51 155.69 40.07 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.191 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . 0.638 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 28.2 p-10 -165.98 157.3 13.66 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.778 177.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . 0.725 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 6.8 t60 -174.55 120.98 0.25 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.202 174.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 391' ' ' GLN . . . . . 0.997 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 21.3 tt0 -75.35 149.51 38.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.438 0.637 . . . . 0.0 112.115 -177.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 392' ' ' TRP . . . . . . . . . . . . . 70.5 t-105 -146.12 143.35 29.27 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.426 177.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . 0.675 ' HD2' ' HE2' ' A' ' 395' ' ' LYS . 12.3 p90 -104.15 107.38 18.26 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 173.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . 0.701 ' HG2' HE22 ' A' ' 375' ' ' GLN . 0.0 OUTLIER -94.33 123.05 37.49 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.805 0.812 . . . . 0.0 110.972 -170.836 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.675 ' HE2' ' HD2' ' A' ' 393' ' ' PHE . 48.6 mttm . . . . . 0 C--O 1.245 0.834 0 CA-C-N 114.464 -1.244 . . . . 0.0 108.911 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' THR . . . . . 0.467 ' O ' HG23 ' A' ' 335' ' ' THR . 5.2 t . . . . . 0 CA--C 1.538 0.505 0 CA-C-O 121.486 0.66 . . . . 0.0 111.001 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -65.98 124.67 23.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.151 0.501 . . . . 0.0 110.023 177.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' THR . . . . . 0.486 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 14.3 t 175.79 -170.58 0.06 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.113 -171.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 61.3 t -63.64 108.86 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 168.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.56 142.14 55.29 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.747 0.308 . . . . 0.0 110.567 -169.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . 0.692 ' OD1' HG21 ' A' ' 310' ' ' THR . 16.1 t70 -64.46 131.91 48.48 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.813 0.816 . . . . 0.0 112.004 -170.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -37.72 -30.65 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 112.975 -1.921 . . . . 0.0 115.222 -177.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.692 HG21 ' OD1' ' A' ' 308' ' ' ASP . 11.6 t -105.19 -1.85 24.89 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 118.747 0.703 . . . . 0.0 112.376 -169.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 27.0 mmmt -70.13 -35.05 73.79 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.284 0.564 . . . . 0.0 110.908 -178.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.735 ' HB3' ' HE2' ' A' ' 364' ' ' MET . 0.1 OUTLIER -90.47 177.64 6.32 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 122.296 1.046 . . . . 0.0 112.544 -174.553 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 14.2 t -161.8 168.86 22.41 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 113.534 -1.666 . . . . 0.0 108.978 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 92.9 m95 -83.91 96.72 8.91 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 121.371 0.605 . . . . 0.0 110.648 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.676 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 56.7 tttm -66.61 -40.13 88.69 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 167.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 61.4 ttt180 -158.9 131.79 7.05 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.333 168.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . 0.498 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -74.87 163.66 66.69 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.059 -176.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . 0.498 ' HD2' ' HB1' ' A' ' 317' ' ' ALA . 4.9 Cg_exo -37.64 116.05 0.19 Allowed 'Trans proline' 0 C--N 1.362 1.239 0 C-N-CA 123.58 2.853 . . . . 0.0 113.364 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' THR . . . . . 0.585 ' O ' HG21 ' A' ' 327' ' ' VAL . 28.8 m -132.9 138.36 46.95 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.424 -176.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . 0.427 ' OD2' ' HZ2' ' A' ' 392' ' ' TRP . 45.5 m-20 -61.13 132.83 55.0 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -178.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' SER . . . . . 0.451 ' C ' ' H ' ' A' ' 323' ' ' HIS . 60.3 p -71.52 1.58 6.3 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 122.492 0.317 . . . . 0.0 111.466 -174.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 70.52 -22.06 0.54 Allowed Glycine 0 CA--C 1.521 0.452 0 C-N-CA 121.438 -0.411 . . . . 0.0 113.642 -170.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . 0.596 ' O ' ' HB3' ' A' ' 324' ' ' ASP . 93.5 m-70 -77.67 -41.74 37.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.993 0.396 . . . . 0.0 111.7 -172.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . 0.596 ' HB3' ' O ' ' A' ' 323' ' ' HIS . 4.5 p-10 144.37 13.89 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.721 0 O-C-N 124.354 1.034 . . . . 0.0 109.89 -163.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' THR . . . . . 0.458 ' HA ' ' HG2' ' A' ' 375' ' ' GLN . 6.5 p -150.13 -170.23 3.59 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -170.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 373' ' ' GLU . 1.4 t -130.04 148.71 33.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.173 0.511 . . . . 0.0 111.03 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 327' ' ' VAL . . . . . 0.631 ' HA ' ' O ' ' A' ' 372' ' ' ILE . 19.1 m -128.7 157.42 41.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.982 178.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 328' ' ' MET . . . . . 0.657 ' HE1' HG21 ' A' ' 385' ' ' VAL . 23.1 ptt? -140.89 156.3 46.13 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 170.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.676 ' HG2' ' HD3' ' A' ' 315' ' ' LYS . 22.8 tt0 -121.8 119.12 30.75 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.412 HG21 ' HE3' ' A' ' 364' ' ' MET . 19.5 m -122.97 142.23 40.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 120.676 0.274 . . . . 0.0 110.792 -175.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . 0.544 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -125.49 138.28 10.82 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.247 -0.978 . . . . 0.0 113.199 -173.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . 0.841 ' HE2' ' HB ' ' A' ' 335' ' ' THR . 0.0 OUTLIER -147.61 163.13 37.56 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 176.114 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 15.1 m -151.96 44.48 0.74 Allowed 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -174.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -139.34 -65.82 0.04 OUTLIER Glycine 0 C--N 1.331 0.258 0 C-N-CA 119.369 -1.396 . . . . 0.0 112.126 169.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 335' ' ' THR . . . . . 0.841 ' HB ' ' HE2' ' A' ' 332' ' ' PHE . 28.6 m -52.9 140.56 24.21 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.234 -0.983 . . . . 0.0 109.236 172.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.622 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 21.9 ptt180 -87.91 178.37 2.18 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 117.592 -1.194 . . . . 0.0 108.725 176.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . 0.622 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 2.2 Cg_exo -27.65 104.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.372 1.776 0 C-N-CA 123.573 2.849 . . . . 0.0 113.58 -178.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 338' ' ' CYS . . . . . 0.589 ' SG ' ' HB2' ' A' ' 364' ' ' MET . 22.2 p -116.74 -174.3 2.55 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 113.882 -1.508 . . . . 0.0 110.286 -167.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 -111.71 101.6 9.96 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . 0.481 HG12 HG12 ' A' ' 342' ' ' VAL . 13.4 tt -77.61 121.93 85.05 Favored Pre-proline 0 C--N 1.325 -0.47 0 C-N-CA 119.118 -1.033 . . . . 0.0 110.849 -167.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -78.16 80.55 2.96 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.252 1.968 . . . . 0.0 111.954 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.63 HG13 HG11 ' A' ' 385' ' ' VAL . 30.2 m -106.07 153.31 7.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.355 -178.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.467 ' HG3' ' HB2' ' A' ' 384' ' ' TYR . 40.3 ptt180 -168.33 174.99 6.65 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -179.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 344' ' ' ALA . . . . . 0.655 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -149.81 144.36 25.95 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.931 -0.708 . . . . 0.0 110.885 177.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.567 ' HB ' ' HA ' ' A' ' 350' ' ' PRO . 4.6 m -116.72 147.09 20.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -69.53 125.59 27.17 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 176.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 347' ' ' HIS . . . . . 0.51 ' O ' HG21 ' A' ' 349' ' ' VAL . 5.0 t60 43.88 60.17 2.82 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 124.422 1.077 . . . . 0.0 111.665 172.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . 0.61 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 43.02 42.79 5.26 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 115.046 0.778 . . . . 0.0 115.046 -174.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . 0.51 HG21 ' O ' ' A' ' 347' ' ' HIS . 75.5 t -139.98 101.8 7.0 Favored Pre-proline 0 C--N 1.331 -0.227 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 350' ' ' PRO . . . . . 0.567 ' HA ' ' HB ' ' A' ' 345' ' ' VAL . 12.5 Cg_exo -75.41 54.8 3.95 Favored 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 122.913 2.408 . . . . 0.0 113.834 -176.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -100.15 -56.35 2.39 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 176.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.7 p -112.28 123.69 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.854 172.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . 0.538 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 6.1 t30 -65.8 122.25 16.89 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.371 174.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.448 HG12 HD21 ' A' ' 376' ' ' LEU . 29.1 m -97.56 4.51 9.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.143 176.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 355' ' ' ALA . . . . . 0.655 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -76.93 83.95 3.48 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.893 -179.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 356' ' ' MET . . . . . 0.677 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 53.3 ttp -95.36 99.87 11.73 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 169.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.46 ' HB2' ' HA ' ' A' ' 360' ' ' PRO . 36.5 mt -85.34 116.49 23.7 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.768 -162.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.728 ' HB ' ' CB ' ' A' ' 373' ' ' GLU . 1.7 mm -64.6 -24.36 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 174.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 72.3 m -118.61 85.15 26.23 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 114.294 -1.321 . . . . 0.0 108.257 169.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 360' ' ' PRO . . . . . 0.46 ' HA ' ' HB2' ' A' ' 357' ' ' LEU . 75.0 Cg_endo -84.3 26.04 0.67 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.115 2.543 . . . . 0.0 114.448 -167.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -166.52 68.34 1.04 Allowed Pre-proline 0 C--N 1.311 -1.093 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.587 173.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . 0.54 ' HB3' HG21 ' A' ' 372' ' ' ILE . 58.6 Cg_endo -82.54 169.05 14.08 Favored 'Trans proline' 0 C--O 1.246 0.889 0 C-N-CA 122.542 2.161 . . . . 0.0 113.317 -178.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 4.2 p -143.7 -176.53 5.01 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.087 -168.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 364' ' ' MET . . . . . 0.79 ' HA ' ' HA2' ' A' ' 369' ' ' GLY . 42.4 mtp . . . . . 0 C--N 1.312 -1.026 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 172.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . 0.56 ' HA2' ' HD1' ' A' ' 332' ' ' PHE . . . . . . . . 0 N--CA 1.447 -0.573 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . 0.79 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -54.61 -47.19 71.57 Favored Glycine 0 CA--C 1.505 -0.548 0 C-N-CA 121.371 -0.442 . . . . 0.0 113.391 177.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . 0.594 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 90.12 -134.61 12.44 Favored Glycine 0 N--CA 1.438 -1.194 0 C-N-CA 119.943 -1.122 . . . . 0.0 110.917 -172.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -103.16 140.61 37.12 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.513 0.673 . . . . 0.0 111.697 -177.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 372' ' ' ILE . . . . . 0.631 ' O ' ' HA ' ' A' ' 327' ' ' VAL . 1.5 mt -128.25 161.31 36.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.044 176.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . 0.728 ' CB ' ' HB ' ' A' ' 358' ' ' ILE . 38.8 mt-10 -124.49 128.54 49.14 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.484 0.659 . . . . 0.0 110.97 -179.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 374' ' ' MET . . . . . 0.594 ' HE3' ' HB ' ' A' ' 372' ' ' ILE . 0.1 OUTLIER -140.32 157.31 45.76 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.38 -1.282 . . . . 0.0 108.188 -179.923 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 375' ' ' GLN . . . . . 0.818 HE21 ' HA ' ' A' ' 375' ' ' GLN . 0.0 OUTLIER 179.83 175.45 0.78 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 118.224 0.465 . . . . 0.0 109.803 179.124 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 376' ' ' LEU . . . . . 1.044 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 11.2 tp -166.69 164.45 10.38 Favored Pre-proline 0 N--CA 1.446 -0.63 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 176.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 377' ' ' PRO . . . . . 1.044 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 80.0 Cg_exo -43.63 133.92 7.39 Favored 'Trans proline' 0 CA--C 1.533 0.433 0 C-N-CA 121.38 1.387 . . . . 0.0 111.3 169.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . 0.545 ' HA ' HE22 ' A' ' 394' ' ' GLN . 4.7 Cg_exo -35.47 144.22 0.08 OUTLIER 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 125.177 3.918 . . . . 0.0 114.223 -175.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 151.17 -159.69 28.31 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -164.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . 0.461 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 7.5 m-20 -104.7 131.55 52.01 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 118.013 0.906 . . . . 0.0 110.939 175.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.435 ' HA ' HG22 ' A' ' 354' ' ' VAL . 10.0 m120 -128.5 145.53 51.08 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 177.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 1.043 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -143.91 136.97 23.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 176.634 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . 0.644 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 13.4 mt -100.72 131.71 47.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.326 -173.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 384' ' ' TYR . . . . . 0.467 ' HB2' ' HG3' ' A' ' 343' ' ' ARG . 5.0 m-85 -99.91 133.72 43.86 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 114.51 -1.223 . . . . 0.0 108.163 167.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . 0.817 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 4.5 t -124.21 82.05 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 177.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 59.91 -108.57 1.79 Allowed Glycine 0 N--CA 1.434 -1.455 0 C-N-CA 119.837 -1.173 . . . . 0.0 110.848 -167.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -83.12 -15.51 50.47 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 175.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . 0.817 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 4.1 mp -69.68 155.77 40.0 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.477 0.179 . . . . 0.0 110.625 177.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . 0.644 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 4.9 p-10 -171.41 152.25 3.24 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.426 174.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . 0.4 ' O ' HG12 ' A' ' 382' ' ' ILE . 6.5 t60 -173.91 120.45 0.29 Allowed 'General case' 0 C--O 1.237 0.421 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 177.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 391' ' ' GLN . . . . . 1.043 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 7.5 tt0 -76.35 152.94 36.18 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.294 0.568 . . . . 0.0 112.496 -175.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 392' ' ' TRP . . . . . 0.427 ' HZ2' ' OD2' ' A' ' 320' ' ' ASP . 59.0 t-105 -150.2 148.82 29.38 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.397 177.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -111.64 114.03 26.8 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 173.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . 0.545 HE22 ' HA ' ' A' ' 378' ' ' PRO . 0.0 OUTLIER -103.01 127.31 50.3 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.334 0.588 . . . . 0.0 110.069 -172.885 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.566 ' HD3' ' H ' ' A' ' 395' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.021 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.514 -174.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' THR . . . . . 0.433 ' O ' HG21 ' A' ' 305' ' ' THR . 10.0 t . . . . . 0 CA--C 1.535 0.378 0 CA-C-O 121.471 0.653 . . . . 0.0 111.437 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . 0.443 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 43.7 p90 -64.03 120.87 12.85 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 172.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' THR . . . . . 0.602 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 14.2 t 170.75 -166.75 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -170.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 19.2 t -65.32 110.58 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 171.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.79 141.33 55.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.007 0.432 . . . . 0.0 110.955 -173.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . 0.623 ' OD1' HG21 ' A' ' 310' ' ' THR . 9.4 t70 -60.82 123.02 16.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.944 -177.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 34.7 pttt -45.28 -17.53 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 115.4 1.629 . . . . 0.0 115.4 -177.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.623 HG21 ' OD1' ' A' ' 308' ' ' ASP . 10.6 t -109.63 9.08 25.14 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 120.212 1.369 . . . . 0.0 112.252 -174.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . 0.419 ' HG3' ' HB3' ' A' ' 308' ' ' ASP . 26.2 mtpp -90.42 -27.03 19.56 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -174.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.752 ' HZ ' ' HA3' ' A' ' 386' ' ' GLY . 0.4 OUTLIER -85.91 173.55 9.89 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.887 0.851 . . . . 0.0 112.443 -175.925 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 11.2 t -153.6 158.91 41.87 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.203 -1.362 . . . . 0.0 109.101 -178.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 16.4 m95 -79.79 95.53 6.04 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 120.981 0.42 . . . . 0.0 111.376 -176.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.483 ' HB3' ' C ' ' A' ' 329' ' ' GLU . 31.8 tptt -63.37 -49.64 73.06 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 167.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 3.8 ttm180 -154.73 131.55 10.77 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.211 -0.904 . . . . 0.0 108.918 175.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -75.07 159.31 82.99 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-O 119.051 -0.499 . . . . 0.0 110.908 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -34.27 113.24 0.08 OUTLIER 'Trans proline' 0 C--N 1.365 1.397 0 C-N-CA 123.78 2.987 . . . . 0.0 113.545 177.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' THR . . . . . 0.484 ' O ' HG21 ' A' ' 327' ' ' VAL . 21.0 m -130.89 137.15 49.2 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.932 -175.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -58.82 128.18 35.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.664 -0.244 . . . . 0.0 110.36 -179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 60.5 p -74.68 3.98 7.0 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.026 0.53 . . . . 0.0 111.85 -173.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 70.61 -18.79 0.74 Allowed Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.238 -0.506 . . . . 0.0 114.08 -172.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . 0.445 ' O ' ' CB ' ' A' ' 324' ' ' ASP . 11.5 m170 -92.01 -13.75 30.5 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 117.579 0.69 . . . . 0.0 112.791 -174.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . 0.445 ' CB ' ' O ' ' A' ' 323' ' ' HIS . 29.9 t70 108.0 35.39 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 O-C-N 125.329 1.643 . . . . 0.0 109.033 -175.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' THR . . . . . 0.569 ' HA ' ' CG ' ' A' ' 375' ' ' GLN . 3.3 p -150.97 -173.77 4.59 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . 0.666 HG23 ' HG2' ' A' ' 375' ' ' GLN . 0.6 OUTLIER -130.04 143.74 40.13 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.589 0 CA-C-N 118.776 0.716 . . . . 0.0 111.511 -177.33 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 327' ' ' VAL . . . . . 0.62 ' HA ' ' O ' ' A' ' 372' ' ' ILE . 19.2 m -123.28 146.2 29.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.466 176.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 328' ' ' MET . . . . . 0.702 ' HE2' ' HB ' ' A' ' 372' ' ' ILE . 6.1 ptp -130.61 153.5 48.85 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 174.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.483 ' C ' ' HB3' ' A' ' 315' ' ' LYS . 3.8 tt0 -125.75 126.27 44.31 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.561 HG21 ' HA3' ' A' ' 369' ' ' GLY . 10.7 m -125.58 159.05 33.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.351 -176.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . 0.525 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -130.8 135.59 8.35 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 118.843 -1.646 . . . . 0.0 114.482 178.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . 0.992 ' H ' ' HA2' ' A' ' 368' ' ' GLY . 36.2 m-85 -112.52 171.49 7.49 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.442 0.697 . . . . 0.0 110.074 170.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 34.7 m -130.58 -15.17 3.58 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 174.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -123.82 -66.42 0.2 Allowed Glycine 0 C--O 1.224 -0.484 0 C-N-CA 119.766 -1.207 . . . . 0.0 113.659 -175.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 335' ' ' THR . . . . . . . . . . . . . 12.8 m -54.16 129.01 33.32 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 123.747 0.322 . . . . 0.0 111.202 -176.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.648 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 6.4 ptm180 -88.7 179.45 1.63 Allowed Pre-proline 0 CA--C 1.532 0.269 0 CA-C-O 117.442 -1.266 . . . . 0.0 108.123 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . 0.648 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -26.89 99.41 0.02 OUTLIER 'Trans proline' 0 C--N 1.372 1.816 0 C-N-CA 123.888 3.059 . . . . 0.0 114.155 -175.574 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 338' ' ' CYS . . . . . 0.602 ' HB2' ' O ' ' A' ' 305' ' ' THR . 19.2 p -115.61 -175.61 2.75 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 113.583 -1.644 . . . . 0.0 109.302 -169.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -106.54 96.34 6.38 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . 0.838 HD13 ' HD2' ' A' ' 341' ' ' PRO . 9.3 tp -75.54 120.05 79.88 Favored Pre-proline 0 C--N 1.325 -0.457 0 C-N-CA 119.011 -1.076 . . . . 0.0 110.924 -168.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 341' ' ' PRO . . . . . 0.838 ' HD2' HD13 ' A' ' 340' ' ' ILE . 53.5 Cg_endo -72.87 79.45 1.96 Allowed 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 121.92 1.746 . . . . 0.0 111.216 175.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.605 HG12 HG13 ' A' ' 340' ' ' ILE . 2.5 m -103.85 109.64 27.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.273 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.594 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 18.9 ptt180 -127.45 175.64 8.07 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 344' ' ' ALA . . . . . 0.65 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -147.42 145.87 29.38 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.407 176.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.426 ' HB ' ' HA ' ' A' ' 350' ' ' PRO . 10.4 m -115.63 143.34 25.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 176.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -62.05 115.85 4.44 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.326 176.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 347' ' ' HIS . . . . . 0.734 ' HB3' ' HB2' ' A' ' 380' ' ' ASP . 13.6 p80 33.62 73.17 0.07 Allowed 'General case' 0 N--CA 1.472 0.664 0 O-C-N 124.618 1.199 . . . . 0.0 113.822 177.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . 0.712 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 53.18 31.59 41.76 Favored Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 115.324 0.89 . . . . 0.0 115.324 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 49.8 t -139.49 102.88 7.16 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 118.584 1.192 . . . . 0.0 109.011 178.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 350' ' ' PRO . . . . . 0.426 ' HA ' ' HB ' ' A' ' 345' ' ' VAL . 16.7 Cg_exo -71.88 62.55 3.15 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.966 2.444 . . . . 0.0 112.778 178.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -100.87 -55.98 2.44 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 177.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.2 p -121.54 131.43 73.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.434 174.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . 0.426 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 43.4 t30 -64.19 113.04 3.3 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.551 174.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 27.5 m -97.25 5.16 9.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.05 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 355' ' ' ALA . . . . . 0.65 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -76.38 86.25 3.15 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.027 0.441 . . . . 0.0 111.272 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.96 100.58 12.08 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 171.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.581 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 23.8 mt -85.57 120.17 26.72 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.931 -164.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.675 ' HB ' ' CB ' ' A' ' 373' ' ' GLU . 2.1 mm -65.86 -25.9 37.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 173.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 50.4 m -120.68 82.27 33.9 Favored Pre-proline 0 N--CA 1.446 -0.652 0 CA-C-N 114.41 -1.268 . . . . 0.0 108.153 170.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 360' ' ' PRO . . . . . 0.446 ' HA ' ' HB2' ' A' ' 357' ' ' LEU . 86.6 Cg_endo -85.86 21.0 1.14 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.088 2.525 . . . . 0.0 113.785 -169.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 361' ' ' ASN . . . . . 0.538 ' N ' ' HD3' ' A' ' 362' ' ' PRO . 15.8 m120 -145.77 52.88 1.66 Allowed Pre-proline 0 C--N 1.312 -1.054 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.348 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . 0.538 ' HD3' ' N ' ' A' ' 361' ' ' ASN . 11.0 Cg_endo -78.81 147.11 21.38 Favored 'Trans proline' 0 C--O 1.251 1.161 0 C-N-CA 121.635 1.557 . . . . 0.0 113.142 -177.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 6.3 p -139.99 116.85 10.97 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.664 -169.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 364' ' ' MET . . . . . 0.753 ' HG3' HD12 ' A' ' 340' ' ' ILE . 11.3 mmt . . . . . 0 C--N 1.311 -1.094 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.96 -170.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . 0.992 ' HA2' ' H ' ' A' ' 332' ' ' PHE . . . . . . . . 0 N--CA 1.448 -0.516 0 N-CA-C 114.535 0.574 . . . . 0.0 114.535 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . 0.561 ' HA3' HG21 ' A' ' 330' ' ' VAL . . . -177.18 93.47 0.09 OUTLIER Glycine 0 C--N 1.312 -0.759 0 N-CA-C 107.652 -2.179 . . . . 0.0 107.652 -171.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . 0.423 ' O ' ' HG3' ' A' ' 329' ' ' GLU . . . -74.31 -43.24 32.28 Favored Glycine 0 C--N 1.304 -1.248 0 C-N-CA 120.826 -0.702 . . . . 0.0 114.639 -155.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -166.2 136.6 3.42 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 120.966 0.413 . . . . 0.0 110.754 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 372' ' ' ILE . . . . . 0.702 ' HB ' ' HE2' ' A' ' 328' ' ' MET . 0.9 OUTLIER -136.67 135.52 48.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.947 176.771 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . 0.675 ' CB ' ' HB ' ' A' ' 358' ' ' ILE . 25.8 mt-10 -110.98 131.22 55.23 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.703 -176.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 374' ' ' MET . . . . . 0.626 ' HG2' HD12 ' A' ' 383' ' ' ILE . 0.0 OUTLIER -137.17 165.1 26.9 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.794 -1.093 . . . . 0.0 108.627 178.987 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 375' ' ' GLN . . . . . 1.052 HE21 ' HA ' ' A' ' 375' ' ' GLN . 0.0 OUTLIER -176.14 -175.95 0.75 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.807 0.813 . . . . 0.0 110.813 169.309 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 376' ' ' LEU . . . . . 0.952 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 14.5 tp -166.21 162.9 12.09 Favored Pre-proline 0 N--CA 1.437 -1.081 0 N-CA-C 103.806 -2.664 . . . . 0.0 103.806 173.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 377' ' ' PRO . . . . . 0.952 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 66.6 Cg_exo -39.65 130.99 1.84 Allowed 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 121.356 1.37 . . . . 0.0 110.705 167.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -37.2 141.32 0.18 Allowed 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 124.201 3.267 . . . . 0.0 112.694 -176.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 149.43 -174.86 28.86 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -163.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . 0.734 ' HB2' ' HB3' ' A' ' 347' ' ' HIS . 6.1 m-20 -94.41 125.92 39.35 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 117.501 0.65 . . . . 0.0 110.167 -175.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.585 HD21 ' HG2' ' A' ' 394' ' ' GLN . 28.4 m-80 -137.29 170.24 16.43 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 1.024 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -160.55 143.98 4.82 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 175.426 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . 0.685 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 44.2 mt -101.48 128.82 53.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.31 -175.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 384' ' ' TYR . . . . . 0.594 ' O ' ' HG2' ' A' ' 343' ' ' ARG . 0.7 OUTLIER -104.06 92.07 4.22 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.971 171.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . 0.467 ' O ' ' HB2' ' A' ' 388' ' ' LEU . 15.2 t -84.0 89.45 2.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 178.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . 0.752 ' HA3' ' HZ ' ' A' ' 312' ' ' PHE . . . 61.05 -116.52 9.46 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.1 -1.048 . . . . 0.0 111.136 -172.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -78.49 -20.76 50.12 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.848 0.356 . . . . 0.0 111.366 174.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . 0.556 HD12 ' CD1' ' A' ' 312' ' ' PHE . 2.4 mp -70.26 155.12 41.1 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.37 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . 0.685 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 7.0 p30 -167.8 152.73 6.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.886 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -173.48 118.55 0.29 Allowed 'General case' 0 C--O 1.24 0.554 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 177.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 391' ' ' GLN . . . . . 1.024 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 15.5 tt0 -80.93 153.32 27.61 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.894 0.878 . . . . 0.0 112.081 -176.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 392' ' ' TRP . . . . . 0.451 ' CD1' ' NE2' ' A' ' 394' ' ' GLN . 6.0 t-105 -172.31 150.99 2.45 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.47 -178.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . 0.471 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 21.3 p90 -102.34 119.12 38.28 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 121.214 -0.929 . . . . 0.0 108.807 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . 0.709 ' HG3' HE22 ' A' ' 375' ' ' GLN . 3.4 mm100 -85.98 127.28 34.6 Favored 'General case' 0 C--O 1.238 0.469 0 O-C-N 121.909 -0.495 . . . . 0.0 109.878 -167.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm . . . . . 0 C--O 1.246 0.897 0 O-C-N 124.348 1.03 . . . . 0.0 110.651 175.793 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' THR . . . . . 0.474 HG21 HG23 ' A' ' 335' ' ' THR . 5.8 t . . . . . 0 CA--C 1.537 0.48 0 CA-C-O 121.344 0.592 . . . . 0.0 111.764 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -68.11 122.87 19.18 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 175.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' THR . . . . . 0.477 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 7.4 t 178.54 -167.89 0.07 Allowed 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -171.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 30.8 t -69.78 113.65 5.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 167.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.6 147.27 53.5 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.842 0.83 . . . . 0.0 112.135 -169.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . 0.456 ' OD1' HG21 ' A' ' 310' ' ' THR . 12.1 t70 -66.58 128.21 35.35 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.163 -1.381 . . . . 0.0 110.145 177.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.64 -13.13 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 115.775 1.769 . . . . 0.0 115.775 -176.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.456 HG21 ' OD1' ' A' ' 308' ' ' ASP . 12.0 t -108.96 -2.37 18.32 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 119.775 1.17 . . . . 0.0 113.086 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . 0.67 ' HE2' ' OG1' ' A' ' 335' ' ' THR . 31.2 mmmt -65.69 -35.68 81.45 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -173.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.586 ' HA ' ' O ' ' A' ' 331' ' ' GLY . 0.1 OUTLIER -86.01 174.25 9.34 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 122.086 0.946 . . . . 0.0 112.405 -175.129 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 12.6 t -151.98 161.47 42.58 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 113.65 -1.614 . . . . 0.0 109.459 -177.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . 0.539 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 28.8 m-90 -77.32 124.19 27.53 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 121.295 0.569 . . . . 0.0 110.034 -178.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.591 ' HB3' ' HB3' ' A' ' 329' ' ' GLU . 63.0 tttt -108.04 -41.95 4.8 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 172.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.619 ' HB3' ' HB2' ' A' ' 329' ' ' GLU . 3.9 ttm180 -151.16 130.02 12.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.762 171.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -70.25 157.74 89.19 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.453 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . 0.605 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 1.6 Cg_endo -45.66 118.44 2.23 Favored 'Trans proline' 0 C--N 1.359 1.118 0 C-N-CA 122.541 2.161 . . . . 0.0 112.27 -178.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' THR . . . . . 0.462 ' O ' HG21 ' A' ' 327' ' ' VAL . 47.5 m -134.96 145.16 47.87 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.243 -174.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -60.07 134.5 57.11 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' SER . . . . . 0.465 ' C ' ' H ' ' A' ' 323' ' ' HIS . 79.9 p -76.92 1.04 18.77 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -173.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 73.1 -20.47 1.14 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.833 -169.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . 0.465 ' H ' ' C ' ' A' ' 321' ' ' SER . 96.6 m-70 -112.2 50.15 0.87 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.111 0.482 . . . . 0.0 110.369 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 9.5 t70 54.03 38.22 28.5 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.835 174.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' THR . . . . . 0.439 ' HB ' HG13 ' A' ' 358' ' ' ILE . 2.6 p -150.86 -168.47 3.11 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 175.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . 0.693 HG13 HE22 ' A' ' 394' ' ' GLN . 0.4 OUTLIER -129.13 141.25 47.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 118.245 0.475 . . . . 0.0 110.873 -178.782 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 327' ' ' VAL . . . . . 0.471 HG12 ' HG2' ' A' ' 373' ' ' GLU . 17.6 m -121.35 149.16 24.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.682 177.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 328' ' ' MET . . . . . 0.673 ' SD ' ' HB ' ' A' ' 372' ' ' ILE . 0.1 OUTLIER -141.94 150.73 41.82 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 176.194 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.619 ' HB2' ' HB3' ' A' ' 316' ' ' ARG . 9.9 mt-10 -124.94 128.86 49.27 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 120.825 0.345 . . . . 0.0 110.2 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.45 HG21 ' HA3' ' A' ' 369' ' ' GLY . 1.8 m -131.78 152.66 37.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.854 -178.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . 0.586 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -113.86 178.15 18.21 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-O 119.475 -0.625 . . . . 0.0 112.536 -178.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . 0.673 ' HB2' ' SD ' ' A' ' 364' ' ' MET . 0.5 OUTLIER -128.77 142.83 50.86 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 117.467 0.633 . . . . 0.0 111.158 -178.409 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 5.3 p -87.57 -17.64 31.53 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 173.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 177.09 -39.61 0.1 OUTLIER Glycine 0 C--N 1.338 0.641 0 C-N-CA 117.943 -2.075 . . . . 0.0 116.045 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 335' ' ' THR . . . . . 0.67 ' OG1' ' HE2' ' A' ' 311' ' ' LYS . 81.2 m -52.91 131.78 36.27 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.813 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 1.4 ptp180 -79.24 -179.98 1.59 Allowed Pre-proline 0 N--CA 1.449 -0.495 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -177.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . 0.813 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 1.3 Cg_exo -27.56 100.88 0.02 OUTLIER 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 123.269 2.646 . . . . 0.0 113.742 178.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 338' ' ' CYS . . . . . 0.92 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 26.3 p -130.54 150.39 51.76 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.402 -176.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -67.17 123.93 21.67 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.444 170.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . 0.437 HG12 HG12 ' A' ' 342' ' ' VAL . 19.2 tt -94.64 117.73 66.93 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.155 -176.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -70.37 82.29 0.89 Allowed 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.513 2.142 . . . . 0.0 112.042 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.593 HG13 HG11 ' A' ' 385' ' ' VAL . 11.4 m -102.31 115.4 44.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.468 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -130.34 178.13 6.82 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 344' ' ' ALA . . . . . 0.563 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -151.21 148.85 28.73 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.89 177.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 14.7 m -121.57 146.86 25.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -70.17 119.19 13.99 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 177.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 347' ' ' HIS . . . . . 0.638 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 68.8 t60 47.36 57.5 5.77 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 124.172 0.92 . . . . 0.0 111.457 174.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . 0.608 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 44.83 44.22 8.58 Favored Glycine 0 CA--C 1.521 0.413 0 N-CA-C 114.671 0.628 . . . . 0.0 114.671 -172.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . 0.503 HG21 ' O ' ' A' ' 347' ' ' HIS . 57.4 t -139.82 102.23 7.05 Favored Pre-proline 0 C--O 1.234 0.271 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -76.36 64.19 7.18 Favored 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 123.06 2.507 . . . . 0.0 113.847 -175.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -100.52 -57.09 2.18 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 174.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 4.3 p -115.55 125.94 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.676 174.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . 0.449 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 39.5 t30 -62.89 108.89 1.29 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.57 174.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.502 ' HA ' HD23 ' A' ' 376' ' ' LEU . 27.6 m -86.81 0.97 6.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.078 -179.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 355' ' ' ALA . . . . . 0.563 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -76.88 84.32 3.45 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 121.476 0.655 . . . . 0.0 110.468 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 356' ' ' MET . . . . . 0.671 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 11.9 tpt -98.96 103.62 15.59 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 170.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.522 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 42.4 mt -86.2 119.64 26.7 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.177 -161.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.679 ' HB ' ' CB ' ' A' ' 373' ' ' GLU . 3.0 mm -64.77 -27.18 41.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 173.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 89.8 m -122.06 84.53 45.4 Favored Pre-proline 0 N--CA 1.449 -0.52 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.572 171.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -85.39 28.07 0.58 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.119 2.546 . . . . 0.0 113.65 -171.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 361' ' ' ASN . . . . . 0.427 ' N ' ' HD3' ' A' ' 362' ' ' PRO . 2.4 p-10 -148.59 55.0 1.91 Allowed Pre-proline 0 C--N 1.313 -0.99 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.488 177.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . 0.708 ' HB3' HG21 ' A' ' 372' ' ' ILE . 73.5 Cg_endo -85.08 162.53 11.61 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 121.884 1.723 . . . . 0.0 113.041 -179.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 363' ' ' THR . . . . . 0.65 ' O ' ' HA2' ' A' ' 369' ' ' GLY . 1.2 p -145.2 -172.7 3.92 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.89 -172.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 364' ' ' MET . . . . . 0.92 ' HG2' ' SG ' ' A' ' 338' ' ' CYS . 9.3 ptp . . . . . 0 C--N 1.316 -0.876 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 162.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . 0.453 ' HA2' ' HB3' ' A' ' 332' ' ' PHE . . . . . . . . 0 N--CA 1.449 -0.468 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . 0.65 ' HA2' ' O ' ' A' ' 363' ' ' THR . . . -47.53 -54.0 11.61 Favored Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.921 -0.657 . . . . 0.0 113.303 172.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . 0.574 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 89.26 -126.97 8.46 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.441 -0.885 . . . . 0.0 111.447 -176.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -101.76 131.74 47.89 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.708 0.29 . . . . 0.0 111.213 -175.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 372' ' ' ILE . . . . . 0.708 HG21 ' HB3' ' A' ' 362' ' ' PRO . 0.2 OUTLIER -131.03 166.1 29.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 173.698 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . 0.679 ' CB ' ' HB ' ' A' ' 358' ' ' ILE . 24.1 mt-10 -133.97 132.64 40.4 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.363 0.601 . . . . 0.0 111.349 177.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 374' ' ' MET . . . . . 0.578 ' HE3' HG12 ' A' ' 326' ' ' VAL . 0.0 OUTLIER -135.08 166.17 23.69 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 177.245 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 375' ' ' GLN . . . . . 0.895 HE22 ' HG3' ' A' ' 394' ' ' GLN . 0.0 OUTLIER 175.93 176.0 0.26 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.345 0.521 . . . . 0.0 109.694 170.995 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 376' ' ' LEU . . . . . 1.04 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 9.4 tp -166.18 175.36 2.32 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 103.498 -2.779 . . . . 0.0 103.498 177.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 377' ' ' PRO . . . . . 1.04 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 58.2 Cg_exo -40.87 130.36 2.83 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 CA-C-N 121.789 1.675 . . . . 0.0 111.882 167.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -41.05 146.98 0.31 Allowed 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 124.018 3.145 . . . . 0.0 112.207 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 145.34 -168.39 27.21 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.18 -1.01 . . . . 0.0 110.83 -163.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . 0.638 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 3.1 m-20 -88.35 119.81 29.13 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 117.134 0.467 . . . . 0.0 110.026 -178.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -132.99 144.64 50.23 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 1.057 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -143.86 137.04 24.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.218 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . 0.692 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 44.1 mt -97.96 127.7 50.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.506 -175.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 384' ' ' TYR . . . . . 0.514 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.2 OUTLIER -104.64 91.73 3.99 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 114.322 -1.308 . . . . 0.0 108.426 173.475 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . 0.593 HG11 HG13 ' A' ' 342' ' ' VAL . 17.7 t -84.23 89.44 2.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 64.23 -110.35 3.39 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 120.278 -0.963 . . . . 0.0 110.725 -170.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -94.22 -9.13 37.22 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.867 0.334 . . . . 0.0 111.366 172.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . 0.56 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 3.1 mp -66.75 153.35 43.51 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 174.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . 0.692 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 9.0 p30 -164.06 156.51 17.28 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.927 177.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . 0.605 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 23.4 t-80 -174.75 117.83 0.19 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.924 172.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 391' ' ' GLN . . . . . 1.057 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 0.6 OUTLIER -79.08 154.35 29.47 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.11 0.481 . . . . 0.0 110.978 -179.958 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 392' ' ' TRP . . . . . 0.494 ' HD1' ' OE1' ' A' ' 394' ' ' GLN . 6.6 t-105 -166.73 150.93 7.21 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.111 -0.95 . . . . 0.0 108.51 -178.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -105.93 119.67 39.77 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . 0.895 ' HG3' HE22 ' A' ' 375' ' ' GLN . 3.8 mm100 -85.67 113.22 21.71 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -173.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.71 ' HD3' ' H ' ' A' ' 395' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.131 -0.938 . . . . 0.0 111.285 -178.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 303' ' ' THR . . . . . 0.421 ' O ' HG21 ' A' ' 303' ' ' THR . 4.5 t . . . . . 0 N--CA 1.445 -0.696 0 CA-C-O 121.532 0.682 . . . . 0.0 110.664 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . 0.567 ' HB3' ' HE ' ' A' ' 336' ' ' ARG . 5.2 p90 -74.46 127.31 32.74 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 171.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 305' ' ' THR . . . . . 0.464 ' HB ' ' O ' ' A' ' 304' ' ' TYR . 11.6 t 172.82 -169.83 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -173.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 37.2 t -66.78 112.83 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 169.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . 0.447 ' CB ' ' HE3' ' A' ' 364' ' ' MET . 0.1 OUTLIER -67.81 141.02 56.63 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.436 -171.976 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . 0.569 ' HB3' ' HG3' ' A' ' 311' ' ' LYS . 10.4 t0 -59.33 124.45 20.05 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.044 -176.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -40.7 -29.85 0.1 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.101 -1.408 . . . . 0.0 114.418 -177.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 11.4 t -107.08 1.41 24.22 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.348 0.594 . . . . 0.0 111.123 -170.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . 0.569 ' HG3' ' HB3' ' A' ' 308' ' ' ASP . 49.2 mtpt -90.36 43.85 1.17 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.534 0.683 . . . . 0.0 110.079 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.516 ' HB3' HD12 ' A' ' 388' ' ' LEU . 0.3 OUTLIER -140.7 157.14 45.87 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.635 -168.464 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 15.0 p -144.72 152.83 40.98 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.967 175.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . 0.605 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 20.1 m-90 -79.94 94.51 5.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.97 0.414 . . . . 0.0 110.231 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 18.8 tttm -71.24 -42.59 68.66 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.167 173.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 41.0 ttm105 -154.99 98.56 2.04 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.105 173.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -41.91 152.07 0.31 Allowed Pre-proline 0 N--CA 1.472 0.662 0 C-N-CA 123.695 0.798 . . . . 0.0 112.441 174.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 1.0 OUTLIER -44.24 117.11 1.21 Allowed 'Trans proline' 0 C--N 1.365 1.443 0 C-N-CA 123.083 2.522 . . . . 0.0 113.099 -174.292 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 319' ' ' THR . . . . . 0.622 ' O ' HG21 ' A' ' 327' ' ' VAL . 10.1 m -133.41 144.15 49.35 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.004 -174.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -59.1 129.64 43.11 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.625 0.25 . . . . 0.0 110.566 177.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 321' ' ' SER . . . . . 0.547 ' HB3' HG11 ' A' ' 327' ' ' VAL . 59.6 p -77.96 6.73 7.17 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.513 0.725 . . . . 0.0 111.771 -174.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 81.7 -16.75 18.27 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.649 -0.786 . . . . 0.0 113.039 -170.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . 0.4 ' O ' ' HB2' ' A' ' 324' ' ' ASP . 20.7 m80 -98.34 7.61 45.98 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 117.19 0.495 . . . . 0.0 111.217 -177.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 323' ' ' HIS . 36.9 m-20 72.33 49.66 0.21 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.947 0.88 . . . . 0.0 109.233 -177.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 325' ' ' THR . . . . . 0.549 ' HB ' HG13 ' A' ' 358' ' ' ILE . 4.5 p -157.99 163.92 37.31 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 -177.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -111.0 132.63 58.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 119.755 1.161 . . . . 0.0 112.619 -172.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 327' ' ' VAL . . . . . 0.848 HG12 ' HG2' ' A' ' 373' ' ' GLU . 15.4 m -115.2 163.98 11.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.878 174.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 328' ' ' MET . . . . . 0.412 ' HE2' ' HB2' ' A' ' 328' ' ' MET . 10.1 ptm -153.33 152.25 30.9 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 172.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -114.1 135.31 54.16 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.562 HG21 ' HA3' ' A' ' 369' ' ' GLY . 3.1 m -132.94 146.66 32.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 C-N-CA 120.366 -0.534 . . . . 0.0 112.275 -178.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . 0.57 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -118.66 134.6 10.97 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.241 -0.98 . . . . 0.0 112.062 -179.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . 0.749 ' HB3' ' SD ' ' A' ' 364' ' ' MET . 0.1 OUTLIER -89.56 157.65 17.97 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -177.112 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 36.0 t -71.11 -33.36 70.08 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 112.658 -2.064 . . . . 0.0 112.29 169.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 168.62 -17.89 0.07 OUTLIER Glycine 0 CA--C 1.526 0.776 0 C-N-CA 119.62 -1.276 . . . . 0.0 114.689 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 335' ' ' THR . . . . . 0.487 ' O ' ' HD2' ' A' ' 332' ' ' PHE . 25.8 m -54.62 120.09 6.21 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.699 0.25 . . . . 0.0 110.889 176.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.682 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 9.2 ptt180 -75.46 -176.53 0.58 Allowed Pre-proline 0 N--CA 1.467 0.38 0 CA-C-O 117.62 -1.181 . . . . 0.0 108.85 -172.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . 0.844 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.1 OUTLIER -26.67 95.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 123.693 2.929 . . . . 0.0 113.379 177.072 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 338' ' ' CYS . . . . . 0.573 ' O ' HG21 ' A' ' 363' ' ' THR . 13.7 p -115.7 -175.44 2.72 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 113.656 -1.611 . . . . 0.0 110.89 -167.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -110.61 100.42 9.21 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . 0.818 HG22 HG12 ' A' ' 342' ' ' VAL . 24.8 mt -74.8 116.53 54.59 Favored Pre-proline 0 C--N 1.324 -0.531 0 C-N-CA 120.057 -0.657 . . . . 0.0 110.836 -169.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.76 81.65 2.71 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.47 2.114 . . . . 0.0 110.992 177.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.818 HG12 HG22 ' A' ' 340' ' ' ILE . 4.1 m -103.26 134.09 45.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.989 0.899 . . . . 0.0 111.459 -178.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.609 ' HG3' ' HB2' ' A' ' 384' ' ' TYR . 20.8 ptt180 -140.51 176.93 8.38 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 113.899 -1.5 . . . . 0.0 107.734 174.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 344' ' ' ALA . . . . . 0.708 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -144.57 144.99 31.58 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 120.546 -0.462 . . . . 0.0 109.903 172.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.445 ' HB ' ' HA ' ' A' ' 350' ' ' PRO . 11.6 m -119.07 144.98 25.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.1 119.19 10.36 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 177.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 347' ' ' HIS . . . . . 0.73 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 25.5 t-80 46.92 63.84 1.78 Allowed 'General case' 0 N--CA 1.468 0.461 0 O-C-N 124.337 1.023 . . . . 0.0 112.015 170.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . 0.494 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 43.19 42.01 5.17 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 114.926 0.73 . . . . 0.0 114.926 -174.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . 0.542 HG21 ' O ' ' A' ' 347' ' ' HIS . 65.3 t -142.38 103.23 5.52 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 117.792 0.796 . . . . 0.0 108.928 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 350' ' ' PRO . . . . . 0.445 ' HA ' ' HB ' ' A' ' 345' ' ' VAL . 16.1 Cg_exo -72.26 51.8 1.8 Allowed 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.872 2.381 . . . . 0.0 113.073 178.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -103.06 -7.59 21.25 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -178.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 2.4 p -170.72 110.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.065 -169.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . 0.517 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 50.7 t30 -65.25 108.87 2.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.247 177.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.481 HG12 HD22 ' A' ' 376' ' ' LEU . 27.7 m -91.13 0.88 8.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.438 178.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 355' ' ' ALA . . . . . 0.708 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -74.44 83.3 1.96 Allowed 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.098 0.475 . . . . 0.0 111.459 -176.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 356' ' ' MET . . . . . 0.54 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 35.4 ttm -95.36 98.64 10.72 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 168.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.666 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 18.8 mt -80.32 141.65 35.25 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.323 -162.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.702 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 4.2 mm -80.45 -25.28 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 178.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 7.9 m -140.34 97.94 7.5 Favored Pre-proline 0 N--CA 1.445 -0.71 0 CA-C-N 113.513 -1.676 . . . . 0.0 108.797 175.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 360' ' ' PRO . . . . . 0.493 ' HA ' HD12 ' A' ' 357' ' ' LEU . 72.1 Cg_endo -85.83 34.42 0.48 Allowed 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.968 2.445 . . . . 0.0 112.808 -175.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -142.8 64.23 14.81 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.434 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . 0.523 ' HG3' HG22 ' A' ' 342' ' ' VAL . 90.2 Cg_endo -80.9 143.17 14.38 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.355 2.037 . . . . 0.0 111.481 178.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 363' ' ' THR . . . . . 0.573 HG21 ' O ' ' A' ' 338' ' ' CYS . 0.8 OUTLIER -143.47 148.94 36.83 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -174.611 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 364' ' ' MET . . . . . 0.844 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 37.1 mtm . . . . . 0 CA--C 1.495 -1.147 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . 0.57 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . 0.562 ' HA3' HG21 ' A' ' 330' ' ' VAL . . . -64.15 108.31 2.2 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 170.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -71.5 -31.2 65.8 Favored Glycine 0 C--N 1.313 -0.699 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.907 -169.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -164.74 141.68 6.15 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.051 0.453 . . . . 0.0 110.813 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 372' ' ' ILE . . . . . 0.728 HD11 HG11 ' A' ' 342' ' ' VAL . 1.7 mt -133.61 144.57 35.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 171.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . 0.848 ' HG2' HG12 ' A' ' 327' ' ' VAL . 40.0 mt-10 -129.24 125.05 36.03 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.494 -0.482 . . . . 0.0 109.981 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 374' ' ' MET . . . . . 0.666 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 0.0 OUTLIER -140.31 161.45 37.65 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.008 -175.54 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 375' ' ' GLN . . . . . 0.833 HE22 ' HG2' ' A' ' 394' ' ' GLN . 7.3 tp60 -178.52 175.28 1.14 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 174.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 376' ' ' LEU . . . . . 0.832 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 10.8 tp -166.56 157.05 10.81 Favored Pre-proline 0 N--CA 1.444 -0.77 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 377' ' ' PRO . . . . . 0.832 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 82.7 Cg_exo -42.39 132.08 4.99 Favored 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 121.828 1.685 . . . . 0.0 111.008 168.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . 0.777 ' HA ' HE22 ' A' ' 394' ' ' GLN . 5.8 Cg_exo -35.74 139.84 0.13 Allowed 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 124.935 3.757 . . . . 0.0 113.75 -173.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 154.72 -165.08 31.94 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -162.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . 0.73 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 11.8 m-20 -102.91 129.08 49.5 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 117.881 0.841 . . . . 0.0 110.634 177.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.41 ' HB2' ' HE2' ' A' ' 374' ' ' MET . 8.5 m120 -125.71 166.4 16.84 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 176.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 1.005 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -159.66 140.59 4.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 168.886 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . 0.484 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 24.3 mt -96.76 135.39 31.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.919 -175.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 384' ' ' TYR . . . . . 0.626 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 3.4 m-85 -105.11 129.34 53.54 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 167.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 6.1 t -117.56 82.22 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 65.51 -108.8 2.53 Favored Glycine 0 N--CA 1.431 -1.646 0 C-N-CA 120.001 -1.095 . . . . 0.0 110.51 -161.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -93.77 -10.71 33.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.652 0.226 . . . . 0.0 111.543 176.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . 0.626 ' O ' ' HA ' ' A' ' 384' ' ' TYR . 1.1 tp -65.22 146.87 54.39 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . 0.484 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 27.5 p-10 -157.07 147.71 21.45 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.595 0.236 . . . . 0.0 111.077 178.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . 0.463 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 5.3 t60 -172.62 122.33 0.43 Allowed 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.724 176.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 391' ' ' GLN . . . . . 1.005 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 7.9 tt0 -79.2 151.37 31.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.333 0.587 . . . . 0.0 112.367 -173.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 392' ' ' TRP . . . . . . . . . . . . . 43.6 t-105 -148.48 132.54 17.25 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.792 -1.094 . . . . 0.0 109.31 177.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -99.45 109.18 21.77 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . 0.833 ' HG2' HE22 ' A' ' 375' ' ' GLN . 0.0 OUTLIER -97.8 127.19 43.57 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.303 0.573 . . . . 0.0 110.502 -170.05 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.777 -178.382 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 303' ' ' THR . . . . . 0.504 HG21 HG23 ' A' ' 335' ' ' THR . 7.1 t . . . . . 0 N--CA 1.451 -0.407 0 CA-C-O 121.159 0.504 . . . . 0.0 111.691 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . 0.692 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 30.9 p90 -67.09 119.65 12.37 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.307 -0.557 . . . . 0.0 109.794 175.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 305' ' ' THR . . . . . 0.432 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 12.3 t 176.23 -167.67 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -171.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 23.1 t -64.73 108.21 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 169.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . 0.457 ' SG ' ' HE1' ' A' ' 364' ' ' MET . 0.5 OUTLIER -70.71 140.8 51.52 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.732 -169.26 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . 0.565 ' OD2' HG21 ' A' ' 310' ' ' THR . 20.3 t70 -66.85 128.34 35.94 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.442 0.639 . . . . 0.0 111.567 -176.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.543 ' HD2' ' N ' ' A' ' 310' ' ' THR . 0.0 OUTLIER -42.48 -22.44 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 115.954 1.835 . . . . 0.0 115.954 -173.867 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.565 HG21 ' OD2' ' A' ' 308' ' ' ASP . 11.7 t -105.54 -3.81 21.96 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 118.976 0.807 . . . . 0.0 111.62 -170.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . 0.428 ' HB3' ' HE2' ' A' ' 311' ' ' LYS . 10.4 mmmm -67.97 -24.74 65.18 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.873 -177.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.605 ' HE1' ' H ' ' A' ' 369' ' ' GLY . 2.1 m-85 -81.16 173.04 12.93 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 122.01 0.91 . . . . 0.0 113.313 -176.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 313' ' ' THR . . . . . 0.498 ' C ' HD22 ' A' ' 388' ' ' LEU . 14.2 t -148.58 155.21 40.8 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 113.878 -1.51 . . . . 0.0 108.718 177.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 11.6 m-90 -79.23 93.8 5.31 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.17 0.51 . . . . 0.0 110.115 -178.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.571 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 59.6 tttm -76.97 -55.09 5.76 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.186 172.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -142.04 126.21 17.45 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 176.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -69.12 158.04 87.64 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-O 119.14 -0.457 . . . . 0.0 110.286 178.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . 0.483 ' HG3' HD11 ' A' ' 383' ' ' ILE . 87.2 Cg_exo -40.16 117.66 0.47 Allowed 'Trans proline' 0 C--N 1.36 1.152 0 C-N-CA 122.458 2.105 . . . . 0.0 111.997 174.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 13.6 m -136.13 140.56 43.76 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.801 -174.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -55.53 126.95 27.47 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.147 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 321' ' ' SER . . . . . 0.44 ' HB3' HG11 ' A' ' 327' ' ' VAL . 33.5 p -87.1 10.9 15.23 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.644 0.259 . . . . 0.0 111.447 -172.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 85.6 -31.37 3.91 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.53 -173.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 58.7 m-70 -87.06 28.31 0.93 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.82 0.31 . . . . 0.0 111.61 -176.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 48.65 50.62 16.9 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.877 0.846 . . . . 0.0 109.884 -172.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 325' ' ' THR . . . . . 0.532 ' HB ' HG13 ' A' ' 358' ' ' ILE . 11.6 p -154.34 177.14 11.48 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 -175.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -123.16 142.5 39.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 119.536 1.062 . . . . 0.0 112.18 -174.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 327' ' ' VAL . . . . . 0.611 ' HA ' ' O ' ' A' ' 372' ' ' ILE . 3.7 m -124.77 147.65 29.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.897 172.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 328' ' ' MET . . . . . 0.876 ' HE2' HG21 ' A' ' 385' ' ' VAL . 16.5 ptt? -130.84 156.58 44.78 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 173.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.592 ' HA ' ' O ' ' A' ' 370' ' ' GLY . 7.9 tt0 -124.19 125.91 45.23 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.547 HG12 HG22 ' A' ' 385' ' ' VAL . 15.7 m -126.5 143.58 39.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.416 -174.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . 0.557 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -122.74 135.97 10.41 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.692 -176.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . 0.494 ' CD1' ' HA2' ' A' ' 368' ' ' GLY . 0.2 OUTLIER -90.62 155.74 18.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 122.058 0.933 . . . . 0.0 113.122 -177.374 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 30.4 t -78.72 -37.52 41.26 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 113.862 -1.517 . . . . 0.0 112.948 171.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -173.69 -25.75 0.03 OUTLIER Glycine 0 CA--C 1.526 0.727 0 C-N-CA 118.651 -1.737 . . . . 0.0 115.405 -178.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 335' ' ' THR . . . . . 0.683 ' HB ' ' SD ' ' A' ' 364' ' ' MET . 25.9 m -52.7 127.27 22.57 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.699 0.285 . . . . 0.0 110.385 176.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.73 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 2.2 ptm180 -87.72 -179.26 1.28 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 117.378 -1.296 . . . . 0.0 108.491 -174.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . 0.73 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -26.46 98.35 0.02 OUTLIER 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 123.862 3.041 . . . . 0.0 114.115 -175.137 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 338' ' ' CYS . . . . . 0.776 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 1.8 p -109.84 -176.55 3.03 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 113.6 -1.636 . . . . 0.0 110.136 -171.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -109.4 100.51 9.59 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 175.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . 0.855 HG22 HG12 ' A' ' 342' ' ' VAL . 29.9 mt -74.82 114.38 33.98 Favored Pre-proline 0 C--N 1.329 -0.315 0 C-N-CA 120.069 -0.653 . . . . 0.0 111.307 -167.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -79.51 81.46 2.78 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.499 2.132 . . . . 0.0 111.309 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.855 HG12 HG22 ' A' ' 340' ' ' ILE . 4.1 m -103.08 128.33 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-O 121.508 0.671 . . . . 0.0 110.651 -178.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -140.74 175.77 9.34 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 174.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 344' ' ' ALA . . . . . 0.535 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -147.89 149.82 32.97 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.064 -0.654 . . . . 0.0 111.334 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 11.0 m -118.86 146.62 23.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 176.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . 0.46 ' HB2' HG13 ' A' ' 354' ' ' VAL . . . -70.11 117.73 12.05 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 177.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 347' ' ' HIS . . . . . 0.875 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 15.3 t-80 48.31 62.18 2.65 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 124.166 0.916 . . . . 0.0 112.007 173.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . 0.769 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 43.35 40.08 4.54 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.963 -0.637 . . . . 0.0 114.507 -173.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . 0.606 HG21 ' O ' ' A' ' 347' ' ' HIS . 94.9 t -138.13 101.58 8.43 Favored Pre-proline 0 C--O 1.235 0.319 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -72.04 68.88 3.17 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.593 2.196 . . . . 0.0 112.357 178.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -99.85 -56.35 2.41 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 176.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 5.3 p -128.88 136.9 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.264 172.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . 0.535 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 35.0 t30 -62.18 110.58 1.66 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.905 174.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.51 ' CG1' HD23 ' A' ' 376' ' ' LEU . 27.7 m -88.36 3.04 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.346 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 355' ' ' ALA . . . . . 0.458 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -75.14 82.29 2.31 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.312 0.577 . . . . 0.0 110.771 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 356' ' ' MET . . . . . 0.55 ' HB2' ' O ' ' A' ' 375' ' ' GLN . 62.5 mtt -98.19 99.67 10.92 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 168.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.664 HD12 ' HA ' ' A' ' 360' ' ' PRO . 34.5 mt -82.1 141.48 33.1 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.052 -162.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.67 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 4.1 mm -83.64 -21.53 8.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 178.036 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 6.6 m -141.39 96.97 6.89 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 113.828 -1.533 . . . . 0.0 108.673 171.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 360' ' ' PRO . . . . . 0.664 ' HA ' HD12 ' A' ' 357' ' ' LEU . 91.5 Cg_endo -89.05 39.89 0.48 Allowed 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 123.136 2.557 . . . . 0.0 114.259 -170.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 361' ' ' ASN . . . . . 0.56 ' N ' HD21 ' A' ' 361' ' ' ASN . 0.0 OUTLIER -156.85 72.78 4.7 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-O 121.406 0.622 . . . . 0.0 111.234 176.689 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . 0.738 ' HG2' ' HB ' ' A' ' 340' ' ' ILE . 83.2 Cg_endo -85.08 154.31 11.11 Favored 'Trans proline' 0 C--O 1.243 0.731 0 C-N-CA 122.788 2.325 . . . . 0.0 113.029 176.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 1.8 p -143.98 141.12 30.0 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.054 -176.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 364' ' ' MET . . . . . 0.776 ' HG2' ' SG ' ' A' ' 338' ' ' CYS . 10.7 ptp . . . . . 0 CA--C 1.5 -0.98 0 C-N-CA 119.578 -0.849 . . . . 0.0 108.785 178.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . 0.557 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . . . . . . 0 N--CA 1.451 -0.359 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . 0.72 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -57.98 -32.46 66.64 Favored Glycine 0 CA--C 1.506 -0.53 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.835 173.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . 0.592 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 82.78 -131.36 10.32 Favored Glycine 0 N--CA 1.435 -1.379 0 C-N-CA 120.029 -1.081 . . . . 0.0 111.081 -177.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -103.46 137.66 41.25 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.336 0.589 . . . . 0.0 111.558 -175.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 372' ' ' ILE . . . . . 0.644 HG21 ' HB3' ' A' ' 362' ' ' PRO . 0.8 OUTLIER -130.41 150.33 34.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.366 176.73 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . 0.67 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 38.4 mt-10 -116.62 127.08 54.13 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.513 -175.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 374' ' ' MET . . . . . 0.799 ' HG2' HD12 ' A' ' 383' ' ' ILE . 4.1 ppp? -139.38 160.51 39.67 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.153 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 375' ' ' GLN . . . . . 0.834 HE21 ' HA ' ' A' ' 375' ' ' GLN . 0.0 OUTLIER -176.44 174.54 1.91 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.95 0.405 . . . . 0.0 110.89 174.346 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 376' ' ' LEU . . . . . 0.893 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 6.6 tp -165.17 158.74 14.18 Favored Pre-proline 0 N--CA 1.445 -0.676 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 377' ' ' PRO . . . . . 0.893 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 66.4 Cg_exo -40.97 129.34 2.89 Favored 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 121.77 1.647 . . . . 0.0 111.259 167.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . 0.63 ' HA ' HE22 ' A' ' 394' ' ' GLN . 2.7 Cg_exo -35.8 140.75 0.12 Allowed 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 124.948 3.765 . . . . 0.0 113.502 -174.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 151.45 -161.77 29.31 Favored Glycine 0 N--CA 1.442 -0.935 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -162.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . 0.875 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 5.3 m-20 -101.86 129.42 48.09 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 117.918 0.859 . . . . 0.0 110.877 177.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.533 ' HB3' ' HE2' ' A' ' 374' ' ' MET . 9.7 m120 -128.66 146.25 50.92 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 176.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 1.038 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -149.61 138.17 14.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 177.773 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . 0.799 HD12 ' HG2' ' A' ' 374' ' ' MET . 43.9 mt -101.63 135.66 37.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.693 -171.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -105.12 96.68 6.7 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.549 -1.205 . . . . 0.0 108.795 169.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . 0.876 HG21 ' HE2' ' A' ' 328' ' ' MET . 2.3 t -80.36 79.2 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.778 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 174.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 65.93 -104.45 1.02 Allowed Glycine 0 N--CA 1.43 -1.753 0 C-N-CA 119.388 -1.387 . . . . 0.0 110.16 -163.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 387' ' ' ASP . . . . . 0.535 ' HB2' ' HD3' ' A' ' 309' ' ' LYS . 35.9 t70 -98.63 -12.15 21.39 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 175.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . 0.498 HD22 ' C ' ' A' ' 313' ' ' THR . 0.8 OUTLIER -71.69 107.91 4.76 Favored 'General case' 0 CA--C 1.511 -0.537 0 O-C-N 121.771 -0.581 . . . . 0.0 109.773 179.464 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . 0.451 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 5.8 p30 -114.17 144.05 43.82 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 -176.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -169.42 108.61 0.43 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.09 0.472 . . . . 0.0 111.286 -177.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 391' ' ' GLN . . . . . 1.038 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 19.6 tt0 -78.01 154.16 31.73 Favored 'General case' 0 C--N 1.345 0.407 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -172.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 392' ' ' TRP . . . . . . . . . . . . . 39.7 t-105 -154.71 148.43 25.43 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.321 177.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -107.25 119.16 38.64 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 173.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . 0.634 ' HG2' HE22 ' A' ' 375' ' ' GLN . 0.0 OUTLIER -108.86 136.76 47.88 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.456 0.646 . . . . 0.0 111.857 -169.745 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 19.8 tptp . . . . . 0 C--O 1.247 0.936 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.988 175.528 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 303' ' ' THR . . . . . 0.526 ' O ' HG23 ' A' ' 335' ' ' THR . 6.1 t . . . . . 0 CA--C 1.536 0.441 0 CA-C-O 120.908 0.385 . . . . 0.0 111.613 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . 0.414 ' O ' ' HB ' ' A' ' 305' ' ' THR . 5.3 p90 -59.38 132.47 54.11 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.077 177.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 305' ' ' THR . . . . . 0.457 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 15.2 t 172.5 -167.68 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -172.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 64.7 t -62.19 114.23 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 171.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . 0.582 ' HB3' ' HE2' ' A' ' 364' ' ' MET . 0.1 OUTLIER -69.03 135.18 50.46 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.146 0.498 . . . . 0.0 111.753 -172.193 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . 0.549 ' HB3' ' HZ2' ' A' ' 311' ' ' LYS . 22.4 t70 -55.29 111.58 0.9 Allowed 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.475 175.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.521 ' HD3' ' HB2' ' A' ' 387' ' ' ASP . 0.0 OUTLIER -40.77 -24.36 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 115.845 1.795 . . . . 0.0 115.845 -169.189 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.517 ' N ' ' HD2' ' A' ' 309' ' ' LYS . 11.7 t -98.71 -4.14 34.27 Favored 'General case' 0 C--N 1.314 -0.96 0 O-C-N 121.677 -0.639 . . . . 0.0 111.773 -171.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . 0.551 ' HE3' ' H ' ' A' ' 335' ' ' THR . 29.0 mtmm -84.87 48.56 1.57 Allowed 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 120.936 0.398 . . . . 0.0 111.081 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.533 ' CD1' ' HB ' ' A' ' 330' ' ' VAL . 4.9 m-85 -139.65 153.82 47.4 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.662 -178.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 22.7 p -138.18 149.19 45.6 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.17 177.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 8.4 m-90 -67.7 116.12 8.04 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.471 0.653 . . . . 0.0 110.217 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.435 ' HB3' ' C ' ' A' ' 329' ' ' GLU . 53.2 tptt -96.69 -57.45 2.29 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 172.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 316' ' ' ARG . 27.2 ttm-85 -139.04 114.81 9.99 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.631 -1.168 . . . . 0.0 108.298 172.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . 0.478 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -68.21 160.8 73.3 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -178.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . 0.618 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 3.8 Cg_exo -43.06 110.96 0.19 Allowed 'Trans proline' 0 C--N 1.358 1.058 0 C-N-CA 122.237 1.958 . . . . 0.0 112.875 -175.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 319' ' ' THR . . . . . 0.456 ' O ' HG21 ' A' ' 327' ' ' VAL . 31.1 m -127.07 128.76 46.77 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.266 -174.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -55.69 120.35 7.14 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 82.9 p -47.74 -54.26 12.74 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.205 0.602 . . . . 0.0 111.053 -169.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 141.47 -17.04 2.67 Favored Glycine 0 N--CA 1.443 -0.86 0 CA-C-N 114.909 -1.042 . . . . 0.0 111.532 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . 0.562 ' O ' ' HB2' ' A' ' 324' ' ' ASP . 7.1 t-80 -122.73 23.94 9.29 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 120.722 0.296 . . . . 0.0 110.585 -179.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . 0.562 ' HB2' ' O ' ' A' ' 323' ' ' HIS . 5.6 m-20 92.69 45.94 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.122 0.969 . . . . 0.0 111.751 169.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 325' ' ' THR . . . . . 0.676 ' HA ' ' HG2' ' A' ' 375' ' ' GLN . 1.8 p -154.55 -167.1 2.51 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 174.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . 0.966 HG22 ' HZ2' ' A' ' 392' ' ' TRP . 3.0 t -134.38 142.13 41.64 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.395 0 CA-C-N 119.477 1.035 . . . . 0.0 111.855 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 327' ' ' VAL . . . . . 0.606 HG12 ' HG2' ' A' ' 373' ' ' GLU . 17.4 m -119.02 156.32 21.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.882 174.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 328' ' ' MET . . . . . 0.457 ' HE2' ' HB2' ' A' ' 328' ' ' MET . 0.0 OUTLIER -148.02 150.48 34.03 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.718 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.435 ' C ' ' HB3' ' A' ' 315' ' ' LYS . 24.5 tt0 -132.99 132.5 41.97 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -175.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.721 HG13 HG13 ' A' ' 385' ' ' VAL . 0.0 OUTLIER -130.02 150.82 35.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -176.17 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . 0.502 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -120.72 134.52 10.31 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.052 176.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -103.83 174.65 5.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.142 0.471 . . . . 0.0 111.092 -179.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 30.2 m -148.66 49.37 1.01 Allowed 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 170.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -177.05 -88.35 0.07 OUTLIER Glycine 0 C--N 1.339 0.703 0 C-N-CA 119.794 -1.193 . . . . 0.0 113.925 168.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 335' ' ' THR . . . . . 0.691 ' O ' ' HE1' ' A' ' 364' ' ' MET . 50.3 m -51.3 130.62 27.23 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 114.701 -0.75 . . . . 0.0 110.324 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.784 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 8.1 ptm180 -79.1 -176.01 0.65 Allowed Pre-proline 0 CA--C 1.533 0.322 0 CA-C-O 117.633 -1.175 . . . . 0.0 108.986 -174.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . 0.784 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -24.79 103.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 123.955 3.103 . . . . 0.0 114.045 -177.479 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 338' ' ' CYS . . . . . 0.732 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 8.9 p -111.42 -174.95 2.58 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 113.587 -1.642 . . . . 0.0 111.023 -168.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -107.89 96.51 6.43 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 177.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . 0.803 HG22 HG12 ' A' ' 342' ' ' VAL . 27.3 mt -74.08 120.41 81.2 Favored Pre-proline 0 C--N 1.327 -0.387 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.185 -166.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -81.25 80.69 2.9 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 122.295 1.996 . . . . 0.0 111.057 175.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.803 HG12 HG22 ' A' ' 340' ' ' ILE . 6.7 m -100.13 123.5 53.02 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.024 0 CA-C-O 121.986 0.898 . . . . 0.0 109.837 176.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.469 ' HG3' ' HB2' ' A' ' 384' ' ' TYR . 24.3 ptt180 -132.94 173.05 11.81 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.324 -1.307 . . . . 0.0 107.748 176.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 344' ' ' ALA . . . . . 0.628 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -143.27 141.09 30.92 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 173.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 17.5 m -115.83 145.27 21.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -63.91 115.83 5.24 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.005 177.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 347' ' ' HIS . . . . . 0.585 ' HB3' ' CB ' ' A' ' 380' ' ' ASP . 23.8 p80 35.79 71.11 0.13 Allowed 'General case' 0 N--CA 1.475 0.793 0 O-C-N 124.53 1.144 . . . . 0.0 112.601 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . 0.756 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 41.99 47.15 5.23 Favored Glycine 0 C--N 1.333 0.403 0 N-CA-C 115.191 0.836 . . . . 0.0 115.191 -175.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . 0.411 HG21 ' O ' ' A' ' 347' ' ' HIS . 90.1 t -142.61 102.49 5.44 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 176.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -75.95 66.1 6.84 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.865 2.377 . . . . 0.0 112.781 -178.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -100.99 -55.97 2.43 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 177.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 7.4 p -124.96 133.18 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.45 171.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -64.82 112.49 3.28 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.333 177.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.518 ' HB ' HD22 ' A' ' 376' ' ' LEU . 32.7 m -89.98 1.8 7.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.917 178.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 355' ' ' ALA . . . . . 0.628 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -74.44 84.11 1.98 Allowed 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.181 0.515 . . . . 0.0 110.558 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 356' ' ' MET . . . . . 0.607 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 58.6 ttp -94.0 99.95 12.17 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 172.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.566 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 19.9 mt -85.34 115.45 23.1 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.494 -161.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.54 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 3.1 mm -59.18 -26.65 34.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.045 174.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 34.5 m -137.53 90.73 14.6 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.701 174.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -83.6 38.93 0.75 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.416 2.744 . . . . 0.0 113.461 -172.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -147.57 69.37 11.29 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.689 177.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . 0.906 ' HB3' HG21 ' A' ' 372' ' ' ILE . 63.0 Cg_endo -79.59 143.58 17.04 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.234 1.956 . . . . 0.0 111.825 176.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 363' ' ' THR . . . . . 0.408 ' O ' ' HA2' ' A' ' 369' ' ' GLY . 1.3 p -143.64 133.76 24.32 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.45 -173.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 364' ' ' MET . . . . . 0.732 ' HG2' ' SG ' ' A' ' 338' ' ' CYS . 19.2 ptt? . . . . . 0 CA--C 1.501 -0.928 0 C-N-CA 119.095 -1.042 . . . . 0.0 109.195 177.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . 0.502 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . . . . . . 0 N--CA 1.448 -0.543 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . 0.558 ' HA3' HG21 ' A' ' 330' ' ' VAL . . . -65.42 103.8 0.87 Allowed Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.736 -0.945 . . . . 0.0 110.736 170.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . 0.405 ' O ' ' HG3' ' A' ' 329' ' ' GLU . . . -72.41 -32.7 62.01 Favored Glycine 0 C--N 1.317 -0.514 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.518 -167.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -164.29 138.65 5.54 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 123.823 0.366 . . . . 0.0 110.458 179.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 372' ' ' ILE . . . . . 0.906 HG21 ' HB3' ' A' ' 362' ' ' PRO . 0.3 OUTLIER -137.63 156.14 31.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 171.063 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . 0.606 ' HG2' HG12 ' A' ' 327' ' ' VAL . 43.1 mt-10 -134.62 125.53 27.36 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -178.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 374' ' ' MET . . . . . 0.566 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 2.4 mtt -142.94 164.51 29.89 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -174.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 375' ' ' GLN . . . . . 0.733 HE21 ' HA ' ' A' ' 375' ' ' GLN . 0.0 OUTLIER 177.97 179.08 0.32 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.132 0.423 . . . . 0.0 110.929 175.653 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 376' ' ' LEU . . . . . 0.912 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 14.2 tp -165.95 160.74 13.09 Favored Pre-proline 0 N--CA 1.446 -0.64 0 N-CA-C 104.867 -2.271 . . . . 0.0 104.867 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 377' ' ' PRO . . . . . 0.912 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 81.2 Cg_exo -44.54 131.09 9.6 Favored 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 121.502 1.468 . . . . 0.0 111.328 169.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . 0.725 ' HA ' HE22 ' A' ' 394' ' ' GLN . 2.8 Cg_exo -37.03 138.86 0.22 Allowed 'Trans proline' 0 C--N 1.36 1.176 0 C-N-CA 124.607 3.538 . . . . 0.0 112.911 -175.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 152.66 -163.81 30.5 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 -162.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . 0.585 ' CB ' ' HB3' ' A' ' 347' ' ' HIS . 17.6 m-20 -98.86 122.59 42.29 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 117.468 0.634 . . . . 0.0 111.5 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.552 ' HB2' ' CH2' ' A' ' 392' ' ' TRP . 6.1 m120 -124.83 175.17 7.45 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 171.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 1.024 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -163.19 141.42 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 167.304 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . 0.648 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 45.9 mt -101.71 132.23 48.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 C-N-CA 119.674 -0.81 . . . . 0.0 110.456 -174.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 384' ' ' TYR . . . . . 0.548 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 1.9 m-85 -102.33 128.89 48.7 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.483 -1.235 . . . . 0.0 107.782 168.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . 0.721 HG13 HG13 ' A' ' 330' ' ' VAL . 15.2 t -118.48 77.15 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 63.16 -110.49 3.4 Favored Glycine 0 N--CA 1.43 -1.716 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.842 -161.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 387' ' ' ASP . . . . . 0.521 ' HB2' ' HD3' ' A' ' 309' ' ' LYS . 34.1 t70 -81.15 -20.31 41.6 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 177.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . 0.548 ' O ' ' HA ' ' A' ' 384' ' ' TYR . 1.2 mp -68.54 153.03 44.55 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.909 -0.317 . . . . 0.0 110.254 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . 0.648 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 5.0 p-10 -160.24 155.26 24.59 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.08 177.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . 0.618 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 31.6 t60 -171.46 112.12 0.34 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.816 175.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 391' ' ' GLN . . . . . 1.024 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 15.3 tt0 -75.93 149.33 37.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.788 -178.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 392' ' ' TRP . . . . . 0.966 ' HZ2' HG22 ' A' ' 326' ' ' VAL . 0.1 OUTLIER -168.18 151.32 5.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.049 0.452 . . . . 0.0 110.142 -179.111 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -101.05 118.87 37.84 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 178.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . 0.725 HE22 ' HA ' ' A' ' 378' ' ' PRO . 0.0 OUTLIER -95.64 131.81 41.48 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.308 -170.27 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.453 ' HD2' ' HA ' ' A' ' 395' ' ' LYS . 21.7 tptp . . . . . 0 C--O 1.252 1.223 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.281 178.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 303' ' ' THR . . . . . 0.548 HG21 HG23 ' A' ' 335' ' ' THR . 5.2 t . . . . . 0 CA--C 1.536 0.412 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . 0.507 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 25.9 p90 -64.21 127.85 33.22 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 175.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 14.3 t 178.45 -167.13 0.06 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -170.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 34.3 t -65.06 114.34 2.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 165.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.37 139.0 57.17 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.346 0.593 . . . . 0.0 110.414 -170.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . 0.441 ' HB3' ' HG2' ' A' ' 311' ' ' LYS . 5.4 t70 -60.94 126.71 28.36 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.609 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.507 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -44.02 -13.61 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 -175.38 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.404 ' N ' ' HD2' ' A' ' 309' ' ' LYS . 12.5 t -108.07 0.46 21.73 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 119.39 0.996 . . . . 0.0 111.8 -176.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . 0.478 ' HE2' ' OG1' ' A' ' 335' ' ' THR . 29.6 mmmt -72.68 -33.06 66.26 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -175.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.637 ' HA ' ' O ' ' A' ' 331' ' ' GLY . 0.6 OUTLIER -90.95 175.67 6.88 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 122.29 1.043 . . . . 0.0 112.798 -174.77 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 8.7 t -153.98 162.27 41.34 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 113.285 -1.78 . . . . 0.0 109.697 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . 0.626 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 24.0 m-90 -77.75 92.88 4.22 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -178.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -71.57 -43.04 67.03 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 171.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -154.02 124.4 7.0 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 171.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . 0.503 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . . . -70.7 163.59 62.74 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 119.139 -0.458 . . . . 0.0 109.99 -177.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . 0.537 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 2.4 Cg_endo -46.19 113.5 0.63 Allowed 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 122.067 1.845 . . . . 0.0 112.281 -179.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 319' ' ' THR . . . . . 0.492 ' O ' HG21 ' A' ' 327' ' ' VAL . 21.7 m -129.5 133.96 47.53 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.881 -172.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . 0.475 ' HA ' HG13 ' A' ' 326' ' ' VAL . 28.4 t70 -55.84 123.14 13.24 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -178.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 81.0 p -62.66 -47.78 82.18 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 121.339 0.59 . . . . 0.0 109.883 -174.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 120.27 -15.0 10.11 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -109.05 49.2 0.83 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.774 0.797 . . . . 0.0 108.974 177.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 50.67 41.12 25.52 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 114.647 -1.161 . . . . 0.0 112.597 -178.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 325' ' ' THR . . . . . 0.543 ' HA ' ' HG3' ' A' ' 375' ' ' GLN . 6.2 p -150.39 -173.42 4.45 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 175.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . 0.806 HG23 ' HG2' ' A' ' 375' ' ' GLN . 1.5 t -133.75 146.0 32.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.94 -178.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 327' ' ' VAL . . . . . 0.596 HG12 ' HG2' ' A' ' 373' ' ' GLU . 20.6 m -123.6 155.86 30.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.774 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 328' ' ' MET . . . . . 0.481 ' CG ' HD12 ' A' ' 372' ' ' ILE . 0.0 OUTLIER -143.63 154.21 43.31 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 173.934 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -132.58 130.65 40.57 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.643 HG23 HD11 ' A' ' 340' ' ' ILE . 0.0 OUTLIER -118.54 162.21 16.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -179.231 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . 0.767 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -118.55 172.65 14.57 Favored Glycine 0 C--O 1.227 -0.341 0 C-N-CA 119.712 -1.232 . . . . 0.0 112.531 172.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . 0.783 ' HD1' ' HA2' ' A' ' 368' ' ' GLY . 0.9 OUTLIER -127.84 135.78 50.52 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 179.726 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 29.0 m -85.82 -21.01 28.32 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 176.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -171.53 -50.37 0.04 OUTLIER Glycine 0 C--N 1.335 0.518 0 C-N-CA 118.357 -1.878 . . . . 0.0 115.054 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 335' ' ' THR . . . . . 0.548 HG23 HG21 ' A' ' 303' ' ' THR . 65.8 m -49.59 129.74 19.69 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 123.892 0.407 . . . . 0.0 110.115 -178.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.623 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 1.0 OUTLIER -82.37 176.45 3.81 Favored Pre-proline 0 N--CA 1.451 -0.416 0 CA-C-O 117.366 -1.302 . . . . 0.0 107.631 -172.413 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . 0.691 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.1 OUTLIER -25.25 98.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.363 1.342 0 C-N-CA 123.727 2.951 . . . . 0.0 114.053 -173.323 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 338' ' ' CYS . . . . . 0.697 ' SG ' ' HB2' ' A' ' 364' ' ' MET . 6.5 p -129.7 139.54 51.32 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 113.971 -1.468 . . . . 0.0 108.444 -171.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -65.6 124.54 22.64 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.395 -0.522 . . . . 0.0 109.706 177.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . 0.643 HD11 HG23 ' A' ' 330' ' ' VAL . 18.6 tt -98.45 118.72 62.94 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.273 -177.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.7 95.23 0.71 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.949 2.432 . . . . 0.0 112.336 -177.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.658 HG13 HG11 ' A' ' 385' ' ' VAL . 15.4 m -110.07 122.53 64.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.643 0.735 . . . . 0.0 110.812 179.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -133.5 -178.25 4.91 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 173.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 344' ' ' ALA . . . . . 0.548 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -147.03 147.81 31.04 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.629 177.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.522 HG21 HG21 ' A' ' 382' ' ' ILE . 4.8 m -118.94 142.47 33.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 177.053 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . 0.488 ' HB2' HG13 ' A' ' 354' ' ' VAL . . . -65.48 127.67 32.78 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 177.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 347' ' ' HIS . . . . . 0.581 ' O ' HG21 ' A' ' 349' ' ' VAL . 35.2 t60 41.44 60.38 2.13 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 124.204 0.94 . . . . 0.0 112.038 174.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . 0.427 ' H ' ' CG2' ' A' ' 382' ' ' ILE . . . 44.85 38.62 5.85 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 115.035 0.774 . . . . 0.0 115.035 -175.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . 0.581 HG21 ' O ' ' A' ' 347' ' ' HIS . 58.4 t -135.85 103.15 10.04 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 117.917 0.859 . . . . 0.0 108.863 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 350' ' ' PRO . . . . . 0.509 ' HA ' ' HB ' ' A' ' 345' ' ' VAL . 15.4 Cg_exo -72.65 62.12 3.71 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.861 2.374 . . . . 0.0 112.936 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -100.4 -55.2 2.67 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 7.7 p -124.83 133.76 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.456 174.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . 0.49 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 37.4 t30 -66.72 116.14 7.31 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.482 176.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.633 ' HB ' HD21 ' A' ' 376' ' ' LEU . 27.5 m -101.06 5.92 10.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.292 -176.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 355' ' ' ALA . . . . . 0.548 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -74.82 87.03 2.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.194 0.521 . . . . 0.0 112.027 -177.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.1 99.45 11.43 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 170.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.531 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 43.1 mt -87.37 121.82 30.32 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.607 -164.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.886 HD12 ' HB2' ' A' ' 375' ' ' GLN . 2.8 mm -63.25 -29.77 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.565 175.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 359' ' ' THR . . . . . 0.406 ' HA ' ' HD3' ' A' ' 360' ' ' PRO . 27.6 m -133.81 91.42 25.07 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.467 173.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 360' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 359' ' ' THR . 3.8 Cg_endo -85.01 39.9 0.78 Allowed 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 123.518 2.812 . . . . 0.0 113.801 -170.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -158.4 70.74 3.86 Favored Pre-proline 0 C--N 1.319 -0.76 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.288 176.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . 0.445 ' HG3' HG22 ' A' ' 342' ' ' VAL . 97.8 Cg_endo -84.31 147.99 11.5 Favored 'Trans proline' 0 C--O 1.247 0.94 0 C-N-CA 122.17 1.913 . . . . 0.0 111.759 173.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 4.6 m -143.07 150.95 40.22 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -174.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 364' ' ' MET . . . . . 0.697 ' HB2' ' SG ' ' A' ' 338' ' ' CYS . 60.3 mtp . . . . . 0 C--N 1.307 -1.254 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.584 -176.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . 0.783 ' HA2' ' HD1' ' A' ' 332' ' ' PHE . . . . . . . . 0 CA--C 1.494 -1.255 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . 0.61 ' HA3' HG21 ' A' ' 330' ' ' VAL . . . -109.17 5.55 31.96 Favored Glycine 0 C--N 1.307 -1.07 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 168.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 75.44 -84.06 0.87 Allowed Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 114.693 -0.754 . . . . 0.0 113.949 174.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -166.81 141.52 4.1 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.222 -0.489 . . . . 0.0 110.596 -173.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 372' ' ' ILE . . . . . 0.652 HD11 HG11 ' A' ' 342' ' ' VAL . 0.7 OUTLIER -136.72 145.4 30.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.113 175.395 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . 0.652 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 43.5 mt-10 -127.71 125.68 40.46 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 177.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 374' ' ' MET . . . . . 0.924 ' HE2' HD12 ' A' ' 383' ' ' ILE . 0.0 OUTLIER -139.18 156.07 47.38 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.286 -174.227 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 375' ' ' GLN . . . . . 0.914 HE22 ' HG2' ' A' ' 394' ' ' GLN . 0.0 OUTLIER -168.94 175.82 5.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.422 0.629 . . . . 0.0 112.337 175.798 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 376' ' ' LEU . . . . . 0.633 HD21 ' HB ' ' A' ' 354' ' ' VAL . 16.4 tp -168.18 145.09 3.38 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 174.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 377' ' ' PRO . . . . . 0.608 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 80.8 Cg_exo -40.93 140.92 1.04 Allowed 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.266 1.977 . . . . 0.0 112.165 177.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . 0.851 ' HA ' HE22 ' A' ' 394' ' ' GLN . 4.4 Cg_exo -35.46 139.65 0.12 Allowed 'Trans proline' 0 C--N 1.357 1.008 1 C-N-CA 125.488 4.125 . . . . 0.0 114.106 -169.437 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 149.74 -163.09 29.29 Favored Glycine 0 N--CA 1.442 -0.916 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -166.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . 0.552 ' OD1' ' HB2' ' A' ' 347' ' ' HIS . 1.5 p30 -113.2 136.76 52.37 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.781 0.8 . . . . 0.0 111.804 176.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -136.05 171.26 14.72 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.818 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 1.06 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -156.91 143.93 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.826 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 174.133 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . 0.924 HD12 ' HE2' ' A' ' 374' ' ' MET . 45.1 mt -95.3 127.95 46.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.147 -177.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -103.31 92.32 4.45 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.097 170.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . 0.658 HG11 HG13 ' A' ' 342' ' ' VAL . 15.6 t -87.86 82.9 2.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 178.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 57.81 -111.32 2.93 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.415 -0.898 . . . . 0.0 111.777 -173.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 387' ' ' ASP . . . . . 0.412 ' HB2' ' HD3' ' A' ' 309' ' ' LYS . 32.1 t70 -77.03 -24.84 52.07 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.884 0.373 . . . . 0.0 111.306 175.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . 0.629 HD12 ' HD1' ' A' ' 312' ' ' PHE . 3.6 mp -71.43 156.46 39.43 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.403 -179.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . 0.699 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 7.7 p30 -169.49 153.56 5.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.196 178.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . 0.537 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 56.7 t-80 -175.88 117.7 0.15 Allowed 'General case' 0 N--CA 1.469 0.503 0 O-C-N 123.283 0.365 . . . . 0.0 110.486 177.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 391' ' ' GLN . . . . . 1.06 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 4.1 tt0 -73.4 154.94 39.81 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.103 0.478 . . . . 0.0 112.114 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 392' ' ' TRP . . . . . 0.462 ' HE1' ' HB3' ' A' ' 394' ' ' GLN . 0.1 OUTLIER -160.76 151.4 18.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.804 176.558 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -113.91 131.85 56.14 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 177.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . 0.914 ' HG2' HE22 ' A' ' 375' ' ' GLN . 0.0 OUTLIER -111.72 136.13 51.39 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.753 0.311 . . . . 0.0 110.542 -177.131 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.475 ' O ' ' HB3' ' A' ' 378' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.922 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.462 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 303' ' ' THR . . . . . 0.545 ' O ' HG23 ' A' ' 335' ' ' THR . 4.3 t . . . . . 0 CA--C 1.535 0.402 0 CA-C-O 120.787 0.327 . . . . 0.0 111.218 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . 0.478 ' HB3' ' NE ' ' A' ' 336' ' ' ARG . 0.8 OUTLIER -59.35 133.27 55.95 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.965 0.412 . . . . 0.0 110.002 178.814 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 305' ' ' THR . . . . . 0.509 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 12.8 t 174.46 -170.68 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -175.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 18.5 t -65.46 116.25 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 170.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . 0.479 ' HB3' ' CE2' ' A' ' 332' ' ' PHE . 0.0 OUTLIER -67.65 139.26 56.8 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -173.134 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . 0.624 ' OD2' HG21 ' A' ' 310' ' ' THR . 15.8 t70 -59.45 118.03 5.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.064 -176.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.447 ' HD2' ' N ' ' A' ' 310' ' ' THR . 0.0 OUTLIER -48.2 -15.87 0.08 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -168.781 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.624 HG21 ' OD2' ' A' ' 308' ' ' ASP . 9.2 t -99.35 -10.93 21.69 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 118.663 0.665 . . . . 0.0 110.82 -175.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . 0.565 ' HE2' ' CE1' ' A' ' 332' ' ' PHE . 24.5 mtpt -83.67 51.99 2.15 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.487 0.661 . . . . 0.0 110.579 -178.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.495 ' HZ ' ' HG3' ' A' ' 364' ' ' MET . 11.3 m-85 -141.7 151.89 43.38 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.675 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 18.7 p -142.49 152.52 42.78 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.559 -1.2 . . . . 0.0 109.296 178.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 65.7 m95 -82.23 95.39 7.53 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.132 0.491 . . . . 0.0 110.804 178.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.763 ' HA ' ' HE3' ' A' ' 315' ' ' LYS . 0.4 OUTLIER -65.3 -46.47 80.24 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 167.56 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 8.0 ttm180 -150.09 126.71 10.92 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.883 173.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . 0.488 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -72.94 160.91 81.76 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-O 119.218 -0.42 . . . . 0.0 110.162 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . 0.535 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 2.7 Cg_endo -43.55 114.35 0.49 Allowed 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 122.653 2.236 . . . . 0.0 112.492 -176.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 319' ' ' THR . . . . . 0.464 ' O ' HG21 ' A' ' 327' ' ' VAL . 15.8 m -133.78 136.37 44.48 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.438 -174.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -63.66 125.8 25.48 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -176.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 93.7 p -56.17 -48.79 75.66 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.782 -171.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 133.69 -10.44 4.91 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 36.8 t-80 -128.03 61.34 1.44 Allowed 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.346 0.593 . . . . 0.0 109.74 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 52.76 35.62 19.1 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 114.921 -1.036 . . . . 0.0 113.547 177.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 325' ' ' THR . . . . . 0.652 ' HA ' ' HG3' ' A' ' 375' ' ' GLN . 3.7 p -148.48 -175.12 4.8 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 177.134 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . 0.787 HG23 ' HG2' ' A' ' 375' ' ' GLN . 0.2 OUTLIER -130.88 145.91 34.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.34 0.59 . . . . 0.0 111.032 -177.327 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 327' ' ' VAL . . . . . 0.53 HG12 ' HG3' ' A' ' 373' ' ' GLU . 16.9 m -123.44 150.48 27.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.97 175.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 328' ' ' MET . . . . . 0.521 ' SD ' ' HB ' ' A' ' 372' ' ' ILE . 0.1 OUTLIER -139.65 149.54 43.86 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 175.229 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.732 ' HG2' ' HG2' ' A' ' 315' ' ' LYS . 4.6 tt0 -125.3 121.63 34.54 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -177.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.436 ' HB ' ' HD1' ' A' ' 312' ' ' PHE . 4.2 m -126.65 145.03 34.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.718 -174.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -111.67 131.82 10.49 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 119.915 -1.136 . . . . 0.0 112.381 179.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . 1.013 ' H ' ' HA2' ' A' ' 368' ' ' GLY . 4.1 t80 -133.87 136.71 44.53 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.011 -0.736 . . . . 0.0 109.011 176.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 19.9 m -129.78 62.36 1.55 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -171.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . 0.406 ' HA3' ' HZ3' ' A' ' 311' ' ' LYS . . . -164.26 -84.28 0.05 OUTLIER Glycine 0 CA--C 1.52 0.348 0 C-N-CA 119.25 -1.452 . . . . 0.0 113.877 163.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 335' ' ' THR . . . . . 0.949 ' HB ' ' HZ ' ' A' ' 332' ' ' PHE . 35.3 m -50.59 135.82 22.31 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.328 -0.936 . . . . 0.0 109.89 179.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.885 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 17.8 ptt180 -72.69 179.98 0.96 Allowed Pre-proline 0 CA--C 1.523 -0.078 0 CA-C-O 117.783 -1.103 . . . . 0.0 108.923 -178.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . 0.885 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -25.96 101.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.366 1.474 0 C-N-CA 123.653 2.902 . . . . 0.0 112.905 178.631 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 338' ' ' CYS . . . . . 0.547 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 29.0 p -113.88 -175.71 2.74 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 113.81 -1.541 . . . . 0.0 109.465 -165.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -108.74 96.97 6.7 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . 0.747 ' HB ' ' SD ' ' A' ' 364' ' ' MET . 15.7 tt -73.8 131.23 82.07 Favored Pre-proline 0 C--N 1.325 -0.472 0 C-N-CA 119.604 -0.838 . . . . 0.0 111.449 -169.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -81.58 79.28 3.25 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 121.67 1.58 . . . . 0.0 111.156 172.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.677 HG21 HG22 ' A' ' 340' ' ' ILE . 2.5 m -101.62 116.09 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 CA-C-O 121.756 0.789 . . . . 0.0 110.313 177.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.524 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 25.6 ptt180 -133.8 177.85 7.4 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.761 -1.108 . . . . 0.0 108.162 178.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 344' ' ' ALA . . . . . 0.591 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -149.95 147.16 27.55 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.579 176.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.489 ' HB ' ' HA ' ' A' ' 350' ' ' PRO . 5.8 m -118.38 143.03 30.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 177.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.26 121.88 15.81 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 177.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 347' ' ' HIS . . . . . 0.512 ' O ' HG21 ' A' ' 349' ' ' VAL . 41.3 t-80 43.9 61.85 2.16 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 124.277 0.986 . . . . 0.0 112.54 173.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . 0.577 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 46.9 38.05 9.94 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 114.733 0.653 . . . . 0.0 114.733 -175.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . 0.512 HG21 ' O ' ' A' ' 347' ' ' HIS . 58.5 t -138.34 102.88 8.0 Favored Pre-proline 0 C--O 1.235 0.305 0 CA-C-N 117.859 0.829 . . . . 0.0 108.91 178.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 350' ' ' PRO . . . . . 0.489 ' HA ' ' HB ' ' A' ' 345' ' ' VAL . 15.0 Cg_exo -72.6 63.53 3.78 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.848 2.366 . . . . 0.0 112.837 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -100.05 -56.23 2.42 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 7.6 p -125.05 133.1 70.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.278 174.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . 0.47 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 41.8 t30 -64.42 116.57 6.24 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.942 176.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.576 ' HB ' ' HG ' ' A' ' 376' ' ' LEU . 27.4 m -98.53 3.81 10.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.348 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 355' ' ' ALA . . . . . 0.591 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -74.14 84.58 1.84 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.278 0.561 . . . . 0.0 111.026 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 356' ' ' MET . . . . . 0.493 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 22.7 ttt -98.78 98.43 9.54 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 173.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.636 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 57.6 mt -83.06 147.39 28.16 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.655 -161.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.694 ' HB ' ' CB ' ' A' ' 373' ' ' GLU . 4.4 mm -88.68 -19.95 7.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 178.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 20.6 m -133.75 92.94 21.83 Favored Pre-proline 0 N--CA 1.445 -0.682 0 CA-C-N 113.605 -1.634 . . . . 0.0 108.339 171.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -88.51 25.77 0.61 Allowed 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 123.024 2.483 . . . . 0.0 114.074 -170.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 361' ' ' ASN . . . . . 0.482 ' N ' ' HD3' ' A' ' 362' ' ' PRO . 40.9 m-80 -149.65 57.6 2.85 Favored Pre-proline 0 C--N 1.314 -0.953 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.864 176.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . 0.482 ' HD3' ' N ' ' A' ' 361' ' ' ASN . 4.9 Cg_endo -75.52 111.44 3.3 Favored 'Trans proline' 0 C--O 1.247 0.951 0 C-N-CA 121.447 1.432 . . . . 0.0 112.932 179.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 363' ' ' THR . . . . . 0.472 HG21 ' O ' ' A' ' 338' ' ' CYS . 15.8 p -96.68 125.54 41.22 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 114.924 -1.034 . . . . 0.0 111.59 167.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 364' ' ' MET . . . . . 0.794 ' HB3' ' CA ' ' A' ' 369' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.319 -0.734 0 CA-C-N 114.073 -1.421 . . . . 0.0 111.241 -176.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . 1.013 ' HA2' ' H ' ' A' ' 332' ' ' PHE . . . . . . . . 0 N--CA 1.449 -0.442 0 N-CA-C 111.426 -0.67 . . . . 0.0 111.426 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . 0.794 ' CA ' ' HB3' ' A' ' 364' ' ' MET . . . -76.41 -32.15 52.35 Favored Glycine 0 CA--C 1.498 -1.007 0 C-N-CA 120.37 -0.919 . . . . 0.0 113.163 177.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 87.6 -132.42 11.18 Favored Glycine 0 N--CA 1.438 -1.18 0 C-N-CA 120.03 -1.081 . . . . 0.0 111.002 -172.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -103.13 136.7 42.44 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.155 0.502 . . . . 0.0 111.4 -176.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 372' ' ' ILE . . . . . 0.521 ' HB ' ' SD ' ' A' ' 328' ' ' MET . 0.1 OUTLIER -128.07 165.18 27.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.584 175.752 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . 0.694 ' CB ' ' HB ' ' A' ' 358' ' ' ILE . 11.3 mp0 -128.79 130.36 46.9 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.153 0.502 . . . . 0.0 110.637 -177.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 374' ' ' MET . . . . . 0.678 ' HG2' HD12 ' A' ' 383' ' ' ILE . 0.0 OUTLIER -137.8 166.86 22.96 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.026 179.722 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 375' ' ' GLN . . . . . 0.787 ' HG2' HG23 ' A' ' 326' ' ' VAL . 0.0 OUTLIER -173.54 176.15 2.84 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.425 0.631 . . . . 0.0 110.809 168.153 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 376' ' ' LEU . . . . . 0.788 HD22 ' HD2' ' A' ' 377' ' ' PRO . 2.6 tm? -168.0 128.97 1.15 Allowed Pre-proline 0 C--N 1.317 -0.834 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 175.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 377' ' ' PRO . . . . . 0.788 ' HD2' HD22 ' A' ' 376' ' ' LEU . 34.0 Cg_exo -26.73 130.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 124.22 3.28 . . . . 0.0 113.161 -178.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -35.46 133.51 0.23 Allowed 'Trans proline' 0 C--N 1.361 1.2 0 C-N-CA 124.373 3.382 . . . . 0.0 113.0 -167.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 151.0 -174.45 30.27 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 -160.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . 0.638 ' HB3' ' CD2' ' A' ' 393' ' ' PHE . 4.4 p30 -98.41 125.25 43.5 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 117.787 0.794 . . . . 0.0 111.984 -173.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.562 HD21 ' HG2' ' A' ' 394' ' ' GLN . 33.1 m-80 -139.76 153.56 47.19 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.514 -176.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 0.992 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -144.5 140.3 23.97 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.872 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.676 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . 0.678 HD12 ' HG2' ' A' ' 374' ' ' MET . 37.3 mt -98.94 130.44 47.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.938 -175.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 384' ' ' TYR . . . . . 0.538 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.2 OUTLIER -106.71 92.0 3.92 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.006 174.058 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . 0.423 ' O ' ' HB2' ' A' ' 388' ' ' LEU . 9.5 t -87.02 87.71 2.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 64.57 -112.6 5.14 Favored Glycine 0 N--CA 1.442 -0.942 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -169.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -83.95 -16.81 42.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.72 0.295 . . . . 0.0 111.289 174.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' A' ' 384' ' ' TYR . 1.2 mp -68.51 151.52 46.68 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.348 -179.134 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . 0.566 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 29.0 p30 -159.36 151.35 20.75 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.679 177.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . 0.535 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 8.7 t60 -172.26 116.1 0.34 Allowed 'General case' 0 C--O 1.239 0.504 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.481 175.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 391' ' ' GLN . . . . . 0.992 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 4.1 tt0 -76.87 153.75 34.45 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.803 -177.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 392' ' ' TRP . . . . . 0.452 ' HD1' ' CD ' ' A' ' 394' ' ' GLN . 38.8 t-105 -167.08 153.34 8.14 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.948 178.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . 0.638 ' CD2' ' HB3' ' A' ' 380' ' ' ASP . 29.2 m-85 -106.75 110.92 23.22 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 176.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . 0.594 ' HG3' HE22 ' A' ' 375' ' ' GLN . 5.3 mm100 -75.76 107.55 8.01 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -169.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 9.7 ptmm? . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.466 -177.444 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 303' ' ' THR . . . . . 0.611 HG21 HG23 ' A' ' 335' ' ' THR . 14.9 t . . . . . 0 CA--C 1.535 0.372 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -66.78 120.83 14.19 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.058 -177.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 305' ' ' THR . . . . . 0.594 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 9.4 t 173.55 -167.03 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.519 -170.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 37.2 t -64.91 113.07 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 169.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . 0.418 ' SG ' ' HE2' ' A' ' 332' ' ' PHE . 0.0 OUTLIER -68.36 142.59 55.42 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.953 0.406 . . . . 0.0 110.712 -171.332 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . 0.85 ' HB3' ' HG3' ' A' ' 311' ' ' LYS . 6.6 t70 -60.87 126.3 26.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.442 -173.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 17.6 pttm -38.45 -29.62 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 125.849 1.659 . . . . 0.0 114.841 -178.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 12.3 t -108.72 4.31 23.62 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 121.723 -0.611 . . . . 0.0 112.029 -169.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . 0.85 ' HG3' ' HB3' ' A' ' 308' ' ' ASP . 27.8 mtpp -83.8 -28.79 27.86 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -173.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.621 ' HE2' ' O ' ' A' ' 385' ' ' VAL . 0.1 OUTLIER -85.01 175.71 8.88 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.621 0.724 . . . . 0.0 112.159 -176.163 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 5.2 t -153.2 159.45 42.66 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.329 -1.305 . . . . 0.0 109.476 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . 0.449 ' CH2' ' HD3' ' A' ' 318' ' ' PRO . 52.5 m95 -81.99 95.9 7.55 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-O 121.161 0.505 . . . . 0.0 110.518 -179.121 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.608 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 65.4 tttm -65.82 -43.18 89.36 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 168.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 316' ' ' ARG . 44.8 ttm105 -149.28 125.31 10.65 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.846 172.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . 0.543 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -71.02 164.09 59.73 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.309 -179.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . 0.581 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 2.1 Cg_endo -45.59 108.66 0.15 Allowed 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 122.56 2.174 . . . . 0.0 112.03 -179.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 319' ' ' THR . . . . . 0.402 ' O ' HG21 ' A' ' 327' ' ' VAL . 30.1 m -120.5 124.29 45.04 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.647 -174.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . 0.525 ' HA ' HG13 ' A' ' 326' ' ' VAL . 11.4 t70 -53.57 121.62 8.13 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 177.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 60.2 p -61.21 -43.69 98.47 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.236 0.541 . . . . 0.0 109.794 -172.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 116.8 -8.79 16.6 Favored Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 109.911 -1.275 . . . . 0.0 109.911 178.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -127.1 62.37 1.34 Allowed 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 114.541 -0.83 . . . . 0.0 109.823 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 29.5 t70 64.43 17.99 11.1 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.577 171.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 325' ' ' THR . . . . . 0.532 ' HA ' ' HG2' ' A' ' 375' ' ' GLN . 17.8 p -149.45 -174.58 4.71 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 121.828 -0.545 . . . . 0.0 110.285 -176.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . 0.525 HG13 ' HA ' ' A' ' 320' ' ' ASP . 0.6 OUTLIER -135.56 146.07 30.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.202 0.525 . . . . 0.0 111.095 -177.707 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 327' ' ' VAL . . . . . 0.486 HG12 ' HG2' ' A' ' 373' ' ' GLU . 19.8 m -124.33 153.74 31.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.645 177.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 328' ' ' MET . . . . . 0.822 ' SD ' ' HB ' ' A' ' 372' ' ' ILE . 0.0 OUTLIER -145.48 157.84 43.94 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 174.977 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.608 ' HG2' ' HD3' ' A' ' 315' ' ' LYS . 8.0 tt0 -136.21 128.19 29.5 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 120.588 -0.445 . . . . 0.0 109.898 -178.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.717 HG22 HD13 ' A' ' 372' ' ' ILE . 1.5 m -129.63 147.09 33.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -173.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -120.89 134.96 10.49 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.533 -176.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . 0.876 ' H ' ' HA2' ' A' ' 368' ' ' GLY . 0.9 OUTLIER -110.69 152.2 26.82 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.099 0.476 . . . . 0.0 110.67 178.748 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 17.5 m -88.8 -36.64 15.96 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -172.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -146.12 -39.23 0.05 OUTLIER Glycine 0 C--N 1.333 0.394 0 C-N-CA 118.983 -1.58 . . . . 0.0 114.313 -176.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 335' ' ' THR . . . . . 0.611 HG23 HG21 ' A' ' 303' ' ' THR . 22.8 m -53.5 129.53 32.75 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.906 0.384 . . . . 0.0 110.727 -177.281 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.889 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 7.2 ptm180 -87.58 -176.38 0.71 Allowed Pre-proline 0 N--CA 1.455 -0.2 0 CA-C-O 117.268 -1.348 . . . . 0.0 107.857 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . 0.889 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 37.4 Cg_exo -26.28 97.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 123.482 2.788 . . . . 0.0 113.862 -179.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 338' ' ' CYS . . . . . 0.594 ' HB2' ' O ' ' A' ' 305' ' ' THR . 30.0 p -117.55 -176.23 2.98 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.965 -173.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 11.7 mpt_? -111.95 108.39 17.72 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 -177.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . 0.786 ' HB ' ' SD ' ' A' ' 364' ' ' MET . 15.0 tt -73.1 131.77 83.16 Favored Pre-proline 0 C--O 1.236 0.37 0 C-N-CA 119.527 -0.869 . . . . 0.0 111.964 -170.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -87.46 78.72 1.62 Allowed 'Trans proline' 0 N--CA 1.447 -1.21 0 C-N-CA 122.069 1.846 . . . . 0.0 110.976 168.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.777 HG21 HG22 ' A' ' 340' ' ' ILE . 2.5 m -103.51 124.62 57.86 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.872 0 CA-C-O 121.686 0.755 . . . . 0.0 110.613 177.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 28.4 ptt180 -141.11 177.48 8.04 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 173.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 344' ' ' ALA . . . . . 0.552 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -147.18 147.89 30.97 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 120.314 -0.555 . . . . 0.0 110.336 176.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.467 ' HB ' ' HA ' ' A' ' 350' ' ' PRO . 10.6 m -118.54 145.86 23.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.23 116.37 5.93 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 176.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 347' ' ' HIS . . . . . 0.661 ' HB3' ' CB ' ' A' ' 380' ' ' ASP . 7.9 p-80 34.7 71.47 0.11 Allowed 'General case' 0 N--CA 1.476 0.846 0 O-C-N 124.498 1.124 . . . . 0.0 113.651 176.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . 0.756 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 51.88 34.96 38.64 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 115.109 0.804 . . . . 0.0 115.109 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . 0.404 HG21 ' O ' ' A' ' 347' ' ' HIS . 49.9 t -139.65 101.26 7.31 Favored Pre-proline 0 C--O 1.234 0.282 0 CA-C-N 118.531 1.166 . . . . 0.0 108.327 177.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 350' ' ' PRO . . . . . 0.467 ' HA ' ' HB ' ' A' ' 345' ' ' VAL . 12.1 Cg_exo -75.76 61.9 6.35 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.847 2.365 . . . . 0.0 113.097 -179.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -101.02 -56.41 2.33 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 5.5 p -119.4 128.72 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.895 173.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . 0.503 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 31.8 t30 -64.64 116.56 6.35 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.549 176.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.446 ' HB ' ' HG ' ' A' ' 376' ' ' LEU . 16.7 m -92.28 -1.22 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.701 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 355' ' ' ALA . . . . . 0.552 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -76.14 89.12 3.05 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.222 0.534 . . . . 0.0 112.009 -176.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.73 103.08 13.82 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 170.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.538 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 53.8 mt -86.47 121.99 29.8 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.53 -161.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.656 ' HB ' ' CB ' ' A' ' 373' ' ' GLU . 2.5 mm -63.48 -23.79 34.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.506 174.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 16.7 m -128.14 92.02 42.87 Favored Pre-proline 0 N--CA 1.45 -0.475 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.23 169.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -88.82 24.14 0.7 Allowed 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 123.105 2.537 . . . . 0.0 113.47 -171.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 361' ' ' ASN . . . . . 0.558 ' N ' ' HD3' ' A' ' 362' ' ' PRO . 28.3 p-10 -145.23 50.92 1.2 Allowed Pre-proline 0 C--N 1.313 -1.012 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.305 178.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . 0.583 ' HG2' HG21 ' A' ' 340' ' ' ILE . 5.7 Cg_endo -75.2 108.2 2.66 Favored 'Trans proline' 0 C--O 1.249 1.063 0 C-N-CA 121.648 1.566 . . . . 0.0 113.323 -177.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 363' ' ' THR . . . . . 0.632 ' HA ' ' HE2' ' A' ' 364' ' ' MET . 2.0 p -92.11 167.02 12.36 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 114.693 -1.139 . . . . 0.0 112.011 166.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 364' ' ' MET . . . . . 0.786 ' SD ' ' HB ' ' A' ' 340' ' ' ILE . 0.2 OUTLIER . . . . . 0 CA--C 1.496 -1.129 0 CA-C-N 113.716 -1.584 . . . . 0.0 111.188 -172.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . 0.876 ' HA2' ' H ' ' A' ' 332' ' ' PHE . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 111.778 -0.529 . . . . 0.0 111.778 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . 0.494 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -76.8 -34.04 44.54 Favored Glycine 0 C--N 1.334 0.448 0 CA-C-N 117.686 0.743 . . . . 0.0 113.06 178.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 94.39 -50.61 2.11 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.298 -0.953 . . . . 0.0 113.521 179.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -166.36 144.38 5.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 117.08 0.44 . . . . 0.0 111.423 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 372' ' ' ILE . . . . . 0.822 ' HB ' ' SD ' ' A' ' 328' ' ' MET . 0.3 OUTLIER -138.28 158.58 32.06 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 169.474 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . 0.656 ' CB ' ' HB ' ' A' ' 358' ' ' ILE . 52.0 mt-10 -133.29 129.79 38.06 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.79 0.329 . . . . 0.0 110.326 178.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 374' ' ' MET . . . . . 0.625 ' HG2' HD12 ' A' ' 383' ' ' ILE . 4.9 ppp? -136.83 162.72 32.45 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -179.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 375' ' ' GLN . . . . . 1.014 HE22 ' HG3' ' A' ' 394' ' ' GLN . 0.0 OUTLIER 172.52 177.81 0.09 Allowed 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 171.507 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 376' ' ' LEU . . . . . 0.635 HD11 HD22 ' A' ' 381' ' ' ASN . 0.0 OUTLIER -168.5 178.37 1.06 Allowed Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 173.822 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 377' ' ' PRO . . . . . 0.447 ' HD2' ' HB2' ' A' ' 376' ' ' LEU . 92.0 Cg_exo -44.66 125.4 6.26 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 CA-C-N 121.131 1.44 . . . . 0.0 111.176 169.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -36.79 147.08 0.08 OUTLIER 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 124.593 3.529 . . . . 0.0 113.943 -173.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 153.87 -174.44 32.4 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -164.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . 0.661 ' CB ' ' HB3' ' A' ' 347' ' ' HIS . 4.4 m-20 -93.0 124.76 37.2 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 117.558 0.679 . . . . 0.0 109.373 -178.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.635 HD22 HD11 ' A' ' 376' ' ' LEU . 0.6 OUTLIER -120.38 168.56 11.17 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.942 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 1.053 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -160.63 136.74 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 165.662 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . 0.625 HD12 ' HG2' ' A' ' 374' ' ' MET . 37.3 mt -95.37 130.01 44.71 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 C-N-CA 119.383 -0.927 . . . . 0.0 109.489 -174.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 384' ' ' TYR . . . . . 0.559 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.3 OUTLIER -107.65 90.9 3.44 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 114.352 -1.295 . . . . 0.0 108.114 173.237 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . 0.621 ' O ' ' HE2' ' A' ' 312' ' ' PHE . 10.6 t -84.43 91.25 2.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 175.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 61.02 -112.01 4.31 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.171 -171.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -90.05 -13.51 35.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.853 0.358 . . . . 0.0 111.354 176.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . 0.559 ' O ' ' HA ' ' A' ' 384' ' ' TYR . 1.6 mp -67.8 146.44 53.7 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 175.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . 0.573 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 30.2 p30 -155.58 152.25 28.55 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.042 178.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . 0.581 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 13.0 t60 -173.62 119.43 0.3 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.783 174.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 391' ' ' GLN . . . . . 1.053 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 0.8 OUTLIER -82.91 153.04 25.28 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.617 0.722 . . . . 0.0 112.023 -178.235 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 392' ' ' TRP . . . . . 0.5 ' HD1' ' OE1' ' A' ' 394' ' ' GLN . 8.3 t-105 -173.16 137.79 0.71 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 113.977 -1.465 . . . . 0.0 107.753 176.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . 0.52 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 30.8 p90 -100.18 129.77 46.24 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -176.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . 1.014 ' HG3' HE22 ' A' ' 375' ' ' GLN . 3.3 mm100 -89.61 110.45 21.32 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -172.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.568 ' HA ' ' HE2' ' A' ' 395' ' ' LYS . 0.6 OUTLIER . . . . . 0 C--O 1.246 0.904 0 CA-C-O 118.109 -0.948 . . . . 0.0 109.623 -173.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 303' ' ' THR . . . . . 0.582 HG21 HG23 ' A' ' 335' ' ' THR . 5.7 t . . . . . 0 CA--C 1.539 0.542 0 CA-C-O 121.445 0.641 . . . . 0.0 111.723 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . 0.546 ' HB3' ' HD3' ' A' ' 336' ' ' ARG . 39.4 p90 -69.87 128.65 37.12 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 175.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 305' ' ' THR . . . . . 0.493 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 7.3 t 175.86 -170.72 0.06 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -172.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 16.5 t -75.92 106.87 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 107.354 -1.351 . . . . 0.0 107.354 170.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -69.9 155.62 40.29 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.786 0.803 . . . . 0.0 113.031 -168.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . 0.694 ' OD2' HG21 ' A' ' 310' ' ' THR . 23.1 t70 -67.2 122.23 17.38 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.765 178.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.488 ' HB2' ' N ' ' A' ' 387' ' ' ASP . 31.7 pttt -40.66 -32.86 0.23 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 113.506 -1.679 . . . . 0.0 115.499 -173.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.694 HG21 ' OD2' ' A' ' 308' ' ' ASP . 10.0 t -105.77 16.42 25.29 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.882 0.849 . . . . 0.0 110.735 -165.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . 0.526 ' HE3' ' OG1' ' A' ' 335' ' ' THR . 17.4 mtmm -99.46 47.63 0.95 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.626 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 1.039 ' HZ ' HD13 ' A' ' 340' ' ' ILE . 6.1 m-85 -139.98 160.58 39.6 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.65 -171.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 69.5 p -134.59 150.35 50.7 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.849 175.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . 0.552 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 28.0 m-90 -78.01 92.55 4.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.248 0.546 . . . . 0.0 109.761 174.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.467 ' HB3' ' O ' ' A' ' 329' ' ' GLU . 28.5 tptp -68.93 -49.67 56.0 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 170.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 17.0 ttm180 -151.91 125.63 8.99 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.742 175.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . 0.403 ' HB2' ' CG ' ' A' ' 390' ' ' HIS . . . -76.53 157.8 81.95 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-O 119.106 -0.474 . . . . 0.0 110.419 -176.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . 0.866 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 80.3 Cg_exo -37.56 111.76 0.1 Allowed 'Trans proline' 0 C--N 1.363 1.339 0 C-N-CA 123.187 2.592 . . . . 0.0 113.537 -178.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 319' ' ' THR . . . . . 0.518 ' O ' HG21 ' A' ' 327' ' ' VAL . 16.4 m -134.86 138.52 44.25 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.7 -173.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -58.01 126.45 27.5 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.929 0.395 . . . . 0.0 110.075 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 92.4 p -59.44 -44.32 92.96 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.51 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 131.58 -13.32 5.37 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.139 176.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . 0.456 ' O ' ' HB2' ' A' ' 324' ' ' ASP . 95.0 m-70 -114.27 20.51 15.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.588 0.233 . . . . 0.0 110.67 -179.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' A' ' 323' ' ' HIS . 10.6 m-20 84.76 43.99 0.02 OUTLIER 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.148 172.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 325' ' ' THR . . . . . 0.476 ' HB ' HG13 ' A' ' 358' ' ' ILE . 5.5 p -151.85 172.68 15.82 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 174.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . 0.661 HG22 ' HZ2' ' A' ' 392' ' ' TRP . 0.2 OUTLIER -123.66 141.89 42.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 119.945 1.248 . . . . 0.0 111.784 -173.04 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 327' ' ' VAL . . . . . 0.832 HG12 ' HG2' ' A' ' 373' ' ' GLU . 17.8 m -120.86 155.55 24.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.676 176.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 328' ' ' MET . . . . . 0.52 ' HE3' ' HD3' ' A' ' 318' ' ' PRO . 6.6 ptm -146.54 157.93 43.81 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.815 -1.179 . . . . 0.0 107.815 172.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.545 ' HA ' ' O ' ' A' ' 370' ' ' GLY . 16.2 tt0 -128.42 129.39 46.09 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -175.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.519 ' HB ' ' HD1' ' A' ' 312' ' ' PHE . 7.5 m -129.68 149.67 33.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -175.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -109.13 178.22 20.61 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 175.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . 0.511 ' CD1' ' HA2' ' A' ' 368' ' ' GLY . 0.1 OUTLIER -138.56 158.19 44.72 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 117.939 0.869 . . . . 0.0 113.239 -177.211 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 9.7 t -65.54 -70.92 0.21 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.313 -1.312 . . . . 0.0 112.271 171.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -166.73 -22.68 0.02 OUTLIER Glycine 0 CA--C 1.53 1.022 0 C-N-CA 119.04 -1.552 . . . . 0.0 115.475 -176.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 335' ' ' THR . . . . . 0.582 HG23 HG21 ' A' ' 303' ' ' THR . 29.3 m -51.06 131.22 27.08 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 117.136 0.468 . . . . 0.0 109.781 174.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.758 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 1.3 ptm180 -69.23 177.36 1.22 Allowed Pre-proline 0 CA--C 1.518 -0.285 0 CA-C-O 118.456 -0.783 . . . . 0.0 109.198 -172.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . 0.758 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.2 OUTLIER -28.28 105.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.358 1.064 0 C-N-CA 123.253 2.635 . . . . 0.0 112.864 175.22 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 338' ' ' CYS . . . . . 0.81 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 31.6 p -125.47 155.29 40.74 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.275 -1.33 . . . . 0.0 107.615 -174.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -68.29 116.99 9.5 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.369 171.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . 1.039 HD13 ' HZ ' ' A' ' 312' ' ' PHE . 33.8 mm -79.0 118.87 74.95 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.614 -174.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -75.72 79.87 2.73 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.01 1.806 . . . . 0.0 110.804 176.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.771 HG12 HG23 ' A' ' 340' ' ' ILE . 2.5 m -103.87 118.76 51.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.612 0.72 . . . . 0.0 110.098 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -135.72 177.88 7.48 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 176.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 344' ' ' ALA . . . . . 0.547 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -146.67 146.46 30.38 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.495 178.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 17.3 m -119.48 142.65 33.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.4 115.45 5.12 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.561 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 347' ' ' HIS . . . . . 0.511 ' O ' HG21 ' A' ' 349' ' ' VAL . 63.8 t60 41.49 68.05 0.49 Allowed 'General case' 0 N--CA 1.471 0.6 0 O-C-N 124.571 1.169 . . . . 0.0 111.593 176.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . 0.564 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 46.01 39.39 8.98 Favored Glycine 0 C--N 1.333 0.39 0 N-CA-C 115.385 0.914 . . . . 0.0 115.385 -177.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . 0.511 HG21 ' O ' ' A' ' 347' ' ' HIS . 59.8 t -138.88 101.8 7.77 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 118.47 1.135 . . . . 0.0 108.53 178.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -75.14 64.47 6.17 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 122.893 2.396 . . . . 0.0 113.104 -178.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -100.72 -55.84 2.48 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 176.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 4.9 p -123.5 130.96 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.634 173.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . 0.471 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 33.1 t30 -66.13 121.16 14.54 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.801 176.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.636 ' HB ' ' HG ' ' A' ' 376' ' ' LEU . 26.6 m -101.01 4.11 10.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.733 -178.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 355' ' ' ALA . . . . . 0.547 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -72.01 87.36 1.04 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.132 0.492 . . . . 0.0 112.199 -177.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 356' ' ' MET . . . . . 0.573 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 37.0 ttm -97.81 100.54 11.91 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 169.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.65 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 26.4 mt -85.63 122.9 30.39 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.591 -164.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.642 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 3.7 mm -61.1 -30.49 47.83 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 CA-C-N 115.313 -0.858 . . . . 0.0 108.943 173.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 18.8 m -135.48 97.13 13.23 Favored Pre-proline 0 N--CA 1.451 -0.393 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.404 175.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -90.79 37.32 0.32 Allowed 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 123.356 2.704 . . . . 0.0 113.706 -174.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -140.2 61.88 18.69 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.202 176.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . 0.712 ' HB3' HG21 ' A' ' 372' ' ' ILE . 93.9 Cg_endo -84.77 143.06 9.37 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.115 1.877 . . . . 0.0 112.016 176.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 18.4 p -142.47 134.05 26.64 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -178.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 364' ' ' MET . . . . . 0.81 ' HG2' ' SG ' ' A' ' 338' ' ' CYS . 16.3 ptt? . . . . . 0 CA--C 1.49 -1.337 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 176.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . 0.511 ' HA2' ' CD1' ' A' ' 332' ' ' PHE . . . . . . . . 0 CA--C 1.516 0.119 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . 0.735 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -51.91 -40.65 50.49 Favored Glycine 0 C--N 1.335 0.489 0 CA-C-N 117.541 0.671 . . . . 0.0 113.627 174.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . 0.545 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 83.24 -127.09 7.82 Favored Glycine 0 N--CA 1.439 -1.141 0 C-N-CA 120.259 -0.972 . . . . 0.0 111.572 -178.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -102.08 139.41 37.74 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.384 0.612 . . . . 0.0 112.017 -173.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 372' ' ' ILE . . . . . 0.712 HG21 ' HB3' ' A' ' 362' ' ' PRO . 0.5 OUTLIER -131.78 155.5 41.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.093 175.751 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . 0.832 ' HG2' HG12 ' A' ' 327' ' ' VAL . 40.8 mt-10 -133.37 128.39 35.52 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.467 -178.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 374' ' ' MET . . . . . 0.687 ' HE1' ' HB ' ' A' ' 372' ' ' ILE . 0.1 OUTLIER -147.72 165.84 29.26 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.392 -173.937 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 375' ' ' GLN . . . . . 1.022 HE22 ' HG2' ' A' ' 394' ' ' GLN . 0.0 OUTLIER 179.55 175.08 0.76 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 175.874 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 376' ' ' LEU . . . . . 0.7 HD21 ' HD2' ' A' ' 377' ' ' PRO . 2.1 tm? -166.69 143.13 3.89 Favored Pre-proline 0 N--CA 1.445 -0.691 0 N-CA-C 104.373 -2.455 . . . . 0.0 104.373 -176.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 377' ' ' PRO . . . . . 0.7 ' HD2' HD21 ' A' ' 376' ' ' LEU . 46.5 Cg_exo -36.53 134.27 0.33 Allowed 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.569 2.179 . . . . 0.0 112.638 174.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . 0.767 ' HA ' HE22 ' A' ' 394' ' ' GLN . 57.1 Cg_exo -33.86 135.82 0.11 Allowed 'Trans proline' 0 C--N 1.365 1.404 0 C-N-CA 124.875 3.717 . . . . 0.0 114.205 -172.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 153.15 -168.71 31.98 Favored Glycine 0 N--CA 1.441 -1.01 0 N-CA-C 110.256 -1.137 . . . . 0.0 110.256 -166.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.88 130.85 48.45 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 117.103 0.451 . . . . 0.0 110.701 179.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 -136.5 169.97 16.82 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 1.105 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -157.22 143.97 9.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 173.008 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . 0.808 HD11 ' HG3' ' A' ' 318' ' ' PRO . 21.2 mt -100.22 132.89 44.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.558 -176.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 384' ' ' TYR . . . . . 0.536 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 14.6 m-85 -104.71 97.48 7.37 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.183 169.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . 0.517 HG22 HG12 ' A' ' 330' ' ' VAL . 9.7 t -83.84 82.9 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 173.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 63.59 -109.05 2.5 Favored Glycine 0 N--CA 1.434 -1.493 0 C-N-CA 120.39 -0.91 . . . . 0.0 111.223 -166.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 387' ' ' ASP . . . . . 0.488 ' N ' ' HB2' ' A' ' 309' ' ' LYS . 6.9 t70 -93.5 -11.48 31.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.624 0.25 . . . . 0.0 110.894 177.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . 0.552 ' HG ' ' CE2' ' A' ' 314' ' ' TRP . 1.0 OUTLIER -69.07 151.17 46.78 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 174.981 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . 0.547 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 8.2 p30 -156.63 152.38 27.1 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 121.061 -0.256 . . . . 0.0 110.476 -178.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . 0.866 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 4.9 t-80 -174.11 116.39 0.22 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.485 171.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 391' ' ' GLN . . . . . 1.105 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 14.6 tt0 -79.53 154.72 28.61 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.44 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 392' ' ' TRP . . . . . 0.661 ' HZ2' HG22 ' A' ' 326' ' ' VAL . 0.6 OUTLIER -163.8 152.36 13.55 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 114.955 -1.02 . . . . 0.0 108.282 179.691 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -110.52 125.58 53.48 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . 1.022 ' HG2' HE22 ' A' ' 375' ' ' GLN . 0.0 OUTLIER -104.46 119.99 40.23 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 -178.355 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? . . . . . 0 C--N 1.315 -0.926 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.118 -168.521 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 303' ' ' THR . . . . . 0.49 ' O ' HG23 ' A' ' 335' ' ' THR . 5.3 t . . . . . 0 CA--C 1.538 0.489 0 CA-C-O 121.394 0.616 . . . . 0.0 111.198 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . 0.54 ' HB3' ' NE ' ' A' ' 336' ' ' ARG . 0.9 OUTLIER -69.37 132.85 47.04 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 121.727 -0.608 . . . . 0.0 109.421 174.383 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 305' ' ' THR . . . . . 0.523 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 12.9 t 172.38 -169.24 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -177.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 38.6 t -64.16 110.97 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 170.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -69.22 140.69 54.55 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 -171.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . 0.603 ' OD1' HG21 ' A' ' 310' ' ' THR . 11.2 t70 -61.89 131.06 48.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.452 0.644 . . . . 0.0 111.376 -171.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.486 ' HA ' ' HA3' ' A' ' 386' ' ' GLY . 23.4 pttm -37.95 -38.13 0.29 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 113.245 -1.798 . . . . 0.0 114.523 -178.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.603 HG21 ' OD1' ' A' ' 308' ' ' ASP . 13.9 t -98.9 -8.32 25.81 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.067 0.461 . . . . 0.0 111.574 -166.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . 0.485 ' HZ3' ' CB ' ' A' ' 335' ' ' THR . 6.3 mtpm? -74.71 -22.16 58.99 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.319 -175.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.701 ' HD2' ' HB ' ' A' ' 330' ' ' VAL . 49.3 m-85 -70.85 169.26 15.06 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-O 121.934 0.874 . . . . 0.0 112.915 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 313' ' ' THR . . . . . 0.439 HG21 ' O ' ' A' ' 331' ' ' GLY . 11.6 t -151.64 153.25 34.08 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.46 169.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 20.1 m95 -78.11 96.77 5.23 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.143 0.496 . . . . 0.0 111.487 -177.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.587 ' HD3' ' HB3' ' A' ' 329' ' ' GLU . 50.9 tttp -65.94 -46.93 76.38 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 168.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.759 ' HB3' ' HB2' ' A' ' 329' ' ' GLU . 70.9 ttt180 -153.35 97.29 2.14 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.09 175.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -44.68 154.88 0.4 Allowed Pre-proline 0 N--CA 1.476 0.845 0 C-N-CA 123.634 0.774 . . . . 0.0 112.583 175.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . 0.515 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 3.2 Cg_exo -38.67 112.27 0.13 Allowed 'Trans proline' 0 C--N 1.367 1.516 0 C-N-CA 123.676 2.917 . . . . 0.0 113.626 -174.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 319' ' ' THR . . . . . 0.447 ' O ' HG21 ' A' ' 327' ' ' VAL . 32.8 m -127.19 132.44 50.48 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.548 -1.206 . . . . 0.0 109.655 -177.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -59.45 118.45 6.03 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 88.9 p -52.41 -55.68 20.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.536 0.684 . . . . 0.0 111.038 -168.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 136.4 -18.17 3.71 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 109.266 -1.533 . . . . 0.0 109.266 -175.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -104.61 43.58 1.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.714 -0.743 . . . . 0.0 109.217 178.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 49.72 49.2 20.49 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.411 -177.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 1.7 p -155.89 -168.38 2.76 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . 0.568 ' HB ' ' HG3' ' A' ' 374' ' ' MET . 0.3 OUTLIER -127.19 145.48 34.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 118.89 0.768 . . . . 0.0 111.653 -179.627 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 327' ' ' VAL . . . . . 0.48 HG12 ' HG3' ' A' ' 373' ' ' GLU . 11.5 m -119.45 152.43 21.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.846 170.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 328' ' ' MET . . . . . 0.606 ' HE3' ' HB3' ' A' ' 374' ' ' MET . 0.0 OUTLIER -140.09 142.86 36.06 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 175.989 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.759 ' HB2' ' HB3' ' A' ' 316' ' ' ARG . 6.4 mt-10 -122.48 128.55 50.98 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.12 0.486 . . . . 0.0 109.954 179.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.701 ' HB ' ' HD2' ' A' ' 312' ' ' PHE . 0.9 OUTLIER -130.05 146.07 34.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.906 -175.825 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . 0.439 ' O ' HG21 ' A' ' 313' ' ' THR . . . -125.6 140.73 12.43 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.043 -178.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . 0.764 ' CD1' ' HA2' ' A' ' 368' ' ' GLY . 0.4 OUTLIER -111.45 176.64 4.94 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -178.246 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 333' ' ' SER . . . . . 0.432 ' OG ' ' HE2' ' A' ' 311' ' ' LYS . 4.7 p -100.98 -66.66 0.9 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 114.161 -1.381 . . . . 0.0 113.351 172.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -122.05 -43.68 0.39 Allowed Glycine 0 CA--C 1.535 1.315 0 N-CA-C 116.511 1.364 . . . . 0.0 116.511 -167.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 335' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 303' ' ' THR . 33.9 m -52.4 123.04 9.91 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 117.374 0.587 . . . . 0.0 111.404 -176.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.845 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 12.5 ptt180 -75.2 -176.27 0.54 Allowed Pre-proline 0 CA--C 1.529 0.137 0 CA-C-O 117.726 -1.13 . . . . 0.0 109.018 -176.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . 0.845 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -27.27 98.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.371 1.745 0 C-N-CA 123.549 2.833 . . . . 0.0 113.253 177.197 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 338' ' ' CYS . . . . . 0.687 ' SG ' ' HE2' ' A' ' 364' ' ' MET . 14.9 p -114.89 -175.63 2.73 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 113.787 -1.551 . . . . 0.0 110.336 -168.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -108.64 101.51 10.65 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 178.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . 0.731 HG23 HG21 ' A' ' 342' ' ' VAL . 39.3 mt -72.37 118.05 64.15 Favored Pre-proline 0 C--O 1.236 0.362 0 C-N-CA 120.328 -0.549 . . . . 0.0 111.253 -169.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -79.88 78.11 3.82 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 122.21 1.94 . . . . 0.0 111.065 176.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.89 HG11 HG11 ' A' ' 385' ' ' VAL . 0.0 OUTLIER -103.77 115.82 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.235 174.642 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.435 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 37.5 ptt180 -129.46 174.28 9.79 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 177.013 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 344' ' ' ALA . . . . . 0.575 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -146.89 145.44 29.83 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.441 177.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 13.3 m -117.35 145.39 23.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.25 115.25 4.85 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.592 175.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 347' ' ' HIS . . . . . 0.659 ' HB3' ' CB ' ' A' ' 380' ' ' ASP . 11.6 p80 32.47 74.46 0.05 Allowed 'General case' 0 N--CA 1.476 0.861 0 O-C-N 124.745 1.278 . . . . 0.0 113.159 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . 0.818 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 47.51 41.46 17.96 Favored Glycine 0 C--N 1.331 0.301 0 N-CA-C 115.396 0.918 . . . . 0.0 115.396 -178.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 58.6 t -142.8 102.12 5.37 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 118.396 1.098 . . . . 0.0 108.181 176.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -78.02 53.64 4.54 Favored 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 123.072 2.514 . . . . 0.0 113.248 -176.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -102.73 -4.89 24.36 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 122.009 0.909 . . . . 0.0 108.996 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 2.4 p -170.09 104.96 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.668 -164.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . 0.501 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 56.5 t30 -64.12 108.92 1.67 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.994 177.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.509 ' HB ' ' HG ' ' A' ' 376' ' ' LEU . 28.0 m -91.6 3.75 7.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.995 179.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 355' ' ' ALA . . . . . 0.575 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -79.0 84.25 5.03 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.402 0.62 . . . . 0.0 111.275 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 3.0 tmm? -96.04 103.26 15.14 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 170.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.518 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 27.7 mt -86.65 115.28 24.01 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.881 -163.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.693 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 3.4 mm -58.57 -24.91 26.67 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.05 177.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 29.9 m -134.03 90.76 25.62 Favored Pre-proline 0 N--CA 1.445 -0.694 0 CA-C-N 114.446 -1.252 . . . . 0.0 108.37 173.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -84.19 34.58 0.52 Allowed 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 123.094 2.529 . . . . 0.0 113.151 -172.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -140.01 61.75 19.03 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.205 178.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . 0.854 ' HB3' HG21 ' A' ' 372' ' ' ILE . 41.5 Cg_endo -80.92 137.46 11.03 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.299 1.999 . . . . 0.0 111.83 178.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.87 141.37 30.27 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.015 -173.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 364' ' ' MET . . . . . 0.765 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 30.3 mtm . . . . . 0 CA--C 1.492 -1.288 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 176.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . 0.764 ' HA2' ' CD1' ' A' ' 332' ' ' PHE . . . . . . . . 0 N--CA 1.451 -0.341 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . 0.627 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -50.26 -37.69 31.84 Favored Glycine 0 CA--C 1.505 -0.562 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.869 171.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . 0.555 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 78.88 -128.1 8.41 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 120.302 -0.952 . . . . 0.0 111.318 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -103.47 141.39 36.06 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.355 0.598 . . . . 0.0 111.984 -175.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 372' ' ' ILE . . . . . 0.854 HG21 ' HB3' ' A' ' 362' ' ' PRO . 0.5 OUTLIER -136.81 159.73 37.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.35 175.803 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . 0.693 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 2.5 mp0 -125.54 128.52 48.09 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.187 0.518 . . . . 0.0 110.913 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 374' ' ' MET . . . . . 0.606 ' HB3' ' HE3' ' A' ' 328' ' ' MET . 1.9 ptm -130.45 167.49 18.53 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.946 -1.025 . . . . 0.0 108.475 179.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 375' ' ' GLN . . . . . 0.73 HE21 ' H ' ' A' ' 376' ' ' LEU . 13.2 tp60 -179.67 171.67 1.18 Allowed 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 164.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 376' ' ' LEU . . . . . 0.838 HD23 ' HD2' ' A' ' 377' ' ' PRO . 2.5 tm? -165.89 137.64 3.12 Favored Pre-proline 0 C--N 1.311 -1.097 0 N-CA-C 104.015 -2.587 . . . . 0.0 104.015 -178.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 377' ' ' PRO . . . . . 0.838 ' HD2' HD23 ' A' ' 376' ' ' LEU . 31.0 Cg_exo -26.92 119.6 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.544 2.829 . . . . 0.0 112.495 177.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -37.09 139.02 0.22 Allowed 'Trans proline' 0 C--N 1.359 1.122 0 C-N-CA 124.286 3.324 . . . . 0.0 113.071 -169.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 153.66 -164.55 31.21 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -157.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . 0.659 ' CB ' ' HB3' ' A' ' 347' ' ' HIS . 8.8 m-20 -96.59 121.63 38.63 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 118.103 0.951 . . . . 0.0 110.741 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -125.95 163.8 22.2 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 0.999 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -156.94 139.62 6.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 171.685 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . 0.671 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 40.9 mt -98.65 129.85 48.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.092 -174.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 384' ' ' TYR . . . . . 0.667 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.9 OUTLIER -108.89 92.63 4.13 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.437 -1.256 . . . . 0.0 109.207 172.862 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . 0.89 HG11 HG11 ' A' ' 342' ' ' VAL . 3.5 t -85.47 85.52 2.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 176.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . 0.486 ' HA3' ' HA ' ' A' ' 309' ' ' LYS . . . 66.17 -112.38 4.88 Favored Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 120.356 -0.926 . . . . 0.0 110.919 -168.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -85.94 -17.04 36.53 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.867 0.365 . . . . 0.0 110.93 175.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . 0.667 ' O ' ' HA ' ' A' ' 384' ' ' TYR . 1.3 mp -65.33 147.07 54.08 Favored 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . 0.671 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 8.2 p30 -159.7 151.02 19.74 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.714 -0.221 . . . . 0.0 110.745 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . 0.515 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 11.5 t-80 -172.95 115.65 0.28 Allowed 'General case' 0 C--N 1.328 -0.353 0 O-C-N 123.517 0.511 . . . . 0.0 110.119 176.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 391' ' ' GLN . . . . . 0.999 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 0.8 OUTLIER -83.0 154.22 24.58 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.249 0.547 . . . . 0.0 111.76 -177.637 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 392' ' ' TRP . . . . . 0.432 ' HD1' ' CD ' ' A' ' 394' ' ' GLN . 23.8 t-105 -169.93 150.5 3.87 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.891 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . 0.507 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 9.1 p90 -104.83 109.67 21.73 Favored 'General case' 0 C--N 1.317 -0.843 0 O-C-N 121.411 -0.805 . . . . 0.0 108.863 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . 0.647 ' HG3' HE22 ' A' ' 375' ' ' GLN . 4.0 mm100 -78.47 123.53 27.15 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -165.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt . . . . . 0 C--O 1.249 1.028 0 CA-C-O 117.918 -1.039 . . . . 0.0 110.802 -179.384 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 303' ' ' THR . . . . . 0.402 HG21 ' O ' ' A' ' 303' ' ' THR . 9.1 t . . . . . 0 CA--C 1.536 0.428 0 CA-C-O 121.266 0.555 . . . . 0.0 111.914 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . 0.492 ' HB2' ' O ' ' A' ' 337' ' ' PRO . 5.5 p90 -65.06 131.17 45.85 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 174.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 305' ' ' THR . . . . . 0.572 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 12.0 t 175.57 -167.98 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -170.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 8.4 t -75.67 105.64 4.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 168.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . 0.473 ' HB3' HG22 ' A' ' 335' ' ' THR . 0.1 OUTLIER -70.49 156.35 39.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.918 0.866 . . . . 0.0 113.315 -167.206 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . 0.573 ' OD2' HG21 ' A' ' 310' ' ' THR . 26.2 t70 -70.07 130.35 41.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.046 -1.433 . . . . 0.0 111.801 -175.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -38.76 -28.78 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 115.982 1.845 . . . . 0.0 115.982 -174.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 310' ' ' THR . . . . . 0.573 HG21 ' OD2' ' A' ' 308' ' ' ASP . 12.7 t -108.19 0.75 21.67 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 119.323 0.965 . . . . 0.0 112.283 -169.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . 0.426 ' HE3' ' HB3' ' A' ' 311' ' ' LYS . 27.7 mtpp -88.46 43.26 1.12 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -171.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . 0.411 ' HA ' ' O ' ' A' ' 331' ' ' GLY . 0.0 OUTLIER -152.48 177.89 10.14 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.655 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 8.9 t -152.89 160.48 43.06 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.191 177.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -64.33 125.35 24.31 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.456 ' HB3' ' C ' ' A' ' 329' ' ' GLU . 19.9 ttmm -104.43 -45.58 4.62 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 170.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 45.7 ttm105 -149.78 125.65 10.5 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 114.737 -1.119 . . . . 0.0 109.078 170.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . 0.489 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -71.53 161.39 78.74 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-O 119.202 -0.428 . . . . 0.0 110.048 -179.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . 0.658 ' HD3' ' HE3' ' A' ' 328' ' ' MET . 3.5 Cg_exo -44.5 113.21 0.42 Allowed 'Trans proline' 0 C--N 1.358 1.058 0 C-N-CA 122.384 2.056 . . . . 0.0 112.548 -177.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 319' ' ' THR . . . . . 0.633 ' O ' HG21 ' A' ' 327' ' ' VAL . 19.6 m -129.42 138.63 51.58 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.695 -174.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -59.22 127.82 34.05 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.731 0.3 . . . . 0.0 110.706 175.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 67.3 p -79.14 6.01 10.67 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.551 0.74 . . . . 0.0 111.973 -174.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 84.86 -20.76 13.64 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.4 -0.905 . . . . 0.0 113.559 -172.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 86.8 t60 -98.01 7.03 46.97 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 117.388 0.594 . . . . 0.0 110.751 -177.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 36.2 t70 71.85 53.49 0.2 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 122.582 1.182 . . . . 0.0 108.806 -176.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 325' ' ' THR . . . . . 0.834 ' HA ' ' HG3' ' A' ' 375' ' ' GLN . 5.0 p -155.82 161.98 40.54 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . 0.552 HG23 ' HG2' ' A' ' 375' ' ' GLN . 0.2 OUTLIER -110.71 138.48 38.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 119.628 1.104 . . . . 0.0 111.807 -173.552 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 327' ' ' VAL . . . . . 0.649 HG12 ' HG2' ' A' ' 373' ' ' GLU . 15.8 m -114.78 161.08 13.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.736 173.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 328' ' ' MET . . . . . 0.658 ' HE3' ' HD3' ' A' ' 318' ' ' PRO . 0.0 OUTLIER -149.31 152.06 35.23 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 178.272 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.456 ' C ' ' HB3' ' A' ' 315' ' ' LYS . 9.9 tt0 -137.02 135.88 37.96 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -176.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.628 HG21 ' HA3' ' A' ' 369' ' ' GLY . 1.7 m -133.64 161.12 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -176.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . 0.733 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -127.49 134.14 8.17 Favored Glycine 0 CA--C 1.522 0.529 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.03 176.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . 0.411 ' HB3' ' SD ' ' A' ' 364' ' ' MET . 0.1 OUTLIER -90.34 160.47 16.1 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -174.84 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 11.4 p -101.1 4.42 42.15 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.43 -1.259 . . . . 0.0 114.297 173.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 166.55 -46.57 0.26 Allowed Glycine 0 CA--C 1.525 0.679 0 C-N-CA 118.292 -1.909 . . . . 0.0 115.764 173.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 335' ' ' THR . . . . . 0.652 ' HB ' ' CE ' ' A' ' 364' ' ' MET . 41.0 m -54.74 122.54 10.93 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.584 0.192 . . . . 0.0 110.527 -178.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.804 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 16.5 ptt180 -79.2 179.54 1.76 Allowed Pre-proline 0 C--O 1.227 -0.121 0 CA-C-O 117.417 -1.277 . . . . 0.0 108.336 -175.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . 0.804 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.9 OUTLIER -26.12 100.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.37 1.703 0 C-N-CA 123.578 2.852 . . . . 0.0 113.695 -175.143 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 338' ' ' CYS . . . . . 0.895 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 32.1 p -132.32 153.36 50.8 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.256 -170.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 -67.96 114.1 6.22 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.863 173.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . 0.612 HD13 ' HB2' ' A' ' 362' ' ' PRO . 28.9 pt -93.64 119.16 67.41 Favored Pre-proline 0 C--N 1.321 -0.666 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.196 -177.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.68 82.67 0.72 Allowed 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.787 2.325 . . . . 0.0 111.943 -178.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.673 HG11 HD11 ' A' ' 372' ' ' ILE . 34.5 m -102.59 124.71 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-O 122.135 0.969 . . . . 0.0 110.645 -178.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.456 ' HG3' ' HB2' ' A' ' 384' ' ' TYR . 30.0 ptt180 -137.28 178.76 6.84 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 114.527 -1.215 . . . . 0.0 107.961 177.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 344' ' ' ALA . . . . . 0.557 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -149.12 146.21 27.58 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.815 174.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 13.0 m -120.16 147.8 23.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -71.27 119.86 16.02 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 178.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 347' ' ' HIS . . . . . 0.641 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 3.8 t60 46.79 62.07 2.52 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 124.284 0.99 . . . . 0.0 111.377 174.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . 0.702 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 42.14 44.61 4.87 Favored Glycine 0 C--N 1.332 0.357 0 N-CA-C 114.564 0.586 . . . . 0.0 114.564 -173.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . 0.569 HG21 ' O ' ' A' ' 347' ' ' HIS . 96.8 t -141.57 102.32 5.98 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -73.02 67.35 4.08 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.767 2.311 . . . . 0.0 112.5 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -100.51 -57.19 2.16 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 5.4 p -124.57 132.76 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.574 171.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . 0.452 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 50.6 t30 -61.83 109.71 1.32 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.13 175.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.414 ' O ' ' HB2' ' A' ' 376' ' ' LEU . 20.6 m -86.36 3.82 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.091 178.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 355' ' ' ALA . . . . . 0.557 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -79.98 82.22 6.1 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.104 -0.639 . . . . 0.0 110.999 178.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.67 99.16 10.79 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 169.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.667 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 34.6 mt -80.16 139.25 36.88 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.261 -0.882 . . . . 0.0 111.488 -159.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.893 HD12 ' HB2' ' A' ' 375' ' ' GLN . 3.0 mm -80.53 -21.85 11.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 3.4 m -139.55 94.83 9.21 Favored Pre-proline 0 N--CA 1.448 -0.567 0 CA-C-N 113.578 -1.646 . . . . 0.0 108.185 171.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 360' ' ' PRO . . . . . 0.411 ' HA ' HD12 ' A' ' 357' ' ' LEU . 1.3 Cg_endo -83.74 35.75 0.57 Allowed 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 123.494 2.796 . . . . 0.0 113.263 -173.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -141.72 60.04 10.74 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.714 176.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . 0.845 ' HB3' HG21 ' A' ' 372' ' ' ILE . 66.0 Cg_endo -79.47 145.74 18.85 Favored 'Trans proline' 0 C--O 1.241 0.656 0 C-N-CA 122.564 2.176 . . . . 0.0 112.618 -176.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 363' ' ' THR . . . . . 0.448 ' O ' ' HA2' ' A' ' 369' ' ' GLY . 0.8 OUTLIER -144.72 168.31 20.5 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.598 -174.421 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 364' ' ' MET . . . . . 0.895 ' HG2' ' SG ' ' A' ' 338' ' ' CYS . 13.7 ptt? . . . . . 0 C--N 1.313 -1.009 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.4 172.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . 0.733 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . . . . . . 0 N--CA 1.45 -0.433 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . 0.628 ' HA3' HG21 ' A' ' 330' ' ' VAL . . . -64.82 107.59 1.94 Allowed Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 172.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -75.77 -29.54 59.18 Favored Glycine 0 C--N 1.312 -0.799 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.609 -169.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -166.27 143.51 5.21 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.057 0.456 . . . . 0.0 111.249 175.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 372' ' ' ILE . . . . . 0.845 HG21 ' HB3' ' A' ' 362' ' ' PRO . 1.1 mt -135.15 150.22 29.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.002 170.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . 0.698 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 43.3 mt-10 -130.8 127.7 39.22 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.226 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 374' ' ' MET . . . . . 0.755 ' HE2' ' HB ' ' A' ' 372' ' ' ILE . 0.2 OUTLIER -141.73 160.27 40.52 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.219 -175.215 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 375' ' ' GLN . . . . . 0.893 ' HB2' HD12 ' A' ' 358' ' ' ILE . 0.0 OUTLIER -175.23 173.7 2.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.283 0.563 . . . . 0.0 111.653 172.717 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 376' ' ' LEU . . . . . 0.712 HD23 ' HD2' ' A' ' 377' ' ' PRO . 1.8 tm? -168.57 138.81 2.0 Allowed Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 105.11 -2.181 . . . . 0.0 105.11 -178.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 377' ' ' PRO . . . . . 0.712 ' HD2' HD23 ' A' ' 376' ' ' LEU . 51.9 Cg_exo -34.3 135.22 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.951 2.434 . . . . 0.0 112.528 174.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . 0.787 ' HA ' HE22 ' A' ' 394' ' ' GLN . 3.0 Cg_exo -35.59 138.61 0.14 Allowed 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 125.162 3.908 . . . . 0.0 113.63 -171.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 155.46 -160.98 30.25 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 -162.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . 0.641 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 21.8 m-20 -105.14 128.28 53.3 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 118.252 1.026 . . . . 0.0 110.527 174.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.55 HD21 ' C ' ' A' ' 380' ' ' ASP . 0.9 OUTLIER -126.32 138.48 53.59 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.226 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 1.085 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -141.12 135.25 32.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 177.9 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . 0.643 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 20.9 mt -98.9 132.31 44.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 C-N-CA 119.786 -0.766 . . . . 0.0 110.281 -171.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 384' ' ' TYR . . . . . 0.456 ' HB2' ' HG3' ' A' ' 343' ' ' ARG . 5.7 m-85 -102.76 131.15 49.81 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 168.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . 0.56 HG11 HG13 ' A' ' 342' ' ' VAL . 12.6 t -119.71 84.67 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 178.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 59.1 -109.13 1.91 Allowed Glycine 0 N--CA 1.434 -1.468 0 C-N-CA 120.363 -0.922 . . . . 0.0 111.002 -164.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -84.9 -20.27 31.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.566 0.183 . . . . 0.0 111.487 176.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . 0.451 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 0.7 OUTLIER -67.0 154.99 39.81 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.71 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . 0.643 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 7.9 p30 -164.96 160.31 19.0 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.231 175.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . 0.415 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 26.6 t60 -173.65 117.17 0.26 Allowed 'General case' 0 C--O 1.238 0.487 0 O-C-N 123.51 0.506 . . . . 0.0 110.285 173.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 391' ' ' GLN . . . . . 1.085 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 2.5 mt-30 -65.28 146.08 55.39 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 392' ' ' TRP . . . . . . . . . . . . . 50.4 t-105 -149.72 147.83 28.52 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.894 176.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -110.91 115.6 29.78 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 173.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . 0.787 HE22 ' HA ' ' A' ' 378' ' ' PRO . 0.0 OUTLIER -100.45 126.53 46.86 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 121.699 -0.626 . . . . 0.0 109.656 -176.78 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm . . . . . 0 C--N 1.313 -1.017 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.855 -179.37 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 303' ' ' THR . . . . . 0.505 ' O ' HG21 ' A' ' 305' ' ' THR . 10.3 t . . . . . 0 CA--C 1.533 0.31 0 CA-C-O 121.029 0.442 . . . . 0.0 111.744 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 304' ' ' TYR . . . . . 0.419 ' HB3' ' HG2' ' A' ' 336' ' ' ARG . 31.4 p90 -63.28 129.84 41.99 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 120.903 0.382 . . . . 0.0 110.412 -175.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 305' ' ' THR . . . . . 0.505 HG21 ' O ' ' A' ' 303' ' ' THR . 12.4 t 171.88 -166.88 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -167.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 42.2 t -63.91 112.36 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 170.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 307' ' ' CYS . . . . . 0.441 ' HB2' ' CE2' ' A' ' 332' ' ' PHE . 0.0 OUTLIER -67.99 147.05 52.95 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.13 0.491 . . . . 0.0 111.63 -170.07 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -57.07 109.17 0.61 Allowed 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.014 176.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 309' ' ' LYS . . . . . 0.489 ' HB2' ' N ' ' A' ' 387' ' ' ASP . 26.8 pttt -41.47 -27.12 0.08 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 113.892 -1.504 . . . . 0.0 114.716 -175.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 10.0 t -102.87 17.92 22.8 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.616 0.722 . . . . 0.0 110.428 -170.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 311' ' ' LYS . . . . . 0.609 ' HB2' ' CE2' ' A' ' 332' ' ' PHE . 25.2 mtpp -98.72 -14.39 19.8 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.406 178.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -75.05 162.32 28.66 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.11 177.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 313' ' ' THR . . . . . 0.412 HG21 ' O ' ' A' ' 331' ' ' GLY . 8.9 t -141.67 154.9 45.64 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.038 176.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 7.8 m-90 -75.65 92.6 2.97 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 315' ' ' LYS . . . . . 0.513 ' HB3' ' O ' ' A' ' 329' ' ' GLU . 24.0 tptm -73.74 -56.51 4.89 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 171.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.407 ' NH2' HG22 ' A' ' 319' ' ' THR . 58.2 ttt180 -147.11 125.3 12.17 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . 0.449 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . . . -68.69 160.07 78.86 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 119.136 -0.459 . . . . 0.0 109.956 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 318' ' ' PRO . . . . . 0.449 ' HD2' ' HB3' ' A' ' 317' ' ' ALA . 3.9 Cg_exo -41.87 115.78 0.48 Allowed 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 122.823 2.348 . . . . 0.0 112.091 -178.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 319' ' ' THR . . . . . 0.407 HG22 ' NH2' ' A' ' 316' ' ' ARG . 21.5 m -128.68 132.96 48.08 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.246 -174.107 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -62.99 114.86 3.93 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -177.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 69.9 p -55.81 -46.34 78.06 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 123.543 0.527 . . . . 0.0 110.711 -163.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 126.67 -16.2 6.58 Favored Glycine 0 N--CA 1.442 -0.938 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 -179.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -110.62 52.24 0.74 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 57.88 36.29 26.17 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.646 178.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 325' ' ' THR . . . . . 0.469 ' HB ' HG13 ' A' ' 358' ' ' ILE . 3.1 p -157.13 -167.78 2.43 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -178.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 326' ' ' VAL . . . . . 1.012 HG23 ' HG2' ' A' ' 375' ' ' GLN . 3.6 t -131.83 148.45 32.37 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-O 121.318 0.58 . . . . 0.0 112.028 -178.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 327' ' ' VAL . . . . . 0.546 HG12 ' HG2' ' A' ' 373' ' ' GLU . 15.6 m -128.23 151.22 34.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.478 174.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 328' ' ' MET . . . . . 0.401 ' HE2' ' HB2' ' A' ' 328' ' ' MET . 0.6 OUTLIER -137.34 154.86 49.96 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 169.489 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 329' ' ' GLU . . . . . 0.575 ' HG3' ' O ' ' A' ' 370' ' ' GLY . 14.0 tt0 -123.75 129.44 51.07 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 120.214 -0.594 . . . . 0.0 109.627 -177.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 330' ' ' VAL . . . . . 0.514 HG12 HG13 ' A' ' 385' ' ' VAL . 3.6 m -124.38 145.05 32.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.115 -178.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 331' ' ' GLY . . . . . 0.412 ' O ' HG21 ' A' ' 313' ' ' THR . . . -112.95 133.2 11.17 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 119.963 -1.113 . . . . 0.0 111.964 179.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 332' ' ' PHE . . . . . 0.616 ' CZ ' ' HB ' ' A' ' 335' ' ' THR . 2.6 t80 -141.25 143.14 33.97 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 30.7 p -147.34 49.26 1.1 Allowed 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -171.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -145.48 -80.99 0.04 OUTLIER Glycine 0 C--O 1.23 -0.135 0 C-N-CA 119.78 -1.2 . . . . 0.0 112.03 167.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 335' ' ' THR . . . . . 0.616 ' HB ' ' CZ ' ' A' ' 332' ' ' PHE . 56.1 m -50.82 126.71 16.61 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 172.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 336' ' ' ARG . . . . . 0.57 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 0.0 OUTLIER -81.6 -177.84 1.04 Allowed Pre-proline 0 CA--C 1.533 0.324 0 CA-C-O 117.183 -1.389 . . . . 0.0 107.948 -172.19 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 337' ' ' PRO . . . . . 0.944 ' HA ' ' O ' ' A' ' 364' ' ' MET . 6.6 Cg_exo -23.39 101.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 123.91 3.073 . . . . 0.0 114.197 -172.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 338' ' ' CYS . . . . . 0.54 ' O ' HG21 ' A' ' 363' ' ' THR . 13.6 p -116.39 -176.85 3.04 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 113.898 -1.501 . . . . 0.0 111.38 -165.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -111.0 101.11 9.69 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.391 -1.336 . . . . 0.0 107.391 -178.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 340' ' ' ILE . . . . . 0.826 HG23 HG12 ' A' ' 342' ' ' VAL . 22.4 mt -76.32 117.28 63.16 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.464 -170.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -82.44 82.12 2.32 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.875 2.383 . . . . 0.0 112.235 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 342' ' ' VAL . . . . . 0.826 HG12 HG23 ' A' ' 340' ' ' ILE . 16.4 m -102.16 159.36 4.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.225 0.536 . . . . 0.0 110.2 179.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 343' ' ' ARG . . . . . 0.42 ' CG ' ' HB2' ' A' ' 384' ' ' TYR . 15.7 ptt-85 -169.3 175.63 5.51 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 179.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 344' ' ' ALA . . . . . 0.61 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -150.06 149.78 30.79 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.55 178.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 345' ' ' VAL . . . . . 0.463 ' HB ' ' HA ' ' A' ' 350' ' ' PRO . 5.1 m -121.84 147.97 25.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 175.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -67.17 120.97 14.62 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 176.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 347' ' ' HIS . . . . . 0.605 ' HB2' ' CB ' ' A' ' 380' ' ' ASP . 22.7 t60 38.46 69.86 0.24 Allowed 'General case' 0 N--CA 1.479 0.988 0 O-C-N 124.427 1.079 . . . . 0.0 112.435 175.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 348' ' ' GLY . . . . . 0.902 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 44.45 37.41 4.82 Favored Glycine 0 CA--C 1.52 0.378 0 N-CA-C 115.175 0.83 . . . . 0.0 115.175 -177.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 349' ' ' VAL . . . . . 0.551 HG21 ' O ' ' A' ' 347' ' ' HIS . 60.7 t -139.94 102.25 6.97 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 118.257 1.029 . . . . 0.0 108.566 178.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 350' ' ' PRO . . . . . 0.463 ' HA ' ' HB ' ' A' ' 345' ' ' VAL . 19.2 Cg_exo -71.1 67.36 2.54 Favored 'Trans proline' 0 N--CA 1.465 -0.181 0 C-N-CA 122.801 2.334 . . . . 0.0 112.676 177.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -100.62 -56.87 2.23 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 174.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.7 132.93 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 115.166 -0.924 . . . . 0.0 110.886 173.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 353' ' ' ASN . . . . . 0.599 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 31.6 t30 -63.15 111.11 2.08 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.588 173.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 354' ' ' VAL . . . . . 0.553 HG12 HD23 ' A' ' 376' ' ' LEU . 30.0 m -90.62 4.2 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.317 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 355' ' ' ALA . . . . . 0.61 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -76.81 82.47 3.4 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.238 0.542 . . . . 0.0 111.094 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 356' ' ' MET . . . . . 0.608 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 21.5 ttt -95.97 99.57 11.33 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 170.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 357' ' ' LEU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 47.2 mt -88.84 123.06 32.87 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.709 -161.159 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 358' ' ' ILE . . . . . 0.738 HD12 ' HB2' ' A' ' 375' ' ' GLN . 1.5 mm -67.83 -25.38 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 171.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 54.1 m -122.88 86.07 50.34 Favored Pre-proline 0 N--CA 1.451 -0.375 0 CA-C-N 114.323 -1.308 . . . . 0.0 108.683 170.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -82.84 26.13 0.65 Allowed 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 123.043 2.496 . . . . 0.0 113.022 -172.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 46.5 m-20 -155.83 68.75 5.05 Favored Pre-proline 0 C--N 1.318 -0.804 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.696 178.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 362' ' ' PRO . . . . . 0.802 ' HB3' HG21 ' A' ' 372' ' ' ILE . 49.7 Cg_endo -73.28 151.56 48.87 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 121.745 1.63 . . . . 0.0 111.269 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 363' ' ' THR . . . . . 0.544 ' O ' ' HA2' ' A' ' 369' ' ' GLY . 0.0 OUTLIER -145.4 169.71 17.77 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -173.065 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 364' ' ' MET . . . . . 0.944 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 3.3 ppp? . . . . . 0 CA--C 1.494 -1.181 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 176.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 368' ' ' GLY . . . . . 0.451 ' HA2' ' HE1' ' A' ' 364' ' ' MET . . . . . . . . 0 N--CA 1.452 -0.263 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 369' ' ' GLY . . . . . 0.544 ' HA2' ' O ' ' A' ' 363' ' ' THR . . . -45.26 -45.9 10.73 Favored Glycine 0 C--N 1.339 0.704 0 CA-C-N 117.067 0.433 . . . . 0.0 113.126 172.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 370' ' ' GLY . . . . . 0.575 ' O ' ' HG3' ' A' ' 329' ' ' GLU . . . 83.93 -54.58 4.96 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.606 -0.807 . . . . 0.0 113.256 175.058 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -165.16 142.17 5.83 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.266 0.555 . . . . 0.0 111.527 177.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 372' ' ' ILE . . . . . 0.802 HG21 ' HB3' ' A' ' 362' ' ' PRO . 1.1 mt -131.23 150.16 34.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 170.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 373' ' ' GLU . . . . . 0.671 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 32.5 mt-10 -123.45 126.49 46.86 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.199 178.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 374' ' ' MET . . . . . 0.72 ' HE2' HD13 ' A' ' 383' ' ' ILE . 1.0 OUTLIER -137.26 161.37 36.4 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.452 -176.806 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 375' ' ' GLN . . . . . 1.012 ' HG2' HG23 ' A' ' 326' ' ' VAL . 0.0 OUTLIER -170.51 174.88 4.93 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.782 0.801 . . . . 0.0 111.183 170.722 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 376' ' ' LEU . . . . . 0.553 HD23 HG12 ' A' ' 354' ' ' VAL . 35.6 tp -169.02 123.87 0.73 Allowed Pre-proline 0 N--CA 1.438 -1.034 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 171.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 377' ' ' PRO . . . . . 0.547 ' HD2' HD12 ' A' ' 376' ' ' LEU . 45.2 Cg_exo -27.88 129.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 123.766 2.977 . . . . 0.0 112.101 -177.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -33.77 134.47 0.12 Allowed 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 124.499 3.466 . . . . 0.0 113.961 -161.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 158.51 -178.44 34.74 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -160.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 380' ' ' ASP . . . . . 0.73 ' HA ' ' HA ' ' A' ' 393' ' ' PHE . 3.9 m-20 -90.42 120.06 31.22 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 118.064 0.932 . . . . 0.0 111.155 -174.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 381' ' ' ASN . . . . . 0.463 ' N ' HD21 ' A' ' 381' ' ' ASN . 0.7 OUTLIER -121.28 163.47 18.52 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 176.91 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 382' ' ' ILE . . . . . 1.06 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -159.62 138.02 2.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 168.573 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 383' ' ' ILE . . . . . 0.72 HD13 ' HE2' ' A' ' 374' ' ' MET . 12.8 mt -103.41 135.94 38.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 121.028 0.442 . . . . 0.0 110.286 -171.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 384' ' ' TYR . . . . . 0.424 ' CE2' ' HB3' ' A' ' 389' ' ' ASN . 50.9 m-85 -100.17 136.74 39.6 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 164.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 385' ' ' VAL . . . . . 0.699 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 10.9 t -120.73 77.77 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 177.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 59.73 -106.05 0.89 Allowed Glycine 0 N--CA 1.431 -1.685 0 C-N-CA 120.134 -1.031 . . . . 0.0 111.155 -163.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 387' ' ' ASP . . . . . 0.489 ' N ' ' HB2' ' A' ' 309' ' ' LYS . 10.6 t70 -81.32 -17.42 49.3 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 388' ' ' LEU . . . . . 0.699 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 2.4 mp -70.47 154.36 41.97 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.871 0.367 . . . . 0.0 111.195 178.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 389' ' ' ASN . . . . . 0.424 ' HB3' ' CE2' ' A' ' 384' ' ' TYR . 24.2 p30 -155.93 145.22 20.77 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.384 173.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 390' ' ' HIS . . . . . 0.447 ' CD2' ' HD3' ' A' ' 318' ' ' PRO . 0.2 OUTLIER -170.42 106.81 0.31 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.798 -0.183 . . . . 0.0 111.307 -173.743 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 391' ' ' GLN . . . . . 1.06 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 0.6 OUTLIER -87.87 153.98 20.89 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.212 0.53 . . . . 0.0 112.422 -174.355 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 392' ' ' TRP . . . . . . . . . . . . . 5.5 t-105 -178.0 116.28 0.08 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.143 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 393' ' ' PHE . . . . . 0.73 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 18.4 p90 -66.69 124.7 23.61 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.295 170.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 394' ' ' GLN . . . . . 0.564 ' HG3' ' NE2' ' A' ' 375' ' ' GLN . 5.3 mm100 -80.81 108.79 14.77 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 -175.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 53.2 tptt . . . . . 0 C--O 1.247 0.957 0 CA-C-O 118.795 -0.622 . . . . 0.0 109.985 -174.499 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' THR . . . . . 0.456 ' O ' HG21 ' A' ' 303' ' ' THR . 8.8 t . . . . . 0 CA--C 1.537 0.455 0 CA-C-O 121.697 0.761 . . . . 0.0 111.734 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . 0.537 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 13.9 p90 -70.12 117.0 11.14 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' THR . . . . . 0.458 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 11.0 t 172.22 -166.83 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -168.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 39.1 t -64.5 109.55 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 171.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . 0.4 ' HB3' HG22 ' A' ' 335' ' ' THR . 0.4 OUTLIER -72.6 144.6 47.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.199 -173.788 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . 0.577 ' OD1' HG21 ' A' ' 310' ' ' THR . 16.4 t70 -70.9 127.2 31.78 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.546 0.689 . . . . 0.0 110.711 -177.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.507 ' HD3' ' HB2' ' A' ' 387' ' ' ASP . 0.0 OUTLIER -44.85 -18.52 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 116.123 1.897 . . . . 0.0 116.123 -173.465 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.577 HG21 ' OD1' ' A' ' 308' ' ' ASP . 10.9 t -108.29 5.68 25.84 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 119.761 1.164 . . . . 0.0 111.725 -171.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.463 ' HB3' ' HE3' ' A' ' 311' ' ' LYS . 25.3 mtpp -86.26 -25.77 25.35 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -171.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.502 ' HA ' ' O ' ' A' ' 331' ' ' GLY . 0.0 OUTLIER -83.14 174.74 10.53 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.664 0.745 . . . . 0.0 111.269 178.369 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 32.0 p -139.33 156.87 46.73 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.867 -177.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . 0.658 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 26.8 m-90 -76.39 92.34 3.36 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.54 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 84.8 tttt -77.67 -52.04 9.63 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 119.909 -0.716 . . . . 0.0 109.09 170.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.519 ' HB3' ' HB3' ' A' ' 329' ' ' GLU . 9.2 ttp180 -143.66 121.15 11.72 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 172.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . 0.495 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -72.49 162.49 73.74 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.993 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . 0.625 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 5.7 Cg_exo -42.31 115.48 0.5 Allowed 'Trans proline' 0 C--N 1.358 1.072 0 C-N-CA 122.586 2.191 . . . . 0.0 112.846 -177.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' THR . . . . . 0.438 ' O ' HG21 ' A' ' 327' ' ' VAL . 45.6 m -131.08 136.95 48.87 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.532 -174.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -60.12 116.88 4.51 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 97.3 p -52.28 -53.57 42.34 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.185 0.517 . . . . 0.0 111.37 -167.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 141.88 -26.44 2.36 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.62 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 17.1 t60 -99.24 12.23 36.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.032 0.444 . . . . 0.0 110.039 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . 0.409 ' O ' HG23 ' A' ' 325' ' ' THR . 24.6 t70 86.86 53.74 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.878 175.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' THR . . . . . 0.409 HG23 ' O ' ' A' ' 324' ' ' ASP . 0.9 OUTLIER -158.58 -167.48 2.16 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 113.67 -1.605 . . . . 0.0 106.906 176.423 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . 0.721 ' HB ' ' HG3' ' A' ' 374' ' ' MET . 0.6 OUTLIER -125.72 145.89 32.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 119.704 1.138 . . . . 0.0 111.64 -178.689 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' VAL . . . . . 0.458 HG12 ' HG2' ' A' ' 373' ' ' GLU . 13.6 m -123.56 152.58 28.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.751 172.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' MET . . . . . 0.648 ' SD ' ' HB ' ' A' ' 372' ' ' ILE . 0.1 OUTLIER -142.4 149.69 39.68 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 173.152 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.54 ' HG2' ' HD3' ' A' ' 315' ' ' LYS . 46.6 tt0 -129.43 125.14 35.82 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.071 -175.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.51 HG12 HG13 ' A' ' 385' ' ' VAL . 2.8 m -129.97 146.84 33.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -174.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . 0.502 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -118.03 137.96 13.52 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.573 -176.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -89.43 156.33 18.75 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.894 0.854 . . . . 0.0 112.957 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 2.3 p -94.79 -19.56 20.23 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.496 -1.229 . . . . 0.0 113.813 171.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -176.23 -37.22 0.05 OUTLIER Glycine 0 CA--C 1.525 0.717 0 C-N-CA 118.979 -1.582 . . . . 0.0 114.991 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' THR . . . . . 0.691 ' HB ' ' SD ' ' A' ' 364' ' ' MET . 90.7 m -53.36 127.21 23.97 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.682 0.277 . . . . 0.0 111.192 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.537 ' HG3' ' HB3' ' A' ' 304' ' ' TYR . 2.0 ptm180 -91.69 179.67 1.34 Allowed Pre-proline 0 CA--C 1.534 0.333 0 CA-C-O 117.248 -1.358 . . . . 0.0 107.914 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . 0.557 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.2 OUTLIER -23.99 96.96 0.01 OUTLIER 'Trans proline' 0 C--N 1.375 1.935 0 C-N-CA 124.098 3.199 . . . . 0.0 114.501 -168.256 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' CYS . . . . . 0.776 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 2.2 p -111.17 -177.61 3.25 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 113.928 -1.487 . . . . 0.0 109.94 -172.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -109.93 99.84 8.9 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 176.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . 0.653 HG21 HG12 ' A' ' 342' ' ' VAL . 43.7 mt -74.42 118.78 72.65 Favored Pre-proline 0 C--N 1.327 -0.412 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.181 -168.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -76.89 80.53 2.82 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.373 2.049 . . . . 0.0 111.238 176.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.653 HG12 HG21 ' A' ' 340' ' ' ILE . 1.4 m -102.16 111.77 33.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 114.849 -1.068 . . . . 0.0 110.106 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -127.14 174.63 8.76 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 178.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' ALA . . . . . 0.6 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -146.53 145.63 30.21 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.474 176.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 11.5 m -117.72 145.46 23.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 177.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -66.51 119.2 11.25 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.375 175.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . 0.534 ' O ' HG21 ' A' ' 349' ' ' VAL . 20.7 t60 40.72 66.61 0.61 Allowed 'General case' 0 N--CA 1.474 0.775 0 O-C-N 124.491 1.119 . . . . 0.0 111.95 175.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . 0.575 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 47.32 34.17 8.57 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 115.271 0.869 . . . . 0.0 115.271 -178.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . 0.534 HG21 ' O ' ' A' ' 347' ' ' HIS . 63.7 t -135.7 102.81 10.27 Favored Pre-proline 0 C--O 1.233 0.235 0 CA-C-N 118.371 1.086 . . . . 0.0 108.685 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -74.54 62.35 5.42 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.866 2.377 . . . . 0.0 112.837 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -100.15 -56.26 2.41 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.5 p -120.65 128.9 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-N 115.113 -0.948 . . . . 0.0 110.36 173.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . 0.445 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 33.0 t30 -64.49 119.63 10.78 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.526 175.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.462 ' O ' ' HB2' ' A' ' 376' ' ' LEU . 29.1 m -98.32 6.22 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.94 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . 0.6 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -77.55 84.99 3.92 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.474 0.654 . . . . 0.0 111.142 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' MET . . . . . 0.573 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 21.4 ttt -99.3 100.11 11.15 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 106.16 -1.792 . . . . 0.0 106.16 171.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.609 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 47.1 mt -86.21 121.95 29.52 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.416 -160.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.678 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 3.2 mm -64.43 -28.98 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 108.137 -1.061 . . . . 0.0 108.137 174.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 86.4 m -123.46 84.52 52.64 Favored Pre-proline 0 N--CA 1.45 -0.438 0 CA-C-N 114.27 -1.332 . . . . 0.0 108.459 172.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -85.33 27.66 0.59 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.06 2.507 . . . . 0.0 114.287 -169.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 35.7 m-20 -149.2 66.31 8.48 Favored Pre-proline 0 C--N 1.315 -0.922 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.123 177.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . 0.868 ' HB3' HG21 ' A' ' 372' ' ' ILE . 75.9 Cg_endo -81.43 149.08 16.64 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.183 1.922 . . . . 0.0 112.666 178.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' THR . . . . . 0.466 HG21 ' O ' ' A' ' 338' ' ' CYS . 2.6 p -143.75 147.59 34.41 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.615 -174.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' MET . . . . . 0.776 ' HG2' ' SG ' ' A' ' 338' ' ' CYS . 10.3 ptp -102.59 129.69 49.23 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 119.444 -0.902 . . . . 0.0 108.911 177.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -120.42 -166.13 1.28 Allowed 'General case' 0 C--N 1.321 -0.648 0 O-C-N 124.87 1.356 . . . . 0.0 111.412 -172.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . 0.561 HD21 ' N ' ' A' ' 366' ' ' ASN . 0.0 OUTLIER -56.7 -12.95 2.1 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -178.11 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -120.24 3.14 10.88 Favored 'General case' 0 C--N 1.332 -0.19 0 O-C-N 121.57 -0.706 . . . . 0.0 110.926 176.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 112.65 -179.75 19.36 Favored Glycine 0 N--CA 1.451 -0.347 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . 0.561 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -50.35 -42.01 41.32 Favored Glycine 0 CA--C 1.504 -0.611 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.04 172.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . 0.522 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 82.33 -130.42 9.69 Favored Glycine 0 N--CA 1.436 -1.34 0 C-N-CA 120.11 -1.043 . . . . 0.0 110.76 -177.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -103.3 138.16 40.45 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.323 0.582 . . . . 0.0 111.25 -175.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 372' ' ' ILE . . . . . 0.868 HG21 ' HB3' ' A' ' 362' ' ' PRO . 0.1 OUTLIER -130.48 165.23 31.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.41 -0.814 . . . . 0.0 108.999 175.921 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . 0.678 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 43.2 mt-10 -132.96 128.69 37.0 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.096 0.474 . . . . 0.0 110.483 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 374' ' ' MET . . . . . 0.721 ' HG3' ' HB ' ' A' ' 326' ' ' VAL . 0.0 OUTLIER -133.95 165.67 24.48 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -178.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 375' ' ' GLN . . . . . 0.774 HE21 ' H ' ' A' ' 376' ' ' LEU . 14.2 tp60 -177.67 172.83 1.7 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.155 -0.684 . . . . 0.0 109.155 169.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' LEU . . . . . 0.774 ' H ' HE21 ' A' ' 375' ' ' GLN . 2.5 tm? -165.81 133.89 2.38 Favored Pre-proline 0 C--N 1.309 -1.163 0 N-CA-C 103.753 -2.684 . . . . 0.0 103.753 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' PRO . . . . . 0.75 ' HD2' HD22 ' A' ' 376' ' ' LEU . 34.6 Cg_exo -28.07 126.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.479 2.786 . . . . 0.0 112.586 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -35.12 134.03 0.18 Allowed 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 124.574 3.516 . . . . 0.0 113.358 -167.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 157.1 -170.62 34.38 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -162.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . 0.693 ' HA ' ' HA ' ' A' ' 393' ' ' PHE . 2.9 m-20 -89.85 120.02 30.73 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 117.509 0.654 . . . . 0.0 110.515 -177.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -125.28 166.78 15.9 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 176.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 0.965 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -160.57 139.83 3.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 169.694 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . 0.712 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 40.8 mt -99.64 125.06 53.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 C-N-CA 119.367 -0.933 . . . . 0.0 109.539 -175.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -101.07 92.36 4.97 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.29 171.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . 0.51 HG13 HG12 ' A' ' 330' ' ' VAL . 11.7 t -84.9 85.62 2.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 60.63 -112.57 4.71 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.508 -0.853 . . . . 0.0 111.329 -170.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' ASP . . . . . 0.507 ' HB2' ' HD3' ' A' ' 309' ' ' LYS . 3.5 t70 -83.18 -18.13 40.43 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.091 0.472 . . . . 0.0 110.512 177.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . 0.658 ' HG ' ' CE2' ' A' ' 314' ' ' TRP . 3.4 mp -72.06 156.58 39.05 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.894 177.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . 0.712 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 7.7 p30 -168.96 158.17 8.49 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.316 177.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . 0.625 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 37.5 t-80 -174.83 116.93 0.18 Allowed 'General case' 0 C--O 1.237 0.431 0 O-C-N 123.419 0.45 . . . . 0.0 110.011 175.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' GLN . . . . . 0.965 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 8.2 tt0 -77.6 153.27 33.4 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.019 0.438 . . . . 0.0 112.073 -179.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' TRP . . . . . 0.401 ' CD1' ' NE2' ' A' ' 394' ' ' GLN . 23.9 t-105 -179.49 115.27 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.873 178.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . 0.693 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 12.3 p90 -68.21 121.05 15.39 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.21 0.529 . . . . 0.0 110.249 172.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . 0.625 ' HG3' HE22 ' A' ' 375' ' ' GLN . 4.2 mm100 -84.27 119.09 24.64 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -172.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.496 ' HB3' ' HZ3' ' A' ' 395' ' ' LYS . 4.1 mmmp? . . . . . 0 C--O 1.246 0.919 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.393 -176.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' THR . . . . . 0.429 ' O ' HG21 ' A' ' 303' ' ' THR . 6.4 t . . . . . 0 CA--C 1.538 0.497 0 CA-C-O 121.602 0.715 . . . . 0.0 111.181 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . 0.529 ' HB3' ' NE ' ' A' ' 336' ' ' ARG . 33.5 p90 -76.75 126.46 31.03 Favored 'General case' 0 CA--C 1.516 -0.358 0 O-C-N 121.806 -0.558 . . . . 0.0 109.729 176.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' THR . . . . . 0.503 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 10.0 t -179.9 -173.91 0.25 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.245 -174.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.481 HG11 ' O ' ' A' ' 306' ' ' VAL . 7.5 p -63.09 111.54 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 167.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.67 144.25 51.12 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.377 -169.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . 0.471 ' OD2' HG21 ' A' ' 310' ' ' THR . 34.0 t70 -67.56 119.96 13.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.322 0.582 . . . . 0.0 110.448 -178.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.61 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -46.12 -12.17 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 -172.631 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.471 HG21 ' OD2' ' A' ' 308' ' ' ASP . 8.1 t -107.2 -0.67 22.52 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 119.079 0.854 . . . . 0.0 111.319 -175.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -83.85 -25.11 30.57 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -173.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.61 ' CZ ' ' HA ' ' A' ' 309' ' ' LYS . 0.1 OUTLIER -83.22 174.68 10.55 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.759 0.79 . . . . 0.0 111.155 176.882 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 14.7 t -149.78 159.67 44.16 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.542 -1.208 . . . . 0.0 108.769 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . 0.426 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 29.0 m-90 -69.17 117.64 11.07 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 121.353 0.597 . . . . 0.0 110.28 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.954 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 59.4 tttm -97.47 -47.81 5.53 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 173.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.535 HH21 HG23 ' A' ' 327' ' ' VAL . 41.1 ttp-105 -154.61 130.03 9.8 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.955 168.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . 0.572 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . . . -66.13 166.0 18.96 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.993 -178.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . 0.572 ' HD2' ' HB3' ' A' ' 317' ' ' ALA . 3.6 Cg_exo -44.3 116.27 0.99 Allowed 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.559 2.173 . . . . 0.0 112.368 178.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 55.0 m -128.7 132.18 48.0 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.466 -174.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.94 125.35 23.23 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 175.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' SER . . . . . 0.47 ' C ' ' H ' ' A' ' 323' ' ' HIS . 59.5 p -70.24 5.6 1.64 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 123.423 0.689 . . . . 0.0 112.489 -168.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 74.56 -25.58 1.12 Allowed Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.319 -169.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . 0.47 ' H ' ' C ' ' A' ' 321' ' ' SER . 2.2 t-160 -106.42 46.46 0.92 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.114 0.483 . . . . 0.0 109.98 -178.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 50.34 43.66 26.65 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 114.96 -1.018 . . . . 0.0 113.533 177.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' THR . . . . . 0.648 ' HA ' ' CG ' ' A' ' 375' ' ' GLN . 2.1 p -150.84 -168.12 3.01 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 174.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . 0.825 ' HB ' ' HG2' ' A' ' 374' ' ' MET . 0.2 OUTLIER -129.3 144.73 37.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 118.979 0.809 . . . . 0.0 111.019 179.707 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' VAL . . . . . 0.569 HG12 ' HG2' ' A' ' 373' ' ' GLU . 15.0 m -128.39 143.86 39.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.024 174.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' MET . . . . . 0.454 ' HE1' ' HD3' ' A' ' 318' ' ' PRO . 0.0 OUTLIER -135.04 149.46 50.13 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 178.297 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.954 ' HG2' ' HD3' ' A' ' 315' ' ' LYS . 7.7 tt0 -131.12 131.07 43.88 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 120.657 -0.417 . . . . 0.0 109.994 -173.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.651 HG13 HG13 ' A' ' 385' ' ' VAL . 0.0 OUTLIER -126.81 161.29 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -178.18 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . 0.53 ' HA2' ' CA ' ' A' ' 368' ' ' GLY . . . -127.69 137.8 10.05 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.729 175.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . 0.945 ' H ' ' HA2' ' A' ' 368' ' ' GLY . 0.2 OUTLIER -89.96 155.6 19.0 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.541 0.686 . . . . 0.0 111.807 179.185 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 2.6 p -95.84 -13.99 23.58 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 171.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -176.44 -40.72 0.05 OUTLIER Glycine 0 CA--C 1.528 0.859 0 C-N-CA 118.961 -1.59 . . . . 0.0 115.19 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' THR . . . . . 0.552 ' HB ' ' SD ' ' A' ' 364' ' ' MET . 82.8 m -52.78 132.84 37.11 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.823 0.344 . . . . 0.0 111.533 -177.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.854 HH21 ' HB2' ' A' ' 337' ' ' PRO . 0.2 OUTLIER -87.87 177.4 2.7 Favored Pre-proline 0 C--N 1.338 0.077 0 CA-C-O 117.389 -1.291 . . . . 0.0 107.875 -179.143 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . 0.854 ' HB2' HH21 ' A' ' 336' ' ' ARG . 1.0 OUTLIER -26.64 98.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.367 1.535 0 C-N-CA 123.723 2.949 . . . . 0.0 114.138 -174.432 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' CYS . . . . . 0.767 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 6.5 p -111.48 -176.19 2.88 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 113.559 -1.655 . . . . 0.0 110.376 -171.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -111.54 98.9 7.77 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 174.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . 0.764 ' HB ' ' HG2' ' A' ' 362' ' ' PRO . 68.5 mt -74.49 119.59 77.33 Favored Pre-proline 0 C--N 1.328 -0.338 0 O-C-N 123.416 0.448 . . . . 0.0 110.906 -171.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.2 82.32 2.4 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.928 2.419 . . . . 0.0 112.162 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.66 HG12 HG22 ' A' ' 340' ' ' ILE . 9.9 m -99.04 151.65 4.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.382 178.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 -162.34 171.34 17.37 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 176.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' ALA . . . . . 0.641 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -145.97 144.67 30.27 Favored 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.008 176.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.556 ' HB ' ' HA ' ' A' ' 350' ' ' PRO . 4.9 m -116.27 143.83 25.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 176.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -63.6 123.23 18.29 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 176.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . 0.502 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 37.2 t-80 42.52 62.97 1.55 Allowed 'General case' 0 N--CA 1.473 0.711 0 O-C-N 124.268 0.98 . . . . 0.0 112.749 170.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . 0.531 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 50.75 29.72 19.55 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 115.25 0.86 . . . . 0.0 115.25 -177.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . 0.5 HG21 ' O ' ' A' ' 347' ' ' HIS . 50.6 t -136.2 103.08 9.74 Favored Pre-proline 0 C--O 1.234 0.247 0 CA-C-N 118.267 1.033 . . . . 0.0 109.784 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . 0.556 ' HA ' ' HB ' ' A' ' 345' ' ' VAL . 17.1 Cg_exo -71.98 62.62 3.24 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 123.095 2.53 . . . . 0.0 112.884 178.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -100.12 -56.05 2.47 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 178.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 4.6 p -124.64 133.4 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.451 174.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -64.85 117.35 7.43 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.89 177.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.592 HG12 HD21 ' A' ' 376' ' ' LEU . 27.9 m -99.79 7.54 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.917 179.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . 0.641 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -78.62 82.94 4.83 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.029 0.443 . . . . 0.0 110.568 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' MET . . . . . 0.597 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 22.4 ttt -97.46 51.96 1.1 Allowed 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 175.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.76 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 11.7 mt -24.53 111.59 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 112.901 -1.954 . . . . 0.0 115.226 170.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.791 HD12 ' HB2' ' A' ' 375' ' ' GLN . 3.9 mm -60.36 -22.89 26.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 113.352 -1.749 . . . . 0.0 108.48 168.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 55.1 m -139.23 90.34 11.82 Favored Pre-proline 0 N--CA 1.451 -0.419 0 CA-C-N 114.265 -1.334 . . . . 0.0 108.648 177.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' PRO . . . . . 0.545 ' HA ' HD12 ' A' ' 357' ' ' LEU . 92.6 Cg_endo -82.17 45.34 1.91 Allowed 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 123.27 2.647 . . . . 0.0 114.445 -170.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -174.58 80.44 0.34 Allowed Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 120.958 0.408 . . . . 0.0 110.375 176.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . 0.764 ' HG2' ' HB ' ' A' ' 340' ' ' ILE . 95.3 Cg_endo -82.65 112.39 2.13 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.702 2.268 . . . . 0.0 111.932 176.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' THR . . . . . 0.412 HG21 ' O ' ' A' ' 338' ' ' CYS . 4.0 p -90.81 142.19 28.02 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.764 0.792 . . . . 0.0 112.5 173.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' MET . . . . . 0.845 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 5.2 ptp -96.44 143.97 26.98 Favored 'General case' 0 CA--C 1.504 -0.827 0 CA-C-N 114.067 -1.424 . . . . 0.0 109.457 178.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -141.21 -168.13 2.55 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.64 1.213 . . . . 0.0 110.821 -174.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . 0.581 ' C ' HD21 ' A' ' 366' ' ' ASN . 0.2 OUTLIER -60.22 -4.6 0.85 Allowed 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -176.699 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' ASN . . . . . 0.569 ' N ' HD21 ' A' ' 366' ' ' ASN . 10.0 p30 -113.15 -11.38 13.3 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.198 0.523 . . . . 0.0 110.618 -174.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . 0.945 ' HA2' ' H ' ' A' ' 332' ' ' PHE . . . 138.48 -132.05 5.63 Favored Glycine 0 CA--C 1.504 -0.637 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -175.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . 0.593 ' HA3' HG21 ' A' ' 330' ' ' VAL . . . -104.37 3.27 43.37 Favored Glycine 0 C--N 1.317 -0.505 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 175.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 73.15 -93.38 0.68 Allowed Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 114.96 -0.62 . . . . 0.0 113.575 175.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -152.29 133.49 14.34 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.411 -0.395 . . . . 0.0 111.084 -170.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 372' ' ' ILE . . . . . 0.751 ' HB ' ' HE1' ' A' ' 374' ' ' MET . 0.7 OUTLIER -129.63 135.38 61.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 173.392 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . 0.569 ' HG2' HG12 ' A' ' 327' ' ' VAL . 40.9 mt-10 -122.43 126.72 48.53 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 374' ' ' MET . . . . . 0.825 ' HG2' ' HB ' ' A' ' 326' ' ' VAL . 0.1 OUTLIER -134.47 165.5 25.02 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 123.505 0.722 . . . . 0.0 110.718 -175.692 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 375' ' ' GLN . . . . . 0.864 HE21 ' HA ' ' A' ' 375' ' ' GLN . 0.0 OUTLIER -173.5 -173.81 0.93 Allowed 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.545 0.688 . . . . 0.0 111.668 162.835 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' LEU . . . . . 0.971 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 10.5 tp -166.15 166.97 9.04 Favored Pre-proline 0 N--CA 1.443 -0.79 0 N-CA-C 104.481 -2.415 . . . . 0.0 104.481 171.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' PRO . . . . . 0.971 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 2.9 Cg_endo -43.48 133.81 7.0 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 121.58 1.52 . . . . 0.0 110.684 167.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_exo -37.8 140.04 0.29 Allowed 'Trans proline' 0 C--N 1.358 1.077 0 C-N-CA 123.85 3.033 . . . . 0.0 112.371 -177.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 148.61 -169.45 29.16 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.122 -1.037 . . . . 0.0 110.565 -160.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . 0.502 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 2.2 m-20 -98.72 128.52 45.0 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 117.583 0.692 . . . . 0.0 111.29 -175.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -127.07 168.73 14.21 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 176.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 1.059 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -161.04 138.6 2.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 168.835 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . 0.735 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 17.3 mt -104.62 130.29 55.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 C-N-CA 119.928 -0.709 . . . . 0.0 109.418 -172.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' TYR . . . . . 0.53 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 3.5 m-85 -101.57 98.56 8.86 Favored 'General case' 0 N--CA 1.441 -0.884 0 O-C-N 124.318 1.011 . . . . 0.0 108.572 169.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . 0.651 HG13 HG13 ' A' ' 330' ' ' VAL . 25.9 t -86.63 84.71 2.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 175.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 62.15 -112.06 4.52 Favored Glycine 0 N--CA 1.439 -1.132 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 -169.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' ASP . . . . . 0.513 ' HB2' ' HD3' ' A' ' 309' ' ' LYS . 0.7 OUTLIER -85.03 -15.26 44.71 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.781 0.324 . . . . 0.0 110.947 177.426 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' A' ' 384' ' ' TYR . 3.3 mp -70.34 155.07 41.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.023 177.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . 0.735 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 6.4 p30 -167.12 157.01 10.97 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.808 -0.178 . . . . 0.0 110.898 175.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . 0.544 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 33.0 t-80 -175.03 123.19 0.24 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.852 175.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' GLN . . . . . 1.059 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 25.3 tt0 -78.52 153.61 31.15 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.066 0.46 . . . . 0.0 111.585 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' TRP . . . . . 0.485 ' N ' ' HG2' ' A' ' 391' ' ' GLN . 10.7 t-105 -166.36 145.87 5.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.605 174.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . 0.48 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 13.5 p90 -103.3 118.79 37.58 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . 0.785 ' HG3' HE22 ' A' ' 375' ' ' GLN . 3.0 mm100 -83.14 112.96 20.3 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -168.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.402 ' HE2' ' HB2' ' A' ' 395' ' ' LYS . 31.2 mtmm . . . . . 0 C--O 1.248 1.026 0 O-C-N 124.225 0.953 . . . . 0.0 111.462 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' THR . . . . . 0.604 HG21 HG23 ' A' ' 335' ' ' THR . 8.9 t . . . . . 0 CA--C 1.539 0.527 0 CA-C-O 121.575 0.702 . . . . 0.0 111.232 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -63.54 119.11 9.18 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 174.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' THR . . . . . 0.409 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 12.1 t 174.9 -168.33 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -172.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 36.4 t -65.22 106.95 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 169.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . 0.545 ' HB3' HG22 ' A' ' 335' ' ' THR . 0.5 OUTLIER -69.91 140.86 53.16 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.264 -167.892 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . 0.566 ' OD1' HG21 ' A' ' 310' ' ' THR . 14.0 t70 -63.41 132.68 52.23 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.953 -174.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.553 ' HD2' ' N ' ' A' ' 310' ' ' THR . 0.0 OUTLIER -41.5 -20.36 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 116.104 1.89 . . . . 0.0 116.104 -175.428 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.566 HG21 ' OD1' ' A' ' 308' ' ' ASP . 6.7 t -108.31 2.54 22.68 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 119.134 0.879 . . . . 0.0 112.196 -174.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 24.9 mmmt -74.01 -33.14 63.68 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -173.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.929 ' HD1' HD11 ' A' ' 388' ' ' LEU . 0.0 OUTLIER -86.08 175.18 8.69 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 122.006 0.908 . . . . 0.0 111.672 -175.992 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 11.1 t -144.3 155.45 43.83 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 113.871 -1.513 . . . . 0.0 107.755 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 16.4 m-90 -75.69 93.11 3.04 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.237 0.541 . . . . 0.0 109.598 178.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.437 ' HB3' ' C ' ' A' ' 329' ' ' GLU . 25.1 tptp -65.95 -43.82 86.84 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 170.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.461 ' NH2' HG22 ' A' ' 319' ' ' THR . 24.8 ttt180 -152.83 130.79 11.78 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.142 170.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . 0.438 ' HB2' ' CD2' ' A' ' 390' ' ' HIS . . . -69.5 159.04 85.26 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.649 -178.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . 0.773 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 78.7 Cg_exo -39.71 112.7 0.16 Allowed 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 122.65 2.234 . . . . 0.0 112.742 178.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' THR . . . . . 0.461 HG22 ' NH2' ' A' ' 316' ' ' ARG . 19.0 m -131.89 135.33 46.57 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.166 -173.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -57.38 124.13 17.86 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 84.5 p -62.16 -47.84 82.73 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.448 0.642 . . . . 0.0 110.014 -174.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 123.64 -14.62 8.09 Favored Glycine 0 N--CA 1.443 -0.892 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -111.86 53.09 0.73 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.284 0.564 . . . . 0.0 109.884 178.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 22.9 t70 57.28 33.94 24.04 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 114.746 -1.116 . . . . 0.0 112.464 177.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' THR . . . . . 0.53 ' HB ' HG13 ' A' ' 358' ' ' ILE . 10.0 p -152.5 -172.55 4.27 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . 0.405 HG12 ' HE3' ' A' ' 374' ' ' MET . 0.4 OUTLIER -132.12 145.45 34.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.338 0.59 . . . . 0.0 111.377 -177.216 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' VAL . . . . . 0.554 ' HA ' ' O ' ' A' ' 372' ' ' ILE . 15.8 m -127.11 155.94 38.34 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.895 176.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 5.0 ptm -142.09 159.43 42.24 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 167.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.535 ' HG3' ' O ' ' A' ' 370' ' ' GLY . 9.7 tt0 -124.45 129.39 50.57 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -176.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.561 HG21 ' HA3' ' A' ' 369' ' ' GLY . 3.1 m -125.55 146.19 31.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.88 -179.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . 0.685 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -124.47 140.42 12.55 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.116 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . 0.584 ' HD1' ' HA2' ' A' ' 368' ' ' GLY . 7.9 p90 -89.3 146.67 24.56 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.96 0.886 . . . . 0.0 111.69 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 28.2 t -86.84 -28.6 22.8 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.114 -1.403 . . . . 0.0 111.961 172.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -159.23 -44.58 0.02 OUTLIER Glycine 0 C--N 1.336 0.56 0 C-N-CA 119.605 -1.283 . . . . 0.0 113.917 -179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' THR . . . . . 0.604 HG23 HG21 ' A' ' 303' ' ' THR . 27.1 m -52.69 124.55 14.12 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 123.795 0.35 . . . . 0.0 110.949 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.573 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 33.3 ptt85 -87.29 -177.38 0.88 Allowed Pre-proline 0 CA--C 1.532 0.285 0 CA-C-O 117.089 -1.434 . . . . 0.0 108.37 -174.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . 0.774 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.1 OUTLIER -26.63 96.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 123.751 2.967 . . . . 0.0 114.151 -176.449 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' CYS . . . . . 0.493 ' SG ' ' HG3' ' A' ' 364' ' ' MET . 12.1 p -112.42 -176.83 3.01 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 113.515 -1.675 . . . . 0.0 110.074 -171.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 11.2 mpt_? -112.21 103.08 11.22 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 178.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . 0.805 HG23 HG12 ' A' ' 342' ' ' VAL . 29.7 mt -74.17 119.99 79.14 Favored Pre-proline 0 C--N 1.324 -0.508 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.486 -167.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.65 81.26 2.67 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.853 2.368 . . . . 0.0 111.561 177.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.805 HG12 HG23 ' A' ' 340' ' ' ILE . 4.6 m -102.41 155.38 5.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-O 121.747 0.784 . . . . 0.0 110.887 -178.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 22.4 ptt180 -166.31 174.94 8.63 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' ALA . . . . . 0.614 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -150.9 145.0 25.35 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.849 -0.74 . . . . 0.0 110.893 177.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 9.2 m -119.88 147.16 23.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -70.12 122.86 20.26 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 176.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . 0.504 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 47.2 t60 43.96 60.43 2.73 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 124.149 0.906 . . . . 0.0 111.413 174.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . 0.696 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 44.09 46.04 7.93 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 114.637 0.615 . . . . 0.0 114.637 -174.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . 0.417 HG21 ' O ' ' A' ' 347' ' ' HIS . 73.5 t -141.64 102.5 5.93 Favored Pre-proline 0 C--N 1.33 -0.251 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -76.15 49.7 2.64 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.603 2.202 . . . . 0.0 112.625 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -102.11 -5.54 24.36 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 2.6 p -169.8 106.31 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 114.561 -1.199 . . . . 0.0 110.055 -167.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . 0.451 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 38.1 t30 -64.74 111.78 2.93 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.688 178.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.524 ' HA ' HD22 ' A' ' 376' ' ' LEU . 31.5 m -91.2 -0.59 9.55 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.212 177.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . 0.614 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -74.25 84.55 1.89 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.213 0.53 . . . . 0.0 111.462 -176.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' MET . . . . . 0.654 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 47.6 ttp -97.9 101.14 12.56 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 168.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.513 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 27.6 mt -85.35 119.33 25.6 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.192 -163.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.709 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 2.5 mm -61.79 -28.98 45.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.506 175.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 22.4 m -130.14 90.08 43.2 Favored Pre-proline 0 N--CA 1.443 -0.8 0 CA-C-N 114.3 -1.318 . . . . 0.0 108.539 173.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -83.87 36.86 0.61 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.142 2.561 . . . . 0.0 113.055 -173.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -153.35 71.56 6.88 Favored Pre-proline 0 C--N 1.317 -0.83 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.257 175.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . 0.603 ' HB2' HD13 ' A' ' 340' ' ' ILE . 94.7 Cg_endo -81.43 145.02 14.68 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.568 2.179 . . . . 0.0 111.387 176.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' THR . . . . . 0.448 ' O ' ' HA2' ' A' ' 369' ' ' GLY . 0.5 OUTLIER -144.26 140.19 29.08 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 -173.008 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' MET . . . . . 0.774 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 41.4 mtm -95.47 110.05 22.16 Favored 'General case' 0 CA--C 1.492 -1.286 0 C-N-CA 119.398 -0.921 . . . . 0.0 109.198 178.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -97.96 -167.33 1.5 Allowed 'General case' 0 C--N 1.312 -1.04 0 O-C-N 124.77 1.294 . . . . 0.0 110.437 -175.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . 0.527 HD21 ' N ' ' A' ' 367' ' ' ASN . 0.3 OUTLIER -54.05 -7.82 0.15 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -179.433 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' ASN . . . . . 0.527 ' N ' HD21 ' A' ' 366' ' ' ASN . 9.7 p30 -124.09 -1.64 8.23 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 121.655 -0.653 . . . . 0.0 110.98 -178.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . 0.685 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . 116.66 -176.63 16.39 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -172.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . 0.585 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -46.84 -25.79 2.49 Favored Glycine 0 CA--C 1.522 0.504 0 CA-C-N 117.7 0.75 . . . . 0.0 114.517 174.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . 0.535 ' O ' ' HG3' ' A' ' 329' ' ' GLU . . . 77.35 -57.82 3.7 Favored Glycine 0 C--O 1.228 -0.228 0 C-N-CA 120.867 -0.682 . . . . 0.0 113.034 176.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -165.87 147.06 6.9 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.126 0.489 . . . . 0.0 111.431 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 372' ' ' ILE . . . . . 0.715 HD11 HG11 ' A' ' 342' ' ' VAL . 1.3 mt -131.6 140.03 49.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.448 170.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . 0.709 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 40.8 mt-10 -119.44 123.7 44.71 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.428 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 374' ' ' MET . . . . . 0.533 ' HG2' HD12 ' A' ' 383' ' ' ILE . 0.0 OUTLIER -138.63 164.38 29.64 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.817 -176.866 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 375' ' ' GLN . . . . . 0.943 HE21 ' HA ' ' A' ' 375' ' ' GLN . 0.0 OUTLIER 177.54 175.0 0.47 Allowed 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 173.585 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' LEU . . . . . 1.015 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 8.9 tp -166.88 173.59 3.05 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 177.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' PRO . . . . . 1.015 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 75.2 Cg_exo -41.08 127.61 2.8 Favored 'Trans proline' 0 C--N 1.348 0.5 0 CA-C-N 121.465 1.559 . . . . 0.0 111.225 166.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -41.67 148.16 0.34 Allowed 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 123.826 3.017 . . . . 0.0 112.568 -177.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 142.31 -163.75 27.06 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 119.763 -1.208 . . . . 0.0 111.07 -162.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . 0.584 ' C ' HD21 ' A' ' 381' ' ' ASN . 4.8 m-20 -89.44 115.87 27.2 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 117.32 0.56 . . . . 0.0 111.163 -176.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.584 HD21 ' C ' ' A' ' 380' ' ' ASP . 0.8 OUTLIER -126.62 147.55 49.89 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.039 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 1.001 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -148.71 137.73 15.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 176.609 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . 0.659 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 28.2 mt -99.49 132.69 44.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.206 -173.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' TYR . . . . . 0.611 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 1.8 m-85 -106.13 99.91 9.48 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.177 -1.374 . . . . 0.0 109.071 170.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . 0.743 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 2.8 t -84.83 86.61 2.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 174.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 60.42 -106.36 1.03 Allowed Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 120.003 -1.094 . . . . 0.0 110.718 -169.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' ASP . . . . . 0.436 ' HB2' ' HB2' ' A' ' 309' ' ' LYS . 17.8 t70 -89.97 -14.36 34.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.502 0.192 . . . . 0.0 111.325 176.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . 0.929 HD11 ' HD1' ' A' ' 312' ' ' PHE . 3.0 mp -67.67 153.82 42.85 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 176.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . 0.659 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 30.5 p-10 -163.75 154.42 15.78 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.017 176.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . 0.773 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 9.2 t60 -173.41 116.38 0.26 Allowed 'General case' 0 C--O 1.241 0.633 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 174.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' GLN . . . . . 1.001 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 8.6 tt0 -80.59 153.67 27.89 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.973 -177.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' TRP . . . . . 0.494 ' HD1' ' OE1' ' A' ' 394' ' ' GLN . 32.0 t-105 -166.09 153.15 9.77 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.964 -1.017 . . . . 0.0 109.208 -176.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -110.11 118.06 35.38 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . 0.902 ' HG3' HE22 ' A' ' 375' ' ' GLN . 4.0 mm100 -80.33 104.11 10.66 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -173.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.153 -0.927 . . . . 0.0 111.293 -174.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' THR . . . . . 0.475 ' O ' HG21 ' A' ' 303' ' ' THR . 10.2 t . . . . . 0 CA--C 1.536 0.416 0 CA-C-O 121.89 0.852 . . . . 0.0 111.374 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . 0.548 ' HB3' ' NE ' ' A' ' 336' ' ' ARG . 17.2 p90 -67.06 130.77 44.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.814 174.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' THR . . . . . 0.513 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 14.8 t 173.1 -169.17 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -175.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 41.3 t -66.43 112.42 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 169.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.0 140.41 57.71 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -172.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . 0.581 ' OD1' HG21 ' A' ' 310' ' ' THR . 12.5 t70 -62.24 130.92 47.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.538 0.685 . . . . 0.0 111.46 -170.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 18.3 pttm -38.47 -29.71 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 113.175 -1.829 . . . . 0.0 115.066 -177.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.581 HG21 ' OD1' ' A' ' 308' ' ' ASP . 12.0 t -108.37 0.28 21.07 Favored 'General case' 0 N--CA 1.443 -0.817 0 O-C-N 121.685 -0.634 . . . . 0.0 112.425 -170.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -84.87 -29.18 25.48 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -173.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.462 ' CD1' ' HE2' ' A' ' 364' ' ' MET . 0.1 OUTLIER -81.1 173.76 12.25 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.639 0.733 . . . . 0.0 111.012 -179.75 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 6.4 t -147.49 159.02 44.2 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.004 -178.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . 0.448 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 25.3 m-90 -71.03 122.02 19.28 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 178.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.712 ' HD3' ' HB3' ' A' ' 329' ' ' GLU . 70.8 tttt -102.52 -42.92 5.79 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 173.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.805 ' HB3' ' HB2' ' A' ' 329' ' ' GLU . 19.8 ttm-85 -149.39 128.15 12.5 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.85 169.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -71.52 158.73 87.32 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . 0.726 ' HD3' ' HE2' ' A' ' 328' ' ' MET . 3.3 Cg_exo -43.01 111.15 0.2 Allowed 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 122.65 2.233 . . . . 0.0 112.487 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' THR . . . . . 0.53 ' O ' HG21 ' A' ' 327' ' ' VAL . 32.2 m -129.26 131.27 46.98 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.624 -174.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -59.34 125.32 23.14 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 86.6 p -58.79 -45.08 90.67 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.832 -173.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 136.7 -3.52 3.52 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.363 176.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 6.3 t-80 -143.7 70.68 1.31 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.052 0.453 . . . . 0.0 110.304 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 58.31 30.14 19.11 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.01 -0.995 . . . . 0.0 113.666 175.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' THR . . . . . 0.622 ' HA ' ' CG ' ' A' ' 375' ' ' GLN . 11.1 p -153.48 179.2 9.02 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . 0.78 HG23 ' HG2' ' A' ' 375' ' ' GLN . 0.5 OUTLIER -134.03 144.76 34.57 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.404 0 CA-C-O 121.106 0.479 . . . . 0.0 111.142 -172.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' VAL . . . . . 0.573 HG12 ' HG3' ' A' ' 373' ' ' GLU . 14.1 m -118.86 155.52 21.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.662 175.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' MET . . . . . 0.726 ' HE2' ' HD3' ' A' ' 318' ' ' PRO . 0.0 OUTLIER -143.56 153.42 42.55 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 176.71 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.805 ' HB2' ' HB3' ' A' ' 316' ' ' ARG . 8.9 mt-10 -134.7 133.43 39.99 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.003 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.594 HG21 ' HA3' ' A' ' 369' ' ' GLY . 2.4 m -132.81 159.05 43.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.004 0.431 . . . . 0.0 111.853 -179.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . 0.464 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -129.27 136.21 8.86 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.19 -1.005 . . . . 0.0 112.582 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . 0.422 ' HD1' ' CA ' ' A' ' 368' ' ' GLY . 2.1 p90 -90.31 154.45 19.7 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.682 0.753 . . . . 0.0 111.807 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 27.6 p -119.1 30.69 7.02 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.528 -1.214 . . . . 0.0 112.515 173.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 164.65 -51.29 0.29 Allowed Glycine 0 C--O 1.225 -0.465 0 C-N-CA 119.388 -1.387 . . . . 0.0 114.122 169.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' THR . . . . . . . . . . . . . 2.8 m -55.79 124.47 17.63 Favored 'General case' 0 C--N 1.317 -0.827 0 O-C-N 123.695 0.291 . . . . 0.0 111.5 -178.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.711 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 5.5 ppt_? -80.66 -178.63 1.2 Allowed Pre-proline 0 N--CA 1.462 0.132 0 CA-C-O 116.921 -1.514 . . . . 0.0 107.843 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . 0.842 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.7 OUTLIER -24.35 96.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 123.566 2.844 . . . . 0.0 113.733 -179.083 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' CYS . . . . . 0.596 ' SG ' ' HB2' ' A' ' 364' ' ' MET . 18.3 p -117.76 -176.8 3.11 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.091 -1.868 . . . . 0.0 109.927 -168.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -110.35 103.76 12.46 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -178.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . 0.726 HG12 ' HG3' ' A' ' 364' ' ' MET . 55.4 mt -72.2 121.15 83.93 Favored Pre-proline 0 C--N 1.328 -0.364 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.48 -171.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . 0.456 ' O ' ' HA ' ' A' ' 385' ' ' VAL . 74.2 Cg_endo -79.83 77.9 3.9 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 121.556 1.504 . . . . 0.0 110.947 174.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.762 HG11 HG11 ' A' ' 385' ' ' VAL . 0.0 OUTLIER -105.08 117.66 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-O 122.238 1.018 . . . . 0.0 110.555 175.628 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.441 ' HG3' ' HB2' ' A' ' 384' ' ' TYR . 25.9 ptt180 -130.49 179.34 5.99 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 113.575 -1.648 . . . . 0.0 106.983 177.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' ALA . . . . . 0.563 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -149.29 147.66 28.62 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.963 175.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 10.5 m -119.52 141.7 38.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.53 116.68 7.05 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . 0.56 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 57.9 t-80 44.67 65.89 0.98 Allowed 'General case' 0 N--CA 1.472 0.626 0 O-C-N 124.345 1.028 . . . . 0.0 111.447 175.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . 0.5 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 42.97 41.14 4.47 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 115.096 0.799 . . . . 0.0 115.096 -175.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . 0.546 HG21 ' O ' ' A' ' 347' ' ' HIS . 87.6 t -140.5 102.49 6.58 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 118.112 0.956 . . . . 0.0 108.661 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -74.63 66.25 5.68 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 122.99 2.46 . . . . 0.0 113.376 -178.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -100.47 -57.79 2.04 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 174.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 5.9 p -116.98 130.69 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.641 174.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . 0.507 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 38.1 t30 -62.92 108.26 1.16 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.423 171.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.422 ' HB ' ' OD1' ' A' ' 381' ' ' ASN . 20.4 m -88.96 5.28 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.0 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . 0.563 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -77.46 82.03 3.92 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.317 0.58 . . . . 0.0 110.436 177.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' MET . . . . . 0.525 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 39.1 ttm -98.03 99.83 11.12 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 172.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.642 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 46.4 mt -85.15 146.71 26.98 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.38 -159.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.695 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 2.4 mm -90.81 -21.7 6.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 176.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' THR . . . . . 0.443 ' HG1' ' CD ' ' A' ' 373' ' ' GLU . 97.5 m -127.1 84.83 62.47 Favored Pre-proline 0 N--CA 1.446 -0.655 0 CA-C-N 113.216 -1.811 . . . . 0.0 108.257 172.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -80.62 27.6 0.56 Allowed 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.798 2.332 . . . . 0.0 112.758 -175.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -147.66 61.66 6.35 Favored Pre-proline 0 C--N 1.315 -0.901 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.512 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . 0.48 ' HB2' HD13 ' A' ' 340' ' ' ILE . 90.2 Cg_endo -85.11 102.39 0.78 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.124 1.883 . . . . 0.0 112.066 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' THR . . . . . 0.424 HG21 ' O ' ' A' ' 338' ' ' CYS . 1.3 p -93.04 168.87 10.84 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 122.05 0.929 . . . . 0.0 113.273 171.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' MET . . . . . 0.842 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 43.9 mtt -115.63 128.03 55.64 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-N 113.819 -1.537 . . . . 0.0 109.324 174.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.534 ' CD ' ' HG3' ' A' ' 337' ' ' PRO . 53.9 mm-40 -121.71 -163.29 1.04 Allowed 'General case' 0 C--N 1.313 -0.993 0 O-C-N 124.275 0.984 . . . . 0.0 109.83 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . 0.592 HD21 ' N ' ' A' ' 366' ' ' ASN . 0.1 OUTLIER -40.39 -28.03 0.06 Allowed 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -178.655 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -111.84 7.87 20.28 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 121.4 -0.813 . . . . 0.0 112.247 -177.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . 0.464 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . 99.07 -164.49 20.5 Favored Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 -177.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . 0.594 ' HA3' HG21 ' A' ' 330' ' ' VAL . . . -70.62 95.65 0.54 Allowed Glycine 0 CA--C 1.507 -0.425 0 C-N-CA 120.081 -1.057 . . . . 0.0 110.78 168.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -70.94 -27.17 72.67 Favored Glycine 0 C--N 1.313 -0.71 0 CA-C-N 115.166 -0.517 . . . . 0.0 112.939 -166.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -164.44 136.71 4.71 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.942 0.401 . . . . 0.0 110.685 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 372' ' ' ILE . . . . . 0.596 HG13 ' CG ' ' A' ' 328' ' ' MET . 0.4 OUTLIER -127.31 145.4 34.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 173.005 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . 0.695 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 3.8 mp0 -127.38 127.09 43.63 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 175.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 374' ' ' MET . . . . . 0.688 ' HG2' HD12 ' A' ' 383' ' ' ILE . 4.3 ppp? -138.3 166.83 23.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.926 -175.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 375' ' ' GLN . . . . . 0.78 ' HG2' HG23 ' A' ' 326' ' ' VAL . 0.0 OUTLIER -173.9 175.32 2.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.194 0.521 . . . . 0.0 110.59 165.945 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' LEU . . . . . 0.71 HD22 ' HD2' ' A' ' 377' ' ' PRO . 2.2 tm? -167.79 129.42 1.22 Allowed Pre-proline 0 C--N 1.315 -0.903 0 N-CA-C 105.11 -2.181 . . . . 0.0 105.11 176.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' PRO . . . . . 0.71 ' HD2' HD22 ' A' ' 376' ' ' LEU . 58.7 Cg_exo -24.97 125.79 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 124.503 3.469 . . . . 0.0 112.874 -179.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -35.51 134.42 0.22 Allowed 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 124.82 3.68 . . . . 0.0 113.019 -165.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 157.7 -171.79 34.88 Favored Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -159.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . 0.56 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 5.7 m-20 -97.07 127.46 43.06 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 117.494 0.647 . . . . 0.0 110.342 -178.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.52 HD21 ' HG2' ' A' ' 394' ' ' GLN . 25.5 m-80 -131.09 168.56 17.21 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 1.043 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -158.87 140.18 4.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 169.775 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . 0.688 HD12 ' HG2' ' A' ' 374' ' ' MET . 44.3 mt -99.82 130.44 48.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 C-N-CA 119.656 -0.818 . . . . 0.0 109.473 -175.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' TYR . . . . . 0.453 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 2.5 m-85 -100.95 136.6 40.55 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 169.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . 0.762 HG11 HG11 ' A' ' 342' ' ' VAL . 6.1 t -126.67 85.47 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 176.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 66.56 -109.75 3.09 Favored Glycine 0 N--CA 1.435 -1.432 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 -166.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -95.47 -7.52 37.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.856 0.328 . . . . 0.0 111.883 172.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . 0.477 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 1.4 mp -66.05 150.07 49.27 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 173.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . 0.532 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 7.7 p30 -166.05 154.78 11.22 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 121.275 -0.17 . . . . 0.0 110.669 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . 0.505 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 3.9 t60 -173.49 116.34 0.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.145 176.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' GLN . . . . . 1.043 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 6.3 tt0 -77.64 153.85 32.78 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.209 0.528 . . . . 0.0 112.364 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' TRP . . . . . 0.446 ' HD1' ' OE1' ' A' ' 394' ' ' GLN . 17.1 t-105 -169.53 147.71 3.61 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.054 176.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . 0.51 ' HB2' ' HE3' ' A' ' 395' ' ' LYS . 5.9 p90 -102.27 114.9 29.46 Favored 'General case' 0 C--N 1.313 -0.987 0 O-C-N 121.408 -0.807 . . . . 0.0 109.023 -178.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . 0.753 ' HG3' HE22 ' A' ' 375' ' ' GLN . 2.8 mm100 -83.23 107.17 15.59 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -171.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.51 ' HE3' ' HB2' ' A' ' 393' ' ' PHE . 33.7 mmtp . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.022 -0.989 . . . . 0.0 109.965 -172.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 2.4 t . . . . . 0 CA--C 1.534 0.362 0 CA-C-O 121.306 0.574 . . . . 0.0 111.753 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . 0.514 ' HB3' ' NE ' ' A' ' 336' ' ' ARG . 21.7 p90 -63.11 124.27 20.72 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.931 0.396 . . . . 0.0 110.563 172.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' THR . . . . . 0.584 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 9.7 t -179.85 -176.75 0.36 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -176.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 47.8 t -64.21 112.69 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 166.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . 0.678 ' HB2' ' CZ ' ' A' ' 332' ' ' PHE . 0.0 OUTLIER -68.16 138.55 55.76 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.032 0.444 . . . . 0.0 110.456 -171.088 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . 0.582 ' OD2' HG21 ' A' ' 310' ' ' THR . 14.7 t70 -61.32 133.12 55.51 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.01 -171.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.432 ' O ' ' CE1' ' A' ' 312' ' ' PHE . 22.1 pttp -38.59 -28.94 0.03 OUTLIER 'General case' 0 C--O 1.22 -0.5 0 CA-C-N 113.097 -1.865 . . . . 0.0 114.973 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.582 HG21 ' OD2' ' A' ' 308' ' ' ASP . 13.5 t -109.05 10.4 26.13 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 119.286 0.948 . . . . 0.0 113.192 -169.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.488 ' HB2' ' CE2' ' A' ' 332' ' ' PHE . 28.6 mtpp -96.02 -19.76 19.22 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 -174.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.723 ' HD2' ' HE1' ' A' ' 332' ' ' PHE . 0.3 OUTLIER -86.43 173.0 9.95 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.937 0.875 . . . . 0.0 111.882 177.124 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 8.9 t -153.34 162.11 41.63 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 113.981 -1.463 . . . . 0.0 109.131 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 14.5 m-90 -76.17 95.47 3.69 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 120.884 0.373 . . . . 0.0 110.38 -177.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.544 ' HB3' ' HB3' ' A' ' 329' ' ' GLU . 59.4 tttm -65.68 -46.62 78.39 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 165.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.599 ' HB3' ' HB2' ' A' ' 329' ' ' GLU . 40.7 ttt180 -153.09 128.32 9.81 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 114.45 -1.25 . . . . 0.0 108.864 169.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . 0.502 ' HB3' ' CG ' ' A' ' 390' ' ' HIS . . . -74.45 160.93 80.09 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-O 118.757 -0.64 . . . . 0.0 109.871 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . 0.934 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 85.5 Cg_exo -36.87 108.87 0.06 OUTLIER 'Trans proline' 0 C--N 1.362 1.282 0 C-N-CA 123.149 2.566 . . . . 0.0 113.36 -178.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' THR . . . . . 0.442 ' O ' HG21 ' A' ' 327' ' ' VAL . 18.6 m -127.44 132.86 49.99 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.944 -175.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . 0.552 ' HB2' ' CZ2' ' A' ' 392' ' ' TRP . 13.5 t70 -55.61 124.95 19.06 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 60.0 p -62.98 -46.73 86.32 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.411 0.624 . . . . 0.0 110.116 -173.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 122.8 -7.94 9.38 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -124.47 56.79 1.27 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.141 -0.529 . . . . 0.0 110.703 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . 0.571 ' HA ' ' HD3' ' A' ' 395' ' ' LYS . 21.5 m-20 56.87 31.19 19.22 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.458 176.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' THR . . . . . 0.524 ' HB ' HG13 ' A' ' 358' ' ' ILE . 15.7 p -150.67 -179.26 7.1 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -178.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 1.3 t -129.57 144.42 38.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.178 0.513 . . . . 0.0 110.973 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' VAL . . . . . 0.559 HG12 ' HG2' ' A' ' 373' ' ' GLU . 16.7 m -120.06 154.48 23.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.336 176.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' MET . . . . . 0.489 ' SD ' HG11 ' A' ' 330' ' ' VAL . 0.0 OUTLIER -143.15 147.07 34.35 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 176.722 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.599 ' HB2' ' HB3' ' A' ' 316' ' ' ARG . 9.0 mt-10 -130.32 128.13 40.88 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 121.076 0.465 . . . . 0.0 110.957 -176.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.489 HG11 ' SD ' ' A' ' 328' ' ' MET . 0.0 OUTLIER -128.35 149.8 33.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.928 -175.971 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . 0.634 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -128.72 141.78 12.9 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.503 -0.856 . . . . 0.0 113.094 -179.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . 0.723 ' HE1' ' HD2' ' A' ' 312' ' ' PHE . 3.5 m-85 -112.81 178.03 4.43 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.358 0.663 . . . . 0.0 111.041 174.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 50.7 m -136.03 4.41 2.98 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 170.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -145.68 -62.93 0.01 OUTLIER Glycine 0 C--N 1.34 0.767 0 C-N-CA 119.029 -1.558 . . . . 0.0 114.768 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' THR . . . . . 0.467 HG21 ' HB3' ' A' ' 338' ' ' CYS . 13.9 m -53.95 132.46 42.16 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.122 0.487 . . . . 0.0 111.11 -175.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.868 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 2.8 ptm180 -82.29 -176.76 0.83 Allowed Pre-proline 0 C--O 1.226 -0.133 0 CA-C-O 117.981 -1.009 . . . . 0.0 108.952 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . 0.868 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.4 OUTLIER -31.7 98.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 123.264 2.643 . . . . 0.0 112.802 174.172 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' CYS . . . . . 0.592 ' O ' HG21 ' A' ' 363' ' ' THR . 26.3 p -119.91 -174.25 2.72 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 113.522 -1.672 . . . . 0.0 109.578 -170.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -108.96 107.12 17.37 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -178.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . 0.884 HD13 ' HB2' ' A' ' 362' ' ' PRO . 32.9 mt -73.26 120.12 79.37 Favored Pre-proline 0 C--N 1.329 -0.313 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.963 -173.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -77.11 80.36 2.89 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.187 1.925 . . . . 0.0 111.202 175.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.69 HG11 HG22 ' A' ' 340' ' ' ILE . 11.7 m -97.41 146.3 7.89 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.662 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.091 178.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.443 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 24.4 ptt180 -163.82 171.98 14.72 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 172.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -147.97 143.66 27.46 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.797 177.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.432 ' HB ' ' HA ' ' A' ' 350' ' ' PRO . 6.2 m -115.96 144.39 23.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -63.23 117.13 6.14 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.279 -0.418 . . . . 0.0 112.014 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . 0.722 ' HB3' ' CB ' ' A' ' 380' ' ' ASP . 11.6 p80 30.37 75.5 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 O-C-N 124.721 1.263 . . . . 0.0 113.671 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . 0.811 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 53.64 28.44 37.83 Favored Glycine 0 CA--C 1.519 0.337 0 N-CA-C 115.69 1.036 . . . . 0.0 115.69 178.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . 0.455 HG21 ' O ' ' A' ' 347' ' ' HIS . 46.9 t -137.15 101.79 9.2 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 118.948 1.374 . . . . 0.0 108.731 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . 0.432 ' HA ' ' HB ' ' A' ' 345' ' ' VAL . 15.2 Cg_exo -73.06 66.51 4.17 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 123.112 2.542 . . . . 0.0 112.865 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -99.87 -55.39 2.66 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.282 -1.006 . . . . 0.0 108.282 177.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 4.7 p -130.1 136.2 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.215 174.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . 0.464 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 52.1 t30 -63.18 117.82 7.07 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.187 177.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 30.5 m -95.25 5.1 8.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.844 176.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . 0.464 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -77.47 84.16 3.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.235 0.541 . . . . 0.0 111.405 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.94 102.9 14.77 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 170.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.55 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 32.3 mt -83.45 117.93 23.4 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.41 -162.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.664 HD12 ' HB3' ' A' ' 375' ' ' GLN . 4.4 mm -59.54 -29.12 41.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.358 173.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 12.6 m -131.91 94.12 25.55 Favored Pre-proline 0 N--CA 1.446 -0.672 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.573 172.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -81.83 34.6 0.55 Allowed 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 123.522 2.815 . . . . 0.0 112.899 -173.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -151.63 70.68 8.11 Favored Pre-proline 0 C--N 1.316 -0.889 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.98 177.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . 0.941 ' HB3' HG21 ' A' ' 372' ' ' ILE . 60.3 Cg_endo -80.88 141.02 13.1 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.313 2.008 . . . . 0.0 111.314 175.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' THR . . . . . 0.598 ' O ' ' HA2' ' A' ' 369' ' ' GLY . 1.0 OUTLIER -143.66 143.25 31.36 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -174.11 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' MET . . . . . 0.76 ' HA ' ' HA2' ' A' ' 369' ' ' GLY . 5.2 mmt -110.87 142.18 43.27 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -178.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.514 ' HG2' ' HG3' ' A' ' 337' ' ' PRO . 27.2 mt-10 -125.64 -168.5 1.85 Allowed 'General case' 0 C--N 1.318 -0.772 0 O-C-N 123.398 0.436 . . . . 0.0 110.953 175.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . 0.447 HD21 ' N ' ' A' ' 366' ' ' ASN . 0.1 OUTLIER -43.25 -31.85 0.68 Allowed 'General case' 0 N--CA 1.472 0.626 0 O-C-N 124.232 0.958 . . . . 0.0 113.221 -179.037 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -111.03 -1.46 16.28 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -177.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . 0.634 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . 124.81 178.66 15.41 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.257 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . 0.76 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -68.07 -24.99 74.58 Favored Glycine 0 C--N 1.333 0.368 0 N-CA-C 114.132 0.413 . . . . 0.0 114.132 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . 0.567 ' O ' ' HG2' ' A' ' 329' ' ' GLU . . . 85.37 -58.15 4.91 Favored Glycine 0 C--N 1.318 -0.417 0 C-N-CA 120.143 -1.027 . . . . 0.0 113.313 178.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -165.87 145.84 6.45 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.14 0.495 . . . . 0.0 112.173 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 372' ' ' ILE . . . . . 0.941 HG21 ' HB3' ' A' ' 362' ' ' PRO . 0.7 OUTLIER -136.13 156.25 36.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.451 171.441 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . 0.593 ' CB ' ' HB ' ' A' ' 358' ' ' ILE . 42.5 mt-10 -134.4 126.54 29.77 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -178.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 374' ' ' MET . . . . . 0.55 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 2.9 mtt -142.65 165.03 28.49 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -176.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 375' ' ' GLN . . . . . 0.775 HE21 ' HA ' ' A' ' 375' ' ' GLN . 0.0 OUTLIER -178.62 173.45 1.3 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.784 0.326 . . . . 0.0 110.296 176.981 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 376' ' ' LEU . . . . . 0.691 HD21 ' HD2' ' A' ' 377' ' ' PRO . 2.0 tm? -165.62 139.62 3.79 Favored Pre-proline 0 C--N 1.318 -0.785 0 N-CA-C 104.44 -2.43 . . . . 0.0 104.44 -177.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 377' ' ' PRO . . . . . 0.691 ' HD2' HD21 ' A' ' 376' ' ' LEU . 37.8 Cg_exo -33.89 129.63 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.761 2.307 . . . . 0.0 112.299 175.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.699 ' HA ' HE22 ' A' ' 394' ' ' GLN . 75.8 Cg_exo -34.03 138.85 0.08 OUTLIER 'Trans proline' 0 C--N 1.362 1.243 0 C-N-CA 124.926 3.75 . . . . 0.0 113.932 -170.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 155.32 -158.38 28.38 Favored Glycine 0 N--CA 1.441 -0.975 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 -163.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . 0.722 ' CB ' ' HB3' ' A' ' 347' ' ' HIS . 8.9 m-20 -109.32 132.79 53.8 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 118.149 0.974 . . . . 0.0 111.522 175.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -126.25 168.7 13.73 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 176.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 1.053 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -160.05 138.49 2.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 168.048 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . 0.605 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 57.6 mt -99.16 128.81 50.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 C-N-CA 120.074 -0.65 . . . . 0.0 109.926 -173.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' TYR . . . . . 0.443 ' O ' ' HG2' ' A' ' 343' ' ' ARG . 0.2 OUTLIER -104.26 99.57 9.29 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 114.302 -1.317 . . . . 0.0 108.791 170.771 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . 0.49 ' O ' ' HB2' ' A' ' 388' ' ' LEU . 11.5 t -94.77 88.21 2.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 174.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 67.82 -116.99 8.24 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.123 -1.037 . . . . 0.0 110.851 -174.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -92.43 -4.26 53.98 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 117.783 0.792 . . . . 0.0 111.684 171.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . 0.686 HD12 ' HD1' ' A' ' 312' ' ' PHE . 2.5 mp -71.15 150.79 45.05 Favored 'General case' 0 CA--C 1.522 -0.113 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 172.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . 0.605 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 7.3 p30 -164.44 152.22 12.11 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.651 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . 0.934 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 30.5 t60 -175.56 119.5 0.17 Allowed 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.493 0.495 . . . . 0.0 110.4 176.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' GLN . . . . . 1.053 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 15.0 tt0 -78.03 153.24 32.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.404 0.621 . . . . 0.0 112.582 -179.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' TRP . . . . . 0.552 ' CZ2' ' HB2' ' A' ' 320' ' ' ASP . 52.7 t-105 -153.49 143.59 22.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.884 178.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -104.48 110.03 22.14 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 176.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . 0.699 HE22 ' HA ' ' A' ' 378' ' ' PRO . 0.0 OUTLIER -101.23 134.34 44.43 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 121.822 -0.549 . . . . 0.0 111.617 -164.847 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.571 ' HD3' ' HA ' ' A' ' 324' ' ' ASP . 13.2 mmmm . . . . . 0 C--O 1.245 0.824 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.794 -178.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 7.5 t . . . . . 0 CA--C 1.537 0.446 0 CA-C-O 121.12 0.486 . . . . 0.0 111.799 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . 0.619 ' HB2' ' O ' ' A' ' 337' ' ' PRO . 39.7 p90 -67.1 129.59 40.38 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' THR . . . . . 0.459 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 12.4 t 173.02 -167.18 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -170.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.467 HG11 ' O ' ' A' ' 306' ' ' VAL . 7.8 p -62.09 112.17 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 172.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -73.54 137.75 44.56 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.175 -173.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . 0.732 ' OD1' HG21 ' A' ' 310' ' ' THR . 9.4 t70 -60.36 119.9 8.84 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.034 177.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.444 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 29.0 pttt -42.09 -22.45 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 115.961 1.837 . . . . 0.0 115.961 -175.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.732 HG21 ' OD1' ' A' ' 308' ' ' ASP . 6.2 t -107.54 12.44 27.73 Favored 'General case' 0 C--N 1.314 -0.959 0 O-C-N 121.331 -0.856 . . . . 0.0 111.206 -170.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.453 ' HE3' ' OG1' ' A' ' 335' ' ' THR . 19.9 mtmm -96.37 -22.94 16.87 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -174.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.546 ' HD2' ' HE3' ' A' ' 364' ' ' MET . 0.1 OUTLIER -85.86 174.62 9.17 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.517 0.675 . . . . 0.0 110.957 176.678 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 13.2 t -147.83 158.46 44.04 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.34 -177.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . 0.499 ' HZ3' ' HB2' ' A' ' 328' ' ' MET . 19.2 m95 -79.44 95.61 5.83 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-O 121.018 0.437 . . . . 0.0 110.775 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.546 ' HG2' ' OE1' ' A' ' 329' ' ' GLU . 4.3 ttpp -69.91 -43.49 71.6 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 169.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 3.8 ttm180 -153.04 101.85 2.6 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.634 174.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -41.49 154.77 0.23 Allowed Pre-proline 0 N--CA 1.476 0.83 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 171.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 3.8 Cg_exo -38.17 114.17 0.16 Allowed 'Trans proline' 0 C--N 1.366 1.493 0 C-N-CA 123.777 2.985 . . . . 0.0 113.228 -176.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' THR . . . . . 0.52 ' O ' HG21 ' A' ' 327' ' ' VAL . 16.9 m -134.38 137.39 44.07 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.32 -174.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -59.17 131.32 50.67 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -177.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' SER . . . . . 0.442 ' C ' ' H ' ' A' ' 323' ' ' HIS . 51.5 p -80.34 5.86 13.66 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 122.149 -0.344 . . . . 0.0 111.6 -175.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 74.0 -22.34 1.22 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.105 -175.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . 0.442 ' H ' ' C ' ' A' ' 321' ' ' SER . 94.7 m-70 -102.33 47.77 0.89 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.381 0.61 . . . . 0.0 110.328 -177.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . 0.453 ' O ' HG23 ' A' ' 325' ' ' THR . 4.9 t70 55.94 39.18 30.59 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 114.403 -1.272 . . . . 0.0 111.659 174.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 324' ' ' ASP . 4.0 p -160.29 -171.59 3.24 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . 0.767 ' HB ' ' SD ' ' A' ' 374' ' ' MET . 0.3 OUTLIER -132.57 146.2 33.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.546 0.689 . . . . 0.0 111.558 -175.125 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' VAL . . . . . 0.576 HG12 ' HG2' ' A' ' 373' ' ' GLU . 14.9 m -122.61 157.81 27.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.276 175.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' MET . . . . . 0.765 ' HE3' ' HB ' ' A' ' 372' ' ' ILE . 0.0 OUTLIER -135.62 146.67 48.14 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 173.223 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.546 ' OE1' ' HG2' ' A' ' 315' ' ' LYS . 9.5 tt0 -120.67 122.4 40.39 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -177.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 2.7 m -128.76 151.56 35.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.521 0.201 . . . . 0.0 111.301 -176.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . 0.792 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -126.84 139.4 11.22 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.478 -177.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . 0.438 ' H ' ' CA ' ' A' ' 368' ' ' GLY . 0.8 OUTLIER -89.37 152.88 21.27 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.367 0.603 . . . . 0.0 111.858 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 8.7 t -107.39 2.12 24.15 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 174.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -173.38 -63.6 0.05 OUTLIER Glycine 0 C--N 1.341 0.834 0 C-N-CA 118.676 -1.726 . . . . 0.0 115.144 175.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' THR . . . . . 0.453 ' OG1' ' HE3' ' A' ' 311' ' ' LYS . 51.5 m -52.46 134.13 34.96 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 123.805 0.356 . . . . 0.0 111.251 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.624 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 16.1 ptt180 -90.62 -175.95 0.58 Allowed Pre-proline 0 CA--C 1.536 0.429 0 CA-C-O 117.212 -1.375 . . . . 0.0 108.624 -175.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . 0.703 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.1 OUTLIER -24.07 96.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 124.061 3.174 . . . . 0.0 114.65 -170.869 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' CYS . . . . . 0.741 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 3.9 p -109.95 -176.05 2.9 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 113.719 -1.582 . . . . 0.0 110.32 -169.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -112.16 96.3 5.95 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 177.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . 0.744 ' HB ' ' HG2' ' A' ' 362' ' ' PRO . 61.9 mt -78.18 118.86 74.79 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.302 -169.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -79.65 82.46 2.49 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.837 2.358 . . . . 0.0 111.903 177.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.734 HG12 HG21 ' A' ' 340' ' ' ILE . 4.2 m -100.94 123.68 54.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.504 0.669 . . . . 0.0 110.669 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -132.07 173.97 10.67 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 176.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' ALA . . . . . 0.64 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -144.96 140.97 28.6 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.718 175.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.414 HG21 HG21 ' A' ' 382' ' ' ILE . 10.6 m -114.62 140.59 34.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . 0.539 ' HB2' HG13 ' A' ' 354' ' ' VAL . . . -67.62 121.4 15.81 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . 0.567 ' O ' HG21 ' A' ' 349' ' ' VAL . 6.9 t60 46.62 59.79 3.7 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 124.336 1.022 . . . . 0.0 111.038 174.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 45.86 39.16 8.4 Favored Glycine 0 C--N 1.335 0.515 0 N-CA-C 115.097 0.799 . . . . 0.0 115.097 -174.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . 0.567 HG21 ' O ' ' A' ' 347' ' ' HIS . 58.9 t -137.35 102.19 8.94 Favored Pre-proline 0 C--O 1.235 0.301 0 CA-C-N 118.219 1.009 . . . . 0.0 108.949 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . 0.413 ' HA ' ' HB ' ' A' ' 345' ' ' VAL . 9.0 Cg_exo -75.82 61.38 6.28 Favored 'Trans proline' 0 N--CA 1.464 -0.209 0 C-N-CA 122.802 2.334 . . . . 0.0 113.245 -178.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -100.51 -56.76 2.26 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 175.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 2.3 p -117.48 127.49 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.535 174.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -63.38 112.08 2.57 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.774 175.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.681 HG12 ' HG ' ' A' ' 376' ' ' LEU . 4.2 m -92.68 9.02 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.713 177.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . 0.64 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -79.17 82.97 5.28 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.147 0.498 . . . . 0.0 111.041 176.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 5.4 tmm? -92.92 100.5 12.95 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 169.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.447 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 22.2 mt -86.89 117.87 25.9 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.072 -163.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.705 ' HB ' ' CB ' ' A' ' 373' ' ' GLU . 2.7 mm -61.46 -25.03 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.632 175.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 19.5 m -138.91 93.72 10.41 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.828 173.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -88.61 41.1 0.57 Allowed 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 123.275 2.65 . . . . 0.0 114.063 -171.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -161.83 72.48 2.41 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-O 121.235 0.54 . . . . 0.0 109.779 175.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . 0.795 ' HB3' HG21 ' A' ' 372' ' ' ILE . 87.8 Cg_endo -82.58 108.57 1.71 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.79 2.327 . . . . 0.0 112.302 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 16.8 p -89.78 144.28 26.1 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.671 0.748 . . . . 0.0 112.326 171.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' MET . . . . . 0.741 ' HG2' ' SG ' ' A' ' 338' ' ' CYS . 5.7 ptp -93.94 125.39 38.54 Favored 'General case' 0 CA--C 1.499 -0.981 0 CA-C-N 114.387 -1.279 . . . . 0.0 108.153 174.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.477 ' HG2' ' HG3' ' A' ' 337' ' ' PRO . 33.6 mt-10 -126.52 -163.39 1.23 Allowed 'General case' 0 C--N 1.315 -0.921 0 O-C-N 124.511 1.132 . . . . 0.0 110.344 -172.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -48.37 -23.95 1.08 Allowed 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -171.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -112.32 -1.98 14.95 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.828 0.74 . . . . 0.0 110.967 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . 0.792 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . 115.11 -168.21 12.51 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -172.275 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . 0.434 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -48.23 -34.31 12.47 Favored Glycine 0 CA--C 1.519 0.313 0 CA-C-N 117.725 0.763 . . . . 0.0 113.303 172.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . 0.467 ' O ' ' HG3' ' A' ' 329' ' ' GLU . . . 81.53 -58.17 4.88 Favored Glycine 0 C--O 1.227 -0.314 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.584 176.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -165.19 137.82 4.42 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.043 0.449 . . . . 0.0 111.125 178.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 372' ' ' ILE . . . . . 0.795 HG21 ' HB3' ' A' ' 362' ' ' PRO . 0.9 OUTLIER -134.4 159.1 42.12 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 172.846 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . 0.705 ' CB ' ' HB ' ' A' ' 358' ' ' ILE . 36.5 mt-10 -128.21 125.92 39.94 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.581 -177.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 374' ' ' MET . . . . . 0.767 ' SD ' ' HB ' ' A' ' 326' ' ' VAL . 0.0 OUTLIER -136.43 160.37 38.97 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -179.083 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 375' ' ' GLN . . . . . 0.826 HE21 ' HA ' ' A' ' 375' ' ' GLN . 0.0 OUTLIER -177.91 170.11 1.93 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.918 0.39 . . . . 0.0 110.208 172.592 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 376' ' ' LEU . . . . . 0.722 HD21 ' HD2' ' A' ' 377' ' ' PRO . 2.3 tm? -166.93 131.81 1.66 Allowed Pre-proline 0 N--CA 1.439 -0.991 0 N-CA-C 104.537 -2.394 . . . . 0.0 104.537 -178.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 377' ' ' PRO . . . . . 0.722 ' HD2' HD21 ' A' ' 376' ' ' LEU . 35.7 Cg_exo -28.95 131.0 0.04 OUTLIER 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 123.788 2.992 . . . . 0.0 112.811 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -35.56 138.21 0.15 Allowed 'Trans proline' 0 C--N 1.359 1.106 0 C-N-CA 124.658 3.572 . . . . 0.0 113.582 -166.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 151.87 -165.07 30.56 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 -160.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . 0.46 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 15.8 m-20 -99.7 128.78 45.8 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 117.925 0.862 . . . . 0.0 111.23 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.411 HD22 ' HB3' ' A' ' 376' ' ' LEU . 9.5 m120 -128.43 159.79 34.3 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 174.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 1.054 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -150.55 139.1 14.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 170.313 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . 0.656 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 31.5 mt -99.51 127.02 52.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.44 -176.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' TYR . . . . . 0.426 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.2 OUTLIER -104.41 92.54 4.37 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.226 174.017 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . 0.521 ' O ' ' HB2' ' A' ' 388' ' ' LEU . 20.3 t -85.13 86.19 2.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 178.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 60.46 -112.57 4.66 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.287 -0.959 . . . . 0.0 111.341 -170.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' ASP . . . . . 0.402 ' N ' ' HB2' ' A' ' 309' ' ' LYS . 4.9 t70 -82.86 -17.05 45.23 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.008 0.432 . . . . 0.0 110.793 176.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . 0.521 ' HB2' ' O ' ' A' ' 385' ' ' VAL . 2.3 mp -69.38 151.83 45.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.209 177.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . 0.656 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 7.6 p30 -165.37 153.34 11.24 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.575 176.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . 0.446 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 35.5 t-80 -173.74 113.74 0.21 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.323 177.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' GLN . . . . . 1.054 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 13.6 tt0 -73.65 154.62 39.64 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.293 177.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' TRP . . . . . 0.555 ' HD1' ' OE1' ' A' ' 394' ' ' GLN . 17.8 t-105 -166.63 150.99 7.41 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.77 177.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -105.33 115.89 31.03 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . 0.746 ' HG3' HE22 ' A' ' 375' ' ' GLN . 3.5 mm100 -84.4 113.96 21.55 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -170.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 1.7 ptmm? . . . . . 0 C--O 1.251 1.172 0 CA-C-O 118.442 -0.79 . . . . 0.0 110.818 -178.252 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' THR . . . . . 0.501 HG21 HG23 ' A' ' 335' ' ' THR . 10.4 t . . . . . 0 CA--C 1.539 0.543 0 CA-C-O 121.949 0.881 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -69.84 116.38 10.16 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 175.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' THR . . . . . 0.574 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 13.0 t 177.38 -172.32 0.1 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -172.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 56.2 t -65.81 110.59 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 169.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . 1.015 ' HB3' HG22 ' A' ' 335' ' ' THR . 0.0 OUTLIER -68.37 135.83 52.41 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.966 0.413 . . . . 0.0 110.43 -169.886 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . 0.553 ' OD1' HG21 ' A' ' 310' ' ' THR . 17.1 t70 -64.32 126.16 26.91 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.31 -174.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.445 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -47.9 -17.74 0.13 Allowed 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 -168.85 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.553 HG21 ' OD1' ' A' ' 308' ' ' ASP . 11.8 t -108.92 3.28 22.12 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 119.88 1.218 . . . . 0.0 111.999 -173.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -78.51 -30.91 47.41 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -173.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.588 ' CD1' ' HE3' ' A' ' 364' ' ' MET . 0.0 OUTLIER -79.77 176.32 9.82 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-O 122.198 0.999 . . . . 0.0 111.821 -173.951 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 8.8 t -148.66 156.93 43.06 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 113.487 -1.688 . . . . 0.0 107.995 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 27.6 m-90 -68.66 121.19 15.93 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 54.4 tptt -103.13 -41.94 5.93 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 173.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -154.83 130.62 10.03 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.308 170.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -69.31 162.09 68.71 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.631 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . 0.725 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 53.8 Cg_exo -46.13 111.39 0.34 Allowed 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 122.311 2.007 . . . . 0.0 112.087 177.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' THR . . . . . 0.558 ' O ' HG21 ' A' ' 327' ' ' VAL . 17.2 m -130.08 132.7 46.27 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.655 -172.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -54.99 124.74 17.72 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 178.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' SER . . . . . 0.519 ' C ' ' H ' ' A' ' 323' ' ' HIS . 23.8 p -75.71 0.96 15.96 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.756 0.422 . . . . 0.0 111.848 -170.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 72.57 -26.91 0.73 Allowed Glycine 0 C--N 1.331 0.29 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.453 -169.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . 0.519 ' H ' ' C ' ' A' ' 321' ' ' SER . 30.4 t60 -95.87 44.6 1.08 Allowed 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 121.087 0.47 . . . . 0.0 109.789 -175.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 17.5 t70 59.12 31.51 21.35 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.001 175.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' THR . . . . . 0.813 ' HA ' ' HG3' ' A' ' 375' ' ' GLN . 4.6 p -152.05 -171.88 4.06 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -178.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . 0.403 HG13 ' C ' ' A' ' 319' ' ' THR . 48.2 t -137.71 129.17 39.65 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.611 0 CA-C-N 118.466 0.575 . . . . 0.0 111.085 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' VAL . . . . . 0.558 HG21 ' O ' ' A' ' 319' ' ' THR . 12.5 m -107.46 163.07 5.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.524 -178.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' MET . . . . . 0.534 ' HE3' ' HD3' ' A' ' 318' ' ' PRO . 0.0 OUTLIER -145.65 154.61 42.3 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 174.433 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' A' ' 370' ' ' GLY . 16.5 tt0 -133.28 130.53 39.07 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.387 -175.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.51 HG11 ' SD ' ' A' ' 328' ' ' MET . 0.2 OUTLIER -130.01 153.31 38.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.839 -178.277 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -121.18 137.12 11.62 Favored Glycine 0 CA--C 1.522 0.484 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.852 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . 0.459 ' HD2' ' N ' ' A' ' 335' ' ' THR . 1.3 p90 -88.05 155.85 19.6 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.673 0.749 . . . . 0.0 112.768 -178.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 28.3 p -115.69 20.93 14.32 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.76 -1.109 . . . . 0.0 112.764 169.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 164.24 -14.11 0.09 OUTLIER Glycine 0 N--CA 1.465 0.588 0 C-N-CA 120.112 -1.042 . . . . 0.0 113.846 173.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' THR . . . . . 1.015 HG22 ' HB3' ' A' ' 307' ' ' CYS . 0.2 OUTLIER -85.99 118.42 25.46 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 179.656 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 336' ' ' ARG . 4.8 ptp180 -100.22 178.94 1.12 Allowed Pre-proline 0 N--CA 1.451 -0.421 0 CA-C-O 116.549 -1.691 . . . . 0.0 106.475 174.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . 0.565 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.1 OUTLIER -23.26 91.04 0.0 OUTLIER 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 123.736 2.957 . . . . 0.0 114.387 -164.047 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' CYS . . . . . 0.574 ' HB2' ' O ' ' A' ' 305' ' ' THR . 14.2 p -115.41 -176.74 2.98 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 112.68 -2.055 . . . . 0.0 109.303 -170.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? -111.4 101.8 10.23 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . 0.723 HG12 ' HG3' ' A' ' 364' ' ' MET . 59.1 mt -72.95 118.78 71.32 Favored Pre-proline 0 C--N 1.325 -0.488 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.515 -170.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -74.18 79.24 2.44 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 121.969 1.78 . . . . 0.0 110.644 175.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.722 HG12 HG23 ' A' ' 340' ' ' ILE . 1.1 m -103.13 122.91 56.18 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.86 0 CA-C-O 121.874 0.845 . . . . 0.0 111.076 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.504 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 15.4 ptt180 -135.62 176.77 8.37 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 114.046 -1.434 . . . . 0.0 108.029 175.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' ALA . . . . . 0.587 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -148.66 144.31 27.07 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.554 175.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 11.6 m -117.09 144.9 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 176.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -68.66 116.08 8.77 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 178.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . 0.61 ' HB2' ' CB ' ' A' ' 380' ' ' ASP . 12.2 t60 40.64 67.68 0.49 Allowed 'General case' 0 N--CA 1.478 0.96 0 O-C-N 124.399 1.062 . . . . 0.0 111.519 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . 0.763 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 40.96 48.19 4.21 Favored Glycine 0 C--N 1.332 0.353 0 N-CA-C 115.206 0.842 . . . . 0.0 115.206 -174.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . 0.667 HG11 ' HG2' ' A' ' 351' ' ' GLU . 61.8 t -141.43 101.5 6.12 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 118.173 0.986 . . . . 0.0 108.457 176.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -80.53 72.3 6.6 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 123.131 2.554 . . . . 0.0 113.679 -176.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . 0.667 ' HG2' HG11 ' A' ' 349' ' ' VAL . 4.8 mm-40 -99.52 -58.04 2.02 Favored 'General case' 0 CA--C 1.502 -0.9 0 CA-C-O 122.6 1.191 . . . . 0.0 107.937 171.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . 0.454 HG11 ' HB2' ' A' ' 351' ' ' GLU . 1.1 p -125.47 127.17 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 112.644 -2.071 . . . . 0.0 110.127 -177.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -62.64 114.44 3.58 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.998 178.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.666 ' HB ' ' OD1' ' A' ' 381' ' ' ASN . 3.5 m -94.05 6.62 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.131 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . 0.587 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -74.67 83.13 2.08 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.886 0.374 . . . . 0.0 111.33 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 356' ' ' MET . . . . . 0.627 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 37.0 ttm -94.9 98.31 10.62 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 171.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.618 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 42.8 mt -87.46 123.92 32.89 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.802 -162.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.758 HD12 ' HB2' ' A' ' 375' ' ' GLN . 2.3 mm -62.88 -23.6 33.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.526 173.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 8.3 m -132.38 92.18 28.92 Favored Pre-proline 0 N--CA 1.447 -0.582 0 CA-C-N 114.499 -1.228 . . . . 0.0 108.547 170.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -86.41 28.77 0.53 Allowed 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.133 2.555 . . . . 0.0 112.466 -175.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -156.9 65.66 3.75 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 114.77 -1.104 . . . . 0.0 109.217 177.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . 0.699 ' HB2' HD12 ' A' ' 340' ' ' ILE . 87.2 Cg_endo -86.03 114.6 1.36 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.5 2.134 . . . . 0.0 111.991 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' THR . . . . . 0.408 HG21 ' O ' ' A' ' 338' ' ' CYS . 15.1 p -92.64 147.08 23.17 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 171.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' MET . . . . . 0.723 ' HG3' HG12 ' A' ' 340' ' ' ILE . 46.6 mtt -95.78 134.42 38.75 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-N 113.936 -1.484 . . . . 0.0 108.449 172.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.543 ' HA ' ' HD3' ' A' ' 337' ' ' PRO . 45.9 mt-10 -117.16 -167.66 1.34 Allowed 'General case' 0 C--N 1.32 -0.676 0 O-C-N 123.939 0.774 . . . . 0.0 111.22 -176.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . 0.504 HD21 ' N ' ' A' ' 367' ' ' ASN . 0.2 OUTLIER -59.39 -6.83 1.11 Allowed 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 179.631 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' ASN . . . . . 0.504 ' N ' HD21 ' A' ' 366' ' ' ASN . 7.6 p30 -113.49 -2.08 13.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.362 0.601 . . . . 0.0 109.906 178.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 109.98 -176.6 19.32 Favored Glycine 0 N--CA 1.451 -0.356 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -172.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . 0.694 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -46.64 -40.89 12.17 Favored Glycine 0 CA--C 1.519 0.305 0 CA-C-N 117.588 0.694 . . . . 0.0 113.476 173.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . 0.414 ' O ' ' HG3' ' A' ' 329' ' ' GLU . . . 83.28 -51.17 4.53 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.152 177.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -166.01 143.79 5.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.921 0.391 . . . . 0.0 111.616 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 372' ' ' ILE . . . . . 0.721 HD11 HG11 ' A' ' 342' ' ' VAL . 0.9 OUTLIER -134.71 151.46 31.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 170.398 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . 0.616 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 44.5 mt-10 -128.75 126.86 40.87 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.815 0.34 . . . . 0.0 110.355 -178.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 374' ' ' MET . . . . . 0.735 ' HG2' HD12 ' A' ' 383' ' ' ILE . 4.2 ppp? -137.3 165.1 26.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.589 -178.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 375' ' ' GLN . . . . . 0.813 ' HG3' ' HA ' ' A' ' 325' ' ' THR . 0.3 OUTLIER -177.32 -179.9 0.91 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.303 0.573 . . . . 0.0 111.692 168.954 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 376' ' ' LEU . . . . . 0.701 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 13.1 tp -167.96 155.0 7.68 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 178.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 377' ' ' PRO . . . . . 0.701 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 82.8 Cg_exo -45.53 131.67 12.49 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 121.287 1.325 . . . . 0.0 110.046 167.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.544 ' HA ' ' NE2' ' A' ' 394' ' ' GLN . 4.0 Cg_exo -35.07 141.12 0.09 OUTLIER 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 125.103 3.869 . . . . 0.0 113.979 -171.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 152.64 -167.37 31.49 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 -163.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . 0.61 ' CB ' ' HB2' ' A' ' 347' ' ' HIS . 5.0 m-20 -99.4 124.31 44.43 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 117.548 0.674 . . . . 0.0 111.395 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.666 ' OD1' ' HB ' ' A' ' 354' ' ' VAL . 15.9 m-80 -134.19 141.64 47.12 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 0.997 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -142.58 137.05 28.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -179.837 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . 0.735 HD12 ' HG2' ' A' ' 374' ' ' MET . 47.6 mt -98.25 127.83 50.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.751 -172.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' TYR . . . . . 0.504 ' O ' ' HG2' ' A' ' 343' ' ' ARG . 0.3 OUTLIER -104.98 91.42 3.8 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.197 173.469 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . 0.416 HG13 HG13 ' A' ' 330' ' ' VAL . 9.3 t -83.34 90.27 2.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 61.45 -113.26 5.52 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.461 -0.876 . . . . 0.0 111.027 -170.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -88.11 -16.36 33.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.759 0.314 . . . . 0.0 110.883 175.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . 0.495 HD21 HG12 ' A' ' 330' ' ' VAL . 0.9 OUTLIER -69.51 155.69 40.07 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.191 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . 0.638 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 28.2 p-10 -165.98 157.3 13.66 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.778 177.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . 0.725 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 6.8 t60 -174.55 120.98 0.25 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.202 174.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' GLN . . . . . 0.997 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 21.3 tt0 -75.35 149.51 38.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.438 0.637 . . . . 0.0 112.115 -177.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' TRP . . . . . . . . . . . . . 70.5 t-105 -146.12 143.35 29.27 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.426 177.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . 0.675 ' HD2' ' HE2' ' A' ' 395' ' ' LYS . 12.3 p90 -104.15 107.38 18.26 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 173.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . 0.701 ' HG2' HE22 ' A' ' 375' ' ' GLN . 0.0 OUTLIER -94.33 123.05 37.49 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.805 0.812 . . . . 0.0 110.972 -170.836 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.675 ' HE2' ' HD2' ' A' ' 393' ' ' PHE . 48.6 mttm . . . . . 0 C--O 1.245 0.834 0 CA-C-N 114.464 -1.244 . . . . 0.0 108.911 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' THR . . . . . 0.467 ' O ' HG23 ' A' ' 335' ' ' THR . 5.2 t . . . . . 0 CA--C 1.538 0.505 0 CA-C-O 121.486 0.66 . . . . 0.0 111.001 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -65.98 124.67 23.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.151 0.501 . . . . 0.0 110.023 177.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' THR . . . . . 0.486 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 14.3 t 175.79 -170.58 0.06 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.113 -171.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 61.3 t -63.64 108.86 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 168.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.56 142.14 55.29 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.747 0.308 . . . . 0.0 110.567 -169.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . 0.692 ' OD1' HG21 ' A' ' 310' ' ' THR . 16.1 t70 -64.46 131.91 48.48 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.813 0.816 . . . . 0.0 112.004 -170.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -37.72 -30.65 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 112.975 -1.921 . . . . 0.0 115.222 -177.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.692 HG21 ' OD1' ' A' ' 308' ' ' ASP . 11.6 t -105.19 -1.85 24.89 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 118.747 0.703 . . . . 0.0 112.376 -169.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 27.0 mmmt -70.13 -35.05 73.79 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.284 0.564 . . . . 0.0 110.908 -178.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.735 ' HB3' ' HE2' ' A' ' 364' ' ' MET . 0.1 OUTLIER -90.47 177.64 6.32 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 122.296 1.046 . . . . 0.0 112.544 -174.553 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 14.2 t -161.8 168.86 22.41 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 113.534 -1.666 . . . . 0.0 108.978 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 92.9 m95 -83.91 96.72 8.91 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 121.371 0.605 . . . . 0.0 110.648 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.676 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 56.7 tttm -66.61 -40.13 88.69 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 167.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 61.4 ttt180 -158.9 131.79 7.05 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.333 168.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . 0.498 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -74.87 163.66 66.69 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.059 -176.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . 0.498 ' HD2' ' HB1' ' A' ' 317' ' ' ALA . 4.9 Cg_exo -37.64 116.05 0.19 Allowed 'Trans proline' 0 C--N 1.362 1.239 0 C-N-CA 123.58 2.853 . . . . 0.0 113.364 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' THR . . . . . 0.585 ' O ' HG21 ' A' ' 327' ' ' VAL . 28.8 m -132.9 138.36 46.95 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.424 -176.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . 0.427 ' OD2' ' HZ2' ' A' ' 392' ' ' TRP . 45.5 m-20 -61.13 132.83 55.0 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -178.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' SER . . . . . 0.451 ' C ' ' H ' ' A' ' 323' ' ' HIS . 60.3 p -71.52 1.58 6.3 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 122.492 0.317 . . . . 0.0 111.466 -174.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 70.52 -22.06 0.54 Allowed Glycine 0 CA--C 1.521 0.452 0 C-N-CA 121.438 -0.411 . . . . 0.0 113.642 -170.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . 0.596 ' O ' ' HB3' ' A' ' 324' ' ' ASP . 93.5 m-70 -77.67 -41.74 37.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.993 0.396 . . . . 0.0 111.7 -172.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . 0.596 ' HB3' ' O ' ' A' ' 323' ' ' HIS . 4.5 p-10 144.37 13.89 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.721 0 O-C-N 124.354 1.034 . . . . 0.0 109.89 -163.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' THR . . . . . 0.458 ' HA ' ' HG2' ' A' ' 375' ' ' GLN . 6.5 p -150.13 -170.23 3.59 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -170.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 373' ' ' GLU . 1.4 t -130.04 148.71 33.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.173 0.511 . . . . 0.0 111.03 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' VAL . . . . . 0.631 ' HA ' ' O ' ' A' ' 372' ' ' ILE . 19.1 m -128.7 157.42 41.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.982 178.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' MET . . . . . 0.657 ' HE1' HG21 ' A' ' 385' ' ' VAL . 23.1 ptt? -140.89 156.3 46.13 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 170.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.676 ' HG2' ' HD3' ' A' ' 315' ' ' LYS . 22.8 tt0 -121.8 119.12 30.75 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.412 HG21 ' HE3' ' A' ' 364' ' ' MET . 19.5 m -122.97 142.23 40.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 120.676 0.274 . . . . 0.0 110.792 -175.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . 0.544 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -125.49 138.28 10.82 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.247 -0.978 . . . . 0.0 113.199 -173.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . 0.841 ' HE2' ' HB ' ' A' ' 335' ' ' THR . 0.0 OUTLIER -147.61 163.13 37.56 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 176.114 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 15.1 m -151.96 44.48 0.74 Allowed 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -174.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -139.34 -65.82 0.04 OUTLIER Glycine 0 C--N 1.331 0.258 0 C-N-CA 119.369 -1.396 . . . . 0.0 112.126 169.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' THR . . . . . 0.841 ' HB ' ' HE2' ' A' ' 332' ' ' PHE . 28.6 m -52.9 140.56 24.21 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.234 -0.983 . . . . 0.0 109.236 172.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.622 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 21.9 ptt180 -87.91 178.37 2.18 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 117.592 -1.194 . . . . 0.0 108.725 176.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . 0.622 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 2.2 Cg_exo -27.65 104.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.372 1.776 0 C-N-CA 123.573 2.849 . . . . 0.0 113.58 -178.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' CYS . . . . . 0.589 ' SG ' ' HB2' ' A' ' 364' ' ' MET . 22.2 p -116.74 -174.3 2.55 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 113.882 -1.508 . . . . 0.0 110.286 -167.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 -111.71 101.6 9.96 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . 0.481 HG12 HG12 ' A' ' 342' ' ' VAL . 13.4 tt -77.61 121.93 85.05 Favored Pre-proline 0 C--N 1.325 -0.47 0 C-N-CA 119.118 -1.033 . . . . 0.0 110.849 -167.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -78.16 80.55 2.96 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.252 1.968 . . . . 0.0 111.954 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.63 HG13 HG11 ' A' ' 385' ' ' VAL . 30.2 m -106.07 153.31 7.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.355 -178.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.467 ' HG3' ' HB2' ' A' ' 384' ' ' TYR . 40.3 ptt180 -168.33 174.99 6.65 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -179.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' ALA . . . . . 0.655 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -149.81 144.36 25.95 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.931 -0.708 . . . . 0.0 110.885 177.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.567 ' HB ' ' HA ' ' A' ' 350' ' ' PRO . 4.6 m -116.72 147.09 20.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -69.53 125.59 27.17 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 176.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . 0.51 ' O ' HG21 ' A' ' 349' ' ' VAL . 5.0 t60 43.88 60.17 2.82 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 124.422 1.077 . . . . 0.0 111.665 172.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . 0.61 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 43.02 42.79 5.26 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 115.046 0.778 . . . . 0.0 115.046 -174.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . 0.51 HG21 ' O ' ' A' ' 347' ' ' HIS . 75.5 t -139.98 101.8 7.0 Favored Pre-proline 0 C--N 1.331 -0.227 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . 0.567 ' HA ' ' HB ' ' A' ' 345' ' ' VAL . 12.5 Cg_exo -75.41 54.8 3.95 Favored 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 122.913 2.408 . . . . 0.0 113.834 -176.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -100.15 -56.35 2.39 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 176.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.7 p -112.28 123.69 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.854 172.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . 0.538 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 6.1 t30 -65.8 122.25 16.89 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.371 174.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.448 HG12 HD21 ' A' ' 376' ' ' LEU . 29.1 m -97.56 4.51 9.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.143 176.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . 0.655 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -76.93 83.95 3.48 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.893 -179.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 356' ' ' MET . . . . . 0.677 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 53.3 ttp -95.36 99.87 11.73 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 169.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.46 ' HB2' ' HA ' ' A' ' 360' ' ' PRO . 36.5 mt -85.34 116.49 23.7 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.768 -162.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.728 ' HB ' ' CB ' ' A' ' 373' ' ' GLU . 1.7 mm -64.6 -24.36 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 174.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 72.3 m -118.61 85.15 26.23 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 114.294 -1.321 . . . . 0.0 108.257 169.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' PRO . . . . . 0.46 ' HA ' ' HB2' ' A' ' 357' ' ' LEU . 75.0 Cg_endo -84.3 26.04 0.67 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.115 2.543 . . . . 0.0 114.448 -167.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -166.52 68.34 1.04 Allowed Pre-proline 0 C--N 1.311 -1.093 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.587 173.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . 0.54 ' HB3' HG21 ' A' ' 372' ' ' ILE . 58.6 Cg_endo -82.54 169.05 14.08 Favored 'Trans proline' 0 C--O 1.246 0.889 0 C-N-CA 122.542 2.161 . . . . 0.0 113.317 -178.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 4.2 p -143.7 -176.53 5.01 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.087 -168.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' MET . . . . . 0.79 ' HA ' ' HA2' ' A' ' 369' ' ' GLY . 42.4 mtp -144.83 127.61 16.28 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 172.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.454 ' O ' ' HE1' ' A' ' 332' ' ' PHE . 48.4 mt-10 -117.52 -169.62 1.7 Allowed 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.295 -172.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . 0.642 HD21 ' N ' ' A' ' 367' ' ' ASN . 0.2 OUTLIER -58.78 -21.99 57.19 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -171.676 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' ASN . . . . . 0.642 ' N ' HD21 ' A' ' 366' ' ' ASN . 26.8 m120 -101.11 -4.41 27.38 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.564 -0.71 . . . . 0.0 110.729 176.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . 0.56 ' HA2' ' HD1' ' A' ' 332' ' ' PHE . . . 116.94 172.9 16.45 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -173.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . 0.79 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -54.61 -47.19 71.57 Favored Glycine 0 CA--C 1.505 -0.548 0 C-N-CA 121.371 -0.442 . . . . 0.0 113.391 177.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . 0.594 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 90.12 -134.61 12.44 Favored Glycine 0 N--CA 1.438 -1.194 0 C-N-CA 119.943 -1.122 . . . . 0.0 110.917 -172.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -103.16 140.61 37.12 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.513 0.673 . . . . 0.0 111.697 -177.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 372' ' ' ILE . . . . . 0.631 ' O ' ' HA ' ' A' ' 327' ' ' VAL . 1.5 mt -128.25 161.31 36.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.044 176.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . 0.728 ' CB ' ' HB ' ' A' ' 358' ' ' ILE . 38.8 mt-10 -124.49 128.54 49.14 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.484 0.659 . . . . 0.0 110.97 -179.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 374' ' ' MET . . . . . 0.594 ' HE3' ' HB ' ' A' ' 372' ' ' ILE . 0.1 OUTLIER -140.32 157.31 45.76 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.38 -1.282 . . . . 0.0 108.188 -179.923 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 375' ' ' GLN . . . . . 0.818 HE21 ' HA ' ' A' ' 375' ' ' GLN . 0.0 OUTLIER 179.83 175.45 0.78 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 118.224 0.465 . . . . 0.0 109.803 179.124 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 376' ' ' LEU . . . . . 1.044 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 11.2 tp -166.69 164.45 10.38 Favored Pre-proline 0 N--CA 1.446 -0.63 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 176.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 377' ' ' PRO . . . . . 1.044 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 80.0 Cg_exo -43.63 133.92 7.39 Favored 'Trans proline' 0 CA--C 1.533 0.433 0 C-N-CA 121.38 1.387 . . . . 0.0 111.3 169.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.545 ' HA ' HE22 ' A' ' 394' ' ' GLN . 4.7 Cg_exo -35.47 144.22 0.08 OUTLIER 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 125.177 3.918 . . . . 0.0 114.223 -175.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 151.17 -159.69 28.31 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -164.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . 0.461 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 7.5 m-20 -104.7 131.55 52.01 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 118.013 0.906 . . . . 0.0 110.939 175.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.435 ' HA ' HG22 ' A' ' 354' ' ' VAL . 10.0 m120 -128.5 145.53 51.08 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 177.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 1.043 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -143.91 136.97 23.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 176.634 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . 0.644 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 13.4 mt -100.72 131.71 47.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.326 -173.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' TYR . . . . . 0.467 ' HB2' ' HG3' ' A' ' 343' ' ' ARG . 5.0 m-85 -99.91 133.72 43.86 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 114.51 -1.223 . . . . 0.0 108.163 167.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . 0.817 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 4.5 t -124.21 82.05 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 177.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 59.91 -108.57 1.79 Allowed Glycine 0 N--CA 1.434 -1.455 0 C-N-CA 119.837 -1.173 . . . . 0.0 110.848 -167.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -83.12 -15.51 50.47 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 175.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . 0.817 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 4.1 mp -69.68 155.77 40.0 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.477 0.179 . . . . 0.0 110.625 177.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . 0.644 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 4.9 p-10 -171.41 152.25 3.24 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.426 174.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . 0.4 ' O ' HG12 ' A' ' 382' ' ' ILE . 6.5 t60 -173.91 120.45 0.29 Allowed 'General case' 0 C--O 1.237 0.421 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 177.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' GLN . . . . . 1.043 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 7.5 tt0 -76.35 152.94 36.18 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.294 0.568 . . . . 0.0 112.496 -175.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' TRP . . . . . 0.427 ' HZ2' ' OD2' ' A' ' 320' ' ' ASP . 59.0 t-105 -150.2 148.82 29.38 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.397 177.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -111.64 114.03 26.8 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 173.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . 0.545 HE22 ' HA ' ' A' ' 378' ' ' PRO . 0.0 OUTLIER -103.01 127.31 50.3 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.334 0.588 . . . . 0.0 110.069 -172.885 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.566 ' HD3' ' H ' ' A' ' 395' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.021 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.514 -174.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' THR . . . . . 0.433 ' O ' HG21 ' A' ' 305' ' ' THR . 10.0 t . . . . . 0 CA--C 1.535 0.378 0 CA-C-O 121.471 0.653 . . . . 0.0 111.437 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . 0.443 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 43.7 p90 -64.03 120.87 12.85 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 172.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' THR . . . . . 0.602 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 14.2 t 170.75 -166.75 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -170.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 19.2 t -65.32 110.58 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 171.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.79 141.33 55.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.007 0.432 . . . . 0.0 110.955 -173.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . 0.623 ' OD1' HG21 ' A' ' 310' ' ' THR . 9.4 t70 -60.82 123.02 16.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.944 -177.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 34.7 pttt -45.28 -17.53 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 115.4 1.629 . . . . 0.0 115.4 -177.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.623 HG21 ' OD1' ' A' ' 308' ' ' ASP . 10.6 t -109.63 9.08 25.14 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 120.212 1.369 . . . . 0.0 112.252 -174.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.419 ' HG3' ' HB3' ' A' ' 308' ' ' ASP . 26.2 mtpp -90.42 -27.03 19.56 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -174.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.752 ' HZ ' ' HA3' ' A' ' 386' ' ' GLY . 0.4 OUTLIER -85.91 173.55 9.89 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.887 0.851 . . . . 0.0 112.443 -175.925 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 11.2 t -153.6 158.91 41.87 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.203 -1.362 . . . . 0.0 109.101 -178.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 16.4 m95 -79.79 95.53 6.04 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 120.981 0.42 . . . . 0.0 111.376 -176.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.483 ' HB3' ' C ' ' A' ' 329' ' ' GLU . 31.8 tptt -63.37 -49.64 73.06 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 167.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 3.8 ttm180 -154.73 131.55 10.77 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.211 -0.904 . . . . 0.0 108.918 175.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -75.07 159.31 82.99 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-O 119.051 -0.499 . . . . 0.0 110.908 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -34.27 113.24 0.08 OUTLIER 'Trans proline' 0 C--N 1.365 1.397 0 C-N-CA 123.78 2.987 . . . . 0.0 113.545 177.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' THR . . . . . 0.484 ' O ' HG21 ' A' ' 327' ' ' VAL . 21.0 m -130.89 137.15 49.2 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.932 -175.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -58.82 128.18 35.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.664 -0.244 . . . . 0.0 110.36 -179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 60.5 p -74.68 3.98 7.0 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.026 0.53 . . . . 0.0 111.85 -173.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 70.61 -18.79 0.74 Allowed Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.238 -0.506 . . . . 0.0 114.08 -172.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . 0.445 ' O ' ' CB ' ' A' ' 324' ' ' ASP . 11.5 m170 -92.01 -13.75 30.5 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 117.579 0.69 . . . . 0.0 112.791 -174.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . 0.445 ' CB ' ' O ' ' A' ' 323' ' ' HIS . 29.9 t70 108.0 35.39 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 O-C-N 125.329 1.643 . . . . 0.0 109.033 -175.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' THR . . . . . 0.569 ' HA ' ' CG ' ' A' ' 375' ' ' GLN . 3.3 p -150.97 -173.77 4.59 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . 0.666 HG23 ' HG2' ' A' ' 375' ' ' GLN . 0.6 OUTLIER -130.04 143.74 40.13 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.589 0 CA-C-N 118.776 0.716 . . . . 0.0 111.511 -177.33 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' VAL . . . . . 0.62 ' HA ' ' O ' ' A' ' 372' ' ' ILE . 19.2 m -123.28 146.2 29.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.466 176.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' MET . . . . . 0.702 ' HE2' ' HB ' ' A' ' 372' ' ' ILE . 6.1 ptp -130.61 153.5 48.85 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 174.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.483 ' C ' ' HB3' ' A' ' 315' ' ' LYS . 3.8 tt0 -125.75 126.27 44.31 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.561 HG21 ' HA3' ' A' ' 369' ' ' GLY . 10.7 m -125.58 159.05 33.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.351 -176.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . 0.525 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -130.8 135.59 8.35 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 118.843 -1.646 . . . . 0.0 114.482 178.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . 0.992 ' H ' ' HA2' ' A' ' 368' ' ' GLY . 36.2 m-85 -112.52 171.49 7.49 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.442 0.697 . . . . 0.0 110.074 170.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 34.7 m -130.58 -15.17 3.58 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 174.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -123.82 -66.42 0.2 Allowed Glycine 0 C--O 1.224 -0.484 0 C-N-CA 119.766 -1.207 . . . . 0.0 113.659 -175.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' THR . . . . . . . . . . . . . 12.8 m -54.16 129.01 33.32 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 123.747 0.322 . . . . 0.0 111.202 -176.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.648 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 6.4 ptm180 -88.7 179.45 1.63 Allowed Pre-proline 0 CA--C 1.532 0.269 0 CA-C-O 117.442 -1.266 . . . . 0.0 108.123 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . 0.648 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -26.89 99.41 0.02 OUTLIER 'Trans proline' 0 C--N 1.372 1.816 0 C-N-CA 123.888 3.059 . . . . 0.0 114.155 -175.574 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' CYS . . . . . 0.602 ' HB2' ' O ' ' A' ' 305' ' ' THR . 19.2 p -115.61 -175.61 2.75 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 113.583 -1.644 . . . . 0.0 109.302 -169.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -106.54 96.34 6.38 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . 0.838 HD13 ' HD2' ' A' ' 341' ' ' PRO . 9.3 tp -75.54 120.05 79.88 Favored Pre-proline 0 C--N 1.325 -0.457 0 C-N-CA 119.011 -1.076 . . . . 0.0 110.924 -168.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . 0.838 ' HD2' HD13 ' A' ' 340' ' ' ILE . 53.5 Cg_endo -72.87 79.45 1.96 Allowed 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 121.92 1.746 . . . . 0.0 111.216 175.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.605 HG12 HG13 ' A' ' 340' ' ' ILE . 2.5 m -103.85 109.64 27.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.273 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.594 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 18.9 ptt180 -127.45 175.64 8.07 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' ALA . . . . . 0.65 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -147.42 145.87 29.38 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.407 176.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.426 ' HB ' ' HA ' ' A' ' 350' ' ' PRO . 10.4 m -115.63 143.34 25.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 176.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -62.05 115.85 4.44 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.326 176.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . 0.734 ' HB3' ' HB2' ' A' ' 380' ' ' ASP . 13.6 p80 33.62 73.17 0.07 Allowed 'General case' 0 N--CA 1.472 0.664 0 O-C-N 124.618 1.199 . . . . 0.0 113.822 177.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . 0.712 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 53.18 31.59 41.76 Favored Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 115.324 0.89 . . . . 0.0 115.324 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 49.8 t -139.49 102.88 7.16 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 118.584 1.192 . . . . 0.0 109.011 178.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . 0.426 ' HA ' ' HB ' ' A' ' 345' ' ' VAL . 16.7 Cg_exo -71.88 62.55 3.15 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.966 2.444 . . . . 0.0 112.778 178.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -100.87 -55.98 2.44 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 177.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.2 p -121.54 131.43 73.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.434 174.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . 0.426 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 43.4 t30 -64.19 113.04 3.3 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.551 174.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 27.5 m -97.25 5.16 9.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.05 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . 0.65 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -76.38 86.25 3.15 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.027 0.441 . . . . 0.0 111.272 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.96 100.58 12.08 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 171.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.581 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 23.8 mt -85.57 120.17 26.72 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.931 -164.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.675 ' HB ' ' CB ' ' A' ' 373' ' ' GLU . 2.1 mm -65.86 -25.9 37.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 173.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 50.4 m -120.68 82.27 33.9 Favored Pre-proline 0 N--CA 1.446 -0.652 0 CA-C-N 114.41 -1.268 . . . . 0.0 108.153 170.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' PRO . . . . . 0.446 ' HA ' ' HB2' ' A' ' 357' ' ' LEU . 86.6 Cg_endo -85.86 21.0 1.14 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.088 2.525 . . . . 0.0 113.785 -169.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . 0.538 ' N ' ' HD3' ' A' ' 362' ' ' PRO . 15.8 m120 -145.77 52.88 1.66 Allowed Pre-proline 0 C--N 1.312 -1.054 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.348 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . 0.538 ' HD3' ' N ' ' A' ' 361' ' ' ASN . 11.0 Cg_endo -78.81 147.11 21.38 Favored 'Trans proline' 0 C--O 1.251 1.161 0 C-N-CA 121.635 1.557 . . . . 0.0 113.142 -177.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 6.3 p -139.99 116.85 10.97 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.664 -169.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' MET . . . . . 0.753 ' HG3' HD12 ' A' ' 340' ' ' ILE . 11.3 mmt -98.15 147.24 24.77 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.96 -170.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.572 ' HG2' ' HD3' ' A' ' 337' ' ' PRO . 40.9 mt-10 -125.5 177.9 5.94 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 122.108 0.956 . . . . 0.0 112.604 -172.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . 0.552 HD21 ' N ' ' A' ' 367' ' ' ASN . 0.2 OUTLIER -60.16 -4.7 0.85 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 113.407 -1.724 . . . . 0.0 111.621 173.567 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' ASN . . . . . 0.552 ' N ' HD21 ' A' ' 366' ' ' ASN . 25.5 p30 -112.45 -5.29 14.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.858 0.361 . . . . 0.0 110.152 -175.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . 0.992 ' HA2' ' H ' ' A' ' 332' ' ' PHE . . . 134.73 -119.69 2.23 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.272 -0.966 . . . . 0.0 114.535 177.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . 0.561 ' HA3' HG21 ' A' ' 330' ' ' VAL . . . -177.18 93.47 0.09 OUTLIER Glycine 0 C--N 1.312 -0.759 0 N-CA-C 107.652 -2.179 . . . . 0.0 107.652 -171.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . 0.423 ' O ' ' HG3' ' A' ' 329' ' ' GLU . . . -74.31 -43.24 32.28 Favored Glycine 0 C--N 1.304 -1.248 0 C-N-CA 120.826 -0.702 . . . . 0.0 114.639 -155.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -166.2 136.6 3.42 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 120.966 0.413 . . . . 0.0 110.754 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 372' ' ' ILE . . . . . 0.702 ' HB ' ' HE2' ' A' ' 328' ' ' MET . 0.9 OUTLIER -136.67 135.52 48.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.947 176.771 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . 0.675 ' CB ' ' HB ' ' A' ' 358' ' ' ILE . 25.8 mt-10 -110.98 131.22 55.23 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.703 -176.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 374' ' ' MET . . . . . 0.626 ' HG2' HD12 ' A' ' 383' ' ' ILE . 0.0 OUTLIER -137.17 165.1 26.9 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.794 -1.093 . . . . 0.0 108.627 178.987 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 375' ' ' GLN . . . . . 1.052 HE21 ' HA ' ' A' ' 375' ' ' GLN . 0.0 OUTLIER -176.14 -175.95 0.75 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.807 0.813 . . . . 0.0 110.813 169.309 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 376' ' ' LEU . . . . . 0.952 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 14.5 tp -166.21 162.9 12.09 Favored Pre-proline 0 N--CA 1.437 -1.081 0 N-CA-C 103.806 -2.664 . . . . 0.0 103.806 173.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 377' ' ' PRO . . . . . 0.952 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 66.6 Cg_exo -39.65 130.99 1.84 Allowed 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 121.356 1.37 . . . . 0.0 110.705 167.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -37.2 141.32 0.18 Allowed 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 124.201 3.267 . . . . 0.0 112.694 -176.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 149.43 -174.86 28.86 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -163.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . 0.734 ' HB2' ' HB3' ' A' ' 347' ' ' HIS . 6.1 m-20 -94.41 125.92 39.35 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 117.501 0.65 . . . . 0.0 110.167 -175.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.585 HD21 ' HG2' ' A' ' 394' ' ' GLN . 28.4 m-80 -137.29 170.24 16.43 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 1.024 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -160.55 143.98 4.82 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 175.426 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . 0.685 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 44.2 mt -101.48 128.82 53.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.31 -175.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' TYR . . . . . 0.594 ' O ' ' HG2' ' A' ' 343' ' ' ARG . 0.7 OUTLIER -104.06 92.07 4.22 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.971 171.935 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . 0.467 ' O ' ' HB2' ' A' ' 388' ' ' LEU . 15.2 t -84.0 89.45 2.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 178.242 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . 0.752 ' HA3' ' HZ ' ' A' ' 312' ' ' PHE . . . 61.05 -116.52 9.46 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.1 -1.048 . . . . 0.0 111.136 -172.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -78.49 -20.76 50.12 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.848 0.356 . . . . 0.0 111.366 174.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . 0.556 HD12 ' CD1' ' A' ' 312' ' ' PHE . 2.4 mp -70.26 155.12 41.1 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.37 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . 0.685 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 7.0 p30 -167.8 152.73 6.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.886 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -173.48 118.55 0.29 Allowed 'General case' 0 C--O 1.24 0.554 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 177.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' GLN . . . . . 1.024 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 15.5 tt0 -80.93 153.32 27.61 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.894 0.878 . . . . 0.0 112.081 -176.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' TRP . . . . . 0.451 ' CD1' ' NE2' ' A' ' 394' ' ' GLN . 6.0 t-105 -172.31 150.99 2.45 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.47 -178.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . 0.471 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 21.3 p90 -102.34 119.12 38.28 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 121.214 -0.929 . . . . 0.0 108.807 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . 0.709 ' HG3' HE22 ' A' ' 375' ' ' GLN . 3.4 mm100 -85.98 127.28 34.6 Favored 'General case' 0 C--O 1.238 0.469 0 O-C-N 121.909 -0.495 . . . . 0.0 109.878 -167.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm . . . . . 0 C--O 1.246 0.897 0 O-C-N 124.348 1.03 . . . . 0.0 110.651 175.793 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' THR . . . . . 0.474 HG21 HG23 ' A' ' 335' ' ' THR . 5.8 t . . . . . 0 CA--C 1.537 0.48 0 CA-C-O 121.344 0.592 . . . . 0.0 111.764 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -68.11 122.87 19.18 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 175.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' THR . . . . . 0.477 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 7.4 t 178.54 -167.89 0.07 Allowed 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -171.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 30.8 t -69.78 113.65 5.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 167.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.6 147.27 53.5 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.842 0.83 . . . . 0.0 112.135 -169.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . 0.456 ' OD1' HG21 ' A' ' 310' ' ' THR . 12.1 t70 -66.58 128.21 35.35 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.163 -1.381 . . . . 0.0 110.145 177.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.64 -13.13 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 115.775 1.769 . . . . 0.0 115.775 -176.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.456 HG21 ' OD1' ' A' ' 308' ' ' ASP . 12.0 t -108.96 -2.37 18.32 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 119.775 1.17 . . . . 0.0 113.086 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.67 ' HE2' ' OG1' ' A' ' 335' ' ' THR . 31.2 mmmt -65.69 -35.68 81.45 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -173.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.586 ' HA ' ' O ' ' A' ' 331' ' ' GLY . 0.1 OUTLIER -86.01 174.25 9.34 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 122.086 0.946 . . . . 0.0 112.405 -175.129 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 12.6 t -151.98 161.47 42.58 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 113.65 -1.614 . . . . 0.0 109.459 -177.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . 0.539 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 28.8 m-90 -77.32 124.19 27.53 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 121.295 0.569 . . . . 0.0 110.034 -178.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.591 ' HB3' ' HB3' ' A' ' 329' ' ' GLU . 63.0 tttt -108.04 -41.95 4.8 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 172.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.619 ' HB3' ' HB2' ' A' ' 329' ' ' GLU . 3.9 ttm180 -151.16 130.02 12.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.762 171.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -70.25 157.74 89.19 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.453 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . 0.605 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 1.6 Cg_endo -45.66 118.44 2.23 Favored 'Trans proline' 0 C--N 1.359 1.118 0 C-N-CA 122.541 2.161 . . . . 0.0 112.27 -178.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' THR . . . . . 0.462 ' O ' HG21 ' A' ' 327' ' ' VAL . 47.5 m -134.96 145.16 47.87 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.243 -174.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -60.07 134.5 57.11 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' SER . . . . . 0.465 ' C ' ' H ' ' A' ' 323' ' ' HIS . 79.9 p -76.92 1.04 18.77 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -173.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 73.1 -20.47 1.14 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.833 -169.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . 0.465 ' H ' ' C ' ' A' ' 321' ' ' SER . 96.6 m-70 -112.2 50.15 0.87 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.111 0.482 . . . . 0.0 110.369 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 9.5 t70 54.03 38.22 28.5 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.835 174.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' THR . . . . . 0.439 ' HB ' HG13 ' A' ' 358' ' ' ILE . 2.6 p -150.86 -168.47 3.11 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 175.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . 0.693 HG13 HE22 ' A' ' 394' ' ' GLN . 0.4 OUTLIER -129.13 141.25 47.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 118.245 0.475 . . . . 0.0 110.873 -178.782 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' VAL . . . . . 0.471 HG12 ' HG2' ' A' ' 373' ' ' GLU . 17.6 m -121.35 149.16 24.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.682 177.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' MET . . . . . 0.673 ' SD ' ' HB ' ' A' ' 372' ' ' ILE . 0.1 OUTLIER -141.94 150.73 41.82 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 176.194 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.619 ' HB2' ' HB3' ' A' ' 316' ' ' ARG . 9.9 mt-10 -124.94 128.86 49.27 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 120.825 0.345 . . . . 0.0 110.2 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.45 HG21 ' HA3' ' A' ' 369' ' ' GLY . 1.8 m -131.78 152.66 37.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.854 -178.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . 0.586 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -113.86 178.15 18.21 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-O 119.475 -0.625 . . . . 0.0 112.536 -178.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . 0.673 ' HB2' ' SD ' ' A' ' 364' ' ' MET . 0.5 OUTLIER -128.77 142.83 50.86 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 117.467 0.633 . . . . 0.0 111.158 -178.409 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 5.3 p -87.57 -17.64 31.53 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 173.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 177.09 -39.61 0.1 OUTLIER Glycine 0 C--N 1.338 0.641 0 C-N-CA 117.943 -2.075 . . . . 0.0 116.045 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' THR . . . . . 0.67 ' OG1' ' HE2' ' A' ' 311' ' ' LYS . 81.2 m -52.91 131.78 36.27 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.813 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 1.4 ptp180 -79.24 -179.98 1.59 Allowed Pre-proline 0 N--CA 1.449 -0.495 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -177.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . 0.813 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 1.3 Cg_exo -27.56 100.88 0.02 OUTLIER 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 123.269 2.646 . . . . 0.0 113.742 178.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' CYS . . . . . 0.92 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 26.3 p -130.54 150.39 51.76 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.402 -176.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -67.17 123.93 21.67 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.444 170.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . 0.437 HG12 HG12 ' A' ' 342' ' ' VAL . 19.2 tt -94.64 117.73 66.93 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.155 -176.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -70.37 82.29 0.89 Allowed 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.513 2.142 . . . . 0.0 112.042 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.593 HG13 HG11 ' A' ' 385' ' ' VAL . 11.4 m -102.31 115.4 44.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.468 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -130.34 178.13 6.82 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' ALA . . . . . 0.563 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -151.21 148.85 28.73 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.89 177.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 14.7 m -121.57 146.86 25.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -70.17 119.19 13.99 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 177.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . 0.638 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 68.8 t60 47.36 57.5 5.77 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 124.172 0.92 . . . . 0.0 111.457 174.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . 0.608 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 44.83 44.22 8.58 Favored Glycine 0 CA--C 1.521 0.413 0 N-CA-C 114.671 0.628 . . . . 0.0 114.671 -172.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . 0.503 HG21 ' O ' ' A' ' 347' ' ' HIS . 57.4 t -139.82 102.23 7.05 Favored Pre-proline 0 C--O 1.234 0.271 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -76.36 64.19 7.18 Favored 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 123.06 2.507 . . . . 0.0 113.847 -175.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -100.52 -57.09 2.18 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 174.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 4.3 p -115.55 125.94 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.676 174.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . 0.449 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 39.5 t30 -62.89 108.89 1.29 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.57 174.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.502 ' HA ' HD23 ' A' ' 376' ' ' LEU . 27.6 m -86.81 0.97 6.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.078 -179.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . 0.563 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -76.88 84.32 3.45 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 121.476 0.655 . . . . 0.0 110.468 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 356' ' ' MET . . . . . 0.671 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 11.9 tpt -98.96 103.62 15.59 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 170.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.522 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 42.4 mt -86.2 119.64 26.7 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.177 -161.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.679 ' HB ' ' CB ' ' A' ' 373' ' ' GLU . 3.0 mm -64.77 -27.18 41.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 173.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 89.8 m -122.06 84.53 45.4 Favored Pre-proline 0 N--CA 1.449 -0.52 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.572 171.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -85.39 28.07 0.58 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.119 2.546 . . . . 0.0 113.65 -171.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . 0.427 ' N ' ' HD3' ' A' ' 362' ' ' PRO . 2.4 p-10 -148.59 55.0 1.91 Allowed Pre-proline 0 C--N 1.313 -0.99 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.488 177.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . 0.708 ' HB3' HG21 ' A' ' 372' ' ' ILE . 73.5 Cg_endo -85.08 162.53 11.61 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 121.884 1.723 . . . . 0.0 113.041 -179.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' THR . . . . . 0.65 ' O ' ' HA2' ' A' ' 369' ' ' GLY . 1.2 p -145.2 -172.7 3.92 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.89 -172.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' MET . . . . . 0.92 ' HG2' ' SG ' ' A' ' 338' ' ' CYS . 9.3 ptp -131.91 134.44 45.68 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 162.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -124.42 -164.51 1.27 Allowed 'General case' 0 C--N 1.319 -0.731 0 O-C-N 124.647 1.217 . . . . 0.0 110.164 -170.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -55.64 -10.58 0.71 Allowed 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -177.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 12.5 p-10 -126.76 1.03 6.73 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.909 0.385 . . . . 0.0 110.913 -175.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . 0.453 ' HA2' ' HB3' ' A' ' 332' ' ' PHE . . . 108.14 -178.5 21.36 Favored Glycine 0 N--CA 1.449 -0.468 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 -177.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . 0.65 ' HA2' ' O ' ' A' ' 363' ' ' THR . . . -47.53 -54.0 11.61 Favored Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.921 -0.657 . . . . 0.0 113.303 172.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . 0.574 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 89.26 -126.97 8.46 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.441 -0.885 . . . . 0.0 111.447 -176.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -101.76 131.74 47.89 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.708 0.29 . . . . 0.0 111.213 -175.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 372' ' ' ILE . . . . . 0.708 HG21 ' HB3' ' A' ' 362' ' ' PRO . 0.2 OUTLIER -131.03 166.1 29.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 173.698 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . 0.679 ' CB ' ' HB ' ' A' ' 358' ' ' ILE . 24.1 mt-10 -133.97 132.64 40.4 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.363 0.601 . . . . 0.0 111.349 177.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 374' ' ' MET . . . . . 0.578 ' HE3' HG12 ' A' ' 326' ' ' VAL . 0.0 OUTLIER -135.08 166.17 23.69 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 177.245 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 375' ' ' GLN . . . . . 0.895 HE22 ' HG3' ' A' ' 394' ' ' GLN . 0.0 OUTLIER 175.93 176.0 0.26 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.345 0.521 . . . . 0.0 109.694 170.995 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 376' ' ' LEU . . . . . 1.04 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 9.4 tp -166.18 175.36 2.32 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 103.498 -2.779 . . . . 0.0 103.498 177.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 377' ' ' PRO . . . . . 1.04 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 58.2 Cg_exo -40.87 130.36 2.83 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 CA-C-N 121.789 1.675 . . . . 0.0 111.882 167.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -41.05 146.98 0.31 Allowed 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 124.018 3.145 . . . . 0.0 112.207 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 145.34 -168.39 27.21 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.18 -1.01 . . . . 0.0 110.83 -163.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . 0.638 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 3.1 m-20 -88.35 119.81 29.13 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 117.134 0.467 . . . . 0.0 110.026 -178.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -132.99 144.64 50.23 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 1.057 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -143.86 137.04 24.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.218 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . 0.692 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 44.1 mt -97.96 127.7 50.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.506 -175.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' TYR . . . . . 0.514 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.2 OUTLIER -104.64 91.73 3.99 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 114.322 -1.308 . . . . 0.0 108.426 173.475 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . 0.593 HG11 HG13 ' A' ' 342' ' ' VAL . 17.7 t -84.23 89.44 2.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 64.23 -110.35 3.39 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 120.278 -0.963 . . . . 0.0 110.725 -170.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -94.22 -9.13 37.22 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.867 0.334 . . . . 0.0 111.366 172.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . 0.56 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 3.1 mp -66.75 153.35 43.51 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 174.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . 0.692 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 9.0 p30 -164.06 156.51 17.28 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.927 177.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . 0.605 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 23.4 t-80 -174.75 117.83 0.19 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.924 172.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' GLN . . . . . 1.057 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 0.6 OUTLIER -79.08 154.35 29.47 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.11 0.481 . . . . 0.0 110.978 -179.958 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' TRP . . . . . 0.494 ' HD1' ' OE1' ' A' ' 394' ' ' GLN . 6.6 t-105 -166.73 150.93 7.21 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.111 -0.95 . . . . 0.0 108.51 -178.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -105.93 119.67 39.77 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . 0.895 ' HG3' HE22 ' A' ' 375' ' ' GLN . 3.8 mm100 -85.67 113.22 21.71 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -173.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.71 ' HD3' ' H ' ' A' ' 395' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.131 -0.938 . . . . 0.0 111.285 -178.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 303' ' ' THR . . . . . 0.421 ' O ' HG21 ' A' ' 303' ' ' THR . 4.5 t . . . . . 0 N--CA 1.445 -0.696 0 CA-C-O 121.532 0.682 . . . . 0.0 110.664 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . 0.567 ' HB3' ' HE ' ' A' ' 336' ' ' ARG . 5.2 p90 -74.46 127.31 32.74 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 171.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 305' ' ' THR . . . . . 0.464 ' HB ' ' O ' ' A' ' 304' ' ' TYR . 11.6 t 172.82 -169.83 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -173.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 37.2 t -66.78 112.83 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 169.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . 0.447 ' CB ' ' HE3' ' A' ' 364' ' ' MET . 0.1 OUTLIER -67.81 141.02 56.63 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.436 -171.976 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . 0.569 ' HB3' ' HG3' ' A' ' 311' ' ' LYS . 10.4 t0 -59.33 124.45 20.05 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.044 -176.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -40.7 -29.85 0.1 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.101 -1.408 . . . . 0.0 114.418 -177.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 11.4 t -107.08 1.41 24.22 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.348 0.594 . . . . 0.0 111.123 -170.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.569 ' HG3' ' HB3' ' A' ' 308' ' ' ASP . 49.2 mtpt -90.36 43.85 1.17 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.534 0.683 . . . . 0.0 110.079 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.516 ' HB3' HD12 ' A' ' 388' ' ' LEU . 0.3 OUTLIER -140.7 157.14 45.87 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.635 -168.464 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 15.0 p -144.72 152.83 40.98 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.967 175.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . 0.605 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 20.1 m-90 -79.94 94.51 5.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.97 0.414 . . . . 0.0 110.231 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 18.8 tttm -71.24 -42.59 68.66 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.167 173.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 41.0 ttm105 -154.99 98.56 2.04 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.105 173.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -41.91 152.07 0.31 Allowed Pre-proline 0 N--CA 1.472 0.662 0 C-N-CA 123.695 0.798 . . . . 0.0 112.441 174.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 1.0 OUTLIER -44.24 117.11 1.21 Allowed 'Trans proline' 0 C--N 1.365 1.443 0 C-N-CA 123.083 2.522 . . . . 0.0 113.099 -174.292 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 319' ' ' THR . . . . . 0.622 ' O ' HG21 ' A' ' 327' ' ' VAL . 10.1 m -133.41 144.15 49.35 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.004 -174.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -59.1 129.64 43.11 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.625 0.25 . . . . 0.0 110.566 177.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 321' ' ' SER . . . . . 0.547 ' HB3' HG11 ' A' ' 327' ' ' VAL . 59.6 p -77.96 6.73 7.17 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.513 0.725 . . . . 0.0 111.771 -174.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 81.7 -16.75 18.27 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.649 -0.786 . . . . 0.0 113.039 -170.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . 0.4 ' O ' ' HB2' ' A' ' 324' ' ' ASP . 20.7 m80 -98.34 7.61 45.98 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 117.19 0.495 . . . . 0.0 111.217 -177.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 323' ' ' HIS . 36.9 m-20 72.33 49.66 0.21 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.947 0.88 . . . . 0.0 109.233 -177.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 325' ' ' THR . . . . . 0.549 ' HB ' HG13 ' A' ' 358' ' ' ILE . 4.5 p -157.99 163.92 37.31 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 -177.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -111.0 132.63 58.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 119.755 1.161 . . . . 0.0 112.619 -172.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 327' ' ' VAL . . . . . 0.848 HG12 ' HG2' ' A' ' 373' ' ' GLU . 15.4 m -115.2 163.98 11.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.878 174.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 328' ' ' MET . . . . . 0.412 ' HE2' ' HB2' ' A' ' 328' ' ' MET . 10.1 ptm -153.33 152.25 30.9 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 172.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -114.1 135.31 54.16 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.562 HG21 ' HA3' ' A' ' 369' ' ' GLY . 3.1 m -132.94 146.66 32.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 C-N-CA 120.366 -0.534 . . . . 0.0 112.275 -178.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . 0.57 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -118.66 134.6 10.97 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.241 -0.98 . . . . 0.0 112.062 -179.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . 0.749 ' HB3' ' SD ' ' A' ' 364' ' ' MET . 0.1 OUTLIER -89.56 157.65 17.97 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -177.112 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 36.0 t -71.11 -33.36 70.08 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 112.658 -2.064 . . . . 0.0 112.29 169.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 168.62 -17.89 0.07 OUTLIER Glycine 0 CA--C 1.526 0.776 0 C-N-CA 119.62 -1.276 . . . . 0.0 114.689 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 335' ' ' THR . . . . . 0.487 ' O ' ' HD2' ' A' ' 332' ' ' PHE . 25.8 m -54.62 120.09 6.21 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.699 0.25 . . . . 0.0 110.889 176.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.682 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 9.2 ptt180 -75.46 -176.53 0.58 Allowed Pre-proline 0 N--CA 1.467 0.38 0 CA-C-O 117.62 -1.181 . . . . 0.0 108.85 -172.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . 0.844 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.1 OUTLIER -26.67 95.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 123.693 2.929 . . . . 0.0 113.379 177.072 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 338' ' ' CYS . . . . . 0.573 ' O ' HG21 ' A' ' 363' ' ' THR . 13.7 p -115.7 -175.44 2.72 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 113.656 -1.611 . . . . 0.0 110.89 -167.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -110.61 100.42 9.21 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . 0.818 HG22 HG12 ' A' ' 342' ' ' VAL . 24.8 mt -74.8 116.53 54.59 Favored Pre-proline 0 C--N 1.324 -0.531 0 C-N-CA 120.057 -0.657 . . . . 0.0 110.836 -169.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.76 81.65 2.71 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.47 2.114 . . . . 0.0 110.992 177.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.818 HG12 HG22 ' A' ' 340' ' ' ILE . 4.1 m -103.26 134.09 45.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.989 0.899 . . . . 0.0 111.459 -178.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.609 ' HG3' ' HB2' ' A' ' 384' ' ' TYR . 20.8 ptt180 -140.51 176.93 8.38 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 113.899 -1.5 . . . . 0.0 107.734 174.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 344' ' ' ALA . . . . . 0.708 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -144.57 144.99 31.58 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 120.546 -0.462 . . . . 0.0 109.903 172.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.445 ' HB ' ' HA ' ' A' ' 350' ' ' PRO . 11.6 m -119.07 144.98 25.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.1 119.19 10.36 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 177.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . 0.73 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 25.5 t-80 46.92 63.84 1.78 Allowed 'General case' 0 N--CA 1.468 0.461 0 O-C-N 124.337 1.023 . . . . 0.0 112.015 170.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . 0.494 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 43.19 42.01 5.17 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 114.926 0.73 . . . . 0.0 114.926 -174.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . 0.542 HG21 ' O ' ' A' ' 347' ' ' HIS . 65.3 t -142.38 103.23 5.52 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 117.792 0.796 . . . . 0.0 108.928 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . 0.445 ' HA ' ' HB ' ' A' ' 345' ' ' VAL . 16.1 Cg_exo -72.26 51.8 1.8 Allowed 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.872 2.381 . . . . 0.0 113.073 178.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -103.06 -7.59 21.25 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -178.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 2.4 p -170.72 110.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.065 -169.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . 0.517 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 50.7 t30 -65.25 108.87 2.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.247 177.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.481 HG12 HD22 ' A' ' 376' ' ' LEU . 27.7 m -91.13 0.88 8.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.438 178.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . 0.708 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -74.44 83.3 1.96 Allowed 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.098 0.475 . . . . 0.0 111.459 -176.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 356' ' ' MET . . . . . 0.54 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 35.4 ttm -95.36 98.64 10.72 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 168.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.666 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 18.8 mt -80.32 141.65 35.25 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.323 -162.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.702 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 4.2 mm -80.45 -25.28 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 178.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 7.9 m -140.34 97.94 7.5 Favored Pre-proline 0 N--CA 1.445 -0.71 0 CA-C-N 113.513 -1.676 . . . . 0.0 108.797 175.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 360' ' ' PRO . . . . . 0.493 ' HA ' HD12 ' A' ' 357' ' ' LEU . 72.1 Cg_endo -85.83 34.42 0.48 Allowed 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.968 2.445 . . . . 0.0 112.808 -175.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -142.8 64.23 14.81 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.434 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . 0.523 ' HG3' HG22 ' A' ' 342' ' ' VAL . 90.2 Cg_endo -80.9 143.17 14.38 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.355 2.037 . . . . 0.0 111.481 178.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 363' ' ' THR . . . . . 0.573 HG21 ' O ' ' A' ' 338' ' ' CYS . 0.8 OUTLIER -143.47 148.94 36.83 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -174.611 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 364' ' ' MET . . . . . 0.844 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 37.1 mtm -101.2 141.21 34.41 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -134.84 -166.11 1.77 Allowed 'General case' 0 C--N 1.322 -0.627 0 O-C-N 125.095 1.497 . . . . 0.0 110.529 -177.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . 0.467 HD21 ' N ' ' A' ' 366' ' ' ASN . 0.1 OUTLIER -41.91 -27.36 0.12 Allowed 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -179.781 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -111.81 -1.26 15.63 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.718 -0.614 . . . . 0.0 111.416 -177.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . 0.57 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . 112.31 -165.14 12.04 Favored Glycine 0 N--CA 1.451 -0.317 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -173.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . 0.562 ' HA3' HG21 ' A' ' 330' ' ' VAL . . . -64.15 108.31 2.2 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 170.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -71.5 -31.2 65.8 Favored Glycine 0 C--N 1.313 -0.699 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.907 -169.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -164.74 141.68 6.15 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.051 0.453 . . . . 0.0 110.813 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 372' ' ' ILE . . . . . 0.728 HD11 HG11 ' A' ' 342' ' ' VAL . 1.7 mt -133.61 144.57 35.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 171.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . 0.848 ' HG2' HG12 ' A' ' 327' ' ' VAL . 40.0 mt-10 -129.24 125.05 36.03 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.494 -0.482 . . . . 0.0 109.981 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 374' ' ' MET . . . . . 0.666 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 0.0 OUTLIER -140.31 161.45 37.65 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.008 -175.54 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 375' ' ' GLN . . . . . 0.833 HE22 ' HG2' ' A' ' 394' ' ' GLN . 7.3 tp60 -178.52 175.28 1.14 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 174.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 376' ' ' LEU . . . . . 0.832 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 10.8 tp -166.56 157.05 10.81 Favored Pre-proline 0 N--CA 1.444 -0.77 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 377' ' ' PRO . . . . . 0.832 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 82.7 Cg_exo -42.39 132.08 4.99 Favored 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 121.828 1.685 . . . . 0.0 111.008 168.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.777 ' HA ' HE22 ' A' ' 394' ' ' GLN . 5.8 Cg_exo -35.74 139.84 0.13 Allowed 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 124.935 3.757 . . . . 0.0 113.75 -173.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 154.72 -165.08 31.94 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -162.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . 0.73 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 11.8 m-20 -102.91 129.08 49.5 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 117.881 0.841 . . . . 0.0 110.634 177.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.41 ' HB2' ' HE2' ' A' ' 374' ' ' MET . 8.5 m120 -125.71 166.4 16.84 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 176.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 1.005 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -159.66 140.59 4.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 168.886 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . 0.484 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 24.3 mt -96.76 135.39 31.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.919 -175.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 384' ' ' TYR . . . . . 0.626 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 3.4 m-85 -105.11 129.34 53.54 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 167.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 6.1 t -117.56 82.22 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 65.51 -108.8 2.53 Favored Glycine 0 N--CA 1.431 -1.646 0 C-N-CA 120.001 -1.095 . . . . 0.0 110.51 -161.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -93.77 -10.71 33.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.652 0.226 . . . . 0.0 111.543 176.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . 0.626 ' O ' ' HA ' ' A' ' 384' ' ' TYR . 1.1 tp -65.22 146.87 54.39 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . 0.484 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 27.5 p-10 -157.07 147.71 21.45 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.595 0.236 . . . . 0.0 111.077 178.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . 0.463 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 5.3 t60 -172.62 122.33 0.43 Allowed 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.724 176.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 391' ' ' GLN . . . . . 1.005 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 7.9 tt0 -79.2 151.37 31.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.333 0.587 . . . . 0.0 112.367 -173.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 392' ' ' TRP . . . . . . . . . . . . . 43.6 t-105 -148.48 132.54 17.25 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.792 -1.094 . . . . 0.0 109.31 177.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -99.45 109.18 21.77 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . 0.833 ' HG2' HE22 ' A' ' 375' ' ' GLN . 0.0 OUTLIER -97.8 127.19 43.57 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.303 0.573 . . . . 0.0 110.502 -170.05 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.777 -178.382 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 303' ' ' THR . . . . . 0.504 HG21 HG23 ' A' ' 335' ' ' THR . 7.1 t . . . . . 0 N--CA 1.451 -0.407 0 CA-C-O 121.159 0.504 . . . . 0.0 111.691 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . 0.692 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 30.9 p90 -67.09 119.65 12.37 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.307 -0.557 . . . . 0.0 109.794 175.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 305' ' ' THR . . . . . 0.432 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 12.3 t 176.23 -167.67 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -171.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 23.1 t -64.73 108.21 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 169.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . 0.457 ' SG ' ' HE1' ' A' ' 364' ' ' MET . 0.5 OUTLIER -70.71 140.8 51.52 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.732 -169.26 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . 0.565 ' OD2' HG21 ' A' ' 310' ' ' THR . 20.3 t70 -66.85 128.34 35.94 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.442 0.639 . . . . 0.0 111.567 -176.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.543 ' HD2' ' N ' ' A' ' 310' ' ' THR . 0.0 OUTLIER -42.48 -22.44 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 115.954 1.835 . . . . 0.0 115.954 -173.867 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.565 HG21 ' OD2' ' A' ' 308' ' ' ASP . 11.7 t -105.54 -3.81 21.96 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 118.976 0.807 . . . . 0.0 111.62 -170.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.428 ' HB3' ' HE2' ' A' ' 311' ' ' LYS . 10.4 mmmm -67.97 -24.74 65.18 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.873 -177.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.605 ' HE1' ' H ' ' A' ' 369' ' ' GLY . 2.1 m-85 -81.16 173.04 12.93 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 122.01 0.91 . . . . 0.0 113.313 -176.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 313' ' ' THR . . . . . 0.498 ' C ' HD22 ' A' ' 388' ' ' LEU . 14.2 t -148.58 155.21 40.8 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 113.878 -1.51 . . . . 0.0 108.718 177.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 11.6 m-90 -79.23 93.8 5.31 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.17 0.51 . . . . 0.0 110.115 -178.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.571 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 59.6 tttm -76.97 -55.09 5.76 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.186 172.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -142.04 126.21 17.45 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 176.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -69.12 158.04 87.64 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-O 119.14 -0.457 . . . . 0.0 110.286 178.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . 0.483 ' HG3' HD11 ' A' ' 383' ' ' ILE . 87.2 Cg_exo -40.16 117.66 0.47 Allowed 'Trans proline' 0 C--N 1.36 1.152 0 C-N-CA 122.458 2.105 . . . . 0.0 111.997 174.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 13.6 m -136.13 140.56 43.76 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.801 -174.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -55.53 126.95 27.47 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.147 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 321' ' ' SER . . . . . 0.44 ' HB3' HG11 ' A' ' 327' ' ' VAL . 33.5 p -87.1 10.9 15.23 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.644 0.259 . . . . 0.0 111.447 -172.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 85.6 -31.37 3.91 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.53 -173.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 58.7 m-70 -87.06 28.31 0.93 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.82 0.31 . . . . 0.0 111.61 -176.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 48.65 50.62 16.9 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.877 0.846 . . . . 0.0 109.884 -172.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 325' ' ' THR . . . . . 0.532 ' HB ' HG13 ' A' ' 358' ' ' ILE . 11.6 p -154.34 177.14 11.48 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 -175.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -123.16 142.5 39.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 119.536 1.062 . . . . 0.0 112.18 -174.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 327' ' ' VAL . . . . . 0.611 ' HA ' ' O ' ' A' ' 372' ' ' ILE . 3.7 m -124.77 147.65 29.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.897 172.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 328' ' ' MET . . . . . 0.876 ' HE2' HG21 ' A' ' 385' ' ' VAL . 16.5 ptt? -130.84 156.58 44.78 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 173.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.592 ' HA ' ' O ' ' A' ' 370' ' ' GLY . 7.9 tt0 -124.19 125.91 45.23 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.547 HG12 HG22 ' A' ' 385' ' ' VAL . 15.7 m -126.5 143.58 39.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.416 -174.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . 0.557 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -122.74 135.97 10.41 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.692 -176.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . 0.494 ' CD1' ' HA2' ' A' ' 368' ' ' GLY . 0.2 OUTLIER -90.62 155.74 18.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 122.058 0.933 . . . . 0.0 113.122 -177.374 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 30.4 t -78.72 -37.52 41.26 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 113.862 -1.517 . . . . 0.0 112.948 171.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -173.69 -25.75 0.03 OUTLIER Glycine 0 CA--C 1.526 0.727 0 C-N-CA 118.651 -1.737 . . . . 0.0 115.405 -178.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 335' ' ' THR . . . . . 0.683 ' HB ' ' SD ' ' A' ' 364' ' ' MET . 25.9 m -52.7 127.27 22.57 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.699 0.285 . . . . 0.0 110.385 176.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.73 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 2.2 ptm180 -87.72 -179.26 1.28 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 117.378 -1.296 . . . . 0.0 108.491 -174.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . 0.73 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -26.46 98.35 0.02 OUTLIER 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 123.862 3.041 . . . . 0.0 114.115 -175.137 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 338' ' ' CYS . . . . . 0.776 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 1.8 p -109.84 -176.55 3.03 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 113.6 -1.636 . . . . 0.0 110.136 -171.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -109.4 100.51 9.59 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 175.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . 0.855 HG22 HG12 ' A' ' 342' ' ' VAL . 29.9 mt -74.82 114.38 33.98 Favored Pre-proline 0 C--N 1.329 -0.315 0 C-N-CA 120.069 -0.653 . . . . 0.0 111.307 -167.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -79.51 81.46 2.78 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.499 2.132 . . . . 0.0 111.309 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.855 HG12 HG22 ' A' ' 340' ' ' ILE . 4.1 m -103.08 128.33 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-O 121.508 0.671 . . . . 0.0 110.651 -178.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -140.74 175.77 9.34 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 174.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 344' ' ' ALA . . . . . 0.535 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -147.89 149.82 32.97 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.064 -0.654 . . . . 0.0 111.334 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 11.0 m -118.86 146.62 23.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 176.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . 0.46 ' HB2' HG13 ' A' ' 354' ' ' VAL . . . -70.11 117.73 12.05 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 177.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . 0.875 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 15.3 t-80 48.31 62.18 2.65 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 124.166 0.916 . . . . 0.0 112.007 173.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . 0.769 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 43.35 40.08 4.54 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.963 -0.637 . . . . 0.0 114.507 -173.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . 0.606 HG21 ' O ' ' A' ' 347' ' ' HIS . 94.9 t -138.13 101.58 8.43 Favored Pre-proline 0 C--O 1.235 0.319 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -72.04 68.88 3.17 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.593 2.196 . . . . 0.0 112.357 178.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -99.85 -56.35 2.41 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 176.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 5.3 p -128.88 136.9 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.264 172.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . 0.535 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 35.0 t30 -62.18 110.58 1.66 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.905 174.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.51 ' CG1' HD23 ' A' ' 376' ' ' LEU . 27.7 m -88.36 3.04 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.346 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . 0.458 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -75.14 82.29 2.31 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.312 0.577 . . . . 0.0 110.771 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 356' ' ' MET . . . . . 0.55 ' HB2' ' O ' ' A' ' 375' ' ' GLN . 62.5 mtt -98.19 99.67 10.92 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 168.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.664 HD12 ' HA ' ' A' ' 360' ' ' PRO . 34.5 mt -82.1 141.48 33.1 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.052 -162.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.67 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 4.1 mm -83.64 -21.53 8.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 178.036 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 6.6 m -141.39 96.97 6.89 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 113.828 -1.533 . . . . 0.0 108.673 171.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 360' ' ' PRO . . . . . 0.664 ' HA ' HD12 ' A' ' 357' ' ' LEU . 91.5 Cg_endo -89.05 39.89 0.48 Allowed 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 123.136 2.557 . . . . 0.0 114.259 -170.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . 0.56 ' N ' HD21 ' A' ' 361' ' ' ASN . 0.0 OUTLIER -156.85 72.78 4.7 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-O 121.406 0.622 . . . . 0.0 111.234 176.689 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . 0.738 ' HG2' ' HB ' ' A' ' 340' ' ' ILE . 83.2 Cg_endo -85.08 154.31 11.11 Favored 'Trans proline' 0 C--O 1.243 0.731 0 C-N-CA 122.788 2.325 . . . . 0.0 113.029 176.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 1.8 p -143.98 141.12 30.0 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.054 -176.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 364' ' ' MET . . . . . 0.776 ' HG2' ' SG ' ' A' ' 338' ' ' CYS . 10.7 ptp -94.83 130.87 41.22 Favored 'General case' 0 CA--C 1.5 -0.98 0 C-N-CA 119.578 -0.849 . . . . 0.0 108.785 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -126.82 -166.76 1.63 Allowed 'General case' 0 C--N 1.322 -0.616 0 O-C-N 124.824 1.327 . . . . 0.0 111.777 -171.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . 0.521 HD21 ' N ' ' A' ' 366' ' ' ASN . 0.1 OUTLIER -42.99 -30.95 0.46 Allowed 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -178.328 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -116.66 3.11 13.05 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 121.846 -0.534 . . . . 0.0 112.188 -175.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . 0.557 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . 122.87 -176.88 16.59 Favored Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -177.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . 0.72 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -57.98 -32.46 66.64 Favored Glycine 0 CA--C 1.506 -0.53 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.835 173.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . 0.592 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 82.78 -131.36 10.32 Favored Glycine 0 N--CA 1.435 -1.379 0 C-N-CA 120.029 -1.081 . . . . 0.0 111.081 -177.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -103.46 137.66 41.25 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.336 0.589 . . . . 0.0 111.558 -175.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 372' ' ' ILE . . . . . 0.644 HG21 ' HB3' ' A' ' 362' ' ' PRO . 0.8 OUTLIER -130.41 150.33 34.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.366 176.73 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . 0.67 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 38.4 mt-10 -116.62 127.08 54.13 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.513 -175.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 374' ' ' MET . . . . . 0.799 ' HG2' HD12 ' A' ' 383' ' ' ILE . 4.1 ppp? -139.38 160.51 39.67 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.153 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 375' ' ' GLN . . . . . 0.834 HE21 ' HA ' ' A' ' 375' ' ' GLN . 0.0 OUTLIER -176.44 174.54 1.91 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.95 0.405 . . . . 0.0 110.89 174.346 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 376' ' ' LEU . . . . . 0.893 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 6.6 tp -165.17 158.74 14.18 Favored Pre-proline 0 N--CA 1.445 -0.676 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 377' ' ' PRO . . . . . 0.893 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 66.4 Cg_exo -40.97 129.34 2.89 Favored 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 121.77 1.647 . . . . 0.0 111.259 167.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.63 ' HA ' HE22 ' A' ' 394' ' ' GLN . 2.7 Cg_exo -35.8 140.75 0.12 Allowed 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 124.948 3.765 . . . . 0.0 113.502 -174.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 151.45 -161.77 29.31 Favored Glycine 0 N--CA 1.442 -0.935 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -162.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . 0.875 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 5.3 m-20 -101.86 129.42 48.09 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 117.918 0.859 . . . . 0.0 110.877 177.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.533 ' HB3' ' HE2' ' A' ' 374' ' ' MET . 9.7 m120 -128.66 146.25 50.92 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 176.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 1.038 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -149.61 138.17 14.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 177.773 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . 0.799 HD12 ' HG2' ' A' ' 374' ' ' MET . 43.9 mt -101.63 135.66 37.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.693 -171.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -105.12 96.68 6.7 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.549 -1.205 . . . . 0.0 108.795 169.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . 0.876 HG21 ' HE2' ' A' ' 328' ' ' MET . 2.3 t -80.36 79.2 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.778 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 174.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 65.93 -104.45 1.02 Allowed Glycine 0 N--CA 1.43 -1.753 0 C-N-CA 119.388 -1.387 . . . . 0.0 110.16 -163.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 387' ' ' ASP . . . . . 0.535 ' HB2' ' HD3' ' A' ' 309' ' ' LYS . 35.9 t70 -98.63 -12.15 21.39 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 175.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . 0.498 HD22 ' C ' ' A' ' 313' ' ' THR . 0.8 OUTLIER -71.69 107.91 4.76 Favored 'General case' 0 CA--C 1.511 -0.537 0 O-C-N 121.771 -0.581 . . . . 0.0 109.773 179.464 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . 0.451 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 5.8 p30 -114.17 144.05 43.82 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 -176.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -169.42 108.61 0.43 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.09 0.472 . . . . 0.0 111.286 -177.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 391' ' ' GLN . . . . . 1.038 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 19.6 tt0 -78.01 154.16 31.73 Favored 'General case' 0 C--N 1.345 0.407 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -172.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 392' ' ' TRP . . . . . . . . . . . . . 39.7 t-105 -154.71 148.43 25.43 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.321 177.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -107.25 119.16 38.64 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 173.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . 0.634 ' HG2' HE22 ' A' ' 375' ' ' GLN . 0.0 OUTLIER -108.86 136.76 47.88 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.456 0.646 . . . . 0.0 111.857 -169.745 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 19.8 tptp . . . . . 0 C--O 1.247 0.936 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.988 175.528 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 303' ' ' THR . . . . . 0.526 ' O ' HG23 ' A' ' 335' ' ' THR . 6.1 t . . . . . 0 CA--C 1.536 0.441 0 CA-C-O 120.908 0.385 . . . . 0.0 111.613 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . 0.414 ' O ' ' HB ' ' A' ' 305' ' ' THR . 5.3 p90 -59.38 132.47 54.11 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.077 177.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 305' ' ' THR . . . . . 0.457 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 15.2 t 172.5 -167.68 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -172.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 64.7 t -62.19 114.23 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 171.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . 0.582 ' HB3' ' HE2' ' A' ' 364' ' ' MET . 0.1 OUTLIER -69.03 135.18 50.46 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.146 0.498 . . . . 0.0 111.753 -172.193 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . 0.549 ' HB3' ' HZ2' ' A' ' 311' ' ' LYS . 22.4 t70 -55.29 111.58 0.9 Allowed 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.475 175.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.521 ' HD3' ' HB2' ' A' ' 387' ' ' ASP . 0.0 OUTLIER -40.77 -24.36 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 115.845 1.795 . . . . 0.0 115.845 -169.189 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.517 ' N ' ' HD2' ' A' ' 309' ' ' LYS . 11.7 t -98.71 -4.14 34.27 Favored 'General case' 0 C--N 1.314 -0.96 0 O-C-N 121.677 -0.639 . . . . 0.0 111.773 -171.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.551 ' HE3' ' H ' ' A' ' 335' ' ' THR . 29.0 mtmm -84.87 48.56 1.57 Allowed 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 120.936 0.398 . . . . 0.0 111.081 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.533 ' CD1' ' HB ' ' A' ' 330' ' ' VAL . 4.9 m-85 -139.65 153.82 47.4 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.662 -178.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 22.7 p -138.18 149.19 45.6 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.17 177.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 8.4 m-90 -67.7 116.12 8.04 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.471 0.653 . . . . 0.0 110.217 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.435 ' HB3' ' C ' ' A' ' 329' ' ' GLU . 53.2 tptt -96.69 -57.45 2.29 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 172.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 316' ' ' ARG . 27.2 ttm-85 -139.04 114.81 9.99 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.631 -1.168 . . . . 0.0 108.298 172.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . 0.478 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -68.21 160.8 73.3 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -178.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . 0.618 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 3.8 Cg_exo -43.06 110.96 0.19 Allowed 'Trans proline' 0 C--N 1.358 1.058 0 C-N-CA 122.237 1.958 . . . . 0.0 112.875 -175.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 319' ' ' THR . . . . . 0.456 ' O ' HG21 ' A' ' 327' ' ' VAL . 31.1 m -127.07 128.76 46.77 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.266 -174.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -55.69 120.35 7.14 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 82.9 p -47.74 -54.26 12.74 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.205 0.602 . . . . 0.0 111.053 -169.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 141.47 -17.04 2.67 Favored Glycine 0 N--CA 1.443 -0.86 0 CA-C-N 114.909 -1.042 . . . . 0.0 111.532 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . 0.562 ' O ' ' HB2' ' A' ' 324' ' ' ASP . 7.1 t-80 -122.73 23.94 9.29 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 120.722 0.296 . . . . 0.0 110.585 -179.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . 0.562 ' HB2' ' O ' ' A' ' 323' ' ' HIS . 5.6 m-20 92.69 45.94 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.122 0.969 . . . . 0.0 111.751 169.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 325' ' ' THR . . . . . 0.676 ' HA ' ' HG2' ' A' ' 375' ' ' GLN . 1.8 p -154.55 -167.1 2.51 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 174.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . 0.966 HG22 ' HZ2' ' A' ' 392' ' ' TRP . 3.0 t -134.38 142.13 41.64 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.395 0 CA-C-N 119.477 1.035 . . . . 0.0 111.855 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 327' ' ' VAL . . . . . 0.606 HG12 ' HG2' ' A' ' 373' ' ' GLU . 17.4 m -119.02 156.32 21.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.882 174.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 328' ' ' MET . . . . . 0.457 ' HE2' ' HB2' ' A' ' 328' ' ' MET . 0.0 OUTLIER -148.02 150.48 34.03 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.718 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.435 ' C ' ' HB3' ' A' ' 315' ' ' LYS . 24.5 tt0 -132.99 132.5 41.97 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -175.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.721 HG13 HG13 ' A' ' 385' ' ' VAL . 0.0 OUTLIER -130.02 150.82 35.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -176.17 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . 0.502 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -120.72 134.52 10.31 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.052 176.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -103.83 174.65 5.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.142 0.471 . . . . 0.0 111.092 -179.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 30.2 m -148.66 49.37 1.01 Allowed 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 170.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -177.05 -88.35 0.07 OUTLIER Glycine 0 C--N 1.339 0.703 0 C-N-CA 119.794 -1.193 . . . . 0.0 113.925 168.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 335' ' ' THR . . . . . 0.691 ' O ' ' HE1' ' A' ' 364' ' ' MET . 50.3 m -51.3 130.62 27.23 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 114.701 -0.75 . . . . 0.0 110.324 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.784 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 8.1 ptm180 -79.1 -176.01 0.65 Allowed Pre-proline 0 CA--C 1.533 0.322 0 CA-C-O 117.633 -1.175 . . . . 0.0 108.986 -174.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . 0.784 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -24.79 103.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 123.955 3.103 . . . . 0.0 114.045 -177.479 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 338' ' ' CYS . . . . . 0.732 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 8.9 p -111.42 -174.95 2.58 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 113.587 -1.642 . . . . 0.0 111.023 -168.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -107.89 96.51 6.43 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 177.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . 0.803 HG22 HG12 ' A' ' 342' ' ' VAL . 27.3 mt -74.08 120.41 81.2 Favored Pre-proline 0 C--N 1.327 -0.387 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.185 -166.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -81.25 80.69 2.9 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 122.295 1.996 . . . . 0.0 111.057 175.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.803 HG12 HG22 ' A' ' 340' ' ' ILE . 6.7 m -100.13 123.5 53.02 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.024 0 CA-C-O 121.986 0.898 . . . . 0.0 109.837 176.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.469 ' HG3' ' HB2' ' A' ' 384' ' ' TYR . 24.3 ptt180 -132.94 173.05 11.81 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.324 -1.307 . . . . 0.0 107.748 176.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 344' ' ' ALA . . . . . 0.628 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -143.27 141.09 30.92 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 173.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 17.5 m -115.83 145.27 21.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -63.91 115.83 5.24 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.005 177.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . 0.585 ' HB3' ' CB ' ' A' ' 380' ' ' ASP . 23.8 p80 35.79 71.11 0.13 Allowed 'General case' 0 N--CA 1.475 0.793 0 O-C-N 124.53 1.144 . . . . 0.0 112.601 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . 0.756 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 41.99 47.15 5.23 Favored Glycine 0 C--N 1.333 0.403 0 N-CA-C 115.191 0.836 . . . . 0.0 115.191 -175.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . 0.411 HG21 ' O ' ' A' ' 347' ' ' HIS . 90.1 t -142.61 102.49 5.44 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 176.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -75.95 66.1 6.84 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.865 2.377 . . . . 0.0 112.781 -178.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -100.99 -55.97 2.43 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 177.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 7.4 p -124.96 133.18 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.45 171.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -64.82 112.49 3.28 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.333 177.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.518 ' HB ' HD22 ' A' ' 376' ' ' LEU . 32.7 m -89.98 1.8 7.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.917 178.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . 0.628 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -74.44 84.11 1.98 Allowed 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.181 0.515 . . . . 0.0 110.558 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 356' ' ' MET . . . . . 0.607 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 58.6 ttp -94.0 99.95 12.17 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 172.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.566 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 19.9 mt -85.34 115.45 23.1 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.494 -161.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.54 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 3.1 mm -59.18 -26.65 34.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.045 174.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 34.5 m -137.53 90.73 14.6 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.701 174.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -83.6 38.93 0.75 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.416 2.744 . . . . 0.0 113.461 -172.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -147.57 69.37 11.29 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.689 177.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . 0.906 ' HB3' HG21 ' A' ' 372' ' ' ILE . 63.0 Cg_endo -79.59 143.58 17.04 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.234 1.956 . . . . 0.0 111.825 176.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 363' ' ' THR . . . . . 0.408 ' O ' ' HA2' ' A' ' 369' ' ' GLY . 1.3 p -143.64 133.76 24.32 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.45 -173.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 364' ' ' MET . . . . . 0.732 ' HG2' ' SG ' ' A' ' 338' ' ' CYS . 19.2 ptt? -98.72 111.95 24.17 Favored 'General case' 0 CA--C 1.501 -0.928 0 C-N-CA 119.095 -1.042 . . . . 0.0 109.195 177.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.457 ' CD ' ' HG3' ' A' ' 337' ' ' PRO . 67.1 mm-40 -103.13 -163.74 1.02 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 113.029 -1.896 . . . . 0.0 109.947 -173.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -48.31 -22.84 0.75 Allowed 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -179.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -111.12 -2.58 15.78 Favored 'General case' 0 N--CA 1.463 0.182 0 O-C-N 121.795 -0.566 . . . . 0.0 111.273 -178.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . 0.502 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . 107.73 -167.19 13.38 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -172.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . 0.558 ' HA3' HG21 ' A' ' 330' ' ' VAL . . . -65.42 103.8 0.87 Allowed Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.736 -0.945 . . . . 0.0 110.736 170.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . 0.405 ' O ' ' HG3' ' A' ' 329' ' ' GLU . . . -72.41 -32.7 62.01 Favored Glycine 0 C--N 1.317 -0.514 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.518 -167.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -164.29 138.65 5.54 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 123.823 0.366 . . . . 0.0 110.458 179.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 372' ' ' ILE . . . . . 0.906 HG21 ' HB3' ' A' ' 362' ' ' PRO . 0.3 OUTLIER -137.63 156.14 31.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 171.063 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . 0.606 ' HG2' HG12 ' A' ' 327' ' ' VAL . 43.1 mt-10 -134.62 125.53 27.36 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -178.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 374' ' ' MET . . . . . 0.566 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 2.4 mtt -142.94 164.51 29.89 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -174.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 375' ' ' GLN . . . . . 0.733 HE21 ' HA ' ' A' ' 375' ' ' GLN . 0.0 OUTLIER 177.97 179.08 0.32 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.132 0.423 . . . . 0.0 110.929 175.653 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 376' ' ' LEU . . . . . 0.912 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 14.2 tp -165.95 160.74 13.09 Favored Pre-proline 0 N--CA 1.446 -0.64 0 N-CA-C 104.867 -2.271 . . . . 0.0 104.867 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 377' ' ' PRO . . . . . 0.912 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 81.2 Cg_exo -44.54 131.09 9.6 Favored 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 121.502 1.468 . . . . 0.0 111.328 169.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.725 ' HA ' HE22 ' A' ' 394' ' ' GLN . 2.8 Cg_exo -37.03 138.86 0.22 Allowed 'Trans proline' 0 C--N 1.36 1.176 0 C-N-CA 124.607 3.538 . . . . 0.0 112.911 -175.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 152.66 -163.81 30.5 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 -162.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . 0.585 ' CB ' ' HB3' ' A' ' 347' ' ' HIS . 17.6 m-20 -98.86 122.59 42.29 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 117.468 0.634 . . . . 0.0 111.5 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.552 ' HB2' ' CH2' ' A' ' 392' ' ' TRP . 6.1 m120 -124.83 175.17 7.45 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 171.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 1.024 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -163.19 141.42 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 167.304 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . 0.648 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 45.9 mt -101.71 132.23 48.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 C-N-CA 119.674 -0.81 . . . . 0.0 110.456 -174.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 384' ' ' TYR . . . . . 0.548 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 1.9 m-85 -102.33 128.89 48.7 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.483 -1.235 . . . . 0.0 107.782 168.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . 0.721 HG13 HG13 ' A' ' 330' ' ' VAL . 15.2 t -118.48 77.15 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 63.16 -110.49 3.4 Favored Glycine 0 N--CA 1.43 -1.716 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.842 -161.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 387' ' ' ASP . . . . . 0.521 ' HB2' ' HD3' ' A' ' 309' ' ' LYS . 34.1 t70 -81.15 -20.31 41.6 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 177.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . 0.548 ' O ' ' HA ' ' A' ' 384' ' ' TYR . 1.2 mp -68.54 153.03 44.55 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.909 -0.317 . . . . 0.0 110.254 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . 0.648 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 5.0 p-10 -160.24 155.26 24.59 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.08 177.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . 0.618 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 31.6 t60 -171.46 112.12 0.34 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.816 175.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 391' ' ' GLN . . . . . 1.024 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 15.3 tt0 -75.93 149.33 37.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.788 -178.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 392' ' ' TRP . . . . . 0.966 ' HZ2' HG22 ' A' ' 326' ' ' VAL . 0.1 OUTLIER -168.18 151.32 5.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.049 0.452 . . . . 0.0 110.142 -179.111 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -101.05 118.87 37.84 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 178.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . 0.725 HE22 ' HA ' ' A' ' 378' ' ' PRO . 0.0 OUTLIER -95.64 131.81 41.48 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.308 -170.27 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.453 ' HD2' ' HA ' ' A' ' 395' ' ' LYS . 21.7 tptp . . . . . 0 C--O 1.252 1.223 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.281 178.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 303' ' ' THR . . . . . 0.548 HG21 HG23 ' A' ' 335' ' ' THR . 5.2 t . . . . . 0 CA--C 1.536 0.412 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . 0.507 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 25.9 p90 -64.21 127.85 33.22 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 175.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 14.3 t 178.45 -167.13 0.06 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -170.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 34.3 t -65.06 114.34 2.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 165.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.37 139.0 57.17 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.346 0.593 . . . . 0.0 110.414 -170.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . 0.441 ' HB3' ' HG2' ' A' ' 311' ' ' LYS . 5.4 t70 -60.94 126.71 28.36 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.609 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.507 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -44.02 -13.61 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 -175.38 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.404 ' N ' ' HD2' ' A' ' 309' ' ' LYS . 12.5 t -108.07 0.46 21.73 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 119.39 0.996 . . . . 0.0 111.8 -176.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.478 ' HE2' ' OG1' ' A' ' 335' ' ' THR . 29.6 mmmt -72.68 -33.06 66.26 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -175.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.637 ' HA ' ' O ' ' A' ' 331' ' ' GLY . 0.6 OUTLIER -90.95 175.67 6.88 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 122.29 1.043 . . . . 0.0 112.798 -174.77 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 8.7 t -153.98 162.27 41.34 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 113.285 -1.78 . . . . 0.0 109.697 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . 0.626 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 24.0 m-90 -77.75 92.88 4.22 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -178.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -71.57 -43.04 67.03 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 171.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -154.02 124.4 7.0 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 171.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . 0.503 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . . . -70.7 163.59 62.74 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 119.139 -0.458 . . . . 0.0 109.99 -177.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . 0.537 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 2.4 Cg_endo -46.19 113.5 0.63 Allowed 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 122.067 1.845 . . . . 0.0 112.281 -179.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 319' ' ' THR . . . . . 0.492 ' O ' HG21 ' A' ' 327' ' ' VAL . 21.7 m -129.5 133.96 47.53 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.881 -172.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . 0.475 ' HA ' HG13 ' A' ' 326' ' ' VAL . 28.4 t70 -55.84 123.14 13.24 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -178.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 81.0 p -62.66 -47.78 82.18 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 121.339 0.59 . . . . 0.0 109.883 -174.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 120.27 -15.0 10.11 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -109.05 49.2 0.83 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.774 0.797 . . . . 0.0 108.974 177.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 50.67 41.12 25.52 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 114.647 -1.161 . . . . 0.0 112.597 -178.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 325' ' ' THR . . . . . 0.543 ' HA ' ' HG3' ' A' ' 375' ' ' GLN . 6.2 p -150.39 -173.42 4.45 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 175.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . 0.806 HG23 ' HG2' ' A' ' 375' ' ' GLN . 1.5 t -133.75 146.0 32.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.94 -178.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 327' ' ' VAL . . . . . 0.596 HG12 ' HG2' ' A' ' 373' ' ' GLU . 20.6 m -123.6 155.86 30.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.774 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 328' ' ' MET . . . . . 0.481 ' CG ' HD12 ' A' ' 372' ' ' ILE . 0.0 OUTLIER -143.63 154.21 43.31 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 173.934 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -132.58 130.65 40.57 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.643 HG23 HD11 ' A' ' 340' ' ' ILE . 0.0 OUTLIER -118.54 162.21 16.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -179.231 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . 0.767 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -118.55 172.65 14.57 Favored Glycine 0 C--O 1.227 -0.341 0 C-N-CA 119.712 -1.232 . . . . 0.0 112.531 172.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . 0.783 ' HD1' ' HA2' ' A' ' 368' ' ' GLY . 0.9 OUTLIER -127.84 135.78 50.52 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 179.726 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 29.0 m -85.82 -21.01 28.32 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 176.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -171.53 -50.37 0.04 OUTLIER Glycine 0 C--N 1.335 0.518 0 C-N-CA 118.357 -1.878 . . . . 0.0 115.054 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 335' ' ' THR . . . . . 0.548 HG23 HG21 ' A' ' 303' ' ' THR . 65.8 m -49.59 129.74 19.69 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 123.892 0.407 . . . . 0.0 110.115 -178.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.623 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 1.0 OUTLIER -82.37 176.45 3.81 Favored Pre-proline 0 N--CA 1.451 -0.416 0 CA-C-O 117.366 -1.302 . . . . 0.0 107.631 -172.413 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . 0.691 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.1 OUTLIER -25.25 98.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.363 1.342 0 C-N-CA 123.727 2.951 . . . . 0.0 114.053 -173.323 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 338' ' ' CYS . . . . . 0.697 ' SG ' ' HB2' ' A' ' 364' ' ' MET . 6.5 p -129.7 139.54 51.32 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 113.971 -1.468 . . . . 0.0 108.444 -171.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -65.6 124.54 22.64 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.395 -0.522 . . . . 0.0 109.706 177.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . 0.643 HD11 HG23 ' A' ' 330' ' ' VAL . 18.6 tt -98.45 118.72 62.94 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.273 -177.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.7 95.23 0.71 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.949 2.432 . . . . 0.0 112.336 -177.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.658 HG13 HG11 ' A' ' 385' ' ' VAL . 15.4 m -110.07 122.53 64.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.643 0.735 . . . . 0.0 110.812 179.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 14.6 ptt180 -133.5 -178.25 4.91 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 173.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 344' ' ' ALA . . . . . 0.548 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -147.03 147.81 31.04 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.629 177.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.522 HG21 HG21 ' A' ' 382' ' ' ILE . 4.8 m -118.94 142.47 33.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 177.053 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . 0.488 ' HB2' HG13 ' A' ' 354' ' ' VAL . . . -65.48 127.67 32.78 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 177.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . 0.581 ' O ' HG21 ' A' ' 349' ' ' VAL . 35.2 t60 41.44 60.38 2.13 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 124.204 0.94 . . . . 0.0 112.038 174.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . 0.427 ' H ' ' CG2' ' A' ' 382' ' ' ILE . . . 44.85 38.62 5.85 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 115.035 0.774 . . . . 0.0 115.035 -175.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . 0.581 HG21 ' O ' ' A' ' 347' ' ' HIS . 58.4 t -135.85 103.15 10.04 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 117.917 0.859 . . . . 0.0 108.863 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . 0.509 ' HA ' ' HB ' ' A' ' 345' ' ' VAL . 15.4 Cg_exo -72.65 62.12 3.71 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.861 2.374 . . . . 0.0 112.936 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -100.4 -55.2 2.67 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 7.7 p -124.83 133.76 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.456 174.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . 0.49 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 37.4 t30 -66.72 116.14 7.31 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.482 176.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.633 ' HB ' HD21 ' A' ' 376' ' ' LEU . 27.5 m -101.06 5.92 10.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.292 -176.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . 0.548 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -74.82 87.03 2.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.194 0.521 . . . . 0.0 112.027 -177.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.1 99.45 11.43 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 170.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.531 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 43.1 mt -87.37 121.82 30.32 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.607 -164.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.886 HD12 ' HB2' ' A' ' 375' ' ' GLN . 2.8 mm -63.25 -29.77 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.565 175.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 359' ' ' THR . . . . . 0.406 ' HA ' ' HD3' ' A' ' 360' ' ' PRO . 27.6 m -133.81 91.42 25.07 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.467 173.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 360' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 359' ' ' THR . 3.8 Cg_endo -85.01 39.9 0.78 Allowed 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 123.518 2.812 . . . . 0.0 113.801 -170.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -158.4 70.74 3.86 Favored Pre-proline 0 C--N 1.319 -0.76 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.288 176.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . 0.445 ' HG3' HG22 ' A' ' 342' ' ' VAL . 97.8 Cg_endo -84.31 147.99 11.5 Favored 'Trans proline' 0 C--O 1.247 0.94 0 C-N-CA 122.17 1.913 . . . . 0.0 111.759 173.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 4.6 m -143.07 150.95 40.22 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -174.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 364' ' ' MET . . . . . 0.697 ' HB2' ' SG ' ' A' ' 338' ' ' CYS . 60.3 mtp -100.14 120.98 40.7 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.584 -176.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.474 ' HG2' ' HG3' ' A' ' 337' ' ' PRO . 57.8 mt-10 -145.26 -166.0 2.32 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.005 -1.452 . . . . 0.0 109.68 -165.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . 0.529 HD21 ' N ' ' A' ' 366' ' ' ASN . 0.1 OUTLIER -49.38 -9.38 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 63.8 m-80 -107.35 -14.72 14.81 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.475 1.034 . . . . 0.0 110.027 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . 0.783 ' HA2' ' HD1' ' A' ' 332' ' ' PHE . . . 126.12 -105.42 0.79 Allowed Glycine 0 CA--C 1.494 -1.255 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -171.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . 0.61 ' HA3' HG21 ' A' ' 330' ' ' VAL . . . -109.17 5.55 31.96 Favored Glycine 0 C--N 1.307 -1.07 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 168.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 75.44 -84.06 0.87 Allowed Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 114.693 -0.754 . . . . 0.0 113.949 174.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -166.81 141.52 4.1 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.222 -0.489 . . . . 0.0 110.596 -173.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 372' ' ' ILE . . . . . 0.652 HD11 HG11 ' A' ' 342' ' ' VAL . 0.7 OUTLIER -136.72 145.4 30.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.113 175.395 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . 0.652 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 43.5 mt-10 -127.71 125.68 40.46 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 177.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 374' ' ' MET . . . . . 0.924 ' HE2' HD12 ' A' ' 383' ' ' ILE . 0.0 OUTLIER -139.18 156.07 47.38 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.286 -174.227 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 375' ' ' GLN . . . . . 0.914 HE22 ' HG2' ' A' ' 394' ' ' GLN . 0.0 OUTLIER -168.94 175.82 5.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.422 0.629 . . . . 0.0 112.337 175.798 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 376' ' ' LEU . . . . . 0.633 HD21 ' HB ' ' A' ' 354' ' ' VAL . 16.4 tp -168.18 145.09 3.38 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 174.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 377' ' ' PRO . . . . . 0.608 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 80.8 Cg_exo -40.93 140.92 1.04 Allowed 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.266 1.977 . . . . 0.0 112.165 177.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.851 ' HA ' HE22 ' A' ' 394' ' ' GLN . 4.4 Cg_exo -35.46 139.65 0.12 Allowed 'Trans proline' 0 C--N 1.357 1.008 1 C-N-CA 125.488 4.125 . . . . 0.0 114.106 -169.437 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 149.74 -163.09 29.29 Favored Glycine 0 N--CA 1.442 -0.916 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -166.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . 0.552 ' OD1' ' HB2' ' A' ' 347' ' ' HIS . 1.5 p30 -113.2 136.76 52.37 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.781 0.8 . . . . 0.0 111.804 176.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -136.05 171.26 14.72 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.818 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 1.06 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -156.91 143.93 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.826 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 174.133 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . 0.924 HD12 ' HE2' ' A' ' 374' ' ' MET . 45.1 mt -95.3 127.95 46.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.147 -177.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -103.31 92.32 4.45 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.097 170.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . 0.658 HG11 HG13 ' A' ' 342' ' ' VAL . 15.6 t -87.86 82.9 2.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 178.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 57.81 -111.32 2.93 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.415 -0.898 . . . . 0.0 111.777 -173.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 387' ' ' ASP . . . . . 0.412 ' HB2' ' HD3' ' A' ' 309' ' ' LYS . 32.1 t70 -77.03 -24.84 52.07 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.884 0.373 . . . . 0.0 111.306 175.258 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . 0.629 HD12 ' HD1' ' A' ' 312' ' ' PHE . 3.6 mp -71.43 156.46 39.43 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.403 -179.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . 0.699 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 7.7 p30 -169.49 153.56 5.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.196 178.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . 0.537 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 56.7 t-80 -175.88 117.7 0.15 Allowed 'General case' 0 N--CA 1.469 0.503 0 O-C-N 123.283 0.365 . . . . 0.0 110.486 177.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 391' ' ' GLN . . . . . 1.06 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 4.1 tt0 -73.4 154.94 39.81 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.103 0.478 . . . . 0.0 112.114 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 392' ' ' TRP . . . . . 0.462 ' HE1' ' HB3' ' A' ' 394' ' ' GLN . 0.1 OUTLIER -160.76 151.4 18.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.804 176.558 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -113.91 131.85 56.14 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 177.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . 0.914 ' HG2' HE22 ' A' ' 375' ' ' GLN . 0.0 OUTLIER -111.72 136.13 51.39 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.753 0.311 . . . . 0.0 110.542 -177.131 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.475 ' O ' ' HB3' ' A' ' 378' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.922 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.462 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 303' ' ' THR . . . . . 0.545 ' O ' HG23 ' A' ' 335' ' ' THR . 4.3 t . . . . . 0 CA--C 1.535 0.402 0 CA-C-O 120.787 0.327 . . . . 0.0 111.218 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . 0.478 ' HB3' ' NE ' ' A' ' 336' ' ' ARG . 0.8 OUTLIER -59.35 133.27 55.95 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.965 0.412 . . . . 0.0 110.002 178.814 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 305' ' ' THR . . . . . 0.509 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 12.8 t 174.46 -170.68 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -175.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 18.5 t -65.46 116.25 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 170.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . 0.479 ' HB3' ' CE2' ' A' ' 332' ' ' PHE . 0.0 OUTLIER -67.65 139.26 56.8 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -173.134 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . 0.624 ' OD2' HG21 ' A' ' 310' ' ' THR . 15.8 t70 -59.45 118.03 5.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.064 -176.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.447 ' HD2' ' N ' ' A' ' 310' ' ' THR . 0.0 OUTLIER -48.2 -15.87 0.08 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -168.781 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.624 HG21 ' OD2' ' A' ' 308' ' ' ASP . 9.2 t -99.35 -10.93 21.69 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 118.663 0.665 . . . . 0.0 110.82 -175.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.565 ' HE2' ' CE1' ' A' ' 332' ' ' PHE . 24.5 mtpt -83.67 51.99 2.15 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.487 0.661 . . . . 0.0 110.579 -178.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.495 ' HZ ' ' HG3' ' A' ' 364' ' ' MET . 11.3 m-85 -141.7 151.89 43.38 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.675 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 18.7 p -142.49 152.52 42.78 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.559 -1.2 . . . . 0.0 109.296 178.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 65.7 m95 -82.23 95.39 7.53 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.132 0.491 . . . . 0.0 110.804 178.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.763 ' HA ' ' HE3' ' A' ' 315' ' ' LYS . 0.4 OUTLIER -65.3 -46.47 80.24 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 167.56 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 8.0 ttm180 -150.09 126.71 10.92 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.883 173.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . 0.488 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -72.94 160.91 81.76 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-O 119.218 -0.42 . . . . 0.0 110.162 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . 0.535 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 2.7 Cg_endo -43.55 114.35 0.49 Allowed 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 122.653 2.236 . . . . 0.0 112.492 -176.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 319' ' ' THR . . . . . 0.464 ' O ' HG21 ' A' ' 327' ' ' VAL . 15.8 m -133.78 136.37 44.48 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.438 -174.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -63.66 125.8 25.48 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -176.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 93.7 p -56.17 -48.79 75.66 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.782 -171.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 133.69 -10.44 4.91 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 36.8 t-80 -128.03 61.34 1.44 Allowed 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.346 0.593 . . . . 0.0 109.74 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 52.76 35.62 19.1 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 114.921 -1.036 . . . . 0.0 113.547 177.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 325' ' ' THR . . . . . 0.652 ' HA ' ' HG3' ' A' ' 375' ' ' GLN . 3.7 p -148.48 -175.12 4.8 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 177.134 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . 0.787 HG23 ' HG2' ' A' ' 375' ' ' GLN . 0.2 OUTLIER -130.88 145.91 34.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.34 0.59 . . . . 0.0 111.032 -177.327 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 327' ' ' VAL . . . . . 0.53 HG12 ' HG3' ' A' ' 373' ' ' GLU . 16.9 m -123.44 150.48 27.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.97 175.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 328' ' ' MET . . . . . 0.521 ' SD ' ' HB ' ' A' ' 372' ' ' ILE . 0.1 OUTLIER -139.65 149.54 43.86 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 175.229 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.732 ' HG2' ' HG2' ' A' ' 315' ' ' LYS . 4.6 tt0 -125.3 121.63 34.54 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -177.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.436 ' HB ' ' HD1' ' A' ' 312' ' ' PHE . 4.2 m -126.65 145.03 34.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.718 -174.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -111.67 131.82 10.49 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 119.915 -1.136 . . . . 0.0 112.381 179.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . 1.013 ' H ' ' HA2' ' A' ' 368' ' ' GLY . 4.1 t80 -133.87 136.71 44.53 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.011 -0.736 . . . . 0.0 109.011 176.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 19.9 m -129.78 62.36 1.55 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -171.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . 0.406 ' HA3' ' HZ3' ' A' ' 311' ' ' LYS . . . -164.26 -84.28 0.05 OUTLIER Glycine 0 CA--C 1.52 0.348 0 C-N-CA 119.25 -1.452 . . . . 0.0 113.877 163.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 335' ' ' THR . . . . . 0.949 ' HB ' ' HZ ' ' A' ' 332' ' ' PHE . 35.3 m -50.59 135.82 22.31 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.328 -0.936 . . . . 0.0 109.89 179.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.885 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 17.8 ptt180 -72.69 179.98 0.96 Allowed Pre-proline 0 CA--C 1.523 -0.078 0 CA-C-O 117.783 -1.103 . . . . 0.0 108.923 -178.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . 0.885 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -25.96 101.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.366 1.474 0 C-N-CA 123.653 2.902 . . . . 0.0 112.905 178.631 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 338' ' ' CYS . . . . . 0.547 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 29.0 p -113.88 -175.71 2.74 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 113.81 -1.541 . . . . 0.0 109.465 -165.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -108.74 96.97 6.7 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . 0.747 ' HB ' ' SD ' ' A' ' 364' ' ' MET . 15.7 tt -73.8 131.23 82.07 Favored Pre-proline 0 C--N 1.325 -0.472 0 C-N-CA 119.604 -0.838 . . . . 0.0 111.449 -169.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -81.58 79.28 3.25 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 121.67 1.58 . . . . 0.0 111.156 172.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.677 HG21 HG22 ' A' ' 340' ' ' ILE . 2.5 m -101.62 116.09 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 CA-C-O 121.756 0.789 . . . . 0.0 110.313 177.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.524 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 25.6 ptt180 -133.8 177.85 7.4 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.761 -1.108 . . . . 0.0 108.162 178.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 344' ' ' ALA . . . . . 0.591 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -149.95 147.16 27.55 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.579 176.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.489 ' HB ' ' HA ' ' A' ' 350' ' ' PRO . 5.8 m -118.38 143.03 30.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 177.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.26 121.88 15.81 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 177.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . 0.512 ' O ' HG21 ' A' ' 349' ' ' VAL . 41.3 t-80 43.9 61.85 2.16 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 124.277 0.986 . . . . 0.0 112.54 173.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . 0.577 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 46.9 38.05 9.94 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 114.733 0.653 . . . . 0.0 114.733 -175.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . 0.512 HG21 ' O ' ' A' ' 347' ' ' HIS . 58.5 t -138.34 102.88 8.0 Favored Pre-proline 0 C--O 1.235 0.305 0 CA-C-N 117.859 0.829 . . . . 0.0 108.91 178.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . 0.489 ' HA ' ' HB ' ' A' ' 345' ' ' VAL . 15.0 Cg_exo -72.6 63.53 3.78 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.848 2.366 . . . . 0.0 112.837 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -100.05 -56.23 2.42 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 7.6 p -125.05 133.1 70.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.278 174.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . 0.47 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 41.8 t30 -64.42 116.57 6.24 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.942 176.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.576 ' HB ' ' HG ' ' A' ' 376' ' ' LEU . 27.4 m -98.53 3.81 10.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.348 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . 0.591 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -74.14 84.58 1.84 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.278 0.561 . . . . 0.0 111.026 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 356' ' ' MET . . . . . 0.493 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 22.7 ttt -98.78 98.43 9.54 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 173.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.636 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 57.6 mt -83.06 147.39 28.16 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.655 -161.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.694 ' HB ' ' CB ' ' A' ' 373' ' ' GLU . 4.4 mm -88.68 -19.95 7.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 178.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 20.6 m -133.75 92.94 21.83 Favored Pre-proline 0 N--CA 1.445 -0.682 0 CA-C-N 113.605 -1.634 . . . . 0.0 108.339 171.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -88.51 25.77 0.61 Allowed 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 123.024 2.483 . . . . 0.0 114.074 -170.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . 0.482 ' N ' ' HD3' ' A' ' 362' ' ' PRO . 40.9 m-80 -149.65 57.6 2.85 Favored Pre-proline 0 C--N 1.314 -0.953 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.864 176.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . 0.482 ' HD3' ' N ' ' A' ' 361' ' ' ASN . 4.9 Cg_endo -75.52 111.44 3.3 Favored 'Trans proline' 0 C--O 1.247 0.951 0 C-N-CA 121.447 1.432 . . . . 0.0 112.932 179.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 363' ' ' THR . . . . . 0.472 HG21 ' O ' ' A' ' 338' ' ' CYS . 15.8 p -96.68 125.54 41.22 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 114.924 -1.034 . . . . 0.0 111.59 167.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 364' ' ' MET . . . . . 0.794 ' HB3' ' CA ' ' A' ' 369' ' ' GLY . 0.0 OUTLIER -112.4 143.65 43.17 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.073 -1.421 . . . . 0.0 111.241 -176.089 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.465 ' HG2' ' HG3' ' A' ' 337' ' ' PRO . 41.9 mt-10 -103.6 172.36 6.85 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.953 0.882 . . . . 0.0 112.156 -171.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . 0.554 HD21 ' N ' ' A' ' 367' ' ' ASN . 0.2 OUTLIER -51.48 -6.29 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 113.167 -1.833 . . . . 0.0 113.569 172.977 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 367' ' ' ASN . . . . . 0.554 ' N ' HD21 ' A' ' 366' ' ' ASN . 10.1 p30 -115.71 -3.38 12.27 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.23 0.538 . . . . 0.0 110.26 -176.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . 1.013 ' HA2' ' H ' ' A' ' 332' ' ' PHE . . . 123.98 161.45 11.13 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.426 -176.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . 0.794 ' CA ' ' HB3' ' A' ' 364' ' ' MET . . . -76.41 -32.15 52.35 Favored Glycine 0 CA--C 1.498 -1.007 0 C-N-CA 120.37 -0.919 . . . . 0.0 113.163 177.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 87.6 -132.42 11.18 Favored Glycine 0 N--CA 1.438 -1.18 0 C-N-CA 120.03 -1.081 . . . . 0.0 111.002 -172.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -103.13 136.7 42.44 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.155 0.502 . . . . 0.0 111.4 -176.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 372' ' ' ILE . . . . . 0.521 ' HB ' ' SD ' ' A' ' 328' ' ' MET . 0.1 OUTLIER -128.07 165.18 27.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.584 175.752 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . 0.694 ' CB ' ' HB ' ' A' ' 358' ' ' ILE . 11.3 mp0 -128.79 130.36 46.9 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.153 0.502 . . . . 0.0 110.637 -177.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 374' ' ' MET . . . . . 0.678 ' HG2' HD12 ' A' ' 383' ' ' ILE . 0.0 OUTLIER -137.8 166.86 22.96 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.026 179.722 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 375' ' ' GLN . . . . . 0.787 ' HG2' HG23 ' A' ' 326' ' ' VAL . 0.0 OUTLIER -173.54 176.15 2.84 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.425 0.631 . . . . 0.0 110.809 168.153 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 376' ' ' LEU . . . . . 0.788 HD22 ' HD2' ' A' ' 377' ' ' PRO . 2.6 tm? -168.0 128.97 1.15 Allowed Pre-proline 0 C--N 1.317 -0.834 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 175.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 377' ' ' PRO . . . . . 0.788 ' HD2' HD22 ' A' ' 376' ' ' LEU . 34.0 Cg_exo -26.73 130.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 124.22 3.28 . . . . 0.0 113.161 -178.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -35.46 133.51 0.23 Allowed 'Trans proline' 0 C--N 1.361 1.2 0 C-N-CA 124.373 3.382 . . . . 0.0 113.0 -167.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 151.0 -174.45 30.27 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 -160.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . 0.638 ' HB3' ' CD2' ' A' ' 393' ' ' PHE . 4.4 p30 -98.41 125.25 43.5 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 117.787 0.794 . . . . 0.0 111.984 -173.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.562 HD21 ' HG2' ' A' ' 394' ' ' GLN . 33.1 m-80 -139.76 153.56 47.19 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.514 -176.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 0.992 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -144.5 140.3 23.97 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.872 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.676 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . 0.678 HD12 ' HG2' ' A' ' 374' ' ' MET . 37.3 mt -98.94 130.44 47.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.938 -175.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 384' ' ' TYR . . . . . 0.538 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.2 OUTLIER -106.71 92.0 3.92 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.006 174.058 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . 0.423 ' O ' ' HB2' ' A' ' 388' ' ' LEU . 9.5 t -87.02 87.71 2.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 64.57 -112.6 5.14 Favored Glycine 0 N--CA 1.442 -0.942 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -169.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -83.95 -16.81 42.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.72 0.295 . . . . 0.0 111.289 174.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . 0.538 ' O ' ' HA ' ' A' ' 384' ' ' TYR . 1.2 mp -68.51 151.52 46.68 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.348 -179.134 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . 0.566 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 29.0 p30 -159.36 151.35 20.75 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.679 177.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . 0.535 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 8.7 t60 -172.26 116.1 0.34 Allowed 'General case' 0 C--O 1.239 0.504 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.481 175.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 391' ' ' GLN . . . . . 0.992 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 4.1 tt0 -76.87 153.75 34.45 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.803 -177.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 392' ' ' TRP . . . . . 0.452 ' HD1' ' CD ' ' A' ' 394' ' ' GLN . 38.8 t-105 -167.08 153.34 8.14 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.948 178.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . 0.638 ' CD2' ' HB3' ' A' ' 380' ' ' ASP . 29.2 m-85 -106.75 110.92 23.22 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 176.415 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . 0.594 ' HG3' HE22 ' A' ' 375' ' ' GLN . 5.3 mm100 -75.76 107.55 8.01 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -169.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 9.7 ptmm? . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.466 -177.444 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 303' ' ' THR . . . . . 0.611 HG21 HG23 ' A' ' 335' ' ' THR . 14.9 t . . . . . 0 CA--C 1.535 0.372 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -66.78 120.83 14.19 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.058 -177.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 305' ' ' THR . . . . . 0.594 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 9.4 t 173.55 -167.03 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.519 -170.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 37.2 t -64.91 113.07 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 169.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . 0.418 ' SG ' ' HE2' ' A' ' 332' ' ' PHE . 0.0 OUTLIER -68.36 142.59 55.42 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.953 0.406 . . . . 0.0 110.712 -171.332 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . 0.85 ' HB3' ' HG3' ' A' ' 311' ' ' LYS . 6.6 t70 -60.87 126.3 26.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.442 -173.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 17.6 pttm -38.45 -29.62 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 125.849 1.659 . . . . 0.0 114.841 -178.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 12.3 t -108.72 4.31 23.62 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 121.723 -0.611 . . . . 0.0 112.029 -169.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.85 ' HG3' ' HB3' ' A' ' 308' ' ' ASP . 27.8 mtpp -83.8 -28.79 27.86 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -173.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.621 ' HE2' ' O ' ' A' ' 385' ' ' VAL . 0.1 OUTLIER -85.01 175.71 8.88 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.621 0.724 . . . . 0.0 112.159 -176.163 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 5.2 t -153.2 159.45 42.66 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.329 -1.305 . . . . 0.0 109.476 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . 0.449 ' CH2' ' HD3' ' A' ' 318' ' ' PRO . 52.5 m95 -81.99 95.9 7.55 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-O 121.161 0.505 . . . . 0.0 110.518 -179.121 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.608 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 65.4 tttm -65.82 -43.18 89.36 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 168.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 316' ' ' ARG . 44.8 ttm105 -149.28 125.31 10.65 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.846 172.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . 0.543 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -71.02 164.09 59.73 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.309 -179.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . 0.581 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 2.1 Cg_endo -45.59 108.66 0.15 Allowed 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 122.56 2.174 . . . . 0.0 112.03 -179.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 319' ' ' THR . . . . . 0.402 ' O ' HG21 ' A' ' 327' ' ' VAL . 30.1 m -120.5 124.29 45.04 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.647 -174.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . 0.525 ' HA ' HG13 ' A' ' 326' ' ' VAL . 11.4 t70 -53.57 121.62 8.13 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 177.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 60.2 p -61.21 -43.69 98.47 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.236 0.541 . . . . 0.0 109.794 -172.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 116.8 -8.79 16.6 Favored Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 109.911 -1.275 . . . . 0.0 109.911 178.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -127.1 62.37 1.34 Allowed 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 114.541 -0.83 . . . . 0.0 109.823 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 29.5 t70 64.43 17.99 11.1 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.577 171.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 325' ' ' THR . . . . . 0.532 ' HA ' ' HG2' ' A' ' 375' ' ' GLN . 17.8 p -149.45 -174.58 4.71 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 121.828 -0.545 . . . . 0.0 110.285 -176.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . 0.525 HG13 ' HA ' ' A' ' 320' ' ' ASP . 0.6 OUTLIER -135.56 146.07 30.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.202 0.525 . . . . 0.0 111.095 -177.707 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 327' ' ' VAL . . . . . 0.486 HG12 ' HG2' ' A' ' 373' ' ' GLU . 19.8 m -124.33 153.74 31.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.645 177.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 328' ' ' MET . . . . . 0.822 ' SD ' ' HB ' ' A' ' 372' ' ' ILE . 0.0 OUTLIER -145.48 157.84 43.94 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 174.977 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.608 ' HG2' ' HD3' ' A' ' 315' ' ' LYS . 8.0 tt0 -136.21 128.19 29.5 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 120.588 -0.445 . . . . 0.0 109.898 -178.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.717 HG22 HD13 ' A' ' 372' ' ' ILE . 1.5 m -129.63 147.09 33.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -173.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -120.89 134.96 10.49 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.533 -176.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . 0.876 ' H ' ' HA2' ' A' ' 368' ' ' GLY . 0.9 OUTLIER -110.69 152.2 26.82 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.099 0.476 . . . . 0.0 110.67 178.748 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 17.5 m -88.8 -36.64 15.96 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -172.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -146.12 -39.23 0.05 OUTLIER Glycine 0 C--N 1.333 0.394 0 C-N-CA 118.983 -1.58 . . . . 0.0 114.313 -176.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 335' ' ' THR . . . . . 0.611 HG23 HG21 ' A' ' 303' ' ' THR . 22.8 m -53.5 129.53 32.75 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.906 0.384 . . . . 0.0 110.727 -177.281 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.889 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 7.2 ptm180 -87.58 -176.38 0.71 Allowed Pre-proline 0 N--CA 1.455 -0.2 0 CA-C-O 117.268 -1.348 . . . . 0.0 107.857 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . 0.889 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 37.4 Cg_exo -26.28 97.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 123.482 2.788 . . . . 0.0 113.862 -179.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 338' ' ' CYS . . . . . 0.594 ' HB2' ' O ' ' A' ' 305' ' ' THR . 30.0 p -117.55 -176.23 2.98 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.965 -173.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 11.7 mpt_? -111.95 108.39 17.72 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 -177.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . 0.786 ' HB ' ' SD ' ' A' ' 364' ' ' MET . 15.0 tt -73.1 131.77 83.16 Favored Pre-proline 0 C--O 1.236 0.37 0 C-N-CA 119.527 -0.869 . . . . 0.0 111.964 -170.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -87.46 78.72 1.62 Allowed 'Trans proline' 0 N--CA 1.447 -1.21 0 C-N-CA 122.069 1.846 . . . . 0.0 110.976 168.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.777 HG21 HG22 ' A' ' 340' ' ' ILE . 2.5 m -103.51 124.62 57.86 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.872 0 CA-C-O 121.686 0.755 . . . . 0.0 110.613 177.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 28.4 ptt180 -141.11 177.48 8.04 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 173.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 344' ' ' ALA . . . . . 0.552 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -147.18 147.89 30.97 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 120.314 -0.555 . . . . 0.0 110.336 176.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.467 ' HB ' ' HA ' ' A' ' 350' ' ' PRO . 10.6 m -118.54 145.86 23.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.23 116.37 5.93 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 176.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . 0.661 ' HB3' ' CB ' ' A' ' 380' ' ' ASP . 7.9 p-80 34.7 71.47 0.11 Allowed 'General case' 0 N--CA 1.476 0.846 0 O-C-N 124.498 1.124 . . . . 0.0 113.651 176.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . 0.756 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 51.88 34.96 38.64 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 115.109 0.804 . . . . 0.0 115.109 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . 0.404 HG21 ' O ' ' A' ' 347' ' ' HIS . 49.9 t -139.65 101.26 7.31 Favored Pre-proline 0 C--O 1.234 0.282 0 CA-C-N 118.531 1.166 . . . . 0.0 108.327 177.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . 0.467 ' HA ' ' HB ' ' A' ' 345' ' ' VAL . 12.1 Cg_exo -75.76 61.9 6.35 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.847 2.365 . . . . 0.0 113.097 -179.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -101.02 -56.41 2.33 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 5.5 p -119.4 128.72 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.895 173.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . 0.503 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 31.8 t30 -64.64 116.56 6.35 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.549 176.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.446 ' HB ' ' HG ' ' A' ' 376' ' ' LEU . 16.7 m -92.28 -1.22 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.701 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . 0.552 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -76.14 89.12 3.05 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.222 0.534 . . . . 0.0 112.009 -176.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.73 103.08 13.82 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 170.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.538 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 53.8 mt -86.47 121.99 29.8 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.53 -161.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.656 ' HB ' ' CB ' ' A' ' 373' ' ' GLU . 2.5 mm -63.48 -23.79 34.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.506 174.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 16.7 m -128.14 92.02 42.87 Favored Pre-proline 0 N--CA 1.45 -0.475 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.23 169.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -88.82 24.14 0.7 Allowed 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 123.105 2.537 . . . . 0.0 113.47 -171.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . 0.558 ' N ' ' HD3' ' A' ' 362' ' ' PRO . 28.3 p-10 -145.23 50.92 1.2 Allowed Pre-proline 0 C--N 1.313 -1.012 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.305 178.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . 0.583 ' HG2' HG21 ' A' ' 340' ' ' ILE . 5.7 Cg_endo -75.2 108.2 2.66 Favored 'Trans proline' 0 C--O 1.249 1.063 0 C-N-CA 121.648 1.566 . . . . 0.0 113.323 -177.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 363' ' ' THR . . . . . 0.632 ' HA ' ' HE2' ' A' ' 364' ' ' MET . 2.0 p -92.11 167.02 12.36 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 114.693 -1.139 . . . . 0.0 112.011 166.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 364' ' ' MET . . . . . 0.786 ' SD ' ' HB ' ' A' ' 340' ' ' ILE . 0.2 OUTLIER -144.42 149.81 36.67 Favored 'General case' 0 CA--C 1.496 -1.129 0 CA-C-N 113.716 -1.584 . . . . 0.0 111.188 -172.46 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.463 ' HG2' ' HD3' ' A' ' 337' ' ' PRO . 55.8 mt-10 -120.5 177.96 4.85 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-O 122.144 0.974 . . . . 0.0 111.999 -179.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . 0.542 HD21 ' N ' ' A' ' 366' ' ' ASN . 0.1 OUTLIER -49.16 -5.59 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 112.533 -2.122 . . . . 0.0 113.597 174.717 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 367' ' ' ASN . . . . . 0.43 ' H ' ' C ' ' A' ' 365' ' ' GLU . 11.0 p30 -118.29 -10.11 10.29 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 121.647 -0.658 . . . . 0.0 110.342 -179.033 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . 0.876 ' HA2' ' H ' ' A' ' 332' ' ' PHE . . . 129.33 176.97 14.64 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 121.186 -0.531 . . . . 0.0 111.778 -174.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . 0.494 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -76.8 -34.04 44.54 Favored Glycine 0 C--N 1.334 0.448 0 CA-C-N 117.686 0.743 . . . . 0.0 113.06 178.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 94.39 -50.61 2.11 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.298 -0.953 . . . . 0.0 113.521 179.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -166.36 144.38 5.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 117.08 0.44 . . . . 0.0 111.423 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 372' ' ' ILE . . . . . 0.822 ' HB ' ' SD ' ' A' ' 328' ' ' MET . 0.3 OUTLIER -138.28 158.58 32.06 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 169.474 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . 0.656 ' CB ' ' HB ' ' A' ' 358' ' ' ILE . 52.0 mt-10 -133.29 129.79 38.06 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.79 0.329 . . . . 0.0 110.326 178.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 374' ' ' MET . . . . . 0.625 ' HG2' HD12 ' A' ' 383' ' ' ILE . 4.9 ppp? -136.83 162.72 32.45 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -179.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 375' ' ' GLN . . . . . 1.014 HE22 ' HG3' ' A' ' 394' ' ' GLN . 0.0 OUTLIER 172.52 177.81 0.09 Allowed 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 171.507 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 376' ' ' LEU . . . . . 0.635 HD11 HD22 ' A' ' 381' ' ' ASN . 0.0 OUTLIER -168.5 178.37 1.06 Allowed Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 173.822 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 377' ' ' PRO . . . . . 0.447 ' HD2' ' HB2' ' A' ' 376' ' ' LEU . 92.0 Cg_exo -44.66 125.4 6.26 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 CA-C-N 121.131 1.44 . . . . 0.0 111.176 169.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -36.79 147.08 0.08 OUTLIER 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 124.593 3.529 . . . . 0.0 113.943 -173.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 153.87 -174.44 32.4 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -164.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . 0.661 ' CB ' ' HB3' ' A' ' 347' ' ' HIS . 4.4 m-20 -93.0 124.76 37.2 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 117.558 0.679 . . . . 0.0 109.373 -178.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.635 HD22 HD11 ' A' ' 376' ' ' LEU . 0.6 OUTLIER -120.38 168.56 11.17 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.942 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 1.053 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -160.63 136.74 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 165.662 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . 0.625 HD12 ' HG2' ' A' ' 374' ' ' MET . 37.3 mt -95.37 130.01 44.71 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 C-N-CA 119.383 -0.927 . . . . 0.0 109.489 -174.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 384' ' ' TYR . . . . . 0.559 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.3 OUTLIER -107.65 90.9 3.44 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 114.352 -1.295 . . . . 0.0 108.114 173.237 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . 0.621 ' O ' ' HE2' ' A' ' 312' ' ' PHE . 10.6 t -84.43 91.25 2.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 175.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 61.02 -112.01 4.31 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.171 -171.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -90.05 -13.51 35.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.853 0.358 . . . . 0.0 111.354 176.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . 0.559 ' O ' ' HA ' ' A' ' 384' ' ' TYR . 1.6 mp -67.8 146.44 53.7 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 175.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . 0.573 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 30.2 p30 -155.58 152.25 28.55 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.042 178.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . 0.581 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 13.0 t60 -173.62 119.43 0.3 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.783 174.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 391' ' ' GLN . . . . . 1.053 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 0.8 OUTLIER -82.91 153.04 25.28 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.617 0.722 . . . . 0.0 112.023 -178.235 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 392' ' ' TRP . . . . . 0.5 ' HD1' ' OE1' ' A' ' 394' ' ' GLN . 8.3 t-105 -173.16 137.79 0.71 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 113.977 -1.465 . . . . 0.0 107.753 176.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . 0.52 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 30.8 p90 -100.18 129.77 46.24 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -176.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . 1.014 ' HG3' HE22 ' A' ' 375' ' ' GLN . 3.3 mm100 -89.61 110.45 21.32 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -172.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.568 ' HA ' ' HE2' ' A' ' 395' ' ' LYS . 0.6 OUTLIER . . . . . 0 C--O 1.246 0.904 0 CA-C-O 118.109 -0.948 . . . . 0.0 109.623 -173.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 303' ' ' THR . . . . . 0.582 HG21 HG23 ' A' ' 335' ' ' THR . 5.7 t . . . . . 0 CA--C 1.539 0.542 0 CA-C-O 121.445 0.641 . . . . 0.0 111.723 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . 0.546 ' HB3' ' HD3' ' A' ' 336' ' ' ARG . 39.4 p90 -69.87 128.65 37.12 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 175.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 305' ' ' THR . . . . . 0.493 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 7.3 t 175.86 -170.72 0.06 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -172.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 16.5 t -75.92 106.87 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 107.354 -1.351 . . . . 0.0 107.354 170.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -69.9 155.62 40.29 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.786 0.803 . . . . 0.0 113.031 -168.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . 0.694 ' OD2' HG21 ' A' ' 310' ' ' THR . 23.1 t70 -67.2 122.23 17.38 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.765 178.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.488 ' HB2' ' N ' ' A' ' 387' ' ' ASP . 31.7 pttt -40.66 -32.86 0.23 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 113.506 -1.679 . . . . 0.0 115.499 -173.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.694 HG21 ' OD2' ' A' ' 308' ' ' ASP . 10.0 t -105.77 16.42 25.29 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.882 0.849 . . . . 0.0 110.735 -165.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.526 ' HE3' ' OG1' ' A' ' 335' ' ' THR . 17.4 mtmm -99.46 47.63 0.95 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.626 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 1.039 ' HZ ' HD13 ' A' ' 340' ' ' ILE . 6.1 m-85 -139.98 160.58 39.6 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.65 -171.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 69.5 p -134.59 150.35 50.7 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.849 175.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . 0.552 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 28.0 m-90 -78.01 92.55 4.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.248 0.546 . . . . 0.0 109.761 174.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.467 ' HB3' ' O ' ' A' ' 329' ' ' GLU . 28.5 tptp -68.93 -49.67 56.0 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 170.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 17.0 ttm180 -151.91 125.63 8.99 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.742 175.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . 0.403 ' HB2' ' CG ' ' A' ' 390' ' ' HIS . . . -76.53 157.8 81.95 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-O 119.106 -0.474 . . . . 0.0 110.419 -176.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . 0.866 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 80.3 Cg_exo -37.56 111.76 0.1 Allowed 'Trans proline' 0 C--N 1.363 1.339 0 C-N-CA 123.187 2.592 . . . . 0.0 113.537 -178.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 319' ' ' THR . . . . . 0.518 ' O ' HG21 ' A' ' 327' ' ' VAL . 16.4 m -134.86 138.52 44.25 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.7 -173.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -58.01 126.45 27.5 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.929 0.395 . . . . 0.0 110.075 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 92.4 p -59.44 -44.32 92.96 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.51 -179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 131.58 -13.32 5.37 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.139 176.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . 0.456 ' O ' ' HB2' ' A' ' 324' ' ' ASP . 95.0 m-70 -114.27 20.51 15.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.588 0.233 . . . . 0.0 110.67 -179.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' A' ' 323' ' ' HIS . 10.6 m-20 84.76 43.99 0.02 OUTLIER 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.148 172.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 325' ' ' THR . . . . . 0.476 ' HB ' HG13 ' A' ' 358' ' ' ILE . 5.5 p -151.85 172.68 15.82 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 174.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . 0.661 HG22 ' HZ2' ' A' ' 392' ' ' TRP . 0.2 OUTLIER -123.66 141.89 42.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 119.945 1.248 . . . . 0.0 111.784 -173.04 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 327' ' ' VAL . . . . . 0.832 HG12 ' HG2' ' A' ' 373' ' ' GLU . 17.8 m -120.86 155.55 24.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.676 176.321 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 328' ' ' MET . . . . . 0.52 ' HE3' ' HD3' ' A' ' 318' ' ' PRO . 6.6 ptm -146.54 157.93 43.81 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.815 -1.179 . . . . 0.0 107.815 172.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.545 ' HA ' ' O ' ' A' ' 370' ' ' GLY . 16.2 tt0 -128.42 129.39 46.09 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -175.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.519 ' HB ' ' HD1' ' A' ' 312' ' ' PHE . 7.5 m -129.68 149.67 33.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -175.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -109.13 178.22 20.61 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 175.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . 0.511 ' CD1' ' HA2' ' A' ' 368' ' ' GLY . 0.1 OUTLIER -138.56 158.19 44.72 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 117.939 0.869 . . . . 0.0 113.239 -177.211 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 9.7 t -65.54 -70.92 0.21 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.313 -1.312 . . . . 0.0 112.271 171.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -166.73 -22.68 0.02 OUTLIER Glycine 0 CA--C 1.53 1.022 0 C-N-CA 119.04 -1.552 . . . . 0.0 115.475 -176.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 335' ' ' THR . . . . . 0.582 HG23 HG21 ' A' ' 303' ' ' THR . 29.3 m -51.06 131.22 27.08 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 117.136 0.468 . . . . 0.0 109.781 174.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.758 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 1.3 ptm180 -69.23 177.36 1.22 Allowed Pre-proline 0 CA--C 1.518 -0.285 0 CA-C-O 118.456 -0.783 . . . . 0.0 109.198 -172.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . 0.758 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.2 OUTLIER -28.28 105.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.358 1.064 0 C-N-CA 123.253 2.635 . . . . 0.0 112.864 175.22 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 338' ' ' CYS . . . . . 0.81 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 31.6 p -125.47 155.29 40.74 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.275 -1.33 . . . . 0.0 107.615 -174.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -68.29 116.99 9.5 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.369 171.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . 1.039 HD13 ' HZ ' ' A' ' 312' ' ' PHE . 33.8 mm -79.0 118.87 74.95 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.614 -174.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -75.72 79.87 2.73 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.01 1.806 . . . . 0.0 110.804 176.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.771 HG12 HG23 ' A' ' 340' ' ' ILE . 2.5 m -103.87 118.76 51.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.612 0.72 . . . . 0.0 110.098 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -135.72 177.88 7.48 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 176.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 344' ' ' ALA . . . . . 0.547 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -146.67 146.46 30.38 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.495 178.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 17.3 m -119.48 142.65 33.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.4 115.45 5.12 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.561 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . 0.511 ' O ' HG21 ' A' ' 349' ' ' VAL . 63.8 t60 41.49 68.05 0.49 Allowed 'General case' 0 N--CA 1.471 0.6 0 O-C-N 124.571 1.169 . . . . 0.0 111.593 176.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . 0.564 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 46.01 39.39 8.98 Favored Glycine 0 C--N 1.333 0.39 0 N-CA-C 115.385 0.914 . . . . 0.0 115.385 -177.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . 0.511 HG21 ' O ' ' A' ' 347' ' ' HIS . 59.8 t -138.88 101.8 7.77 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 118.47 1.135 . . . . 0.0 108.53 178.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -75.14 64.47 6.17 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 122.893 2.396 . . . . 0.0 113.104 -178.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -100.72 -55.84 2.48 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 176.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 4.9 p -123.5 130.96 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.634 173.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . 0.471 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 33.1 t30 -66.13 121.16 14.54 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.801 176.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.636 ' HB ' ' HG ' ' A' ' 376' ' ' LEU . 26.6 m -101.01 4.11 10.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.733 -178.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . 0.547 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -72.01 87.36 1.04 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.132 0.492 . . . . 0.0 112.199 -177.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 356' ' ' MET . . . . . 0.573 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 37.0 ttm -97.81 100.54 11.91 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 169.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.65 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 26.4 mt -85.63 122.9 30.39 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.591 -164.748 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.642 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 3.7 mm -61.1 -30.49 47.83 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 CA-C-N 115.313 -0.858 . . . . 0.0 108.943 173.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 18.8 m -135.48 97.13 13.23 Favored Pre-proline 0 N--CA 1.451 -0.393 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.404 175.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -90.79 37.32 0.32 Allowed 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 123.356 2.704 . . . . 0.0 113.706 -174.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -140.2 61.88 18.69 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.202 176.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . 0.712 ' HB3' HG21 ' A' ' 372' ' ' ILE . 93.9 Cg_endo -84.77 143.06 9.37 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.115 1.877 . . . . 0.0 112.016 176.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 18.4 p -142.47 134.05 26.64 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -178.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 364' ' ' MET . . . . . 0.81 ' HG2' ' SG ' ' A' ' 338' ' ' CYS . 16.3 ptt? -95.38 121.51 37.13 Favored 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 176.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . 0.524 ' HG2' ' HG3' ' A' ' 337' ' ' PRO . 37.9 mt-10 -116.75 -167.54 1.31 Allowed 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 113.778 -1.555 . . . . 0.0 109.369 -170.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . 0.431 HD21 ' N ' ' A' ' 367' ' ' ASN . 0.2 OUTLIER -56.68 -6.04 0.28 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -177.69 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 367' ' ' ASN . . . . . 0.431 ' N ' HD21 ' A' ' 366' ' ' ASN . 0.9 OUTLIER -122.3 1.31 9.64 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.591 -0.693 . . . . 0.0 110.781 179.212 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . 0.511 ' HA2' ' CD1' ' A' ' 332' ' ' PHE . . . 112.61 174.92 19.47 Favored Glycine 0 CA--C 1.516 0.119 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -178.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . 0.735 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -51.91 -40.65 50.49 Favored Glycine 0 C--N 1.335 0.489 0 CA-C-N 117.541 0.671 . . . . 0.0 113.627 174.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . 0.545 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 83.24 -127.09 7.82 Favored Glycine 0 N--CA 1.439 -1.141 0 C-N-CA 120.259 -0.972 . . . . 0.0 111.572 -178.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -102.08 139.41 37.74 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.384 0.612 . . . . 0.0 112.017 -173.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 372' ' ' ILE . . . . . 0.712 HG21 ' HB3' ' A' ' 362' ' ' PRO . 0.5 OUTLIER -131.78 155.5 41.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.093 175.751 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . 0.832 ' HG2' HG12 ' A' ' 327' ' ' VAL . 40.8 mt-10 -133.37 128.39 35.52 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.467 -178.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 374' ' ' MET . . . . . 0.687 ' HE1' ' HB ' ' A' ' 372' ' ' ILE . 0.1 OUTLIER -147.72 165.84 29.26 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.392 -173.937 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 375' ' ' GLN . . . . . 1.022 HE22 ' HG2' ' A' ' 394' ' ' GLN . 0.0 OUTLIER 179.55 175.08 0.76 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 175.874 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 376' ' ' LEU . . . . . 0.7 HD21 ' HD2' ' A' ' 377' ' ' PRO . 2.1 tm? -166.69 143.13 3.89 Favored Pre-proline 0 N--CA 1.445 -0.691 0 N-CA-C 104.373 -2.455 . . . . 0.0 104.373 -176.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 377' ' ' PRO . . . . . 0.7 ' HD2' HD21 ' A' ' 376' ' ' LEU . 46.5 Cg_exo -36.53 134.27 0.33 Allowed 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.569 2.179 . . . . 0.0 112.638 174.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.767 ' HA ' HE22 ' A' ' 394' ' ' GLN . 57.1 Cg_exo -33.86 135.82 0.11 Allowed 'Trans proline' 0 C--N 1.365 1.404 0 C-N-CA 124.875 3.717 . . . . 0.0 114.205 -172.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 153.15 -168.71 31.98 Favored Glycine 0 N--CA 1.441 -1.01 0 N-CA-C 110.256 -1.137 . . . . 0.0 110.256 -166.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.88 130.85 48.45 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 117.103 0.451 . . . . 0.0 110.701 179.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 -136.5 169.97 16.82 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 1.105 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -157.22 143.97 9.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 173.008 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . 0.808 HD11 ' HG3' ' A' ' 318' ' ' PRO . 21.2 mt -100.22 132.89 44.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.558 -176.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 384' ' ' TYR . . . . . 0.536 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 14.6 m-85 -104.71 97.48 7.37 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.183 169.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . 0.517 HG22 HG12 ' A' ' 330' ' ' VAL . 9.7 t -83.84 82.9 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 173.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 63.59 -109.05 2.5 Favored Glycine 0 N--CA 1.434 -1.493 0 C-N-CA 120.39 -0.91 . . . . 0.0 111.223 -166.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 387' ' ' ASP . . . . . 0.488 ' N ' ' HB2' ' A' ' 309' ' ' LYS . 6.9 t70 -93.5 -11.48 31.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.624 0.25 . . . . 0.0 110.894 177.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . 0.552 ' HG ' ' CE2' ' A' ' 314' ' ' TRP . 1.0 OUTLIER -69.07 151.17 46.78 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 174.981 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . 0.547 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 8.2 p30 -156.63 152.38 27.1 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 121.061 -0.256 . . . . 0.0 110.476 -178.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . 0.866 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 4.9 t-80 -174.11 116.39 0.22 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.485 171.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 391' ' ' GLN . . . . . 1.105 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 14.6 tt0 -79.53 154.72 28.61 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.44 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 392' ' ' TRP . . . . . 0.661 ' HZ2' HG22 ' A' ' 326' ' ' VAL . 0.6 OUTLIER -163.8 152.36 13.55 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 114.955 -1.02 . . . . 0.0 108.282 179.691 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -110.52 125.58 53.48 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . 1.022 ' HG2' HE22 ' A' ' 375' ' ' GLN . 0.0 OUTLIER -104.46 119.99 40.23 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 -178.355 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? . . . . . 0 C--N 1.315 -0.926 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.118 -168.521 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 303' ' ' THR . . . . . 0.49 ' O ' HG23 ' A' ' 335' ' ' THR . 5.3 t . . . . . 0 CA--C 1.538 0.489 0 CA-C-O 121.394 0.616 . . . . 0.0 111.198 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . 0.54 ' HB3' ' NE ' ' A' ' 336' ' ' ARG . 0.9 OUTLIER -69.37 132.85 47.04 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 121.727 -0.608 . . . . 0.0 109.421 174.383 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 305' ' ' THR . . . . . 0.523 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 12.9 t 172.38 -169.24 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -177.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 38.6 t -64.16 110.97 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 170.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -69.22 140.69 54.55 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 -171.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . 0.603 ' OD1' HG21 ' A' ' 310' ' ' THR . 11.2 t70 -61.89 131.06 48.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.452 0.644 . . . . 0.0 111.376 -171.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.486 ' HA ' ' HA3' ' A' ' 386' ' ' GLY . 23.4 pttm -37.95 -38.13 0.29 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 113.245 -1.798 . . . . 0.0 114.523 -178.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.603 HG21 ' OD1' ' A' ' 308' ' ' ASP . 13.9 t -98.9 -8.32 25.81 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.067 0.461 . . . . 0.0 111.574 -166.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.485 ' HZ3' ' CB ' ' A' ' 335' ' ' THR . 6.3 mtpm? -74.71 -22.16 58.99 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.319 -175.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.701 ' HD2' ' HB ' ' A' ' 330' ' ' VAL . 49.3 m-85 -70.85 169.26 15.06 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-O 121.934 0.874 . . . . 0.0 112.915 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 313' ' ' THR . . . . . 0.439 HG21 ' O ' ' A' ' 331' ' ' GLY . 11.6 t -151.64 153.25 34.08 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.46 169.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 20.1 m95 -78.11 96.77 5.23 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.143 0.496 . . . . 0.0 111.487 -177.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.587 ' HD3' ' HB3' ' A' ' 329' ' ' GLU . 50.9 tttp -65.94 -46.93 76.38 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 168.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.759 ' HB3' ' HB2' ' A' ' 329' ' ' GLU . 70.9 ttt180 -153.35 97.29 2.14 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.09 175.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -44.68 154.88 0.4 Allowed Pre-proline 0 N--CA 1.476 0.845 0 C-N-CA 123.634 0.774 . . . . 0.0 112.583 175.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . 0.515 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 3.2 Cg_exo -38.67 112.27 0.13 Allowed 'Trans proline' 0 C--N 1.367 1.516 0 C-N-CA 123.676 2.917 . . . . 0.0 113.626 -174.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 319' ' ' THR . . . . . 0.447 ' O ' HG21 ' A' ' 327' ' ' VAL . 32.8 m -127.19 132.44 50.48 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.548 -1.206 . . . . 0.0 109.655 -177.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -59.45 118.45 6.03 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 88.9 p -52.41 -55.68 20.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.536 0.684 . . . . 0.0 111.038 -168.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 136.4 -18.17 3.71 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 109.266 -1.533 . . . . 0.0 109.266 -175.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -104.61 43.58 1.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.714 -0.743 . . . . 0.0 109.217 178.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 49.72 49.2 20.49 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.411 -177.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 1.7 p -155.89 -168.38 2.76 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . 0.568 ' HB ' ' HG3' ' A' ' 374' ' ' MET . 0.3 OUTLIER -127.19 145.48 34.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 118.89 0.768 . . . . 0.0 111.653 -179.627 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 327' ' ' VAL . . . . . 0.48 HG12 ' HG3' ' A' ' 373' ' ' GLU . 11.5 m -119.45 152.43 21.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.846 170.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 328' ' ' MET . . . . . 0.606 ' HE3' ' HB3' ' A' ' 374' ' ' MET . 0.0 OUTLIER -140.09 142.86 36.06 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 175.989 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.759 ' HB2' ' HB3' ' A' ' 316' ' ' ARG . 6.4 mt-10 -122.48 128.55 50.98 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.12 0.486 . . . . 0.0 109.954 179.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.701 ' HB ' ' HD2' ' A' ' 312' ' ' PHE . 0.9 OUTLIER -130.05 146.07 34.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.906 -175.825 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . 0.439 ' O ' HG21 ' A' ' 313' ' ' THR . . . -125.6 140.73 12.43 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.043 -178.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . 0.764 ' CD1' ' HA2' ' A' ' 368' ' ' GLY . 0.4 OUTLIER -111.45 176.64 4.94 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -178.246 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 333' ' ' SER . . . . . 0.432 ' OG ' ' HE2' ' A' ' 311' ' ' LYS . 4.7 p -100.98 -66.66 0.9 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 114.161 -1.381 . . . . 0.0 113.351 172.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -122.05 -43.68 0.39 Allowed Glycine 0 CA--C 1.535 1.315 0 N-CA-C 116.511 1.364 . . . . 0.0 116.511 -167.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 335' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 303' ' ' THR . 33.9 m -52.4 123.04 9.91 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 117.374 0.587 . . . . 0.0 111.404 -176.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.845 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 12.5 ptt180 -75.2 -176.27 0.54 Allowed Pre-proline 0 CA--C 1.529 0.137 0 CA-C-O 117.726 -1.13 . . . . 0.0 109.018 -176.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . 0.845 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -27.27 98.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.371 1.745 0 C-N-CA 123.549 2.833 . . . . 0.0 113.253 177.197 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 338' ' ' CYS . . . . . 0.687 ' SG ' ' HE2' ' A' ' 364' ' ' MET . 14.9 p -114.89 -175.63 2.73 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 113.787 -1.551 . . . . 0.0 110.336 -168.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -108.64 101.51 10.65 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 178.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . 0.731 HG23 HG21 ' A' ' 342' ' ' VAL . 39.3 mt -72.37 118.05 64.15 Favored Pre-proline 0 C--O 1.236 0.362 0 C-N-CA 120.328 -0.549 . . . . 0.0 111.253 -169.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -79.88 78.11 3.82 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 122.21 1.94 . . . . 0.0 111.065 176.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.89 HG11 HG11 ' A' ' 385' ' ' VAL . 0.0 OUTLIER -103.77 115.82 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.235 174.642 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.435 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 37.5 ptt180 -129.46 174.28 9.79 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 177.013 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 344' ' ' ALA . . . . . 0.575 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -146.89 145.44 29.83 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.441 177.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 13.3 m -117.35 145.39 23.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.25 115.25 4.85 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.592 175.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . 0.659 ' HB3' ' CB ' ' A' ' 380' ' ' ASP . 11.6 p80 32.47 74.46 0.05 Allowed 'General case' 0 N--CA 1.476 0.861 0 O-C-N 124.745 1.278 . . . . 0.0 113.159 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . 0.818 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 47.51 41.46 17.96 Favored Glycine 0 C--N 1.331 0.301 0 N-CA-C 115.396 0.918 . . . . 0.0 115.396 -178.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 58.6 t -142.8 102.12 5.37 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 118.396 1.098 . . . . 0.0 108.181 176.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -78.02 53.64 4.54 Favored 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 123.072 2.514 . . . . 0.0 113.248 -176.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -102.73 -4.89 24.36 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 122.009 0.909 . . . . 0.0 108.996 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 2.4 p -170.09 104.96 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.668 -164.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . 0.501 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 56.5 t30 -64.12 108.92 1.67 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.994 177.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.509 ' HB ' ' HG ' ' A' ' 376' ' ' LEU . 28.0 m -91.6 3.75 7.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.995 179.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . 0.575 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -79.0 84.25 5.03 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.402 0.62 . . . . 0.0 111.275 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 3.0 tmm? -96.04 103.26 15.14 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 170.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.518 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 27.7 mt -86.65 115.28 24.01 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.881 -163.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.693 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 3.4 mm -58.57 -24.91 26.67 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.05 177.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 29.9 m -134.03 90.76 25.62 Favored Pre-proline 0 N--CA 1.445 -0.694 0 CA-C-N 114.446 -1.252 . . . . 0.0 108.37 173.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -84.19 34.58 0.52 Allowed 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 123.094 2.529 . . . . 0.0 113.151 -172.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -140.01 61.75 19.03 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.205 178.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . 0.854 ' HB3' HG21 ' A' ' 372' ' ' ILE . 41.5 Cg_endo -80.92 137.46 11.03 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.299 1.999 . . . . 0.0 111.83 178.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.87 141.37 30.27 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.015 -173.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 364' ' ' MET . . . . . 0.765 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 30.3 mtm -97.04 125.09 41.23 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 176.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -117.38 -167.42 1.31 Allowed 'General case' 0 C--N 1.313 -0.996 0 O-C-N 124.705 1.253 . . . . 0.0 108.889 177.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . 0.506 HD21 ' N ' ' A' ' 366' ' ' ASN . 0.1 OUTLIER -46.27 -32.81 3.3 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 -176.162 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -100.48 3.63 43.08 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 121.72 -0.613 . . . . 0.0 111.392 -176.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . 0.764 ' HA2' ' CD1' ' A' ' 332' ' ' PHE . . . 113.44 -179.48 18.96 Favored Glycine 0 N--CA 1.451 -0.341 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -179.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . 0.627 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -50.26 -37.69 31.84 Favored Glycine 0 CA--C 1.505 -0.562 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.869 171.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . 0.555 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 78.88 -128.1 8.41 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 120.302 -0.952 . . . . 0.0 111.318 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -103.47 141.39 36.06 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.355 0.598 . . . . 0.0 111.984 -175.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 372' ' ' ILE . . . . . 0.854 HG21 ' HB3' ' A' ' 362' ' ' PRO . 0.5 OUTLIER -136.81 159.73 37.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.35 175.803 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . 0.693 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 2.5 mp0 -125.54 128.52 48.09 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.187 0.518 . . . . 0.0 110.913 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 374' ' ' MET . . . . . 0.606 ' HB3' ' HE3' ' A' ' 328' ' ' MET . 1.9 ptm -130.45 167.49 18.53 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.946 -1.025 . . . . 0.0 108.475 179.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 375' ' ' GLN . . . . . 0.73 HE21 ' H ' ' A' ' 376' ' ' LEU . 13.2 tp60 -179.67 171.67 1.18 Allowed 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 164.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 376' ' ' LEU . . . . . 0.838 HD23 ' HD2' ' A' ' 377' ' ' PRO . 2.5 tm? -165.89 137.64 3.12 Favored Pre-proline 0 C--N 1.311 -1.097 0 N-CA-C 104.015 -2.587 . . . . 0.0 104.015 -178.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 377' ' ' PRO . . . . . 0.838 ' HD2' HD23 ' A' ' 376' ' ' LEU . 31.0 Cg_exo -26.92 119.6 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.544 2.829 . . . . 0.0 112.495 177.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -37.09 139.02 0.22 Allowed 'Trans proline' 0 C--N 1.359 1.122 0 C-N-CA 124.286 3.324 . . . . 0.0 113.071 -169.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 153.66 -164.55 31.21 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -157.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . 0.659 ' CB ' ' HB3' ' A' ' 347' ' ' HIS . 8.8 m-20 -96.59 121.63 38.63 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 118.103 0.951 . . . . 0.0 110.741 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -125.95 163.8 22.2 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 0.999 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -156.94 139.62 6.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 171.685 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . 0.671 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 40.9 mt -98.65 129.85 48.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.092 -174.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 384' ' ' TYR . . . . . 0.667 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.9 OUTLIER -108.89 92.63 4.13 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.437 -1.256 . . . . 0.0 109.207 172.862 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . 0.89 HG11 HG11 ' A' ' 342' ' ' VAL . 3.5 t -85.47 85.52 2.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 176.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . 0.486 ' HA3' ' HA ' ' A' ' 309' ' ' LYS . . . 66.17 -112.38 4.88 Favored Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 120.356 -0.926 . . . . 0.0 110.919 -168.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -85.94 -17.04 36.53 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.867 0.365 . . . . 0.0 110.93 175.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . 0.667 ' O ' ' HA ' ' A' ' 384' ' ' TYR . 1.3 mp -65.33 147.07 54.08 Favored 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . 0.671 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 8.2 p30 -159.7 151.02 19.74 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.714 -0.221 . . . . 0.0 110.745 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . 0.515 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 11.5 t-80 -172.95 115.65 0.28 Allowed 'General case' 0 C--N 1.328 -0.353 0 O-C-N 123.517 0.511 . . . . 0.0 110.119 176.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 391' ' ' GLN . . . . . 0.999 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 0.8 OUTLIER -83.0 154.22 24.58 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.249 0.547 . . . . 0.0 111.76 -177.637 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 392' ' ' TRP . . . . . 0.432 ' HD1' ' CD ' ' A' ' 394' ' ' GLN . 23.8 t-105 -169.93 150.5 3.87 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.891 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . 0.507 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 9.1 p90 -104.83 109.67 21.73 Favored 'General case' 0 C--N 1.317 -0.843 0 O-C-N 121.411 -0.805 . . . . 0.0 108.863 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . 0.647 ' HG3' HE22 ' A' ' 375' ' ' GLN . 4.0 mm100 -78.47 123.53 27.15 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -165.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt . . . . . 0 C--O 1.249 1.028 0 CA-C-O 117.918 -1.039 . . . . 0.0 110.802 -179.384 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 303' ' ' THR . . . . . 0.402 HG21 ' O ' ' A' ' 303' ' ' THR . 9.1 t . . . . . 0 CA--C 1.536 0.428 0 CA-C-O 121.266 0.555 . . . . 0.0 111.914 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . 0.492 ' HB2' ' O ' ' A' ' 337' ' ' PRO . 5.5 p90 -65.06 131.17 45.85 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 174.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 305' ' ' THR . . . . . 0.572 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 12.0 t 175.57 -167.98 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -170.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 8.4 t -75.67 105.64 4.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 168.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . 0.473 ' HB3' HG22 ' A' ' 335' ' ' THR . 0.1 OUTLIER -70.49 156.35 39.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.918 0.866 . . . . 0.0 113.315 -167.206 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . 0.573 ' OD2' HG21 ' A' ' 310' ' ' THR . 26.2 t70 -70.07 130.35 41.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.046 -1.433 . . . . 0.0 111.801 -175.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -38.76 -28.78 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 115.982 1.845 . . . . 0.0 115.982 -174.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 310' ' ' THR . . . . . 0.573 HG21 ' OD2' ' A' ' 308' ' ' ASP . 12.7 t -108.19 0.75 21.67 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 119.323 0.965 . . . . 0.0 112.283 -169.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.426 ' HE3' ' HB3' ' A' ' 311' ' ' LYS . 27.7 mtpp -88.46 43.26 1.12 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -171.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . 0.411 ' HA ' ' O ' ' A' ' 331' ' ' GLY . 0.0 OUTLIER -152.48 177.89 10.14 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.655 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 8.9 t -152.89 160.48 43.06 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.191 177.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -64.33 125.35 24.31 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.456 ' HB3' ' C ' ' A' ' 329' ' ' GLU . 19.9 ttmm -104.43 -45.58 4.62 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 170.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 45.7 ttm105 -149.78 125.65 10.5 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 114.737 -1.119 . . . . 0.0 109.078 170.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . 0.489 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -71.53 161.39 78.74 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-O 119.202 -0.428 . . . . 0.0 110.048 -179.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . 0.658 ' HD3' ' HE3' ' A' ' 328' ' ' MET . 3.5 Cg_exo -44.5 113.21 0.42 Allowed 'Trans proline' 0 C--N 1.358 1.058 0 C-N-CA 122.384 2.056 . . . . 0.0 112.548 -177.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 319' ' ' THR . . . . . 0.633 ' O ' HG21 ' A' ' 327' ' ' VAL . 19.6 m -129.42 138.63 51.58 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.695 -174.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -59.22 127.82 34.05 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.731 0.3 . . . . 0.0 110.706 175.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 67.3 p -79.14 6.01 10.67 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.551 0.74 . . . . 0.0 111.973 -174.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 84.86 -20.76 13.64 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.4 -0.905 . . . . 0.0 113.559 -172.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 86.8 t60 -98.01 7.03 46.97 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 117.388 0.594 . . . . 0.0 110.751 -177.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 36.2 t70 71.85 53.49 0.2 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 122.582 1.182 . . . . 0.0 108.806 -176.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 325' ' ' THR . . . . . 0.834 ' HA ' ' HG3' ' A' ' 375' ' ' GLN . 5.0 p -155.82 161.98 40.54 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . 0.552 HG23 ' HG2' ' A' ' 375' ' ' GLN . 0.2 OUTLIER -110.71 138.48 38.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 119.628 1.104 . . . . 0.0 111.807 -173.552 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 327' ' ' VAL . . . . . 0.649 HG12 ' HG2' ' A' ' 373' ' ' GLU . 15.8 m -114.78 161.08 13.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.736 173.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 328' ' ' MET . . . . . 0.658 ' HE3' ' HD3' ' A' ' 318' ' ' PRO . 0.0 OUTLIER -149.31 152.06 35.23 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 178.272 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.456 ' C ' ' HB3' ' A' ' 315' ' ' LYS . 9.9 tt0 -137.02 135.88 37.96 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -176.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.628 HG21 ' HA3' ' A' ' 369' ' ' GLY . 1.7 m -133.64 161.12 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -176.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . 0.733 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -127.49 134.14 8.17 Favored Glycine 0 CA--C 1.522 0.529 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.03 176.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . 0.411 ' HB3' ' SD ' ' A' ' 364' ' ' MET . 0.1 OUTLIER -90.34 160.47 16.1 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -174.84 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 11.4 p -101.1 4.42 42.15 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.43 -1.259 . . . . 0.0 114.297 173.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 166.55 -46.57 0.26 Allowed Glycine 0 CA--C 1.525 0.679 0 C-N-CA 118.292 -1.909 . . . . 0.0 115.764 173.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 335' ' ' THR . . . . . 0.652 ' HB ' ' CE ' ' A' ' 364' ' ' MET . 41.0 m -54.74 122.54 10.93 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.584 0.192 . . . . 0.0 110.527 -178.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.804 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 16.5 ptt180 -79.2 179.54 1.76 Allowed Pre-proline 0 C--O 1.227 -0.121 0 CA-C-O 117.417 -1.277 . . . . 0.0 108.336 -175.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . 0.804 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.9 OUTLIER -26.12 100.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.37 1.703 0 C-N-CA 123.578 2.852 . . . . 0.0 113.695 -175.143 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 338' ' ' CYS . . . . . 0.895 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 32.1 p -132.32 153.36 50.8 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.256 -170.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 -67.96 114.1 6.22 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.863 173.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . 0.612 HD13 ' HB2' ' A' ' 362' ' ' PRO . 28.9 pt -93.64 119.16 67.41 Favored Pre-proline 0 C--N 1.321 -0.666 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.196 -177.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.68 82.67 0.72 Allowed 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.787 2.325 . . . . 0.0 111.943 -178.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.673 HG11 HD11 ' A' ' 372' ' ' ILE . 34.5 m -102.59 124.71 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-O 122.135 0.969 . . . . 0.0 110.645 -178.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.456 ' HG3' ' HB2' ' A' ' 384' ' ' TYR . 30.0 ptt180 -137.28 178.76 6.84 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 114.527 -1.215 . . . . 0.0 107.961 177.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 344' ' ' ALA . . . . . 0.557 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -149.12 146.21 27.58 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.815 174.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 13.0 m -120.16 147.8 23.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -71.27 119.86 16.02 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 178.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . 0.641 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 3.8 t60 46.79 62.07 2.52 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 124.284 0.99 . . . . 0.0 111.377 174.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . 0.702 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 42.14 44.61 4.87 Favored Glycine 0 C--N 1.332 0.357 0 N-CA-C 114.564 0.586 . . . . 0.0 114.564 -173.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . 0.569 HG21 ' O ' ' A' ' 347' ' ' HIS . 96.8 t -141.57 102.32 5.98 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -73.02 67.35 4.08 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.767 2.311 . . . . 0.0 112.5 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -100.51 -57.19 2.16 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 5.4 p -124.57 132.76 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.574 171.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . 0.452 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 50.6 t30 -61.83 109.71 1.32 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.13 175.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.414 ' O ' ' HB2' ' A' ' 376' ' ' LEU . 20.6 m -86.36 3.82 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.091 178.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . 0.557 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -79.98 82.22 6.1 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.104 -0.639 . . . . 0.0 110.999 178.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.67 99.16 10.79 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 169.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.667 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 34.6 mt -80.16 139.25 36.88 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.261 -0.882 . . . . 0.0 111.488 -159.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.893 HD12 ' HB2' ' A' ' 375' ' ' GLN . 3.0 mm -80.53 -21.85 11.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 3.4 m -139.55 94.83 9.21 Favored Pre-proline 0 N--CA 1.448 -0.567 0 CA-C-N 113.578 -1.646 . . . . 0.0 108.185 171.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 360' ' ' PRO . . . . . 0.411 ' HA ' HD12 ' A' ' 357' ' ' LEU . 1.3 Cg_endo -83.74 35.75 0.57 Allowed 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 123.494 2.796 . . . . 0.0 113.263 -173.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -141.72 60.04 10.74 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.714 176.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . 0.845 ' HB3' HG21 ' A' ' 372' ' ' ILE . 66.0 Cg_endo -79.47 145.74 18.85 Favored 'Trans proline' 0 C--O 1.241 0.656 0 C-N-CA 122.564 2.176 . . . . 0.0 112.618 -176.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 363' ' ' THR . . . . . 0.448 ' O ' ' HA2' ' A' ' 369' ' ' GLY . 0.8 OUTLIER -144.72 168.31 20.5 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.598 -174.421 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 364' ' ' MET . . . . . 0.895 ' HG2' ' SG ' ' A' ' 338' ' ' CYS . 13.7 ptt? -132.16 129.63 40.07 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.4 172.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -113.08 -164.99 0.95 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.216 -1.357 . . . . 0.0 110.929 -167.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . 0.429 HD21 ' N ' ' A' ' 366' ' ' ASN . 0.1 OUTLIER -56.55 -5.59 0.23 Allowed 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 178.355 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -125.29 2.83 7.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.462 0.648 . . . . 0.0 110.603 177.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . 0.733 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . 104.02 -174.81 22.66 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 -176.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . 0.628 ' HA3' HG21 ' A' ' 330' ' ' VAL . . . -64.82 107.59 1.94 Allowed Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 172.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -75.77 -29.54 59.18 Favored Glycine 0 C--N 1.312 -0.799 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.609 -169.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -166.27 143.51 5.21 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.057 0.456 . . . . 0.0 111.249 175.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 372' ' ' ILE . . . . . 0.845 HG21 ' HB3' ' A' ' 362' ' ' PRO . 1.1 mt -135.15 150.22 29.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.002 170.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . 0.698 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 43.3 mt-10 -130.8 127.7 39.22 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.226 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 374' ' ' MET . . . . . 0.755 ' HE2' ' HB ' ' A' ' 372' ' ' ILE . 0.2 OUTLIER -141.73 160.27 40.52 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.219 -175.215 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 375' ' ' GLN . . . . . 0.893 ' HB2' HD12 ' A' ' 358' ' ' ILE . 0.0 OUTLIER -175.23 173.7 2.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.283 0.563 . . . . 0.0 111.653 172.717 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 376' ' ' LEU . . . . . 0.712 HD23 ' HD2' ' A' ' 377' ' ' PRO . 1.8 tm? -168.57 138.81 2.0 Allowed Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 105.11 -2.181 . . . . 0.0 105.11 -178.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 377' ' ' PRO . . . . . 0.712 ' HD2' HD23 ' A' ' 376' ' ' LEU . 51.9 Cg_exo -34.3 135.22 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.951 2.434 . . . . 0.0 112.528 174.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . 0.787 ' HA ' HE22 ' A' ' 394' ' ' GLN . 3.0 Cg_exo -35.59 138.61 0.14 Allowed 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 125.162 3.908 . . . . 0.0 113.63 -171.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 155.46 -160.98 30.25 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 -162.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . 0.641 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 21.8 m-20 -105.14 128.28 53.3 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 118.252 1.026 . . . . 0.0 110.527 174.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.55 HD21 ' C ' ' A' ' 380' ' ' ASP . 0.9 OUTLIER -126.32 138.48 53.59 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.226 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 1.085 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -141.12 135.25 32.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 177.9 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . 0.643 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 20.9 mt -98.9 132.31 44.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 C-N-CA 119.786 -0.766 . . . . 0.0 110.281 -171.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 384' ' ' TYR . . . . . 0.456 ' HB2' ' HG3' ' A' ' 343' ' ' ARG . 5.7 m-85 -102.76 131.15 49.81 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 168.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . 0.56 HG11 HG13 ' A' ' 342' ' ' VAL . 12.6 t -119.71 84.67 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 178.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 59.1 -109.13 1.91 Allowed Glycine 0 N--CA 1.434 -1.468 0 C-N-CA 120.363 -0.922 . . . . 0.0 111.002 -164.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -84.9 -20.27 31.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.566 0.183 . . . . 0.0 111.487 176.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . 0.451 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 0.7 OUTLIER -67.0 154.99 39.81 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.71 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . 0.643 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 7.9 p30 -164.96 160.31 19.0 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.231 175.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . 0.415 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 26.6 t60 -173.65 117.17 0.26 Allowed 'General case' 0 C--O 1.238 0.487 0 O-C-N 123.51 0.506 . . . . 0.0 110.285 173.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 391' ' ' GLN . . . . . 1.085 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 2.5 mt-30 -65.28 146.08 55.39 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 392' ' ' TRP . . . . . . . . . . . . . 50.4 t-105 -149.72 147.83 28.52 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.894 176.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -110.91 115.6 29.78 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 173.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . 0.787 HE22 ' HA ' ' A' ' 378' ' ' PRO . 0.0 OUTLIER -100.45 126.53 46.86 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 121.699 -0.626 . . . . 0.0 109.656 -176.78 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm . . . . . 0 C--N 1.313 -1.017 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.855 -179.37 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 303' ' ' THR . . . . . 0.505 ' O ' HG21 ' A' ' 305' ' ' THR . 10.3 t . . . . . 0 CA--C 1.533 0.31 0 CA-C-O 121.029 0.442 . . . . 0.0 111.744 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 304' ' ' TYR . . . . . 0.419 ' HB3' ' HG2' ' A' ' 336' ' ' ARG . 31.4 p90 -63.28 129.84 41.99 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 120.903 0.382 . . . . 0.0 110.412 -175.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 305' ' ' THR . . . . . 0.505 HG21 ' O ' ' A' ' 303' ' ' THR . 12.4 t 171.88 -166.88 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -167.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 42.2 t -63.91 112.36 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 170.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 307' ' ' CYS . . . . . 0.441 ' HB2' ' CE2' ' A' ' 332' ' ' PHE . 0.0 OUTLIER -67.99 147.05 52.95 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.13 0.491 . . . . 0.0 111.63 -170.07 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -57.07 109.17 0.61 Allowed 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.014 176.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 309' ' ' LYS . . . . . 0.489 ' HB2' ' N ' ' A' ' 387' ' ' ASP . 26.8 pttt -41.47 -27.12 0.08 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 113.892 -1.504 . . . . 0.0 114.716 -175.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 10.0 t -102.87 17.92 22.8 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.616 0.722 . . . . 0.0 110.428 -170.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 311' ' ' LYS . . . . . 0.609 ' HB2' ' CE2' ' A' ' 332' ' ' PHE . 25.2 mtpp -98.72 -14.39 19.8 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.406 178.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 312' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -75.05 162.32 28.66 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.11 177.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 313' ' ' THR . . . . . 0.412 HG21 ' O ' ' A' ' 331' ' ' GLY . 8.9 t -141.67 154.9 45.64 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.038 176.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 7.8 m-90 -75.65 92.6 2.97 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 315' ' ' LYS . . . . . 0.513 ' HB3' ' O ' ' A' ' 329' ' ' GLU . 24.0 tptm -73.74 -56.51 4.89 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 171.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.407 ' NH2' HG22 ' A' ' 319' ' ' THR . 58.2 ttt180 -147.11 125.3 12.17 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . 0.449 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . . . -68.69 160.07 78.86 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 119.136 -0.459 . . . . 0.0 109.956 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . 0.449 ' HD2' ' HB3' ' A' ' 317' ' ' ALA . 3.9 Cg_exo -41.87 115.78 0.48 Allowed 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 122.823 2.348 . . . . 0.0 112.091 -178.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 319' ' ' THR . . . . . 0.407 HG22 ' NH2' ' A' ' 316' ' ' ARG . 21.5 m -128.68 132.96 48.08 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.246 -174.107 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -62.99 114.86 3.93 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -177.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 69.9 p -55.81 -46.34 78.06 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 123.543 0.527 . . . . 0.0 110.711 -163.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 126.67 -16.2 6.58 Favored Glycine 0 N--CA 1.442 -0.938 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 -179.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -110.62 52.24 0.74 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 57.88 36.29 26.17 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.646 178.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 325' ' ' THR . . . . . 0.469 ' HB ' HG13 ' A' ' 358' ' ' ILE . 3.1 p -157.13 -167.78 2.43 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -178.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 326' ' ' VAL . . . . . 1.012 HG23 ' HG2' ' A' ' 375' ' ' GLN . 3.6 t -131.83 148.45 32.37 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-O 121.318 0.58 . . . . 0.0 112.028 -178.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 327' ' ' VAL . . . . . 0.546 HG12 ' HG2' ' A' ' 373' ' ' GLU . 15.6 m -128.23 151.22 34.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.478 174.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 328' ' ' MET . . . . . 0.401 ' HE2' ' HB2' ' A' ' 328' ' ' MET . 0.6 OUTLIER -137.34 154.86 49.96 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 169.489 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.575 ' HG3' ' O ' ' A' ' 370' ' ' GLY . 14.0 tt0 -123.75 129.44 51.07 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 120.214 -0.594 . . . . 0.0 109.627 -177.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 330' ' ' VAL . . . . . 0.514 HG12 HG13 ' A' ' 385' ' ' VAL . 3.6 m -124.38 145.05 32.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.115 -178.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 331' ' ' GLY . . . . . 0.412 ' O ' HG21 ' A' ' 313' ' ' THR . . . -112.95 133.2 11.17 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 119.963 -1.113 . . . . 0.0 111.964 179.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 332' ' ' PHE . . . . . 0.616 ' CZ ' ' HB ' ' A' ' 335' ' ' THR . 2.6 t80 -141.25 143.14 33.97 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 30.7 p -147.34 49.26 1.1 Allowed 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -171.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -145.48 -80.99 0.04 OUTLIER Glycine 0 C--O 1.23 -0.135 0 C-N-CA 119.78 -1.2 . . . . 0.0 112.03 167.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 335' ' ' THR . . . . . 0.616 ' HB ' ' CZ ' ' A' ' 332' ' ' PHE . 56.1 m -50.82 126.71 16.61 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 172.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 336' ' ' ARG . . . . . 0.57 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 0.0 OUTLIER -81.6 -177.84 1.04 Allowed Pre-proline 0 CA--C 1.533 0.324 0 CA-C-O 117.183 -1.389 . . . . 0.0 107.948 -172.19 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 337' ' ' PRO . . . . . 0.944 ' HA ' ' O ' ' A' ' 364' ' ' MET . 6.6 Cg_exo -23.39 101.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 123.91 3.073 . . . . 0.0 114.197 -172.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 338' ' ' CYS . . . . . 0.54 ' O ' HG21 ' A' ' 363' ' ' THR . 13.6 p -116.39 -176.85 3.04 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 113.898 -1.501 . . . . 0.0 111.38 -165.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -111.0 101.11 9.69 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.391 -1.336 . . . . 0.0 107.391 -178.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 340' ' ' ILE . . . . . 0.826 HG23 HG12 ' A' ' 342' ' ' VAL . 22.4 mt -76.32 117.28 63.16 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.464 -170.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -82.44 82.12 2.32 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.875 2.383 . . . . 0.0 112.235 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 342' ' ' VAL . . . . . 0.826 HG12 HG23 ' A' ' 340' ' ' ILE . 16.4 m -102.16 159.36 4.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.225 0.536 . . . . 0.0 110.2 179.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 343' ' ' ARG . . . . . 0.42 ' CG ' ' HB2' ' A' ' 384' ' ' TYR . 15.7 ptt-85 -169.3 175.63 5.51 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 179.623 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 344' ' ' ALA . . . . . 0.61 ' N ' ' HB3' ' A' ' 355' ' ' ALA . . . -150.06 149.78 30.79 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.55 178.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 345' ' ' VAL . . . . . 0.463 ' HB ' ' HA ' ' A' ' 350' ' ' PRO . 5.1 m -121.84 147.97 25.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 175.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -67.17 120.97 14.62 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 176.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 347' ' ' HIS . . . . . 0.605 ' HB2' ' CB ' ' A' ' 380' ' ' ASP . 22.7 t60 38.46 69.86 0.24 Allowed 'General case' 0 N--CA 1.479 0.988 0 O-C-N 124.427 1.079 . . . . 0.0 112.435 175.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . 0.902 ' H ' HG23 ' A' ' 382' ' ' ILE . . . 44.45 37.41 4.82 Favored Glycine 0 CA--C 1.52 0.378 0 N-CA-C 115.175 0.83 . . . . 0.0 115.175 -177.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 349' ' ' VAL . . . . . 0.551 HG21 ' O ' ' A' ' 347' ' ' HIS . 60.7 t -139.94 102.25 6.97 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 118.257 1.029 . . . . 0.0 108.566 178.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 350' ' ' PRO . . . . . 0.463 ' HA ' ' HB ' ' A' ' 345' ' ' VAL . 19.2 Cg_exo -71.1 67.36 2.54 Favored 'Trans proline' 0 N--CA 1.465 -0.181 0 C-N-CA 122.801 2.334 . . . . 0.0 112.676 177.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -100.62 -56.87 2.23 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 174.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.7 132.93 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 115.166 -0.924 . . . . 0.0 110.886 173.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 353' ' ' ASN . . . . . 0.599 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 31.6 t30 -63.15 111.11 2.08 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.588 173.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 354' ' ' VAL . . . . . 0.553 HG12 HD23 ' A' ' 376' ' ' LEU . 30.0 m -90.62 4.2 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.317 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 355' ' ' ALA . . . . . 0.61 ' HB3' ' N ' ' A' ' 344' ' ' ALA . . . -76.81 82.47 3.4 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.238 0.542 . . . . 0.0 111.094 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 356' ' ' MET . . . . . 0.608 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 21.5 ttt -95.97 99.57 11.33 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 170.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 357' ' ' LEU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 47.2 mt -88.84 123.06 32.87 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.709 -161.159 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 358' ' ' ILE . . . . . 0.738 HD12 ' HB2' ' A' ' 375' ' ' GLN . 1.5 mm -67.83 -25.38 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 171.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 54.1 m -122.88 86.07 50.34 Favored Pre-proline 0 N--CA 1.451 -0.375 0 CA-C-N 114.323 -1.308 . . . . 0.0 108.683 170.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -82.84 26.13 0.65 Allowed 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 123.043 2.496 . . . . 0.0 113.022 -172.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 46.5 m-20 -155.83 68.75 5.05 Favored Pre-proline 0 C--N 1.318 -0.804 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.696 178.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 362' ' ' PRO . . . . . 0.802 ' HB3' HG21 ' A' ' 372' ' ' ILE . 49.7 Cg_endo -73.28 151.56 48.87 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 121.745 1.63 . . . . 0.0 111.269 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 363' ' ' THR . . . . . 0.544 ' O ' ' HA2' ' A' ' 369' ' ' GLY . 0.0 OUTLIER -145.4 169.71 17.77 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -173.065 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 364' ' ' MET . . . . . 0.944 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 3.3 ppp? -127.24 142.97 51.34 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 176.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -135.09 -165.01 1.61 Allowed 'General case' 0 C--N 1.319 -0.76 0 O-C-N 124.999 1.437 . . . . 0.0 109.729 178.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 366' ' ' ASN . . . . . 0.467 HD21 ' N ' ' A' ' 366' ' ' ASN . 0.1 OUTLIER -45.27 -28.69 0.85 Allowed 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -174.091 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -109.32 3.29 21.44 Favored 'General case' 0 C--O 1.234 0.239 0 O-C-N 121.513 -0.742 . . . . 0.0 111.852 -177.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 368' ' ' GLY . . . . . 0.451 ' HA2' ' HE1' ' A' ' 364' ' ' MET . . . 109.23 -171.79 15.62 Favored Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 -179.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 369' ' ' GLY . . . . . 0.544 ' HA2' ' O ' ' A' ' 363' ' ' THR . . . -45.26 -45.9 10.73 Favored Glycine 0 C--N 1.339 0.704 0 CA-C-N 117.067 0.433 . . . . 0.0 113.126 172.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 370' ' ' GLY . . . . . 0.575 ' O ' ' HG3' ' A' ' 329' ' ' GLU . . . 83.93 -54.58 4.96 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.606 -0.807 . . . . 0.0 113.256 175.058 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -165.16 142.17 5.83 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.266 0.555 . . . . 0.0 111.527 177.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 372' ' ' ILE . . . . . 0.802 HG21 ' HB3' ' A' ' 362' ' ' PRO . 1.1 mt -131.23 150.16 34.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 170.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 373' ' ' GLU . . . . . 0.671 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 32.5 mt-10 -123.45 126.49 46.86 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.199 178.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 374' ' ' MET . . . . . 0.72 ' HE2' HD13 ' A' ' 383' ' ' ILE . 1.0 OUTLIER -137.26 161.37 36.4 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.452 -176.806 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 375' ' ' GLN . . . . . 1.012 ' HG2' HG23 ' A' ' 326' ' ' VAL . 0.0 OUTLIER -170.51 174.88 4.93 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.782 0.801 . . . . 0.0 111.183 170.722 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 376' ' ' LEU . . . . . 0.553 HD23 HG12 ' A' ' 354' ' ' VAL . 35.6 tp -169.02 123.87 0.73 Allowed Pre-proline 0 N--CA 1.438 -1.034 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 171.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 377' ' ' PRO . . . . . 0.547 ' HD2' HD12 ' A' ' 376' ' ' LEU . 45.2 Cg_exo -27.88 129.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 123.766 2.977 . . . . 0.0 112.101 -177.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -33.77 134.47 0.12 Allowed 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 124.499 3.466 . . . . 0.0 113.961 -161.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 158.51 -178.44 34.74 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -160.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . 0.73 ' HA ' ' HA ' ' A' ' 393' ' ' PHE . 3.9 m-20 -90.42 120.06 31.22 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 118.064 0.932 . . . . 0.0 111.155 -174.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 381' ' ' ASN . . . . . 0.463 ' N ' HD21 ' A' ' 381' ' ' ASN . 0.7 OUTLIER -121.28 163.47 18.52 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 176.91 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 382' ' ' ILE . . . . . 1.06 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -159.62 138.02 2.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 168.573 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 383' ' ' ILE . . . . . 0.72 HD13 ' HE2' ' A' ' 374' ' ' MET . 12.8 mt -103.41 135.94 38.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 121.028 0.442 . . . . 0.0 110.286 -171.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 384' ' ' TYR . . . . . 0.424 ' CE2' ' HB3' ' A' ' 389' ' ' ASN . 50.9 m-85 -100.17 136.74 39.6 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 164.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 385' ' ' VAL . . . . . 0.699 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 10.9 t -120.73 77.77 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 177.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 59.73 -106.05 0.89 Allowed Glycine 0 N--CA 1.431 -1.685 0 C-N-CA 120.134 -1.031 . . . . 0.0 111.155 -163.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 387' ' ' ASP . . . . . 0.489 ' N ' ' HB2' ' A' ' 309' ' ' LYS . 10.6 t70 -81.32 -17.42 49.3 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 388' ' ' LEU . . . . . 0.699 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 2.4 mp -70.47 154.36 41.97 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.871 0.367 . . . . 0.0 111.195 178.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 389' ' ' ASN . . . . . 0.424 ' HB3' ' CE2' ' A' ' 384' ' ' TYR . 24.2 p30 -155.93 145.22 20.77 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.384 173.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 390' ' ' HIS . . . . . 0.447 ' CD2' ' HD3' ' A' ' 318' ' ' PRO . 0.2 OUTLIER -170.42 106.81 0.31 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.798 -0.183 . . . . 0.0 111.307 -173.743 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 391' ' ' GLN . . . . . 1.06 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 0.6 OUTLIER -87.87 153.98 20.89 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.212 0.53 . . . . 0.0 112.422 -174.355 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 392' ' ' TRP . . . . . . . . . . . . . 5.5 t-105 -178.0 116.28 0.08 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.143 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 393' ' ' PHE . . . . . 0.73 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 18.4 p90 -66.69 124.7 23.61 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.295 170.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . 0.564 ' HG3' ' NE2' ' A' ' 375' ' ' GLN . 5.3 mm100 -80.81 108.79 14.77 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 -175.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 53.2 tptt . . . . . 0 C--O 1.247 0.957 0 CA-C-O 118.795 -0.622 . . . . 0.0 109.985 -174.499 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 303' ' ' THR . . . . . 0.455 ' O ' HG23 ' A' ' 303' ' ' THR . 8.8 t . . . . . 0 CA--C 1.537 0.455 0 CA-C-O 121.697 0.761 . . . . 0.0 111.734 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 304' ' ' TYR . . . . . 0.571 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 13.9 p90 -70.12 117.0 11.14 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.465 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 11.0 t 172.22 -166.83 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -168.125 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 39.1 t -64.5 109.55 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 171.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 307' ' ' CYS . . . . . 0.436 ' HB3' HG21 ' A' ' 335' ' ' THR . 0.4 OUTLIER -72.6 144.6 47.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.199 -173.788 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 308' ' ' ASP . . . . . 0.663 ' OD1' HG22 ' A' ' 310' ' ' THR . 16.4 t70 -70.9 127.2 31.78 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.546 0.689 . . . . 0.0 110.711 -177.242 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.522 ' HD3' ' HB2' ' A' ' 387' ' ' ASP . 0.0 OUTLIER -44.85 -18.52 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 116.123 1.897 . . . . 0.0 116.123 -173.465 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.663 HG22 ' OD1' ' A' ' 308' ' ' ASP . 10.9 t -108.29 5.68 25.84 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 119.761 1.164 . . . . 0.0 111.725 -171.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 311' ' ' LYS . . . . . 0.452 ' HE3' ' HB3' ' A' ' 311' ' ' LYS . 25.3 mtpp -86.26 -25.77 25.35 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -171.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.507 ' HA ' ' O ' ' A' ' 331' ' ' GLY . 0.0 OUTLIER -83.14 174.74 10.53 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.664 0.745 . . . . 0.0 111.269 178.369 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 313' ' ' THR . . . . . 0.408 ' C ' HD21 ' A' ' 388' ' ' LEU . 32.0 p -139.33 156.87 46.73 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.867 -177.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 314' ' ' TRP . . . . . 0.671 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 26.8 m-90 -76.39 92.34 3.36 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.547 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 84.8 tttt -77.67 -52.04 9.63 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 119.909 -0.716 . . . . 0.0 109.09 170.197 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.554 ' HB3' ' HB3' ' A' ' 329' ' ' GLU . 9.2 ttp180 -143.66 121.15 11.72 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 172.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 317' ' ' ALA . . . . . 0.503 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -72.49 162.49 73.74 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.993 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 318' ' ' PRO . . . . . 0.631 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 5.7 Cg_exo -42.31 115.48 0.5 Allowed 'Trans proline' 0 C--N 1.358 1.072 0 C-N-CA 122.586 2.191 . . . . 0.0 112.846 -177.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 45.6 m -131.08 136.95 48.87 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.532 -174.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -60.12 116.88 4.51 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 321' ' ' SER . . . . . 0.6 ' HB3' HG13 ' A' ' 327' ' ' VAL . 97.3 p -52.28 -53.57 42.34 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.185 0.517 . . . . 0.0 111.37 -167.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 141.88 -26.44 2.36 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.62 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 17.1 t60 -99.24 12.23 36.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.032 0.444 . . . . 0.0 110.039 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 24.6 t70 86.86 53.74 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.878 175.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 325' ' ' THR . . . . . 0.647 ' HA ' HE21 ' A' ' 375' ' ' GLN . 0.9 OUTLIER -158.58 -167.48 2.16 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 113.67 -1.605 . . . . 0.0 106.906 176.423 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.729 ' HB ' ' HG3' ' A' ' 374' ' ' MET . 0.6 OUTLIER -125.72 145.89 32.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 119.704 1.138 . . . . 0.0 111.64 -178.689 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 327' ' ' VAL . . . . . 0.772 HG12 ' HG2' ' A' ' 373' ' ' GLU . 13.6 m -123.56 152.58 28.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.751 172.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 328' ' ' MET . . . . . 0.655 ' SD ' ' HB ' ' A' ' 372' ' ' ILE . 0.1 OUTLIER -142.4 149.69 39.68 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 173.152 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.554 ' HB3' ' HB3' ' A' ' 316' ' ' ARG . 46.6 tt0 -129.43 125.14 35.82 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.071 -175.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.506 HG11 HG11 ' A' ' 385' ' ' VAL . 2.8 m -129.97 146.84 33.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -174.168 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 331' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -118.03 137.96 13.52 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.573 -176.347 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -89.43 156.33 18.75 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.894 0.854 . . . . 0.0 112.957 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 2.3 p -94.79 -19.56 20.23 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.496 -1.229 . . . . 0.0 113.813 171.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -176.23 -37.22 0.05 OUTLIER Glycine 0 CA--C 1.525 0.717 0 C-N-CA 118.979 -1.582 . . . . 0.0 114.991 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 335' ' ' THR . . . . . 0.707 ' HB ' ' SD ' ' A' ' 364' ' ' MET . 90.7 m -53.36 127.21 23.97 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.682 0.277 . . . . 0.0 111.192 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.571 ' HG3' ' HB3' ' A' ' 304' ' ' TYR . 2.0 ptm180 -91.69 179.67 1.34 Allowed Pre-proline 0 CA--C 1.534 0.333 0 CA-C-O 117.248 -1.358 . . . . 0.0 107.914 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.575 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.2 OUTLIER -23.99 96.96 0.01 OUTLIER 'Trans proline' 0 C--N 1.375 1.935 0 C-N-CA 124.098 3.199 . . . . 0.0 114.501 -168.256 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 338' ' ' CYS . . . . . 0.771 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 2.2 p -111.17 -177.61 3.25 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 113.928 -1.487 . . . . 0.0 109.94 -172.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -109.93 99.84 8.9 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 176.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 340' ' ' ILE . . . . . 0.724 HG22 HG13 ' A' ' 342' ' ' VAL . 43.7 mt -74.42 118.78 72.65 Favored Pre-proline 0 C--N 1.327 -0.412 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.181 -168.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -76.89 80.53 2.82 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.373 2.049 . . . . 0.0 111.238 176.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.724 HG13 HG22 ' A' ' 340' ' ' ILE . 1.4 m -102.16 111.77 33.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 114.849 -1.068 . . . . 0.0 110.106 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -127.14 174.63 8.76 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 178.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 344' ' ' ALA . . . . . 0.476 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -146.53 145.63 30.21 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.474 176.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.436 HG22 HD12 ' A' ' 382' ' ' ILE . 11.5 m -117.72 145.46 23.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 177.271 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -66.51 119.2 11.25 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.375 175.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 347' ' ' HIS . . . . . 0.547 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 20.7 t60 40.72 66.61 0.61 Allowed 'General case' 0 N--CA 1.474 0.775 0 O-C-N 124.491 1.119 . . . . 0.0 111.95 175.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 348' ' ' GLY . . . . . 0.589 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 47.32 34.17 8.57 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 115.271 0.869 . . . . 0.0 115.271 -178.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 349' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 347' ' ' HIS . 63.7 t -135.7 102.81 10.27 Favored Pre-proline 0 C--O 1.233 0.235 0 CA-C-N 118.371 1.086 . . . . 0.0 108.685 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -74.54 62.35 5.42 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.866 2.377 . . . . 0.0 112.837 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -100.15 -56.26 2.41 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.5 p -120.65 128.9 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-N 115.113 -0.948 . . . . 0.0 110.36 173.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 353' ' ' ASN . . . . . 0.466 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 33.0 t30 -64.49 119.63 10.78 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.526 175.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.467 ' O ' ' HB2' ' A' ' 376' ' ' LEU . 29.1 m -98.32 6.22 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.94 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 355' ' ' ALA . . . . . 0.476 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -77.55 84.99 3.92 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.474 0.654 . . . . 0.0 111.142 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 356' ' ' MET . . . . . 0.579 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 21.4 ttt -99.3 100.11 11.15 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 106.16 -1.792 . . . . 0.0 106.16 171.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.622 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 47.1 mt -86.21 121.95 29.52 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.416 -160.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.725 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 3.2 mm -64.43 -28.98 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 108.137 -1.061 . . . . 0.0 108.137 174.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 86.4 m -123.46 84.52 52.64 Favored Pre-proline 0 N--CA 1.45 -0.438 0 CA-C-N 114.27 -1.332 . . . . 0.0 108.459 172.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -85.33 27.66 0.59 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.06 2.507 . . . . 0.0 114.287 -169.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 35.7 m-20 -149.2 66.31 8.48 Favored Pre-proline 0 C--N 1.315 -0.922 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.123 177.063 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 362' ' ' PRO . . . . . 0.828 ' HB3' HG23 ' A' ' 372' ' ' ILE . 75.9 Cg_endo -81.43 149.08 16.64 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.183 1.922 . . . . 0.0 112.666 178.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 363' ' ' THR . . . . . 0.478 HG22 ' O ' ' A' ' 338' ' ' CYS . 2.6 p -143.75 147.59 34.41 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.615 -174.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 364' ' ' MET . . . . . 0.771 ' HG2' ' SG ' ' A' ' 338' ' ' CYS . 10.3 ptp . . . . . 0 CA--C 1.497 -1.06 0 C-N-CA 119.444 -0.902 . . . . 0.0 108.911 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 369' ' ' GLY . . . . . 0.612 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -50.35 -42.01 41.32 Favored Glycine 0 CA--C 1.504 -0.611 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.04 172.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 370' ' ' GLY . . . . . 0.547 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 82.33 -130.42 9.69 Favored Glycine 0 N--CA 1.436 -1.34 0 C-N-CA 120.11 -1.043 . . . . 0.0 110.76 -177.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -103.3 138.16 40.45 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.323 0.582 . . . . 0.0 111.25 -175.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 372' ' ' ILE . . . . . 0.828 HG23 ' HB3' ' A' ' 362' ' ' PRO . 0.1 OUTLIER -130.48 165.23 31.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.41 -0.814 . . . . 0.0 108.999 175.921 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 373' ' ' GLU . . . . . 0.772 ' HG2' HG12 ' A' ' 327' ' ' VAL . 43.2 mt-10 -132.96 128.69 37.0 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.096 0.474 . . . . 0.0 110.483 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 374' ' ' MET . . . . . 0.729 ' HG3' ' HB ' ' A' ' 326' ' ' VAL . 0.0 OUTLIER -133.95 165.67 24.48 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -178.969 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 375' ' ' GLN . . . . . 0.647 HE21 ' HA ' ' A' ' 325' ' ' THR . 5.9 tp-100 -177.67 172.83 1.7 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.155 -0.684 . . . . 0.0 109.155 169.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 376' ' ' LEU . . . . . 0.776 HD22 ' HD2' ' A' ' 377' ' ' PRO . 2.5 tm? -165.81 133.89 2.38 Favored Pre-proline 0 C--N 1.309 -1.163 0 N-CA-C 103.753 -2.684 . . . . 0.0 103.753 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 377' ' ' PRO . . . . . 0.776 ' HD2' HD22 ' A' ' 376' ' ' LEU . 34.6 Cg_exo -28.07 126.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.479 2.786 . . . . 0.0 112.586 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -35.12 134.03 0.18 Allowed 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 124.574 3.516 . . . . 0.0 113.358 -167.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 157.1 -170.62 34.38 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -162.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 380' ' ' ASP . . . . . 0.713 ' HA ' ' HA ' ' A' ' 393' ' ' PHE . 2.9 m-20 -89.85 120.02 30.73 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 117.509 0.654 . . . . 0.0 110.515 -177.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -125.28 166.78 15.9 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 176.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 0.955 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -160.57 139.83 3.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 169.694 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 383' ' ' ILE . . . . . 0.713 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 40.8 mt -99.64 125.06 53.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 C-N-CA 119.367 -0.933 . . . . 0.0 109.539 -175.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -101.07 92.36 4.97 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.29 171.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 385' ' ' VAL . . . . . 0.506 HG11 HG11 ' A' ' 330' ' ' VAL . 11.7 t -84.9 85.62 2.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 60.63 -112.57 4.71 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.508 -0.853 . . . . 0.0 111.329 -170.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 387' ' ' ASP . . . . . 0.522 ' HB2' ' HD3' ' A' ' 309' ' ' LYS . 3.5 t70 -83.18 -18.13 40.43 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.091 0.472 . . . . 0.0 110.512 177.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 388' ' ' LEU . . . . . 0.671 ' HG ' ' CE2' ' A' ' 314' ' ' TRP . 3.4 mp -72.06 156.58 39.05 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.894 177.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 389' ' ' ASN . . . . . 0.713 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 7.7 p30 -168.96 158.17 8.49 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.316 177.197 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 390' ' ' HIS . . . . . 0.631 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 37.5 t-80 -174.83 116.93 0.18 Allowed 'General case' 0 C--O 1.237 0.431 0 O-C-N 123.419 0.45 . . . . 0.0 110.011 175.076 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 391' ' ' GLN . . . . . 0.955 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 8.2 tt0 -77.6 153.27 33.4 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.019 0.438 . . . . 0.0 112.073 -179.09 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 392' ' ' TRP . . . . . 0.401 ' CD1' ' NE2' ' A' ' 394' ' ' GLN . 23.9 t-105 -179.49 115.27 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.873 178.048 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 393' ' ' PHE . . . . . 0.713 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 12.3 p90 -68.21 121.05 15.39 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.21 0.529 . . . . 0.0 110.249 172.322 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.401 ' NE2' ' CD1' ' A' ' 392' ' ' TRP . 4.2 mm100 -84.27 119.09 24.64 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -172.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 4.1 mmmp? . . . . . 0 C--O 1.246 0.919 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.393 -176.894 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 303' ' ' THR . . . . . 0.423 ' O ' HG23 ' A' ' 303' ' ' THR . 6.4 t . . . . . 0 CA--C 1.538 0.497 0 CA-C-O 121.602 0.715 . . . . 0.0 111.181 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 304' ' ' TYR . . . . . 0.541 ' HB3' ' NE ' ' A' ' 336' ' ' ARG . 33.5 p90 -76.75 126.46 31.03 Favored 'General case' 0 CA--C 1.516 -0.358 0 O-C-N 121.806 -0.558 . . . . 0.0 109.729 176.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.517 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 10.0 t -179.9 -173.91 0.25 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.245 -174.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.09 111.54 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 167.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.67 144.25 51.12 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.377 -169.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 308' ' ' ASP . . . . . 0.491 ' OD2' HG22 ' A' ' 310' ' ' THR . 34.0 t70 -67.56 119.96 13.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.322 0.582 . . . . 0.0 110.448 -178.29 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.651 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -46.12 -12.17 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 -172.631 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.491 HG22 ' OD2' ' A' ' 308' ' ' ASP . 8.1 t -107.2 -0.67 22.52 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 119.079 0.854 . . . . 0.0 111.319 -175.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -83.85 -25.11 30.57 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -173.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.651 ' CZ ' ' HA ' ' A' ' 309' ' ' LYS . 0.1 OUTLIER -83.22 174.68 10.55 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.759 0.79 . . . . 0.0 111.155 176.882 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 313' ' ' THR . . . . . 0.401 ' C ' HD21 ' A' ' 388' ' ' LEU . 14.7 t -149.78 159.67 44.16 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.542 -1.208 . . . . 0.0 108.769 -179.025 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 314' ' ' TRP . . . . . 0.436 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 29.0 m-90 -69.17 117.64 11.07 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 121.353 0.597 . . . . 0.0 110.28 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.964 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 59.4 tttm -97.47 -47.81 5.53 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 173.374 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 41.1 ttp-105 -154.61 130.03 9.8 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.955 168.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 317' ' ' ALA . . . . . 0.561 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -66.13 166.0 18.96 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.993 -178.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 318' ' ' PRO . . . . . 0.567 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 3.6 Cg_exo -44.3 116.27 0.99 Allowed 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.559 2.173 . . . . 0.0 112.368 178.279 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 55.0 m -128.7 132.18 48.0 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.466 -174.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.94 125.35 23.23 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 175.057 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 321' ' ' SER . . . . . 0.438 ' C ' ' H ' ' A' ' 323' ' ' HIS . 59.5 p -70.24 5.6 1.64 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 123.423 0.689 . . . . 0.0 112.489 -168.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 74.56 -25.58 1.12 Allowed Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.319 -169.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 323' ' ' HIS . . . . . 0.438 ' H ' ' C ' ' A' ' 321' ' ' SER . 2.2 t-160 -106.42 46.46 0.92 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.114 0.483 . . . . 0.0 109.98 -178.062 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 50.34 43.66 26.65 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 114.96 -1.018 . . . . 0.0 113.533 177.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 325' ' ' THR . . . . . 0.665 ' HA ' ' HG3' ' A' ' 375' ' ' GLN . 2.1 p -150.84 -168.12 3.01 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 174.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.823 ' HB ' ' HG2' ' A' ' 374' ' ' MET . 0.2 OUTLIER -129.3 144.73 37.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 118.979 0.809 . . . . 0.0 111.019 179.707 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 327' ' ' VAL . . . . . 0.654 HG12 ' HG2' ' A' ' 373' ' ' GLU . 15.0 m -128.39 143.86 39.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.024 174.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 328' ' ' MET . . . . . 0.435 ' CG ' HD12 ' A' ' 372' ' ' ILE . 0.0 OUTLIER -135.04 149.46 50.13 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 178.297 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.964 ' HG2' ' HD3' ' A' ' 315' ' ' LYS . 7.7 tt0 -131.12 131.07 43.88 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 120.657 -0.417 . . . . 0.0 109.994 -173.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.672 HG23 ' HA3' ' A' ' 369' ' ' GLY . 0.0 OUTLIER -126.81 161.29 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -178.18 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 331' ' ' GLY . . . . . 0.555 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -127.69 137.8 10.05 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.729 175.148 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 332' ' ' PHE . . . . . 0.931 ' H ' ' HA2' ' A' ' 368' ' ' GLY . 0.2 OUTLIER -89.96 155.6 19.0 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.541 0.686 . . . . 0.0 111.807 179.185 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 2.6 p -95.84 -13.99 23.58 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 171.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -176.44 -40.72 0.05 OUTLIER Glycine 0 CA--C 1.528 0.859 0 C-N-CA 118.961 -1.59 . . . . 0.0 115.19 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 335' ' ' THR . . . . . 0.567 ' HB ' ' SD ' ' A' ' 364' ' ' MET . 82.8 m -52.78 132.84 37.11 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.823 0.344 . . . . 0.0 111.533 -177.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.865 HH21 ' HB2' ' A' ' 337' ' ' PRO . 0.2 OUTLIER -87.87 177.4 2.7 Favored Pre-proline 0 C--N 1.338 0.077 0 CA-C-O 117.389 -1.291 . . . . 0.0 107.875 -179.143 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.865 ' HB2' HH21 ' A' ' 336' ' ' ARG . 1.0 OUTLIER -26.64 98.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.367 1.535 0 C-N-CA 123.723 2.949 . . . . 0.0 114.138 -174.432 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 338' ' ' CYS . . . . . 0.757 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 6.5 p -111.48 -176.19 2.88 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 113.559 -1.655 . . . . 0.0 110.376 -171.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -111.54 98.9 7.77 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 174.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 340' ' ' ILE . . . . . 0.773 ' HB ' ' HG2' ' A' ' 362' ' ' PRO . 68.5 mt -74.49 119.59 77.33 Favored Pre-proline 0 C--N 1.328 -0.338 0 O-C-N 123.416 0.448 . . . . 0.0 110.906 -171.357 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.2 82.32 2.4 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.928 2.419 . . . . 0.0 112.162 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.706 HG13 HG22 ' A' ' 340' ' ' ILE . 9.9 m -99.04 151.65 4.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.382 178.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 -162.34 171.34 17.37 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 176.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 344' ' ' ALA . . . . . 0.544 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -145.97 144.67 30.27 Favored 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.008 176.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.553 ' HB ' ' HA ' ' A' ' 350' ' ' PRO . 4.9 m -116.27 143.83 25.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 176.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.405 ' HB2' ' CG1' ' A' ' 354' ' ' VAL . . . -63.6 123.23 18.29 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 176.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 347' ' ' HIS . . . . . 0.519 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 37.2 t-80 42.52 62.97 1.55 Allowed 'General case' 0 N--CA 1.473 0.711 0 O-C-N 124.268 0.98 . . . . 0.0 112.749 170.268 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 348' ' ' GLY . . . . . 0.54 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 50.75 29.72 19.55 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 115.25 0.86 . . . . 0.0 115.25 -177.294 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 349' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 347' ' ' HIS . 50.6 t -136.2 103.08 9.74 Favored Pre-proline 0 C--O 1.234 0.247 0 CA-C-N 118.267 1.033 . . . . 0.0 109.784 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 350' ' ' PRO . . . . . 0.553 ' HA ' ' HB ' ' A' ' 345' ' ' VAL . 17.1 Cg_exo -71.98 62.62 3.24 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 123.095 2.53 . . . . 0.0 112.884 178.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -100.12 -56.05 2.47 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 178.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 4.6 p -124.64 133.4 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.451 174.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 353' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 34.0 t30 -64.85 117.35 7.43 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.89 177.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.576 HG12 HD22 ' A' ' 376' ' ' LEU . 27.9 m -99.79 7.54 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.917 179.252 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 355' ' ' ALA . . . . . 0.544 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -78.62 82.94 4.83 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.029 0.443 . . . . 0.0 110.568 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 356' ' ' MET . . . . . 0.614 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 22.4 ttt -97.46 51.96 1.1 Allowed 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 175.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.842 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 11.7 mt -24.53 111.59 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 112.901 -1.954 . . . . 0.0 115.226 170.44 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.82 HD11 ' HB2' ' A' ' 375' ' ' GLN . 3.9 mm -60.36 -22.89 26.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 113.352 -1.749 . . . . 0.0 108.48 168.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 55.1 m -139.23 90.34 11.82 Favored Pre-proline 0 N--CA 1.451 -0.419 0 CA-C-N 114.265 -1.334 . . . . 0.0 108.648 177.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 360' ' ' PRO . . . . . 0.475 ' HA ' HD12 ' A' ' 357' ' ' LEU . 92.6 Cg_endo -82.17 45.34 1.91 Allowed 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 123.27 2.647 . . . . 0.0 114.445 -170.102 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -174.58 80.44 0.34 Allowed Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 120.958 0.408 . . . . 0.0 110.375 176.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 362' ' ' PRO . . . . . 0.773 ' HG2' ' HB ' ' A' ' 340' ' ' ILE . 95.3 Cg_endo -82.65 112.39 2.13 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.702 2.268 . . . . 0.0 111.932 176.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 4.0 p -90.81 142.19 28.02 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.764 0.792 . . . . 0.0 112.5 173.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 364' ' ' MET . . . . . 0.827 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 5.2 ptp . . . . . 0 CA--C 1.504 -0.827 0 CA-C-N 114.067 -1.424 . . . . 0.0 109.457 178.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 368' ' ' GLY . . . . . 0.931 ' HA2' ' H ' ' A' ' 332' ' ' PHE . . . . . . . . 0 CA--C 1.504 -0.637 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 369' ' ' GLY . . . . . 0.672 ' HA3' HG23 ' A' ' 330' ' ' VAL . . . -104.37 3.27 43.37 Favored Glycine 0 C--N 1.317 -0.505 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 175.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 73.15 -93.38 0.68 Allowed Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 114.96 -0.62 . . . . 0.0 113.575 175.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -152.29 133.49 14.34 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.411 -0.395 . . . . 0.0 111.084 -170.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 372' ' ' ILE . . . . . 0.627 HG23 ' HB3' ' A' ' 362' ' ' PRO . 0.7 OUTLIER -129.63 135.38 61.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 173.392 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 373' ' ' GLU . . . . . 0.654 ' HG2' HG12 ' A' ' 327' ' ' VAL . 40.9 mt-10 -122.43 126.72 48.53 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 374' ' ' MET . . . . . 0.842 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 0.1 OUTLIER -134.47 165.5 25.02 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 123.505 0.722 . . . . 0.0 110.718 -175.692 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 375' ' ' GLN . . . . . 0.82 ' HB2' HD11 ' A' ' 358' ' ' ILE . 0.0 OUTLIER -173.5 -173.81 0.93 Allowed 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.545 0.688 . . . . 0.0 111.668 162.835 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 376' ' ' LEU . . . . . 0.962 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 10.5 tp -166.15 166.97 9.04 Favored Pre-proline 0 N--CA 1.443 -0.79 0 N-CA-C 104.481 -2.415 . . . . 0.0 104.481 171.146 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 377' ' ' PRO . . . . . 0.962 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 2.9 Cg_endo -43.48 133.81 7.0 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 121.58 1.52 . . . . 0.0 110.684 167.123 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_exo -37.8 140.04 0.29 Allowed 'Trans proline' 0 C--N 1.358 1.077 0 C-N-CA 123.85 3.033 . . . . 0.0 112.371 -177.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 148.61 -169.45 29.16 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.122 -1.037 . . . . 0.0 110.565 -160.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 380' ' ' ASP . . . . . 0.519 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 2.2 m-20 -98.72 128.52 45.0 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 117.583 0.692 . . . . 0.0 111.29 -175.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.841 ' HB2' HE21 ' A' ' 394' ' ' GLN . 10.5 m120 -127.07 168.73 14.21 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 176.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 1.034 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -161.04 138.6 2.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 168.835 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 383' ' ' ILE . . . . . 0.743 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 17.3 mt -104.62 130.29 55.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 C-N-CA 119.928 -0.709 . . . . 0.0 109.418 -172.157 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 384' ' ' TYR . . . . . 0.536 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 3.5 m-85 -101.57 98.56 8.86 Favored 'General case' 0 N--CA 1.441 -0.884 0 O-C-N 124.318 1.011 . . . . 0.0 108.572 169.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 385' ' ' VAL . . . . . 0.61 HG11 HG11 ' A' ' 330' ' ' VAL . 25.9 t -86.63 84.71 2.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 175.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 62.15 -112.06 4.52 Favored Glycine 0 N--CA 1.439 -1.132 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 -169.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 387' ' ' ASP . . . . . 0.53 ' HB2' ' HD3' ' A' ' 309' ' ' LYS . 0.7 OUTLIER -85.03 -15.26 44.71 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.781 0.324 . . . . 0.0 110.947 177.426 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 388' ' ' LEU . . . . . 0.536 ' O ' ' HA ' ' A' ' 384' ' ' TYR . 3.3 mp -70.34 155.07 41.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.023 177.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 389' ' ' ASN . . . . . 0.743 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 6.4 p30 -167.12 157.01 10.97 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.808 -0.178 . . . . 0.0 110.898 175.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 390' ' ' HIS . . . . . 0.567 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 33.0 t-80 -175.03 123.19 0.24 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.852 175.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 391' ' ' GLN . . . . . 1.034 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 25.3 tt0 -78.52 153.61 31.15 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.066 0.46 . . . . 0.0 111.585 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 392' ' ' TRP . . . . . 0.602 ' HD1' ' NE2' ' A' ' 394' ' ' GLN . 10.7 t-105 -166.36 145.87 5.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.605 174.211 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 393' ' ' PHE . . . . . 0.507 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 13.5 p90 -103.3 118.79 37.58 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.841 HE21 ' HB2' ' A' ' 381' ' ' ASN . 23.2 mm-40 -83.14 112.96 20.3 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -168.199 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.428 ' HZ3' ' NE2' ' A' ' 375' ' ' GLN . 31.2 mtmm . . . . . 0 C--O 1.248 1.026 0 O-C-N 124.225 0.953 . . . . 0.0 111.462 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 303' ' ' THR . . . . . 0.605 HG23 HG23 ' A' ' 335' ' ' THR . 8.9 t . . . . . 0 CA--C 1.539 0.527 0 CA-C-O 121.575 0.702 . . . . 0.0 111.232 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 304' ' ' TYR . . . . . 0.408 ' O ' ' HB ' ' A' ' 305' ' ' THR . 14.2 p90 -63.54 119.11 9.18 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 174.178 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.419 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 12.1 t 174.9 -168.33 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -172.139 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 36.4 t -65.22 106.95 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 169.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 307' ' ' CYS . . . . . 0.596 ' HB3' HG21 ' A' ' 335' ' ' THR . 0.5 OUTLIER -69.91 140.86 53.16 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.264 -167.892 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 308' ' ' ASP . . . . . 0.609 ' OD1' HG22 ' A' ' 310' ' ' THR . 14.0 t70 -63.41 132.68 52.23 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.953 -174.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.566 ' HD2' ' N ' ' A' ' 310' ' ' THR . 0.0 OUTLIER -41.5 -20.36 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 116.104 1.89 . . . . 0.0 116.104 -175.428 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.609 HG22 ' OD1' ' A' ' 308' ' ' ASP . 6.7 t -108.31 2.54 22.68 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 119.134 0.879 . . . . 0.0 112.196 -174.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 311' ' ' LYS . . . . . 0.426 ' HG2' ' HB3' ' A' ' 308' ' ' ASP . 24.9 mmmt -74.01 -33.14 63.68 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -173.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.951 ' HD1' HD13 ' A' ' 388' ' ' LEU . 0.0 OUTLIER -86.08 175.18 8.69 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 122.006 0.908 . . . . 0.0 111.672 -175.992 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 11.1 t -144.3 155.45 43.83 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 113.871 -1.513 . . . . 0.0 107.755 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 16.4 m-90 -75.69 93.11 3.04 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.237 0.541 . . . . 0.0 109.598 178.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.452 ' HB3' ' C ' ' A' ' 329' ' ' GLU . 25.1 tptp -65.95 -43.82 86.84 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 170.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 24.8 ttt180 -152.83 130.79 11.78 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.142 170.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -69.5 159.04 85.26 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.649 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 318' ' ' PRO . . . . . 0.781 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 78.7 Cg_exo -39.71 112.7 0.16 Allowed 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 122.65 2.234 . . . . 0.0 112.742 178.214 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 19.0 m -131.89 135.33 46.57 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.166 -173.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -57.38 124.13 17.86 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 321' ' ' SER . . . . . 0.433 ' HB3' HG13 ' A' ' 327' ' ' VAL . 84.5 p -62.16 -47.84 82.73 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.448 0.642 . . . . 0.0 110.014 -174.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 123.64 -14.62 8.09 Favored Glycine 0 N--CA 1.443 -0.892 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -111.86 53.09 0.73 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.284 0.564 . . . . 0.0 109.884 178.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 22.9 t70 57.28 33.94 24.04 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 114.746 -1.116 . . . . 0.0 112.464 177.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 325' ' ' THR . . . . . 0.557 ' HB ' HG13 ' A' ' 358' ' ' ILE . 10.0 p -152.5 -172.55 4.27 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -132.12 145.45 34.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.338 0.59 . . . . 0.0 111.377 -177.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 327' ' ' VAL . . . . . 0.724 HG12 ' HG2' ' A' ' 373' ' ' GLU . 15.8 m -127.11 155.94 38.34 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.895 176.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 5.0 ptm -142.09 159.43 42.24 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 167.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.552 ' HG3' ' O ' ' A' ' 370' ' ' GLY . 9.7 tt0 -124.45 129.39 50.57 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -176.126 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.594 HG23 ' HA3' ' A' ' 369' ' ' GLY . 3.1 m -125.55 146.19 31.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.88 -179.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 331' ' ' GLY . . . . . 0.727 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -124.47 140.42 12.55 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.116 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 332' ' ' PHE . . . . . 0.572 ' HD1' ' HA2' ' A' ' 368' ' ' GLY . 7.9 p90 -89.3 146.67 24.56 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.96 0.886 . . . . 0.0 111.69 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 28.2 t -86.84 -28.6 22.8 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.114 -1.403 . . . . 0.0 111.961 172.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -159.23 -44.58 0.02 OUTLIER Glycine 0 C--N 1.336 0.56 0 C-N-CA 119.605 -1.283 . . . . 0.0 113.917 -179.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 335' ' ' THR . . . . . 0.605 HG23 HG23 ' A' ' 303' ' ' THR . 27.1 m -52.69 124.55 14.12 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 123.795 0.35 . . . . 0.0 110.949 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.59 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 33.3 ptt85 -87.29 -177.38 0.88 Allowed Pre-proline 0 CA--C 1.532 0.285 0 CA-C-O 117.089 -1.434 . . . . 0.0 108.37 -174.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.775 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.1 OUTLIER -26.63 96.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 123.751 2.967 . . . . 0.0 114.151 -176.449 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 338' ' ' CYS . . . . . 0.482 ' SG ' ' HG3' ' A' ' 364' ' ' MET . 12.1 p -112.42 -176.83 3.01 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 113.515 -1.675 . . . . 0.0 110.074 -171.159 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 11.2 mpt_? -112.21 103.08 11.22 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 178.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 340' ' ' ILE . . . . . 0.832 HG22 HG13 ' A' ' 342' ' ' VAL . 29.7 mt -74.17 119.99 79.14 Favored Pre-proline 0 C--N 1.324 -0.508 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.486 -167.314 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.65 81.26 2.67 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.853 2.368 . . . . 0.0 111.561 177.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.832 HG13 HG22 ' A' ' 340' ' ' ILE . 4.6 m -102.41 155.38 5.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-O 121.747 0.784 . . . . 0.0 110.887 -178.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.467 ' HE ' ' HB3' ' A' ' 384' ' ' TYR . 22.4 ptt180 -166.31 174.94 8.63 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 344' ' ' ALA . . . . . 0.529 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -150.9 145.0 25.35 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.849 -0.74 . . . . 0.0 110.893 177.054 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.439 ' O ' HG23 ' A' ' 382' ' ' ILE . 9.2 m -119.88 147.16 23.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -70.12 122.86 20.26 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 176.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 347' ' ' HIS . . . . . 0.523 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 47.2 t60 43.96 60.43 2.73 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 124.149 0.906 . . . . 0.0 111.413 174.273 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 348' ' ' GLY . . . . . 0.689 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 44.09 46.04 7.93 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 114.637 0.615 . . . . 0.0 114.637 -174.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 349' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 347' ' ' HIS . 73.5 t -141.64 102.5 5.93 Favored Pre-proline 0 C--N 1.33 -0.251 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -76.15 49.7 2.64 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.603 2.202 . . . . 0.0 112.625 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -102.11 -5.54 24.36 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 2.6 p -169.8 106.31 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 114.561 -1.199 . . . . 0.0 110.055 -167.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 353' ' ' ASN . . . . . 0.465 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 38.1 t30 -64.74 111.78 2.93 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.688 178.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.505 ' HA ' HD22 ' A' ' 376' ' ' LEU . 31.5 m -91.2 -0.59 9.55 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.212 177.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 355' ' ' ALA . . . . . 0.529 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -74.25 84.55 1.89 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.213 0.53 . . . . 0.0 111.462 -176.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 356' ' ' MET . . . . . 0.658 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 47.6 ttp -97.9 101.14 12.56 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 168.294 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.521 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 27.6 mt -85.35 119.33 25.6 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.192 -163.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.765 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 2.5 mm -61.79 -28.98 45.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.506 175.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 22.4 m -130.14 90.08 43.2 Favored Pre-proline 0 N--CA 1.443 -0.8 0 CA-C-N 114.3 -1.318 . . . . 0.0 108.539 173.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -83.87 36.86 0.61 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.142 2.561 . . . . 0.0 113.055 -173.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -153.35 71.56 6.88 Favored Pre-proline 0 C--N 1.317 -0.83 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.257 175.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 362' ' ' PRO . . . . . 0.621 ' HB2' HD12 ' A' ' 340' ' ' ILE . 94.7 Cg_endo -81.43 145.02 14.68 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.568 2.179 . . . . 0.0 111.387 176.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 363' ' ' THR . . . . . 0.451 ' O ' ' HA2' ' A' ' 369' ' ' GLY . 0.5 OUTLIER -144.26 140.19 29.08 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 -173.008 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 364' ' ' MET . . . . . 0.775 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 41.4 mtm . . . . . 0 CA--C 1.492 -1.286 0 C-N-CA 119.398 -0.921 . . . . 0.0 109.198 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 368' ' ' GLY . . . . . 0.727 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . . . . . . 0 N--CA 1.449 -0.49 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 369' ' ' GLY . . . . . 0.635 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -46.84 -25.79 2.49 Favored Glycine 0 CA--C 1.522 0.504 0 CA-C-N 117.7 0.75 . . . . 0.0 114.517 174.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 370' ' ' GLY . . . . . 0.552 ' O ' ' HG3' ' A' ' 329' ' ' GLU . . . 77.35 -57.82 3.7 Favored Glycine 0 C--O 1.228 -0.228 0 C-N-CA 120.867 -0.682 . . . . 0.0 113.034 176.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -165.87 147.06 6.9 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.126 0.489 . . . . 0.0 111.431 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 372' ' ' ILE . . . . . 0.747 HD13 HG11 ' A' ' 342' ' ' VAL . 1.3 mt -131.6 140.03 49.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.448 170.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 373' ' ' GLU . . . . . 0.765 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 40.8 mt-10 -119.44 123.7 44.71 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.428 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 374' ' ' MET . . . . . 0.558 ' HG2' HD11 ' A' ' 383' ' ' ILE . 0.0 OUTLIER -138.63 164.38 29.64 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.817 -176.866 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 375' ' ' GLN . . . . . 0.658 ' O ' ' HB3' ' A' ' 356' ' ' MET . 3.0 tp60 177.54 175.0 0.47 Allowed 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 173.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 376' ' ' LEU . . . . . 0.983 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 8.9 tp -166.88 173.59 3.05 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 177.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 377' ' ' PRO . . . . . 0.983 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 75.2 Cg_exo -41.08 127.61 2.8 Favored 'Trans proline' 0 C--N 1.348 0.5 0 CA-C-N 121.465 1.559 . . . . 0.0 111.225 166.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -41.67 148.16 0.34 Allowed 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 123.826 3.017 . . . . 0.0 112.568 -177.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 142.31 -163.75 27.06 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 119.763 -1.208 . . . . 0.0 111.07 -162.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 380' ' ' ASP . . . . . 0.523 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 4.8 m-20 -89.44 115.87 27.2 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 117.32 0.56 . . . . 0.0 111.163 -176.226 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.526 ' HB2' ' OE1' ' A' ' 394' ' ' GLN . 4.8 m-20 -126.62 147.55 49.89 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.039 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 0.99 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -148.71 137.73 15.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 176.609 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 383' ' ' ILE . . . . . 0.668 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 28.2 mt -99.49 132.69 44.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.206 -173.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 384' ' ' TYR . . . . . 0.619 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 1.8 m-85 -106.13 99.91 9.48 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.177 -1.374 . . . . 0.0 109.071 170.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 385' ' ' VAL . . . . . 0.773 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 2.8 t -84.83 86.61 2.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 174.066 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 60.42 -106.36 1.03 Allowed Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 120.003 -1.094 . . . . 0.0 110.718 -169.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 387' ' ' ASP . . . . . 0.448 ' HB2' ' HB2' ' A' ' 309' ' ' LYS . 17.8 t70 -89.97 -14.36 34.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.502 0.192 . . . . 0.0 111.325 176.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 388' ' ' LEU . . . . . 0.951 HD13 ' HD1' ' A' ' 312' ' ' PHE . 3.0 mp -67.67 153.82 42.85 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 176.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 389' ' ' ASN . . . . . 0.668 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 30.5 p-10 -163.75 154.42 15.78 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.017 176.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 390' ' ' HIS . . . . . 0.781 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 63.0 t-80 -173.41 116.38 0.26 Allowed 'General case' 0 C--O 1.241 0.633 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 174.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 391' ' ' GLN . . . . . 0.99 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 8.6 tt0 -80.59 153.67 27.89 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.973 -177.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 392' ' ' TRP . . . . . 0.496 ' HD1' ' OE1' ' A' ' 394' ' ' GLN . 32.0 t-105 -166.09 153.15 9.77 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.964 -1.017 . . . . 0.0 109.208 -176.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -110.11 118.06 35.38 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.526 ' OE1' ' HB2' ' A' ' 381' ' ' ASN . 4.0 mm100 -80.33 104.11 10.66 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -173.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.153 -0.927 . . . . 0.0 111.293 -174.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 303' ' ' THR . . . . . 0.458 ' O ' HG23 ' A' ' 303' ' ' THR . 10.2 t . . . . . 0 CA--C 1.536 0.416 0 CA-C-O 121.89 0.852 . . . . 0.0 111.374 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 304' ' ' TYR . . . . . 0.554 ' HB3' ' NE ' ' A' ' 336' ' ' ARG . 17.2 p90 -67.06 130.77 44.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.814 174.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.527 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 14.8 t 173.1 -169.17 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -175.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 41.3 t -66.43 112.42 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 169.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.0 140.41 57.71 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -172.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 308' ' ' ASP . . . . . 0.584 ' OD1' HG22 ' A' ' 310' ' ' THR . 12.5 t70 -62.24 130.92 47.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.538 0.685 . . . . 0.0 111.46 -170.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 18.3 pttm -38.47 -29.71 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 113.175 -1.829 . . . . 0.0 115.066 -177.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.584 HG22 ' OD1' ' A' ' 308' ' ' ASP . 12.0 t -108.37 0.28 21.07 Favored 'General case' 0 N--CA 1.443 -0.817 0 O-C-N 121.685 -0.634 . . . . 0.0 112.425 -170.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -84.87 -29.18 25.48 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -173.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.456 ' HA ' ' O ' ' A' ' 331' ' ' GLY . 0.1 OUTLIER -81.1 173.76 12.25 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.639 0.733 . . . . 0.0 111.012 -179.75 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 6.4 t -147.49 159.02 44.2 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.004 -178.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 314' ' ' TRP . . . . . 0.454 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 25.3 m-90 -71.03 122.02 19.28 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 178.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.713 ' HD3' ' HB3' ' A' ' 329' ' ' GLU . 70.8 tttt -102.52 -42.92 5.79 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 173.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.821 ' HB3' ' HB2' ' A' ' 329' ' ' GLU . 19.8 ttm-85 -149.39 128.15 12.5 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.85 169.455 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -71.52 158.73 87.32 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 318' ' ' PRO . . . . . 0.519 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 3.3 Cg_exo -43.01 111.15 0.2 Allowed 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 122.65 2.233 . . . . 0.0 112.487 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 32.2 m -129.26 131.27 46.98 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.624 -174.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -59.34 125.32 23.14 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 321' ' ' SER . . . . . 0.413 ' HB3' HG13 ' A' ' 327' ' ' VAL . 86.6 p -58.79 -45.08 90.67 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.832 -173.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 136.7 -3.52 3.52 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.363 176.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 6.3 t-80 -143.7 70.68 1.31 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.052 0.453 . . . . 0.0 110.304 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 58.31 30.14 19.11 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.01 -0.995 . . . . 0.0 113.666 175.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 325' ' ' THR . . . . . 0.617 ' HA ' ' CG ' ' A' ' 375' ' ' GLN . 11.1 p -153.48 179.2 9.02 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.816 HG23 ' HG2' ' A' ' 375' ' ' GLN . 0.5 OUTLIER -134.03 144.76 34.57 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.404 0 CA-C-O 121.106 0.479 . . . . 0.0 111.142 -172.964 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 327' ' ' VAL . . . . . 0.796 HG12 ' HG3' ' A' ' 373' ' ' GLU . 14.1 m -118.86 155.52 21.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.662 175.532 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 328' ' ' MET . . . . . 0.619 ' HG3' HG13 ' A' ' 372' ' ' ILE . 0.0 OUTLIER -143.56 153.42 42.55 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 176.71 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.821 ' HB2' ' HB3' ' A' ' 316' ' ' ARG . 8.9 mt-10 -134.7 133.43 39.99 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.003 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.592 HG23 ' HA3' ' A' ' 369' ' ' GLY . 2.4 m -132.81 159.05 43.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.004 0.431 . . . . 0.0 111.853 -179.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 331' ' ' GLY . . . . . 0.488 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -129.27 136.21 8.86 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.19 -1.005 . . . . 0.0 112.582 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 332' ' ' PHE . . . . . 0.419 ' HD1' ' CA ' ' A' ' 368' ' ' GLY . 2.1 p90 -90.31 154.45 19.7 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.682 0.753 . . . . 0.0 111.807 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 27.6 p -119.1 30.69 7.02 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.528 -1.214 . . . . 0.0 112.515 173.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 164.65 -51.29 0.29 Allowed Glycine 0 C--O 1.225 -0.465 0 C-N-CA 119.388 -1.387 . . . . 0.0 114.122 169.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 335' ' ' THR . . . . . . . . . . . . . 2.8 m -55.79 124.47 17.63 Favored 'General case' 0 C--N 1.317 -0.827 0 O-C-N 123.695 0.291 . . . . 0.0 111.5 -178.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.722 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 5.5 ppt_? -80.66 -178.63 1.2 Allowed Pre-proline 0 N--CA 1.462 0.132 0 CA-C-O 116.921 -1.514 . . . . 0.0 107.843 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.868 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.7 OUTLIER -24.35 96.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 123.566 2.844 . . . . 0.0 113.733 -179.083 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 338' ' ' CYS . . . . . 0.598 ' SG ' ' HB2' ' A' ' 364' ' ' MET . 18.3 p -117.76 -176.8 3.11 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.091 -1.868 . . . . 0.0 109.927 -168.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -110.35 103.76 12.46 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -178.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 340' ' ' ILE . . . . . 0.736 HG12 ' HG3' ' A' ' 364' ' ' MET . 55.4 mt -72.2 121.15 83.93 Favored Pre-proline 0 C--N 1.328 -0.364 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.48 -171.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 341' ' ' PRO . . . . . 0.424 ' O ' ' HA ' ' A' ' 385' ' ' VAL . 74.2 Cg_endo -79.83 77.9 3.9 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 121.556 1.504 . . . . 0.0 110.947 174.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.754 HG13 HG13 ' A' ' 385' ' ' VAL . 0.0 OUTLIER -105.08 117.66 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-O 122.238 1.018 . . . . 0.0 110.555 175.628 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.486 ' HG3' ' HB2' ' A' ' 384' ' ' TYR . 25.9 ptt180 -130.49 179.34 5.99 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 113.575 -1.648 . . . . 0.0 106.983 177.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 344' ' ' ALA . . . . . 0.518 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -149.29 147.66 28.62 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.963 175.092 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.447 HG22 HD12 ' A' ' 382' ' ' ILE . 10.5 m -119.52 141.7 38.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 176.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.53 116.68 7.05 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 347' ' ' HIS . . . . . 0.576 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 57.9 t-80 44.67 65.89 0.98 Allowed 'General case' 0 N--CA 1.472 0.626 0 O-C-N 124.345 1.028 . . . . 0.0 111.447 175.532 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 348' ' ' GLY . . . . . 0.52 ' H ' ' CG2' ' A' ' 382' ' ' ILE . . . 42.97 41.14 4.47 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 115.096 0.799 . . . . 0.0 115.096 -175.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 349' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 347' ' ' HIS . 87.6 t -140.5 102.49 6.58 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 118.112 0.956 . . . . 0.0 108.661 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -74.63 66.25 5.68 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 122.99 2.46 . . . . 0.0 113.376 -178.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -100.47 -57.79 2.04 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 174.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 5.9 p -116.98 130.69 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.641 174.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 353' ' ' ASN . . . . . 0.518 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 38.1 t30 -62.92 108.26 1.16 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.423 171.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.432 HG23 ' CB ' ' A' ' 344' ' ' ALA . 20.4 m -88.96 5.28 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.0 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 355' ' ' ALA . . . . . 0.45 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -77.46 82.03 3.92 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.317 0.58 . . . . 0.0 110.436 177.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 356' ' ' MET . . . . . 0.535 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 39.1 ttm -98.03 99.83 11.12 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 172.024 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.672 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 46.4 mt -85.15 146.71 26.98 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.38 -159.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.751 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 2.4 mm -90.81 -21.7 6.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 176.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 97.5 m -127.1 84.83 62.47 Favored Pre-proline 0 N--CA 1.446 -0.655 0 CA-C-N 113.216 -1.811 . . . . 0.0 108.257 172.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -80.62 27.6 0.56 Allowed 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.798 2.332 . . . . 0.0 112.758 -175.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -147.66 61.66 6.35 Favored Pre-proline 0 C--N 1.315 -0.901 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.512 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 362' ' ' PRO . . . . . 0.466 ' HB2' HD12 ' A' ' 340' ' ' ILE . 90.2 Cg_endo -85.11 102.39 0.78 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.124 1.883 . . . . 0.0 112.066 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 363' ' ' THR . . . . . 0.436 HG22 ' O ' ' A' ' 338' ' ' CYS . 1.3 p -93.04 168.87 10.84 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 122.05 0.929 . . . . 0.0 113.273 171.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 364' ' ' MET . . . . . 0.868 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 43.9 mtt . . . . . 0 CA--C 1.499 -0.989 0 CA-C-N 113.819 -1.537 . . . . 0.0 109.324 174.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 368' ' ' GLY . . . . . 0.488 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . . . . . . 0 N--CA 1.452 -0.271 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 369' ' ' GLY . . . . . 0.592 ' HA3' HG23 ' A' ' 330' ' ' VAL . . . -70.62 95.65 0.54 Allowed Glycine 0 CA--C 1.507 -0.425 0 C-N-CA 120.081 -1.057 . . . . 0.0 110.78 168.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -70.94 -27.17 72.67 Favored Glycine 0 C--N 1.313 -0.71 0 CA-C-N 115.166 -0.517 . . . . 0.0 112.939 -166.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -164.44 136.71 4.71 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.942 0.401 . . . . 0.0 110.685 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 372' ' ' ILE . . . . . 0.619 HG13 ' HG3' ' A' ' 328' ' ' MET . 0.4 OUTLIER -127.31 145.4 34.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 173.005 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 373' ' ' GLU . . . . . 0.796 ' HG3' HG12 ' A' ' 327' ' ' VAL . 3.8 mp0 -127.38 127.09 43.63 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 175.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 374' ' ' MET . . . . . 0.7 ' HG2' HD11 ' A' ' 383' ' ' ILE . 4.3 ppp? -138.3 166.83 23.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.926 -175.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 375' ' ' GLN . . . . . 0.816 ' HG2' HG23 ' A' ' 326' ' ' VAL . 0.0 OUTLIER -173.9 175.32 2.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.194 0.521 . . . . 0.0 110.59 165.945 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 376' ' ' LEU . . . . . 0.74 HD22 ' HD2' ' A' ' 377' ' ' PRO . 2.2 tm? -167.79 129.42 1.22 Allowed Pre-proline 0 C--N 1.315 -0.903 0 N-CA-C 105.11 -2.181 . . . . 0.0 105.11 176.439 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 377' ' ' PRO . . . . . 0.74 ' HD2' HD22 ' A' ' 376' ' ' LEU . 58.7 Cg_exo -24.97 125.79 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 124.503 3.469 . . . . 0.0 112.874 -179.192 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -35.51 134.42 0.22 Allowed 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 124.82 3.68 . . . . 0.0 113.019 -165.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 157.7 -171.79 34.88 Favored Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -159.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 380' ' ' ASP . . . . . 0.576 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 5.7 m-20 -97.07 127.46 43.06 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 117.494 0.647 . . . . 0.0 110.342 -178.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.587 HD22 ' HG2' ' A' ' 394' ' ' GLN . 25.5 m-80 -131.09 168.56 17.21 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 1.021 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -158.87 140.18 4.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 169.775 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 383' ' ' ILE . . . . . 0.7 HD11 ' HG2' ' A' ' 374' ' ' MET . 44.3 mt -99.82 130.44 48.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 C-N-CA 119.656 -0.818 . . . . 0.0 109.473 -175.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 384' ' ' TYR . . . . . 0.486 ' HB2' ' HG3' ' A' ' 343' ' ' ARG . 2.5 m-85 -100.95 136.6 40.55 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 169.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 385' ' ' VAL . . . . . 0.754 HG13 HG13 ' A' ' 342' ' ' VAL . 6.1 t -126.67 85.47 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 176.237 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 66.56 -109.75 3.09 Favored Glycine 0 N--CA 1.435 -1.432 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 -166.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -95.47 -7.52 37.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.856 0.328 . . . . 0.0 111.883 172.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 388' ' ' LEU . . . . . 0.492 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 1.4 mp -66.05 150.07 49.27 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 173.145 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 389' ' ' ASN . . . . . 0.54 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 7.7 p30 -166.05 154.78 11.22 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 121.275 -0.17 . . . . 0.0 110.669 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 390' ' ' HIS . . . . . 0.519 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 3.9 t60 -173.49 116.34 0.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.145 176.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 391' ' ' GLN . . . . . 1.021 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 6.3 tt0 -77.64 153.85 32.78 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.209 0.528 . . . . 0.0 112.364 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 392' ' ' TRP . . . . . 0.446 ' HD1' ' OE1' ' A' ' 394' ' ' GLN . 17.1 t-105 -169.53 147.71 3.61 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.054 176.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 393' ' ' PHE . . . . . 0.523 ' HB2' ' HE3' ' A' ' 395' ' ' LYS . 5.9 p90 -102.27 114.9 29.46 Favored 'General case' 0 C--N 1.313 -0.987 0 O-C-N 121.408 -0.807 . . . . 0.0 109.023 -178.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.587 ' HG2' HD22 ' A' ' 381' ' ' ASN . 2.8 mm100 -83.23 107.17 15.59 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -171.154 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.523 ' HE3' ' HB2' ' A' ' 393' ' ' PHE . 33.7 mmtp . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.022 -0.989 . . . . 0.0 109.965 -172.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 2.4 t . . . . . 0 CA--C 1.534 0.362 0 CA-C-O 121.306 0.574 . . . . 0.0 111.753 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 304' ' ' TYR . . . . . 0.525 ' HB3' ' NE ' ' A' ' 336' ' ' ARG . 21.7 p90 -63.11 124.27 20.72 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.931 0.396 . . . . 0.0 110.563 172.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.596 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 9.7 t -179.85 -176.75 0.36 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -176.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 47.8 t -64.21 112.69 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 166.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 307' ' ' CYS . . . . . 0.691 ' HB2' ' CZ ' ' A' ' 332' ' ' PHE . 0.0 OUTLIER -68.16 138.55 55.76 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.032 0.444 . . . . 0.0 110.456 -171.088 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 308' ' ' ASP . . . . . 0.588 ' OD2' HG22 ' A' ' 310' ' ' THR . 14.7 t70 -61.32 133.12 55.51 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.01 -171.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.432 ' O ' ' CE1' ' A' ' 312' ' ' PHE . 22.1 pttp -38.59 -28.94 0.03 OUTLIER 'General case' 0 C--O 1.22 -0.5 0 CA-C-N 113.097 -1.865 . . . . 0.0 114.973 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.588 HG22 ' OD2' ' A' ' 308' ' ' ASP . 13.5 t -109.05 10.4 26.13 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 119.286 0.948 . . . . 0.0 113.192 -169.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 311' ' ' LYS . . . . . 0.5 ' HB2' ' CE2' ' A' ' 332' ' ' PHE . 28.6 mtpp -96.02 -19.76 19.22 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 -174.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.846 ' HD1' HD13 ' A' ' 388' ' ' LEU . 0.3 OUTLIER -86.43 173.0 9.95 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.937 0.875 . . . . 0.0 111.882 177.124 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 8.9 t -153.34 162.11 41.63 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 113.981 -1.463 . . . . 0.0 109.131 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 14.5 m-90 -76.17 95.47 3.69 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 120.884 0.373 . . . . 0.0 110.38 -177.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.562 ' HB3' ' HB3' ' A' ' 329' ' ' GLU . 59.4 tttm -65.68 -46.62 78.39 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 165.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.62 ' HB3' ' HB2' ' A' ' 329' ' ' GLU . 40.7 ttt180 -153.09 128.32 9.81 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 114.45 -1.25 . . . . 0.0 108.864 169.103 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 317' ' ' ALA . . . . . 0.516 ' HB1' ' CG ' ' A' ' 390' ' ' HIS . . . -74.45 160.93 80.09 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-O 118.757 -0.64 . . . . 0.0 109.871 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 318' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 85.5 Cg_exo -36.87 108.87 0.06 OUTLIER 'Trans proline' 0 C--N 1.362 1.282 0 C-N-CA 123.149 2.566 . . . . 0.0 113.36 -178.253 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 18.6 m -127.44 132.86 49.99 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.944 -175.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 320' ' ' ASP . . . . . 0.571 ' HB2' ' CZ2' ' A' ' 392' ' ' TRP . 13.5 t70 -55.61 124.95 19.06 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 60.0 p -62.98 -46.73 86.32 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.411 0.624 . . . . 0.0 110.116 -173.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 122.8 -7.94 9.38 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -124.47 56.79 1.27 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.141 -0.529 . . . . 0.0 110.703 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 324' ' ' ASP . . . . . 0.587 ' HA ' ' HD3' ' A' ' 395' ' ' LYS . 21.5 m-20 56.87 31.19 19.22 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.458 176.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 325' ' ' THR . . . . . 0.54 ' HB ' HG13 ' A' ' 358' ' ' ILE . 15.7 p -150.67 -179.26 7.1 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -178.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 1.3 t -129.57 144.42 38.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.178 0.513 . . . . 0.0 110.973 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 327' ' ' VAL . . . . . 0.641 HG12 ' HG2' ' A' ' 373' ' ' GLU . 16.7 m -120.06 154.48 23.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.336 176.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 328' ' ' MET . . . . . 0.536 ' SD ' HG13 ' A' ' 330' ' ' VAL . 0.0 OUTLIER -143.15 147.07 34.35 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 176.722 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.62 ' HB2' ' HB3' ' A' ' 316' ' ' ARG . 9.0 mt-10 -130.32 128.13 40.88 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 121.076 0.465 . . . . 0.0 110.957 -176.141 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.536 HG13 ' SD ' ' A' ' 328' ' ' MET . 0.0 OUTLIER -128.35 149.8 33.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.928 -175.971 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 331' ' ' GLY . . . . . 0.662 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -128.72 141.78 12.9 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.503 -0.856 . . . . 0.0 113.094 -179.305 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 332' ' ' PHE . . . . . 0.721 ' HE1' ' HD2' ' A' ' 312' ' ' PHE . 3.5 m-85 -112.81 178.03 4.43 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.358 0.663 . . . . 0.0 111.041 174.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 50.7 m -136.03 4.41 2.98 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 170.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -145.68 -62.93 0.01 OUTLIER Glycine 0 C--N 1.34 0.767 0 C-N-CA 119.029 -1.558 . . . . 0.0 114.768 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 335' ' ' THR . . . . . 0.441 HG22 ' HB3' ' A' ' 338' ' ' CYS . 13.9 m -53.95 132.46 42.16 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.122 0.487 . . . . 0.0 111.11 -175.123 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.882 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 2.8 ptm180 -82.29 -176.76 0.83 Allowed Pre-proline 0 C--O 1.226 -0.133 0 CA-C-O 117.981 -1.009 . . . . 0.0 108.952 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.882 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.4 OUTLIER -31.7 98.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 123.264 2.643 . . . . 0.0 112.802 174.172 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 338' ' ' CYS . . . . . 0.596 ' HB2' ' O ' ' A' ' 305' ' ' THR . 26.3 p -119.91 -174.25 2.72 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 113.522 -1.672 . . . . 0.0 109.578 -170.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -108.96 107.12 17.37 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -178.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 340' ' ' ILE . . . . . 0.884 HD12 ' HB2' ' A' ' 362' ' ' PRO . 32.9 mt -73.26 120.12 79.37 Favored Pre-proline 0 C--N 1.329 -0.313 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.963 -173.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -77.11 80.36 2.89 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.187 1.925 . . . . 0.0 111.202 175.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.698 HG13 HG22 ' A' ' 340' ' ' ILE . 11.7 m -97.41 146.3 7.89 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.662 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.091 178.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.453 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 24.4 ptt180 -163.82 171.98 14.72 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 172.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 344' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -147.97 143.66 27.46 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.797 177.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.416 ' HB ' ' HA ' ' A' ' 350' ' ' PRO . 6.2 m -115.96 144.39 23.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -63.23 117.13 6.14 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.279 -0.418 . . . . 0.0 112.014 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 347' ' ' HIS . . . . . 0.729 ' HB3' ' HB2' ' A' ' 380' ' ' ASP . 11.6 p80 30.37 75.5 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 O-C-N 124.721 1.263 . . . . 0.0 113.671 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 348' ' ' GLY . . . . . 0.768 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 53.64 28.44 37.83 Favored Glycine 0 CA--C 1.519 0.337 0 N-CA-C 115.69 1.036 . . . . 0.0 115.69 178.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 349' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 347' ' ' HIS . 46.9 t -137.15 101.79 9.2 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 118.948 1.374 . . . . 0.0 108.731 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 350' ' ' PRO . . . . . 0.416 ' HA ' ' HB ' ' A' ' 345' ' ' VAL . 15.2 Cg_exo -73.06 66.51 4.17 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 123.112 2.542 . . . . 0.0 112.865 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -99.87 -55.39 2.66 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.282 -1.006 . . . . 0.0 108.282 177.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 4.7 p -130.1 136.2 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.215 174.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 353' ' ' ASN . . . . . 0.478 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 52.1 t30 -63.18 117.82 7.07 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.187 177.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 30.5 m -95.25 5.1 8.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.844 176.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 355' ' ' ALA . . . . . 0.4 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -77.47 84.16 3.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.235 0.541 . . . . 0.0 111.405 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.94 102.9 14.77 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 170.202 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.571 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 32.3 mt -83.45 117.93 23.4 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.41 -162.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.697 HD11 ' HB3' ' A' ' 375' ' ' GLN . 4.4 mm -59.54 -29.12 41.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.358 173.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 12.6 m -131.91 94.12 25.55 Favored Pre-proline 0 N--CA 1.446 -0.672 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.573 172.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -81.83 34.6 0.55 Allowed 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 123.522 2.815 . . . . 0.0 112.899 -173.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -151.63 70.68 8.11 Favored Pre-proline 0 C--N 1.316 -0.889 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.98 177.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 362' ' ' PRO . . . . . 0.983 ' HB3' HG23 ' A' ' 372' ' ' ILE . 60.3 Cg_endo -80.88 141.02 13.1 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.313 2.008 . . . . 0.0 111.314 175.184 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 363' ' ' THR . . . . . 0.611 ' O ' ' HA2' ' A' ' 369' ' ' GLY . 1.0 OUTLIER -143.66 143.25 31.36 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -174.11 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 364' ' ' MET . . . . . 0.807 ' HA ' ' HA2' ' A' ' 369' ' ' GLY . 5.2 mmt . . . . . 0 CA--C 1.5 -0.954 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 368' ' ' GLY . . . . . 0.662 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . . . . . . 0 N--CA 1.453 -0.207 0 N-CA-C 112.257 -0.337 . . . . 0.0 112.257 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 369' ' ' GLY . . . . . 0.807 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -68.07 -24.99 74.58 Favored Glycine 0 C--N 1.333 0.368 0 N-CA-C 114.132 0.413 . . . . 0.0 114.132 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 370' ' ' GLY . . . . . 0.591 ' O ' ' HG2' ' A' ' 329' ' ' GLU . . . 85.37 -58.15 4.91 Favored Glycine 0 C--N 1.318 -0.417 0 C-N-CA 120.143 -1.027 . . . . 0.0 113.313 178.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -165.87 145.84 6.45 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.14 0.495 . . . . 0.0 112.173 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 372' ' ' ILE . . . . . 0.983 HG23 ' HB3' ' A' ' 362' ' ' PRO . 0.7 OUTLIER -136.13 156.25 36.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.451 171.441 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 373' ' ' GLU . . . . . 0.641 ' HG2' HG12 ' A' ' 327' ' ' VAL . 42.5 mt-10 -134.4 126.54 29.77 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -178.272 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 374' ' ' MET . . . . . 0.571 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 2.9 mtt -142.65 165.03 28.49 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -176.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 375' ' ' GLN . . . . . 0.697 ' HB3' HD11 ' A' ' 358' ' ' ILE . 2.7 tp60 -178.62 173.45 1.3 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.784 0.326 . . . . 0.0 110.296 176.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 376' ' ' LEU . . . . . 0.722 HD22 ' HD2' ' A' ' 377' ' ' PRO . 2.0 tm? -165.62 139.62 3.79 Favored Pre-proline 0 C--N 1.318 -0.785 0 N-CA-C 104.44 -2.43 . . . . 0.0 104.44 -177.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 377' ' ' PRO . . . . . 0.722 ' HD2' HD22 ' A' ' 376' ' ' LEU . 37.8 Cg_exo -33.89 129.63 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.761 2.307 . . . . 0.0 112.299 175.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.467 ' HA ' ' OE1' ' A' ' 394' ' ' GLN . 75.8 Cg_exo -34.03 138.85 0.08 OUTLIER 'Trans proline' 0 C--N 1.362 1.243 0 C-N-CA 124.926 3.75 . . . . 0.0 113.932 -170.174 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 155.32 -158.38 28.38 Favored Glycine 0 N--CA 1.441 -0.975 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 -163.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 380' ' ' ASP . . . . . 0.729 ' HB2' ' HB3' ' A' ' 347' ' ' HIS . 8.9 m-20 -109.32 132.79 53.8 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 118.149 0.974 . . . . 0.0 111.522 175.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.47 ' ND2' ' HG2' ' A' ' 394' ' ' GLN . 56.3 m-20 -126.25 168.7 13.73 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 176.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 1.053 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -160.05 138.49 2.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 168.048 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 383' ' ' ILE . . . . . 0.614 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 57.6 mt -99.16 128.81 50.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 C-N-CA 120.074 -0.65 . . . . 0.0 109.926 -173.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 384' ' ' TYR . . . . . 0.453 ' O ' ' HG2' ' A' ' 343' ' ' ARG . 0.2 OUTLIER -104.26 99.57 9.29 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 114.302 -1.317 . . . . 0.0 108.791 170.771 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 385' ' ' VAL . . . . . 0.499 ' O ' ' HB2' ' A' ' 388' ' ' LEU . 11.5 t -94.77 88.21 2.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 174.06 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 67.82 -116.99 8.24 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.123 -1.037 . . . . 0.0 110.851 -174.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -92.43 -4.26 53.98 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 117.783 0.792 . . . . 0.0 111.684 171.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 388' ' ' LEU . . . . . 0.846 HD13 ' HD1' ' A' ' 312' ' ' PHE . 2.5 mp -71.15 150.79 45.05 Favored 'General case' 0 CA--C 1.522 -0.113 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 172.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 389' ' ' ASN . . . . . 0.614 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 7.3 p30 -164.44 152.22 12.11 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.651 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 390' ' ' HIS . . . . . 0.948 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 30.5 t60 -175.56 119.5 0.17 Allowed 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.493 0.495 . . . . 0.0 110.4 176.01 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 391' ' ' GLN . . . . . 1.053 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 15.0 tt0 -78.03 153.24 32.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.404 0.621 . . . . 0.0 112.582 -179.058 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 392' ' ' TRP . . . . . 0.571 ' CZ2' ' HB2' ' A' ' 320' ' ' ASP . 52.7 t-105 -153.49 143.59 22.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.884 178.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -104.48 110.03 22.14 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 176.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.487 ' HB2' HE22 ' A' ' 375' ' ' GLN . 1.0 OUTLIER -101.23 134.34 44.43 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 121.822 -0.549 . . . . 0.0 111.617 -164.847 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.587 ' HD3' ' HA ' ' A' ' 324' ' ' ASP . 13.2 mmmm . . . . . 0 C--O 1.245 0.824 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.794 -178.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 7.5 t . . . . . 0 CA--C 1.537 0.446 0 CA-C-O 121.12 0.486 . . . . 0.0 111.799 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 304' ' ' TYR . . . . . 0.636 ' HB2' ' O ' ' A' ' 337' ' ' PRO . 39.7 p90 -67.1 129.59 40.38 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.467 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 12.4 t 173.02 -167.18 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -170.185 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 7.8 p -62.09 112.17 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 172.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -73.54 137.75 44.56 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.175 -173.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 308' ' ' ASP . . . . . 0.738 ' OD1' HG22 ' A' ' 310' ' ' THR . 9.4 t70 -60.36 119.9 8.84 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.034 177.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.506 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 29.0 pttt -42.09 -22.45 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 115.961 1.837 . . . . 0.0 115.961 -175.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.738 HG22 ' OD1' ' A' ' 308' ' ' ASP . 6.2 t -107.54 12.44 27.73 Favored 'General case' 0 C--N 1.314 -0.959 0 O-C-N 121.331 -0.856 . . . . 0.0 111.206 -170.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 311' ' ' LYS . . . . . 0.459 ' HE3' ' OG1' ' A' ' 335' ' ' THR . 19.9 mtmm -96.37 -22.94 16.87 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -174.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.539 ' HA ' ' O ' ' A' ' 331' ' ' GLY . 0.1 OUTLIER -85.86 174.62 9.17 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.517 0.675 . . . . 0.0 110.957 176.678 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 13.2 t -147.83 158.46 44.04 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.34 -177.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 314' ' ' TRP . . . . . 0.496 ' HZ3' ' HB2' ' A' ' 328' ' ' MET . 19.2 m95 -79.44 95.61 5.83 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-O 121.018 0.437 . . . . 0.0 110.775 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.555 ' HG2' ' OE1' ' A' ' 329' ' ' GLU . 4.3 ttpp -69.91 -43.49 71.6 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 169.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 3.8 ttm180 -153.04 101.85 2.6 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.634 174.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -41.49 154.77 0.23 Allowed Pre-proline 0 N--CA 1.476 0.83 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 171.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 318' ' ' PRO . . . . . 0.461 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 3.8 Cg_exo -38.17 114.17 0.16 Allowed 'Trans proline' 0 C--N 1.366 1.493 0 C-N-CA 123.777 2.985 . . . . 0.0 113.228 -176.242 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 16.9 m -134.38 137.39 44.07 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.32 -174.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -59.17 131.32 50.67 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -177.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 321' ' ' SER . . . . . 0.641 ' HB3' HG13 ' A' ' 327' ' ' VAL . 51.5 p -80.34 5.86 13.66 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 122.149 -0.344 . . . . 0.0 111.6 -175.05 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 74.0 -22.34 1.22 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.105 -175.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 323' ' ' HIS . . . . . 0.411 ' H ' ' C ' ' A' ' 321' ' ' SER . 94.7 m-70 -102.33 47.77 0.89 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.381 0.61 . . . . 0.0 110.328 -177.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 324' ' ' ASP . . . . . 0.431 ' O ' HG23 ' A' ' 325' ' ' THR . 4.9 t70 55.94 39.18 30.59 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 114.403 -1.272 . . . . 0.0 111.659 174.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 325' ' ' THR . . . . . 0.431 HG23 ' O ' ' A' ' 324' ' ' ASP . 4.0 p -160.29 -171.59 3.24 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.766 ' HB ' ' SD ' ' A' ' 374' ' ' MET . 0.3 OUTLIER -132.57 146.2 33.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.546 0.689 . . . . 0.0 111.558 -175.125 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 327' ' ' VAL . . . . . 0.677 HG12 ' HG2' ' A' ' 373' ' ' GLU . 14.9 m -122.61 157.81 27.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.276 175.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 328' ' ' MET . . . . . 0.631 ' SD ' HD13 ' A' ' 383' ' ' ILE . 0.0 OUTLIER -135.62 146.67 48.14 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 173.223 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.555 ' OE1' ' HG2' ' A' ' 315' ' ' LYS . 9.5 tt0 -120.67 122.4 40.39 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -177.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 2.7 m -128.76 151.56 35.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.521 0.201 . . . . 0.0 111.301 -176.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 331' ' ' GLY . . . . . 0.826 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -126.84 139.4 11.22 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.478 -177.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 332' ' ' PHE . . . . . 0.434 ' H ' ' HA2' ' A' ' 368' ' ' GLY . 0.8 OUTLIER -89.37 152.88 21.27 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.367 0.603 . . . . 0.0 111.858 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 8.7 t -107.39 2.12 24.15 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 174.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -173.38 -63.6 0.05 OUTLIER Glycine 0 C--N 1.341 0.834 0 C-N-CA 118.676 -1.726 . . . . 0.0 115.144 175.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 335' ' ' THR . . . . . 0.459 ' OG1' ' HE3' ' A' ' 311' ' ' LYS . 51.5 m -52.46 134.13 34.96 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 123.805 0.356 . . . . 0.0 111.251 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.644 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 16.1 ptt180 -90.62 -175.95 0.58 Allowed Pre-proline 0 CA--C 1.536 0.429 0 CA-C-O 117.212 -1.375 . . . . 0.0 108.624 -175.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.7 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.1 OUTLIER -24.07 96.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 124.061 3.174 . . . . 0.0 114.65 -170.869 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 338' ' ' CYS . . . . . 0.734 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 3.9 p -109.95 -176.05 2.9 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 113.719 -1.582 . . . . 0.0 110.32 -169.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -112.16 96.3 5.95 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 177.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 340' ' ' ILE . . . . . 0.762 HG22 HG13 ' A' ' 342' ' ' VAL . 61.9 mt -78.18 118.86 74.79 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.302 -169.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -79.65 82.46 2.49 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.837 2.358 . . . . 0.0 111.903 177.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.762 HG13 HG22 ' A' ' 340' ' ' ILE . 4.2 m -100.94 123.68 54.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.504 0.669 . . . . 0.0 110.669 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -132.07 173.97 10.67 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 176.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 344' ' ' ALA . . . . . 0.542 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -144.96 140.97 28.6 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.718 175.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.521 HG22 HD12 ' A' ' 382' ' ' ILE . 10.6 m -114.62 140.59 34.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.291 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.423 ' HB2' ' CG1' ' A' ' 354' ' ' VAL . . . -67.62 121.4 15.81 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 347' ' ' HIS . . . . . 0.574 ' O ' HG23 ' A' ' 349' ' ' VAL . 6.9 t60 46.62 59.79 3.7 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 124.336 1.022 . . . . 0.0 111.038 174.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 348' ' ' GLY . . . . . 0.473 ' H ' ' CG2' ' A' ' 382' ' ' ILE . . . 45.86 39.16 8.4 Favored Glycine 0 C--N 1.335 0.515 0 N-CA-C 115.097 0.799 . . . . 0.0 115.097 -174.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 349' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 347' ' ' HIS . 58.9 t -137.35 102.19 8.94 Favored Pre-proline 0 C--O 1.235 0.301 0 CA-C-N 118.219 1.009 . . . . 0.0 108.949 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -75.82 61.38 6.28 Favored 'Trans proline' 0 N--CA 1.464 -0.209 0 C-N-CA 122.802 2.334 . . . . 0.0 113.245 -178.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -100.51 -56.76 2.26 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 175.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 2.3 p -117.48 127.49 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.535 174.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -63.38 112.08 2.57 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.774 175.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.654 HG12 ' HG ' ' A' ' 376' ' ' LEU . 4.2 m -92.68 9.02 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.713 177.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 355' ' ' ALA . . . . . 0.542 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -79.17 82.97 5.28 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.147 0.498 . . . . 0.0 111.041 176.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 5.4 tmm? -92.92 100.5 12.95 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 169.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 22.2 mt -86.89 117.87 25.9 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.072 -163.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.73 ' HB ' ' CB ' ' A' ' 373' ' ' GLU . 2.7 mm -61.46 -25.03 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.632 175.385 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 19.5 m -138.91 93.72 10.41 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.828 173.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -88.61 41.1 0.57 Allowed 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 123.275 2.65 . . . . 0.0 114.063 -171.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -161.83 72.48 2.41 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-O 121.235 0.54 . . . . 0.0 109.779 175.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 362' ' ' PRO . . . . . 0.872 ' HB3' HG23 ' A' ' 372' ' ' ILE . 87.8 Cg_endo -82.58 108.57 1.71 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.79 2.327 . . . . 0.0 112.302 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 16.8 p -89.78 144.28 26.1 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.671 0.748 . . . . 0.0 112.326 171.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 364' ' ' MET . . . . . 0.734 ' HG2' ' SG ' ' A' ' 338' ' ' CYS . 5.7 ptp . . . . . 0 CA--C 1.499 -0.981 0 CA-C-N 114.387 -1.279 . . . . 0.0 108.153 174.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 368' ' ' GLY . . . . . 0.826 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . . . . . . 0 N--CA 1.444 -0.817 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 369' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -48.23 -34.31 12.47 Favored Glycine 0 CA--C 1.519 0.313 0 CA-C-N 117.725 0.763 . . . . 0.0 113.303 172.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 370' ' ' GLY . . . . . 0.49 ' O ' ' HG3' ' A' ' 329' ' ' GLU . . . 81.53 -58.17 4.88 Favored Glycine 0 C--O 1.227 -0.314 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.584 176.082 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -165.19 137.82 4.42 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.043 0.449 . . . . 0.0 111.125 178.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 372' ' ' ILE . . . . . 0.872 HG23 ' HB3' ' A' ' 362' ' ' PRO . 0.9 OUTLIER -134.4 159.1 42.12 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 172.846 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 373' ' ' GLU . . . . . 0.73 ' CB ' ' HB ' ' A' ' 358' ' ' ILE . 36.5 mt-10 -128.21 125.92 39.94 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.581 -177.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 374' ' ' MET . . . . . 0.766 ' SD ' ' HB ' ' A' ' 326' ' ' VAL . 0.0 OUTLIER -136.43 160.37 38.97 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -179.083 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 375' ' ' GLN . . . . . 0.436 ' HB2' HG23 ' A' ' 326' ' ' VAL . 3.2 tp60 -177.91 170.11 1.93 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.918 0.39 . . . . 0.0 110.208 172.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 376' ' ' LEU . . . . . 0.75 HD22 ' HD2' ' A' ' 377' ' ' PRO . 2.3 tm? -166.93 131.81 1.66 Allowed Pre-proline 0 N--CA 1.439 -0.991 0 N-CA-C 104.537 -2.394 . . . . 0.0 104.537 -178.214 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 377' ' ' PRO . . . . . 0.75 ' HD2' HD22 ' A' ' 376' ' ' LEU . 35.7 Cg_exo -28.95 131.0 0.04 OUTLIER 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 123.788 2.992 . . . . 0.0 112.811 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -35.56 138.21 0.15 Allowed 'Trans proline' 0 C--N 1.359 1.106 0 C-N-CA 124.658 3.572 . . . . 0.0 113.582 -166.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 151.87 -165.07 30.56 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 -160.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 380' ' ' ASP . . . . . 0.471 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 15.8 m-20 -99.7 128.78 45.8 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 117.925 0.862 . . . . 0.0 111.23 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.525 ' ND2' ' HG3' ' A' ' 394' ' ' GLN . 60.3 m-20 -128.43 159.79 34.3 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 174.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 1.024 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -150.55 139.1 14.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 170.313 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 383' ' ' ILE . . . . . 0.668 HD11 ' SD ' ' A' ' 374' ' ' MET . 31.5 mt -99.51 127.02 52.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.44 -176.092 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 384' ' ' TYR . . . . . 0.444 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.2 OUTLIER -104.41 92.54 4.37 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.226 174.017 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 385' ' ' VAL . . . . . 0.529 ' O ' ' HB2' ' A' ' 388' ' ' LEU . 20.3 t -85.13 86.19 2.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 178.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 60.46 -112.57 4.66 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.287 -0.959 . . . . 0.0 111.341 -170.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 387' ' ' ASP . . . . . 0.408 ' N ' ' HB2' ' A' ' 309' ' ' LYS . 4.9 t70 -82.86 -17.05 45.23 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.008 0.432 . . . . 0.0 110.793 176.613 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 388' ' ' LEU . . . . . 0.529 ' HB2' ' O ' ' A' ' 385' ' ' VAL . 2.3 mp -69.38 151.83 45.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.209 177.121 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 389' ' ' ASN . . . . . 0.657 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 7.6 p30 -165.37 153.34 11.24 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.575 176.197 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 390' ' ' HIS . . . . . 0.461 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 35.5 t-80 -173.74 113.74 0.21 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.323 177.084 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 391' ' ' GLN . . . . . 1.024 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 13.6 tt0 -73.65 154.62 39.64 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.293 177.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 392' ' ' TRP . . . . . 0.553 ' HD1' ' OE1' ' A' ' 394' ' ' GLN . 17.8 t-105 -166.63 150.99 7.41 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.77 177.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -105.33 115.89 31.03 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.553 ' OE1' ' HD1' ' A' ' 392' ' ' TRP . 3.5 mm100 -84.4 113.96 21.55 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -170.33 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 1.7 ptmm? . . . . . 0 C--O 1.251 1.172 0 CA-C-O 118.442 -0.79 . . . . 0.0 110.818 -178.252 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 303' ' ' THR . . . . . 0.54 HG23 HG23 ' A' ' 335' ' ' THR . 10.4 t . . . . . 0 CA--C 1.539 0.543 0 CA-C-O 121.949 0.881 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -69.84 116.38 10.16 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 175.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.587 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 13.0 t 177.38 -172.32 0.1 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -172.113 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 56.2 t -65.81 110.59 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 169.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 307' ' ' CYS . . . . . 1.009 ' HB3' HG21 ' A' ' 335' ' ' THR . 0.0 OUTLIER -68.37 135.83 52.41 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.966 0.413 . . . . 0.0 110.43 -169.886 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 308' ' ' ASP . . . . . 0.603 ' OD1' HG22 ' A' ' 310' ' ' THR . 17.1 t70 -64.32 126.16 26.91 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.31 -174.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.501 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -47.9 -17.74 0.13 Allowed 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 -168.85 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.603 HG22 ' OD1' ' A' ' 308' ' ' ASP . 11.8 t -108.92 3.28 22.12 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 119.88 1.218 . . . . 0.0 111.999 -173.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -78.51 -30.91 47.41 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -173.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.504 ' HE1' ' HB2' ' A' ' 307' ' ' CYS . 0.0 OUTLIER -79.77 176.32 9.82 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-O 122.198 0.999 . . . . 0.0 111.821 -173.951 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 8.8 t -148.66 156.93 43.06 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 113.487 -1.688 . . . . 0.0 107.995 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 27.6 m-90 -68.66 121.19 15.93 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.409 ' HB3' ' C ' ' A' ' 329' ' ' GLU . 54.4 tptt -103.13 -41.94 5.93 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 173.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -154.83 130.62 10.03 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.308 170.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -69.31 162.09 68.71 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.631 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 318' ' ' PRO . . . . . 0.737 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 53.8 Cg_exo -46.13 111.39 0.34 Allowed 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 122.311 2.007 . . . . 0.0 112.087 177.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 319' ' ' THR . . . . . 0.457 ' C ' HG13 ' A' ' 326' ' ' VAL . 17.2 m -130.08 132.7 46.27 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.655 -172.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -54.99 124.74 17.72 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 178.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 321' ' ' SER . . . . . 0.502 ' C ' ' H ' ' A' ' 323' ' ' HIS . 23.8 p -75.71 0.96 15.96 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.756 0.422 . . . . 0.0 111.848 -170.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 72.57 -26.91 0.73 Allowed Glycine 0 C--N 1.331 0.29 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.453 -169.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 323' ' ' HIS . . . . . 0.502 ' H ' ' C ' ' A' ' 321' ' ' SER . 30.4 t60 -95.87 44.6 1.08 Allowed 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 121.087 0.47 . . . . 0.0 109.789 -175.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 17.5 t70 59.12 31.51 21.35 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.001 175.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 325' ' ' THR . . . . . 0.848 ' HA ' ' HG3' ' A' ' 375' ' ' GLN . 4.6 p -152.05 -171.88 4.06 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -178.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.457 HG13 ' C ' ' A' ' 319' ' ' THR . 48.2 t -137.71 129.17 39.65 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.611 0 CA-C-N 118.466 0.575 . . . . 0.0 111.085 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 327' ' ' VAL . . . . . 0.527 HG12 ' HG2' ' A' ' 373' ' ' GLU . 12.5 m -107.46 163.07 5.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.524 -178.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 328' ' ' MET . . . . . 0.549 ' SD ' HG13 ' A' ' 330' ' ' VAL . 0.0 OUTLIER -145.65 154.61 42.3 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 174.433 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.428 ' HG3' ' O ' ' A' ' 370' ' ' GLY . 16.5 tt0 -133.28 130.53 39.07 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.387 -175.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.549 HG13 ' SD ' ' A' ' 328' ' ' MET . 0.2 OUTLIER -130.01 153.31 38.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.839 -178.277 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 331' ' ' GLY . . . . . 0.414 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -121.18 137.12 11.62 Favored Glycine 0 CA--C 1.522 0.484 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.852 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 332' ' ' PHE . . . . . 0.458 ' HD2' ' N ' ' A' ' 335' ' ' THR . 1.3 p90 -88.05 155.85 19.6 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.673 0.749 . . . . 0.0 112.768 -178.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 28.3 p -115.69 20.93 14.32 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.76 -1.109 . . . . 0.0 112.764 169.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 164.24 -14.11 0.09 OUTLIER Glycine 0 N--CA 1.465 0.588 0 C-N-CA 120.112 -1.042 . . . . 0.0 113.846 173.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 335' ' ' THR . . . . . 1.009 HG21 ' HB3' ' A' ' 307' ' ' CYS . 0.2 OUTLIER -85.99 118.42 25.46 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 179.656 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 336' ' ' ARG . 4.8 ptp180 -100.22 178.94 1.12 Allowed Pre-proline 0 N--CA 1.451 -0.421 0 CA-C-O 116.549 -1.691 . . . . 0.0 106.475 174.422 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.57 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.1 OUTLIER -23.26 91.04 0.0 OUTLIER 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 123.736 2.957 . . . . 0.0 114.387 -164.047 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 338' ' ' CYS . . . . . 0.587 ' HB2' ' O ' ' A' ' 305' ' ' THR . 14.2 p -115.41 -176.74 2.98 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 112.68 -2.055 . . . . 0.0 109.303 -170.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? -111.4 101.8 10.23 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 340' ' ' ILE . . . . . 0.763 HG22 HG13 ' A' ' 342' ' ' VAL . 59.1 mt -72.95 118.78 71.32 Favored Pre-proline 0 C--N 1.325 -0.488 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.515 -170.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -74.18 79.24 2.44 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 121.969 1.78 . . . . 0.0 110.644 175.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.763 HG13 HG22 ' A' ' 340' ' ' ILE . 1.1 m -103.13 122.91 56.18 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.86 0 CA-C-O 121.874 0.845 . . . . 0.0 111.076 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.518 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 15.4 ptt180 -135.62 176.77 8.37 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 114.046 -1.434 . . . . 0.0 108.029 175.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 344' ' ' ALA . . . . . 0.503 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -148.66 144.31 27.07 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.554 175.334 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.436 ' O ' HG23 ' A' ' 382' ' ' ILE . 11.6 m -117.09 144.9 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 176.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -68.66 116.08 8.77 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 178.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 347' ' ' HIS . . . . . 0.627 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 12.2 t60 40.64 67.68 0.49 Allowed 'General case' 0 N--CA 1.478 0.96 0 O-C-N 124.399 1.062 . . . . 0.0 111.519 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 348' ' ' GLY . . . . . 0.76 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 40.96 48.19 4.21 Favored Glycine 0 C--N 1.332 0.353 0 N-CA-C 115.206 0.842 . . . . 0.0 115.206 -174.053 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 349' ' ' VAL . . . . . 0.699 HG12 ' HG2' ' A' ' 351' ' ' GLU . 61.8 t -141.43 101.5 6.12 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 118.173 0.986 . . . . 0.0 108.457 176.302 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -80.53 72.3 6.6 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 123.131 2.554 . . . . 0.0 113.679 -176.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 351' ' ' GLU . . . . . 0.699 ' HG2' HG12 ' A' ' 349' ' ' VAL . 4.8 mm-40 -99.52 -58.04 2.02 Favored 'General case' 0 CA--C 1.502 -0.9 0 CA-C-O 122.6 1.191 . . . . 0.0 107.937 171.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 352' ' ' VAL . . . . . 0.455 HG12 ' HB2' ' A' ' 351' ' ' GLU . 1.1 p -125.47 127.17 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 112.644 -2.071 . . . . 0.0 110.127 -177.269 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -62.64 114.44 3.58 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.998 178.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.796 ' HB ' ' ND2' ' A' ' 381' ' ' ASN . 3.5 m -94.05 6.62 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.131 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 355' ' ' ALA . . . . . 0.503 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -74.67 83.13 2.08 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.886 0.374 . . . . 0.0 111.33 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 356' ' ' MET . . . . . 0.634 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 37.0 ttm -94.9 98.31 10.62 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 171.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.639 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 42.8 mt -87.46 123.92 32.89 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.802 -162.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.776 HD11 ' HB2' ' A' ' 375' ' ' GLN . 2.3 mm -62.88 -23.6 33.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.526 173.313 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 8.3 m -132.38 92.18 28.92 Favored Pre-proline 0 N--CA 1.447 -0.582 0 CA-C-N 114.499 -1.228 . . . . 0.0 108.547 170.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -86.41 28.77 0.53 Allowed 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.133 2.555 . . . . 0.0 112.466 -175.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -156.9 65.66 3.75 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 114.77 -1.104 . . . . 0.0 109.217 177.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 362' ' ' PRO . . . . . 0.712 ' HB2' HD12 ' A' ' 340' ' ' ILE . 87.2 Cg_endo -86.03 114.6 1.36 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.5 2.134 . . . . 0.0 111.991 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 363' ' ' THR . . . . . 0.407 HG22 ' O ' ' A' ' 338' ' ' CYS . 15.1 p -92.64 147.08 23.17 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 171.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 364' ' ' MET . . . . . 0.749 ' HA ' ' HA2' ' A' ' 369' ' ' GLY . 46.6 mtt . . . . . 0 CA--C 1.499 -1.009 0 CA-C-N 113.936 -1.484 . . . . 0.0 108.449 172.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 368' ' ' GLY . . . . . 0.414 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 369' ' ' GLY . . . . . 0.749 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -46.64 -40.89 12.17 Favored Glycine 0 CA--C 1.519 0.305 0 CA-C-N 117.588 0.694 . . . . 0.0 113.476 173.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 370' ' ' GLY . . . . . 0.428 ' O ' ' HG3' ' A' ' 329' ' ' GLU . . . 83.28 -51.17 4.53 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.152 177.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -166.01 143.79 5.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.921 0.391 . . . . 0.0 111.616 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 372' ' ' ILE . . . . . 0.627 HD13 HG11 ' A' ' 342' ' ' VAL . 0.9 OUTLIER -134.71 151.46 31.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 170.398 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 373' ' ' GLU . . . . . 0.66 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 44.5 mt-10 -128.75 126.86 40.87 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.815 0.34 . . . . 0.0 110.355 -178.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 374' ' ' MET . . . . . 0.821 ' HG2' HD11 ' A' ' 383' ' ' ILE . 4.2 ppp? -137.3 165.1 26.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.589 -178.157 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 375' ' ' GLN . . . . . 0.848 ' HG3' ' HA ' ' A' ' 325' ' ' THR . 0.3 OUTLIER -177.32 -179.9 0.91 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.303 0.573 . . . . 0.0 111.692 168.954 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 376' ' ' LEU . . . . . 0.701 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 13.1 tp -167.96 155.0 7.68 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 178.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 377' ' ' PRO . . . . . 0.701 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 82.8 Cg_exo -45.53 131.67 12.49 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 121.287 1.325 . . . . 0.0 110.046 167.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.491 ' CA ' HE22 ' A' ' 394' ' ' GLN . 4.0 Cg_exo -35.07 141.12 0.09 OUTLIER 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 125.103 3.869 . . . . 0.0 113.979 -171.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 152.64 -167.37 31.49 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 -163.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 380' ' ' ASP . . . . . 0.627 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 5.0 m-20 -99.4 124.31 44.43 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 117.548 0.674 . . . . 0.0 111.395 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.796 ' ND2' ' HB ' ' A' ' 354' ' ' VAL . 11.5 m120 -134.19 141.64 47.12 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 0.963 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -142.58 137.05 28.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -179.837 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 383' ' ' ILE . . . . . 0.821 HD11 ' HG2' ' A' ' 374' ' ' MET . 47.6 mt -98.25 127.83 50.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.751 -172.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 384' ' ' TYR . . . . . 0.518 ' O ' ' HG2' ' A' ' 343' ' ' ARG . 0.3 OUTLIER -104.98 91.42 3.8 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.197 173.469 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 9.3 t -83.34 90.27 2.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 61.45 -113.26 5.52 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.461 -0.876 . . . . 0.0 111.027 -170.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -88.11 -16.36 33.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.759 0.314 . . . . 0.0 110.883 175.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 388' ' ' LEU . . . . . 0.437 HD13 ' HD2' ' A' ' 312' ' ' PHE . 0.9 OUTLIER -69.51 155.69 40.07 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.191 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 389' ' ' ASN . . . . . 0.64 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 28.2 p-10 -165.98 157.3 13.66 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.778 177.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 390' ' ' HIS . . . . . 0.737 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 56.5 t-80 -174.55 120.98 0.25 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.202 174.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 391' ' ' GLN . . . . . 0.963 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 21.3 tt0 -75.35 149.51 38.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.438 0.637 . . . . 0.0 112.115 -177.083 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 392' ' ' TRP . . . . . . . . . . . . . 70.5 t-105 -146.12 143.35 29.27 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.426 177.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 393' ' ' PHE . . . . . 0.685 ' HD2' ' HE2' ' A' ' 395' ' ' LYS . 12.3 p90 -104.15 107.38 18.26 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 173.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.491 HE22 ' CA ' ' A' ' 378' ' ' PRO . 2.8 pp0? -94.33 123.05 37.49 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.805 0.812 . . . . 0.0 110.972 -170.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.685 ' HE2' ' HD2' ' A' ' 393' ' ' PHE . 48.6 mttm . . . . . 0 C--O 1.245 0.834 0 CA-C-N 114.464 -1.244 . . . . 0.0 108.911 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 303' ' ' THR . . . . . 0.475 ' O ' HG23 ' A' ' 335' ' ' THR . 5.2 t . . . . . 0 CA--C 1.538 0.505 0 CA-C-O 121.486 0.66 . . . . 0.0 111.001 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -65.98 124.67 23.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.151 0.501 . . . . 0.0 110.023 177.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.501 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 14.3 t 175.79 -170.58 0.06 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.113 -171.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 61.3 t -63.64 108.86 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 168.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.56 142.14 55.29 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.747 0.308 . . . . 0.0 110.567 -169.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 308' ' ' ASP . . . . . 0.689 ' OD1' HG22 ' A' ' 310' ' ' THR . 16.1 t70 -64.46 131.91 48.48 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.813 0.816 . . . . 0.0 112.004 -170.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -37.72 -30.65 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 112.975 -1.921 . . . . 0.0 115.222 -177.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.689 HG22 ' OD1' ' A' ' 308' ' ' ASP . 11.6 t -105.19 -1.85 24.89 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 118.747 0.703 . . . . 0.0 112.376 -169.18 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 27.0 mmmt -70.13 -35.05 73.79 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.284 0.564 . . . . 0.0 110.908 -178.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.635 ' HB3' ' HE1' ' A' ' 364' ' ' MET . 0.1 OUTLIER -90.47 177.64 6.32 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 122.296 1.046 . . . . 0.0 112.544 -174.553 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 14.2 t -161.8 168.86 22.41 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 113.534 -1.666 . . . . 0.0 108.978 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 314' ' ' TRP . . . . . 0.4 ' CE3' ' HA ' ' A' ' 317' ' ' ALA . 92.9 m95 -83.91 96.72 8.91 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 121.371 0.605 . . . . 0.0 110.648 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.684 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 56.7 tttm -66.61 -40.13 88.69 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 167.454 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 61.4 ttt180 -158.9 131.79 7.05 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.333 168.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 317' ' ' ALA . . . . . 0.471 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -74.87 163.66 66.69 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.059 -176.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 318' ' ' PRO . . . . . 0.471 ' HD2' ' HB1' ' A' ' 317' ' ' ALA . 4.9 Cg_exo -37.64 116.05 0.19 Allowed 'Trans proline' 0 C--N 1.362 1.239 0 C-N-CA 123.58 2.853 . . . . 0.0 113.364 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 28.8 m -132.9 138.36 46.95 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.424 -176.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 320' ' ' ASP . . . . . 0.432 ' OD2' ' HZ2' ' A' ' 392' ' ' TRP . 45.5 m-20 -61.13 132.83 55.0 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -178.345 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 321' ' ' SER . . . . . 0.449 ' HB3' HG13 ' A' ' 327' ' ' VAL . 60.3 p -71.52 1.58 6.3 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 122.492 0.317 . . . . 0.0 111.466 -174.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 70.52 -22.06 0.54 Allowed Glycine 0 CA--C 1.521 0.452 0 C-N-CA 121.438 -0.411 . . . . 0.0 113.642 -170.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 323' ' ' HIS . . . . . 0.6 ' O ' ' HB3' ' A' ' 324' ' ' ASP . 40.9 m80 -77.67 -41.74 37.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.993 0.396 . . . . 0.0 111.7 -172.401 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 324' ' ' ASP . . . . . 0.6 ' HB3' ' O ' ' A' ' 323' ' ' HIS . 4.5 p-10 144.37 13.89 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.721 0 O-C-N 124.354 1.034 . . . . 0.0 109.89 -163.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 325' ' ' THR . . . . . 0.455 ' HA ' ' HG2' ' A' ' 375' ' ' GLN . 6.5 p -150.13 -170.23 3.59 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -170.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 373' ' ' GLU . 1.4 t -130.04 148.71 33.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.173 0.511 . . . . 0.0 111.03 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 327' ' ' VAL . . . . . 0.694 HG12 ' HG2' ' A' ' 373' ' ' GLU . 19.1 m -128.7 157.42 41.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.982 178.162 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 328' ' ' MET . . . . . 0.649 ' HE2' HD12 ' A' ' 372' ' ' ILE . 23.1 ptt? -140.89 156.3 46.13 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 170.006 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.684 ' HG2' ' HD3' ' A' ' 315' ' ' LYS . 22.8 tt0 -121.8 119.12 30.75 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 19.5 m -122.97 142.23 40.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 120.676 0.274 . . . . 0.0 110.792 -175.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 331' ' ' GLY . . . . . 0.537 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -125.49 138.28 10.82 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.247 -0.978 . . . . 0.0 113.199 -173.112 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 332' ' ' PHE . . . . . 0.848 ' HE2' ' HB ' ' A' ' 335' ' ' THR . 0.0 OUTLIER -147.61 163.13 37.56 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 176.114 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 15.1 m -151.96 44.48 0.74 Allowed 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -174.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -139.34 -65.82 0.04 OUTLIER Glycine 0 C--N 1.331 0.258 0 C-N-CA 119.369 -1.396 . . . . 0.0 112.126 169.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 335' ' ' THR . . . . . 0.848 ' HB ' ' HE2' ' A' ' 332' ' ' PHE . 28.6 m -52.9 140.56 24.21 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.234 -0.983 . . . . 0.0 109.236 172.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.635 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 21.9 ptt180 -87.91 178.37 2.18 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 117.592 -1.194 . . . . 0.0 108.725 176.357 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.635 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 2.2 Cg_exo -27.65 104.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.372 1.776 0 C-N-CA 123.573 2.849 . . . . 0.0 113.58 -178.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 338' ' ' CYS . . . . . 0.584 ' SG ' ' HB2' ' A' ' 364' ' ' MET . 22.2 p -116.74 -174.3 2.55 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 113.882 -1.508 . . . . 0.0 110.286 -167.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 -111.71 101.6 9.96 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 340' ' ' ILE . . . . . 0.496 HG12 HG13 ' A' ' 342' ' ' VAL . 13.4 tt -77.61 121.93 85.05 Favored Pre-proline 0 C--N 1.325 -0.47 0 C-N-CA 119.118 -1.033 . . . . 0.0 110.849 -167.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -78.16 80.55 2.96 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.252 1.968 . . . . 0.0 111.954 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.604 HG12 HG13 ' A' ' 385' ' ' VAL . 30.2 m -106.07 153.31 7.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.355 -178.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.513 ' HG3' ' HB2' ' A' ' 384' ' ' TYR . 40.3 ptt180 -168.33 174.99 6.65 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -179.059 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 344' ' ' ALA . . . . . 0.549 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -149.81 144.36 25.95 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.931 -0.708 . . . . 0.0 110.885 177.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.547 ' HB ' ' HA ' ' A' ' 350' ' ' PRO . 4.6 m -116.72 147.09 20.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -69.53 125.59 27.17 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 176.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 347' ' ' HIS . . . . . 0.526 ' O ' HG23 ' A' ' 349' ' ' VAL . 5.0 t60 43.88 60.17 2.82 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 124.422 1.077 . . . . 0.0 111.665 172.073 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 348' ' ' GLY . . . . . 0.617 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 43.02 42.79 5.26 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 115.046 0.778 . . . . 0.0 115.046 -174.012 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 349' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 347' ' ' HIS . 75.5 t -139.98 101.8 7.0 Favored Pre-proline 0 C--N 1.331 -0.227 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 350' ' ' PRO . . . . . 0.547 ' HA ' ' HB ' ' A' ' 345' ' ' VAL . 12.5 Cg_exo -75.41 54.8 3.95 Favored 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 122.913 2.408 . . . . 0.0 113.834 -176.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -100.15 -56.35 2.39 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 176.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.7 p -112.28 123.69 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.854 172.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 353' ' ' ASN . . . . . 0.549 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 6.1 t30 -65.8 122.25 16.89 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.371 174.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.459 HG21 ' HA ' ' A' ' 381' ' ' ASN . 29.1 m -97.56 4.51 9.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.143 176.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 355' ' ' ALA . . . . . 0.529 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -76.93 83.95 3.48 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.893 -179.208 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 356' ' ' MET . . . . . 0.683 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 53.3 ttp -95.36 99.87 11.73 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 169.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.437 ' CD2' ' HB3' ' A' ' 374' ' ' MET . 36.5 mt -85.34 116.49 23.7 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.768 -162.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.752 ' HB ' ' CB ' ' A' ' 373' ' ' GLU . 1.7 mm -64.6 -24.36 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 174.188 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 72.3 m -118.61 85.15 26.23 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 114.294 -1.321 . . . . 0.0 108.257 169.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 360' ' ' PRO . . . . . 0.411 ' HA ' ' HB2' ' A' ' 357' ' ' LEU . 75.0 Cg_endo -84.3 26.04 0.67 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.115 2.543 . . . . 0.0 114.448 -167.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -166.52 68.34 1.04 Allowed Pre-proline 0 C--N 1.311 -1.093 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.587 173.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 362' ' ' PRO . . . . . 0.655 ' HB3' HG23 ' A' ' 372' ' ' ILE . 58.6 Cg_endo -82.54 169.05 14.08 Favored 'Trans proline' 0 C--O 1.246 0.889 0 C-N-CA 122.542 2.161 . . . . 0.0 113.317 -178.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 4.2 p -143.7 -176.53 5.01 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.087 -168.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 364' ' ' MET . . . . . 0.8 ' HA ' ' HA2' ' A' ' 369' ' ' GLY . 42.4 mtp . . . . . 0 C--N 1.312 -1.026 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 172.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 368' ' ' GLY . . . . . 0.571 ' HA2' ' HD1' ' A' ' 332' ' ' PHE . . . . . . . . 0 N--CA 1.447 -0.573 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 369' ' ' GLY . . . . . 0.8 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -54.61 -47.19 71.57 Favored Glycine 0 CA--C 1.505 -0.548 0 C-N-CA 121.371 -0.442 . . . . 0.0 113.391 177.506 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 370' ' ' GLY . . . . . 0.62 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 90.12 -134.61 12.44 Favored Glycine 0 N--CA 1.438 -1.194 0 C-N-CA 119.943 -1.122 . . . . 0.0 110.917 -172.32 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -103.16 140.61 37.12 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.513 0.673 . . . . 0.0 111.697 -177.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 372' ' ' ILE . . . . . 0.655 HG23 ' HB3' ' A' ' 362' ' ' PRO . 1.5 mt -128.25 161.31 36.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.044 176.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 373' ' ' GLU . . . . . 0.752 ' CB ' ' HB ' ' A' ' 358' ' ' ILE . 38.8 mt-10 -124.49 128.54 49.14 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.484 0.659 . . . . 0.0 110.97 -179.073 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 374' ' ' MET . . . . . 0.447 ' O ' ' HB2' ' A' ' 375' ' ' GLN . 0.1 OUTLIER -140.32 157.31 45.76 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.38 -1.282 . . . . 0.0 108.188 -179.923 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 375' ' ' GLN . . . . . 0.683 ' O ' ' HB3' ' A' ' 356' ' ' MET . 3.6 tp60 179.83 175.45 0.78 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 118.224 0.465 . . . . 0.0 109.803 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 376' ' ' LEU . . . . . 1.013 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 11.2 tp -166.69 164.45 10.38 Favored Pre-proline 0 N--CA 1.446 -0.63 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 176.523 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 377' ' ' PRO . . . . . 1.013 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 80.0 Cg_exo -43.63 133.92 7.39 Favored 'Trans proline' 0 CA--C 1.533 0.433 0 C-N-CA 121.38 1.387 . . . . 0.0 111.3 169.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.509 ' HB3' ' OXT' ' A' ' 395' ' ' LYS . 4.7 Cg_exo -35.47 144.22 0.08 OUTLIER 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 125.177 3.918 . . . . 0.0 114.223 -175.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 151.17 -159.69 28.31 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -164.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 380' ' ' ASP . . . . . 0.46 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 7.5 m-20 -104.7 131.55 52.01 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 118.013 0.906 . . . . 0.0 110.939 175.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.459 ' HA ' HG21 ' A' ' 354' ' ' VAL . 10.0 m120 -128.5 145.53 51.08 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 177.029 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 1.018 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -143.91 136.97 23.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 176.634 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 383' ' ' ILE . . . . . 0.644 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 13.4 mt -100.72 131.71 47.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.326 -173.196 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 384' ' ' TYR . . . . . 0.513 ' HB2' ' HG3' ' A' ' 343' ' ' ARG . 5.0 m-85 -99.91 133.72 43.86 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 114.51 -1.223 . . . . 0.0 108.163 167.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 385' ' ' VAL . . . . . 0.84 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 4.5 t -124.21 82.05 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 177.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 59.91 -108.57 1.79 Allowed Glycine 0 N--CA 1.434 -1.455 0 C-N-CA 119.837 -1.173 . . . . 0.0 110.848 -167.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -83.12 -15.51 50.47 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 175.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 388' ' ' LEU . . . . . 0.84 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 4.1 mp -69.68 155.77 40.0 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.477 0.179 . . . . 0.0 110.625 177.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 389' ' ' ASN . . . . . 0.644 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 4.9 p-10 -171.41 152.25 3.24 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.426 174.245 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 390' ' ' HIS . . . . . 0.423 ' O ' HG12 ' A' ' 382' ' ' ILE . 6.5 t60 -173.91 120.45 0.29 Allowed 'General case' 0 C--O 1.237 0.421 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 177.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 391' ' ' GLN . . . . . 1.018 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 39.7 tt0 -76.35 152.94 36.18 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.294 0.568 . . . . 0.0 112.496 -175.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 392' ' ' TRP . . . . . 0.432 ' HZ2' ' OD2' ' A' ' 320' ' ' ASP . 59.0 t-105 -150.2 148.82 29.38 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.397 177.075 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -111.64 114.03 26.8 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 173.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.401 HE22 ' CA ' ' A' ' 378' ' ' PRO . 2.4 pp0? -103.01 127.31 50.3 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.334 0.588 . . . . 0.0 110.069 -172.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.648 ' H ' ' HD3' ' A' ' 395' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.021 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.514 -174.267 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 303' ' ' THR . . . . . 0.446 ' O ' HG22 ' A' ' 305' ' ' THR . 10.0 t . . . . . 0 CA--C 1.535 0.378 0 CA-C-O 121.471 0.653 . . . . 0.0 111.437 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 304' ' ' TYR . . . . . 0.478 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 43.7 p90 -64.03 120.87 12.85 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 172.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.619 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 14.2 t 170.75 -166.75 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -170.025 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 19.2 t -65.32 110.58 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 171.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 307' ' ' CYS . . . . . 0.412 ' HB3' HG21 ' A' ' 335' ' ' THR . 0.1 OUTLIER -68.79 141.33 55.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.007 0.432 . . . . 0.0 110.955 -173.698 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 308' ' ' ASP . . . . . 0.609 ' OD1' HG22 ' A' ' 310' ' ' THR . 9.4 t70 -60.82 123.02 16.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.944 -177.259 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 34.7 pttt -45.28 -17.53 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 115.4 1.629 . . . . 0.0 115.4 -177.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.609 HG22 ' OD1' ' A' ' 308' ' ' ASP . 10.6 t -109.63 9.08 25.14 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 120.212 1.369 . . . . 0.0 112.252 -174.266 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 311' ' ' LYS . . . . . 0.447 ' HG3' ' HB3' ' A' ' 308' ' ' ASP . 26.2 mtpp -90.42 -27.03 19.56 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -174.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.839 ' HD1' HD13 ' A' ' 388' ' ' LEU . 0.4 OUTLIER -85.91 173.55 9.89 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.887 0.851 . . . . 0.0 112.443 -175.925 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 11.2 t -153.6 158.91 41.87 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.203 -1.362 . . . . 0.0 109.101 -178.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 16.4 m95 -79.79 95.53 6.04 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 120.981 0.42 . . . . 0.0 111.376 -176.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.499 ' HB3' ' C ' ' A' ' 329' ' ' GLU . 31.8 tptt -63.37 -49.64 73.06 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 167.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.404 ' HB3' ' HB2' ' A' ' 329' ' ' GLU . 3.8 ttm180 -154.73 131.55 10.77 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.211 -0.904 . . . . 0.0 108.918 175.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -75.07 159.31 82.99 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-O 119.051 -0.499 . . . . 0.0 110.908 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -34.27 113.24 0.08 OUTLIER 'Trans proline' 0 C--N 1.365 1.397 0 C-N-CA 123.78 2.987 . . . . 0.0 113.545 177.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 21.0 m -130.89 137.15 49.2 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.932 -175.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -58.82 128.18 35.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.664 -0.244 . . . . 0.0 110.36 -179.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 60.5 p -74.68 3.98 7.0 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.026 0.53 . . . . 0.0 111.85 -173.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 70.61 -18.79 0.74 Allowed Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.238 -0.506 . . . . 0.0 114.08 -172.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 323' ' ' HIS . . . . . 0.445 ' O ' ' CB ' ' A' ' 324' ' ' ASP . 11.5 m170 -92.01 -13.75 30.5 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 117.579 0.69 . . . . 0.0 112.791 -174.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 324' ' ' ASP . . . . . 0.445 ' CB ' ' O ' ' A' ' 323' ' ' HIS . 29.9 t70 108.0 35.39 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 O-C-N 125.329 1.643 . . . . 0.0 109.033 -175.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 325' ' ' THR . . . . . 0.572 ' HA ' ' CG ' ' A' ' 375' ' ' GLN . 3.3 p -150.97 -173.77 4.59 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.697 HG23 ' HG2' ' A' ' 375' ' ' GLN . 0.6 OUTLIER -130.04 143.74 40.13 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.589 0 CA-C-N 118.776 0.716 . . . . 0.0 111.511 -177.33 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 327' ' ' VAL . . . . . 0.835 HG12 ' HG2' ' A' ' 373' ' ' GLU . 19.2 m -123.28 146.2 29.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.466 176.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 328' ' ' MET . . . . . 0.63 ' SD ' HG21 ' A' ' 383' ' ' ILE . 6.1 ptp -130.61 153.5 48.85 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 174.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.499 ' C ' ' HB3' ' A' ' 315' ' ' LYS . 3.8 tt0 -125.75 126.27 44.31 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.541 HG23 ' HA3' ' A' ' 369' ' ' GLY . 10.7 m -125.58 159.05 33.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.351 -176.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 331' ' ' GLY . . . . . 0.528 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -130.8 135.59 8.35 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 118.843 -1.646 . . . . 0.0 114.482 178.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 332' ' ' PHE . . . . . 1.011 ' H ' ' HA2' ' A' ' 368' ' ' GLY . 36.2 m-85 -112.52 171.49 7.49 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.442 0.697 . . . . 0.0 110.074 170.332 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 34.7 m -130.58 -15.17 3.58 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 174.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -123.82 -66.42 0.2 Allowed Glycine 0 C--O 1.224 -0.484 0 C-N-CA 119.766 -1.207 . . . . 0.0 113.659 -175.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 335' ' ' THR . . . . . 0.412 HG21 ' HB3' ' A' ' 307' ' ' CYS . 12.8 m -54.16 129.01 33.32 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 123.747 0.322 . . . . 0.0 111.202 -176.069 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.669 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 6.4 ptm180 -88.7 179.45 1.63 Allowed Pre-proline 0 CA--C 1.532 0.269 0 CA-C-O 117.442 -1.266 . . . . 0.0 108.123 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.669 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -26.89 99.41 0.02 OUTLIER 'Trans proline' 0 C--N 1.372 1.816 0 C-N-CA 123.888 3.059 . . . . 0.0 114.155 -175.574 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 338' ' ' CYS . . . . . 0.619 ' HB2' ' O ' ' A' ' 305' ' ' THR . 19.2 p -115.61 -175.61 2.75 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 113.583 -1.644 . . . . 0.0 109.302 -169.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -106.54 96.34 6.38 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 340' ' ' ILE . . . . . 0.856 HD12 ' HD2' ' A' ' 341' ' ' PRO . 9.3 tp -75.54 120.05 79.88 Favored Pre-proline 0 C--N 1.325 -0.457 0 C-N-CA 119.011 -1.076 . . . . 0.0 110.924 -168.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 341' ' ' PRO . . . . . 0.856 ' HD2' HD12 ' A' ' 340' ' ' ILE . 53.5 Cg_endo -72.87 79.45 1.96 Allowed 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 121.92 1.746 . . . . 0.0 111.216 175.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.69 HG13 HG13 ' A' ' 340' ' ' ILE . 2.5 m -103.85 109.64 27.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.273 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.612 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 18.9 ptt180 -127.45 175.64 8.07 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 344' ' ' ALA . . . . . 0.559 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -147.42 145.87 29.38 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.407 176.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.475 HG22 HD12 ' A' ' 382' ' ' ILE . 10.4 m -115.63 143.34 25.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 176.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -62.05 115.85 4.44 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.326 176.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 347' ' ' HIS . . . . . 0.762 ' HB3' ' HB2' ' A' ' 380' ' ' ASP . 13.6 p80 33.62 73.17 0.07 Allowed 'General case' 0 N--CA 1.472 0.664 0 O-C-N 124.618 1.199 . . . . 0.0 113.822 177.117 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 348' ' ' GLY . . . . . 0.734 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 53.18 31.59 41.76 Favored Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 115.324 0.89 . . . . 0.0 115.324 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 49.8 t -139.49 102.88 7.16 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 118.584 1.192 . . . . 0.0 109.011 178.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -71.88 62.55 3.15 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.966 2.444 . . . . 0.0 112.778 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -100.87 -55.98 2.44 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 177.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.2 p -121.54 131.43 73.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.434 174.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 353' ' ' ASN . . . . . 0.433 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 43.4 t30 -64.19 113.04 3.3 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.551 174.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.401 ' CG1' HD22 ' A' ' 376' ' ' LEU . 27.5 m -97.25 5.16 9.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.05 -178.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 355' ' ' ALA . . . . . 0.559 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -76.38 86.25 3.15 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.027 0.441 . . . . 0.0 111.272 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.96 100.58 12.08 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 171.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.587 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 23.8 mt -85.57 120.17 26.72 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.931 -164.272 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.712 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 2.1 mm -65.86 -25.9 37.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 173.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 50.4 m -120.68 82.27 33.9 Favored Pre-proline 0 N--CA 1.446 -0.652 0 CA-C-N 114.41 -1.268 . . . . 0.0 108.153 170.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -85.86 21.0 1.14 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.088 2.525 . . . . 0.0 113.785 -169.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 361' ' ' ASN . . . . . 0.55 ' N ' ' HD3' ' A' ' 362' ' ' PRO . 15.8 m120 -145.77 52.88 1.66 Allowed Pre-proline 0 C--N 1.312 -1.054 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.348 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 362' ' ' PRO . . . . . 0.55 ' HD3' ' N ' ' A' ' 361' ' ' ASN . 11.0 Cg_endo -78.81 147.11 21.38 Favored 'Trans proline' 0 C--O 1.251 1.161 0 C-N-CA 121.635 1.557 . . . . 0.0 113.142 -177.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 6.3 p -139.99 116.85 10.97 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.664 -169.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 364' ' ' MET . . . . . 0.774 ' HG3' HD13 ' A' ' 340' ' ' ILE . 11.3 mmt . . . . . 0 C--N 1.311 -1.094 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.96 -170.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 368' ' ' GLY . . . . . 1.011 ' HA2' ' H ' ' A' ' 332' ' ' PHE . . . . . . . . 0 N--CA 1.448 -0.516 0 N-CA-C 114.535 0.574 . . . . 0.0 114.535 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 369' ' ' GLY . . . . . 0.541 ' HA3' HG23 ' A' ' 330' ' ' VAL . . . -177.18 93.47 0.09 OUTLIER Glycine 0 C--N 1.312 -0.759 0 N-CA-C 107.652 -2.179 . . . . 0.0 107.652 -171.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 370' ' ' GLY . . . . . 0.442 ' O ' ' HG3' ' A' ' 329' ' ' GLU . . . -74.31 -43.24 32.28 Favored Glycine 0 C--N 1.304 -1.248 0 C-N-CA 120.826 -0.702 . . . . 0.0 114.639 -155.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -166.2 136.6 3.42 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 120.966 0.413 . . . . 0.0 110.754 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 372' ' ' ILE . . . . . 0.62 ' O ' ' HA ' ' A' ' 327' ' ' VAL . 0.9 OUTLIER -136.67 135.52 48.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.947 176.771 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 373' ' ' GLU . . . . . 0.835 ' HG2' HG12 ' A' ' 327' ' ' VAL . 25.8 mt-10 -110.98 131.22 55.23 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.703 -176.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 374' ' ' MET . . . . . 0.649 ' HG2' HD11 ' A' ' 383' ' ' ILE . 0.0 OUTLIER -137.17 165.1 26.9 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.794 -1.093 . . . . 0.0 108.627 178.987 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 375' ' ' GLN . . . . . 0.705 ' HB2' HD11 ' A' ' 358' ' ' ILE . 0.0 OUTLIER -176.14 -175.95 0.75 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.807 0.813 . . . . 0.0 110.813 169.309 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 376' ' ' LEU . . . . . 0.957 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 14.5 tp -166.21 162.9 12.09 Favored Pre-proline 0 N--CA 1.437 -1.081 0 N-CA-C 103.806 -2.664 . . . . 0.0 103.806 173.325 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 377' ' ' PRO . . . . . 0.957 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 66.6 Cg_exo -39.65 130.99 1.84 Allowed 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 121.356 1.37 . . . . 0.0 110.705 167.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -37.2 141.32 0.18 Allowed 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 124.201 3.267 . . . . 0.0 112.694 -176.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 149.43 -174.86 28.86 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -163.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 380' ' ' ASP . . . . . 0.762 ' HB2' ' HB3' ' A' ' 347' ' ' HIS . 6.1 m-20 -94.41 125.92 39.35 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 117.501 0.65 . . . . 0.0 110.167 -175.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.684 ' HB2' HE21 ' A' ' 394' ' ' GLN . 28.4 m-80 -137.29 170.24 16.43 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 1.023 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -160.55 143.98 4.82 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 175.426 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 383' ' ' ILE . . . . . 0.688 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 44.2 mt -101.48 128.82 53.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.31 -175.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 384' ' ' TYR . . . . . 0.612 ' O ' ' HG2' ' A' ' 343' ' ' ARG . 0.7 OUTLIER -104.06 92.07 4.22 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.971 171.935 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 385' ' ' VAL . . . . . 0.478 ' O ' ' HB2' ' A' ' 388' ' ' LEU . 15.2 t -84.0 89.45 2.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 178.242 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 386' ' ' GLY . . . . . 0.752 ' HA3' ' HZ ' ' A' ' 312' ' ' PHE . . . 61.05 -116.52 9.46 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.1 -1.048 . . . . 0.0 111.136 -172.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -78.49 -20.76 50.12 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.848 0.356 . . . . 0.0 111.366 174.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 388' ' ' LEU . . . . . 0.839 HD13 ' HD1' ' A' ' 312' ' ' PHE . 2.4 mp -70.26 155.12 41.1 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.37 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 389' ' ' ASN . . . . . 0.688 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 7.0 p30 -167.8 152.73 6.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.886 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -173.48 118.55 0.29 Allowed 'General case' 0 C--O 1.24 0.554 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 177.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 391' ' ' GLN . . . . . 1.023 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 15.5 tt0 -80.93 153.32 27.61 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.894 0.878 . . . . 0.0 112.081 -176.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 392' ' ' TRP . . . . . 0.532 ' HD1' ' NE2' ' A' ' 394' ' ' GLN . 6.0 t-105 -172.31 150.99 2.45 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.47 -178.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 393' ' ' PHE . . . . . 0.501 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 21.3 p90 -102.34 119.12 38.28 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 121.214 -0.929 . . . . 0.0 108.807 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.684 HE21 ' HB2' ' A' ' 381' ' ' ASN . 18.4 mm-40 -85.98 127.28 34.6 Favored 'General case' 0 C--O 1.238 0.469 0 O-C-N 121.909 -0.495 . . . . 0.0 109.878 -167.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm . . . . . 0 C--O 1.246 0.897 0 O-C-N 124.348 1.03 . . . . 0.0 110.651 175.793 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 303' ' ' THR . . . . . 0.611 HG23 HG23 ' A' ' 335' ' ' THR . 5.8 t . . . . . 0 CA--C 1.537 0.48 0 CA-C-O 121.344 0.592 . . . . 0.0 111.764 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -68.11 122.87 19.18 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 175.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.498 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 7.4 t 178.54 -167.89 0.07 Allowed 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -171.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 30.8 t -69.78 113.65 5.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 167.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 307' ' ' CYS . . . . . 0.502 ' SG ' HG21 ' A' ' 335' ' ' THR . 0.1 OUTLIER -66.6 147.27 53.5 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.842 0.83 . . . . 0.0 112.135 -169.864 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 308' ' ' ASP . . . . . 0.51 ' OD1' HG22 ' A' ' 310' ' ' THR . 12.1 t70 -66.58 128.21 35.35 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.163 -1.381 . . . . 0.0 110.145 177.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.415 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -44.64 -13.13 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 115.775 1.769 . . . . 0.0 115.775 -176.406 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.51 HG22 ' OD1' ' A' ' 308' ' ' ASP . 12.0 t -108.96 -2.37 18.32 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 119.775 1.17 . . . . 0.0 113.086 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 311' ' ' LYS . . . . . 0.676 ' HE2' ' OG1' ' A' ' 335' ' ' THR . 31.2 mmmt -65.69 -35.68 81.45 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -173.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.586 ' HA ' ' O ' ' A' ' 331' ' ' GLY . 0.1 OUTLIER -86.01 174.25 9.34 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 122.086 0.946 . . . . 0.0 112.405 -175.129 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 313' ' ' THR . . . . . 0.42 ' C ' HD21 ' A' ' 388' ' ' LEU . 12.6 t -151.98 161.47 42.58 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 113.65 -1.614 . . . . 0.0 109.459 -177.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 314' ' ' TRP . . . . . 0.546 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 28.8 m-90 -77.32 124.19 27.53 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 121.295 0.569 . . . . 0.0 110.034 -178.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.61 ' HB3' ' HB3' ' A' ' 329' ' ' GLU . 63.0 tttt -108.04 -41.95 4.8 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 172.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.643 ' HB3' ' HB2' ' A' ' 329' ' ' GLU . 3.9 ttm180 -151.16 130.02 12.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.762 171.123 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -70.25 157.74 89.19 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.453 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 318' ' ' PRO . . . . . 0.628 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 1.6 Cg_endo -45.66 118.44 2.23 Favored 'Trans proline' 0 C--N 1.359 1.118 0 C-N-CA 122.541 2.161 . . . . 0.0 112.27 -178.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 47.5 m -134.96 145.16 47.87 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.243 -174.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -60.07 134.5 57.11 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 321' ' ' SER . . . . . 0.49 ' HB3' HG13 ' A' ' 327' ' ' VAL . 79.9 p -76.92 1.04 18.77 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -173.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 73.1 -20.47 1.14 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.833 -169.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 323' ' ' HIS . . . . . 0.427 ' H ' ' C ' ' A' ' 321' ' ' SER . 96.6 m-70 -112.2 50.15 0.87 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.111 0.482 . . . . 0.0 110.369 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 9.5 t70 54.03 38.22 28.5 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.835 174.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 325' ' ' THR . . . . . 0.449 ' HB ' HG13 ' A' ' 358' ' ' ILE . 2.6 p -150.86 -168.47 3.11 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 175.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.569 HG13 HE22 ' A' ' 394' ' ' GLN . 0.4 OUTLIER -129.13 141.25 47.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 118.245 0.475 . . . . 0.0 110.873 -178.782 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 327' ' ' VAL . . . . . 0.828 HG12 ' HG2' ' A' ' 373' ' ' GLU . 17.6 m -121.35 149.16 24.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.682 177.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 328' ' ' MET . . . . . 0.686 ' SD ' ' HB ' ' A' ' 372' ' ' ILE . 0.1 OUTLIER -141.94 150.73 41.82 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 176.194 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.643 ' HB2' ' HB3' ' A' ' 316' ' ' ARG . 9.9 mt-10 -124.94 128.86 49.27 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 120.825 0.345 . . . . 0.0 110.2 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.484 HG23 ' HA3' ' A' ' 369' ' ' GLY . 1.8 m -131.78 152.66 37.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.854 -178.005 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 331' ' ' GLY . . . . . 0.586 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -113.86 178.15 18.21 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-O 119.475 -0.625 . . . . 0.0 112.536 -178.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 332' ' ' PHE . . . . . 0.709 ' HB2' ' SD ' ' A' ' 364' ' ' MET . 0.5 OUTLIER -128.77 142.83 50.86 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 117.467 0.633 . . . . 0.0 111.158 -178.409 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 5.3 p -87.57 -17.64 31.53 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 173.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 177.09 -39.61 0.1 OUTLIER Glycine 0 C--N 1.338 0.641 0 C-N-CA 117.943 -2.075 . . . . 0.0 116.045 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 335' ' ' THR . . . . . 0.676 ' OG1' ' HE2' ' A' ' 311' ' ' LYS . 81.2 m -52.91 131.78 36.27 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.342 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.833 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 1.4 ptp180 -79.24 -179.98 1.59 Allowed Pre-proline 0 N--CA 1.449 -0.495 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -177.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.833 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 1.3 Cg_exo -27.56 100.88 0.02 OUTLIER 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 123.269 2.646 . . . . 0.0 113.742 178.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 338' ' ' CYS . . . . . 0.918 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 26.3 p -130.54 150.39 51.76 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.402 -176.277 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -67.17 123.93 21.67 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.444 170.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 340' ' ' ILE . . . . . 0.426 HG12 HG13 ' A' ' 342' ' ' VAL . 19.2 tt -94.64 117.73 66.93 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.155 -176.496 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -70.37 82.29 0.89 Allowed 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.513 2.142 . . . . 0.0 112.042 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.668 HG12 HG13 ' A' ' 385' ' ' VAL . 11.4 m -102.31 115.4 44.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.468 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.4 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 36.1 ptt180 -130.34 178.13 6.82 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.044 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 344' ' ' ALA . . . . . 0.469 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -151.21 148.85 28.73 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.89 177.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.414 ' O ' HG23 ' A' ' 382' ' ' ILE . 14.7 m -121.57 146.86 25.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -70.17 119.19 13.99 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 177.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 347' ' ' HIS . . . . . 0.661 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 68.8 t60 47.36 57.5 5.77 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 124.172 0.92 . . . . 0.0 111.457 174.063 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 348' ' ' GLY . . . . . 0.619 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 44.83 44.22 8.58 Favored Glycine 0 CA--C 1.521 0.413 0 N-CA-C 114.671 0.628 . . . . 0.0 114.671 -172.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 349' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 347' ' ' HIS . 57.4 t -139.82 102.23 7.05 Favored Pre-proline 0 C--O 1.234 0.271 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -76.36 64.19 7.18 Favored 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 123.06 2.507 . . . . 0.0 113.847 -175.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -100.52 -57.09 2.18 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 174.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 4.3 p -115.55 125.94 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.676 174.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 353' ' ' ASN . . . . . 0.462 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 39.5 t30 -62.89 108.89 1.29 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.57 174.147 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.509 ' HA ' HD22 ' A' ' 376' ' ' LEU . 27.6 m -86.81 0.97 6.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.078 -179.056 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 355' ' ' ALA . . . . . 0.469 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -76.88 84.32 3.45 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 121.476 0.655 . . . . 0.0 110.468 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 356' ' ' MET . . . . . 0.676 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 11.9 tpt -98.96 103.62 15.59 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 170.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.546 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 42.4 mt -86.2 119.64 26.7 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.177 -161.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.699 ' HB ' ' CB ' ' A' ' 373' ' ' GLU . 3.0 mm -64.77 -27.18 41.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 173.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 89.8 m -122.06 84.53 45.4 Favored Pre-proline 0 N--CA 1.449 -0.52 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.572 171.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -85.39 28.07 0.58 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.119 2.546 . . . . 0.0 113.65 -171.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 361' ' ' ASN . . . . . 0.443 ' N ' ' HD3' ' A' ' 362' ' ' PRO . 2.4 p-10 -148.59 55.0 1.91 Allowed Pre-proline 0 C--N 1.313 -0.99 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.488 177.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 362' ' ' PRO . . . . . 0.774 ' HB3' HG23 ' A' ' 372' ' ' ILE . 73.5 Cg_endo -85.08 162.53 11.61 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 121.884 1.723 . . . . 0.0 113.041 -179.101 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 363' ' ' THR . . . . . 0.669 ' O ' ' HA2' ' A' ' 369' ' ' GLY . 1.2 p -145.2 -172.7 3.92 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.89 -172.406 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 364' ' ' MET . . . . . 0.918 ' HG2' ' SG ' ' A' ' 338' ' ' CYS . 9.3 ptp . . . . . 0 C--N 1.316 -0.876 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 162.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 368' ' ' GLY . . . . . 0.473 ' HA2' ' HB3' ' A' ' 332' ' ' PHE . . . . . . . . 0 N--CA 1.449 -0.468 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 369' ' ' GLY . . . . . 0.669 ' HA2' ' O ' ' A' ' 363' ' ' THR . . . -47.53 -54.0 11.61 Favored Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.921 -0.657 . . . . 0.0 113.303 172.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 370' ' ' GLY . . . . . 0.596 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 89.26 -126.97 8.46 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.441 -0.885 . . . . 0.0 111.447 -176.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -101.76 131.74 47.89 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.708 0.29 . . . . 0.0 111.213 -175.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 372' ' ' ILE . . . . . 0.774 HG23 ' HB3' ' A' ' 362' ' ' PRO . 0.2 OUTLIER -131.03 166.1 29.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 173.698 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 373' ' ' GLU . . . . . 0.828 ' HG2' HG12 ' A' ' 327' ' ' VAL . 24.1 mt-10 -133.97 132.64 40.4 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.363 0.601 . . . . 0.0 111.349 177.223 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 374' ' ' MET . . . . . 0.589 ' HG2' HD11 ' A' ' 383' ' ' ILE . 0.0 OUTLIER -135.08 166.17 23.69 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 177.245 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 375' ' ' GLN . . . . . 0.676 ' O ' ' HB3' ' A' ' 356' ' ' MET . 2.5 tp60 175.93 176.0 0.26 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.345 0.521 . . . . 0.0 109.694 170.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 376' ' ' LEU . . . . . 1.002 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 9.4 tp -166.18 175.36 2.32 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 103.498 -2.779 . . . . 0.0 103.498 177.275 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 377' ' ' PRO . . . . . 1.002 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 58.2 Cg_exo -40.87 130.36 2.83 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 CA-C-N 121.789 1.675 . . . . 0.0 111.882 167.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.473 ' HD2' ' HA ' ' A' ' 377' ' ' PRO . 5.1 Cg_exo -41.05 146.98 0.31 Allowed 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 124.018 3.145 . . . . 0.0 112.207 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 145.34 -168.39 27.21 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.18 -1.01 . . . . 0.0 110.83 -163.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 380' ' ' ASP . . . . . 0.661 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 3.1 m-20 -88.35 119.81 29.13 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 117.134 0.467 . . . . 0.0 110.026 -178.202 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.428 HD22 ' HG2' ' A' ' 394' ' ' GLN . 26.2 m-80 -132.99 144.64 50.23 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 1.044 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -143.86 137.04 24.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.218 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 383' ' ' ILE . . . . . 0.698 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 44.1 mt -97.96 127.7 50.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.506 -175.389 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 384' ' ' TYR . . . . . 0.523 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.2 OUTLIER -104.64 91.73 3.99 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 114.322 -1.308 . . . . 0.0 108.426 173.475 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 385' ' ' VAL . . . . . 0.668 HG13 HG12 ' A' ' 342' ' ' VAL . 17.7 t -84.23 89.44 2.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 64.23 -110.35 3.39 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 120.278 -0.963 . . . . 0.0 110.725 -170.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -94.22 -9.13 37.22 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.867 0.334 . . . . 0.0 111.366 172.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 388' ' ' LEU . . . . . 0.583 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 3.1 mp -66.75 153.35 43.51 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 174.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 389' ' ' ASN . . . . . 0.698 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 9.0 p30 -164.06 156.51 17.28 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.927 177.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 390' ' ' HIS . . . . . 0.628 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 23.4 t-80 -174.75 117.83 0.19 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.924 172.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 391' ' ' GLN . . . . . 1.044 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 22.5 tm0? -79.08 154.35 29.47 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.11 0.481 . . . . 0.0 110.978 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 392' ' ' TRP . . . . . 0.499 ' HD1' ' OE1' ' A' ' 394' ' ' GLN . 6.6 t-105 -166.73 150.93 7.21 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.111 -0.95 . . . . 0.0 108.51 -178.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -105.93 119.67 39.77 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.569 HE22 HG13 ' A' ' 326' ' ' VAL . 3.8 mm100 -85.67 113.22 21.71 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -173.004 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.753 ' H ' ' HD3' ' A' ' 395' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.131 -0.938 . . . . 0.0 111.285 -178.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 303' ' ' THR . . . . . 0.403 HG23 ' O ' ' A' ' 303' ' ' THR . 4.5 t . . . . . 0 N--CA 1.445 -0.696 0 CA-C-O 121.532 0.682 . . . . 0.0 110.664 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 304' ' ' TYR . . . . . 0.615 ' HB3' ' HE ' ' A' ' 336' ' ' ARG . 5.2 p90 -74.46 127.31 32.74 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 171.44 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' A' ' 304' ' ' TYR . 11.6 t 172.82 -169.83 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -173.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 37.2 t -66.78 112.83 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 169.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 307' ' ' CYS . . . . . 0.459 ' HB3' HG21 ' A' ' 335' ' ' THR . 0.1 OUTLIER -67.81 141.02 56.63 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.436 -171.976 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 308' ' ' ASP . . . . . 0.561 ' HB3' ' HG3' ' A' ' 311' ' ' LYS . 10.4 t0 -59.33 124.45 20.05 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.044 -176.511 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -40.7 -29.85 0.1 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.101 -1.408 . . . . 0.0 114.418 -177.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 11.4 t -107.08 1.41 24.22 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.348 0.594 . . . . 0.0 111.123 -170.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 311' ' ' LYS . . . . . 0.561 ' HG3' ' HB3' ' A' ' 308' ' ' ASP . 49.2 mtpt -90.36 43.85 1.17 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.534 0.683 . . . . 0.0 110.079 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.691 ' HB3' HD13 ' A' ' 388' ' ' LEU . 0.3 OUTLIER -140.7 157.14 45.87 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.635 -168.464 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 15.0 p -144.72 152.83 40.98 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.967 175.168 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 314' ' ' TRP . . . . . 0.61 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 20.1 m-90 -79.94 94.51 5.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.97 0.414 . . . . 0.0 110.231 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 18.8 tttm -71.24 -42.59 68.66 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.167 173.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 41.0 ttm105 -154.99 98.56 2.04 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.105 173.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -41.91 152.07 0.31 Allowed Pre-proline 0 N--CA 1.472 0.662 0 C-N-CA 123.695 0.798 . . . . 0.0 112.441 174.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 318' ' ' PRO . . . . . 0.483 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 1.0 OUTLIER -44.24 117.11 1.21 Allowed 'Trans proline' 0 C--N 1.365 1.443 0 C-N-CA 123.083 2.522 . . . . 0.0 113.099 -174.292 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 10.1 m -133.41 144.15 49.35 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.004 -174.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -59.1 129.64 43.11 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.625 0.25 . . . . 0.0 110.566 177.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 321' ' ' SER . . . . . 0.734 ' HB3' HG13 ' A' ' 327' ' ' VAL . 59.6 p -77.96 6.73 7.17 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.513 0.725 . . . . 0.0 111.771 -174.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 81.7 -16.75 18.27 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.649 -0.786 . . . . 0.0 113.039 -170.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 20.7 m80 -98.34 7.61 45.98 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 117.19 0.495 . . . . 0.0 111.217 -177.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 72.33 49.66 0.21 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.947 0.88 . . . . 0.0 109.233 -177.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 325' ' ' THR . . . . . 0.699 ' HA ' HE21 ' A' ' 375' ' ' GLN . 4.5 p -157.99 163.92 37.31 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 -177.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -111.0 132.63 58.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 119.755 1.161 . . . . 0.0 112.619 -172.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 327' ' ' VAL . . . . . 0.847 HG12 ' HG2' ' A' ' 373' ' ' GLU . 15.4 m -115.2 163.98 11.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.878 174.216 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 10.1 ptm -153.33 152.25 30.9 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 172.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -114.1 135.31 54.16 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.571 HG23 ' HA3' ' A' ' 369' ' ' GLY . 3.1 m -132.94 146.66 32.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 C-N-CA 120.366 -0.534 . . . . 0.0 112.275 -178.364 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 331' ' ' GLY . . . . . 0.592 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -118.66 134.6 10.97 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.241 -0.98 . . . . 0.0 112.062 -179.189 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 332' ' ' PHE . . . . . 0.763 ' HB3' ' SD ' ' A' ' 364' ' ' MET . 0.1 OUTLIER -89.56 157.65 17.97 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -177.112 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 36.0 t -71.11 -33.36 70.08 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 112.658 -2.064 . . . . 0.0 112.29 169.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 168.62 -17.89 0.07 OUTLIER Glycine 0 CA--C 1.526 0.776 0 C-N-CA 119.62 -1.276 . . . . 0.0 114.689 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 335' ' ' THR . . . . . 0.488 ' O ' ' HD2' ' A' ' 332' ' ' PHE . 25.8 m -54.62 120.09 6.21 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.699 0.25 . . . . 0.0 110.889 176.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.694 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 9.2 ptt180 -75.46 -176.53 0.58 Allowed Pre-proline 0 N--CA 1.467 0.38 0 CA-C-O 117.62 -1.181 . . . . 0.0 108.85 -172.101 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.83 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.1 OUTLIER -26.67 95.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 123.693 2.929 . . . . 0.0 113.379 177.072 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 338' ' ' CYS . . . . . 0.69 ' SG ' ' HE2' ' A' ' 364' ' ' MET . 13.7 p -115.7 -175.44 2.72 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 113.656 -1.611 . . . . 0.0 110.89 -167.291 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -110.61 100.42 9.21 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 340' ' ' ILE . . . . . 0.901 HG22 HG13 ' A' ' 342' ' ' VAL . 24.8 mt -74.8 116.53 54.59 Favored Pre-proline 0 C--N 1.324 -0.531 0 C-N-CA 120.057 -0.657 . . . . 0.0 110.836 -169.11 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.76 81.65 2.71 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.47 2.114 . . . . 0.0 110.992 177.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.901 HG13 HG22 ' A' ' 340' ' ' ILE . 4.1 m -103.26 134.09 45.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.989 0.899 . . . . 0.0 111.459 -178.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.657 ' HG3' ' HB2' ' A' ' 384' ' ' TYR . 20.8 ptt180 -140.51 176.93 8.38 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 113.899 -1.5 . . . . 0.0 107.734 174.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 344' ' ' ALA . . . . . 0.599 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -144.57 144.99 31.58 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 120.546 -0.462 . . . . 0.0 109.903 172.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.511 HG22 HD12 ' A' ' 382' ' ' ILE . 11.6 m -119.07 144.98 25.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.1 119.19 10.36 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 177.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 347' ' ' HIS . . . . . 0.755 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 81.3 t60 46.92 63.84 1.78 Allowed 'General case' 0 N--CA 1.468 0.461 0 O-C-N 124.337 1.023 . . . . 0.0 112.015 170.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 348' ' ' GLY . . . . . 0.559 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 43.19 42.01 5.17 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 114.926 0.73 . . . . 0.0 114.926 -174.266 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 349' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 347' ' ' HIS . 65.3 t -142.38 103.23 5.52 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 117.792 0.796 . . . . 0.0 108.928 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 350' ' ' PRO . . . . . 0.435 ' HA ' ' HB ' ' A' ' 345' ' ' VAL . 16.1 Cg_exo -72.26 51.8 1.8 Allowed 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.872 2.381 . . . . 0.0 113.073 178.49 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -103.06 -7.59 21.25 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -178.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 2.4 p -170.72 110.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.065 -169.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 353' ' ' ASN . . . . . 0.528 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 50.7 t30 -65.25 108.87 2.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.247 177.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.486 ' CG1' HD22 ' A' ' 376' ' ' LEU . 27.7 m -91.13 0.88 8.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.438 178.095 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 355' ' ' ALA . . . . . 0.599 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -74.44 83.3 1.96 Allowed 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.098 0.475 . . . . 0.0 111.459 -176.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 356' ' ' MET . . . . . 0.546 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 35.4 ttm -95.36 98.64 10.72 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 168.14 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.691 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 18.8 mt -80.32 141.65 35.25 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.323 -162.286 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.761 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 4.2 mm -80.45 -25.28 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 178.275 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 7.9 m -140.34 97.94 7.5 Favored Pre-proline 0 N--CA 1.445 -0.71 0 CA-C-N 113.513 -1.676 . . . . 0.0 108.797 175.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -85.83 34.42 0.48 Allowed 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.968 2.445 . . . . 0.0 112.808 -175.19 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -142.8 64.23 14.81 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.434 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 362' ' ' PRO . . . . . 0.535 ' HG3' ' CG2' ' A' ' 342' ' ' VAL . 90.2 Cg_endo -80.9 143.17 14.38 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.355 2.037 . . . . 0.0 111.481 178.163 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 363' ' ' THR . . . . . 0.51 HG23 ' O ' ' A' ' 338' ' ' CYS . 0.8 OUTLIER -143.47 148.94 36.83 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -174.611 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 364' ' ' MET . . . . . 0.83 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 37.1 mtm . . . . . 0 CA--C 1.495 -1.147 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.036 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 368' ' ' GLY . . . . . 0.592 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 369' ' ' GLY . . . . . 0.571 ' HA3' HG23 ' A' ' 330' ' ' VAL . . . -64.15 108.31 2.2 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 170.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -71.5 -31.2 65.8 Favored Glycine 0 C--N 1.313 -0.699 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.907 -169.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -164.74 141.68 6.15 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.051 0.453 . . . . 0.0 110.813 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 372' ' ' ILE . . . . . 0.844 HD13 HG11 ' A' ' 342' ' ' VAL . 1.7 mt -133.61 144.57 35.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 171.09 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 373' ' ' GLU . . . . . 0.847 ' HG2' HG12 ' A' ' 327' ' ' VAL . 40.0 mt-10 -129.24 125.05 36.03 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.494 -0.482 . . . . 0.0 109.981 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 374' ' ' MET . . . . . 0.691 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 0.0 OUTLIER -140.31 161.45 37.65 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.008 -175.54 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 375' ' ' GLN . . . . . 0.699 HE21 ' HA ' ' A' ' 325' ' ' THR . 4.6 tp-100 -178.52 175.28 1.14 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 174.49 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 376' ' ' LEU . . . . . 0.838 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 10.8 tp -166.56 157.05 10.81 Favored Pre-proline 0 N--CA 1.444 -0.77 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 377' ' ' PRO . . . . . 0.838 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 82.7 Cg_exo -42.39 132.08 4.99 Favored 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 121.828 1.685 . . . . 0.0 111.008 168.284 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.489 ' HA ' ' OE1' ' A' ' 394' ' ' GLN . 5.8 Cg_exo -35.74 139.84 0.13 Allowed 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 124.935 3.757 . . . . 0.0 113.75 -173.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 154.72 -165.08 31.94 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -162.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 380' ' ' ASP . . . . . 0.755 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 11.8 m-20 -102.91 129.08 49.5 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 117.881 0.841 . . . . 0.0 110.634 177.264 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -125.71 166.4 16.84 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 176.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 0.98 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -159.66 140.59 4.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 168.886 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 383' ' ' ILE . . . . . 0.488 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 24.3 mt -96.76 135.39 31.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.919 -175.189 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 384' ' ' TYR . . . . . 0.657 ' HB2' ' HG3' ' A' ' 343' ' ' ARG . 3.4 m-85 -105.11 129.34 53.54 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 167.216 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 6.1 t -117.56 82.22 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 65.51 -108.8 2.53 Favored Glycine 0 N--CA 1.431 -1.646 0 C-N-CA 120.001 -1.095 . . . . 0.0 110.51 -161.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -93.77 -10.71 33.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.652 0.226 . . . . 0.0 111.543 176.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 388' ' ' LEU . . . . . 0.691 HD13 ' HB3' ' A' ' 312' ' ' PHE . 1.1 tp -65.22 146.87 54.39 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.477 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 389' ' ' ASN . . . . . 0.488 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 27.5 p-10 -157.07 147.71 21.45 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.595 0.236 . . . . 0.0 111.077 178.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 390' ' ' HIS . . . . . 0.483 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 33.3 t-80 -172.62 122.33 0.43 Allowed 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.724 176.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 391' ' ' GLN . . . . . 0.98 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 40.9 tt0 -79.2 151.37 31.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.333 0.587 . . . . 0.0 112.367 -173.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 392' ' ' TRP . . . . . . . . . . . . . 43.6 t-105 -148.48 132.54 17.25 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.792 -1.094 . . . . 0.0 109.31 177.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -99.45 109.18 21.77 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.489 ' OE1' ' HA ' ' A' ' 378' ' ' PRO . 2.2 pp0? -97.8 127.19 43.57 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.303 0.573 . . . . 0.0 110.502 -170.05 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.777 -178.382 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 303' ' ' THR . . . . . 0.532 HG23 HG23 ' A' ' 335' ' ' THR . 7.1 t . . . . . 0 N--CA 1.451 -0.407 0 CA-C-O 121.159 0.504 . . . . 0.0 111.691 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 304' ' ' TYR . . . . . 0.722 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 30.9 p90 -67.09 119.65 12.37 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.307 -0.557 . . . . 0.0 109.794 175.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.443 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 12.3 t 176.23 -167.67 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -171.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 23.1 t -64.73 108.21 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 169.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.71 140.8 51.52 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.732 -169.26 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 308' ' ' ASP . . . . . 0.591 ' OD2' HG22 ' A' ' 310' ' ' THR . 20.3 t70 -66.85 128.34 35.94 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.442 0.639 . . . . 0.0 111.567 -176.413 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.56 ' HD3' ' HB2' ' A' ' 387' ' ' ASP . 0.0 OUTLIER -42.48 -22.44 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 115.954 1.835 . . . . 0.0 115.954 -173.867 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.591 HG22 ' OD2' ' A' ' 308' ' ' ASP . 11.7 t -105.54 -3.81 21.96 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 118.976 0.807 . . . . 0.0 111.62 -170.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 311' ' ' LYS . . . . . 0.407 ' HB3' ' HE2' ' A' ' 311' ' ' LYS . 10.4 mmmm -67.97 -24.74 65.18 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.873 -177.333 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.671 ' HE1' ' H ' ' A' ' 369' ' ' GLY . 2.1 m-85 -81.16 173.04 12.93 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 122.01 0.91 . . . . 0.0 113.313 -176.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 313' ' ' THR . . . . . 0.528 HG22 ' O ' ' A' ' 331' ' ' GLY . 14.2 t -148.58 155.21 40.8 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 113.878 -1.51 . . . . 0.0 108.718 177.121 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 11.6 m-90 -79.23 93.8 5.31 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.17 0.51 . . . . 0.0 110.115 -178.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.577 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 59.6 tttm -76.97 -55.09 5.76 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.186 172.462 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -142.04 126.21 17.45 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 176.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -69.12 158.04 87.64 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-O 119.14 -0.457 . . . . 0.0 110.286 178.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 318' ' ' PRO . . . . . 0.537 ' HG3' HD12 ' A' ' 383' ' ' ILE . 87.2 Cg_exo -40.16 117.66 0.47 Allowed 'Trans proline' 0 C--N 1.36 1.152 0 C-N-CA 122.458 2.105 . . . . 0.0 111.997 174.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 13.6 m -136.13 140.56 43.76 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.801 -174.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 320' ' ' ASP . . . . . 0.409 ' HA ' ' O ' ' A' ' 325' ' ' THR . 7.0 t70 -55.53 126.95 27.47 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.147 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 321' ' ' SER . . . . . 0.512 ' HB3' HG13 ' A' ' 327' ' ' VAL . 33.5 p -87.1 10.9 15.23 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.644 0.259 . . . . 0.0 111.447 -172.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 85.6 -31.37 3.91 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.53 -173.095 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 58.7 m-70 -87.06 28.31 0.93 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.82 0.31 . . . . 0.0 111.61 -176.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 48.65 50.62 16.9 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.877 0.846 . . . . 0.0 109.884 -172.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 325' ' ' THR . . . . . 0.532 ' HB ' HG13 ' A' ' 358' ' ' ILE . 11.6 p -154.34 177.14 11.48 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 -175.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -123.16 142.5 39.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 119.536 1.062 . . . . 0.0 112.18 -174.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 327' ' ' VAL . . . . . 0.636 HG12 ' HG2' ' A' ' 373' ' ' GLU . 3.7 m -124.77 147.65 29.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.897 172.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 328' ' ' MET . . . . . 0.573 ' CE ' HD12 ' A' ' 372' ' ' ILE . 16.5 ptt? -130.84 156.58 44.78 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 173.391 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.621 ' HA ' ' O ' ' A' ' 370' ' ' GLY . 7.9 tt0 -124.19 125.91 45.23 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.581 HG11 HG21 ' A' ' 385' ' ' VAL . 15.7 m -126.5 143.58 39.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.416 -174.322 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 331' ' ' GLY . . . . . 0.587 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -122.74 135.97 10.41 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.692 -176.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 332' ' ' PHE . . . . . 0.512 ' HD1' ' H ' ' A' ' 332' ' ' PHE . 0.2 OUTLIER -90.62 155.74 18.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 122.058 0.933 . . . . 0.0 113.122 -177.374 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 30.4 t -78.72 -37.52 41.26 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 113.862 -1.517 . . . . 0.0 112.948 171.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -173.69 -25.75 0.03 OUTLIER Glycine 0 CA--C 1.526 0.727 0 C-N-CA 118.651 -1.737 . . . . 0.0 115.405 -178.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 335' ' ' THR . . . . . 0.701 ' HB ' ' SD ' ' A' ' 364' ' ' MET . 25.9 m -52.7 127.27 22.57 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.699 0.285 . . . . 0.0 110.385 176.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.75 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 2.2 ptm180 -87.72 -179.26 1.28 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 117.378 -1.296 . . . . 0.0 108.491 -174.317 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.75 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -26.46 98.35 0.02 OUTLIER 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 123.862 3.041 . . . . 0.0 114.115 -175.137 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 338' ' ' CYS . . . . . 0.769 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 1.8 p -109.84 -176.55 3.03 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 113.6 -1.636 . . . . 0.0 110.136 -171.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 339' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 339' ' ' ARG . 3.5 mpt_? -109.4 100.51 9.59 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 175.381 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 340' ' ' ILE . . . . . 0.889 HG22 HG13 ' A' ' 342' ' ' VAL . 29.9 mt -74.82 114.38 33.98 Favored Pre-proline 0 C--N 1.329 -0.315 0 C-N-CA 120.069 -0.653 . . . . 0.0 111.307 -167.191 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -79.51 81.46 2.78 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.499 2.132 . . . . 0.0 111.309 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.889 HG13 HG22 ' A' ' 340' ' ' ILE . 4.1 m -103.08 128.33 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-O 121.508 0.671 . . . . 0.0 110.651 -178.095 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -140.74 175.77 9.34 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 174.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 344' ' ' ALA . . . . . 0.554 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -147.89 149.82 32.97 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.064 -0.654 . . . . 0.0 111.334 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 11.0 m -118.86 146.62 23.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 176.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.425 ' HB2' ' CG1' ' A' ' 354' ' ' VAL . . . -70.11 117.73 12.05 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 177.231 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 347' ' ' HIS . . . . . 0.903 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 15.3 t-80 48.31 62.18 2.65 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 124.166 0.916 . . . . 0.0 112.007 173.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 348' ' ' GLY . . . . . 0.772 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 43.35 40.08 4.54 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.963 -0.637 . . . . 0.0 114.507 -173.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 349' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 347' ' ' HIS . 94.9 t -138.13 101.58 8.43 Favored Pre-proline 0 C--O 1.235 0.319 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -72.04 68.88 3.17 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.593 2.196 . . . . 0.0 112.357 178.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -99.85 -56.35 2.41 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 176.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 5.3 p -128.88 136.9 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.264 172.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 353' ' ' ASN . . . . . 0.554 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 35.0 t30 -62.18 110.58 1.66 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.905 174.04 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.516 ' CG1' HD22 ' A' ' 376' ' ' LEU . 27.7 m -88.36 3.04 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.346 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -75.14 82.29 2.31 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.312 0.577 . . . . 0.0 110.771 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 356' ' ' MET . . . . . 0.554 ' HB2' ' O ' ' A' ' 375' ' ' GLN . 62.5 mtt -98.19 99.67 10.92 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 168.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.631 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 34.5 mt -82.1 141.48 33.1 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.052 -162.395 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.719 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 4.1 mm -83.64 -21.53 8.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 178.036 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 6.6 m -141.39 96.97 6.89 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 113.828 -1.533 . . . . 0.0 108.673 171.139 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 360' ' ' PRO . . . . . 0.457 ' HA ' HD12 ' A' ' 357' ' ' LEU . 91.5 Cg_endo -89.05 39.89 0.48 Allowed 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 123.136 2.557 . . . . 0.0 114.259 -170.541 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 20.8 p-10 -156.85 72.78 4.7 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-O 121.406 0.622 . . . . 0.0 111.234 176.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 362' ' ' PRO . . . . . 0.746 ' HG2' ' HB ' ' A' ' 340' ' ' ILE . 83.2 Cg_endo -85.08 154.31 11.11 Favored 'Trans proline' 0 C--O 1.243 0.731 0 C-N-CA 122.788 2.325 . . . . 0.0 113.029 176.704 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 1.8 p -143.98 141.12 30.0 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.054 -176.035 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 364' ' ' MET . . . . . 0.769 ' HG2' ' SG ' ' A' ' 338' ' ' CYS . 10.7 ptp . . . . . 0 CA--C 1.5 -0.98 0 C-N-CA 119.578 -0.849 . . . . 0.0 108.785 178.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 368' ' ' GLY . . . . . 0.587 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . . . . . . 0 N--CA 1.451 -0.359 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 369' ' ' GLY . . . . . 0.767 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -57.98 -32.46 66.64 Favored Glycine 0 CA--C 1.506 -0.53 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.835 173.638 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 370' ' ' GLY . . . . . 0.621 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 82.78 -131.36 10.32 Favored Glycine 0 N--CA 1.435 -1.379 0 C-N-CA 120.029 -1.081 . . . . 0.0 111.081 -177.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -103.46 137.66 41.25 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.336 0.589 . . . . 0.0 111.558 -175.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 372' ' ' ILE . . . . . 0.679 HG23 ' HB3' ' A' ' 362' ' ' PRO . 0.8 OUTLIER -130.41 150.33 34.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.366 176.73 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 373' ' ' GLU . . . . . 0.719 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 38.4 mt-10 -116.62 127.08 54.13 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.513 -175.293 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 374' ' ' MET . . . . . 0.87 ' HG2' HD11 ' A' ' 383' ' ' ILE . 4.1 ppp? -139.38 160.51 39.67 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.153 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 375' ' ' GLN . . . . . 0.554 ' O ' ' HB2' ' A' ' 356' ' ' MET . 2.4 tp60 -176.44 174.54 1.91 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.95 0.405 . . . . 0.0 110.89 174.346 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 376' ' ' LEU . . . . . 0.874 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 6.6 tp -165.17 158.74 14.18 Favored Pre-proline 0 N--CA 1.445 -0.676 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 377' ' ' PRO . . . . . 0.874 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 66.4 Cg_exo -40.97 129.34 2.89 Favored 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 121.77 1.647 . . . . 0.0 111.259 167.444 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.503 ' HD2' ' HA ' ' A' ' 377' ' ' PRO . 2.7 Cg_exo -35.8 140.75 0.12 Allowed 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 124.948 3.765 . . . . 0.0 113.502 -174.171 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 151.45 -161.77 29.31 Favored Glycine 0 N--CA 1.442 -0.935 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -162.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 380' ' ' ASP . . . . . 0.903 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 5.3 m-20 -101.86 129.42 48.09 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 117.918 0.859 . . . . 0.0 110.877 177.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.427 ' HB3' ' HE3' ' A' ' 374' ' ' MET . 9.7 m120 -128.66 146.25 50.92 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 176.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 1.052 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -149.61 138.17 14.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 177.773 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 383' ' ' ILE . . . . . 0.87 HD11 ' HG2' ' A' ' 374' ' ' MET . 43.9 mt -101.63 135.66 37.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.693 -171.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -105.12 96.68 6.7 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.549 -1.205 . . . . 0.0 108.795 169.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 385' ' ' VAL . . . . . 0.581 HG21 HG11 ' A' ' 330' ' ' VAL . 2.3 t -80.36 79.2 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.778 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 174.155 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 65.93 -104.45 1.02 Allowed Glycine 0 N--CA 1.43 -1.753 0 C-N-CA 119.388 -1.387 . . . . 0.0 110.16 -163.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 387' ' ' ASP . . . . . 0.56 ' HB2' ' HD3' ' A' ' 309' ' ' LYS . 35.9 t70 -98.63 -12.15 21.39 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 175.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.69 107.91 4.76 Favored 'General case' 0 CA--C 1.511 -0.537 0 O-C-N 121.771 -0.581 . . . . 0.0 109.773 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 389' ' ' ASN . . . . . 0.452 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 5.8 p30 -114.17 144.05 43.82 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 -176.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 390' ' ' HIS . . . . . 0.404 ' CE1' ' HD3' ' A' ' 318' ' ' PRO . 0.3 OUTLIER -169.42 108.61 0.43 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.09 0.472 . . . . 0.0 111.286 -177.31 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 391' ' ' GLN . . . . . 1.052 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 19.6 tt0 -78.01 154.16 31.73 Favored 'General case' 0 C--N 1.345 0.407 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -172.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 392' ' ' TRP . . . . . . . . . . . . . 39.7 t-105 -154.71 148.43 25.43 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.321 177.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -107.25 119.16 38.64 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 173.075 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.455 ' OE1' ' HA ' ' A' ' 378' ' ' PRO . 2.2 pp0? -108.86 136.76 47.88 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.456 0.646 . . . . 0.0 111.857 -169.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 19.8 tptp . . . . . 0 C--O 1.247 0.936 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.988 175.528 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 303' ' ' THR . . . . . 0.534 ' O ' HG23 ' A' ' 335' ' ' THR . 6.1 t . . . . . 0 CA--C 1.536 0.441 0 CA-C-O 120.908 0.385 . . . . 0.0 111.613 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 304' ' ' TYR . . . . . 0.438 ' O ' ' HB ' ' A' ' 305' ' ' THR . 5.3 p90 -59.38 132.47 54.11 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.077 177.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.47 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 15.2 t 172.5 -167.68 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -172.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 64.7 t -62.19 114.23 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 171.072 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 307' ' ' CYS . . . . . 0.616 ' HB3' ' HE1' ' A' ' 364' ' ' MET . 0.1 OUTLIER -69.03 135.18 50.46 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.146 0.498 . . . . 0.0 111.753 -172.193 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 308' ' ' ASP . . . . . 0.451 ' HB3' ' NZ ' ' A' ' 311' ' ' LYS . 22.4 t70 -55.29 111.58 0.9 Allowed 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.475 175.222 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.555 ' HD3' ' HB2' ' A' ' 387' ' ' ASP . 0.0 OUTLIER -40.77 -24.36 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 115.845 1.795 . . . . 0.0 115.845 -169.189 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.531 ' N ' ' HD2' ' A' ' 309' ' ' LYS . 11.7 t -98.71 -4.14 34.27 Favored 'General case' 0 C--N 1.314 -0.96 0 O-C-N 121.677 -0.639 . . . . 0.0 111.773 -171.161 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 311' ' ' LYS . . . . . 0.676 ' HE3' ' H ' ' A' ' 335' ' ' THR . 29.0 mtmm -84.87 48.56 1.57 Allowed 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 120.936 0.398 . . . . 0.0 111.081 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.533 ' CD1' ' HB ' ' A' ' 330' ' ' VAL . 4.9 m-85 -139.65 153.82 47.4 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.662 -178.173 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 22.7 p -138.18 149.19 45.6 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.17 177.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 8.4 m-90 -67.7 116.12 8.04 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.471 0.653 . . . . 0.0 110.217 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.458 ' HB3' ' C ' ' A' ' 329' ' ' GLU . 53.2 tptt -96.69 -57.45 2.29 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 172.547 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 316' ' ' ARG . 27.2 ttm-85 -139.04 114.81 9.99 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.631 -1.168 . . . . 0.0 108.298 172.136 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 317' ' ' ALA . . . . . 0.489 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -68.21 160.8 73.3 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -178.509 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 318' ' ' PRO . . . . . 0.619 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 3.8 Cg_exo -43.06 110.96 0.19 Allowed 'Trans proline' 0 C--N 1.358 1.058 0 C-N-CA 122.237 1.958 . . . . 0.0 112.875 -175.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 31.1 m -127.07 128.76 46.77 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.266 -174.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -55.69 120.35 7.14 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 321' ' ' SER . . . . . 0.489 ' HA ' HG22 ' A' ' 327' ' ' VAL . 82.9 p -47.74 -54.26 12.74 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.205 0.602 . . . . 0.0 111.053 -169.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 141.47 -17.04 2.67 Favored Glycine 0 N--CA 1.443 -0.86 0 CA-C-N 114.909 -1.042 . . . . 0.0 111.532 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 323' ' ' HIS . . . . . 0.56 ' O ' ' HB2' ' A' ' 324' ' ' ASP . 7.1 t-80 -122.73 23.94 9.29 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 120.722 0.296 . . . . 0.0 110.585 -179.259 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 324' ' ' ASP . . . . . 0.56 ' HB2' ' O ' ' A' ' 323' ' ' HIS . 5.6 m-20 92.69 45.94 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.122 0.969 . . . . 0.0 111.751 169.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 325' ' ' THR . . . . . 0.676 ' HA ' ' HG2' ' A' ' 375' ' ' GLN . 1.8 p -154.55 -167.1 2.51 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 174.313 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.956 HG21 ' HZ2' ' A' ' 392' ' ' TRP . 3.0 t -134.38 142.13 41.64 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.395 0 CA-C-N 119.477 1.035 . . . . 0.0 111.855 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 327' ' ' VAL . . . . . 0.804 HG12 ' HG2' ' A' ' 373' ' ' GLU . 17.4 m -119.02 156.32 21.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.882 174.074 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.02 150.48 34.03 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.458 ' C ' ' HB3' ' A' ' 315' ' ' LYS . 24.5 tt0 -132.99 132.5 41.97 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -175.066 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.696 HG11 HG11 ' A' ' 385' ' ' VAL . 0.0 OUTLIER -130.02 150.82 35.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -176.17 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 331' ' ' GLY . . . . . 0.52 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -120.72 134.52 10.31 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.052 176.576 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -103.83 174.65 5.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.142 0.471 . . . . 0.0 111.092 -179.509 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 30.2 m -148.66 49.37 1.01 Allowed 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 170.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -177.05 -88.35 0.07 OUTLIER Glycine 0 C--N 1.339 0.703 0 C-N-CA 119.794 -1.193 . . . . 0.0 113.925 168.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 335' ' ' THR . . . . . 0.676 ' H ' ' HE3' ' A' ' 311' ' ' LYS . 50.3 m -51.3 130.62 27.23 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 114.701 -0.75 . . . . 0.0 110.324 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.802 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 8.1 ptm180 -79.1 -176.01 0.65 Allowed Pre-proline 0 CA--C 1.533 0.322 0 CA-C-O 117.633 -1.175 . . . . 0.0 108.986 -174.024 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.802 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -24.79 103.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 123.955 3.103 . . . . 0.0 114.045 -177.479 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 338' ' ' CYS . . . . . 0.723 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 8.9 p -111.42 -174.95 2.58 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 113.587 -1.642 . . . . 0.0 111.023 -168.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -107.89 96.51 6.43 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 177.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 340' ' ' ILE . . . . . 0.849 HG22 HG13 ' A' ' 342' ' ' VAL . 27.3 mt -74.08 120.41 81.2 Favored Pre-proline 0 C--N 1.327 -0.387 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.185 -166.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -81.25 80.69 2.9 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 122.295 1.996 . . . . 0.0 111.057 175.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.849 HG13 HG22 ' A' ' 340' ' ' ILE . 6.7 m -100.13 123.5 53.02 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.024 0 CA-C-O 121.986 0.898 . . . . 0.0 109.837 176.684 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.516 ' HG3' ' HB2' ' A' ' 384' ' ' TYR . 24.3 ptt180 -132.94 173.05 11.81 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.324 -1.307 . . . . 0.0 107.748 176.692 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 344' ' ' ALA . . . . . 0.553 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -143.27 141.09 30.92 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 173.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 17.5 m -115.83 145.27 21.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -63.91 115.83 5.24 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.005 177.036 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 347' ' ' HIS . . . . . 0.595 ' HB3' ' CB ' ' A' ' 380' ' ' ASP . 23.8 p80 35.79 71.11 0.13 Allowed 'General case' 0 N--CA 1.475 0.793 0 O-C-N 124.53 1.144 . . . . 0.0 112.601 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 348' ' ' GLY . . . . . 0.826 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 41.99 47.15 5.23 Favored Glycine 0 C--N 1.333 0.403 0 N-CA-C 115.191 0.836 . . . . 0.0 115.191 -175.512 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 349' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 347' ' ' HIS . 90.1 t -142.61 102.49 5.44 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 176.462 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -75.95 66.1 6.84 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.865 2.377 . . . . 0.0 112.781 -178.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -100.99 -55.97 2.43 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 177.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 7.4 p -124.96 133.18 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.45 171.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -64.82 112.49 3.28 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.333 177.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.529 ' HB ' HD22 ' A' ' 376' ' ' LEU . 32.7 m -89.98 1.8 7.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.917 178.058 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 355' ' ' ALA . . . . . 0.553 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -74.44 84.11 1.98 Allowed 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.181 0.515 . . . . 0.0 110.558 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 356' ' ' MET . . . . . 0.625 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 58.6 ttp -94.0 99.95 12.17 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 172.318 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.587 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 19.9 mt -85.34 115.45 23.1 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.494 -161.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.595 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 3.1 mm -59.18 -26.65 34.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.045 174.038 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 34.5 m -137.53 90.73 14.6 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.701 174.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -83.6 38.93 0.75 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.416 2.744 . . . . 0.0 113.461 -172.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -147.57 69.37 11.29 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.689 177.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 362' ' ' PRO . . . . . 0.784 ' HB3' HG23 ' A' ' 372' ' ' ILE . 63.0 Cg_endo -79.59 143.58 17.04 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.234 1.956 . . . . 0.0 111.825 176.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 363' ' ' THR . . . . . 0.416 ' O ' ' HA2' ' A' ' 369' ' ' GLY . 1.3 p -143.64 133.76 24.32 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.45 -173.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 364' ' ' MET . . . . . 0.723 ' HG2' ' SG ' ' A' ' 338' ' ' CYS . 19.2 ptt? . . . . . 0 CA--C 1.501 -0.928 0 C-N-CA 119.095 -1.042 . . . . 0.0 109.195 177.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 368' ' ' GLY . . . . . 0.52 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . . . . . . 0 N--CA 1.448 -0.543 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 369' ' ' GLY . . . . . 0.587 ' HA3' HG23 ' A' ' 330' ' ' VAL . . . -65.42 103.8 0.87 Allowed Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.736 -0.945 . . . . 0.0 110.736 170.22 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 370' ' ' GLY . . . . . 0.425 ' O ' ' HG3' ' A' ' 329' ' ' GLU . . . -72.41 -32.7 62.01 Favored Glycine 0 C--N 1.317 -0.514 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.518 -167.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -164.29 138.65 5.54 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 123.823 0.366 . . . . 0.0 110.458 179.09 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 372' ' ' ILE . . . . . 0.784 HG23 ' HB3' ' A' ' 362' ' ' PRO . 0.3 OUTLIER -137.63 156.14 31.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 171.063 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 373' ' ' GLU . . . . . 0.804 ' HG2' HG12 ' A' ' 327' ' ' VAL . 43.1 mt-10 -134.62 125.53 27.36 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -178.291 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 374' ' ' MET . . . . . 0.587 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 2.4 mtt -142.94 164.51 29.89 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -174.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 375' ' ' GLN . . . . . 0.676 ' HG2' ' HA ' ' A' ' 325' ' ' THR . 1.5 tp60 177.97 179.08 0.32 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.132 0.423 . . . . 0.0 110.929 175.653 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 376' ' ' LEU . . . . . 0.916 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 14.2 tp -165.95 160.74 13.09 Favored Pre-proline 0 N--CA 1.446 -0.64 0 N-CA-C 104.867 -2.271 . . . . 0.0 104.867 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 377' ' ' PRO . . . . . 0.916 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 81.2 Cg_exo -44.54 131.09 9.6 Favored 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 121.502 1.468 . . . . 0.0 111.328 169.099 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.55 ' HA ' ' OE1' ' A' ' 394' ' ' GLN . 2.8 Cg_exo -37.03 138.86 0.22 Allowed 'Trans proline' 0 C--N 1.36 1.176 0 C-N-CA 124.607 3.538 . . . . 0.0 112.911 -175.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 152.66 -163.81 30.5 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 -162.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 380' ' ' ASP . . . . . 0.595 ' CB ' ' HB3' ' A' ' 347' ' ' HIS . 17.6 m-20 -98.86 122.59 42.29 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 117.468 0.634 . . . . 0.0 111.5 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.563 ' HB2' ' CH2' ' A' ' 392' ' ' TRP . 6.1 m120 -124.83 175.17 7.45 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 171.582 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 1.019 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -163.19 141.42 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 167.304 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 383' ' ' ILE . . . . . 0.653 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 45.9 mt -101.71 132.23 48.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 C-N-CA 119.674 -0.81 . . . . 0.0 110.456 -174.559 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 384' ' ' TYR . . . . . 0.555 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 1.9 m-85 -102.33 128.89 48.7 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.483 -1.235 . . . . 0.0 107.782 168.248 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 385' ' ' VAL . . . . . 0.696 HG11 HG11 ' A' ' 330' ' ' VAL . 15.2 t -118.48 77.15 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 63.16 -110.49 3.4 Favored Glycine 0 N--CA 1.43 -1.716 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.842 -161.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 387' ' ' ASP . . . . . 0.555 ' HB2' ' HD3' ' A' ' 309' ' ' LYS . 34.1 t70 -81.15 -20.31 41.6 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 177.275 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 388' ' ' LEU . . . . . 0.555 ' O ' ' HA ' ' A' ' 384' ' ' TYR . 1.2 mp -68.54 153.03 44.55 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.909 -0.317 . . . . 0.0 110.254 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 389' ' ' ASN . . . . . 0.653 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 5.0 p-10 -160.24 155.26 24.59 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.08 177.548 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 390' ' ' HIS . . . . . 0.619 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 42.0 t-80 -171.46 112.12 0.34 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.816 175.249 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 391' ' ' GLN . . . . . 1.019 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 15.3 tt0 -75.93 149.33 37.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.788 -178.734 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 392' ' ' TRP . . . . . 0.956 ' HZ2' HG21 ' A' ' 326' ' ' VAL . 0.1 OUTLIER -168.18 151.32 5.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.049 0.452 . . . . 0.0 110.142 -179.111 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -101.05 118.87 37.84 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 178.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.662 ' HB2' HE22 ' A' ' 375' ' ' GLN . 1.0 OUTLIER -95.64 131.81 41.48 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.308 -170.27 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.473 ' HD2' ' HA ' ' A' ' 395' ' ' LYS . 21.7 tptp . . . . . 0 C--O 1.252 1.223 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.281 178.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 303' ' ' THR . . . . . 0.63 HG23 HG23 ' A' ' 335' ' ' THR . 5.2 t . . . . . 0 CA--C 1.536 0.412 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 304' ' ' TYR . . . . . 0.546 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 25.9 p90 -64.21 127.85 33.22 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 175.586 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.408 HG23 ' O ' ' A' ' 306' ' ' VAL . 14.3 t 178.45 -167.13 0.06 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -170.439 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.408 ' O ' HG23 ' A' ' 305' ' ' THR . 34.3 t -65.06 114.34 2.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 165.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.37 139.0 57.17 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.346 0.593 . . . . 0.0 110.414 -170.376 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 308' ' ' ASP . . . . . 0.487 ' HB3' ' HG2' ' A' ' 311' ' ' LYS . 5.4 t70 -60.94 126.71 28.36 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.609 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.547 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -44.02 -13.61 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 -175.38 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.413 ' N ' ' HD2' ' A' ' 309' ' ' LYS . 12.5 t -108.07 0.46 21.73 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 119.39 0.996 . . . . 0.0 111.8 -176.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 311' ' ' LYS . . . . . 0.487 ' HG2' ' HB3' ' A' ' 308' ' ' ASP . 29.6 mmmt -72.68 -33.06 66.26 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -175.525 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.808 ' HD1' HD13 ' A' ' 388' ' ' LEU . 0.6 OUTLIER -90.95 175.67 6.88 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 122.29 1.043 . . . . 0.0 112.798 -174.77 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 8.7 t -153.98 162.27 41.34 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 113.285 -1.78 . . . . 0.0 109.697 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 314' ' ' TRP . . . . . 0.638 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 24.0 m-90 -77.75 92.88 4.22 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -178.404 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -71.57 -43.04 67.03 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 171.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -154.02 124.4 7.0 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 171.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 317' ' ' ALA . . . . . 0.507 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -70.7 163.59 62.74 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 119.139 -0.458 . . . . 0.0 109.99 -177.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 318' ' ' PRO . . . . . 0.546 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 2.4 Cg_endo -46.19 113.5 0.63 Allowed 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 122.067 1.845 . . . . 0.0 112.281 -179.378 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 21.7 m -129.5 133.96 47.53 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.881 -172.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 320' ' ' ASP . . . . . 0.431 ' HA ' HG13 ' A' ' 326' ' ' VAL . 28.4 t70 -55.84 123.14 13.24 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -178.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 321' ' ' SER . . . . . 0.446 ' HB3' HG13 ' A' ' 327' ' ' VAL . 81.0 p -62.66 -47.78 82.18 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 121.339 0.59 . . . . 0.0 109.883 -174.072 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 120.27 -15.0 10.11 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -109.05 49.2 0.83 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.774 0.797 . . . . 0.0 108.974 177.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 50.67 41.12 25.52 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 114.647 -1.161 . . . . 0.0 112.597 -178.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 325' ' ' THR . . . . . 0.584 ' HA ' ' HG3' ' A' ' 375' ' ' GLN . 6.2 p -150.39 -173.42 4.45 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 175.267 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.893 HG23 ' HG2' ' A' ' 375' ' ' GLN . 1.5 t -133.75 146.0 32.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.94 -178.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 327' ' ' VAL . . . . . 0.761 HG12 ' HG2' ' A' ' 373' ' ' GLU . 20.6 m -123.6 155.86 30.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.774 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 328' ' ' MET . . . . . 0.492 ' CG ' HD12 ' A' ' 372' ' ' ILE . 0.0 OUTLIER -143.63 154.21 43.31 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 173.934 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -132.58 130.65 40.57 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.704 HG21 HD13 ' A' ' 340' ' ' ILE . 0.0 OUTLIER -118.54 162.21 16.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -179.231 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 331' ' ' GLY . . . . . 0.802 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -118.55 172.65 14.57 Favored Glycine 0 C--O 1.227 -0.341 0 C-N-CA 119.712 -1.232 . . . . 0.0 112.531 172.394 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 332' ' ' PHE . . . . . 0.794 ' HD1' ' HA2' ' A' ' 368' ' ' GLY . 0.9 OUTLIER -127.84 135.78 50.52 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 179.726 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 29.0 m -85.82 -21.01 28.32 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 176.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -171.53 -50.37 0.04 OUTLIER Glycine 0 C--N 1.335 0.518 0 C-N-CA 118.357 -1.878 . . . . 0.0 115.054 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 335' ' ' THR . . . . . 0.63 HG23 HG23 ' A' ' 303' ' ' THR . 65.8 m -49.59 129.74 19.69 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 123.892 0.407 . . . . 0.0 110.115 -178.2 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.639 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 1.0 OUTLIER -82.37 176.45 3.81 Favored Pre-proline 0 N--CA 1.451 -0.416 0 CA-C-O 117.366 -1.302 . . . . 0.0 107.631 -172.413 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.716 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.1 OUTLIER -25.25 98.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.363 1.342 0 C-N-CA 123.727 2.951 . . . . 0.0 114.053 -173.323 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 338' ' ' CYS . . . . . 0.704 ' SG ' ' HB2' ' A' ' 364' ' ' MET . 6.5 p -129.7 139.54 51.32 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 113.971 -1.468 . . . . 0.0 108.444 -171.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -65.6 124.54 22.64 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.395 -0.522 . . . . 0.0 109.706 177.101 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 340' ' ' ILE . . . . . 0.704 HD13 HG21 ' A' ' 330' ' ' VAL . 18.6 tt -98.45 118.72 62.94 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.273 -177.46 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.7 95.23 0.71 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.949 2.432 . . . . 0.0 112.336 -177.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.75 HG11 HD13 ' A' ' 372' ' ' ILE . 15.4 m -110.07 122.53 64.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.643 0.735 . . . . 0.0 110.812 179.048 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 14.6 ptt180 -133.5 -178.25 4.91 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 173.228 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 344' ' ' ALA . . . . . 0.5 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -147.03 147.81 31.04 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.629 177.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.592 HG22 HD12 ' A' ' 382' ' ' ILE . 4.8 m -118.94 142.47 33.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 177.053 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.469 ' HB2' HG11 ' A' ' 354' ' ' VAL . . . -65.48 127.67 32.78 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 177.117 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 347' ' ' HIS . . . . . 0.591 ' O ' HG23 ' A' ' 349' ' ' VAL . 35.2 t60 41.44 60.38 2.13 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 124.204 0.94 . . . . 0.0 112.038 174.192 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 348' ' ' GLY . . . . . 0.51 ' H ' ' CG2' ' A' ' 382' ' ' ILE . . . 44.85 38.62 5.85 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 115.035 0.774 . . . . 0.0 115.035 -175.378 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 349' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 347' ' ' HIS . 58.4 t -135.85 103.15 10.04 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 117.917 0.859 . . . . 0.0 108.863 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 350' ' ' PRO . . . . . 0.49 ' HA ' ' HB ' ' A' ' 345' ' ' VAL . 15.4 Cg_exo -72.65 62.12 3.71 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.861 2.374 . . . . 0.0 112.936 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -100.4 -55.2 2.67 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 7.7 p -124.83 133.76 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.456 174.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 353' ' ' ASN . . . . . 0.5 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 37.4 t30 -66.72 116.14 7.31 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.482 176.205 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.63 ' HB ' HD22 ' A' ' 376' ' ' LEU . 27.5 m -101.06 5.92 10.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.292 -176.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 355' ' ' ALA . . . . . 0.435 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -74.82 87.03 2.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.194 0.521 . . . . 0.0 112.027 -177.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.1 99.45 11.43 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 170.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 43.1 mt -87.37 121.82 30.32 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.607 -164.28 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.918 HD11 ' HB2' ' A' ' 375' ' ' GLN . 2.8 mm -63.25 -29.77 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.565 175.263 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 27.6 m -133.81 91.42 25.07 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.467 173.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -85.01 39.9 0.78 Allowed 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 123.518 2.812 . . . . 0.0 113.801 -170.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -158.4 70.74 3.86 Favored Pre-proline 0 C--N 1.319 -0.76 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.288 176.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 362' ' ' PRO . . . . . 0.478 ' HG3' HG21 ' A' ' 342' ' ' VAL . 97.8 Cg_endo -84.31 147.99 11.5 Favored 'Trans proline' 0 C--O 1.247 0.94 0 C-N-CA 122.17 1.913 . . . . 0.0 111.759 173.436 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 4.6 m -143.07 150.95 40.22 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -174.099 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 364' ' ' MET . . . . . 0.716 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 60.3 mtp . . . . . 0 C--N 1.307 -1.254 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.584 -176.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 368' ' ' GLY . . . . . 0.802 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . . . . . . 0 CA--C 1.494 -1.255 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 369' ' ' GLY . . . . . 0.584 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -109.17 5.55 31.96 Favored Glycine 0 C--N 1.307 -1.07 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 168.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 75.44 -84.06 0.87 Allowed Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 114.693 -0.754 . . . . 0.0 113.949 174.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -166.81 141.52 4.1 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.222 -0.489 . . . . 0.0 110.596 -173.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 372' ' ' ILE . . . . . 0.75 HD13 HG11 ' A' ' 342' ' ' VAL . 0.7 OUTLIER -136.72 145.4 30.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.113 175.395 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 373' ' ' GLU . . . . . 0.761 ' HG2' HG12 ' A' ' 327' ' ' VAL . 43.5 mt-10 -127.71 125.68 40.46 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 177.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 374' ' ' MET . . . . . 0.786 ' HE3' HD11 ' A' ' 383' ' ' ILE . 0.0 OUTLIER -139.18 156.07 47.38 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.286 -174.227 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 375' ' ' GLN . . . . . 0.918 ' HB2' HD11 ' A' ' 358' ' ' ILE . 0.0 OUTLIER -168.94 175.82 5.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.422 0.629 . . . . 0.0 112.337 175.798 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 376' ' ' LEU . . . . . 0.63 HD22 ' HB ' ' A' ' 354' ' ' VAL . 16.4 tp -168.18 145.09 3.38 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 174.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 377' ' ' PRO . . . . . 0.605 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 80.8 Cg_exo -40.93 140.92 1.04 Allowed 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.266 1.977 . . . . 0.0 112.165 177.181 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.87 ' HA ' HE22 ' A' ' 394' ' ' GLN . 4.4 Cg_exo -35.46 139.65 0.12 Allowed 'Trans proline' 0 C--N 1.357 1.008 1 C-N-CA 125.488 4.125 . . . . 0.0 114.106 -169.437 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 149.74 -163.09 29.29 Favored Glycine 0 N--CA 1.442 -0.916 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -166.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 380' ' ' ASP . . . . . 0.555 ' OD1' ' HB2' ' A' ' 347' ' ' HIS . 1.5 p30 -113.2 136.76 52.37 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.781 0.8 . . . . 0.0 111.804 176.553 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.408 ' HB2' ' CH2' ' A' ' 392' ' ' TRP . 20.2 m-80 -136.05 171.26 14.72 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.818 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 1.017 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -156.91 143.93 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.826 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 174.133 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 383' ' ' ILE . . . . . 0.786 HD11 ' HE3' ' A' ' 374' ' ' MET . 45.1 mt -95.3 127.95 46.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.147 -177.072 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 384' ' ' TYR . . . . . 0.41 ' O ' ' HG2' ' A' ' 343' ' ' ARG . 0.2 OUTLIER -103.31 92.32 4.45 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.097 170.56 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 385' ' ' VAL . . . . . 0.572 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 15.6 t -87.86 82.9 2.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 178.401 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 57.81 -111.32 2.93 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.415 -0.898 . . . . 0.0 111.777 -173.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 387' ' ' ASP . . . . . 0.44 ' HB2' ' HD3' ' A' ' 309' ' ' LYS . 32.1 t70 -77.03 -24.84 52.07 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.884 0.373 . . . . 0.0 111.306 175.258 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 388' ' ' LEU . . . . . 0.808 HD13 ' HD1' ' A' ' 312' ' ' PHE . 3.6 mp -71.43 156.46 39.43 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.403 -179.041 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 389' ' ' ASN . . . . . 0.7 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 7.7 p30 -169.49 153.56 5.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.196 178.221 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 390' ' ' HIS . . . . . 0.546 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 56.7 t-80 -175.88 117.7 0.15 Allowed 'General case' 0 N--CA 1.469 0.503 0 O-C-N 123.283 0.365 . . . . 0.0 110.486 177.13 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 391' ' ' GLN . . . . . 1.017 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 4.1 tt0 -73.4 154.94 39.81 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.103 0.478 . . . . 0.0 112.114 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 392' ' ' TRP . . . . . 0.512 ' HE1' ' HB3' ' A' ' 394' ' ' GLN . 0.1 OUTLIER -160.76 151.4 18.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.804 176.558 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -113.91 131.85 56.14 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 177.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.87 HE22 ' HA ' ' A' ' 378' ' ' PRO . 0.0 OUTLIER -111.72 136.13 51.39 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.753 0.311 . . . . 0.0 110.542 -177.131 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.487 ' O ' ' HB3' ' A' ' 378' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.922 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.462 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 303' ' ' THR . . . . . 0.535 ' O ' HG23 ' A' ' 335' ' ' THR . 4.3 t . . . . . 0 CA--C 1.535 0.402 0 CA-C-O 120.787 0.327 . . . . 0.0 111.218 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 304' ' ' TYR . . . . . 0.489 ' HB3' ' NE ' ' A' ' 336' ' ' ARG . 0.8 OUTLIER -59.35 133.27 55.95 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.965 0.412 . . . . 0.0 110.002 178.814 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.528 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 12.8 t 174.46 -170.68 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -175.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 18.5 t -65.46 116.25 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 170.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 307' ' ' CYS . . . . . 0.486 ' HB3' ' CE2' ' A' ' 332' ' ' PHE . 0.0 OUTLIER -67.65 139.26 56.8 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -173.134 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 308' ' ' ASP . . . . . 0.642 ' OD2' HG22 ' A' ' 310' ' ' THR . 15.8 t70 -59.45 118.03 5.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.064 -176.412 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.455 ' HD2' ' N ' ' A' ' 310' ' ' THR . 0.0 OUTLIER -48.2 -15.87 0.08 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -168.781 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.642 HG22 ' OD2' ' A' ' 308' ' ' ASP . 9.2 t -99.35 -10.93 21.69 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 118.663 0.665 . . . . 0.0 110.82 -175.538 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 311' ' ' LYS . . . . . 0.554 ' HE2' ' CE1' ' A' ' 332' ' ' PHE . 24.5 mtpt -83.67 51.99 2.15 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.487 0.661 . . . . 0.0 110.579 -178.34 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.519 ' HZ ' ' HG3' ' A' ' 364' ' ' MET . 11.3 m-85 -141.7 151.89 43.38 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.675 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 313' ' ' THR . . . . . 0.4 ' C ' HD21 ' A' ' 388' ' ' LEU . 18.7 p -142.49 152.52 42.78 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.559 -1.2 . . . . 0.0 109.296 178.162 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 65.7 m95 -82.23 95.39 7.53 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.132 0.491 . . . . 0.0 110.804 178.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.792 ' HA ' ' HE3' ' A' ' 315' ' ' LYS . 0.4 OUTLIER -65.3 -46.47 80.24 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 167.56 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 8.0 ttm180 -150.09 126.71 10.92 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.883 173.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 317' ' ' ALA . . . . . 0.486 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -72.94 160.91 81.76 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-O 119.218 -0.42 . . . . 0.0 110.162 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 318' ' ' PRO . . . . . 0.545 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 2.7 Cg_endo -43.55 114.35 0.49 Allowed 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 122.653 2.236 . . . . 0.0 112.492 -176.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 15.8 m -133.78 136.37 44.48 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.438 -174.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -63.66 125.8 25.48 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -176.405 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 321' ' ' SER . . . . . 0.528 ' HB3' HG13 ' A' ' 327' ' ' VAL . 93.7 p -56.17 -48.79 75.66 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.782 -171.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 133.69 -10.44 4.91 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 36.8 t-80 -128.03 61.34 1.44 Allowed 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.346 0.593 . . . . 0.0 109.74 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 52.76 35.62 19.1 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 114.921 -1.036 . . . . 0.0 113.547 177.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 325' ' ' THR . . . . . 0.676 ' HA ' ' HG3' ' A' ' 375' ' ' GLN . 3.7 p -148.48 -175.12 4.8 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 177.134 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.832 HG23 ' HG2' ' A' ' 375' ' ' GLN . 0.2 OUTLIER -130.88 145.91 34.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.34 0.59 . . . . 0.0 111.032 -177.327 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 327' ' ' VAL . . . . . 0.668 HG12 ' HG3' ' A' ' 373' ' ' GLU . 16.9 m -123.44 150.48 27.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.97 175.618 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 328' ' ' MET . . . . . 0.532 ' SD ' ' HB ' ' A' ' 372' ' ' ILE . 0.1 OUTLIER -139.65 149.54 43.86 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 175.229 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.732 ' HG2' ' HG2' ' A' ' 315' ' ' LYS . 4.6 tt0 -125.3 121.63 34.54 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -177.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.444 ' HB ' ' HD1' ' A' ' 312' ' ' PHE . 4.2 m -126.65 145.03 34.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.718 -174.325 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 331' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -111.67 131.82 10.49 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 119.915 -1.136 . . . . 0.0 112.381 179.422 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 332' ' ' PHE . . . . . 0.975 ' H ' ' HA2' ' A' ' 368' ' ' GLY . 4.1 t80 -133.87 136.71 44.53 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.011 -0.736 . . . . 0.0 109.011 176.143 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 19.9 m -129.78 62.36 1.55 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -171.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -164.26 -84.28 0.05 OUTLIER Glycine 0 CA--C 1.52 0.348 0 C-N-CA 119.25 -1.452 . . . . 0.0 113.877 163.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 335' ' ' THR . . . . . 0.95 ' HB ' ' HZ ' ' A' ' 332' ' ' PHE . 35.3 m -50.59 135.82 22.31 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.328 -0.936 . . . . 0.0 109.89 179.085 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.891 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 17.8 ptt180 -72.69 179.98 0.96 Allowed Pre-proline 0 CA--C 1.523 -0.078 0 CA-C-O 117.783 -1.103 . . . . 0.0 108.923 -178.288 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.891 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -25.96 101.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.366 1.474 0 C-N-CA 123.653 2.902 . . . . 0.0 112.905 178.631 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 338' ' ' CYS . . . . . 0.563 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 29.0 p -113.88 -175.71 2.74 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 113.81 -1.541 . . . . 0.0 109.465 -165.197 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -108.74 96.97 6.7 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 340' ' ' ILE . . . . . 0.752 ' HB ' ' SD ' ' A' ' 364' ' ' MET . 15.7 tt -73.8 131.23 82.07 Favored Pre-proline 0 C--N 1.325 -0.472 0 C-N-CA 119.604 -0.838 . . . . 0.0 111.449 -169.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -81.58 79.28 3.25 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 121.67 1.58 . . . . 0.0 111.156 172.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.669 HG22 HG23 ' A' ' 340' ' ' ILE . 2.5 m -101.62 116.09 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 CA-C-O 121.756 0.789 . . . . 0.0 110.313 177.667 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.541 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 25.6 ptt180 -133.8 177.85 7.4 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.761 -1.108 . . . . 0.0 108.162 178.197 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 344' ' ' ALA . . . . . 0.493 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -149.95 147.16 27.55 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.579 176.355 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.617 HG22 HD12 ' A' ' 382' ' ' ILE . 5.8 m -118.38 143.03 30.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 177.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.26 121.88 15.81 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 177.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 347' ' ' HIS . . . . . 0.529 ' O ' HG23 ' A' ' 349' ' ' VAL . 41.3 t-80 43.9 61.85 2.16 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 124.277 0.986 . . . . 0.0 112.54 173.094 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 348' ' ' GLY . . . . . 0.564 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 46.9 38.05 9.94 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 114.733 0.653 . . . . 0.0 114.733 -175.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 349' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 347' ' ' HIS . 58.5 t -138.34 102.88 8.0 Favored Pre-proline 0 C--O 1.235 0.305 0 CA-C-N 117.859 0.829 . . . . 0.0 108.91 178.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 350' ' ' PRO . . . . . 0.468 ' HA ' ' HB ' ' A' ' 345' ' ' VAL . 15.0 Cg_exo -72.6 63.53 3.78 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.848 2.366 . . . . 0.0 112.837 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -100.05 -56.23 2.42 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 7.6 p -125.05 133.1 70.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.278 174.32 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 353' ' ' ASN . . . . . 0.484 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 41.8 t30 -64.42 116.57 6.24 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.942 176.583 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.602 ' HB ' ' HG ' ' A' ' 376' ' ' LEU . 27.4 m -98.53 3.81 10.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.348 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 355' ' ' ALA . . . . . 0.493 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -74.14 84.58 1.84 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.278 0.561 . . . . 0.0 111.026 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 356' ' ' MET . . . . . 0.5 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 22.7 ttt -98.78 98.43 9.54 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 173.559 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.66 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 57.6 mt -83.06 147.39 28.16 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.655 -161.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.718 ' HB ' ' CB ' ' A' ' 373' ' ' GLU . 4.4 mm -88.68 -19.95 7.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 178.039 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 20.6 m -133.75 92.94 21.83 Favored Pre-proline 0 N--CA 1.445 -0.682 0 CA-C-N 113.605 -1.634 . . . . 0.0 108.339 171.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -88.51 25.77 0.61 Allowed 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 123.024 2.483 . . . . 0.0 114.074 -170.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 361' ' ' ASN . . . . . 0.498 ' N ' ' HD3' ' A' ' 362' ' ' PRO . 40.9 m-80 -149.65 57.6 2.85 Favored Pre-proline 0 C--N 1.314 -0.953 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.864 176.641 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 362' ' ' PRO . . . . . 0.515 ' HB3' HG23 ' A' ' 372' ' ' ILE . 4.9 Cg_endo -75.52 111.44 3.3 Favored 'Trans proline' 0 C--O 1.247 0.951 0 C-N-CA 121.447 1.432 . . . . 0.0 112.932 179.042 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 363' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 338' ' ' CYS . 15.8 p -96.68 125.54 41.22 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 114.924 -1.034 . . . . 0.0 111.59 167.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 364' ' ' MET . . . . . 0.814 ' HB3' ' CA ' ' A' ' 369' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.319 -0.734 0 CA-C-N 114.073 -1.421 . . . . 0.0 111.241 -176.089 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 368' ' ' GLY . . . . . 0.975 ' HA2' ' H ' ' A' ' 332' ' ' PHE . . . . . . . . 0 N--CA 1.449 -0.442 0 N-CA-C 111.426 -0.67 . . . . 0.0 111.426 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 369' ' ' GLY . . . . . 0.814 ' CA ' ' HB3' ' A' ' 364' ' ' MET . . . -76.41 -32.15 52.35 Favored Glycine 0 CA--C 1.498 -1.007 0 C-N-CA 120.37 -0.919 . . . . 0.0 113.163 177.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 370' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 87.6 -132.42 11.18 Favored Glycine 0 N--CA 1.438 -1.18 0 C-N-CA 120.03 -1.081 . . . . 0.0 111.002 -172.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -103.13 136.7 42.44 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.155 0.502 . . . . 0.0 111.4 -176.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 372' ' ' ILE . . . . . 0.532 ' HB ' ' SD ' ' A' ' 328' ' ' MET . 0.1 OUTLIER -128.07 165.18 27.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.584 175.752 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 373' ' ' GLU . . . . . 0.718 ' CB ' ' HB ' ' A' ' 358' ' ' ILE . 11.3 mp0 -128.79 130.36 46.9 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.153 0.502 . . . . 0.0 110.637 -177.083 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 374' ' ' MET . . . . . 0.676 ' HG2' HD11 ' A' ' 383' ' ' ILE . 0.0 OUTLIER -137.8 166.86 22.96 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.026 179.722 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 375' ' ' GLN . . . . . 0.832 ' HG2' HG23 ' A' ' 326' ' ' VAL . 0.0 OUTLIER -173.54 176.15 2.84 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.425 0.631 . . . . 0.0 110.809 168.153 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 376' ' ' LEU . . . . . 0.799 HD22 ' HD2' ' A' ' 377' ' ' PRO . 2.6 tm? -168.0 128.97 1.15 Allowed Pre-proline 0 C--N 1.317 -0.834 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 175.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 377' ' ' PRO . . . . . 0.799 ' HD2' HD22 ' A' ' 376' ' ' LEU . 34.0 Cg_exo -26.73 130.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 124.22 3.28 . . . . 0.0 113.161 -178.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -35.46 133.51 0.23 Allowed 'Trans proline' 0 C--N 1.361 1.2 0 C-N-CA 124.373 3.382 . . . . 0.0 113.0 -167.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 151.0 -174.45 30.27 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 -160.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 380' ' ' ASP . . . . . 0.66 ' HB3' ' CD2' ' A' ' 393' ' ' PHE . 4.4 p30 -98.41 125.25 43.5 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 117.787 0.794 . . . . 0.0 111.984 -173.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.635 HD22 ' HG2' ' A' ' 394' ' ' GLN . 33.1 m-80 -139.76 153.56 47.19 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.514 -176.141 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 0.981 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -144.5 140.3 23.97 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.872 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.676 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 383' ' ' ILE . . . . . 0.676 HD11 ' HG2' ' A' ' 374' ' ' MET . 37.3 mt -98.94 130.44 47.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.938 -175.434 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 384' ' ' TYR . . . . . 0.55 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.2 OUTLIER -106.71 92.0 3.92 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.006 174.058 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 385' ' ' VAL . . . . . 0.434 ' O ' ' HB2' ' A' ' 388' ' ' LEU . 9.5 t -87.02 87.71 2.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 64.57 -112.6 5.14 Favored Glycine 0 N--CA 1.442 -0.942 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -169.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -83.95 -16.81 42.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.72 0.295 . . . . 0.0 111.289 174.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 388' ' ' LEU . . . . . 0.55 ' O ' ' HA ' ' A' ' 384' ' ' TYR . 1.2 mp -68.51 151.52 46.68 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.348 -179.134 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 389' ' ' ASN . . . . . 0.571 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 29.0 p30 -159.36 151.35 20.75 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.679 177.734 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 390' ' ' HIS . . . . . 0.545 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 8.7 t60 -172.26 116.1 0.34 Allowed 'General case' 0 C--O 1.239 0.504 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.481 175.421 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 391' ' ' GLN . . . . . 0.981 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 4.1 tt0 -76.87 153.75 34.45 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.803 -177.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 392' ' ' TRP . . . . . 0.563 ' HD1' ' NE2' ' A' ' 394' ' ' GLN . 38.8 t-105 -167.08 153.34 8.14 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.948 178.564 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 393' ' ' PHE . . . . . 0.66 ' CD2' ' HB3' ' A' ' 380' ' ' ASP . 29.2 m-85 -106.75 110.92 23.22 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 176.415 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.635 ' HG2' HD22 ' A' ' 381' ' ' ASN . 33.7 mm-40 -75.76 107.55 8.01 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -169.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 9.7 ptmm? . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.466 -177.444 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 303' ' ' THR . . . . . 0.621 HG23 HG23 ' A' ' 335' ' ' THR . 14.9 t . . . . . 0 CA--C 1.535 0.372 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -66.78 120.83 14.19 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.058 -177.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.615 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 9.4 t 173.55 -167.03 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.519 -170.277 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 37.2 t -64.91 113.07 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 169.214 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 307' ' ' CYS . . . . . 0.423 ' SG ' ' HE2' ' A' ' 332' ' ' PHE . 0.0 OUTLIER -68.36 142.59 55.42 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.953 0.406 . . . . 0.0 110.712 -171.332 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 308' ' ' ASP . . . . . 0.856 ' HB3' ' HG3' ' A' ' 311' ' ' LYS . 6.6 t70 -60.87 126.3 26.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.442 -173.237 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.454 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 17.6 pttm -38.45 -29.62 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 125.849 1.659 . . . . 0.0 114.841 -178.64 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 12.3 t -108.72 4.31 23.62 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 121.723 -0.611 . . . . 0.0 112.029 -169.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 311' ' ' LYS . . . . . 0.856 ' HG3' ' HB3' ' A' ' 308' ' ' ASP . 27.8 mtpp -83.8 -28.79 27.86 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -173.661 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.618 ' HE2' ' O ' ' A' ' 385' ' ' VAL . 0.1 OUTLIER -85.01 175.71 8.88 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.621 0.724 . . . . 0.0 112.159 -176.163 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 5.2 t -153.2 159.45 42.66 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.329 -1.305 . . . . 0.0 109.476 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 314' ' ' TRP . . . . . 0.474 ' CH2' ' HD3' ' A' ' 318' ' ' PRO . 52.5 m95 -81.99 95.9 7.55 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-O 121.161 0.505 . . . . 0.0 110.518 -179.121 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.615 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 65.4 tttm -65.82 -43.18 89.36 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 168.248 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.436 HH11 ' HD2' ' A' ' 316' ' ' ARG . 44.8 ttm105 -149.28 125.31 10.65 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.846 172.168 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 317' ' ' ALA . . . . . 0.538 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -71.02 164.09 59.73 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.309 -179.064 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 318' ' ' PRO . . . . . 0.592 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 2.1 Cg_endo -45.59 108.66 0.15 Allowed 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 122.56 2.174 . . . . 0.0 112.03 -179.409 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 30.1 m -120.5 124.29 45.04 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.647 -174.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 320' ' ' ASP . . . . . 0.557 ' HA ' HG13 ' A' ' 326' ' ' VAL . 11.4 t70 -53.57 121.62 8.13 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 177.318 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 60.2 p -61.21 -43.69 98.47 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.236 0.541 . . . . 0.0 109.794 -172.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 116.8 -8.79 16.6 Favored Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 109.911 -1.275 . . . . 0.0 109.911 178.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -127.1 62.37 1.34 Allowed 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 114.541 -0.83 . . . . 0.0 109.823 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 29.5 t70 64.43 17.99 11.1 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.577 171.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 325' ' ' THR . . . . . 0.526 ' HA ' ' HG2' ' A' ' 375' ' ' GLN . 17.8 p -149.45 -174.58 4.71 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 121.828 -0.545 . . . . 0.0 110.285 -176.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.557 HG13 ' HA ' ' A' ' 320' ' ' ASP . 0.6 OUTLIER -135.56 146.07 30.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.202 0.525 . . . . 0.0 111.095 -177.707 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 327' ' ' VAL . . . . . 0.619 HG12 ' HG2' ' A' ' 373' ' ' GLU . 19.8 m -124.33 153.74 31.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.645 177.485 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 328' ' ' MET . . . . . 0.843 ' SD ' ' HB ' ' A' ' 372' ' ' ILE . 0.0 OUTLIER -145.48 157.84 43.94 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 174.977 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.615 ' HG2' ' HD3' ' A' ' 315' ' ' LYS . 8.0 tt0 -136.21 128.19 29.5 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 120.588 -0.445 . . . . 0.0 109.898 -178.01 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.68 HG22 HD11 ' A' ' 372' ' ' ILE . 1.5 m -129.63 147.09 33.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -173.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -120.89 134.96 10.49 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.533 -176.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 332' ' ' PHE . . . . . 0.862 ' H ' ' HA2' ' A' ' 368' ' ' GLY . 0.9 OUTLIER -110.69 152.2 26.82 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.099 0.476 . . . . 0.0 110.67 178.748 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 17.5 m -88.8 -36.64 15.96 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -172.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -146.12 -39.23 0.05 OUTLIER Glycine 0 C--N 1.333 0.394 0 C-N-CA 118.983 -1.58 . . . . 0.0 114.313 -176.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 335' ' ' THR . . . . . 0.621 HG23 HG23 ' A' ' 303' ' ' THR . 22.8 m -53.5 129.53 32.75 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.906 0.384 . . . . 0.0 110.727 -177.281 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.895 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 7.2 ptm180 -87.58 -176.38 0.71 Allowed Pre-proline 0 N--CA 1.455 -0.2 0 CA-C-O 117.268 -1.348 . . . . 0.0 107.857 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.895 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 37.4 Cg_exo -26.28 97.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 123.482 2.788 . . . . 0.0 113.862 -179.328 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 338' ' ' CYS . . . . . 0.615 ' HB2' ' O ' ' A' ' 305' ' ' THR . 30.0 p -117.55 -176.23 2.98 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.965 -173.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 11.7 mpt_? -111.95 108.39 17.72 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 -177.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 340' ' ' ILE . . . . . 0.8 ' HB ' ' SD ' ' A' ' 364' ' ' MET . 15.0 tt -73.1 131.77 83.16 Favored Pre-proline 0 C--O 1.236 0.37 0 C-N-CA 119.527 -0.869 . . . . 0.0 111.964 -170.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -87.46 78.72 1.62 Allowed 'Trans proline' 0 N--CA 1.447 -1.21 0 C-N-CA 122.069 1.846 . . . . 0.0 110.976 168.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.798 HG22 HG23 ' A' ' 340' ' ' ILE . 2.5 m -103.51 124.62 57.86 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.872 0 CA-C-O 121.686 0.755 . . . . 0.0 110.613 177.451 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.4 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 28.4 ptt180 -141.11 177.48 8.04 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 173.347 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 344' ' ' ALA . . . . . 0.523 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -147.18 147.89 30.97 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 120.314 -0.555 . . . . 0.0 110.336 176.048 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.489 HG22 HD12 ' A' ' 382' ' ' ILE . 10.6 m -118.54 145.86 23.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.23 116.37 5.93 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 176.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 347' ' ' HIS . . . . . 0.665 ' HB3' ' CB ' ' A' ' 380' ' ' ASP . 7.9 p-80 34.7 71.47 0.11 Allowed 'General case' 0 N--CA 1.476 0.846 0 O-C-N 124.498 1.124 . . . . 0.0 113.651 176.271 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 348' ' ' GLY . . . . . 0.8 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 51.88 34.96 38.64 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 115.109 0.804 . . . . 0.0 115.109 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 349' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 347' ' ' HIS . 49.9 t -139.65 101.26 7.31 Favored Pre-proline 0 C--O 1.234 0.282 0 CA-C-N 118.531 1.166 . . . . 0.0 108.327 177.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 350' ' ' PRO . . . . . 0.442 ' HA ' ' HB ' ' A' ' 345' ' ' VAL . 12.1 Cg_exo -75.76 61.9 6.35 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.847 2.365 . . . . 0.0 113.097 -179.135 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -101.02 -56.41 2.33 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 5.5 p -119.4 128.72 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.895 173.183 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 353' ' ' ASN . . . . . 0.523 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 31.8 t30 -64.64 116.56 6.35 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.549 176.614 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.464 ' HB ' ' HG ' ' A' ' 376' ' ' LEU . 16.7 m -92.28 -1.22 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.701 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 355' ' ' ALA . . . . . 0.435 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -76.14 89.12 3.05 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.222 0.534 . . . . 0.0 112.009 -176.336 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.73 103.08 13.82 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 170.082 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.554 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 53.8 mt -86.47 121.99 29.8 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.53 -161.621 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.68 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 2.5 mm -63.48 -23.79 34.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.506 174.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 16.7 m -128.14 92.02 42.87 Favored Pre-proline 0 N--CA 1.45 -0.475 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.23 169.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -88.82 24.14 0.7 Allowed 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 123.105 2.537 . . . . 0.0 113.47 -171.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 361' ' ' ASN . . . . . 0.572 ' N ' ' HD3' ' A' ' 362' ' ' PRO . 28.3 p-10 -145.23 50.92 1.2 Allowed Pre-proline 0 C--N 1.313 -1.012 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.305 178.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 362' ' ' PRO . . . . . 0.585 ' HB3' HG23 ' A' ' 372' ' ' ILE . 5.7 Cg_endo -75.2 108.2 2.66 Favored 'Trans proline' 0 C--O 1.249 1.063 0 C-N-CA 121.648 1.566 . . . . 0.0 113.323 -177.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 363' ' ' THR . . . . . 0.511 ' HA ' ' HE2' ' A' ' 364' ' ' MET . 2.0 p -92.11 167.02 12.36 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 114.693 -1.139 . . . . 0.0 112.011 166.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 364' ' ' MET . . . . . 0.8 ' SD ' ' HB ' ' A' ' 340' ' ' ILE . 0.2 OUTLIER . . . . . 0 CA--C 1.496 -1.129 0 CA-C-N 113.716 -1.584 . . . . 0.0 111.188 -172.46 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 368' ' ' GLY . . . . . 0.862 ' HA2' ' H ' ' A' ' 332' ' ' PHE . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 111.778 -0.529 . . . . 0.0 111.778 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 369' ' ' GLY . . . . . 0.504 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -76.8 -34.04 44.54 Favored Glycine 0 C--N 1.334 0.448 0 CA-C-N 117.686 0.743 . . . . 0.0 113.06 178.355 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 94.39 -50.61 2.11 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.298 -0.953 . . . . 0.0 113.521 179.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -166.36 144.38 5.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 117.08 0.44 . . . . 0.0 111.423 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 372' ' ' ILE . . . . . 0.843 ' HB ' ' SD ' ' A' ' 328' ' ' MET . 0.3 OUTLIER -138.28 158.58 32.06 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 169.474 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 373' ' ' GLU . . . . . 0.68 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 52.0 mt-10 -133.29 129.79 38.06 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.79 0.329 . . . . 0.0 110.326 178.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 374' ' ' MET . . . . . 0.64 ' HG2' HD11 ' A' ' 383' ' ' ILE . 4.9 ppp? -136.83 162.72 32.45 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -179.009 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 375' ' ' GLN . . . . . 0.622 ' HB3' HD11 ' A' ' 358' ' ' ILE . 3.4 tp60 172.52 177.81 0.09 Allowed 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 171.507 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 376' ' ' LEU . . . . . 0.63 HD11 HD21 ' A' ' 381' ' ' ASN . 0.0 OUTLIER -168.5 178.37 1.06 Allowed Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 173.822 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 377' ' ' PRO . . . . . 0.461 ' HD2' ' HB2' ' A' ' 376' ' ' LEU . 92.0 Cg_exo -44.66 125.4 6.26 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 CA-C-N 121.131 1.44 . . . . 0.0 111.176 169.532 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -36.79 147.08 0.08 OUTLIER 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 124.593 3.529 . . . . 0.0 113.943 -173.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 153.87 -174.44 32.4 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -164.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 380' ' ' ASP . . . . . 0.665 ' CB ' ' HB3' ' A' ' 347' ' ' HIS . 4.4 m-20 -93.0 124.76 37.2 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 117.558 0.679 . . . . 0.0 109.373 -178.292 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.63 HD21 HD11 ' A' ' 376' ' ' LEU . 0.6 OUTLIER -120.38 168.56 11.17 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.942 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 1.027 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -160.63 136.74 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 165.662 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 383' ' ' ILE . . . . . 0.64 HD11 ' HG2' ' A' ' 374' ' ' MET . 37.3 mt -95.37 130.01 44.71 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 C-N-CA 119.383 -0.927 . . . . 0.0 109.489 -174.231 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 384' ' ' TYR . . . . . 0.565 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.3 OUTLIER -107.65 90.9 3.44 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 114.352 -1.295 . . . . 0.0 108.114 173.237 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 385' ' ' VAL . . . . . 0.618 ' O ' ' HE2' ' A' ' 312' ' ' PHE . 10.6 t -84.43 91.25 2.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 175.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 61.02 -112.01 4.31 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.171 -171.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -90.05 -13.51 35.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.853 0.358 . . . . 0.0 111.354 176.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 388' ' ' LEU . . . . . 0.565 ' O ' ' HA ' ' A' ' 384' ' ' TYR . 1.6 mp -67.8 146.44 53.7 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 175.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 389' ' ' ASN . . . . . 0.578 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 30.2 p30 -155.58 152.25 28.55 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.042 178.203 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 390' ' ' HIS . . . . . 0.592 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 44.6 t-80 -173.62 119.43 0.3 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.783 174.47 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 391' ' ' GLN . . . . . 1.027 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 24.9 tm0? -82.91 153.04 25.28 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.617 0.722 . . . . 0.0 112.023 -178.235 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 392' ' ' TRP . . . . . 0.494 ' HD1' ' OE1' ' A' ' 394' ' ' GLN . 8.3 t-105 -173.16 137.79 0.71 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 113.977 -1.465 . . . . 0.0 107.753 176.395 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 393' ' ' PHE . . . . . 0.56 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 30.8 p90 -100.18 129.77 46.24 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -176.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.499 ' HG3' ' OE1' ' A' ' 375' ' ' GLN . 3.3 mm100 -89.61 110.45 21.32 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -172.449 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.594 ' HE2' ' HA ' ' A' ' 395' ' ' LYS . 0.6 OUTLIER . . . . . 0 C--O 1.246 0.904 0 CA-C-O 118.109 -0.948 . . . . 0.0 109.623 -173.203 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 303' ' ' THR . . . . . 0.628 HG23 HG23 ' A' ' 335' ' ' THR . 5.7 t . . . . . 0 CA--C 1.539 0.542 0 CA-C-O 121.445 0.641 . . . . 0.0 111.723 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 304' ' ' TYR . . . . . 0.533 ' HB3' ' HD3' ' A' ' 336' ' ' ARG . 39.4 p90 -69.87 128.65 37.12 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 175.21 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.508 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 7.3 t 175.86 -170.72 0.06 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -172.485 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 16.5 t -75.92 106.87 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 107.354 -1.351 . . . . 0.0 107.354 170.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -69.9 155.62 40.29 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.786 0.803 . . . . 0.0 113.031 -168.029 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 308' ' ' ASP . . . . . 0.657 ' OD2' HG22 ' A' ' 310' ' ' THR . 23.1 t70 -67.2 122.23 17.38 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.765 178.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.492 ' HB2' ' N ' ' A' ' 387' ' ' ASP . 31.7 pttt -40.66 -32.86 0.23 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 113.506 -1.679 . . . . 0.0 115.499 -173.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.657 HG22 ' OD2' ' A' ' 308' ' ' ASP . 10.0 t -105.77 16.42 25.29 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.882 0.849 . . . . 0.0 110.735 -165.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 311' ' ' LYS . . . . . 0.533 ' HE3' ' OG1' ' A' ' 335' ' ' THR . 17.4 mtmm -99.46 47.63 0.95 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.626 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 1.039 ' HZ ' HD12 ' A' ' 340' ' ' ILE . 6.1 m-85 -139.98 160.58 39.6 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.65 -171.045 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 313' ' ' THR . . . . . 0.408 ' C ' HD21 ' A' ' 388' ' ' LEU . 69.5 p -134.59 150.35 50.7 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.849 175.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 314' ' ' TRP . . . . . 0.557 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 28.0 m-90 -78.01 92.55 4.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.248 0.546 . . . . 0.0 109.761 174.721 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.478 ' HB3' ' C ' ' A' ' 329' ' ' GLU . 28.5 tptp -68.93 -49.67 56.0 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 170.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 17.0 ttm180 -151.91 125.63 8.99 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.742 175.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 317' ' ' ALA . . . . . 0.403 ' HB1' ' CG ' ' A' ' 390' ' ' HIS . . . -76.53 157.8 81.95 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-O 119.106 -0.474 . . . . 0.0 110.419 -176.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 318' ' ' PRO . . . . . 0.88 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 80.3 Cg_exo -37.56 111.76 0.1 Allowed 'Trans proline' 0 C--N 1.363 1.339 0 C-N-CA 123.187 2.592 . . . . 0.0 113.537 -178.122 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 16.4 m -134.86 138.52 44.25 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.7 -173.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -58.01 126.45 27.5 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.929 0.395 . . . . 0.0 110.075 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 321' ' ' SER . . . . . 0.512 ' HB3' HG13 ' A' ' 327' ' ' VAL . 92.4 p -59.44 -44.32 92.96 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.51 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 131.58 -13.32 5.37 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.139 176.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 323' ' ' HIS . . . . . 0.453 ' O ' ' HB2' ' A' ' 324' ' ' ASP . 95.0 m-70 -114.27 20.51 15.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.588 0.233 . . . . 0.0 110.67 -179.067 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 324' ' ' ASP . . . . . 0.453 ' HB2' ' O ' ' A' ' 323' ' ' HIS . 10.6 m-20 84.76 43.99 0.02 OUTLIER 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.148 172.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 325' ' ' THR . . . . . 0.486 ' HB ' HG13 ' A' ' 358' ' ' ILE . 5.5 p -151.85 172.68 15.82 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 174.292 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.73 HG21 ' HZ2' ' A' ' 392' ' ' TRP . 0.2 OUTLIER -123.66 141.89 42.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 119.945 1.248 . . . . 0.0 111.784 -173.04 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 327' ' ' VAL . . . . . 0.814 HG12 ' HG2' ' A' ' 373' ' ' GLU . 17.8 m -120.86 155.55 24.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.676 176.321 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 328' ' ' MET . . . . . 0.608 ' HE3' ' HD3' ' A' ' 318' ' ' PRO . 6.6 ptm -146.54 157.93 43.81 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.815 -1.179 . . . . 0.0 107.815 172.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.587 ' HA ' ' O ' ' A' ' 370' ' ' GLY . 16.2 tt0 -128.42 129.39 46.09 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -175.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.586 HG11 HG21 ' A' ' 385' ' ' VAL . 7.5 m -129.68 149.67 33.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -175.561 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -109.13 178.22 20.61 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 175.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 332' ' ' PHE . . . . . 0.528 ' HB2' ' SD ' ' A' ' 364' ' ' MET . 0.1 OUTLIER -138.56 158.19 44.72 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 117.939 0.869 . . . . 0.0 113.239 -177.211 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 9.7 t -65.54 -70.92 0.21 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.313 -1.312 . . . . 0.0 112.271 171.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -166.73 -22.68 0.02 OUTLIER Glycine 0 CA--C 1.53 1.022 0 C-N-CA 119.04 -1.552 . . . . 0.0 115.475 -176.11 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 335' ' ' THR . . . . . 0.628 HG23 HG23 ' A' ' 303' ' ' THR . 29.3 m -51.06 131.22 27.08 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 117.136 0.468 . . . . 0.0 109.781 174.349 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.772 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 1.3 ptm180 -69.23 177.36 1.22 Allowed Pre-proline 0 CA--C 1.518 -0.285 0 CA-C-O 118.456 -0.783 . . . . 0.0 109.198 -172.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.772 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.2 OUTLIER -28.28 105.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.358 1.064 0 C-N-CA 123.253 2.635 . . . . 0.0 112.864 175.22 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 338' ' ' CYS . . . . . 0.809 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 31.6 p -125.47 155.29 40.74 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.275 -1.33 . . . . 0.0 107.615 -174.428 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -68.29 116.99 9.5 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.369 171.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 340' ' ' ILE . . . . . 1.039 HD12 ' HZ ' ' A' ' 312' ' ' PHE . 33.8 mm -79.0 118.87 74.95 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.614 -174.584 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -75.72 79.87 2.73 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.01 1.806 . . . . 0.0 110.804 176.489 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.833 HG13 HG22 ' A' ' 340' ' ' ILE . 2.5 m -103.87 118.76 51.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.612 0.72 . . . . 0.0 110.098 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -135.72 177.88 7.48 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 176.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 344' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -146.67 146.46 30.38 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.495 178.002 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 17.3 m -119.48 142.65 33.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.4 115.45 5.12 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.561 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 347' ' ' HIS . . . . . 0.524 ' O ' HG23 ' A' ' 349' ' ' VAL . 63.8 t60 41.49 68.05 0.49 Allowed 'General case' 0 N--CA 1.471 0.6 0 O-C-N 124.571 1.169 . . . . 0.0 111.593 176.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 348' ' ' GLY . . . . . 0.634 ' H ' ' CG2' ' A' ' 382' ' ' ILE . . . 46.01 39.39 8.98 Favored Glycine 0 C--N 1.333 0.39 0 N-CA-C 115.385 0.914 . . . . 0.0 115.385 -177.255 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 349' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 347' ' ' HIS . 59.8 t -138.88 101.8 7.77 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 118.47 1.135 . . . . 0.0 108.53 178.4 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -75.14 64.47 6.17 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 122.893 2.396 . . . . 0.0 113.104 -178.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -100.72 -55.84 2.48 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 176.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 4.9 p -123.5 130.96 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.634 173.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 353' ' ' ASN . . . . . 0.485 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 33.1 t30 -66.13 121.16 14.54 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.801 176.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.655 ' HB ' ' HG ' ' A' ' 376' ' ' LEU . 26.6 m -101.01 4.11 10.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.733 -178.798 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 355' ' ' ALA . . . . . 0.471 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -72.01 87.36 1.04 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.132 0.492 . . . . 0.0 112.199 -177.581 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 356' ' ' MET . . . . . 0.579 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 37.0 ttm -97.81 100.54 11.91 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 169.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.673 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 26.4 mt -85.63 122.9 30.39 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.591 -164.748 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.695 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 3.7 mm -61.1 -30.49 47.83 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 CA-C-N 115.313 -0.858 . . . . 0.0 108.943 173.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 18.8 m -135.48 97.13 13.23 Favored Pre-proline 0 N--CA 1.451 -0.393 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.404 175.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -90.79 37.32 0.32 Allowed 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 123.356 2.704 . . . . 0.0 113.706 -174.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -140.2 61.88 18.69 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.202 176.203 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 362' ' ' PRO . . . . . 0.76 ' HB3' HG23 ' A' ' 372' ' ' ILE . 93.9 Cg_endo -84.77 143.06 9.37 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.115 1.877 . . . . 0.0 112.016 176.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 18.4 p -142.47 134.05 26.64 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -178.218 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 364' ' ' MET . . . . . 0.809 ' HG2' ' SG ' ' A' ' 338' ' ' CYS . 16.3 ptt? . . . . . 0 CA--C 1.49 -1.337 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 176.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 368' ' ' GLY . . . . . 0.507 ' HA2' ' CD1' ' A' ' 332' ' ' PHE . . . . . . . . 0 CA--C 1.516 0.119 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 369' ' ' GLY . . . . . 0.795 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -51.91 -40.65 50.49 Favored Glycine 0 C--N 1.335 0.489 0 CA-C-N 117.541 0.671 . . . . 0.0 113.627 174.601 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 370' ' ' GLY . . . . . 0.587 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 83.24 -127.09 7.82 Favored Glycine 0 N--CA 1.439 -1.141 0 C-N-CA 120.259 -0.972 . . . . 0.0 111.572 -178.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -102.08 139.41 37.74 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.384 0.612 . . . . 0.0 112.017 -173.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 372' ' ' ILE . . . . . 0.76 HG23 ' HB3' ' A' ' 362' ' ' PRO . 0.5 OUTLIER -131.78 155.5 41.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.093 175.751 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 373' ' ' GLU . . . . . 0.814 ' HG2' HG12 ' A' ' 327' ' ' VAL . 40.8 mt-10 -133.37 128.39 35.52 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.467 -178.027 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 374' ' ' MET . . . . . 0.673 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 0.1 OUTLIER -147.72 165.84 29.26 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.392 -173.937 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 375' ' ' GLN . . . . . 0.579 ' O ' ' HB3' ' A' ' 356' ' ' MET . 1.7 tp60 179.55 175.08 0.76 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 175.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 376' ' ' LEU . . . . . 0.745 HD22 ' HD2' ' A' ' 377' ' ' PRO . 2.1 tm? -166.69 143.13 3.89 Favored Pre-proline 0 N--CA 1.445 -0.691 0 N-CA-C 104.373 -2.455 . . . . 0.0 104.373 -176.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 377' ' ' PRO . . . . . 0.745 ' HD2' HD22 ' A' ' 376' ' ' LEU . 46.5 Cg_exo -36.53 134.27 0.33 Allowed 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.569 2.179 . . . . 0.0 112.638 174.549 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.54 ' HA ' ' OE1' ' A' ' 394' ' ' GLN . 57.1 Cg_exo -33.86 135.82 0.11 Allowed 'Trans proline' 0 C--N 1.365 1.404 0 C-N-CA 124.875 3.717 . . . . 0.0 114.205 -172.548 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 153.15 -168.71 31.98 Favored Glycine 0 N--CA 1.441 -1.01 0 N-CA-C 110.256 -1.137 . . . . 0.0 110.256 -166.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.88 130.85 48.45 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 117.103 0.451 . . . . 0.0 110.701 179.258 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.655 HD21 HG21 ' A' ' 354' ' ' VAL . 11.4 m120 -136.5 169.97 16.82 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.152 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 1.123 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -157.22 143.97 9.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 173.008 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 383' ' ' ILE . . . . . 0.851 HD12 ' HG3' ' A' ' 318' ' ' PRO . 21.2 mt -100.22 132.89 44.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.558 -176.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 384' ' ' TYR . . . . . 0.526 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 14.6 m-85 -104.71 97.48 7.37 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.183 169.619 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 385' ' ' VAL . . . . . 0.586 HG21 HG11 ' A' ' 330' ' ' VAL . 9.7 t -83.84 82.9 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 173.668 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 63.59 -109.05 2.5 Favored Glycine 0 N--CA 1.434 -1.493 0 C-N-CA 120.39 -0.91 . . . . 0.0 111.223 -166.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 387' ' ' ASP . . . . . 0.492 ' N ' ' HB2' ' A' ' 309' ' ' LYS . 6.9 t70 -93.5 -11.48 31.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.624 0.25 . . . . 0.0 110.894 177.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 388' ' ' LEU . . . . . 0.557 ' HG ' ' CE2' ' A' ' 314' ' ' TRP . 1.0 OUTLIER -69.07 151.17 46.78 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 174.981 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 389' ' ' ASN . . . . . 0.554 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 8.2 p30 -156.63 152.38 27.1 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 121.061 -0.256 . . . . 0.0 110.476 -178.201 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 390' ' ' HIS . . . . . 0.88 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 4.9 t-80 -174.11 116.39 0.22 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.485 171.606 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 391' ' ' GLN . . . . . 1.123 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 14.6 tt0 -79.53 154.72 28.61 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.44 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 392' ' ' TRP . . . . . 0.73 ' HZ2' HG21 ' A' ' 326' ' ' VAL . 0.6 OUTLIER -163.8 152.36 13.55 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 114.955 -1.02 . . . . 0.0 108.282 179.691 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -110.52 125.58 53.48 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.54 ' OE1' ' HA ' ' A' ' 378' ' ' PRO . 2.2 pp0? -104.46 119.99 40.23 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 -178.355 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? . . . . . 0 C--N 1.315 -0.926 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.118 -168.521 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 303' ' ' THR . . . . . 0.496 ' O ' HG23 ' A' ' 335' ' ' THR . 5.3 t . . . . . 0 CA--C 1.538 0.489 0 CA-C-O 121.394 0.616 . . . . 0.0 111.198 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 304' ' ' TYR . . . . . 0.548 ' HB3' ' NE ' ' A' ' 336' ' ' ARG . 0.9 OUTLIER -69.37 132.85 47.04 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 121.727 -0.608 . . . . 0.0 109.421 174.383 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.539 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 12.9 t 172.38 -169.24 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -177.556 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 38.6 t -64.16 110.97 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 170.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -69.22 140.69 54.55 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 -171.622 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 308' ' ' ASP . . . . . 0.613 ' OD1' HG22 ' A' ' 310' ' ' THR . 11.2 t70 -61.89 131.06 48.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.452 0.644 . . . . 0.0 111.376 -171.567 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.473 ' HA ' ' HA3' ' A' ' 386' ' ' GLY . 23.4 pttm -37.95 -38.13 0.29 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 113.245 -1.798 . . . . 0.0 114.523 -178.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.613 HG22 ' OD1' ' A' ' 308' ' ' ASP . 13.9 t -98.9 -8.32 25.81 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.067 0.461 . . . . 0.0 111.574 -166.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 311' ' ' LYS . . . . . 0.505 ' HZ3' ' HB3' ' A' ' 311' ' ' LYS . 6.3 mtpm? -74.71 -22.16 58.99 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.319 -175.542 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.698 ' HD2' ' HB ' ' A' ' 330' ' ' VAL . 49.3 m-85 -70.85 169.26 15.06 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-O 121.934 0.874 . . . . 0.0 112.915 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 313' ' ' THR . . . . . 0.456 HG22 ' O ' ' A' ' 331' ' ' GLY . 11.6 t -151.64 153.25 34.08 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.46 169.298 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 20.1 m95 -78.11 96.77 5.23 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.143 0.496 . . . . 0.0 111.487 -177.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.593 ' HD3' ' HB3' ' A' ' 329' ' ' GLU . 50.9 tttp -65.94 -46.93 76.38 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 168.618 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.792 ' HB3' ' HB2' ' A' ' 329' ' ' GLU . 70.9 ttt180 -153.35 97.29 2.14 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.09 175.413 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -44.68 154.88 0.4 Allowed Pre-proline 0 N--CA 1.476 0.845 0 C-N-CA 123.634 0.774 . . . . 0.0 112.583 175.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 318' ' ' PRO . . . . . 0.526 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 3.2 Cg_exo -38.67 112.27 0.13 Allowed 'Trans proline' 0 C--N 1.367 1.516 0 C-N-CA 123.676 2.917 . . . . 0.0 113.626 -174.601 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 32.8 m -127.19 132.44 50.48 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.548 -1.206 . . . . 0.0 109.655 -177.281 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -59.45 118.45 6.03 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 321' ' ' SER . . . . . 0.54 ' HB3' HG13 ' A' ' 327' ' ' VAL . 88.9 p -52.41 -55.68 20.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.536 0.684 . . . . 0.0 111.038 -168.548 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 136.4 -18.17 3.71 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 109.266 -1.533 . . . . 0.0 109.266 -175.287 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -104.61 43.58 1.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.714 -0.743 . . . . 0.0 109.217 178.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 49.72 49.2 20.49 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.411 -177.039 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 325' ' ' THR . . . . . 0.623 ' HA ' HE21 ' A' ' 375' ' ' GLN . 1.7 p -155.89 -168.38 2.76 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.536 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.596 ' HB ' ' HG3' ' A' ' 374' ' ' MET . 0.3 OUTLIER -127.19 145.48 34.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 118.89 0.768 . . . . 0.0 111.653 -179.627 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 327' ' ' VAL . . . . . 0.7 HG12 ' HG3' ' A' ' 373' ' ' GLU . 11.5 m -119.45 152.43 21.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.846 170.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 328' ' ' MET . . . . . 0.57 ' SD ' HD13 ' A' ' 383' ' ' ILE . 0.0 OUTLIER -140.09 142.86 36.06 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 175.989 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.792 ' HB2' ' HB3' ' A' ' 316' ' ' ARG . 6.4 mt-10 -122.48 128.55 50.98 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.12 0.486 . . . . 0.0 109.954 179.414 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.698 ' HB ' ' HD2' ' A' ' 312' ' ' PHE . 0.9 OUTLIER -130.05 146.07 34.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.906 -175.825 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 331' ' ' GLY . . . . . 0.456 ' O ' HG22 ' A' ' 313' ' ' THR . . . -125.6 140.73 12.43 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.043 -178.355 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 332' ' ' PHE . . . . . 0.762 ' CD1' ' HA2' ' A' ' 368' ' ' GLY . 0.4 OUTLIER -111.45 176.64 4.94 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -178.246 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 333' ' ' SER . . . . . 0.449 ' OG ' ' HE2' ' A' ' 311' ' ' LYS . 4.7 p -100.98 -66.66 0.9 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 114.161 -1.381 . . . . 0.0 113.351 172.271 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -122.05 -43.68 0.39 Allowed Glycine 0 CA--C 1.535 1.315 0 N-CA-C 116.511 1.364 . . . . 0.0 116.511 -167.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 335' ' ' THR . . . . . 0.496 HG23 ' O ' ' A' ' 303' ' ' THR . 33.9 m -52.4 123.04 9.91 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 117.374 0.587 . . . . 0.0 111.404 -176.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.855 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 12.5 ptt180 -75.2 -176.27 0.54 Allowed Pre-proline 0 CA--C 1.529 0.137 0 CA-C-O 117.726 -1.13 . . . . 0.0 109.018 -176.228 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.855 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -27.27 98.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.371 1.745 0 C-N-CA 123.549 2.833 . . . . 0.0 113.253 177.197 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 338' ' ' CYS . . . . . 0.782 ' SG ' ' HE2' ' A' ' 364' ' ' MET . 14.9 p -114.89 -175.63 2.73 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 113.787 -1.551 . . . . 0.0 110.336 -168.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -108.64 101.51 10.65 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 178.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 340' ' ' ILE . . . . . 0.843 HG22 HG22 ' A' ' 342' ' ' VAL . 39.3 mt -72.37 118.05 64.15 Favored Pre-proline 0 C--O 1.236 0.362 0 C-N-CA 120.328 -0.549 . . . . 0.0 111.253 -169.276 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -79.88 78.11 3.82 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 122.21 1.94 . . . . 0.0 111.065 176.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.865 HG13 HG13 ' A' ' 385' ' ' VAL . 0.0 OUTLIER -103.77 115.82 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.235 174.642 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 37.5 ptt180 -129.46 174.28 9.79 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 177.013 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 344' ' ' ALA . . . . . 0.508 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -146.89 145.44 29.83 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.441 177.524 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.403 HG22 HD12 ' A' ' 382' ' ' ILE . 13.3 m -117.35 145.39 23.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.269 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.25 115.25 4.85 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.592 175.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 347' ' ' HIS . . . . . 0.663 ' HB3' ' CB ' ' A' ' 380' ' ' ASP . 11.6 p80 32.47 74.46 0.05 Allowed 'General case' 0 N--CA 1.476 0.861 0 O-C-N 124.745 1.278 . . . . 0.0 113.159 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 348' ' ' GLY . . . . . 0.84 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 47.51 41.46 17.96 Favored Glycine 0 C--N 1.331 0.301 0 N-CA-C 115.396 0.918 . . . . 0.0 115.396 -178.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 58.6 t -142.8 102.12 5.37 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 118.396 1.098 . . . . 0.0 108.181 176.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -78.02 53.64 4.54 Favored 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 123.072 2.514 . . . . 0.0 113.248 -176.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -102.73 -4.89 24.36 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 122.009 0.909 . . . . 0.0 108.996 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 2.4 p -170.09 104.96 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.668 -164.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 353' ' ' ASN . . . . . 0.508 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 56.5 t30 -64.12 108.92 1.67 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.994 177.613 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.534 ' HB ' ' HG ' ' A' ' 376' ' ' LEU . 28.0 m -91.6 3.75 7.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.995 179.187 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 355' ' ' ALA . . . . . 0.461 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -79.0 84.25 5.03 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.402 0.62 . . . . 0.0 111.275 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 3.0 tmm? -96.04 103.26 15.14 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 170.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.528 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 27.7 mt -86.65 115.28 24.01 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.881 -163.27 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.737 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 3.4 mm -58.57 -24.91 26.67 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.05 177.572 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 29.9 m -134.03 90.76 25.62 Favored Pre-proline 0 N--CA 1.445 -0.694 0 CA-C-N 114.446 -1.252 . . . . 0.0 108.37 173.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -84.19 34.58 0.52 Allowed 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 123.094 2.529 . . . . 0.0 113.151 -172.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -140.01 61.75 19.03 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.205 178.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 362' ' ' PRO . . . . . 0.758 ' HB3' HG23 ' A' ' 372' ' ' ILE . 41.5 Cg_endo -80.92 137.46 11.03 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.299 1.999 . . . . 0.0 111.83 178.196 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.87 141.37 30.27 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.015 -173.337 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 364' ' ' MET . . . . . 0.782 ' HE2' ' SG ' ' A' ' 338' ' ' CYS . 30.3 mtm . . . . . 0 CA--C 1.492 -1.288 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 176.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 368' ' ' GLY . . . . . 0.762 ' HA2' ' CD1' ' A' ' 332' ' ' PHE . . . . . . . . 0 N--CA 1.451 -0.341 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 369' ' ' GLY . . . . . 0.694 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -50.26 -37.69 31.84 Favored Glycine 0 CA--C 1.505 -0.562 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.869 171.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 370' ' ' GLY . . . . . 0.589 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 78.88 -128.1 8.41 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 120.302 -0.952 . . . . 0.0 111.318 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -103.47 141.39 36.06 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.355 0.598 . . . . 0.0 111.984 -175.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 372' ' ' ILE . . . . . 0.758 HG23 ' HB3' ' A' ' 362' ' ' PRO . 0.5 OUTLIER -136.81 159.73 37.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.35 175.803 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 373' ' ' GLU . . . . . 0.737 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 2.5 mp0 -125.54 128.52 48.09 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.187 0.518 . . . . 0.0 110.913 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 374' ' ' MET . . . . . 0.596 ' HG3' ' HB ' ' A' ' 326' ' ' VAL . 1.9 ptm -130.45 167.49 18.53 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.946 -1.025 . . . . 0.0 108.475 179.529 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 375' ' ' GLN . . . . . 0.623 HE21 ' HA ' ' A' ' 325' ' ' THR . 5.9 tp-100 -179.67 171.67 1.18 Allowed 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 164.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 376' ' ' LEU . . . . . 0.869 HD22 ' HD2' ' A' ' 377' ' ' PRO . 2.5 tm? -165.89 137.64 3.12 Favored Pre-proline 0 C--N 1.311 -1.097 0 N-CA-C 104.015 -2.587 . . . . 0.0 104.015 -178.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 377' ' ' PRO . . . . . 0.869 ' HD2' HD22 ' A' ' 376' ' ' LEU . 31.0 Cg_exo -26.92 119.6 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.544 2.829 . . . . 0.0 112.495 177.646 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -37.09 139.02 0.22 Allowed 'Trans proline' 0 C--N 1.359 1.122 0 C-N-CA 124.286 3.324 . . . . 0.0 113.071 -169.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 153.66 -164.55 31.21 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -157.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 380' ' ' ASP . . . . . 0.663 ' CB ' ' HB3' ' A' ' 347' ' ' HIS . 8.8 m-20 -96.59 121.63 38.63 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 118.103 0.951 . . . . 0.0 110.741 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.653 ' HB2' HE21 ' A' ' 394' ' ' GLN . 9.6 m120 -125.95 163.8 22.2 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 1.0 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -156.94 139.62 6.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 171.685 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 383' ' ' ILE . . . . . 0.677 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 40.9 mt -98.65 129.85 48.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.092 -174.367 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 384' ' ' TYR . . . . . 0.671 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.9 OUTLIER -108.89 92.63 4.13 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.437 -1.256 . . . . 0.0 109.207 172.862 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 385' ' ' VAL . . . . . 0.865 HG13 HG13 ' A' ' 342' ' ' VAL . 3.5 t -85.47 85.52 2.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 176.643 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 386' ' ' GLY . . . . . 0.473 ' HA3' ' HA ' ' A' ' 309' ' ' LYS . . . 66.17 -112.38 4.88 Favored Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 120.356 -0.926 . . . . 0.0 110.919 -168.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -85.94 -17.04 36.53 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.867 0.365 . . . . 0.0 110.93 175.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 388' ' ' LEU . . . . . 0.671 ' O ' ' HA ' ' A' ' 384' ' ' TYR . 1.3 mp -65.33 147.07 54.08 Favored 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.118 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 389' ' ' ASN . . . . . 0.677 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 8.2 p30 -159.7 151.02 19.74 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.714 -0.221 . . . . 0.0 110.745 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 390' ' ' HIS . . . . . 0.526 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 11.5 t-80 -172.95 115.65 0.28 Allowed 'General case' 0 C--N 1.328 -0.353 0 O-C-N 123.517 0.511 . . . . 0.0 110.119 176.345 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 391' ' ' GLN . . . . . 1.0 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 25.3 tm0? -83.0 154.22 24.58 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.249 0.547 . . . . 0.0 111.76 -177.637 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 392' ' ' TRP . . . . . 0.518 ' HD1' ' NE2' ' A' ' 394' ' ' GLN . 23.8 t-105 -169.93 150.5 3.87 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.891 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 393' ' ' PHE . . . . . 0.541 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 9.1 p90 -104.83 109.67 21.73 Favored 'General case' 0 C--N 1.317 -0.843 0 O-C-N 121.411 -0.805 . . . . 0.0 108.863 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.653 HE21 ' HB2' ' A' ' 381' ' ' ASN . 27.2 mm-40 -78.47 123.53 27.15 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -165.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt . . . . . 0 C--O 1.249 1.028 0 CA-C-O 117.918 -1.039 . . . . 0.0 110.802 -179.384 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 303' ' ' THR . . . . . 0.425 ' O ' HG23 ' A' ' 335' ' ' THR . 9.1 t . . . . . 0 CA--C 1.536 0.428 0 CA-C-O 121.266 0.555 . . . . 0.0 111.914 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 304' ' ' TYR . . . . . 0.509 ' HB2' ' O ' ' A' ' 337' ' ' PRO . 5.5 p90 -65.06 131.17 45.85 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 174.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.59 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 12.0 t 175.57 -167.98 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -170.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.409 ' HA ' ' HB2' ' A' ' 339' ' ' ARG . 8.4 t -75.67 105.64 4.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 168.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 307' ' ' CYS . . . . . 0.531 ' HB3' HG21 ' A' ' 335' ' ' THR . 0.1 OUTLIER -70.49 156.35 39.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.918 0.866 . . . . 0.0 113.315 -167.206 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 308' ' ' ASP . . . . . 0.578 ' OD2' HG22 ' A' ' 310' ' ' THR . 26.2 t70 -70.07 130.35 41.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.046 -1.433 . . . . 0.0 111.801 -175.245 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -38.76 -28.78 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 115.982 1.845 . . . . 0.0 115.982 -174.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 310' ' ' THR . . . . . 0.578 HG22 ' OD2' ' A' ' 308' ' ' ASP . 12.7 t -108.19 0.75 21.67 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 119.323 0.965 . . . . 0.0 112.283 -169.134 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 311' ' ' LYS . . . . . 0.418 ' HE3' ' HB3' ' A' ' 311' ' ' LYS . 27.7 mtpp -88.46 43.26 1.12 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -171.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.493 ' HD2' HD13 ' A' ' 388' ' ' LEU . 0.0 OUTLIER -152.48 177.89 10.14 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.655 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 8.9 t -152.89 160.48 43.06 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.191 177.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -64.33 125.35 24.31 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.49 ' HB3' ' C ' ' A' ' 329' ' ' GLU . 19.9 ttmm -104.43 -45.58 4.62 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 170.029 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 45.7 ttm105 -149.78 125.65 10.5 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 114.737 -1.119 . . . . 0.0 109.078 170.023 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 317' ' ' ALA . . . . . 0.496 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -71.53 161.39 78.74 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-O 119.202 -0.428 . . . . 0.0 110.048 -179.225 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 318' ' ' PRO . . . . . 0.517 ' HB3' ' CD1' ' A' ' 383' ' ' ILE . 3.5 Cg_exo -44.5 113.21 0.42 Allowed 'Trans proline' 0 C--N 1.358 1.058 0 C-N-CA 122.384 2.056 . . . . 0.0 112.548 -177.107 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 19.6 m -129.42 138.63 51.58 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.695 -174.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -59.22 127.82 34.05 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.731 0.3 . . . . 0.0 110.706 175.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 321' ' ' SER . . . . . 0.592 ' HB3' HG13 ' A' ' 327' ' ' VAL . 67.3 p -79.14 6.01 10.67 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.551 0.74 . . . . 0.0 111.973 -174.043 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 84.86 -20.76 13.64 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.4 -0.905 . . . . 0.0 113.559 -172.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 86.8 t60 -98.01 7.03 46.97 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 117.388 0.594 . . . . 0.0 110.751 -177.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 36.2 t70 71.85 53.49 0.2 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 122.582 1.182 . . . . 0.0 108.806 -176.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 325' ' ' THR . . . . . 0.864 ' HA ' ' HG3' ' A' ' 375' ' ' GLN . 5.0 p -155.82 161.98 40.54 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.67 HG23 ' HG2' ' A' ' 375' ' ' GLN . 0.2 OUTLIER -110.71 138.48 38.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 119.628 1.104 . . . . 0.0 111.807 -173.552 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 327' ' ' VAL . . . . . 0.695 HG12 ' HG2' ' A' ' 373' ' ' GLU . 15.8 m -114.78 161.08 13.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.736 173.375 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 328' ' ' MET . . . . . 0.51 ' SD ' HG13 ' A' ' 330' ' ' VAL . 0.0 OUTLIER -149.31 152.06 35.23 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 178.272 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.49 ' C ' ' HB3' ' A' ' 315' ' ' LYS . 9.9 tt0 -137.02 135.88 37.96 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -176.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.61 HG23 ' HA3' ' A' ' 369' ' ' GLY . 1.7 m -133.64 161.12 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -176.583 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 331' ' ' GLY . . . . . 0.756 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -127.49 134.14 8.17 Favored Glycine 0 CA--C 1.522 0.529 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.03 176.197 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 332' ' ' PHE . . . . . 0.495 ' HD1' ' H ' ' A' ' 332' ' ' PHE . 0.1 OUTLIER -90.34 160.47 16.1 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -174.84 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 11.4 p -101.1 4.42 42.15 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.43 -1.259 . . . . 0.0 114.297 173.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 166.55 -46.57 0.26 Allowed Glycine 0 CA--C 1.525 0.679 0 C-N-CA 118.292 -1.909 . . . . 0.0 115.764 173.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 335' ' ' THR . . . . . 0.666 ' HB ' ' CE ' ' A' ' 364' ' ' MET . 41.0 m -54.74 122.54 10.93 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.584 0.192 . . . . 0.0 110.527 -178.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.819 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 16.5 ptt180 -79.2 179.54 1.76 Allowed Pre-proline 0 C--O 1.227 -0.121 0 CA-C-O 117.417 -1.277 . . . . 0.0 108.336 -175.365 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.819 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.9 OUTLIER -26.12 100.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.37 1.703 0 C-N-CA 123.578 2.852 . . . . 0.0 113.695 -175.143 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 338' ' ' CYS . . . . . 0.903 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 32.1 p -132.32 153.36 50.8 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.256 -170.539 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 339' ' ' ARG . . . . . 0.409 ' HB2' ' HA ' ' A' ' 306' ' ' VAL . 22.2 mmm180 -67.96 114.1 6.22 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.863 173.086 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 340' ' ' ILE . . . . . 0.632 HD11 ' HB2' ' A' ' 362' ' ' PRO . 28.9 pt -93.64 119.16 67.41 Favored Pre-proline 0 C--N 1.321 -0.666 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.196 -177.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.68 82.67 0.72 Allowed 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.787 2.325 . . . . 0.0 111.943 -178.19 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.844 HG11 HD13 ' A' ' 372' ' ' ILE . 34.5 m -102.59 124.71 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-O 122.135 0.969 . . . . 0.0 110.645 -178.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.504 ' HG3' ' HB2' ' A' ' 384' ' ' TYR . 30.0 ptt180 -137.28 178.76 6.84 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 114.527 -1.215 . . . . 0.0 107.961 177.686 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 344' ' ' ALA . . . . . 0.468 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -149.12 146.21 27.58 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.815 174.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 13.0 m -120.16 147.8 23.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -71.27 119.86 16.02 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 178.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 347' ' ' HIS . . . . . 0.658 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 3.8 t60 46.79 62.07 2.52 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 124.284 0.99 . . . . 0.0 111.377 174.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 348' ' ' GLY . . . . . 0.707 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 42.14 44.61 4.87 Favored Glycine 0 C--N 1.332 0.357 0 N-CA-C 114.564 0.586 . . . . 0.0 114.564 -173.553 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 349' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 347' ' ' HIS . 96.8 t -141.57 102.32 5.98 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -73.02 67.35 4.08 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.767 2.311 . . . . 0.0 112.5 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -100.51 -57.19 2.16 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 5.4 p -124.57 132.76 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.574 171.282 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 353' ' ' ASN . . . . . 0.468 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 50.6 t30 -61.83 109.71 1.32 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.13 175.724 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.422 ' O ' ' HB2' ' A' ' 376' ' ' LEU . 20.6 m -86.36 3.82 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.091 178.501 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 355' ' ' ALA . . . . . 0.458 ' HB1' HD21 ' A' ' 357' ' ' LEU . . . -79.98 82.22 6.1 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.104 -0.639 . . . . 0.0 110.999 178.362 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.67 99.16 10.79 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 169.574 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.693 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 34.6 mt -80.16 139.25 36.88 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.261 -0.882 . . . . 0.0 111.488 -159.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.914 HD11 ' HB2' ' A' ' 375' ' ' GLN . 3.0 mm -80.53 -21.85 11.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 3.4 m -139.55 94.83 9.21 Favored Pre-proline 0 N--CA 1.448 -0.567 0 CA-C-N 113.578 -1.646 . . . . 0.0 108.185 171.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -83.74 35.75 0.57 Allowed 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 123.494 2.796 . . . . 0.0 113.263 -173.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -141.72 60.04 10.74 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.714 176.323 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 362' ' ' PRO . . . . . 0.879 ' HB3' HG23 ' A' ' 372' ' ' ILE . 66.0 Cg_endo -79.47 145.74 18.85 Favored 'Trans proline' 0 C--O 1.241 0.656 0 C-N-CA 122.564 2.176 . . . . 0.0 112.618 -176.302 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 363' ' ' THR . . . . . 0.474 ' O ' ' HA2' ' A' ' 369' ' ' GLY . 0.8 OUTLIER -144.72 168.31 20.5 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.598 -174.421 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 364' ' ' MET . . . . . 0.903 ' HG2' ' SG ' ' A' ' 338' ' ' CYS . 13.7 ptt? . . . . . 0 C--N 1.313 -1.009 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.4 172.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 368' ' ' GLY . . . . . 0.756 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . . . . . . 0 N--CA 1.45 -0.433 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 369' ' ' GLY . . . . . 0.61 ' HA3' HG23 ' A' ' 330' ' ' VAL . . . -64.82 107.59 1.94 Allowed Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 172.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -75.77 -29.54 59.18 Favored Glycine 0 C--N 1.312 -0.799 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.609 -169.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -166.27 143.51 5.21 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.057 0.456 . . . . 0.0 111.249 175.007 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 372' ' ' ILE . . . . . 0.879 HG23 ' HB3' ' A' ' 362' ' ' PRO . 1.1 mt -135.15 150.22 29.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.002 170.427 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 373' ' ' GLU . . . . . 0.765 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 43.3 mt-10 -130.8 127.7 39.22 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.226 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 374' ' ' MET . . . . . 0.693 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 0.2 OUTLIER -141.73 160.27 40.52 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.219 -175.215 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 375' ' ' GLN . . . . . 0.914 ' HB2' HD11 ' A' ' 358' ' ' ILE . 0.0 OUTLIER -175.23 173.7 2.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.283 0.563 . . . . 0.0 111.653 172.717 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 376' ' ' LEU . . . . . 0.749 HD22 ' HD2' ' A' ' 377' ' ' PRO . 1.8 tm? -168.57 138.81 2.0 Allowed Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 105.11 -2.181 . . . . 0.0 105.11 -178.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 377' ' ' PRO . . . . . 0.749 ' HD2' HD22 ' A' ' 376' ' ' LEU . 51.9 Cg_exo -34.3 135.22 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.951 2.434 . . . . 0.0 112.528 174.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 378' ' ' PRO . . . . . 0.509 ' HA ' ' OE1' ' A' ' 394' ' ' GLN . 3.0 Cg_exo -35.59 138.61 0.14 Allowed 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 125.162 3.908 . . . . 0.0 113.63 -171.116 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 155.46 -160.98 30.25 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 -162.282 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 380' ' ' ASP . . . . . 0.658 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 21.8 m-20 -105.14 128.28 53.3 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 118.252 1.026 . . . . 0.0 110.527 174.622 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.584 HD22 ' CB ' ' A' ' 376' ' ' LEU . 7.0 m-20 -126.32 138.48 53.59 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 1.071 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -141.12 135.25 32.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 177.9 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 383' ' ' ILE . . . . . 0.643 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 20.9 mt -98.9 132.31 44.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 C-N-CA 119.786 -0.766 . . . . 0.0 110.281 -171.238 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 384' ' ' TYR . . . . . 0.504 ' HB2' ' HG3' ' A' ' 343' ' ' ARG . 5.7 m-85 -102.76 131.15 49.81 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 168.372 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 385' ' ' VAL . . . . . 0.643 HG13 HG12 ' A' ' 342' ' ' VAL . 12.6 t -119.71 84.67 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 178.263 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 59.1 -109.13 1.91 Allowed Glycine 0 N--CA 1.434 -1.468 0 C-N-CA 120.363 -0.922 . . . . 0.0 111.002 -164.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -84.9 -20.27 31.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.566 0.183 . . . . 0.0 111.487 176.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 388' ' ' LEU . . . . . 0.493 HD13 ' HD2' ' A' ' 312' ' ' PHE . 0.7 OUTLIER -67.0 154.99 39.81 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.71 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 389' ' ' ASN . . . . . 0.643 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 7.9 p30 -164.96 160.31 19.0 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.231 175.003 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 390' ' ' HIS . . . . . 0.434 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 23.2 t-80 -173.65 117.17 0.26 Allowed 'General case' 0 C--O 1.238 0.487 0 O-C-N 123.51 0.506 . . . . 0.0 110.285 173.016 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 391' ' ' GLN . . . . . 1.071 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 2.5 mt-30 -65.28 146.08 55.39 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 392' ' ' TRP . . . . . . . . . . . . . 50.4 t-105 -149.72 147.83 28.52 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.894 176.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -110.91 115.6 29.78 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 173.081 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.509 ' OE1' ' HA ' ' A' ' 378' ' ' PRO . 2.7 pp0? -100.45 126.53 46.86 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 121.699 -0.626 . . . . 0.0 109.656 -176.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm . . . . . 0 C--N 1.313 -1.017 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.855 -179.37 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 303' ' ' THR . . . . . 0.504 ' O ' HG22 ' A' ' 305' ' ' THR . 10.3 t . . . . . 0 CA--C 1.533 0.31 0 CA-C-O 121.029 0.442 . . . . 0.0 111.744 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 304' ' ' TYR . . . . . 0.453 ' HB3' ' HG2' ' A' ' 336' ' ' ARG . 31.4 p90 -63.28 129.84 41.99 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 120.903 0.382 . . . . 0.0 110.412 -175.261 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.504 HG22 ' O ' ' A' ' 303' ' ' THR . 12.4 t 171.88 -166.88 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -167.54 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 42.2 t -63.91 112.36 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 170.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 307' ' ' CYS . . . . . 0.463 ' HB2' ' CE2' ' A' ' 332' ' ' PHE . 0.0 OUTLIER -67.99 147.05 52.95 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.13 0.491 . . . . 0.0 111.63 -170.07 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -57.07 109.17 0.61 Allowed 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.014 176.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 309' ' ' LYS . . . . . 0.492 ' HB2' ' N ' ' A' ' 387' ' ' ASP . 26.8 pttt -41.47 -27.12 0.08 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 113.892 -1.504 . . . . 0.0 114.716 -175.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 10.0 t -102.87 17.92 22.8 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.616 0.722 . . . . 0.0 110.428 -170.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 311' ' ' LYS . . . . . 0.621 ' HB2' ' CE2' ' A' ' 332' ' ' PHE . 25.2 mtpp -98.72 -14.39 19.8 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.406 178.361 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 312' ' ' PHE . . . . . 0.459 ' HB2' HD13 ' A' ' 388' ' ' LEU . 97.4 m-85 -75.05 162.32 28.66 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.11 177.509 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 313' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 331' ' ' GLY . 8.9 t -141.67 154.9 45.64 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.038 176.351 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 314' ' ' TRP . . . . . 0.412 ' H ' ' HE3' ' A' ' 314' ' ' TRP . 7.8 m-90 -75.65 92.6 2.97 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.639 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 315' ' ' LYS . . . . . 0.524 ' HB3' ' O ' ' A' ' 329' ' ' GLU . 24.0 tptm -73.74 -56.51 4.89 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 171.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.415 ' NH2' HG21 ' A' ' 319' ' ' THR . 58.2 ttt180 -147.11 125.3 12.17 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 317' ' ' ALA . . . . . 0.432 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -68.69 160.07 78.86 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 119.136 -0.459 . . . . 0.0 109.956 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 318' ' ' PRO . . . . . 0.473 ' HD3' ' CD2' ' A' ' 390' ' ' HIS . 3.9 Cg_exo -41.87 115.78 0.48 Allowed 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 122.823 2.348 . . . . 0.0 112.091 -178.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 319' ' ' THR . . . . . 0.415 HG21 ' NH2' ' A' ' 316' ' ' ARG . 21.5 m -128.68 132.96 48.08 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.246 -174.107 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -62.99 114.86 3.93 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -177.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 321' ' ' SER . . . . . 0.539 ' HB3' HG13 ' A' ' 327' ' ' VAL . 69.9 p -55.81 -46.34 78.06 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 123.543 0.527 . . . . 0.0 110.711 -163.141 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 126.67 -16.2 6.58 Favored Glycine 0 N--CA 1.442 -0.938 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 -179.094 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -110.62 52.24 0.74 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 57.88 36.29 26.17 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.646 178.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 325' ' ' THR . . . . . 0.478 ' HB ' HG13 ' A' ' 358' ' ' ILE . 3.1 p -157.13 -167.78 2.43 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -178.128 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 326' ' ' VAL . . . . . 0.997 HG23 ' HG2' ' A' ' 375' ' ' GLN . 3.6 t -131.83 148.45 32.37 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-O 121.318 0.58 . . . . 0.0 112.028 -178.443 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 327' ' ' VAL . . . . . 0.846 HG12 ' HG2' ' A' ' 373' ' ' GLU . 15.6 m -128.23 151.22 34.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.478 174.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 328' ' ' MET . . . . . 0.516 ' HG2' ' HE1' ' A' ' 374' ' ' MET . 0.6 OUTLIER -137.34 154.86 49.96 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 169.489 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 329' ' ' GLU . . . . . 0.584 ' HG3' ' O ' ' A' ' 370' ' ' GLY . 14.0 tt0 -123.75 129.44 51.07 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 120.214 -0.594 . . . . 0.0 109.627 -177.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 330' ' ' VAL . . . . . 0.501 HG11 HG11 ' A' ' 385' ' ' VAL . 3.6 m -124.38 145.05 32.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.115 -178.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 331' ' ' GLY . . . . . 0.427 ' O ' HG22 ' A' ' 313' ' ' THR . . . -112.95 133.2 11.17 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 119.963 -1.113 . . . . 0.0 111.964 179.135 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 332' ' ' PHE . . . . . 0.621 ' CE2' ' HB2' ' A' ' 311' ' ' LYS . 2.6 t80 -141.25 143.14 33.97 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 30.7 p -147.34 49.26 1.1 Allowed 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -171.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -145.48 -80.99 0.04 OUTLIER Glycine 0 C--O 1.23 -0.135 0 C-N-CA 119.78 -1.2 . . . . 0.0 112.03 167.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 335' ' ' THR . . . . . 0.614 ' HB ' ' CZ ' ' A' ' 332' ' ' PHE . 56.1 m -50.82 126.71 16.61 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 172.16 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 336' ' ' ARG . . . . . 0.583 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 0.0 OUTLIER -81.6 -177.84 1.04 Allowed Pre-proline 0 CA--C 1.533 0.324 0 CA-C-O 117.183 -1.389 . . . . 0.0 107.948 -172.19 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 337' ' ' PRO . . . . . 0.933 ' HA ' ' O ' ' A' ' 364' ' ' MET . 6.6 Cg_exo -23.39 101.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 123.91 3.073 . . . . 0.0 114.197 -172.064 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 338' ' ' CYS . . . . . 0.569 ' H ' ' HG3' ' A' ' 364' ' ' MET . 13.6 p -116.39 -176.85 3.04 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 113.898 -1.501 . . . . 0.0 111.38 -165.423 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -111.0 101.11 9.69 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.391 -1.336 . . . . 0.0 107.391 -178.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 340' ' ' ILE . . . . . 0.849 HG22 HG13 ' A' ' 342' ' ' VAL . 22.4 mt -76.32 117.28 63.16 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.464 -170.386 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -82.44 82.12 2.32 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.875 2.383 . . . . 0.0 112.235 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 342' ' ' VAL . . . . . 0.849 HG13 HG22 ' A' ' 340' ' ' ILE . 16.4 m -102.16 159.36 4.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.225 0.536 . . . . 0.0 110.2 179.165 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 343' ' ' ARG . . . . . 0.44 ' CG ' ' HB2' ' A' ' 384' ' ' TYR . 15.7 ptt-85 -169.3 175.63 5.51 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 179.623 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 344' ' ' ALA . . . . . 0.615 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -150.06 149.78 30.79 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.55 178.227 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 345' ' ' VAL . . . . . 0.467 ' HB ' ' HA ' ' A' ' 350' ' ' PRO . 5.1 m -121.84 147.97 25.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 175.263 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -67.17 120.97 14.62 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 176.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 347' ' ' HIS . . . . . 0.607 ' HB2' ' CB ' ' A' ' 380' ' ' ASP . 22.7 t60 38.46 69.86 0.24 Allowed 'General case' 0 N--CA 1.479 0.988 0 O-C-N 124.427 1.079 . . . . 0.0 112.435 175.353 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 348' ' ' GLY . . . . . 0.812 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 44.45 37.41 4.82 Favored Glycine 0 CA--C 1.52 0.378 0 N-CA-C 115.175 0.83 . . . . 0.0 115.175 -177.543 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 349' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 347' ' ' HIS . 60.7 t -139.94 102.25 6.97 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 118.257 1.029 . . . . 0.0 108.566 178.755 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 350' ' ' PRO . . . . . 0.467 ' HA ' ' HB ' ' A' ' 345' ' ' VAL . 19.2 Cg_exo -71.1 67.36 2.54 Favored 'Trans proline' 0 N--CA 1.465 -0.181 0 C-N-CA 122.801 2.334 . . . . 0.0 112.676 177.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -100.62 -56.87 2.23 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 174.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.7 132.93 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 115.166 -0.924 . . . . 0.0 110.886 173.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 353' ' ' ASN . . . . . 0.615 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 31.6 t30 -63.15 111.11 2.08 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.588 173.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 354' ' ' VAL . . . . . 0.561 HG12 HD22 ' A' ' 376' ' ' LEU . 30.0 m -90.62 4.2 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.317 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 355' ' ' ALA . . . . . 0.48 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -76.81 82.47 3.4 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.238 0.542 . . . . 0.0 111.094 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 356' ' ' MET . . . . . 0.612 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 21.5 ttt -95.97 99.57 11.33 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 170.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 357' ' ' LEU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 47.2 mt -88.84 123.06 32.87 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.709 -161.159 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 358' ' ' ILE . . . . . 0.797 HD11 ' HB2' ' A' ' 375' ' ' GLN . 1.5 mm -67.83 -25.38 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 171.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 54.1 m -122.88 86.07 50.34 Favored Pre-proline 0 N--CA 1.451 -0.375 0 CA-C-N 114.323 -1.308 . . . . 0.0 108.683 170.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -82.84 26.13 0.65 Allowed 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 123.043 2.496 . . . . 0.0 113.022 -172.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 46.5 m-20 -155.83 68.75 5.05 Favored Pre-proline 0 C--N 1.318 -0.804 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.696 178.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 362' ' ' PRO . . . . . 0.824 ' HB3' HG23 ' A' ' 372' ' ' ILE . 49.7 Cg_endo -73.28 151.56 48.87 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 121.745 1.63 . . . . 0.0 111.269 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 363' ' ' THR . . . . . 0.561 HG22 ' O ' ' A' ' 338' ' ' CYS . 0.0 OUTLIER -145.4 169.71 17.77 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -173.065 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 364' ' ' MET . . . . . 0.933 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 3.3 ppp? . . . . . 0 CA--C 1.494 -1.181 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 176.105 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.263 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 369' ' ' GLY . . . . . 0.552 ' HA2' ' O ' ' A' ' 363' ' ' THR . . . -45.26 -45.9 10.73 Favored Glycine 0 C--N 1.339 0.704 0 CA-C-N 117.067 0.433 . . . . 0.0 113.126 172.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 370' ' ' GLY . . . . . 0.584 ' O ' ' HG3' ' A' ' 329' ' ' GLU . . . 83.93 -54.58 4.96 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.606 -0.807 . . . . 0.0 113.256 175.058 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -165.16 142.17 5.83 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.266 0.555 . . . . 0.0 111.527 177.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 372' ' ' ILE . . . . . 0.824 HG23 ' HB3' ' A' ' 362' ' ' PRO . 1.1 mt -131.23 150.16 34.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 170.463 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 373' ' ' GLU . . . . . 0.846 ' HG2' HG12 ' A' ' 327' ' ' VAL . 32.5 mt-10 -123.45 126.49 46.86 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.199 178.36 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 374' ' ' MET . . . . . 0.525 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 1.0 OUTLIER -137.26 161.37 36.4 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.452 -176.806 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 375' ' ' GLN . . . . . 0.997 ' HG2' HG23 ' A' ' 326' ' ' VAL . 0.0 OUTLIER -170.51 174.88 4.93 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.782 0.801 . . . . 0.0 111.183 170.722 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 376' ' ' LEU . . . . . 0.567 HD12 ' HD2' ' A' ' 377' ' ' PRO . 35.6 tp -169.02 123.87 0.73 Allowed Pre-proline 0 N--CA 1.438 -1.034 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 171.048 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 377' ' ' PRO . . . . . 0.567 ' HD2' HD12 ' A' ' 376' ' ' LEU . 45.2 Cg_exo -27.88 129.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 123.766 2.977 . . . . 0.0 112.101 -177.085 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -33.77 134.47 0.12 Allowed 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 124.499 3.466 . . . . 0.0 113.961 -161.234 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 158.51 -178.44 34.74 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -160.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 380' ' ' ASP . . . . . 0.75 ' HA ' ' HA ' ' A' ' 393' ' ' PHE . 3.9 m-20 -90.42 120.06 31.22 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 118.064 0.932 . . . . 0.0 111.155 -174.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 381' ' ' ASN . . . . . 0.559 HD22 ' HB3' ' A' ' 376' ' ' LEU . 2.6 m-20 -121.28 163.47 18.52 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 176.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 382' ' ' ILE . . . . . 1.04 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -159.62 138.02 2.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 168.573 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 383' ' ' ILE . . . . . 0.407 ' HB ' ' CD2' ' A' ' 390' ' ' HIS . 12.8 mt -103.41 135.94 38.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 121.028 0.442 . . . . 0.0 110.286 -171.581 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 384' ' ' TYR . . . . . 0.44 ' HB2' ' CG ' ' A' ' 343' ' ' ARG . 50.9 m-85 -100.17 136.74 39.6 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 164.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 385' ' ' VAL . . . . . 0.725 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 10.9 t -120.73 77.77 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 177.064 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 386' ' ' GLY . . . . . 0.424 ' HA3' ' HB2' ' A' ' 309' ' ' LYS . . . 59.73 -106.05 0.89 Allowed Glycine 0 N--CA 1.431 -1.685 0 C-N-CA 120.134 -1.031 . . . . 0.0 111.155 -163.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 387' ' ' ASP . . . . . 0.492 ' N ' ' HB2' ' A' ' 309' ' ' LYS . 10.6 t70 -81.32 -17.42 49.3 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 388' ' ' LEU . . . . . 0.725 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 2.4 mp -70.47 154.36 41.97 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.871 0.367 . . . . 0.0 111.195 178.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 389' ' ' ASN . . . . . 0.438 ' HB3' ' CE2' ' A' ' 384' ' ' TYR . 24.2 p30 -155.93 145.22 20.77 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.384 173.533 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 390' ' ' HIS . . . . . 0.473 ' CD2' ' HD3' ' A' ' 318' ' ' PRO . 0.2 OUTLIER -170.42 106.81 0.31 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.798 -0.183 . . . . 0.0 111.307 -173.743 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 391' ' ' GLN . . . . . 1.04 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 21.2 tm0? -87.87 153.98 20.89 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.212 0.53 . . . . 0.0 112.422 -174.355 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 392' ' ' TRP . . . . . . . . . . . . . 5.5 t-105 -178.0 116.28 0.08 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.143 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 393' ' ' PHE . . . . . 0.75 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 18.4 p90 -66.69 124.7 23.61 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.295 170.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 394' ' ' GLN . . . . . 0.402 ' HG3' ' OE1' ' A' ' 375' ' ' GLN . 5.3 mm100 -80.81 108.79 14.77 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 -175.465 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 53.2 tptt . . . . . 0 C--O 1.247 0.957 0 CA-C-O 118.795 -0.622 . . . . 0.0 109.985 -174.499 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 303' ' ' THR . . . . . 0.455 ' O ' HG23 ' A' ' 303' ' ' THR . 8.8 t . . . . . 0 CA--C 1.537 0.455 0 CA-C-O 121.697 0.761 . . . . 0.0 111.734 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 304' ' ' TYR . . . . . 0.571 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 13.9 p90 -70.12 117.0 11.14 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.465 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 11.0 t 172.22 -166.83 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -168.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 39.1 t -64.5 109.55 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 171.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 307' ' ' CYS . . . . . 0.436 ' HB3' HG21 ' A' ' 335' ' ' THR . 0.4 OUTLIER -72.6 144.6 47.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.199 -173.788 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 308' ' ' ASP . . . . . 0.663 ' OD1' HG22 ' A' ' 310' ' ' THR . 16.4 t70 -70.9 127.2 31.78 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.546 0.689 . . . . 0.0 110.711 -177.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.522 ' HD3' ' HB2' ' A' ' 387' ' ' ASP . 0.0 OUTLIER -44.85 -18.52 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 116.123 1.897 . . . . 0.0 116.123 -173.465 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.663 HG22 ' OD1' ' A' ' 308' ' ' ASP . 10.9 t -108.29 5.68 25.84 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 119.761 1.164 . . . . 0.0 111.725 -171.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.452 ' HE3' ' HB3' ' A' ' 311' ' ' LYS . 25.3 mtpp -86.26 -25.77 25.35 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -171.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.507 ' HA ' ' O ' ' A' ' 331' ' ' GLY . 0.0 OUTLIER -83.14 174.74 10.53 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.664 0.745 . . . . 0.0 111.269 178.369 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 313' ' ' THR . . . . . 0.408 ' C ' HD21 ' A' ' 388' ' ' LEU . 32.0 p -139.33 156.87 46.73 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.867 -177.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 314' ' ' TRP . . . . . 0.671 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 26.8 m-90 -76.39 92.34 3.36 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.547 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 84.8 tttt -77.67 -52.04 9.63 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 119.909 -0.716 . . . . 0.0 109.09 170.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.554 ' HB3' ' HB3' ' A' ' 329' ' ' GLU . 9.2 ttp180 -143.66 121.15 11.72 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 172.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 317' ' ' ALA . . . . . 0.503 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -72.49 162.49 73.74 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.993 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 318' ' ' PRO . . . . . 0.631 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 5.7 Cg_exo -42.31 115.48 0.5 Allowed 'Trans proline' 0 C--N 1.358 1.072 0 C-N-CA 122.586 2.191 . . . . 0.0 112.846 -177.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 45.6 m -131.08 136.95 48.87 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.532 -174.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -60.12 116.88 4.51 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 321' ' ' SER . . . . . 0.6 ' HB3' HG13 ' A' ' 327' ' ' VAL . 97.3 p -52.28 -53.57 42.34 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.185 0.517 . . . . 0.0 111.37 -167.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 141.88 -26.44 2.36 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.62 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 17.1 t60 -99.24 12.23 36.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.032 0.444 . . . . 0.0 110.039 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 24.6 t70 86.86 53.74 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.878 175.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 325' ' ' THR . . . . . 0.647 ' HA ' HE21 ' A' ' 375' ' ' GLN . 0.9 OUTLIER -158.58 -167.48 2.16 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 113.67 -1.605 . . . . 0.0 106.906 176.423 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.729 ' HB ' ' HG3' ' A' ' 374' ' ' MET . 0.6 OUTLIER -125.72 145.89 32.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 119.704 1.138 . . . . 0.0 111.64 -178.689 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 327' ' ' VAL . . . . . 0.772 HG12 ' HG2' ' A' ' 373' ' ' GLU . 13.6 m -123.56 152.58 28.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.751 172.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 328' ' ' MET . . . . . 0.655 ' SD ' ' HB ' ' A' ' 372' ' ' ILE . 0.1 OUTLIER -142.4 149.69 39.68 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 173.152 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.554 ' HB3' ' HB3' ' A' ' 316' ' ' ARG . 46.6 tt0 -129.43 125.14 35.82 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.071 -175.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.506 HG11 HG11 ' A' ' 385' ' ' VAL . 2.8 m -129.97 146.84 33.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -174.168 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 331' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -118.03 137.96 13.52 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.573 -176.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -89.43 156.33 18.75 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.894 0.854 . . . . 0.0 112.957 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 2.3 p -94.79 -19.56 20.23 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.496 -1.229 . . . . 0.0 113.813 171.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -176.23 -37.22 0.05 OUTLIER Glycine 0 CA--C 1.525 0.717 0 C-N-CA 118.979 -1.582 . . . . 0.0 114.991 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 335' ' ' THR . . . . . 0.707 ' HB ' ' SD ' ' A' ' 364' ' ' MET . 90.7 m -53.36 127.21 23.97 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.682 0.277 . . . . 0.0 111.192 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.571 ' HG3' ' HB3' ' A' ' 304' ' ' TYR . 2.0 ptm180 -91.69 179.67 1.34 Allowed Pre-proline 0 CA--C 1.534 0.333 0 CA-C-O 117.248 -1.358 . . . . 0.0 107.914 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.575 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.2 OUTLIER -23.99 96.96 0.01 OUTLIER 'Trans proline' 0 C--N 1.375 1.935 0 C-N-CA 124.098 3.199 . . . . 0.0 114.501 -168.256 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 338' ' ' CYS . . . . . 0.771 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 2.2 p -111.17 -177.61 3.25 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 113.928 -1.487 . . . . 0.0 109.94 -172.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -109.93 99.84 8.9 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 176.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 340' ' ' ILE . . . . . 0.724 HG22 HG13 ' A' ' 342' ' ' VAL . 43.7 mt -74.42 118.78 72.65 Favored Pre-proline 0 C--N 1.327 -0.412 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.181 -168.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -76.89 80.53 2.82 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.373 2.049 . . . . 0.0 111.238 176.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.724 HG13 HG22 ' A' ' 340' ' ' ILE . 1.4 m -102.16 111.77 33.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 114.849 -1.068 . . . . 0.0 110.106 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -127.14 174.63 8.76 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 178.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 344' ' ' ALA . . . . . 0.476 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -146.53 145.63 30.21 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.474 176.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.436 HG22 HD12 ' A' ' 382' ' ' ILE . 11.5 m -117.72 145.46 23.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 177.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -66.51 119.2 11.25 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.375 175.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 347' ' ' HIS . . . . . 0.547 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 20.7 t60 40.72 66.61 0.61 Allowed 'General case' 0 N--CA 1.474 0.775 0 O-C-N 124.491 1.119 . . . . 0.0 111.95 175.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 348' ' ' GLY . . . . . 0.589 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 47.32 34.17 8.57 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 115.271 0.869 . . . . 0.0 115.271 -178.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 349' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 347' ' ' HIS . 63.7 t -135.7 102.81 10.27 Favored Pre-proline 0 C--O 1.233 0.235 0 CA-C-N 118.371 1.086 . . . . 0.0 108.685 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -74.54 62.35 5.42 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.866 2.377 . . . . 0.0 112.837 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -100.15 -56.26 2.41 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.5 p -120.65 128.9 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-N 115.113 -0.948 . . . . 0.0 110.36 173.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 353' ' ' ASN . . . . . 0.466 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 33.0 t30 -64.49 119.63 10.78 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.526 175.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.467 ' O ' ' HB2' ' A' ' 376' ' ' LEU . 29.1 m -98.32 6.22 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.94 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 355' ' ' ALA . . . . . 0.476 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -77.55 84.99 3.92 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.474 0.654 . . . . 0.0 111.142 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 356' ' ' MET . . . . . 0.579 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 21.4 ttt -99.3 100.11 11.15 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 106.16 -1.792 . . . . 0.0 106.16 171.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.622 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 47.1 mt -86.21 121.95 29.52 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.416 -160.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.725 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 3.2 mm -64.43 -28.98 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 108.137 -1.061 . . . . 0.0 108.137 174.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 86.4 m -123.46 84.52 52.64 Favored Pre-proline 0 N--CA 1.45 -0.438 0 CA-C-N 114.27 -1.332 . . . . 0.0 108.459 172.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -85.33 27.66 0.59 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.06 2.507 . . . . 0.0 114.287 -169.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 35.7 m-20 -149.2 66.31 8.48 Favored Pre-proline 0 C--N 1.315 -0.922 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.123 177.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 362' ' ' PRO . . . . . 0.828 ' HB3' HG23 ' A' ' 372' ' ' ILE . 75.9 Cg_endo -81.43 149.08 16.64 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.183 1.922 . . . . 0.0 112.666 178.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 363' ' ' THR . . . . . 0.478 HG22 ' O ' ' A' ' 338' ' ' CYS . 2.6 p -143.75 147.59 34.41 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.615 -174.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 364' ' ' MET . . . . . 0.771 ' HG2' ' SG ' ' A' ' 338' ' ' CYS . 10.3 ptp -102.59 129.69 49.23 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 119.444 -0.902 . . . . 0.0 108.911 177.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -120.42 -166.13 1.28 Allowed 'General case' 0 C--N 1.321 -0.648 0 O-C-N 124.87 1.356 . . . . 0.0 111.412 -172.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 31.6 p-10 -56.7 -12.95 2.1 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -178.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -120.24 3.14 10.88 Favored 'General case' 0 C--N 1.332 -0.19 0 O-C-N 121.57 -0.706 . . . . 0.0 110.926 176.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 112.65 -179.75 19.36 Favored Glycine 0 N--CA 1.451 -0.347 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 369' ' ' GLY . . . . . 0.612 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -50.35 -42.01 41.32 Favored Glycine 0 CA--C 1.504 -0.611 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.04 172.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 370' ' ' GLY . . . . . 0.547 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 82.33 -130.42 9.69 Favored Glycine 0 N--CA 1.436 -1.34 0 C-N-CA 120.11 -1.043 . . . . 0.0 110.76 -177.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -103.3 138.16 40.45 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.323 0.582 . . . . 0.0 111.25 -175.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 372' ' ' ILE . . . . . 0.828 HG23 ' HB3' ' A' ' 362' ' ' PRO . 0.1 OUTLIER -130.48 165.23 31.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.41 -0.814 . . . . 0.0 108.999 175.921 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.772 ' HG2' HG12 ' A' ' 327' ' ' VAL . 43.2 mt-10 -132.96 128.69 37.0 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.096 0.474 . . . . 0.0 110.483 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 374' ' ' MET . . . . . 0.729 ' HG3' ' HB ' ' A' ' 326' ' ' VAL . 0.0 OUTLIER -133.95 165.67 24.48 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -178.969 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 375' ' ' GLN . . . . . 0.647 HE21 ' HA ' ' A' ' 325' ' ' THR . 5.9 tp-100 -177.67 172.83 1.7 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.155 -0.684 . . . . 0.0 109.155 169.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 376' ' ' LEU . . . . . 0.776 HD22 ' HD2' ' A' ' 377' ' ' PRO . 2.5 tm? -165.81 133.89 2.38 Favored Pre-proline 0 C--N 1.309 -1.163 0 N-CA-C 103.753 -2.684 . . . . 0.0 103.753 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 377' ' ' PRO . . . . . 0.776 ' HD2' HD22 ' A' ' 376' ' ' LEU . 34.6 Cg_exo -28.07 126.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.479 2.786 . . . . 0.0 112.586 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -35.12 134.03 0.18 Allowed 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 124.574 3.516 . . . . 0.0 113.358 -167.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 157.1 -170.62 34.38 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -162.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 380' ' ' ASP . . . . . 0.713 ' HA ' ' HA ' ' A' ' 393' ' ' PHE . 2.9 m-20 -89.85 120.02 30.73 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 117.509 0.654 . . . . 0.0 110.515 -177.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -125.28 166.78 15.9 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 176.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 0.955 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -160.57 139.83 3.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 169.694 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 383' ' ' ILE . . . . . 0.713 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 40.8 mt -99.64 125.06 53.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 C-N-CA 119.367 -0.933 . . . . 0.0 109.539 -175.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -101.07 92.36 4.97 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.29 171.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 385' ' ' VAL . . . . . 0.506 HG11 HG11 ' A' ' 330' ' ' VAL . 11.7 t -84.9 85.62 2.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 60.63 -112.57 4.71 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.508 -0.853 . . . . 0.0 111.329 -170.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 387' ' ' ASP . . . . . 0.522 ' HB2' ' HD3' ' A' ' 309' ' ' LYS . 3.5 t70 -83.18 -18.13 40.43 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.091 0.472 . . . . 0.0 110.512 177.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 388' ' ' LEU . . . . . 0.671 ' HG ' ' CE2' ' A' ' 314' ' ' TRP . 3.4 mp -72.06 156.58 39.05 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.894 177.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 389' ' ' ASN . . . . . 0.713 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 7.7 p30 -168.96 158.17 8.49 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.316 177.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 390' ' ' HIS . . . . . 0.631 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 37.5 t-80 -174.83 116.93 0.18 Allowed 'General case' 0 C--O 1.237 0.431 0 O-C-N 123.419 0.45 . . . . 0.0 110.011 175.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 391' ' ' GLN . . . . . 0.955 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 8.2 tt0 -77.6 153.27 33.4 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.019 0.438 . . . . 0.0 112.073 -179.09 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 392' ' ' TRP . . . . . 0.401 ' CD1' ' NE2' ' A' ' 394' ' ' GLN . 23.9 t-105 -179.49 115.27 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.873 178.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 393' ' ' PHE . . . . . 0.713 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 12.3 p90 -68.21 121.05 15.39 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.21 0.529 . . . . 0.0 110.249 172.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.401 ' NE2' ' CD1' ' A' ' 392' ' ' TRP . 4.2 mm100 -84.27 119.09 24.64 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -172.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 4.1 mmmp? . . . . . 0 C--O 1.246 0.919 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.393 -176.894 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 303' ' ' THR . . . . . 0.423 ' O ' HG23 ' A' ' 303' ' ' THR . 6.4 t . . . . . 0 CA--C 1.538 0.497 0 CA-C-O 121.602 0.715 . . . . 0.0 111.181 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 304' ' ' TYR . . . . . 0.541 ' HB3' ' NE ' ' A' ' 336' ' ' ARG . 33.5 p90 -76.75 126.46 31.03 Favored 'General case' 0 CA--C 1.516 -0.358 0 O-C-N 121.806 -0.558 . . . . 0.0 109.729 176.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.517 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 10.0 t -179.9 -173.91 0.25 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.245 -174.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.09 111.54 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 167.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.67 144.25 51.12 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.377 -169.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 308' ' ' ASP . . . . . 0.491 ' OD2' HG22 ' A' ' 310' ' ' THR . 34.0 t70 -67.56 119.96 13.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.322 0.582 . . . . 0.0 110.448 -178.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.651 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -46.12 -12.17 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 -172.631 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.491 HG22 ' OD2' ' A' ' 308' ' ' ASP . 8.1 t -107.2 -0.67 22.52 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 119.079 0.854 . . . . 0.0 111.319 -175.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -83.85 -25.11 30.57 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -173.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.651 ' CZ ' ' HA ' ' A' ' 309' ' ' LYS . 0.1 OUTLIER -83.22 174.68 10.55 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.759 0.79 . . . . 0.0 111.155 176.882 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 313' ' ' THR . . . . . 0.401 ' C ' HD21 ' A' ' 388' ' ' LEU . 14.7 t -149.78 159.67 44.16 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.542 -1.208 . . . . 0.0 108.769 -179.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 314' ' ' TRP . . . . . 0.436 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 29.0 m-90 -69.17 117.64 11.07 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 121.353 0.597 . . . . 0.0 110.28 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.964 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 59.4 tttm -97.47 -47.81 5.53 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 173.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 41.1 ttp-105 -154.61 130.03 9.8 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.955 168.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 317' ' ' ALA . . . . . 0.561 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -66.13 166.0 18.96 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.993 -178.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 318' ' ' PRO . . . . . 0.567 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 3.6 Cg_exo -44.3 116.27 0.99 Allowed 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.559 2.173 . . . . 0.0 112.368 178.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 55.0 m -128.7 132.18 48.0 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.466 -174.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.94 125.35 23.23 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 175.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 321' ' ' SER . . . . . 0.438 ' C ' ' H ' ' A' ' 323' ' ' HIS . 59.5 p -70.24 5.6 1.64 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 123.423 0.689 . . . . 0.0 112.489 -168.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 74.56 -25.58 1.12 Allowed Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.319 -169.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 323' ' ' HIS . . . . . 0.438 ' H ' ' C ' ' A' ' 321' ' ' SER . 2.2 t-160 -106.42 46.46 0.92 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.114 0.483 . . . . 0.0 109.98 -178.062 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 50.34 43.66 26.65 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 114.96 -1.018 . . . . 0.0 113.533 177.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 325' ' ' THR . . . . . 0.665 ' HA ' ' HG3' ' A' ' 375' ' ' GLN . 2.1 p -150.84 -168.12 3.01 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 174.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.823 ' HB ' ' HG2' ' A' ' 374' ' ' MET . 0.2 OUTLIER -129.3 144.73 37.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 118.979 0.809 . . . . 0.0 111.019 179.707 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 327' ' ' VAL . . . . . 0.654 HG12 ' HG2' ' A' ' 373' ' ' GLU . 15.0 m -128.39 143.86 39.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.024 174.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 328' ' ' MET . . . . . 0.435 ' CG ' HD12 ' A' ' 372' ' ' ILE . 0.0 OUTLIER -135.04 149.46 50.13 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 178.297 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.964 ' HG2' ' HD3' ' A' ' 315' ' ' LYS . 7.7 tt0 -131.12 131.07 43.88 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 120.657 -0.417 . . . . 0.0 109.994 -173.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.672 HG23 ' HA3' ' A' ' 369' ' ' GLY . 0.0 OUTLIER -126.81 161.29 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -178.18 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 331' ' ' GLY . . . . . 0.555 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -127.69 137.8 10.05 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.729 175.148 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 332' ' ' PHE . . . . . 0.931 ' H ' ' HA2' ' A' ' 368' ' ' GLY . 0.2 OUTLIER -89.96 155.6 19.0 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.541 0.686 . . . . 0.0 111.807 179.185 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 2.6 p -95.84 -13.99 23.58 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 171.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -176.44 -40.72 0.05 OUTLIER Glycine 0 CA--C 1.528 0.859 0 C-N-CA 118.961 -1.59 . . . . 0.0 115.19 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 335' ' ' THR . . . . . 0.567 ' HB ' ' SD ' ' A' ' 364' ' ' MET . 82.8 m -52.78 132.84 37.11 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.823 0.344 . . . . 0.0 111.533 -177.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.865 HH21 ' HB2' ' A' ' 337' ' ' PRO . 0.2 OUTLIER -87.87 177.4 2.7 Favored Pre-proline 0 C--N 1.338 0.077 0 CA-C-O 117.389 -1.291 . . . . 0.0 107.875 -179.143 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.865 ' HB2' HH21 ' A' ' 336' ' ' ARG . 1.0 OUTLIER -26.64 98.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.367 1.535 0 C-N-CA 123.723 2.949 . . . . 0.0 114.138 -174.432 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 338' ' ' CYS . . . . . 0.757 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 6.5 p -111.48 -176.19 2.88 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 113.559 -1.655 . . . . 0.0 110.376 -171.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -111.54 98.9 7.77 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 174.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 340' ' ' ILE . . . . . 0.773 ' HB ' ' HG2' ' A' ' 362' ' ' PRO . 68.5 mt -74.49 119.59 77.33 Favored Pre-proline 0 C--N 1.328 -0.338 0 O-C-N 123.416 0.448 . . . . 0.0 110.906 -171.357 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.2 82.32 2.4 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.928 2.419 . . . . 0.0 112.162 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.706 HG13 HG22 ' A' ' 340' ' ' ILE . 9.9 m -99.04 151.65 4.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.382 178.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 -162.34 171.34 17.37 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 176.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 344' ' ' ALA . . . . . 0.544 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -145.97 144.67 30.27 Favored 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.008 176.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.553 ' HB ' ' HA ' ' A' ' 350' ' ' PRO . 4.9 m -116.27 143.83 25.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 176.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.405 ' HB2' ' CG1' ' A' ' 354' ' ' VAL . . . -63.6 123.23 18.29 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 176.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 347' ' ' HIS . . . . . 0.519 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 37.2 t-80 42.52 62.97 1.55 Allowed 'General case' 0 N--CA 1.473 0.711 0 O-C-N 124.268 0.98 . . . . 0.0 112.749 170.268 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 348' ' ' GLY . . . . . 0.54 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 50.75 29.72 19.55 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 115.25 0.86 . . . . 0.0 115.25 -177.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 349' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 347' ' ' HIS . 50.6 t -136.2 103.08 9.74 Favored Pre-proline 0 C--O 1.234 0.247 0 CA-C-N 118.267 1.033 . . . . 0.0 109.784 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 350' ' ' PRO . . . . . 0.553 ' HA ' ' HB ' ' A' ' 345' ' ' VAL . 17.1 Cg_exo -71.98 62.62 3.24 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 123.095 2.53 . . . . 0.0 112.884 178.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -100.12 -56.05 2.47 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 178.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 4.6 p -124.64 133.4 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.451 174.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 353' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 34.0 t30 -64.85 117.35 7.43 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.89 177.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.576 HG12 HD22 ' A' ' 376' ' ' LEU . 27.9 m -99.79 7.54 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.917 179.252 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 355' ' ' ALA . . . . . 0.544 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -78.62 82.94 4.83 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.029 0.443 . . . . 0.0 110.568 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 356' ' ' MET . . . . . 0.614 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 22.4 ttt -97.46 51.96 1.1 Allowed 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 175.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.842 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 11.7 mt -24.53 111.59 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 112.901 -1.954 . . . . 0.0 115.226 170.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.82 HD11 ' HB2' ' A' ' 375' ' ' GLN . 3.9 mm -60.36 -22.89 26.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 113.352 -1.749 . . . . 0.0 108.48 168.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 55.1 m -139.23 90.34 11.82 Favored Pre-proline 0 N--CA 1.451 -0.419 0 CA-C-N 114.265 -1.334 . . . . 0.0 108.648 177.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 360' ' ' PRO . . . . . 0.475 ' HA ' HD12 ' A' ' 357' ' ' LEU . 92.6 Cg_endo -82.17 45.34 1.91 Allowed 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 123.27 2.647 . . . . 0.0 114.445 -170.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -174.58 80.44 0.34 Allowed Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 120.958 0.408 . . . . 0.0 110.375 176.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 362' ' ' PRO . . . . . 0.773 ' HG2' ' HB ' ' A' ' 340' ' ' ILE . 95.3 Cg_endo -82.65 112.39 2.13 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.702 2.268 . . . . 0.0 111.932 176.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 4.0 p -90.81 142.19 28.02 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.764 0.792 . . . . 0.0 112.5 173.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 364' ' ' MET . . . . . 0.827 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 5.2 ptp -96.44 143.97 26.98 Favored 'General case' 0 CA--C 1.504 -0.827 0 CA-C-N 114.067 -1.424 . . . . 0.0 109.457 178.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -141.21 -168.13 2.55 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.64 1.213 . . . . 0.0 110.821 -174.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 366' ' ' ASN . . . . . 0.415 ' HA ' ' CZ ' ' A' ' 332' ' ' PHE . 31.1 p30 -60.22 -4.6 0.85 Allowed 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -176.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -113.15 -11.38 13.3 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.198 0.523 . . . . 0.0 110.618 -174.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 368' ' ' GLY . . . . . 0.931 ' HA2' ' H ' ' A' ' 332' ' ' PHE . . . 138.48 -132.05 5.63 Favored Glycine 0 CA--C 1.504 -0.637 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -175.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 369' ' ' GLY . . . . . 0.672 ' HA3' HG23 ' A' ' 330' ' ' VAL . . . -104.37 3.27 43.37 Favored Glycine 0 C--N 1.317 -0.505 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 175.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 73.15 -93.38 0.68 Allowed Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 114.96 -0.62 . . . . 0.0 113.575 175.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -152.29 133.49 14.34 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.411 -0.395 . . . . 0.0 111.084 -170.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 372' ' ' ILE . . . . . 0.627 HG23 ' HB3' ' A' ' 362' ' ' PRO . 0.7 OUTLIER -129.63 135.38 61.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 173.392 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.654 ' HG2' HG12 ' A' ' 327' ' ' VAL . 40.9 mt-10 -122.43 126.72 48.53 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 374' ' ' MET . . . . . 0.842 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 0.1 OUTLIER -134.47 165.5 25.02 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 123.505 0.722 . . . . 0.0 110.718 -175.692 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 375' ' ' GLN . . . . . 0.82 ' HB2' HD11 ' A' ' 358' ' ' ILE . 0.0 OUTLIER -173.5 -173.81 0.93 Allowed 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.545 0.688 . . . . 0.0 111.668 162.835 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 376' ' ' LEU . . . . . 0.962 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 10.5 tp -166.15 166.97 9.04 Favored Pre-proline 0 N--CA 1.443 -0.79 0 N-CA-C 104.481 -2.415 . . . . 0.0 104.481 171.146 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 377' ' ' PRO . . . . . 0.962 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 2.9 Cg_endo -43.48 133.81 7.0 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 121.58 1.52 . . . . 0.0 110.684 167.123 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_exo -37.8 140.04 0.29 Allowed 'Trans proline' 0 C--N 1.358 1.077 0 C-N-CA 123.85 3.033 . . . . 0.0 112.371 -177.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 148.61 -169.45 29.16 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.122 -1.037 . . . . 0.0 110.565 -160.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 380' ' ' ASP . . . . . 0.519 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 2.2 m-20 -98.72 128.52 45.0 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 117.583 0.692 . . . . 0.0 111.29 -175.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.841 ' HB2' HE21 ' A' ' 394' ' ' GLN . 10.5 m120 -127.07 168.73 14.21 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 176.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 1.034 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -161.04 138.6 2.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 168.835 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 383' ' ' ILE . . . . . 0.743 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 17.3 mt -104.62 130.29 55.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 C-N-CA 119.928 -0.709 . . . . 0.0 109.418 -172.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 384' ' ' TYR . . . . . 0.536 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 3.5 m-85 -101.57 98.56 8.86 Favored 'General case' 0 N--CA 1.441 -0.884 0 O-C-N 124.318 1.011 . . . . 0.0 108.572 169.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 385' ' ' VAL . . . . . 0.61 HG11 HG11 ' A' ' 330' ' ' VAL . 25.9 t -86.63 84.71 2.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 175.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 62.15 -112.06 4.52 Favored Glycine 0 N--CA 1.439 -1.132 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 -169.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 387' ' ' ASP . . . . . 0.53 ' HB2' ' HD3' ' A' ' 309' ' ' LYS . 0.7 OUTLIER -85.03 -15.26 44.71 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.781 0.324 . . . . 0.0 110.947 177.426 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 388' ' ' LEU . . . . . 0.536 ' O ' ' HA ' ' A' ' 384' ' ' TYR . 3.3 mp -70.34 155.07 41.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.023 177.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 389' ' ' ASN . . . . . 0.743 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 6.4 p30 -167.12 157.01 10.97 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.808 -0.178 . . . . 0.0 110.898 175.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 390' ' ' HIS . . . . . 0.567 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 33.0 t-80 -175.03 123.19 0.24 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.852 175.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 391' ' ' GLN . . . . . 1.034 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 25.3 tt0 -78.52 153.61 31.15 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.066 0.46 . . . . 0.0 111.585 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 392' ' ' TRP . . . . . 0.602 ' HD1' ' NE2' ' A' ' 394' ' ' GLN . 10.7 t-105 -166.36 145.87 5.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.605 174.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 393' ' ' PHE . . . . . 0.507 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 13.5 p90 -103.3 118.79 37.58 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.841 HE21 ' HB2' ' A' ' 381' ' ' ASN . 23.2 mm-40 -83.14 112.96 20.3 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -168.199 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.428 ' HZ3' ' NE2' ' A' ' 375' ' ' GLN . 31.2 mtmm . . . . . 0 C--O 1.248 1.026 0 O-C-N 124.225 0.953 . . . . 0.0 111.462 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 303' ' ' THR . . . . . 0.605 HG23 HG23 ' A' ' 335' ' ' THR . 8.9 t . . . . . 0 CA--C 1.539 0.527 0 CA-C-O 121.575 0.702 . . . . 0.0 111.232 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 304' ' ' TYR . . . . . 0.408 ' O ' ' HB ' ' A' ' 305' ' ' THR . 14.2 p90 -63.54 119.11 9.18 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 174.178 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.419 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 12.1 t 174.9 -168.33 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -172.139 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 36.4 t -65.22 106.95 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 169.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 307' ' ' CYS . . . . . 0.596 ' HB3' HG21 ' A' ' 335' ' ' THR . 0.5 OUTLIER -69.91 140.86 53.16 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.264 -167.892 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 308' ' ' ASP . . . . . 0.609 ' OD1' HG22 ' A' ' 310' ' ' THR . 14.0 t70 -63.41 132.68 52.23 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.953 -174.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.566 ' HD2' ' N ' ' A' ' 310' ' ' THR . 0.0 OUTLIER -41.5 -20.36 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 116.104 1.89 . . . . 0.0 116.104 -175.428 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.609 HG22 ' OD1' ' A' ' 308' ' ' ASP . 6.7 t -108.31 2.54 22.68 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 119.134 0.879 . . . . 0.0 112.196 -174.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.426 ' HG2' ' HB3' ' A' ' 308' ' ' ASP . 24.9 mmmt -74.01 -33.14 63.68 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -173.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.951 ' HD1' HD13 ' A' ' 388' ' ' LEU . 0.0 OUTLIER -86.08 175.18 8.69 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 122.006 0.908 . . . . 0.0 111.672 -175.992 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 11.1 t -144.3 155.45 43.83 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 113.871 -1.513 . . . . 0.0 107.755 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 16.4 m-90 -75.69 93.11 3.04 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.237 0.541 . . . . 0.0 109.598 178.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.452 ' HB3' ' C ' ' A' ' 329' ' ' GLU . 25.1 tptp -65.95 -43.82 86.84 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 170.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 24.8 ttt180 -152.83 130.79 11.78 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.142 170.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -69.5 159.04 85.26 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.649 -178.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 318' ' ' PRO . . . . . 0.781 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 78.7 Cg_exo -39.71 112.7 0.16 Allowed 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 122.65 2.234 . . . . 0.0 112.742 178.214 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 19.0 m -131.89 135.33 46.57 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.166 -173.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -57.38 124.13 17.86 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 321' ' ' SER . . . . . 0.433 ' HB3' HG13 ' A' ' 327' ' ' VAL . 84.5 p -62.16 -47.84 82.73 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.448 0.642 . . . . 0.0 110.014 -174.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 123.64 -14.62 8.09 Favored Glycine 0 N--CA 1.443 -0.892 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -111.86 53.09 0.73 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.284 0.564 . . . . 0.0 109.884 178.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 22.9 t70 57.28 33.94 24.04 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 114.746 -1.116 . . . . 0.0 112.464 177.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 325' ' ' THR . . . . . 0.557 ' HB ' HG13 ' A' ' 358' ' ' ILE . 10.0 p -152.5 -172.55 4.27 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -132.12 145.45 34.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.338 0.59 . . . . 0.0 111.377 -177.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 327' ' ' VAL . . . . . 0.724 HG12 ' HG2' ' A' ' 373' ' ' GLU . 15.8 m -127.11 155.94 38.34 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.895 176.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 5.0 ptm -142.09 159.43 42.24 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 167.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.552 ' HG3' ' O ' ' A' ' 370' ' ' GLY . 9.7 tt0 -124.45 129.39 50.57 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -176.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.594 HG23 ' HA3' ' A' ' 369' ' ' GLY . 3.1 m -125.55 146.19 31.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.88 -179.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 331' ' ' GLY . . . . . 0.727 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -124.47 140.42 12.55 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.116 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 332' ' ' PHE . . . . . 0.572 ' HD1' ' HA2' ' A' ' 368' ' ' GLY . 7.9 p90 -89.3 146.67 24.56 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.96 0.886 . . . . 0.0 111.69 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 28.2 t -86.84 -28.6 22.8 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.114 -1.403 . . . . 0.0 111.961 172.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -159.23 -44.58 0.02 OUTLIER Glycine 0 C--N 1.336 0.56 0 C-N-CA 119.605 -1.283 . . . . 0.0 113.917 -179.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 335' ' ' THR . . . . . 0.605 HG23 HG23 ' A' ' 303' ' ' THR . 27.1 m -52.69 124.55 14.12 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 123.795 0.35 . . . . 0.0 110.949 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.59 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 33.3 ptt85 -87.29 -177.38 0.88 Allowed Pre-proline 0 CA--C 1.532 0.285 0 CA-C-O 117.089 -1.434 . . . . 0.0 108.37 -174.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.775 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.1 OUTLIER -26.63 96.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 123.751 2.967 . . . . 0.0 114.151 -176.449 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 338' ' ' CYS . . . . . 0.482 ' SG ' ' HG3' ' A' ' 364' ' ' MET . 12.1 p -112.42 -176.83 3.01 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 113.515 -1.675 . . . . 0.0 110.074 -171.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 11.2 mpt_? -112.21 103.08 11.22 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 178.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 340' ' ' ILE . . . . . 0.832 HG22 HG13 ' A' ' 342' ' ' VAL . 29.7 mt -74.17 119.99 79.14 Favored Pre-proline 0 C--N 1.324 -0.508 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.486 -167.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.65 81.26 2.67 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.853 2.368 . . . . 0.0 111.561 177.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.832 HG13 HG22 ' A' ' 340' ' ' ILE . 4.6 m -102.41 155.38 5.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-O 121.747 0.784 . . . . 0.0 110.887 -178.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.467 ' HE ' ' HB3' ' A' ' 384' ' ' TYR . 22.4 ptt180 -166.31 174.94 8.63 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 344' ' ' ALA . . . . . 0.529 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -150.9 145.0 25.35 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.849 -0.74 . . . . 0.0 110.893 177.054 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.439 ' O ' HG23 ' A' ' 382' ' ' ILE . 9.2 m -119.88 147.16 23.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -70.12 122.86 20.26 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 176.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 347' ' ' HIS . . . . . 0.523 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 47.2 t60 43.96 60.43 2.73 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 124.149 0.906 . . . . 0.0 111.413 174.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 348' ' ' GLY . . . . . 0.689 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 44.09 46.04 7.93 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 114.637 0.615 . . . . 0.0 114.637 -174.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 349' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 347' ' ' HIS . 73.5 t -141.64 102.5 5.93 Favored Pre-proline 0 C--N 1.33 -0.251 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -76.15 49.7 2.64 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.603 2.202 . . . . 0.0 112.625 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -102.11 -5.54 24.36 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 2.6 p -169.8 106.31 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 114.561 -1.199 . . . . 0.0 110.055 -167.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 353' ' ' ASN . . . . . 0.465 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 38.1 t30 -64.74 111.78 2.93 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.688 178.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.505 ' HA ' HD22 ' A' ' 376' ' ' LEU . 31.5 m -91.2 -0.59 9.55 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.212 177.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 355' ' ' ALA . . . . . 0.529 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -74.25 84.55 1.89 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.213 0.53 . . . . 0.0 111.462 -176.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 356' ' ' MET . . . . . 0.658 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 47.6 ttp -97.9 101.14 12.56 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 168.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.521 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 27.6 mt -85.35 119.33 25.6 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.192 -163.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.765 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 2.5 mm -61.79 -28.98 45.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.506 175.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 22.4 m -130.14 90.08 43.2 Favored Pre-proline 0 N--CA 1.443 -0.8 0 CA-C-N 114.3 -1.318 . . . . 0.0 108.539 173.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -83.87 36.86 0.61 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.142 2.561 . . . . 0.0 113.055 -173.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -153.35 71.56 6.88 Favored Pre-proline 0 C--N 1.317 -0.83 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.257 175.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 362' ' ' PRO . . . . . 0.621 ' HB2' HD12 ' A' ' 340' ' ' ILE . 94.7 Cg_endo -81.43 145.02 14.68 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.568 2.179 . . . . 0.0 111.387 176.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 363' ' ' THR . . . . . 0.451 ' O ' ' HA2' ' A' ' 369' ' ' GLY . 0.5 OUTLIER -144.26 140.19 29.08 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 -173.008 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 364' ' ' MET . . . . . 0.775 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 41.4 mtm -95.47 110.05 22.16 Favored 'General case' 0 CA--C 1.492 -1.286 0 C-N-CA 119.398 -0.921 . . . . 0.0 109.198 178.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -97.96 -167.33 1.5 Allowed 'General case' 0 C--N 1.312 -1.04 0 O-C-N 124.77 1.294 . . . . 0.0 110.437 -175.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 27.5 p30 -54.05 -7.82 0.15 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -124.09 -1.64 8.23 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 121.655 -0.653 . . . . 0.0 110.98 -178.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 368' ' ' GLY . . . . . 0.727 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . 116.66 -176.63 16.39 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -172.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 369' ' ' GLY . . . . . 0.635 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -46.84 -25.79 2.49 Favored Glycine 0 CA--C 1.522 0.504 0 CA-C-N 117.7 0.75 . . . . 0.0 114.517 174.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 370' ' ' GLY . . . . . 0.552 ' O ' ' HG3' ' A' ' 329' ' ' GLU . . . 77.35 -57.82 3.7 Favored Glycine 0 C--O 1.228 -0.228 0 C-N-CA 120.867 -0.682 . . . . 0.0 113.034 176.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -165.87 147.06 6.9 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.126 0.489 . . . . 0.0 111.431 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 372' ' ' ILE . . . . . 0.747 HD13 HG11 ' A' ' 342' ' ' VAL . 1.3 mt -131.6 140.03 49.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.448 170.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.765 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 40.8 mt-10 -119.44 123.7 44.71 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.428 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 374' ' ' MET . . . . . 0.558 ' HG2' HD11 ' A' ' 383' ' ' ILE . 0.0 OUTLIER -138.63 164.38 29.64 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.817 -176.866 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 375' ' ' GLN . . . . . 0.658 ' O ' ' HB3' ' A' ' 356' ' ' MET . 3.0 tp60 177.54 175.0 0.47 Allowed 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 173.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 376' ' ' LEU . . . . . 0.983 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 8.9 tp -166.88 173.59 3.05 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 177.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 377' ' ' PRO . . . . . 0.983 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 75.2 Cg_exo -41.08 127.61 2.8 Favored 'Trans proline' 0 C--N 1.348 0.5 0 CA-C-N 121.465 1.559 . . . . 0.0 111.225 166.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -41.67 148.16 0.34 Allowed 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 123.826 3.017 . . . . 0.0 112.568 -177.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 142.31 -163.75 27.06 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 119.763 -1.208 . . . . 0.0 111.07 -162.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 380' ' ' ASP . . . . . 0.523 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 4.8 m-20 -89.44 115.87 27.2 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 117.32 0.56 . . . . 0.0 111.163 -176.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.526 ' HB2' ' OE1' ' A' ' 394' ' ' GLN . 4.8 m-20 -126.62 147.55 49.89 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.039 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 0.99 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -148.71 137.73 15.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 176.609 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 383' ' ' ILE . . . . . 0.668 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 28.2 mt -99.49 132.69 44.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.206 -173.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 384' ' ' TYR . . . . . 0.619 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 1.8 m-85 -106.13 99.91 9.48 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.177 -1.374 . . . . 0.0 109.071 170.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 385' ' ' VAL . . . . . 0.773 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 2.8 t -84.83 86.61 2.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 174.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 60.42 -106.36 1.03 Allowed Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 120.003 -1.094 . . . . 0.0 110.718 -169.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 387' ' ' ASP . . . . . 0.448 ' HB2' ' HB2' ' A' ' 309' ' ' LYS . 17.8 t70 -89.97 -14.36 34.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.502 0.192 . . . . 0.0 111.325 176.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 388' ' ' LEU . . . . . 0.951 HD13 ' HD1' ' A' ' 312' ' ' PHE . 3.0 mp -67.67 153.82 42.85 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 176.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 389' ' ' ASN . . . . . 0.668 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 30.5 p-10 -163.75 154.42 15.78 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.017 176.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 390' ' ' HIS . . . . . 0.781 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 63.0 t-80 -173.41 116.38 0.26 Allowed 'General case' 0 C--O 1.241 0.633 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 174.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 391' ' ' GLN . . . . . 0.99 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 8.6 tt0 -80.59 153.67 27.89 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.973 -177.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 392' ' ' TRP . . . . . 0.496 ' HD1' ' OE1' ' A' ' 394' ' ' GLN . 32.0 t-105 -166.09 153.15 9.77 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.964 -1.017 . . . . 0.0 109.208 -176.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -110.11 118.06 35.38 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.526 ' OE1' ' HB2' ' A' ' 381' ' ' ASN . 4.0 mm100 -80.33 104.11 10.66 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -173.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.153 -0.927 . . . . 0.0 111.293 -174.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 303' ' ' THR . . . . . 0.458 ' O ' HG23 ' A' ' 303' ' ' THR . 10.2 t . . . . . 0 CA--C 1.536 0.416 0 CA-C-O 121.89 0.852 . . . . 0.0 111.374 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 304' ' ' TYR . . . . . 0.554 ' HB3' ' NE ' ' A' ' 336' ' ' ARG . 17.2 p90 -67.06 130.77 44.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.814 174.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.527 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 14.8 t 173.1 -169.17 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -175.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 41.3 t -66.43 112.42 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 169.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.0 140.41 57.71 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -172.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 308' ' ' ASP . . . . . 0.584 ' OD1' HG22 ' A' ' 310' ' ' THR . 12.5 t70 -62.24 130.92 47.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.538 0.685 . . . . 0.0 111.46 -170.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 18.3 pttm -38.47 -29.71 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 113.175 -1.829 . . . . 0.0 115.066 -177.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.584 HG22 ' OD1' ' A' ' 308' ' ' ASP . 12.0 t -108.37 0.28 21.07 Favored 'General case' 0 N--CA 1.443 -0.817 0 O-C-N 121.685 -0.634 . . . . 0.0 112.425 -170.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -84.87 -29.18 25.48 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -173.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.456 ' HA ' ' O ' ' A' ' 331' ' ' GLY . 0.1 OUTLIER -81.1 173.76 12.25 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.639 0.733 . . . . 0.0 111.012 -179.75 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 6.4 t -147.49 159.02 44.2 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.004 -178.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 314' ' ' TRP . . . . . 0.454 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 25.3 m-90 -71.03 122.02 19.28 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 178.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.713 ' HD3' ' HB3' ' A' ' 329' ' ' GLU . 70.8 tttt -102.52 -42.92 5.79 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 173.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.821 ' HB3' ' HB2' ' A' ' 329' ' ' GLU . 19.8 ttm-85 -149.39 128.15 12.5 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.85 169.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -71.52 158.73 87.32 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 318' ' ' PRO . . . . . 0.519 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 3.3 Cg_exo -43.01 111.15 0.2 Allowed 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 122.65 2.233 . . . . 0.0 112.487 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 32.2 m -129.26 131.27 46.98 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.624 -174.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -59.34 125.32 23.14 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 321' ' ' SER . . . . . 0.413 ' HB3' HG13 ' A' ' 327' ' ' VAL . 86.6 p -58.79 -45.08 90.67 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.832 -173.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 136.7 -3.52 3.52 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.363 176.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 6.3 t-80 -143.7 70.68 1.31 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.052 0.453 . . . . 0.0 110.304 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 58.31 30.14 19.11 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.01 -0.995 . . . . 0.0 113.666 175.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 325' ' ' THR . . . . . 0.617 ' HA ' ' CG ' ' A' ' 375' ' ' GLN . 11.1 p -153.48 179.2 9.02 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.816 HG23 ' HG2' ' A' ' 375' ' ' GLN . 0.5 OUTLIER -134.03 144.76 34.57 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.404 0 CA-C-O 121.106 0.479 . . . . 0.0 111.142 -172.964 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 327' ' ' VAL . . . . . 0.796 HG12 ' HG3' ' A' ' 373' ' ' GLU . 14.1 m -118.86 155.52 21.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.662 175.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 328' ' ' MET . . . . . 0.619 ' HG3' HG13 ' A' ' 372' ' ' ILE . 0.0 OUTLIER -143.56 153.42 42.55 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 176.71 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.821 ' HB2' ' HB3' ' A' ' 316' ' ' ARG . 8.9 mt-10 -134.7 133.43 39.99 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.003 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.592 HG23 ' HA3' ' A' ' 369' ' ' GLY . 2.4 m -132.81 159.05 43.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.004 0.431 . . . . 0.0 111.853 -179.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 331' ' ' GLY . . . . . 0.488 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -129.27 136.21 8.86 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.19 -1.005 . . . . 0.0 112.582 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 332' ' ' PHE . . . . . 0.419 ' HD1' ' CA ' ' A' ' 368' ' ' GLY . 2.1 p90 -90.31 154.45 19.7 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.682 0.753 . . . . 0.0 111.807 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 27.6 p -119.1 30.69 7.02 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.528 -1.214 . . . . 0.0 112.515 173.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 164.65 -51.29 0.29 Allowed Glycine 0 C--O 1.225 -0.465 0 C-N-CA 119.388 -1.387 . . . . 0.0 114.122 169.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 335' ' ' THR . . . . . . . . . . . . . 2.8 m -55.79 124.47 17.63 Favored 'General case' 0 C--N 1.317 -0.827 0 O-C-N 123.695 0.291 . . . . 0.0 111.5 -178.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.722 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 5.5 ppt_? -80.66 -178.63 1.2 Allowed Pre-proline 0 N--CA 1.462 0.132 0 CA-C-O 116.921 -1.514 . . . . 0.0 107.843 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.868 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.7 OUTLIER -24.35 96.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 123.566 2.844 . . . . 0.0 113.733 -179.083 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 338' ' ' CYS . . . . . 0.598 ' SG ' ' HB2' ' A' ' 364' ' ' MET . 18.3 p -117.76 -176.8 3.11 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.091 -1.868 . . . . 0.0 109.927 -168.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -110.35 103.76 12.46 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -178.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 340' ' ' ILE . . . . . 0.736 HG12 ' HG3' ' A' ' 364' ' ' MET . 55.4 mt -72.2 121.15 83.93 Favored Pre-proline 0 C--N 1.328 -0.364 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.48 -171.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 341' ' ' PRO . . . . . 0.424 ' O ' ' HA ' ' A' ' 385' ' ' VAL . 74.2 Cg_endo -79.83 77.9 3.9 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 121.556 1.504 . . . . 0.0 110.947 174.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.754 HG13 HG13 ' A' ' 385' ' ' VAL . 0.0 OUTLIER -105.08 117.66 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-O 122.238 1.018 . . . . 0.0 110.555 175.628 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.486 ' HG3' ' HB2' ' A' ' 384' ' ' TYR . 25.9 ptt180 -130.49 179.34 5.99 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 113.575 -1.648 . . . . 0.0 106.983 177.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 344' ' ' ALA . . . . . 0.518 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -149.29 147.66 28.62 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.963 175.092 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.447 HG22 HD12 ' A' ' 382' ' ' ILE . 10.5 m -119.52 141.7 38.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 176.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.53 116.68 7.05 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 347' ' ' HIS . . . . . 0.576 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 57.9 t-80 44.67 65.89 0.98 Allowed 'General case' 0 N--CA 1.472 0.626 0 O-C-N 124.345 1.028 . . . . 0.0 111.447 175.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 348' ' ' GLY . . . . . 0.52 ' H ' ' CG2' ' A' ' 382' ' ' ILE . . . 42.97 41.14 4.47 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 115.096 0.799 . . . . 0.0 115.096 -175.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 349' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 347' ' ' HIS . 87.6 t -140.5 102.49 6.58 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 118.112 0.956 . . . . 0.0 108.661 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -74.63 66.25 5.68 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 122.99 2.46 . . . . 0.0 113.376 -178.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -100.47 -57.79 2.04 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 174.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 5.9 p -116.98 130.69 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.641 174.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 353' ' ' ASN . . . . . 0.518 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 38.1 t30 -62.92 108.26 1.16 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.423 171.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.432 HG23 ' CB ' ' A' ' 344' ' ' ALA . 20.4 m -88.96 5.28 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.0 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 355' ' ' ALA . . . . . 0.45 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -77.46 82.03 3.92 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.317 0.58 . . . . 0.0 110.436 177.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 356' ' ' MET . . . . . 0.535 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 39.1 ttm -98.03 99.83 11.12 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 172.024 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.672 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 46.4 mt -85.15 146.71 26.98 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.38 -159.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.751 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 2.4 mm -90.81 -21.7 6.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 176.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 97.5 m -127.1 84.83 62.47 Favored Pre-proline 0 N--CA 1.446 -0.655 0 CA-C-N 113.216 -1.811 . . . . 0.0 108.257 172.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -80.62 27.6 0.56 Allowed 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.798 2.332 . . . . 0.0 112.758 -175.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -147.66 61.66 6.35 Favored Pre-proline 0 C--N 1.315 -0.901 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.512 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 362' ' ' PRO . . . . . 0.466 ' HB2' HD12 ' A' ' 340' ' ' ILE . 90.2 Cg_endo -85.11 102.39 0.78 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.124 1.883 . . . . 0.0 112.066 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 363' ' ' THR . . . . . 0.436 HG22 ' O ' ' A' ' 338' ' ' CYS . 1.3 p -93.04 168.87 10.84 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 122.05 0.929 . . . . 0.0 113.273 171.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 364' ' ' MET . . . . . 0.868 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 43.9 mtt -115.63 128.03 55.64 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-N 113.819 -1.537 . . . . 0.0 109.324 174.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.539 ' CD ' ' HG3' ' A' ' 337' ' ' PRO . 53.9 mm-40 -121.71 -163.29 1.04 Allowed 'General case' 0 C--N 1.313 -0.993 0 O-C-N 124.275 0.984 . . . . 0.0 109.83 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 31.0 p-10 -40.39 -28.03 0.06 Allowed 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -178.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -111.84 7.87 20.28 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 121.4 -0.813 . . . . 0.0 112.247 -177.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 368' ' ' GLY . . . . . 0.488 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . 99.07 -164.49 20.5 Favored Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 -177.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 369' ' ' GLY . . . . . 0.592 ' HA3' HG23 ' A' ' 330' ' ' VAL . . . -70.62 95.65 0.54 Allowed Glycine 0 CA--C 1.507 -0.425 0 C-N-CA 120.081 -1.057 . . . . 0.0 110.78 168.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -70.94 -27.17 72.67 Favored Glycine 0 C--N 1.313 -0.71 0 CA-C-N 115.166 -0.517 . . . . 0.0 112.939 -166.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -164.44 136.71 4.71 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.942 0.401 . . . . 0.0 110.685 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 372' ' ' ILE . . . . . 0.619 HG13 ' HG3' ' A' ' 328' ' ' MET . 0.4 OUTLIER -127.31 145.4 34.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 173.005 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.796 ' HG3' HG12 ' A' ' 327' ' ' VAL . 3.8 mp0 -127.38 127.09 43.63 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 175.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 374' ' ' MET . . . . . 0.7 ' HG2' HD11 ' A' ' 383' ' ' ILE . 4.3 ppp? -138.3 166.83 23.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.926 -175.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 375' ' ' GLN . . . . . 0.816 ' HG2' HG23 ' A' ' 326' ' ' VAL . 0.0 OUTLIER -173.9 175.32 2.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.194 0.521 . . . . 0.0 110.59 165.945 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 376' ' ' LEU . . . . . 0.74 HD22 ' HD2' ' A' ' 377' ' ' PRO . 2.2 tm? -167.79 129.42 1.22 Allowed Pre-proline 0 C--N 1.315 -0.903 0 N-CA-C 105.11 -2.181 . . . . 0.0 105.11 176.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 377' ' ' PRO . . . . . 0.74 ' HD2' HD22 ' A' ' 376' ' ' LEU . 58.7 Cg_exo -24.97 125.79 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 124.503 3.469 . . . . 0.0 112.874 -179.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -35.51 134.42 0.22 Allowed 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 124.82 3.68 . . . . 0.0 113.019 -165.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 157.7 -171.79 34.88 Favored Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -159.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 380' ' ' ASP . . . . . 0.576 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 5.7 m-20 -97.07 127.46 43.06 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 117.494 0.647 . . . . 0.0 110.342 -178.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.587 HD22 ' HG2' ' A' ' 394' ' ' GLN . 25.5 m-80 -131.09 168.56 17.21 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 1.021 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -158.87 140.18 4.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 169.775 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 383' ' ' ILE . . . . . 0.7 HD11 ' HG2' ' A' ' 374' ' ' MET . 44.3 mt -99.82 130.44 48.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 C-N-CA 119.656 -0.818 . . . . 0.0 109.473 -175.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 384' ' ' TYR . . . . . 0.486 ' HB2' ' HG3' ' A' ' 343' ' ' ARG . 2.5 m-85 -100.95 136.6 40.55 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 169.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 385' ' ' VAL . . . . . 0.754 HG13 HG13 ' A' ' 342' ' ' VAL . 6.1 t -126.67 85.47 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 176.237 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 66.56 -109.75 3.09 Favored Glycine 0 N--CA 1.435 -1.432 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 -166.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -95.47 -7.52 37.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.856 0.328 . . . . 0.0 111.883 172.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 388' ' ' LEU . . . . . 0.492 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 1.4 mp -66.05 150.07 49.27 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 173.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 389' ' ' ASN . . . . . 0.54 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 7.7 p30 -166.05 154.78 11.22 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 121.275 -0.17 . . . . 0.0 110.669 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 390' ' ' HIS . . . . . 0.519 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 3.9 t60 -173.49 116.34 0.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.145 176.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 391' ' ' GLN . . . . . 1.021 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 6.3 tt0 -77.64 153.85 32.78 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.209 0.528 . . . . 0.0 112.364 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 392' ' ' TRP . . . . . 0.446 ' HD1' ' OE1' ' A' ' 394' ' ' GLN . 17.1 t-105 -169.53 147.71 3.61 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.054 176.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 393' ' ' PHE . . . . . 0.523 ' HB2' ' HE3' ' A' ' 395' ' ' LYS . 5.9 p90 -102.27 114.9 29.46 Favored 'General case' 0 C--N 1.313 -0.987 0 O-C-N 121.408 -0.807 . . . . 0.0 109.023 -178.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.587 ' HG2' HD22 ' A' ' 381' ' ' ASN . 2.8 mm100 -83.23 107.17 15.59 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -171.154 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.523 ' HE3' ' HB2' ' A' ' 393' ' ' PHE . 33.7 mmtp . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.022 -0.989 . . . . 0.0 109.965 -172.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 2.4 t . . . . . 0 CA--C 1.534 0.362 0 CA-C-O 121.306 0.574 . . . . 0.0 111.753 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 304' ' ' TYR . . . . . 0.525 ' HB3' ' NE ' ' A' ' 336' ' ' ARG . 21.7 p90 -63.11 124.27 20.72 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.931 0.396 . . . . 0.0 110.563 172.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.596 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 9.7 t -179.85 -176.75 0.36 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -176.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 47.8 t -64.21 112.69 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 166.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 307' ' ' CYS . . . . . 0.691 ' HB2' ' CZ ' ' A' ' 332' ' ' PHE . 0.0 OUTLIER -68.16 138.55 55.76 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.032 0.444 . . . . 0.0 110.456 -171.088 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 308' ' ' ASP . . . . . 0.588 ' OD2' HG22 ' A' ' 310' ' ' THR . 14.7 t70 -61.32 133.12 55.51 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.01 -171.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.432 ' O ' ' CE1' ' A' ' 312' ' ' PHE . 22.1 pttp -38.59 -28.94 0.03 OUTLIER 'General case' 0 C--O 1.22 -0.5 0 CA-C-N 113.097 -1.865 . . . . 0.0 114.973 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.588 HG22 ' OD2' ' A' ' 308' ' ' ASP . 13.5 t -109.05 10.4 26.13 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 119.286 0.948 . . . . 0.0 113.192 -169.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.5 ' HB2' ' CE2' ' A' ' 332' ' ' PHE . 28.6 mtpp -96.02 -19.76 19.22 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 -174.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.846 ' HD1' HD13 ' A' ' 388' ' ' LEU . 0.3 OUTLIER -86.43 173.0 9.95 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.937 0.875 . . . . 0.0 111.882 177.124 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 8.9 t -153.34 162.11 41.63 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 113.981 -1.463 . . . . 0.0 109.131 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 14.5 m-90 -76.17 95.47 3.69 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 120.884 0.373 . . . . 0.0 110.38 -177.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.562 ' HB3' ' HB3' ' A' ' 329' ' ' GLU . 59.4 tttm -65.68 -46.62 78.39 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 165.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.62 ' HB3' ' HB2' ' A' ' 329' ' ' GLU . 40.7 ttt180 -153.09 128.32 9.81 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 114.45 -1.25 . . . . 0.0 108.864 169.103 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 317' ' ' ALA . . . . . 0.516 ' HB1' ' CG ' ' A' ' 390' ' ' HIS . . . -74.45 160.93 80.09 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-O 118.757 -0.64 . . . . 0.0 109.871 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 318' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 85.5 Cg_exo -36.87 108.87 0.06 OUTLIER 'Trans proline' 0 C--N 1.362 1.282 0 C-N-CA 123.149 2.566 . . . . 0.0 113.36 -178.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 18.6 m -127.44 132.86 49.99 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.944 -175.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 320' ' ' ASP . . . . . 0.571 ' HB2' ' CZ2' ' A' ' 392' ' ' TRP . 13.5 t70 -55.61 124.95 19.06 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 60.0 p -62.98 -46.73 86.32 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.411 0.624 . . . . 0.0 110.116 -173.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 122.8 -7.94 9.38 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -124.47 56.79 1.27 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.141 -0.529 . . . . 0.0 110.703 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 324' ' ' ASP . . . . . 0.587 ' HA ' ' HD3' ' A' ' 395' ' ' LYS . 21.5 m-20 56.87 31.19 19.22 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.458 176.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 325' ' ' THR . . . . . 0.54 ' HB ' HG13 ' A' ' 358' ' ' ILE . 15.7 p -150.67 -179.26 7.1 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -178.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 1.3 t -129.57 144.42 38.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.178 0.513 . . . . 0.0 110.973 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 327' ' ' VAL . . . . . 0.641 HG12 ' HG2' ' A' ' 373' ' ' GLU . 16.7 m -120.06 154.48 23.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.336 176.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 328' ' ' MET . . . . . 0.536 ' SD ' HG13 ' A' ' 330' ' ' VAL . 0.0 OUTLIER -143.15 147.07 34.35 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 176.722 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.62 ' HB2' ' HB3' ' A' ' 316' ' ' ARG . 9.0 mt-10 -130.32 128.13 40.88 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 121.076 0.465 . . . . 0.0 110.957 -176.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.536 HG13 ' SD ' ' A' ' 328' ' ' MET . 0.0 OUTLIER -128.35 149.8 33.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.928 -175.971 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 331' ' ' GLY . . . . . 0.662 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -128.72 141.78 12.9 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.503 -0.856 . . . . 0.0 113.094 -179.305 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 332' ' ' PHE . . . . . 0.721 ' HE1' ' HD2' ' A' ' 312' ' ' PHE . 3.5 m-85 -112.81 178.03 4.43 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.358 0.663 . . . . 0.0 111.041 174.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 50.7 m -136.03 4.41 2.98 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 170.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -145.68 -62.93 0.01 OUTLIER Glycine 0 C--N 1.34 0.767 0 C-N-CA 119.029 -1.558 . . . . 0.0 114.768 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 335' ' ' THR . . . . . 0.441 HG22 ' HB3' ' A' ' 338' ' ' CYS . 13.9 m -53.95 132.46 42.16 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.122 0.487 . . . . 0.0 111.11 -175.123 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.882 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 2.8 ptm180 -82.29 -176.76 0.83 Allowed Pre-proline 0 C--O 1.226 -0.133 0 CA-C-O 117.981 -1.009 . . . . 0.0 108.952 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.882 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.4 OUTLIER -31.7 98.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 123.264 2.643 . . . . 0.0 112.802 174.172 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 338' ' ' CYS . . . . . 0.596 ' HB2' ' O ' ' A' ' 305' ' ' THR . 26.3 p -119.91 -174.25 2.72 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 113.522 -1.672 . . . . 0.0 109.578 -170.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -108.96 107.12 17.37 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -178.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 340' ' ' ILE . . . . . 0.884 HD12 ' HB2' ' A' ' 362' ' ' PRO . 32.9 mt -73.26 120.12 79.37 Favored Pre-proline 0 C--N 1.329 -0.313 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.963 -173.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -77.11 80.36 2.89 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.187 1.925 . . . . 0.0 111.202 175.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.698 HG13 HG22 ' A' ' 340' ' ' ILE . 11.7 m -97.41 146.3 7.89 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.662 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.091 178.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.453 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 24.4 ptt180 -163.82 171.98 14.72 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 172.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 344' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -147.97 143.66 27.46 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.797 177.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.416 ' HB ' ' HA ' ' A' ' 350' ' ' PRO . 6.2 m -115.96 144.39 23.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -63.23 117.13 6.14 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.279 -0.418 . . . . 0.0 112.014 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 347' ' ' HIS . . . . . 0.729 ' HB3' ' HB2' ' A' ' 380' ' ' ASP . 11.6 p80 30.37 75.5 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 O-C-N 124.721 1.263 . . . . 0.0 113.671 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 348' ' ' GLY . . . . . 0.768 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 53.64 28.44 37.83 Favored Glycine 0 CA--C 1.519 0.337 0 N-CA-C 115.69 1.036 . . . . 0.0 115.69 178.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 349' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 347' ' ' HIS . 46.9 t -137.15 101.79 9.2 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 118.948 1.374 . . . . 0.0 108.731 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 350' ' ' PRO . . . . . 0.416 ' HA ' ' HB ' ' A' ' 345' ' ' VAL . 15.2 Cg_exo -73.06 66.51 4.17 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 123.112 2.542 . . . . 0.0 112.865 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -99.87 -55.39 2.66 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.282 -1.006 . . . . 0.0 108.282 177.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 4.7 p -130.1 136.2 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.215 174.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 353' ' ' ASN . . . . . 0.478 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 52.1 t30 -63.18 117.82 7.07 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.187 177.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 30.5 m -95.25 5.1 8.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.844 176.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 355' ' ' ALA . . . . . 0.4 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -77.47 84.16 3.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.235 0.541 . . . . 0.0 111.405 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.94 102.9 14.77 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 170.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.571 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 32.3 mt -83.45 117.93 23.4 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.41 -162.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.697 HD11 ' HB3' ' A' ' 375' ' ' GLN . 4.4 mm -59.54 -29.12 41.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.358 173.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 12.6 m -131.91 94.12 25.55 Favored Pre-proline 0 N--CA 1.446 -0.672 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.573 172.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -81.83 34.6 0.55 Allowed 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 123.522 2.815 . . . . 0.0 112.899 -173.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -151.63 70.68 8.11 Favored Pre-proline 0 C--N 1.316 -0.889 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.98 177.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 362' ' ' PRO . . . . . 0.983 ' HB3' HG23 ' A' ' 372' ' ' ILE . 60.3 Cg_endo -80.88 141.02 13.1 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.313 2.008 . . . . 0.0 111.314 175.184 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 363' ' ' THR . . . . . 0.611 ' O ' ' HA2' ' A' ' 369' ' ' GLY . 1.0 OUTLIER -143.66 143.25 31.36 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -174.11 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 364' ' ' MET . . . . . 0.807 ' HA ' ' HA2' ' A' ' 369' ' ' GLY . 5.2 mmt -110.87 142.18 43.27 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -178.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.496 ' HG2' ' HG3' ' A' ' 337' ' ' PRO . 27.2 mt-10 -125.64 -168.5 1.85 Allowed 'General case' 0 C--N 1.318 -0.772 0 O-C-N 123.398 0.436 . . . . 0.0 110.953 175.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 25.1 p-10 -43.25 -31.85 0.68 Allowed 'General case' 0 N--CA 1.472 0.626 0 O-C-N 124.232 0.958 . . . . 0.0 113.221 -179.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -111.03 -1.46 16.28 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -177.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 368' ' ' GLY . . . . . 0.662 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . 124.81 178.66 15.41 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.257 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 369' ' ' GLY . . . . . 0.807 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -68.07 -24.99 74.58 Favored Glycine 0 C--N 1.333 0.368 0 N-CA-C 114.132 0.413 . . . . 0.0 114.132 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 370' ' ' GLY . . . . . 0.591 ' O ' ' HG2' ' A' ' 329' ' ' GLU . . . 85.37 -58.15 4.91 Favored Glycine 0 C--N 1.318 -0.417 0 C-N-CA 120.143 -1.027 . . . . 0.0 113.313 178.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -165.87 145.84 6.45 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.14 0.495 . . . . 0.0 112.173 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 372' ' ' ILE . . . . . 0.983 HG23 ' HB3' ' A' ' 362' ' ' PRO . 0.7 OUTLIER -136.13 156.25 36.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.451 171.441 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.641 ' HG2' HG12 ' A' ' 327' ' ' VAL . 42.5 mt-10 -134.4 126.54 29.77 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -178.272 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 374' ' ' MET . . . . . 0.571 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 2.9 mtt -142.65 165.03 28.49 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -176.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 375' ' ' GLN . . . . . 0.697 ' HB3' HD11 ' A' ' 358' ' ' ILE . 2.7 tp60 -178.62 173.45 1.3 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.784 0.326 . . . . 0.0 110.296 176.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 376' ' ' LEU . . . . . 0.722 HD22 ' HD2' ' A' ' 377' ' ' PRO . 2.0 tm? -165.62 139.62 3.79 Favored Pre-proline 0 C--N 1.318 -0.785 0 N-CA-C 104.44 -2.43 . . . . 0.0 104.44 -177.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 377' ' ' PRO . . . . . 0.722 ' HD2' HD22 ' A' ' 376' ' ' LEU . 37.8 Cg_exo -33.89 129.63 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.761 2.307 . . . . 0.0 112.299 175.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.467 ' HA ' ' OE1' ' A' ' 394' ' ' GLN . 75.8 Cg_exo -34.03 138.85 0.08 OUTLIER 'Trans proline' 0 C--N 1.362 1.243 0 C-N-CA 124.926 3.75 . . . . 0.0 113.932 -170.174 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 155.32 -158.38 28.38 Favored Glycine 0 N--CA 1.441 -0.975 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 -163.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 380' ' ' ASP . . . . . 0.729 ' HB2' ' HB3' ' A' ' 347' ' ' HIS . 8.9 m-20 -109.32 132.79 53.8 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 118.149 0.974 . . . . 0.0 111.522 175.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.47 ' ND2' ' HG2' ' A' ' 394' ' ' GLN . 56.3 m-20 -126.25 168.7 13.73 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 176.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 1.053 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -160.05 138.49 2.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 168.048 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 383' ' ' ILE . . . . . 0.614 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 57.6 mt -99.16 128.81 50.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 C-N-CA 120.074 -0.65 . . . . 0.0 109.926 -173.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 384' ' ' TYR . . . . . 0.453 ' O ' ' HG2' ' A' ' 343' ' ' ARG . 0.2 OUTLIER -104.26 99.57 9.29 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 114.302 -1.317 . . . . 0.0 108.791 170.771 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 385' ' ' VAL . . . . . 0.499 ' O ' ' HB2' ' A' ' 388' ' ' LEU . 11.5 t -94.77 88.21 2.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 174.06 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 67.82 -116.99 8.24 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.123 -1.037 . . . . 0.0 110.851 -174.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -92.43 -4.26 53.98 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 117.783 0.792 . . . . 0.0 111.684 171.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 388' ' ' LEU . . . . . 0.846 HD13 ' HD1' ' A' ' 312' ' ' PHE . 2.5 mp -71.15 150.79 45.05 Favored 'General case' 0 CA--C 1.522 -0.113 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 172.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 389' ' ' ASN . . . . . 0.614 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 7.3 p30 -164.44 152.22 12.11 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.651 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 390' ' ' HIS . . . . . 0.948 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 30.5 t60 -175.56 119.5 0.17 Allowed 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.493 0.495 . . . . 0.0 110.4 176.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 391' ' ' GLN . . . . . 1.053 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 15.0 tt0 -78.03 153.24 32.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.404 0.621 . . . . 0.0 112.582 -179.058 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 392' ' ' TRP . . . . . 0.571 ' CZ2' ' HB2' ' A' ' 320' ' ' ASP . 52.7 t-105 -153.49 143.59 22.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.884 178.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -104.48 110.03 22.14 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 176.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.487 ' HB2' HE22 ' A' ' 375' ' ' GLN . 1.0 OUTLIER -101.23 134.34 44.43 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 121.822 -0.549 . . . . 0.0 111.617 -164.847 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.587 ' HD3' ' HA ' ' A' ' 324' ' ' ASP . 13.2 mmmm . . . . . 0 C--O 1.245 0.824 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.794 -178.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 7.5 t . . . . . 0 CA--C 1.537 0.446 0 CA-C-O 121.12 0.486 . . . . 0.0 111.799 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 304' ' ' TYR . . . . . 0.636 ' HB2' ' O ' ' A' ' 337' ' ' PRO . 39.7 p90 -67.1 129.59 40.38 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.467 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 12.4 t 173.02 -167.18 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -170.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 7.8 p -62.09 112.17 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 172.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -73.54 137.75 44.56 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.175 -173.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 308' ' ' ASP . . . . . 0.738 ' OD1' HG22 ' A' ' 310' ' ' THR . 9.4 t70 -60.36 119.9 8.84 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.034 177.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.506 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 29.0 pttt -42.09 -22.45 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 115.961 1.837 . . . . 0.0 115.961 -175.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.738 HG22 ' OD1' ' A' ' 308' ' ' ASP . 6.2 t -107.54 12.44 27.73 Favored 'General case' 0 C--N 1.314 -0.959 0 O-C-N 121.331 -0.856 . . . . 0.0 111.206 -170.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.459 ' HE3' ' OG1' ' A' ' 335' ' ' THR . 19.9 mtmm -96.37 -22.94 16.87 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -174.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.539 ' HA ' ' O ' ' A' ' 331' ' ' GLY . 0.1 OUTLIER -85.86 174.62 9.17 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.517 0.675 . . . . 0.0 110.957 176.678 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 13.2 t -147.83 158.46 44.04 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.34 -177.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 314' ' ' TRP . . . . . 0.496 ' HZ3' ' HB2' ' A' ' 328' ' ' MET . 19.2 m95 -79.44 95.61 5.83 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-O 121.018 0.437 . . . . 0.0 110.775 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.555 ' HG2' ' OE1' ' A' ' 329' ' ' GLU . 4.3 ttpp -69.91 -43.49 71.6 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 169.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 3.8 ttm180 -153.04 101.85 2.6 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.634 174.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -41.49 154.77 0.23 Allowed Pre-proline 0 N--CA 1.476 0.83 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 171.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 318' ' ' PRO . . . . . 0.461 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 3.8 Cg_exo -38.17 114.17 0.16 Allowed 'Trans proline' 0 C--N 1.366 1.493 0 C-N-CA 123.777 2.985 . . . . 0.0 113.228 -176.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 16.9 m -134.38 137.39 44.07 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.32 -174.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -59.17 131.32 50.67 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -177.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 321' ' ' SER . . . . . 0.641 ' HB3' HG13 ' A' ' 327' ' ' VAL . 51.5 p -80.34 5.86 13.66 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 122.149 -0.344 . . . . 0.0 111.6 -175.05 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 74.0 -22.34 1.22 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.105 -175.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 323' ' ' HIS . . . . . 0.411 ' H ' ' C ' ' A' ' 321' ' ' SER . 94.7 m-70 -102.33 47.77 0.89 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.381 0.61 . . . . 0.0 110.328 -177.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 324' ' ' ASP . . . . . 0.431 ' O ' HG23 ' A' ' 325' ' ' THR . 4.9 t70 55.94 39.18 30.59 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 114.403 -1.272 . . . . 0.0 111.659 174.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 325' ' ' THR . . . . . 0.431 HG23 ' O ' ' A' ' 324' ' ' ASP . 4.0 p -160.29 -171.59 3.24 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.766 ' HB ' ' SD ' ' A' ' 374' ' ' MET . 0.3 OUTLIER -132.57 146.2 33.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.546 0.689 . . . . 0.0 111.558 -175.125 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 327' ' ' VAL . . . . . 0.677 HG12 ' HG2' ' A' ' 373' ' ' GLU . 14.9 m -122.61 157.81 27.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.276 175.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 328' ' ' MET . . . . . 0.631 ' SD ' HD13 ' A' ' 383' ' ' ILE . 0.0 OUTLIER -135.62 146.67 48.14 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 173.223 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.555 ' OE1' ' HG2' ' A' ' 315' ' ' LYS . 9.5 tt0 -120.67 122.4 40.39 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -177.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 2.7 m -128.76 151.56 35.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.521 0.201 . . . . 0.0 111.301 -176.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 331' ' ' GLY . . . . . 0.826 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -126.84 139.4 11.22 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.478 -177.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 332' ' ' PHE . . . . . 0.434 ' H ' ' HA2' ' A' ' 368' ' ' GLY . 0.8 OUTLIER -89.37 152.88 21.27 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.367 0.603 . . . . 0.0 111.858 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 8.7 t -107.39 2.12 24.15 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 174.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -173.38 -63.6 0.05 OUTLIER Glycine 0 C--N 1.341 0.834 0 C-N-CA 118.676 -1.726 . . . . 0.0 115.144 175.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 335' ' ' THR . . . . . 0.459 ' OG1' ' HE3' ' A' ' 311' ' ' LYS . 51.5 m -52.46 134.13 34.96 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 123.805 0.356 . . . . 0.0 111.251 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.644 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 16.1 ptt180 -90.62 -175.95 0.58 Allowed Pre-proline 0 CA--C 1.536 0.429 0 CA-C-O 117.212 -1.375 . . . . 0.0 108.624 -175.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.7 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.1 OUTLIER -24.07 96.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 124.061 3.174 . . . . 0.0 114.65 -170.869 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 338' ' ' CYS . . . . . 0.734 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 3.9 p -109.95 -176.05 2.9 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 113.719 -1.582 . . . . 0.0 110.32 -169.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -112.16 96.3 5.95 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 177.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 340' ' ' ILE . . . . . 0.762 HG22 HG13 ' A' ' 342' ' ' VAL . 61.9 mt -78.18 118.86 74.79 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.302 -169.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -79.65 82.46 2.49 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.837 2.358 . . . . 0.0 111.903 177.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.762 HG13 HG22 ' A' ' 340' ' ' ILE . 4.2 m -100.94 123.68 54.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.504 0.669 . . . . 0.0 110.669 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -132.07 173.97 10.67 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 176.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 344' ' ' ALA . . . . . 0.542 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -144.96 140.97 28.6 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.718 175.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.521 HG22 HD12 ' A' ' 382' ' ' ILE . 10.6 m -114.62 140.59 34.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.423 ' HB2' ' CG1' ' A' ' 354' ' ' VAL . . . -67.62 121.4 15.81 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 347' ' ' HIS . . . . . 0.574 ' O ' HG23 ' A' ' 349' ' ' VAL . 6.9 t60 46.62 59.79 3.7 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 124.336 1.022 . . . . 0.0 111.038 174.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 348' ' ' GLY . . . . . 0.473 ' H ' ' CG2' ' A' ' 382' ' ' ILE . . . 45.86 39.16 8.4 Favored Glycine 0 C--N 1.335 0.515 0 N-CA-C 115.097 0.799 . . . . 0.0 115.097 -174.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 349' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 347' ' ' HIS . 58.9 t -137.35 102.19 8.94 Favored Pre-proline 0 C--O 1.235 0.301 0 CA-C-N 118.219 1.009 . . . . 0.0 108.949 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -75.82 61.38 6.28 Favored 'Trans proline' 0 N--CA 1.464 -0.209 0 C-N-CA 122.802 2.334 . . . . 0.0 113.245 -178.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -100.51 -56.76 2.26 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 175.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 2.3 p -117.48 127.49 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.535 174.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -63.38 112.08 2.57 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.774 175.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.654 HG12 ' HG ' ' A' ' 376' ' ' LEU . 4.2 m -92.68 9.02 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.713 177.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 355' ' ' ALA . . . . . 0.542 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -79.17 82.97 5.28 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.147 0.498 . . . . 0.0 111.041 176.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 5.4 tmm? -92.92 100.5 12.95 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 169.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 22.2 mt -86.89 117.87 25.9 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.072 -163.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.73 ' HB ' ' CB ' ' A' ' 373' ' ' GLU . 2.7 mm -61.46 -25.03 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.632 175.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 19.5 m -138.91 93.72 10.41 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.828 173.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -88.61 41.1 0.57 Allowed 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 123.275 2.65 . . . . 0.0 114.063 -171.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -161.83 72.48 2.41 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-O 121.235 0.54 . . . . 0.0 109.779 175.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 362' ' ' PRO . . . . . 0.872 ' HB3' HG23 ' A' ' 372' ' ' ILE . 87.8 Cg_endo -82.58 108.57 1.71 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.79 2.327 . . . . 0.0 112.302 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 16.8 p -89.78 144.28 26.1 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.671 0.748 . . . . 0.0 112.326 171.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 364' ' ' MET . . . . . 0.734 ' HG2' ' SG ' ' A' ' 338' ' ' CYS . 5.7 ptp -93.94 125.39 38.54 Favored 'General case' 0 CA--C 1.499 -0.981 0 CA-C-N 114.387 -1.279 . . . . 0.0 108.153 174.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.485 ' HG2' ' HG3' ' A' ' 337' ' ' PRO . 33.6 mt-10 -126.52 -163.39 1.23 Allowed 'General case' 0 C--N 1.315 -0.921 0 O-C-N 124.511 1.132 . . . . 0.0 110.344 -172.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -48.37 -23.95 1.08 Allowed 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -171.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 58.9 m-20 -112.32 -1.98 14.95 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.828 0.74 . . . . 0.0 110.967 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 368' ' ' GLY . . . . . 0.826 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . 115.11 -168.21 12.51 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -172.275 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 369' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -48.23 -34.31 12.47 Favored Glycine 0 CA--C 1.519 0.313 0 CA-C-N 117.725 0.763 . . . . 0.0 113.303 172.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 370' ' ' GLY . . . . . 0.49 ' O ' ' HG3' ' A' ' 329' ' ' GLU . . . 81.53 -58.17 4.88 Favored Glycine 0 C--O 1.227 -0.314 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.584 176.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -165.19 137.82 4.42 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.043 0.449 . . . . 0.0 111.125 178.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 372' ' ' ILE . . . . . 0.872 HG23 ' HB3' ' A' ' 362' ' ' PRO . 0.9 OUTLIER -134.4 159.1 42.12 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 172.846 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.73 ' CB ' ' HB ' ' A' ' 358' ' ' ILE . 36.5 mt-10 -128.21 125.92 39.94 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.581 -177.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 374' ' ' MET . . . . . 0.766 ' SD ' ' HB ' ' A' ' 326' ' ' VAL . 0.0 OUTLIER -136.43 160.37 38.97 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -179.083 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 375' ' ' GLN . . . . . 0.436 ' HB2' HG23 ' A' ' 326' ' ' VAL . 3.2 tp60 -177.91 170.11 1.93 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.918 0.39 . . . . 0.0 110.208 172.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 376' ' ' LEU . . . . . 0.75 HD22 ' HD2' ' A' ' 377' ' ' PRO . 2.3 tm? -166.93 131.81 1.66 Allowed Pre-proline 0 N--CA 1.439 -0.991 0 N-CA-C 104.537 -2.394 . . . . 0.0 104.537 -178.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 377' ' ' PRO . . . . . 0.75 ' HD2' HD22 ' A' ' 376' ' ' LEU . 35.7 Cg_exo -28.95 131.0 0.04 OUTLIER 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 123.788 2.992 . . . . 0.0 112.811 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -35.56 138.21 0.15 Allowed 'Trans proline' 0 C--N 1.359 1.106 0 C-N-CA 124.658 3.572 . . . . 0.0 113.582 -166.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 151.87 -165.07 30.56 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 -160.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 380' ' ' ASP . . . . . 0.471 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 15.8 m-20 -99.7 128.78 45.8 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 117.925 0.862 . . . . 0.0 111.23 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.525 ' ND2' ' HG3' ' A' ' 394' ' ' GLN . 60.3 m-20 -128.43 159.79 34.3 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 174.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 1.024 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -150.55 139.1 14.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 170.313 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 383' ' ' ILE . . . . . 0.668 HD11 ' SD ' ' A' ' 374' ' ' MET . 31.5 mt -99.51 127.02 52.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.44 -176.092 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 384' ' ' TYR . . . . . 0.444 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.2 OUTLIER -104.41 92.54 4.37 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.226 174.017 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 385' ' ' VAL . . . . . 0.529 ' O ' ' HB2' ' A' ' 388' ' ' LEU . 20.3 t -85.13 86.19 2.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 178.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 60.46 -112.57 4.66 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.287 -0.959 . . . . 0.0 111.341 -170.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 387' ' ' ASP . . . . . 0.408 ' N ' ' HB2' ' A' ' 309' ' ' LYS . 4.9 t70 -82.86 -17.05 45.23 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.008 0.432 . . . . 0.0 110.793 176.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 388' ' ' LEU . . . . . 0.529 ' HB2' ' O ' ' A' ' 385' ' ' VAL . 2.3 mp -69.38 151.83 45.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.209 177.121 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 389' ' ' ASN . . . . . 0.657 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 7.6 p30 -165.37 153.34 11.24 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.575 176.197 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 390' ' ' HIS . . . . . 0.461 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 35.5 t-80 -173.74 113.74 0.21 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.323 177.084 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 391' ' ' GLN . . . . . 1.024 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 13.6 tt0 -73.65 154.62 39.64 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.293 177.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 392' ' ' TRP . . . . . 0.553 ' HD1' ' OE1' ' A' ' 394' ' ' GLN . 17.8 t-105 -166.63 150.99 7.41 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.77 177.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -105.33 115.89 31.03 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.553 ' OE1' ' HD1' ' A' ' 392' ' ' TRP . 3.5 mm100 -84.4 113.96 21.55 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -170.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 1.7 ptmm? . . . . . 0 C--O 1.251 1.172 0 CA-C-O 118.442 -0.79 . . . . 0.0 110.818 -178.252 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 303' ' ' THR . . . . . 0.54 HG23 HG23 ' A' ' 335' ' ' THR . 10.4 t . . . . . 0 CA--C 1.539 0.543 0 CA-C-O 121.949 0.881 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -69.84 116.38 10.16 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 175.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.587 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 13.0 t 177.38 -172.32 0.1 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -172.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 56.2 t -65.81 110.59 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 169.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 307' ' ' CYS . . . . . 1.009 ' HB3' HG21 ' A' ' 335' ' ' THR . 0.0 OUTLIER -68.37 135.83 52.41 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.966 0.413 . . . . 0.0 110.43 -169.886 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 308' ' ' ASP . . . . . 0.603 ' OD1' HG22 ' A' ' 310' ' ' THR . 17.1 t70 -64.32 126.16 26.91 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.31 -174.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.501 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -47.9 -17.74 0.13 Allowed 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 -168.85 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.603 HG22 ' OD1' ' A' ' 308' ' ' ASP . 11.8 t -108.92 3.28 22.12 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 119.88 1.218 . . . . 0.0 111.999 -173.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -78.51 -30.91 47.41 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -173.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.504 ' HE1' ' HB2' ' A' ' 307' ' ' CYS . 0.0 OUTLIER -79.77 176.32 9.82 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-O 122.198 0.999 . . . . 0.0 111.821 -173.951 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 8.8 t -148.66 156.93 43.06 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 113.487 -1.688 . . . . 0.0 107.995 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 27.6 m-90 -68.66 121.19 15.93 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.409 ' HB3' ' C ' ' A' ' 329' ' ' GLU . 54.4 tptt -103.13 -41.94 5.93 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 173.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -154.83 130.62 10.03 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.308 170.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -69.31 162.09 68.71 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.631 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 318' ' ' PRO . . . . . 0.737 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 53.8 Cg_exo -46.13 111.39 0.34 Allowed 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 122.311 2.007 . . . . 0.0 112.087 177.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 319' ' ' THR . . . . . 0.457 ' C ' HG13 ' A' ' 326' ' ' VAL . 17.2 m -130.08 132.7 46.27 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.655 -172.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -54.99 124.74 17.72 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 178.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 321' ' ' SER . . . . . 0.502 ' C ' ' H ' ' A' ' 323' ' ' HIS . 23.8 p -75.71 0.96 15.96 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.756 0.422 . . . . 0.0 111.848 -170.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 72.57 -26.91 0.73 Allowed Glycine 0 C--N 1.331 0.29 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.453 -169.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 323' ' ' HIS . . . . . 0.502 ' H ' ' C ' ' A' ' 321' ' ' SER . 30.4 t60 -95.87 44.6 1.08 Allowed 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 121.087 0.47 . . . . 0.0 109.789 -175.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 17.5 t70 59.12 31.51 21.35 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.001 175.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 325' ' ' THR . . . . . 0.848 ' HA ' ' HG3' ' A' ' 375' ' ' GLN . 4.6 p -152.05 -171.88 4.06 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -178.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.457 HG13 ' C ' ' A' ' 319' ' ' THR . 48.2 t -137.71 129.17 39.65 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.611 0 CA-C-N 118.466 0.575 . . . . 0.0 111.085 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 327' ' ' VAL . . . . . 0.527 HG12 ' HG2' ' A' ' 373' ' ' GLU . 12.5 m -107.46 163.07 5.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.524 -178.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 328' ' ' MET . . . . . 0.549 ' SD ' HG13 ' A' ' 330' ' ' VAL . 0.0 OUTLIER -145.65 154.61 42.3 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 174.433 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.428 ' HG3' ' O ' ' A' ' 370' ' ' GLY . 16.5 tt0 -133.28 130.53 39.07 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.387 -175.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.549 HG13 ' SD ' ' A' ' 328' ' ' MET . 0.2 OUTLIER -130.01 153.31 38.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.839 -178.277 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 331' ' ' GLY . . . . . 0.414 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -121.18 137.12 11.62 Favored Glycine 0 CA--C 1.522 0.484 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.852 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 332' ' ' PHE . . . . . 0.458 ' HD2' ' N ' ' A' ' 335' ' ' THR . 1.3 p90 -88.05 155.85 19.6 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.673 0.749 . . . . 0.0 112.768 -178.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 28.3 p -115.69 20.93 14.32 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.76 -1.109 . . . . 0.0 112.764 169.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 164.24 -14.11 0.09 OUTLIER Glycine 0 N--CA 1.465 0.588 0 C-N-CA 120.112 -1.042 . . . . 0.0 113.846 173.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 335' ' ' THR . . . . . 1.009 HG21 ' HB3' ' A' ' 307' ' ' CYS . 0.2 OUTLIER -85.99 118.42 25.46 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 179.656 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 336' ' ' ARG . 4.8 ptp180 -100.22 178.94 1.12 Allowed Pre-proline 0 N--CA 1.451 -0.421 0 CA-C-O 116.549 -1.691 . . . . 0.0 106.475 174.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.57 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.1 OUTLIER -23.26 91.04 0.0 OUTLIER 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 123.736 2.957 . . . . 0.0 114.387 -164.047 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 338' ' ' CYS . . . . . 0.587 ' HB2' ' O ' ' A' ' 305' ' ' THR . 14.2 p -115.41 -176.74 2.98 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 112.68 -2.055 . . . . 0.0 109.303 -170.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? -111.4 101.8 10.23 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 340' ' ' ILE . . . . . 0.763 HG22 HG13 ' A' ' 342' ' ' VAL . 59.1 mt -72.95 118.78 71.32 Favored Pre-proline 0 C--N 1.325 -0.488 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.515 -170.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -74.18 79.24 2.44 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 121.969 1.78 . . . . 0.0 110.644 175.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.763 HG13 HG22 ' A' ' 340' ' ' ILE . 1.1 m -103.13 122.91 56.18 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.86 0 CA-C-O 121.874 0.845 . . . . 0.0 111.076 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.518 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 15.4 ptt180 -135.62 176.77 8.37 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 114.046 -1.434 . . . . 0.0 108.029 175.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 344' ' ' ALA . . . . . 0.503 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -148.66 144.31 27.07 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.554 175.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.436 ' O ' HG23 ' A' ' 382' ' ' ILE . 11.6 m -117.09 144.9 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 176.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -68.66 116.08 8.77 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 178.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 347' ' ' HIS . . . . . 0.627 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 12.2 t60 40.64 67.68 0.49 Allowed 'General case' 0 N--CA 1.478 0.96 0 O-C-N 124.399 1.062 . . . . 0.0 111.519 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 348' ' ' GLY . . . . . 0.76 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 40.96 48.19 4.21 Favored Glycine 0 C--N 1.332 0.353 0 N-CA-C 115.206 0.842 . . . . 0.0 115.206 -174.053 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 349' ' ' VAL . . . . . 0.699 HG12 ' HG2' ' A' ' 351' ' ' GLU . 61.8 t -141.43 101.5 6.12 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 118.173 0.986 . . . . 0.0 108.457 176.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -80.53 72.3 6.6 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 123.131 2.554 . . . . 0.0 113.679 -176.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 351' ' ' GLU . . . . . 0.699 ' HG2' HG12 ' A' ' 349' ' ' VAL . 4.8 mm-40 -99.52 -58.04 2.02 Favored 'General case' 0 CA--C 1.502 -0.9 0 CA-C-O 122.6 1.191 . . . . 0.0 107.937 171.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 352' ' ' VAL . . . . . 0.455 HG12 ' HB2' ' A' ' 351' ' ' GLU . 1.1 p -125.47 127.17 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 112.644 -2.071 . . . . 0.0 110.127 -177.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -62.64 114.44 3.58 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.998 178.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.796 ' HB ' ' ND2' ' A' ' 381' ' ' ASN . 3.5 m -94.05 6.62 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.131 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 355' ' ' ALA . . . . . 0.503 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -74.67 83.13 2.08 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.886 0.374 . . . . 0.0 111.33 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 356' ' ' MET . . . . . 0.634 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 37.0 ttm -94.9 98.31 10.62 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 171.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.639 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 42.8 mt -87.46 123.92 32.89 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.802 -162.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.776 HD11 ' HB2' ' A' ' 375' ' ' GLN . 2.3 mm -62.88 -23.6 33.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.526 173.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 8.3 m -132.38 92.18 28.92 Favored Pre-proline 0 N--CA 1.447 -0.582 0 CA-C-N 114.499 -1.228 . . . . 0.0 108.547 170.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -86.41 28.77 0.53 Allowed 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.133 2.555 . . . . 0.0 112.466 -175.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -156.9 65.66 3.75 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 114.77 -1.104 . . . . 0.0 109.217 177.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 362' ' ' PRO . . . . . 0.712 ' HB2' HD12 ' A' ' 340' ' ' ILE . 87.2 Cg_endo -86.03 114.6 1.36 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.5 2.134 . . . . 0.0 111.991 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 363' ' ' THR . . . . . 0.407 HG22 ' O ' ' A' ' 338' ' ' CYS . 15.1 p -92.64 147.08 23.17 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 171.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 364' ' ' MET . . . . . 0.749 ' HA ' ' HA2' ' A' ' 369' ' ' GLY . 46.6 mtt -95.78 134.42 38.75 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-N 113.936 -1.484 . . . . 0.0 108.449 172.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.549 ' HA ' ' HD3' ' A' ' 337' ' ' PRO . 45.9 mt-10 -117.16 -167.66 1.34 Allowed 'General case' 0 C--N 1.32 -0.676 0 O-C-N 123.939 0.774 . . . . 0.0 111.22 -176.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 26.0 p30 -59.39 -6.83 1.11 Allowed 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -113.49 -2.08 13.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.362 0.601 . . . . 0.0 109.906 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 368' ' ' GLY . . . . . 0.414 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . 109.98 -176.6 19.32 Favored Glycine 0 N--CA 1.451 -0.356 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -172.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 369' ' ' GLY . . . . . 0.749 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -46.64 -40.89 12.17 Favored Glycine 0 CA--C 1.519 0.305 0 CA-C-N 117.588 0.694 . . . . 0.0 113.476 173.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 370' ' ' GLY . . . . . 0.428 ' O ' ' HG3' ' A' ' 329' ' ' GLU . . . 83.28 -51.17 4.53 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.152 177.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -166.01 143.79 5.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.921 0.391 . . . . 0.0 111.616 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 372' ' ' ILE . . . . . 0.627 HD13 HG11 ' A' ' 342' ' ' VAL . 0.9 OUTLIER -134.71 151.46 31.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 170.398 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.66 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 44.5 mt-10 -128.75 126.86 40.87 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.815 0.34 . . . . 0.0 110.355 -178.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 374' ' ' MET . . . . . 0.821 ' HG2' HD11 ' A' ' 383' ' ' ILE . 4.2 ppp? -137.3 165.1 26.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.589 -178.157 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 375' ' ' GLN . . . . . 0.848 ' HG3' ' HA ' ' A' ' 325' ' ' THR . 0.3 OUTLIER -177.32 -179.9 0.91 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.303 0.573 . . . . 0.0 111.692 168.954 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 376' ' ' LEU . . . . . 0.701 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 13.1 tp -167.96 155.0 7.68 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 178.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 377' ' ' PRO . . . . . 0.701 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 82.8 Cg_exo -45.53 131.67 12.49 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 121.287 1.325 . . . . 0.0 110.046 167.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.491 ' CA ' HE22 ' A' ' 394' ' ' GLN . 4.0 Cg_exo -35.07 141.12 0.09 OUTLIER 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 125.103 3.869 . . . . 0.0 113.979 -171.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 152.64 -167.37 31.49 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 -163.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 380' ' ' ASP . . . . . 0.627 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 5.0 m-20 -99.4 124.31 44.43 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 117.548 0.674 . . . . 0.0 111.395 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.796 ' ND2' ' HB ' ' A' ' 354' ' ' VAL . 11.5 m120 -134.19 141.64 47.12 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 0.963 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -142.58 137.05 28.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -179.837 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 383' ' ' ILE . . . . . 0.821 HD11 ' HG2' ' A' ' 374' ' ' MET . 47.6 mt -98.25 127.83 50.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.751 -172.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 384' ' ' TYR . . . . . 0.518 ' O ' ' HG2' ' A' ' 343' ' ' ARG . 0.3 OUTLIER -104.98 91.42 3.8 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.197 173.469 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 9.3 t -83.34 90.27 2.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 61.45 -113.26 5.52 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.461 -0.876 . . . . 0.0 111.027 -170.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -88.11 -16.36 33.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.759 0.314 . . . . 0.0 110.883 175.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 388' ' ' LEU . . . . . 0.437 HD13 ' HD2' ' A' ' 312' ' ' PHE . 0.9 OUTLIER -69.51 155.69 40.07 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.191 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 389' ' ' ASN . . . . . 0.64 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 28.2 p-10 -165.98 157.3 13.66 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.778 177.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 390' ' ' HIS . . . . . 0.737 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 56.5 t-80 -174.55 120.98 0.25 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.202 174.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 391' ' ' GLN . . . . . 0.963 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 21.3 tt0 -75.35 149.51 38.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.438 0.637 . . . . 0.0 112.115 -177.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 392' ' ' TRP . . . . . . . . . . . . . 70.5 t-105 -146.12 143.35 29.27 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.426 177.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 393' ' ' PHE . . . . . 0.685 ' HD2' ' HE2' ' A' ' 395' ' ' LYS . 12.3 p90 -104.15 107.38 18.26 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 173.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.491 HE22 ' CA ' ' A' ' 378' ' ' PRO . 2.8 pp0? -94.33 123.05 37.49 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.805 0.812 . . . . 0.0 110.972 -170.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.685 ' HE2' ' HD2' ' A' ' 393' ' ' PHE . 48.6 mttm . . . . . 0 C--O 1.245 0.834 0 CA-C-N 114.464 -1.244 . . . . 0.0 108.911 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 303' ' ' THR . . . . . 0.475 ' O ' HG23 ' A' ' 335' ' ' THR . 5.2 t . . . . . 0 CA--C 1.538 0.505 0 CA-C-O 121.486 0.66 . . . . 0.0 111.001 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -65.98 124.67 23.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.151 0.501 . . . . 0.0 110.023 177.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.501 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 14.3 t 175.79 -170.58 0.06 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.113 -171.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 61.3 t -63.64 108.86 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 168.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.56 142.14 55.29 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.747 0.308 . . . . 0.0 110.567 -169.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 308' ' ' ASP . . . . . 0.689 ' OD1' HG22 ' A' ' 310' ' ' THR . 16.1 t70 -64.46 131.91 48.48 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.813 0.816 . . . . 0.0 112.004 -170.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -37.72 -30.65 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 112.975 -1.921 . . . . 0.0 115.222 -177.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.689 HG22 ' OD1' ' A' ' 308' ' ' ASP . 11.6 t -105.19 -1.85 24.89 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 118.747 0.703 . . . . 0.0 112.376 -169.18 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 27.0 mmmt -70.13 -35.05 73.79 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.284 0.564 . . . . 0.0 110.908 -178.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.635 ' HB3' ' HE1' ' A' ' 364' ' ' MET . 0.1 OUTLIER -90.47 177.64 6.32 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 122.296 1.046 . . . . 0.0 112.544 -174.553 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 14.2 t -161.8 168.86 22.41 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 113.534 -1.666 . . . . 0.0 108.978 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 314' ' ' TRP . . . . . 0.4 ' CE3' ' HA ' ' A' ' 317' ' ' ALA . 92.9 m95 -83.91 96.72 8.91 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 121.371 0.605 . . . . 0.0 110.648 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.684 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 56.7 tttm -66.61 -40.13 88.69 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 167.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 61.4 ttt180 -158.9 131.79 7.05 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.333 168.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 317' ' ' ALA . . . . . 0.471 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -74.87 163.66 66.69 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.059 -176.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 318' ' ' PRO . . . . . 0.471 ' HD2' ' HB1' ' A' ' 317' ' ' ALA . 4.9 Cg_exo -37.64 116.05 0.19 Allowed 'Trans proline' 0 C--N 1.362 1.239 0 C-N-CA 123.58 2.853 . . . . 0.0 113.364 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 28.8 m -132.9 138.36 46.95 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.424 -176.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 320' ' ' ASP . . . . . 0.432 ' OD2' ' HZ2' ' A' ' 392' ' ' TRP . 45.5 m-20 -61.13 132.83 55.0 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -178.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 321' ' ' SER . . . . . 0.449 ' HB3' HG13 ' A' ' 327' ' ' VAL . 60.3 p -71.52 1.58 6.3 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 122.492 0.317 . . . . 0.0 111.466 -174.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 70.52 -22.06 0.54 Allowed Glycine 0 CA--C 1.521 0.452 0 C-N-CA 121.438 -0.411 . . . . 0.0 113.642 -170.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 323' ' ' HIS . . . . . 0.6 ' O ' ' HB3' ' A' ' 324' ' ' ASP . 40.9 m80 -77.67 -41.74 37.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.993 0.396 . . . . 0.0 111.7 -172.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 324' ' ' ASP . . . . . 0.6 ' HB3' ' O ' ' A' ' 323' ' ' HIS . 4.5 p-10 144.37 13.89 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.721 0 O-C-N 124.354 1.034 . . . . 0.0 109.89 -163.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 325' ' ' THR . . . . . 0.455 ' HA ' ' HG2' ' A' ' 375' ' ' GLN . 6.5 p -150.13 -170.23 3.59 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -170.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 373' ' ' GLU . 1.4 t -130.04 148.71 33.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.173 0.511 . . . . 0.0 111.03 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 327' ' ' VAL . . . . . 0.694 HG12 ' HG2' ' A' ' 373' ' ' GLU . 19.1 m -128.7 157.42 41.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.982 178.162 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 328' ' ' MET . . . . . 0.649 ' HE2' HD12 ' A' ' 372' ' ' ILE . 23.1 ptt? -140.89 156.3 46.13 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 170.006 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.684 ' HG2' ' HD3' ' A' ' 315' ' ' LYS . 22.8 tt0 -121.8 119.12 30.75 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 19.5 m -122.97 142.23 40.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 120.676 0.274 . . . . 0.0 110.792 -175.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 331' ' ' GLY . . . . . 0.537 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -125.49 138.28 10.82 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.247 -0.978 . . . . 0.0 113.199 -173.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 332' ' ' PHE . . . . . 0.848 ' HE2' ' HB ' ' A' ' 335' ' ' THR . 0.0 OUTLIER -147.61 163.13 37.56 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 176.114 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 15.1 m -151.96 44.48 0.74 Allowed 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -174.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -139.34 -65.82 0.04 OUTLIER Glycine 0 C--N 1.331 0.258 0 C-N-CA 119.369 -1.396 . . . . 0.0 112.126 169.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 335' ' ' THR . . . . . 0.848 ' HB ' ' HE2' ' A' ' 332' ' ' PHE . 28.6 m -52.9 140.56 24.21 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.234 -0.983 . . . . 0.0 109.236 172.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.635 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 21.9 ptt180 -87.91 178.37 2.18 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 117.592 -1.194 . . . . 0.0 108.725 176.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.635 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 2.2 Cg_exo -27.65 104.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.372 1.776 0 C-N-CA 123.573 2.849 . . . . 0.0 113.58 -178.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 338' ' ' CYS . . . . . 0.584 ' SG ' ' HB2' ' A' ' 364' ' ' MET . 22.2 p -116.74 -174.3 2.55 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 113.882 -1.508 . . . . 0.0 110.286 -167.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 -111.71 101.6 9.96 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 340' ' ' ILE . . . . . 0.496 HG12 HG13 ' A' ' 342' ' ' VAL . 13.4 tt -77.61 121.93 85.05 Favored Pre-proline 0 C--N 1.325 -0.47 0 C-N-CA 119.118 -1.033 . . . . 0.0 110.849 -167.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -78.16 80.55 2.96 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.252 1.968 . . . . 0.0 111.954 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.604 HG12 HG13 ' A' ' 385' ' ' VAL . 30.2 m -106.07 153.31 7.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.355 -178.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.513 ' HG3' ' HB2' ' A' ' 384' ' ' TYR . 40.3 ptt180 -168.33 174.99 6.65 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -179.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 344' ' ' ALA . . . . . 0.549 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -149.81 144.36 25.95 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.931 -0.708 . . . . 0.0 110.885 177.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.547 ' HB ' ' HA ' ' A' ' 350' ' ' PRO . 4.6 m -116.72 147.09 20.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -69.53 125.59 27.17 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 176.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 347' ' ' HIS . . . . . 0.526 ' O ' HG23 ' A' ' 349' ' ' VAL . 5.0 t60 43.88 60.17 2.82 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 124.422 1.077 . . . . 0.0 111.665 172.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 348' ' ' GLY . . . . . 0.617 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 43.02 42.79 5.26 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 115.046 0.778 . . . . 0.0 115.046 -174.012 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 349' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 347' ' ' HIS . 75.5 t -139.98 101.8 7.0 Favored Pre-proline 0 C--N 1.331 -0.227 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 350' ' ' PRO . . . . . 0.547 ' HA ' ' HB ' ' A' ' 345' ' ' VAL . 12.5 Cg_exo -75.41 54.8 3.95 Favored 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 122.913 2.408 . . . . 0.0 113.834 -176.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -100.15 -56.35 2.39 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 176.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.7 p -112.28 123.69 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.854 172.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 353' ' ' ASN . . . . . 0.549 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 6.1 t30 -65.8 122.25 16.89 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.371 174.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.459 HG21 ' HA ' ' A' ' 381' ' ' ASN . 29.1 m -97.56 4.51 9.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.143 176.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 355' ' ' ALA . . . . . 0.529 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -76.93 83.95 3.48 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.893 -179.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 356' ' ' MET . . . . . 0.683 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 53.3 ttp -95.36 99.87 11.73 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 169.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.437 ' CD2' ' HB3' ' A' ' 374' ' ' MET . 36.5 mt -85.34 116.49 23.7 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.768 -162.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.752 ' HB ' ' CB ' ' A' ' 373' ' ' GLU . 1.7 mm -64.6 -24.36 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 174.188 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 72.3 m -118.61 85.15 26.23 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 114.294 -1.321 . . . . 0.0 108.257 169.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 360' ' ' PRO . . . . . 0.411 ' HA ' ' HB2' ' A' ' 357' ' ' LEU . 75.0 Cg_endo -84.3 26.04 0.67 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.115 2.543 . . . . 0.0 114.448 -167.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -166.52 68.34 1.04 Allowed Pre-proline 0 C--N 1.311 -1.093 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.587 173.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 362' ' ' PRO . . . . . 0.655 ' HB3' HG23 ' A' ' 372' ' ' ILE . 58.6 Cg_endo -82.54 169.05 14.08 Favored 'Trans proline' 0 C--O 1.246 0.889 0 C-N-CA 122.542 2.161 . . . . 0.0 113.317 -178.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 4.2 p -143.7 -176.53 5.01 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.087 -168.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 364' ' ' MET . . . . . 0.8 ' HA ' ' HA2' ' A' ' 369' ' ' GLY . 42.4 mtp -144.83 127.61 16.28 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 172.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.456 ' O ' ' HE1' ' A' ' 332' ' ' PHE . 48.4 mt-10 -117.52 -169.62 1.7 Allowed 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.295 -172.009 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 31.3 p30 -58.78 -21.99 57.19 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -171.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -101.11 -4.41 27.38 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.564 -0.71 . . . . 0.0 110.729 176.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 368' ' ' GLY . . . . . 0.571 ' HA2' ' HD1' ' A' ' 332' ' ' PHE . . . 116.94 172.9 16.45 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -173.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 369' ' ' GLY . . . . . 0.8 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -54.61 -47.19 71.57 Favored Glycine 0 CA--C 1.505 -0.548 0 C-N-CA 121.371 -0.442 . . . . 0.0 113.391 177.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 370' ' ' GLY . . . . . 0.62 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 90.12 -134.61 12.44 Favored Glycine 0 N--CA 1.438 -1.194 0 C-N-CA 119.943 -1.122 . . . . 0.0 110.917 -172.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -103.16 140.61 37.12 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.513 0.673 . . . . 0.0 111.697 -177.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 372' ' ' ILE . . . . . 0.655 HG23 ' HB3' ' A' ' 362' ' ' PRO . 1.5 mt -128.25 161.31 36.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.044 176.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.752 ' CB ' ' HB ' ' A' ' 358' ' ' ILE . 38.8 mt-10 -124.49 128.54 49.14 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.484 0.659 . . . . 0.0 110.97 -179.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 374' ' ' MET . . . . . 0.447 ' O ' ' HB2' ' A' ' 375' ' ' GLN . 0.1 OUTLIER -140.32 157.31 45.76 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.38 -1.282 . . . . 0.0 108.188 -179.923 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 375' ' ' GLN . . . . . 0.683 ' O ' ' HB3' ' A' ' 356' ' ' MET . 3.6 tp60 179.83 175.45 0.78 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 118.224 0.465 . . . . 0.0 109.803 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 376' ' ' LEU . . . . . 1.013 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 11.2 tp -166.69 164.45 10.38 Favored Pre-proline 0 N--CA 1.446 -0.63 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 176.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 377' ' ' PRO . . . . . 1.013 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 80.0 Cg_exo -43.63 133.92 7.39 Favored 'Trans proline' 0 CA--C 1.533 0.433 0 C-N-CA 121.38 1.387 . . . . 0.0 111.3 169.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.509 ' HB3' ' OXT' ' A' ' 395' ' ' LYS . 4.7 Cg_exo -35.47 144.22 0.08 OUTLIER 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 125.177 3.918 . . . . 0.0 114.223 -175.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 151.17 -159.69 28.31 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -164.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 380' ' ' ASP . . . . . 0.46 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 7.5 m-20 -104.7 131.55 52.01 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 118.013 0.906 . . . . 0.0 110.939 175.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.459 ' HA ' HG21 ' A' ' 354' ' ' VAL . 10.0 m120 -128.5 145.53 51.08 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 177.029 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 1.018 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -143.91 136.97 23.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 176.634 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 383' ' ' ILE . . . . . 0.644 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 13.4 mt -100.72 131.71 47.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.326 -173.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 384' ' ' TYR . . . . . 0.513 ' HB2' ' HG3' ' A' ' 343' ' ' ARG . 5.0 m-85 -99.91 133.72 43.86 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 114.51 -1.223 . . . . 0.0 108.163 167.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 385' ' ' VAL . . . . . 0.84 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 4.5 t -124.21 82.05 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 177.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 59.91 -108.57 1.79 Allowed Glycine 0 N--CA 1.434 -1.455 0 C-N-CA 119.837 -1.173 . . . . 0.0 110.848 -167.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -83.12 -15.51 50.47 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 175.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 388' ' ' LEU . . . . . 0.84 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 4.1 mp -69.68 155.77 40.0 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.477 0.179 . . . . 0.0 110.625 177.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 389' ' ' ASN . . . . . 0.644 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 4.9 p-10 -171.41 152.25 3.24 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.426 174.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 390' ' ' HIS . . . . . 0.423 ' O ' HG12 ' A' ' 382' ' ' ILE . 6.5 t60 -173.91 120.45 0.29 Allowed 'General case' 0 C--O 1.237 0.421 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 177.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 391' ' ' GLN . . . . . 1.018 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 39.7 tt0 -76.35 152.94 36.18 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.294 0.568 . . . . 0.0 112.496 -175.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 392' ' ' TRP . . . . . 0.432 ' HZ2' ' OD2' ' A' ' 320' ' ' ASP . 59.0 t-105 -150.2 148.82 29.38 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.397 177.075 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -111.64 114.03 26.8 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 173.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.401 HE22 ' CA ' ' A' ' 378' ' ' PRO . 2.4 pp0? -103.01 127.31 50.3 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.334 0.588 . . . . 0.0 110.069 -172.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.648 ' H ' ' HD3' ' A' ' 395' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.021 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.514 -174.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 303' ' ' THR . . . . . 0.446 ' O ' HG22 ' A' ' 305' ' ' THR . 10.0 t . . . . . 0 CA--C 1.535 0.378 0 CA-C-O 121.471 0.653 . . . . 0.0 111.437 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 304' ' ' TYR . . . . . 0.478 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 43.7 p90 -64.03 120.87 12.85 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 172.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.619 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 14.2 t 170.75 -166.75 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -170.025 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 19.2 t -65.32 110.58 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 171.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 307' ' ' CYS . . . . . 0.412 ' HB3' HG21 ' A' ' 335' ' ' THR . 0.1 OUTLIER -68.79 141.33 55.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.007 0.432 . . . . 0.0 110.955 -173.698 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 308' ' ' ASP . . . . . 0.609 ' OD1' HG22 ' A' ' 310' ' ' THR . 9.4 t70 -60.82 123.02 16.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.944 -177.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 34.7 pttt -45.28 -17.53 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 115.4 1.629 . . . . 0.0 115.4 -177.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.609 HG22 ' OD1' ' A' ' 308' ' ' ASP . 10.6 t -109.63 9.08 25.14 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 120.212 1.369 . . . . 0.0 112.252 -174.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.447 ' HG3' ' HB3' ' A' ' 308' ' ' ASP . 26.2 mtpp -90.42 -27.03 19.56 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -174.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.839 ' HD1' HD13 ' A' ' 388' ' ' LEU . 0.4 OUTLIER -85.91 173.55 9.89 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.887 0.851 . . . . 0.0 112.443 -175.925 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 11.2 t -153.6 158.91 41.87 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.203 -1.362 . . . . 0.0 109.101 -178.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 16.4 m95 -79.79 95.53 6.04 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 120.981 0.42 . . . . 0.0 111.376 -176.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.499 ' HB3' ' C ' ' A' ' 329' ' ' GLU . 31.8 tptt -63.37 -49.64 73.06 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 167.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.404 ' HB3' ' HB2' ' A' ' 329' ' ' GLU . 3.8 ttm180 -154.73 131.55 10.77 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.211 -0.904 . . . . 0.0 108.918 175.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -75.07 159.31 82.99 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-O 119.051 -0.499 . . . . 0.0 110.908 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -34.27 113.24 0.08 OUTLIER 'Trans proline' 0 C--N 1.365 1.397 0 C-N-CA 123.78 2.987 . . . . 0.0 113.545 177.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 21.0 m -130.89 137.15 49.2 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.932 -175.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -58.82 128.18 35.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.664 -0.244 . . . . 0.0 110.36 -179.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 60.5 p -74.68 3.98 7.0 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.026 0.53 . . . . 0.0 111.85 -173.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 70.61 -18.79 0.74 Allowed Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.238 -0.506 . . . . 0.0 114.08 -172.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 323' ' ' HIS . . . . . 0.445 ' O ' ' CB ' ' A' ' 324' ' ' ASP . 11.5 m170 -92.01 -13.75 30.5 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 117.579 0.69 . . . . 0.0 112.791 -174.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 324' ' ' ASP . . . . . 0.445 ' CB ' ' O ' ' A' ' 323' ' ' HIS . 29.9 t70 108.0 35.39 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 O-C-N 125.329 1.643 . . . . 0.0 109.033 -175.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 325' ' ' THR . . . . . 0.572 ' HA ' ' CG ' ' A' ' 375' ' ' GLN . 3.3 p -150.97 -173.77 4.59 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.697 HG23 ' HG2' ' A' ' 375' ' ' GLN . 0.6 OUTLIER -130.04 143.74 40.13 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.589 0 CA-C-N 118.776 0.716 . . . . 0.0 111.511 -177.33 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 327' ' ' VAL . . . . . 0.835 HG12 ' HG2' ' A' ' 373' ' ' GLU . 19.2 m -123.28 146.2 29.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.466 176.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 328' ' ' MET . . . . . 0.63 ' SD ' HG21 ' A' ' 383' ' ' ILE . 6.1 ptp -130.61 153.5 48.85 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 174.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.499 ' C ' ' HB3' ' A' ' 315' ' ' LYS . 3.8 tt0 -125.75 126.27 44.31 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.541 HG23 ' HA3' ' A' ' 369' ' ' GLY . 10.7 m -125.58 159.05 33.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.351 -176.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 331' ' ' GLY . . . . . 0.528 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -130.8 135.59 8.35 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 118.843 -1.646 . . . . 0.0 114.482 178.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 332' ' ' PHE . . . . . 1.011 ' H ' ' HA2' ' A' ' 368' ' ' GLY . 36.2 m-85 -112.52 171.49 7.49 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.442 0.697 . . . . 0.0 110.074 170.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 34.7 m -130.58 -15.17 3.58 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 174.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -123.82 -66.42 0.2 Allowed Glycine 0 C--O 1.224 -0.484 0 C-N-CA 119.766 -1.207 . . . . 0.0 113.659 -175.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 335' ' ' THR . . . . . 0.412 HG21 ' HB3' ' A' ' 307' ' ' CYS . 12.8 m -54.16 129.01 33.32 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 123.747 0.322 . . . . 0.0 111.202 -176.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.669 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 6.4 ptm180 -88.7 179.45 1.63 Allowed Pre-proline 0 CA--C 1.532 0.269 0 CA-C-O 117.442 -1.266 . . . . 0.0 108.123 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.669 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -26.89 99.41 0.02 OUTLIER 'Trans proline' 0 C--N 1.372 1.816 0 C-N-CA 123.888 3.059 . . . . 0.0 114.155 -175.574 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 338' ' ' CYS . . . . . 0.619 ' HB2' ' O ' ' A' ' 305' ' ' THR . 19.2 p -115.61 -175.61 2.75 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 113.583 -1.644 . . . . 0.0 109.302 -169.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -106.54 96.34 6.38 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 340' ' ' ILE . . . . . 0.856 HD12 ' HD2' ' A' ' 341' ' ' PRO . 9.3 tp -75.54 120.05 79.88 Favored Pre-proline 0 C--N 1.325 -0.457 0 C-N-CA 119.011 -1.076 . . . . 0.0 110.924 -168.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 341' ' ' PRO . . . . . 0.856 ' HD2' HD12 ' A' ' 340' ' ' ILE . 53.5 Cg_endo -72.87 79.45 1.96 Allowed 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 121.92 1.746 . . . . 0.0 111.216 175.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.69 HG13 HG13 ' A' ' 340' ' ' ILE . 2.5 m -103.85 109.64 27.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.273 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.612 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 18.9 ptt180 -127.45 175.64 8.07 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 344' ' ' ALA . . . . . 0.559 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -147.42 145.87 29.38 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.407 176.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.475 HG22 HD12 ' A' ' 382' ' ' ILE . 10.4 m -115.63 143.34 25.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 176.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -62.05 115.85 4.44 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.326 176.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 347' ' ' HIS . . . . . 0.762 ' HB3' ' HB2' ' A' ' 380' ' ' ASP . 13.6 p80 33.62 73.17 0.07 Allowed 'General case' 0 N--CA 1.472 0.664 0 O-C-N 124.618 1.199 . . . . 0.0 113.822 177.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 348' ' ' GLY . . . . . 0.734 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 53.18 31.59 41.76 Favored Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 115.324 0.89 . . . . 0.0 115.324 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 49.8 t -139.49 102.88 7.16 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 118.584 1.192 . . . . 0.0 109.011 178.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -71.88 62.55 3.15 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.966 2.444 . . . . 0.0 112.778 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -100.87 -55.98 2.44 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 177.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.2 p -121.54 131.43 73.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.434 174.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 353' ' ' ASN . . . . . 0.433 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 43.4 t30 -64.19 113.04 3.3 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.551 174.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.401 ' CG1' HD22 ' A' ' 376' ' ' LEU . 27.5 m -97.25 5.16 9.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.05 -178.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 355' ' ' ALA . . . . . 0.559 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -76.38 86.25 3.15 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.027 0.441 . . . . 0.0 111.272 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.96 100.58 12.08 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 171.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.587 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 23.8 mt -85.57 120.17 26.72 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.931 -164.272 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.712 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 2.1 mm -65.86 -25.9 37.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 173.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 50.4 m -120.68 82.27 33.9 Favored Pre-proline 0 N--CA 1.446 -0.652 0 CA-C-N 114.41 -1.268 . . . . 0.0 108.153 170.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -85.86 21.0 1.14 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.088 2.525 . . . . 0.0 113.785 -169.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 361' ' ' ASN . . . . . 0.55 ' N ' ' HD3' ' A' ' 362' ' ' PRO . 15.8 m120 -145.77 52.88 1.66 Allowed Pre-proline 0 C--N 1.312 -1.054 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.348 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 362' ' ' PRO . . . . . 0.55 ' HD3' ' N ' ' A' ' 361' ' ' ASN . 11.0 Cg_endo -78.81 147.11 21.38 Favored 'Trans proline' 0 C--O 1.251 1.161 0 C-N-CA 121.635 1.557 . . . . 0.0 113.142 -177.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 6.3 p -139.99 116.85 10.97 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.664 -169.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 364' ' ' MET . . . . . 0.774 ' HG3' HD13 ' A' ' 340' ' ' ILE . 11.3 mmt -98.15 147.24 24.77 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.96 -170.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.535 ' HG2' ' HD3' ' A' ' 337' ' ' PRO . 40.9 mt-10 -125.5 177.9 5.94 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 122.108 0.956 . . . . 0.0 112.604 -172.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 16.9 p30 -60.16 -4.7 0.85 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 113.407 -1.724 . . . . 0.0 111.621 173.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 367' ' ' ASN . . . . . 0.456 ' OD1' ' HB2' ' A' ' 365' ' ' GLU . 25.5 p30 -112.45 -5.29 14.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.858 0.361 . . . . 0.0 110.152 -175.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 368' ' ' GLY . . . . . 1.011 ' HA2' ' H ' ' A' ' 332' ' ' PHE . . . 134.73 -119.69 2.23 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.272 -0.966 . . . . 0.0 114.535 177.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 369' ' ' GLY . . . . . 0.541 ' HA3' HG23 ' A' ' 330' ' ' VAL . . . -177.18 93.47 0.09 OUTLIER Glycine 0 C--N 1.312 -0.759 0 N-CA-C 107.652 -2.179 . . . . 0.0 107.652 -171.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 370' ' ' GLY . . . . . 0.442 ' O ' ' HG3' ' A' ' 329' ' ' GLU . . . -74.31 -43.24 32.28 Favored Glycine 0 C--N 1.304 -1.248 0 C-N-CA 120.826 -0.702 . . . . 0.0 114.639 -155.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -166.2 136.6 3.42 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 120.966 0.413 . . . . 0.0 110.754 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 372' ' ' ILE . . . . . 0.62 ' O ' ' HA ' ' A' ' 327' ' ' VAL . 0.9 OUTLIER -136.67 135.52 48.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.947 176.771 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.835 ' HG2' HG12 ' A' ' 327' ' ' VAL . 25.8 mt-10 -110.98 131.22 55.23 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.703 -176.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 374' ' ' MET . . . . . 0.649 ' HG2' HD11 ' A' ' 383' ' ' ILE . 0.0 OUTLIER -137.17 165.1 26.9 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.794 -1.093 . . . . 0.0 108.627 178.987 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 375' ' ' GLN . . . . . 0.705 ' HB2' HD11 ' A' ' 358' ' ' ILE . 0.0 OUTLIER -176.14 -175.95 0.75 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.807 0.813 . . . . 0.0 110.813 169.309 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 376' ' ' LEU . . . . . 0.957 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 14.5 tp -166.21 162.9 12.09 Favored Pre-proline 0 N--CA 1.437 -1.081 0 N-CA-C 103.806 -2.664 . . . . 0.0 103.806 173.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 377' ' ' PRO . . . . . 0.957 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 66.6 Cg_exo -39.65 130.99 1.84 Allowed 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 121.356 1.37 . . . . 0.0 110.705 167.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -37.2 141.32 0.18 Allowed 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 124.201 3.267 . . . . 0.0 112.694 -176.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 149.43 -174.86 28.86 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -163.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 380' ' ' ASP . . . . . 0.762 ' HB2' ' HB3' ' A' ' 347' ' ' HIS . 6.1 m-20 -94.41 125.92 39.35 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 117.501 0.65 . . . . 0.0 110.167 -175.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.684 ' HB2' HE21 ' A' ' 394' ' ' GLN . 28.4 m-80 -137.29 170.24 16.43 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 1.023 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -160.55 143.98 4.82 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 175.426 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 383' ' ' ILE . . . . . 0.688 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 44.2 mt -101.48 128.82 53.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.31 -175.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 384' ' ' TYR . . . . . 0.612 ' O ' ' HG2' ' A' ' 343' ' ' ARG . 0.7 OUTLIER -104.06 92.07 4.22 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.971 171.935 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 385' ' ' VAL . . . . . 0.478 ' O ' ' HB2' ' A' ' 388' ' ' LEU . 15.2 t -84.0 89.45 2.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 178.242 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 386' ' ' GLY . . . . . 0.752 ' HA3' ' HZ ' ' A' ' 312' ' ' PHE . . . 61.05 -116.52 9.46 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.1 -1.048 . . . . 0.0 111.136 -172.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -78.49 -20.76 50.12 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.848 0.356 . . . . 0.0 111.366 174.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 388' ' ' LEU . . . . . 0.839 HD13 ' HD1' ' A' ' 312' ' ' PHE . 2.4 mp -70.26 155.12 41.1 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.37 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 389' ' ' ASN . . . . . 0.688 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 7.0 p30 -167.8 152.73 6.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.886 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -173.48 118.55 0.29 Allowed 'General case' 0 C--O 1.24 0.554 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 177.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 391' ' ' GLN . . . . . 1.023 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 15.5 tt0 -80.93 153.32 27.61 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.894 0.878 . . . . 0.0 112.081 -176.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 392' ' ' TRP . . . . . 0.532 ' HD1' ' NE2' ' A' ' 394' ' ' GLN . 6.0 t-105 -172.31 150.99 2.45 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.47 -178.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 393' ' ' PHE . . . . . 0.501 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 21.3 p90 -102.34 119.12 38.28 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 121.214 -0.929 . . . . 0.0 108.807 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.684 HE21 ' HB2' ' A' ' 381' ' ' ASN . 18.4 mm-40 -85.98 127.28 34.6 Favored 'General case' 0 C--O 1.238 0.469 0 O-C-N 121.909 -0.495 . . . . 0.0 109.878 -167.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm . . . . . 0 C--O 1.246 0.897 0 O-C-N 124.348 1.03 . . . . 0.0 110.651 175.793 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 303' ' ' THR . . . . . 0.611 HG23 HG23 ' A' ' 335' ' ' THR . 5.8 t . . . . . 0 CA--C 1.537 0.48 0 CA-C-O 121.344 0.592 . . . . 0.0 111.764 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -68.11 122.87 19.18 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 175.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.498 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 7.4 t 178.54 -167.89 0.07 Allowed 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -171.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 30.8 t -69.78 113.65 5.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 167.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 307' ' ' CYS . . . . . 0.502 ' SG ' HG21 ' A' ' 335' ' ' THR . 0.1 OUTLIER -66.6 147.27 53.5 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.842 0.83 . . . . 0.0 112.135 -169.864 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 308' ' ' ASP . . . . . 0.51 ' OD1' HG22 ' A' ' 310' ' ' THR . 12.1 t70 -66.58 128.21 35.35 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.163 -1.381 . . . . 0.0 110.145 177.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.415 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -44.64 -13.13 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 115.775 1.769 . . . . 0.0 115.775 -176.406 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.51 HG22 ' OD1' ' A' ' 308' ' ' ASP . 12.0 t -108.96 -2.37 18.32 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 119.775 1.17 . . . . 0.0 113.086 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.676 ' HE2' ' OG1' ' A' ' 335' ' ' THR . 31.2 mmmt -65.69 -35.68 81.45 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -173.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.586 ' HA ' ' O ' ' A' ' 331' ' ' GLY . 0.1 OUTLIER -86.01 174.25 9.34 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 122.086 0.946 . . . . 0.0 112.405 -175.129 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 313' ' ' THR . . . . . 0.42 ' C ' HD21 ' A' ' 388' ' ' LEU . 12.6 t -151.98 161.47 42.58 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 113.65 -1.614 . . . . 0.0 109.459 -177.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 314' ' ' TRP . . . . . 0.546 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 28.8 m-90 -77.32 124.19 27.53 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 121.295 0.569 . . . . 0.0 110.034 -178.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.61 ' HB3' ' HB3' ' A' ' 329' ' ' GLU . 63.0 tttt -108.04 -41.95 4.8 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 172.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.643 ' HB3' ' HB2' ' A' ' 329' ' ' GLU . 3.9 ttm180 -151.16 130.02 12.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.762 171.123 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -70.25 157.74 89.19 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.453 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 318' ' ' PRO . . . . . 0.628 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 1.6 Cg_endo -45.66 118.44 2.23 Favored 'Trans proline' 0 C--N 1.359 1.118 0 C-N-CA 122.541 2.161 . . . . 0.0 112.27 -178.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 47.5 m -134.96 145.16 47.87 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.243 -174.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -60.07 134.5 57.11 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 321' ' ' SER . . . . . 0.49 ' HB3' HG13 ' A' ' 327' ' ' VAL . 79.9 p -76.92 1.04 18.77 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -173.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 73.1 -20.47 1.14 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.833 -169.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 323' ' ' HIS . . . . . 0.427 ' H ' ' C ' ' A' ' 321' ' ' SER . 96.6 m-70 -112.2 50.15 0.87 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.111 0.482 . . . . 0.0 110.369 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 9.5 t70 54.03 38.22 28.5 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.835 174.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 325' ' ' THR . . . . . 0.449 ' HB ' HG13 ' A' ' 358' ' ' ILE . 2.6 p -150.86 -168.47 3.11 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 175.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.569 HG13 HE22 ' A' ' 394' ' ' GLN . 0.4 OUTLIER -129.13 141.25 47.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 118.245 0.475 . . . . 0.0 110.873 -178.782 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 327' ' ' VAL . . . . . 0.828 HG12 ' HG2' ' A' ' 373' ' ' GLU . 17.6 m -121.35 149.16 24.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.682 177.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 328' ' ' MET . . . . . 0.686 ' SD ' ' HB ' ' A' ' 372' ' ' ILE . 0.1 OUTLIER -141.94 150.73 41.82 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 176.194 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.643 ' HB2' ' HB3' ' A' ' 316' ' ' ARG . 9.9 mt-10 -124.94 128.86 49.27 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 120.825 0.345 . . . . 0.0 110.2 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.484 HG23 ' HA3' ' A' ' 369' ' ' GLY . 1.8 m -131.78 152.66 37.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.854 -178.005 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 331' ' ' GLY . . . . . 0.586 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -113.86 178.15 18.21 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-O 119.475 -0.625 . . . . 0.0 112.536 -178.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 332' ' ' PHE . . . . . 0.709 ' HB2' ' SD ' ' A' ' 364' ' ' MET . 0.5 OUTLIER -128.77 142.83 50.86 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 117.467 0.633 . . . . 0.0 111.158 -178.409 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 5.3 p -87.57 -17.64 31.53 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 173.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 177.09 -39.61 0.1 OUTLIER Glycine 0 C--N 1.338 0.641 0 C-N-CA 117.943 -2.075 . . . . 0.0 116.045 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 335' ' ' THR . . . . . 0.676 ' OG1' ' HE2' ' A' ' 311' ' ' LYS . 81.2 m -52.91 131.78 36.27 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.342 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.833 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 1.4 ptp180 -79.24 -179.98 1.59 Allowed Pre-proline 0 N--CA 1.449 -0.495 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -177.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.833 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 1.3 Cg_exo -27.56 100.88 0.02 OUTLIER 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 123.269 2.646 . . . . 0.0 113.742 178.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 338' ' ' CYS . . . . . 0.918 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 26.3 p -130.54 150.39 51.76 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.402 -176.277 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -67.17 123.93 21.67 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.444 170.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 340' ' ' ILE . . . . . 0.426 HG12 HG13 ' A' ' 342' ' ' VAL . 19.2 tt -94.64 117.73 66.93 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.155 -176.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -70.37 82.29 0.89 Allowed 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.513 2.142 . . . . 0.0 112.042 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.668 HG12 HG13 ' A' ' 385' ' ' VAL . 11.4 m -102.31 115.4 44.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.468 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.4 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 36.1 ptt180 -130.34 178.13 6.82 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.044 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 344' ' ' ALA . . . . . 0.469 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -151.21 148.85 28.73 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.89 177.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.414 ' O ' HG23 ' A' ' 382' ' ' ILE . 14.7 m -121.57 146.86 25.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -70.17 119.19 13.99 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 177.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 347' ' ' HIS . . . . . 0.661 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 68.8 t60 47.36 57.5 5.77 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 124.172 0.92 . . . . 0.0 111.457 174.063 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 348' ' ' GLY . . . . . 0.619 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 44.83 44.22 8.58 Favored Glycine 0 CA--C 1.521 0.413 0 N-CA-C 114.671 0.628 . . . . 0.0 114.671 -172.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 349' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 347' ' ' HIS . 57.4 t -139.82 102.23 7.05 Favored Pre-proline 0 C--O 1.234 0.271 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -76.36 64.19 7.18 Favored 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 123.06 2.507 . . . . 0.0 113.847 -175.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -100.52 -57.09 2.18 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 174.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 4.3 p -115.55 125.94 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.676 174.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 353' ' ' ASN . . . . . 0.462 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 39.5 t30 -62.89 108.89 1.29 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.57 174.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.509 ' HA ' HD22 ' A' ' 376' ' ' LEU . 27.6 m -86.81 0.97 6.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.078 -179.056 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 355' ' ' ALA . . . . . 0.469 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -76.88 84.32 3.45 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 121.476 0.655 . . . . 0.0 110.468 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 356' ' ' MET . . . . . 0.676 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 11.9 tpt -98.96 103.62 15.59 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 170.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.546 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 42.4 mt -86.2 119.64 26.7 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.177 -161.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.699 ' HB ' ' CB ' ' A' ' 373' ' ' GLU . 3.0 mm -64.77 -27.18 41.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 173.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 89.8 m -122.06 84.53 45.4 Favored Pre-proline 0 N--CA 1.449 -0.52 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.572 171.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -85.39 28.07 0.58 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.119 2.546 . . . . 0.0 113.65 -171.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 361' ' ' ASN . . . . . 0.443 ' N ' ' HD3' ' A' ' 362' ' ' PRO . 2.4 p-10 -148.59 55.0 1.91 Allowed Pre-proline 0 C--N 1.313 -0.99 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.488 177.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 362' ' ' PRO . . . . . 0.774 ' HB3' HG23 ' A' ' 372' ' ' ILE . 73.5 Cg_endo -85.08 162.53 11.61 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 121.884 1.723 . . . . 0.0 113.041 -179.101 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 363' ' ' THR . . . . . 0.669 ' O ' ' HA2' ' A' ' 369' ' ' GLY . 1.2 p -145.2 -172.7 3.92 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.89 -172.406 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 364' ' ' MET . . . . . 0.918 ' HG2' ' SG ' ' A' ' 338' ' ' CYS . 9.3 ptp -131.91 134.44 45.68 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 162.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -124.42 -164.51 1.27 Allowed 'General case' 0 C--N 1.319 -0.731 0 O-C-N 124.647 1.217 . . . . 0.0 110.164 -170.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -55.64 -10.58 0.71 Allowed 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -177.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 12.5 p-10 -126.76 1.03 6.73 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.909 0.385 . . . . 0.0 110.913 -175.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 368' ' ' GLY . . . . . 0.473 ' HA2' ' HB3' ' A' ' 332' ' ' PHE . . . 108.14 -178.5 21.36 Favored Glycine 0 N--CA 1.449 -0.468 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 -177.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 369' ' ' GLY . . . . . 0.669 ' HA2' ' O ' ' A' ' 363' ' ' THR . . . -47.53 -54.0 11.61 Favored Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.921 -0.657 . . . . 0.0 113.303 172.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 370' ' ' GLY . . . . . 0.596 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 89.26 -126.97 8.46 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.441 -0.885 . . . . 0.0 111.447 -176.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -101.76 131.74 47.89 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.708 0.29 . . . . 0.0 111.213 -175.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 372' ' ' ILE . . . . . 0.774 HG23 ' HB3' ' A' ' 362' ' ' PRO . 0.2 OUTLIER -131.03 166.1 29.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 173.698 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.828 ' HG2' HG12 ' A' ' 327' ' ' VAL . 24.1 mt-10 -133.97 132.64 40.4 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.363 0.601 . . . . 0.0 111.349 177.223 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 374' ' ' MET . . . . . 0.589 ' HG2' HD11 ' A' ' 383' ' ' ILE . 0.0 OUTLIER -135.08 166.17 23.69 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 177.245 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 375' ' ' GLN . . . . . 0.676 ' O ' ' HB3' ' A' ' 356' ' ' MET . 2.5 tp60 175.93 176.0 0.26 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.345 0.521 . . . . 0.0 109.694 170.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 376' ' ' LEU . . . . . 1.002 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 9.4 tp -166.18 175.36 2.32 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 103.498 -2.779 . . . . 0.0 103.498 177.275 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 377' ' ' PRO . . . . . 1.002 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 58.2 Cg_exo -40.87 130.36 2.83 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 CA-C-N 121.789 1.675 . . . . 0.0 111.882 167.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.473 ' HD2' ' HA ' ' A' ' 377' ' ' PRO . 5.1 Cg_exo -41.05 146.98 0.31 Allowed 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 124.018 3.145 . . . . 0.0 112.207 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 145.34 -168.39 27.21 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.18 -1.01 . . . . 0.0 110.83 -163.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 380' ' ' ASP . . . . . 0.661 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 3.1 m-20 -88.35 119.81 29.13 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 117.134 0.467 . . . . 0.0 110.026 -178.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.428 HD22 ' HG2' ' A' ' 394' ' ' GLN . 26.2 m-80 -132.99 144.64 50.23 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 1.044 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -143.86 137.04 24.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.218 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 383' ' ' ILE . . . . . 0.698 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 44.1 mt -97.96 127.7 50.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.506 -175.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 384' ' ' TYR . . . . . 0.523 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.2 OUTLIER -104.64 91.73 3.99 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 114.322 -1.308 . . . . 0.0 108.426 173.475 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 385' ' ' VAL . . . . . 0.668 HG13 HG12 ' A' ' 342' ' ' VAL . 17.7 t -84.23 89.44 2.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 64.23 -110.35 3.39 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 120.278 -0.963 . . . . 0.0 110.725 -170.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -94.22 -9.13 37.22 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.867 0.334 . . . . 0.0 111.366 172.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 388' ' ' LEU . . . . . 0.583 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 3.1 mp -66.75 153.35 43.51 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 174.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 389' ' ' ASN . . . . . 0.698 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 9.0 p30 -164.06 156.51 17.28 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.927 177.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 390' ' ' HIS . . . . . 0.628 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 23.4 t-80 -174.75 117.83 0.19 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.924 172.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 391' ' ' GLN . . . . . 1.044 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 22.5 tm0? -79.08 154.35 29.47 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.11 0.481 . . . . 0.0 110.978 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 392' ' ' TRP . . . . . 0.499 ' HD1' ' OE1' ' A' ' 394' ' ' GLN . 6.6 t-105 -166.73 150.93 7.21 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.111 -0.95 . . . . 0.0 108.51 -178.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -105.93 119.67 39.77 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.569 HE22 HG13 ' A' ' 326' ' ' VAL . 3.8 mm100 -85.67 113.22 21.71 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -173.004 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.753 ' H ' ' HD3' ' A' ' 395' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.131 -0.938 . . . . 0.0 111.285 -178.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 303' ' ' THR . . . . . 0.403 HG23 ' O ' ' A' ' 303' ' ' THR . 4.5 t . . . . . 0 N--CA 1.445 -0.696 0 CA-C-O 121.532 0.682 . . . . 0.0 110.664 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 304' ' ' TYR . . . . . 0.615 ' HB3' ' HE ' ' A' ' 336' ' ' ARG . 5.2 p90 -74.46 127.31 32.74 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 171.44 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' A' ' 304' ' ' TYR . 11.6 t 172.82 -169.83 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -173.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 37.2 t -66.78 112.83 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 169.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 307' ' ' CYS . . . . . 0.459 ' HB3' HG21 ' A' ' 335' ' ' THR . 0.1 OUTLIER -67.81 141.02 56.63 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.436 -171.976 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 308' ' ' ASP . . . . . 0.561 ' HB3' ' HG3' ' A' ' 311' ' ' LYS . 10.4 t0 -59.33 124.45 20.05 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.044 -176.511 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -40.7 -29.85 0.1 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.101 -1.408 . . . . 0.0 114.418 -177.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 11.4 t -107.08 1.41 24.22 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.348 0.594 . . . . 0.0 111.123 -170.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.561 ' HG3' ' HB3' ' A' ' 308' ' ' ASP . 49.2 mtpt -90.36 43.85 1.17 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.534 0.683 . . . . 0.0 110.079 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.691 ' HB3' HD13 ' A' ' 388' ' ' LEU . 0.3 OUTLIER -140.7 157.14 45.87 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.635 -168.464 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 15.0 p -144.72 152.83 40.98 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.967 175.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 314' ' ' TRP . . . . . 0.61 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 20.1 m-90 -79.94 94.51 5.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.97 0.414 . . . . 0.0 110.231 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 18.8 tttm -71.24 -42.59 68.66 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.167 173.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 41.0 ttm105 -154.99 98.56 2.04 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.105 173.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -41.91 152.07 0.31 Allowed Pre-proline 0 N--CA 1.472 0.662 0 C-N-CA 123.695 0.798 . . . . 0.0 112.441 174.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 318' ' ' PRO . . . . . 0.483 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 1.0 OUTLIER -44.24 117.11 1.21 Allowed 'Trans proline' 0 C--N 1.365 1.443 0 C-N-CA 123.083 2.522 . . . . 0.0 113.099 -174.292 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 10.1 m -133.41 144.15 49.35 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.004 -174.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -59.1 129.64 43.11 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.625 0.25 . . . . 0.0 110.566 177.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 321' ' ' SER . . . . . 0.734 ' HB3' HG13 ' A' ' 327' ' ' VAL . 59.6 p -77.96 6.73 7.17 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.513 0.725 . . . . 0.0 111.771 -174.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 81.7 -16.75 18.27 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.649 -0.786 . . . . 0.0 113.039 -170.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 20.7 m80 -98.34 7.61 45.98 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 117.19 0.495 . . . . 0.0 111.217 -177.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 72.33 49.66 0.21 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.947 0.88 . . . . 0.0 109.233 -177.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 325' ' ' THR . . . . . 0.699 ' HA ' HE21 ' A' ' 375' ' ' GLN . 4.5 p -157.99 163.92 37.31 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 -177.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -111.0 132.63 58.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 119.755 1.161 . . . . 0.0 112.619 -172.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 327' ' ' VAL . . . . . 0.847 HG12 ' HG2' ' A' ' 373' ' ' GLU . 15.4 m -115.2 163.98 11.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.878 174.216 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 10.1 ptm -153.33 152.25 30.9 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 172.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -114.1 135.31 54.16 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.571 HG23 ' HA3' ' A' ' 369' ' ' GLY . 3.1 m -132.94 146.66 32.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 C-N-CA 120.366 -0.534 . . . . 0.0 112.275 -178.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 331' ' ' GLY . . . . . 0.592 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -118.66 134.6 10.97 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.241 -0.98 . . . . 0.0 112.062 -179.189 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 332' ' ' PHE . . . . . 0.763 ' HB3' ' SD ' ' A' ' 364' ' ' MET . 0.1 OUTLIER -89.56 157.65 17.97 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -177.112 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 36.0 t -71.11 -33.36 70.08 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 112.658 -2.064 . . . . 0.0 112.29 169.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 168.62 -17.89 0.07 OUTLIER Glycine 0 CA--C 1.526 0.776 0 C-N-CA 119.62 -1.276 . . . . 0.0 114.689 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 335' ' ' THR . . . . . 0.488 ' O ' ' HD2' ' A' ' 332' ' ' PHE . 25.8 m -54.62 120.09 6.21 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.699 0.25 . . . . 0.0 110.889 176.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.694 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 9.2 ptt180 -75.46 -176.53 0.58 Allowed Pre-proline 0 N--CA 1.467 0.38 0 CA-C-O 117.62 -1.181 . . . . 0.0 108.85 -172.101 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.83 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.1 OUTLIER -26.67 95.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 123.693 2.929 . . . . 0.0 113.379 177.072 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 338' ' ' CYS . . . . . 0.69 ' SG ' ' HE2' ' A' ' 364' ' ' MET . 13.7 p -115.7 -175.44 2.72 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 113.656 -1.611 . . . . 0.0 110.89 -167.291 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -110.61 100.42 9.21 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 340' ' ' ILE . . . . . 0.901 HG22 HG13 ' A' ' 342' ' ' VAL . 24.8 mt -74.8 116.53 54.59 Favored Pre-proline 0 C--N 1.324 -0.531 0 C-N-CA 120.057 -0.657 . . . . 0.0 110.836 -169.11 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.76 81.65 2.71 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.47 2.114 . . . . 0.0 110.992 177.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.901 HG13 HG22 ' A' ' 340' ' ' ILE . 4.1 m -103.26 134.09 45.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.989 0.899 . . . . 0.0 111.459 -178.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.657 ' HG3' ' HB2' ' A' ' 384' ' ' TYR . 20.8 ptt180 -140.51 176.93 8.38 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 113.899 -1.5 . . . . 0.0 107.734 174.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 344' ' ' ALA . . . . . 0.599 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -144.57 144.99 31.58 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 120.546 -0.462 . . . . 0.0 109.903 172.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.511 HG22 HD12 ' A' ' 382' ' ' ILE . 11.6 m -119.07 144.98 25.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.1 119.19 10.36 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 177.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 347' ' ' HIS . . . . . 0.755 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 81.3 t60 46.92 63.84 1.78 Allowed 'General case' 0 N--CA 1.468 0.461 0 O-C-N 124.337 1.023 . . . . 0.0 112.015 170.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 348' ' ' GLY . . . . . 0.559 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 43.19 42.01 5.17 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 114.926 0.73 . . . . 0.0 114.926 -174.266 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 349' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 347' ' ' HIS . 65.3 t -142.38 103.23 5.52 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 117.792 0.796 . . . . 0.0 108.928 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 350' ' ' PRO . . . . . 0.435 ' HA ' ' HB ' ' A' ' 345' ' ' VAL . 16.1 Cg_exo -72.26 51.8 1.8 Allowed 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.872 2.381 . . . . 0.0 113.073 178.49 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -103.06 -7.59 21.25 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -178.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 2.4 p -170.72 110.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.065 -169.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 353' ' ' ASN . . . . . 0.528 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 50.7 t30 -65.25 108.87 2.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.247 177.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.486 ' CG1' HD22 ' A' ' 376' ' ' LEU . 27.7 m -91.13 0.88 8.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.438 178.095 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 355' ' ' ALA . . . . . 0.599 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -74.44 83.3 1.96 Allowed 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.098 0.475 . . . . 0.0 111.459 -176.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 356' ' ' MET . . . . . 0.546 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 35.4 ttm -95.36 98.64 10.72 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 168.14 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.691 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 18.8 mt -80.32 141.65 35.25 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.323 -162.286 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.761 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 4.2 mm -80.45 -25.28 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 178.275 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 7.9 m -140.34 97.94 7.5 Favored Pre-proline 0 N--CA 1.445 -0.71 0 CA-C-N 113.513 -1.676 . . . . 0.0 108.797 175.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -85.83 34.42 0.48 Allowed 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.968 2.445 . . . . 0.0 112.808 -175.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -142.8 64.23 14.81 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.434 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 362' ' ' PRO . . . . . 0.535 ' HG3' ' CG2' ' A' ' 342' ' ' VAL . 90.2 Cg_endo -80.9 143.17 14.38 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.355 2.037 . . . . 0.0 111.481 178.163 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 363' ' ' THR . . . . . 0.51 HG23 ' O ' ' A' ' 338' ' ' CYS . 0.8 OUTLIER -143.47 148.94 36.83 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -174.611 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 364' ' ' MET . . . . . 0.83 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 37.1 mtm -101.2 141.21 34.41 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.036 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -134.84 -166.11 1.77 Allowed 'General case' 0 C--N 1.322 -0.627 0 O-C-N 125.095 1.497 . . . . 0.0 110.529 -177.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 23.4 p-10 -41.91 -27.36 0.12 Allowed 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -111.81 -1.26 15.63 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.718 -0.614 . . . . 0.0 111.416 -177.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 368' ' ' GLY . . . . . 0.592 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . 112.31 -165.14 12.04 Favored Glycine 0 N--CA 1.451 -0.317 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -173.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 369' ' ' GLY . . . . . 0.571 ' HA3' HG23 ' A' ' 330' ' ' VAL . . . -64.15 108.31 2.2 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 170.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -71.5 -31.2 65.8 Favored Glycine 0 C--N 1.313 -0.699 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.907 -169.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -164.74 141.68 6.15 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.051 0.453 . . . . 0.0 110.813 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 372' ' ' ILE . . . . . 0.844 HD13 HG11 ' A' ' 342' ' ' VAL . 1.7 mt -133.61 144.57 35.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 171.09 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.847 ' HG2' HG12 ' A' ' 327' ' ' VAL . 40.0 mt-10 -129.24 125.05 36.03 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.494 -0.482 . . . . 0.0 109.981 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 374' ' ' MET . . . . . 0.691 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 0.0 OUTLIER -140.31 161.45 37.65 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.008 -175.54 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 375' ' ' GLN . . . . . 0.699 HE21 ' HA ' ' A' ' 325' ' ' THR . 4.6 tp-100 -178.52 175.28 1.14 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 174.49 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 376' ' ' LEU . . . . . 0.838 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 10.8 tp -166.56 157.05 10.81 Favored Pre-proline 0 N--CA 1.444 -0.77 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 377' ' ' PRO . . . . . 0.838 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 82.7 Cg_exo -42.39 132.08 4.99 Favored 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 121.828 1.685 . . . . 0.0 111.008 168.284 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.489 ' HA ' ' OE1' ' A' ' 394' ' ' GLN . 5.8 Cg_exo -35.74 139.84 0.13 Allowed 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 124.935 3.757 . . . . 0.0 113.75 -173.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 154.72 -165.08 31.94 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -162.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 380' ' ' ASP . . . . . 0.755 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 11.8 m-20 -102.91 129.08 49.5 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 117.881 0.841 . . . . 0.0 110.634 177.264 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -125.71 166.4 16.84 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 176.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 0.98 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -159.66 140.59 4.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 168.886 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 383' ' ' ILE . . . . . 0.488 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 24.3 mt -96.76 135.39 31.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.919 -175.189 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 384' ' ' TYR . . . . . 0.657 ' HB2' ' HG3' ' A' ' 343' ' ' ARG . 3.4 m-85 -105.11 129.34 53.54 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 167.216 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 6.1 t -117.56 82.22 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 65.51 -108.8 2.53 Favored Glycine 0 N--CA 1.431 -1.646 0 C-N-CA 120.001 -1.095 . . . . 0.0 110.51 -161.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -93.77 -10.71 33.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.652 0.226 . . . . 0.0 111.543 176.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 388' ' ' LEU . . . . . 0.691 HD13 ' HB3' ' A' ' 312' ' ' PHE . 1.1 tp -65.22 146.87 54.39 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 389' ' ' ASN . . . . . 0.488 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 27.5 p-10 -157.07 147.71 21.45 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.595 0.236 . . . . 0.0 111.077 178.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 390' ' ' HIS . . . . . 0.483 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 33.3 t-80 -172.62 122.33 0.43 Allowed 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.724 176.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 391' ' ' GLN . . . . . 0.98 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 40.9 tt0 -79.2 151.37 31.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.333 0.587 . . . . 0.0 112.367 -173.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 392' ' ' TRP . . . . . . . . . . . . . 43.6 t-105 -148.48 132.54 17.25 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.792 -1.094 . . . . 0.0 109.31 177.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -99.45 109.18 21.77 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.489 ' OE1' ' HA ' ' A' ' 378' ' ' PRO . 2.2 pp0? -97.8 127.19 43.57 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.303 0.573 . . . . 0.0 110.502 -170.05 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.777 -178.382 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 303' ' ' THR . . . . . 0.532 HG23 HG23 ' A' ' 335' ' ' THR . 7.1 t . . . . . 0 N--CA 1.451 -0.407 0 CA-C-O 121.159 0.504 . . . . 0.0 111.691 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 304' ' ' TYR . . . . . 0.722 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 30.9 p90 -67.09 119.65 12.37 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.307 -0.557 . . . . 0.0 109.794 175.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.443 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 12.3 t 176.23 -167.67 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -171.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 23.1 t -64.73 108.21 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 169.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.71 140.8 51.52 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.732 -169.26 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 308' ' ' ASP . . . . . 0.591 ' OD2' HG22 ' A' ' 310' ' ' THR . 20.3 t70 -66.85 128.34 35.94 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.442 0.639 . . . . 0.0 111.567 -176.413 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.56 ' HD3' ' HB2' ' A' ' 387' ' ' ASP . 0.0 OUTLIER -42.48 -22.44 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 115.954 1.835 . . . . 0.0 115.954 -173.867 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.591 HG22 ' OD2' ' A' ' 308' ' ' ASP . 11.7 t -105.54 -3.81 21.96 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 118.976 0.807 . . . . 0.0 111.62 -170.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.407 ' HB3' ' HE2' ' A' ' 311' ' ' LYS . 10.4 mmmm -67.97 -24.74 65.18 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.873 -177.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.671 ' HE1' ' H ' ' A' ' 369' ' ' GLY . 2.1 m-85 -81.16 173.04 12.93 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 122.01 0.91 . . . . 0.0 113.313 -176.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 313' ' ' THR . . . . . 0.528 HG22 ' O ' ' A' ' 331' ' ' GLY . 14.2 t -148.58 155.21 40.8 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 113.878 -1.51 . . . . 0.0 108.718 177.121 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 11.6 m-90 -79.23 93.8 5.31 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.17 0.51 . . . . 0.0 110.115 -178.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.577 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 59.6 tttm -76.97 -55.09 5.76 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.186 172.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -142.04 126.21 17.45 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 176.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -69.12 158.04 87.64 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-O 119.14 -0.457 . . . . 0.0 110.286 178.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 318' ' ' PRO . . . . . 0.537 ' HG3' HD12 ' A' ' 383' ' ' ILE . 87.2 Cg_exo -40.16 117.66 0.47 Allowed 'Trans proline' 0 C--N 1.36 1.152 0 C-N-CA 122.458 2.105 . . . . 0.0 111.997 174.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 13.6 m -136.13 140.56 43.76 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.801 -174.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 320' ' ' ASP . . . . . 0.409 ' HA ' ' O ' ' A' ' 325' ' ' THR . 7.0 t70 -55.53 126.95 27.47 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.147 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 321' ' ' SER . . . . . 0.512 ' HB3' HG13 ' A' ' 327' ' ' VAL . 33.5 p -87.1 10.9 15.23 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.644 0.259 . . . . 0.0 111.447 -172.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 85.6 -31.37 3.91 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.53 -173.095 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 58.7 m-70 -87.06 28.31 0.93 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.82 0.31 . . . . 0.0 111.61 -176.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 48.65 50.62 16.9 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.877 0.846 . . . . 0.0 109.884 -172.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 325' ' ' THR . . . . . 0.532 ' HB ' HG13 ' A' ' 358' ' ' ILE . 11.6 p -154.34 177.14 11.48 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 -175.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -123.16 142.5 39.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 119.536 1.062 . . . . 0.0 112.18 -174.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 327' ' ' VAL . . . . . 0.636 HG12 ' HG2' ' A' ' 373' ' ' GLU . 3.7 m -124.77 147.65 29.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.897 172.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 328' ' ' MET . . . . . 0.573 ' CE ' HD12 ' A' ' 372' ' ' ILE . 16.5 ptt? -130.84 156.58 44.78 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 173.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.621 ' HA ' ' O ' ' A' ' 370' ' ' GLY . 7.9 tt0 -124.19 125.91 45.23 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.581 HG11 HG21 ' A' ' 385' ' ' VAL . 15.7 m -126.5 143.58 39.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.416 -174.322 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 331' ' ' GLY . . . . . 0.587 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -122.74 135.97 10.41 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.692 -176.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 332' ' ' PHE . . . . . 0.512 ' HD1' ' H ' ' A' ' 332' ' ' PHE . 0.2 OUTLIER -90.62 155.74 18.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 122.058 0.933 . . . . 0.0 113.122 -177.374 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 30.4 t -78.72 -37.52 41.26 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 113.862 -1.517 . . . . 0.0 112.948 171.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -173.69 -25.75 0.03 OUTLIER Glycine 0 CA--C 1.526 0.727 0 C-N-CA 118.651 -1.737 . . . . 0.0 115.405 -178.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 335' ' ' THR . . . . . 0.701 ' HB ' ' SD ' ' A' ' 364' ' ' MET . 25.9 m -52.7 127.27 22.57 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.699 0.285 . . . . 0.0 110.385 176.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.75 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 2.2 ptm180 -87.72 -179.26 1.28 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 117.378 -1.296 . . . . 0.0 108.491 -174.317 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.75 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -26.46 98.35 0.02 OUTLIER 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 123.862 3.041 . . . . 0.0 114.115 -175.137 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 338' ' ' CYS . . . . . 0.769 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 1.8 p -109.84 -176.55 3.03 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 113.6 -1.636 . . . . 0.0 110.136 -171.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 339' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 339' ' ' ARG . 3.5 mpt_? -109.4 100.51 9.59 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 175.381 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 340' ' ' ILE . . . . . 0.889 HG22 HG13 ' A' ' 342' ' ' VAL . 29.9 mt -74.82 114.38 33.98 Favored Pre-proline 0 C--N 1.329 -0.315 0 C-N-CA 120.069 -0.653 . . . . 0.0 111.307 -167.191 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -79.51 81.46 2.78 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.499 2.132 . . . . 0.0 111.309 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.889 HG13 HG22 ' A' ' 340' ' ' ILE . 4.1 m -103.08 128.33 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-O 121.508 0.671 . . . . 0.0 110.651 -178.095 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -140.74 175.77 9.34 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 174.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 344' ' ' ALA . . . . . 0.554 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -147.89 149.82 32.97 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.064 -0.654 . . . . 0.0 111.334 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 11.0 m -118.86 146.62 23.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 176.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.425 ' HB2' ' CG1' ' A' ' 354' ' ' VAL . . . -70.11 117.73 12.05 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 177.231 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 347' ' ' HIS . . . . . 0.903 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 15.3 t-80 48.31 62.18 2.65 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 124.166 0.916 . . . . 0.0 112.007 173.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 348' ' ' GLY . . . . . 0.772 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 43.35 40.08 4.54 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.963 -0.637 . . . . 0.0 114.507 -173.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 349' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 347' ' ' HIS . 94.9 t -138.13 101.58 8.43 Favored Pre-proline 0 C--O 1.235 0.319 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -72.04 68.88 3.17 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.593 2.196 . . . . 0.0 112.357 178.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -99.85 -56.35 2.41 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 176.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 5.3 p -128.88 136.9 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.264 172.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 353' ' ' ASN . . . . . 0.554 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 35.0 t30 -62.18 110.58 1.66 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.905 174.04 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.516 ' CG1' HD22 ' A' ' 376' ' ' LEU . 27.7 m -88.36 3.04 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.346 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -75.14 82.29 2.31 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.312 0.577 . . . . 0.0 110.771 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 356' ' ' MET . . . . . 0.554 ' HB2' ' O ' ' A' ' 375' ' ' GLN . 62.5 mtt -98.19 99.67 10.92 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 168.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.631 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 34.5 mt -82.1 141.48 33.1 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.052 -162.395 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.719 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 4.1 mm -83.64 -21.53 8.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 178.036 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 6.6 m -141.39 96.97 6.89 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 113.828 -1.533 . . . . 0.0 108.673 171.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 360' ' ' PRO . . . . . 0.457 ' HA ' HD12 ' A' ' 357' ' ' LEU . 91.5 Cg_endo -89.05 39.89 0.48 Allowed 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 123.136 2.557 . . . . 0.0 114.259 -170.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 20.8 p-10 -156.85 72.78 4.7 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-O 121.406 0.622 . . . . 0.0 111.234 176.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 362' ' ' PRO . . . . . 0.746 ' HG2' ' HB ' ' A' ' 340' ' ' ILE . 83.2 Cg_endo -85.08 154.31 11.11 Favored 'Trans proline' 0 C--O 1.243 0.731 0 C-N-CA 122.788 2.325 . . . . 0.0 113.029 176.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 1.8 p -143.98 141.12 30.0 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.054 -176.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 364' ' ' MET . . . . . 0.769 ' HG2' ' SG ' ' A' ' 338' ' ' CYS . 10.7 ptp -94.83 130.87 41.22 Favored 'General case' 0 CA--C 1.5 -0.98 0 C-N-CA 119.578 -0.849 . . . . 0.0 108.785 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -126.82 -166.76 1.63 Allowed 'General case' 0 C--N 1.322 -0.616 0 O-C-N 124.824 1.327 . . . . 0.0 111.777 -171.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 27.4 p-10 -42.99 -30.95 0.46 Allowed 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -178.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -116.66 3.11 13.05 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 121.846 -0.534 . . . . 0.0 112.188 -175.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 368' ' ' GLY . . . . . 0.587 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . 122.87 -176.88 16.59 Favored Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -177.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 369' ' ' GLY . . . . . 0.767 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -57.98 -32.46 66.64 Favored Glycine 0 CA--C 1.506 -0.53 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.835 173.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 370' ' ' GLY . . . . . 0.621 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 82.78 -131.36 10.32 Favored Glycine 0 N--CA 1.435 -1.379 0 C-N-CA 120.029 -1.081 . . . . 0.0 111.081 -177.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -103.46 137.66 41.25 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.336 0.589 . . . . 0.0 111.558 -175.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 372' ' ' ILE . . . . . 0.679 HG23 ' HB3' ' A' ' 362' ' ' PRO . 0.8 OUTLIER -130.41 150.33 34.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.366 176.73 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.719 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 38.4 mt-10 -116.62 127.08 54.13 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.513 -175.293 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 374' ' ' MET . . . . . 0.87 ' HG2' HD11 ' A' ' 383' ' ' ILE . 4.1 ppp? -139.38 160.51 39.67 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.153 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 375' ' ' GLN . . . . . 0.554 ' O ' ' HB2' ' A' ' 356' ' ' MET . 2.4 tp60 -176.44 174.54 1.91 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.95 0.405 . . . . 0.0 110.89 174.346 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 376' ' ' LEU . . . . . 0.874 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 6.6 tp -165.17 158.74 14.18 Favored Pre-proline 0 N--CA 1.445 -0.676 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 377' ' ' PRO . . . . . 0.874 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 66.4 Cg_exo -40.97 129.34 2.89 Favored 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 121.77 1.647 . . . . 0.0 111.259 167.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.503 ' HD2' ' HA ' ' A' ' 377' ' ' PRO . 2.7 Cg_exo -35.8 140.75 0.12 Allowed 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 124.948 3.765 . . . . 0.0 113.502 -174.171 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 151.45 -161.77 29.31 Favored Glycine 0 N--CA 1.442 -0.935 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -162.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 380' ' ' ASP . . . . . 0.903 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 5.3 m-20 -101.86 129.42 48.09 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 117.918 0.859 . . . . 0.0 110.877 177.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.427 ' HB3' ' HE3' ' A' ' 374' ' ' MET . 9.7 m120 -128.66 146.25 50.92 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 176.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 1.052 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -149.61 138.17 14.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 177.773 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 383' ' ' ILE . . . . . 0.87 HD11 ' HG2' ' A' ' 374' ' ' MET . 43.9 mt -101.63 135.66 37.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.693 -171.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -105.12 96.68 6.7 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.549 -1.205 . . . . 0.0 108.795 169.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 385' ' ' VAL . . . . . 0.581 HG21 HG11 ' A' ' 330' ' ' VAL . 2.3 t -80.36 79.2 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.778 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 174.155 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 65.93 -104.45 1.02 Allowed Glycine 0 N--CA 1.43 -1.753 0 C-N-CA 119.388 -1.387 . . . . 0.0 110.16 -163.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 387' ' ' ASP . . . . . 0.56 ' HB2' ' HD3' ' A' ' 309' ' ' LYS . 35.9 t70 -98.63 -12.15 21.39 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 175.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.69 107.91 4.76 Favored 'General case' 0 CA--C 1.511 -0.537 0 O-C-N 121.771 -0.581 . . . . 0.0 109.773 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 389' ' ' ASN . . . . . 0.452 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 5.8 p30 -114.17 144.05 43.82 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 -176.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 390' ' ' HIS . . . . . 0.404 ' CE1' ' HD3' ' A' ' 318' ' ' PRO . 0.3 OUTLIER -169.42 108.61 0.43 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.09 0.472 . . . . 0.0 111.286 -177.31 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 391' ' ' GLN . . . . . 1.052 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 19.6 tt0 -78.01 154.16 31.73 Favored 'General case' 0 C--N 1.345 0.407 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -172.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 392' ' ' TRP . . . . . . . . . . . . . 39.7 t-105 -154.71 148.43 25.43 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.321 177.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -107.25 119.16 38.64 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 173.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.455 ' OE1' ' HA ' ' A' ' 378' ' ' PRO . 2.2 pp0? -108.86 136.76 47.88 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.456 0.646 . . . . 0.0 111.857 -169.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 19.8 tptp . . . . . 0 C--O 1.247 0.936 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.988 175.528 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 303' ' ' THR . . . . . 0.534 ' O ' HG23 ' A' ' 335' ' ' THR . 6.1 t . . . . . 0 CA--C 1.536 0.441 0 CA-C-O 120.908 0.385 . . . . 0.0 111.613 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 304' ' ' TYR . . . . . 0.438 ' O ' ' HB ' ' A' ' 305' ' ' THR . 5.3 p90 -59.38 132.47 54.11 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.077 177.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.47 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 15.2 t 172.5 -167.68 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -172.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 64.7 t -62.19 114.23 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 171.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 307' ' ' CYS . . . . . 0.616 ' HB3' ' HE1' ' A' ' 364' ' ' MET . 0.1 OUTLIER -69.03 135.18 50.46 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.146 0.498 . . . . 0.0 111.753 -172.193 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 308' ' ' ASP . . . . . 0.451 ' HB3' ' NZ ' ' A' ' 311' ' ' LYS . 22.4 t70 -55.29 111.58 0.9 Allowed 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.475 175.222 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.555 ' HD3' ' HB2' ' A' ' 387' ' ' ASP . 0.0 OUTLIER -40.77 -24.36 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 115.845 1.795 . . . . 0.0 115.845 -169.189 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.531 ' N ' ' HD2' ' A' ' 309' ' ' LYS . 11.7 t -98.71 -4.14 34.27 Favored 'General case' 0 C--N 1.314 -0.96 0 O-C-N 121.677 -0.639 . . . . 0.0 111.773 -171.161 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.676 ' HE3' ' H ' ' A' ' 335' ' ' THR . 29.0 mtmm -84.87 48.56 1.57 Allowed 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 120.936 0.398 . . . . 0.0 111.081 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.533 ' CD1' ' HB ' ' A' ' 330' ' ' VAL . 4.9 m-85 -139.65 153.82 47.4 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.662 -178.173 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 22.7 p -138.18 149.19 45.6 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.17 177.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 8.4 m-90 -67.7 116.12 8.04 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.471 0.653 . . . . 0.0 110.217 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.458 ' HB3' ' C ' ' A' ' 329' ' ' GLU . 53.2 tptt -96.69 -57.45 2.29 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 172.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 316' ' ' ARG . 27.2 ttm-85 -139.04 114.81 9.99 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.631 -1.168 . . . . 0.0 108.298 172.136 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 317' ' ' ALA . . . . . 0.489 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -68.21 160.8 73.3 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -178.509 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 318' ' ' PRO . . . . . 0.619 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 3.8 Cg_exo -43.06 110.96 0.19 Allowed 'Trans proline' 0 C--N 1.358 1.058 0 C-N-CA 122.237 1.958 . . . . 0.0 112.875 -175.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 31.1 m -127.07 128.76 46.77 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.266 -174.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -55.69 120.35 7.14 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 321' ' ' SER . . . . . 0.489 ' HA ' HG22 ' A' ' 327' ' ' VAL . 82.9 p -47.74 -54.26 12.74 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.205 0.602 . . . . 0.0 111.053 -169.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 141.47 -17.04 2.67 Favored Glycine 0 N--CA 1.443 -0.86 0 CA-C-N 114.909 -1.042 . . . . 0.0 111.532 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 323' ' ' HIS . . . . . 0.56 ' O ' ' HB2' ' A' ' 324' ' ' ASP . 7.1 t-80 -122.73 23.94 9.29 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 120.722 0.296 . . . . 0.0 110.585 -179.259 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 324' ' ' ASP . . . . . 0.56 ' HB2' ' O ' ' A' ' 323' ' ' HIS . 5.6 m-20 92.69 45.94 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.122 0.969 . . . . 0.0 111.751 169.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 325' ' ' THR . . . . . 0.676 ' HA ' ' HG2' ' A' ' 375' ' ' GLN . 1.8 p -154.55 -167.1 2.51 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 174.313 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.956 HG21 ' HZ2' ' A' ' 392' ' ' TRP . 3.0 t -134.38 142.13 41.64 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.395 0 CA-C-N 119.477 1.035 . . . . 0.0 111.855 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 327' ' ' VAL . . . . . 0.804 HG12 ' HG2' ' A' ' 373' ' ' GLU . 17.4 m -119.02 156.32 21.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.882 174.074 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.02 150.48 34.03 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.458 ' C ' ' HB3' ' A' ' 315' ' ' LYS . 24.5 tt0 -132.99 132.5 41.97 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -175.066 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.696 HG11 HG11 ' A' ' 385' ' ' VAL . 0.0 OUTLIER -130.02 150.82 35.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -176.17 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 331' ' ' GLY . . . . . 0.52 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -120.72 134.52 10.31 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.052 176.576 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -103.83 174.65 5.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.142 0.471 . . . . 0.0 111.092 -179.509 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 30.2 m -148.66 49.37 1.01 Allowed 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 170.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -177.05 -88.35 0.07 OUTLIER Glycine 0 C--N 1.339 0.703 0 C-N-CA 119.794 -1.193 . . . . 0.0 113.925 168.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 335' ' ' THR . . . . . 0.676 ' H ' ' HE3' ' A' ' 311' ' ' LYS . 50.3 m -51.3 130.62 27.23 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 114.701 -0.75 . . . . 0.0 110.324 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.802 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 8.1 ptm180 -79.1 -176.01 0.65 Allowed Pre-proline 0 CA--C 1.533 0.322 0 CA-C-O 117.633 -1.175 . . . . 0.0 108.986 -174.024 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.802 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -24.79 103.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 123.955 3.103 . . . . 0.0 114.045 -177.479 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 338' ' ' CYS . . . . . 0.723 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 8.9 p -111.42 -174.95 2.58 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 113.587 -1.642 . . . . 0.0 111.023 -168.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -107.89 96.51 6.43 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 177.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 340' ' ' ILE . . . . . 0.849 HG22 HG13 ' A' ' 342' ' ' VAL . 27.3 mt -74.08 120.41 81.2 Favored Pre-proline 0 C--N 1.327 -0.387 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.185 -166.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -81.25 80.69 2.9 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 122.295 1.996 . . . . 0.0 111.057 175.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.849 HG13 HG22 ' A' ' 340' ' ' ILE . 6.7 m -100.13 123.5 53.02 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.024 0 CA-C-O 121.986 0.898 . . . . 0.0 109.837 176.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.516 ' HG3' ' HB2' ' A' ' 384' ' ' TYR . 24.3 ptt180 -132.94 173.05 11.81 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.324 -1.307 . . . . 0.0 107.748 176.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 344' ' ' ALA . . . . . 0.553 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -143.27 141.09 30.92 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 173.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 17.5 m -115.83 145.27 21.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -63.91 115.83 5.24 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.005 177.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 347' ' ' HIS . . . . . 0.595 ' HB3' ' CB ' ' A' ' 380' ' ' ASP . 23.8 p80 35.79 71.11 0.13 Allowed 'General case' 0 N--CA 1.475 0.793 0 O-C-N 124.53 1.144 . . . . 0.0 112.601 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 348' ' ' GLY . . . . . 0.826 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 41.99 47.15 5.23 Favored Glycine 0 C--N 1.333 0.403 0 N-CA-C 115.191 0.836 . . . . 0.0 115.191 -175.512 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 349' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 347' ' ' HIS . 90.1 t -142.61 102.49 5.44 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 176.462 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -75.95 66.1 6.84 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.865 2.377 . . . . 0.0 112.781 -178.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -100.99 -55.97 2.43 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 177.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 7.4 p -124.96 133.18 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.45 171.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -64.82 112.49 3.28 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.333 177.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.529 ' HB ' HD22 ' A' ' 376' ' ' LEU . 32.7 m -89.98 1.8 7.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.917 178.058 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 355' ' ' ALA . . . . . 0.553 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -74.44 84.11 1.98 Allowed 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.181 0.515 . . . . 0.0 110.558 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 356' ' ' MET . . . . . 0.625 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 58.6 ttp -94.0 99.95 12.17 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 172.318 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.587 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 19.9 mt -85.34 115.45 23.1 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.494 -161.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.595 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 3.1 mm -59.18 -26.65 34.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.045 174.038 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 34.5 m -137.53 90.73 14.6 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.701 174.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -83.6 38.93 0.75 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.416 2.744 . . . . 0.0 113.461 -172.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -147.57 69.37 11.29 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.689 177.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 362' ' ' PRO . . . . . 0.784 ' HB3' HG23 ' A' ' 372' ' ' ILE . 63.0 Cg_endo -79.59 143.58 17.04 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.234 1.956 . . . . 0.0 111.825 176.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 363' ' ' THR . . . . . 0.416 ' O ' ' HA2' ' A' ' 369' ' ' GLY . 1.3 p -143.64 133.76 24.32 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.45 -173.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 364' ' ' MET . . . . . 0.723 ' HG2' ' SG ' ' A' ' 338' ' ' CYS . 19.2 ptt? -98.72 111.95 24.17 Favored 'General case' 0 CA--C 1.501 -0.928 0 C-N-CA 119.095 -1.042 . . . . 0.0 109.195 177.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.466 ' CD ' ' HG3' ' A' ' 337' ' ' PRO . 67.1 mm-40 -103.13 -163.74 1.02 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 113.029 -1.896 . . . . 0.0 109.947 -173.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -48.31 -22.84 0.75 Allowed 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -179.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -111.12 -2.58 15.78 Favored 'General case' 0 N--CA 1.463 0.182 0 O-C-N 121.795 -0.566 . . . . 0.0 111.273 -178.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 368' ' ' GLY . . . . . 0.52 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . 107.73 -167.19 13.38 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -172.272 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 369' ' ' GLY . . . . . 0.587 ' HA3' HG23 ' A' ' 330' ' ' VAL . . . -65.42 103.8 0.87 Allowed Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.736 -0.945 . . . . 0.0 110.736 170.22 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 370' ' ' GLY . . . . . 0.425 ' O ' ' HG3' ' A' ' 329' ' ' GLU . . . -72.41 -32.7 62.01 Favored Glycine 0 C--N 1.317 -0.514 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.518 -167.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -164.29 138.65 5.54 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 123.823 0.366 . . . . 0.0 110.458 179.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 372' ' ' ILE . . . . . 0.784 HG23 ' HB3' ' A' ' 362' ' ' PRO . 0.3 OUTLIER -137.63 156.14 31.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 171.063 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.804 ' HG2' HG12 ' A' ' 327' ' ' VAL . 43.1 mt-10 -134.62 125.53 27.36 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -178.291 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 374' ' ' MET . . . . . 0.587 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 2.4 mtt -142.94 164.51 29.89 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -174.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 375' ' ' GLN . . . . . 0.676 ' HG2' ' HA ' ' A' ' 325' ' ' THR . 1.5 tp60 177.97 179.08 0.32 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.132 0.423 . . . . 0.0 110.929 175.653 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 376' ' ' LEU . . . . . 0.916 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 14.2 tp -165.95 160.74 13.09 Favored Pre-proline 0 N--CA 1.446 -0.64 0 N-CA-C 104.867 -2.271 . . . . 0.0 104.867 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 377' ' ' PRO . . . . . 0.916 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 81.2 Cg_exo -44.54 131.09 9.6 Favored 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 121.502 1.468 . . . . 0.0 111.328 169.099 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.55 ' HA ' ' OE1' ' A' ' 394' ' ' GLN . 2.8 Cg_exo -37.03 138.86 0.22 Allowed 'Trans proline' 0 C--N 1.36 1.176 0 C-N-CA 124.607 3.538 . . . . 0.0 112.911 -175.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 152.66 -163.81 30.5 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 -162.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 380' ' ' ASP . . . . . 0.595 ' CB ' ' HB3' ' A' ' 347' ' ' HIS . 17.6 m-20 -98.86 122.59 42.29 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 117.468 0.634 . . . . 0.0 111.5 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.563 ' HB2' ' CH2' ' A' ' 392' ' ' TRP . 6.1 m120 -124.83 175.17 7.45 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 171.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 1.019 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -163.19 141.42 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 167.304 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 383' ' ' ILE . . . . . 0.653 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 45.9 mt -101.71 132.23 48.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 C-N-CA 119.674 -0.81 . . . . 0.0 110.456 -174.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 384' ' ' TYR . . . . . 0.555 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 1.9 m-85 -102.33 128.89 48.7 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.483 -1.235 . . . . 0.0 107.782 168.248 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 385' ' ' VAL . . . . . 0.696 HG11 HG11 ' A' ' 330' ' ' VAL . 15.2 t -118.48 77.15 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 63.16 -110.49 3.4 Favored Glycine 0 N--CA 1.43 -1.716 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.842 -161.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 387' ' ' ASP . . . . . 0.555 ' HB2' ' HD3' ' A' ' 309' ' ' LYS . 34.1 t70 -81.15 -20.31 41.6 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 177.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 388' ' ' LEU . . . . . 0.555 ' O ' ' HA ' ' A' ' 384' ' ' TYR . 1.2 mp -68.54 153.03 44.55 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.909 -0.317 . . . . 0.0 110.254 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 389' ' ' ASN . . . . . 0.653 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 5.0 p-10 -160.24 155.26 24.59 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.08 177.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 390' ' ' HIS . . . . . 0.619 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 42.0 t-80 -171.46 112.12 0.34 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.816 175.249 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 391' ' ' GLN . . . . . 1.019 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 15.3 tt0 -75.93 149.33 37.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.788 -178.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 392' ' ' TRP . . . . . 0.956 ' HZ2' HG21 ' A' ' 326' ' ' VAL . 0.1 OUTLIER -168.18 151.32 5.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.049 0.452 . . . . 0.0 110.142 -179.111 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -101.05 118.87 37.84 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 178.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.662 ' HB2' HE22 ' A' ' 375' ' ' GLN . 1.0 OUTLIER -95.64 131.81 41.48 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.308 -170.27 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.473 ' HD2' ' HA ' ' A' ' 395' ' ' LYS . 21.7 tptp . . . . . 0 C--O 1.252 1.223 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.281 178.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 303' ' ' THR . . . . . 0.63 HG23 HG23 ' A' ' 335' ' ' THR . 5.2 t . . . . . 0 CA--C 1.536 0.412 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 304' ' ' TYR . . . . . 0.546 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 25.9 p90 -64.21 127.85 33.22 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 175.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.408 HG23 ' O ' ' A' ' 306' ' ' VAL . 14.3 t 178.45 -167.13 0.06 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -170.439 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.408 ' O ' HG23 ' A' ' 305' ' ' THR . 34.3 t -65.06 114.34 2.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 165.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.37 139.0 57.17 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.346 0.593 . . . . 0.0 110.414 -170.376 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 308' ' ' ASP . . . . . 0.487 ' HB3' ' HG2' ' A' ' 311' ' ' LYS . 5.4 t70 -60.94 126.71 28.36 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.609 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.547 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -44.02 -13.61 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 -175.38 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.413 ' N ' ' HD2' ' A' ' 309' ' ' LYS . 12.5 t -108.07 0.46 21.73 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 119.39 0.996 . . . . 0.0 111.8 -176.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.487 ' HG2' ' HB3' ' A' ' 308' ' ' ASP . 29.6 mmmt -72.68 -33.06 66.26 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -175.525 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.808 ' HD1' HD13 ' A' ' 388' ' ' LEU . 0.6 OUTLIER -90.95 175.67 6.88 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 122.29 1.043 . . . . 0.0 112.798 -174.77 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 8.7 t -153.98 162.27 41.34 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 113.285 -1.78 . . . . 0.0 109.697 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 314' ' ' TRP . . . . . 0.638 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 24.0 m-90 -77.75 92.88 4.22 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -178.404 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -71.57 -43.04 67.03 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 171.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -154.02 124.4 7.0 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 171.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 317' ' ' ALA . . . . . 0.507 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -70.7 163.59 62.74 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 119.139 -0.458 . . . . 0.0 109.99 -177.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 318' ' ' PRO . . . . . 0.546 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 2.4 Cg_endo -46.19 113.5 0.63 Allowed 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 122.067 1.845 . . . . 0.0 112.281 -179.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 21.7 m -129.5 133.96 47.53 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.881 -172.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 320' ' ' ASP . . . . . 0.431 ' HA ' HG13 ' A' ' 326' ' ' VAL . 28.4 t70 -55.84 123.14 13.24 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -178.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 321' ' ' SER . . . . . 0.446 ' HB3' HG13 ' A' ' 327' ' ' VAL . 81.0 p -62.66 -47.78 82.18 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 121.339 0.59 . . . . 0.0 109.883 -174.072 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 120.27 -15.0 10.11 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -109.05 49.2 0.83 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.774 0.797 . . . . 0.0 108.974 177.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 50.67 41.12 25.52 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 114.647 -1.161 . . . . 0.0 112.597 -178.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 325' ' ' THR . . . . . 0.584 ' HA ' ' HG3' ' A' ' 375' ' ' GLN . 6.2 p -150.39 -173.42 4.45 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 175.267 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.893 HG23 ' HG2' ' A' ' 375' ' ' GLN . 1.5 t -133.75 146.0 32.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.94 -178.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 327' ' ' VAL . . . . . 0.761 HG12 ' HG2' ' A' ' 373' ' ' GLU . 20.6 m -123.6 155.86 30.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.774 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 328' ' ' MET . . . . . 0.492 ' CG ' HD12 ' A' ' 372' ' ' ILE . 0.0 OUTLIER -143.63 154.21 43.31 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 173.934 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -132.58 130.65 40.57 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.704 HG21 HD13 ' A' ' 340' ' ' ILE . 0.0 OUTLIER -118.54 162.21 16.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -179.231 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 331' ' ' GLY . . . . . 0.802 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -118.55 172.65 14.57 Favored Glycine 0 C--O 1.227 -0.341 0 C-N-CA 119.712 -1.232 . . . . 0.0 112.531 172.394 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 332' ' ' PHE . . . . . 0.794 ' HD1' ' HA2' ' A' ' 368' ' ' GLY . 0.9 OUTLIER -127.84 135.78 50.52 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 179.726 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 29.0 m -85.82 -21.01 28.32 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 176.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -171.53 -50.37 0.04 OUTLIER Glycine 0 C--N 1.335 0.518 0 C-N-CA 118.357 -1.878 . . . . 0.0 115.054 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 335' ' ' THR . . . . . 0.63 HG23 HG23 ' A' ' 303' ' ' THR . 65.8 m -49.59 129.74 19.69 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 123.892 0.407 . . . . 0.0 110.115 -178.2 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.639 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 1.0 OUTLIER -82.37 176.45 3.81 Favored Pre-proline 0 N--CA 1.451 -0.416 0 CA-C-O 117.366 -1.302 . . . . 0.0 107.631 -172.413 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.716 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.1 OUTLIER -25.25 98.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.363 1.342 0 C-N-CA 123.727 2.951 . . . . 0.0 114.053 -173.323 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 338' ' ' CYS . . . . . 0.704 ' SG ' ' HB2' ' A' ' 364' ' ' MET . 6.5 p -129.7 139.54 51.32 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 113.971 -1.468 . . . . 0.0 108.444 -171.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -65.6 124.54 22.64 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.395 -0.522 . . . . 0.0 109.706 177.101 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 340' ' ' ILE . . . . . 0.704 HD13 HG21 ' A' ' 330' ' ' VAL . 18.6 tt -98.45 118.72 62.94 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.273 -177.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.7 95.23 0.71 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.949 2.432 . . . . 0.0 112.336 -177.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.75 HG11 HD13 ' A' ' 372' ' ' ILE . 15.4 m -110.07 122.53 64.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.643 0.735 . . . . 0.0 110.812 179.048 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 14.6 ptt180 -133.5 -178.25 4.91 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 173.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 344' ' ' ALA . . . . . 0.5 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -147.03 147.81 31.04 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.629 177.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.592 HG22 HD12 ' A' ' 382' ' ' ILE . 4.8 m -118.94 142.47 33.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 177.053 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.469 ' HB2' HG11 ' A' ' 354' ' ' VAL . . . -65.48 127.67 32.78 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 177.117 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 347' ' ' HIS . . . . . 0.591 ' O ' HG23 ' A' ' 349' ' ' VAL . 35.2 t60 41.44 60.38 2.13 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 124.204 0.94 . . . . 0.0 112.038 174.192 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 348' ' ' GLY . . . . . 0.51 ' H ' ' CG2' ' A' ' 382' ' ' ILE . . . 44.85 38.62 5.85 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 115.035 0.774 . . . . 0.0 115.035 -175.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 349' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 347' ' ' HIS . 58.4 t -135.85 103.15 10.04 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 117.917 0.859 . . . . 0.0 108.863 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 350' ' ' PRO . . . . . 0.49 ' HA ' ' HB ' ' A' ' 345' ' ' VAL . 15.4 Cg_exo -72.65 62.12 3.71 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.861 2.374 . . . . 0.0 112.936 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -100.4 -55.2 2.67 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 7.7 p -124.83 133.76 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.456 174.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 353' ' ' ASN . . . . . 0.5 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 37.4 t30 -66.72 116.14 7.31 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.482 176.205 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.63 ' HB ' HD22 ' A' ' 376' ' ' LEU . 27.5 m -101.06 5.92 10.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.292 -176.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 355' ' ' ALA . . . . . 0.435 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -74.82 87.03 2.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.194 0.521 . . . . 0.0 112.027 -177.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.1 99.45 11.43 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 170.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 43.1 mt -87.37 121.82 30.32 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.607 -164.28 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.918 HD11 ' HB2' ' A' ' 375' ' ' GLN . 2.8 mm -63.25 -29.77 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.565 175.263 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 27.6 m -133.81 91.42 25.07 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.467 173.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -85.01 39.9 0.78 Allowed 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 123.518 2.812 . . . . 0.0 113.801 -170.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -158.4 70.74 3.86 Favored Pre-proline 0 C--N 1.319 -0.76 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.288 176.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 362' ' ' PRO . . . . . 0.478 ' HG3' HG21 ' A' ' 342' ' ' VAL . 97.8 Cg_endo -84.31 147.99 11.5 Favored 'Trans proline' 0 C--O 1.247 0.94 0 C-N-CA 122.17 1.913 . . . . 0.0 111.759 173.436 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 4.6 m -143.07 150.95 40.22 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -174.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 364' ' ' MET . . . . . 0.716 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 60.3 mtp -100.14 120.98 40.7 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.584 -176.399 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.474 ' HG2' ' HG3' ' A' ' 337' ' ' PRO . 57.8 mt-10 -145.26 -166.0 2.32 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.005 -1.452 . . . . 0.0 109.68 -165.449 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 31.2 p-10 -49.38 -9.38 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 26.1 m120 -107.35 -14.72 14.81 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.475 1.034 . . . . 0.0 110.027 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 368' ' ' GLY . . . . . 0.802 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . 126.12 -105.42 0.79 Allowed Glycine 0 CA--C 1.494 -1.255 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -171.394 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 369' ' ' GLY . . . . . 0.584 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -109.17 5.55 31.96 Favored Glycine 0 C--N 1.307 -1.07 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 168.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 75.44 -84.06 0.87 Allowed Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 114.693 -0.754 . . . . 0.0 113.949 174.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -166.81 141.52 4.1 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.222 -0.489 . . . . 0.0 110.596 -173.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 372' ' ' ILE . . . . . 0.75 HD13 HG11 ' A' ' 342' ' ' VAL . 0.7 OUTLIER -136.72 145.4 30.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.113 175.395 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.761 ' HG2' HG12 ' A' ' 327' ' ' VAL . 43.5 mt-10 -127.71 125.68 40.46 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 177.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 374' ' ' MET . . . . . 0.786 ' HE3' HD11 ' A' ' 383' ' ' ILE . 0.0 OUTLIER -139.18 156.07 47.38 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.286 -174.227 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 375' ' ' GLN . . . . . 0.918 ' HB2' HD11 ' A' ' 358' ' ' ILE . 0.0 OUTLIER -168.94 175.82 5.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.422 0.629 . . . . 0.0 112.337 175.798 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 376' ' ' LEU . . . . . 0.63 HD22 ' HB ' ' A' ' 354' ' ' VAL . 16.4 tp -168.18 145.09 3.38 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 174.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 377' ' ' PRO . . . . . 0.605 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 80.8 Cg_exo -40.93 140.92 1.04 Allowed 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.266 1.977 . . . . 0.0 112.165 177.181 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.87 ' HA ' HE22 ' A' ' 394' ' ' GLN . 4.4 Cg_exo -35.46 139.65 0.12 Allowed 'Trans proline' 0 C--N 1.357 1.008 1 C-N-CA 125.488 4.125 . . . . 0.0 114.106 -169.437 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 149.74 -163.09 29.29 Favored Glycine 0 N--CA 1.442 -0.916 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -166.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 380' ' ' ASP . . . . . 0.555 ' OD1' ' HB2' ' A' ' 347' ' ' HIS . 1.5 p30 -113.2 136.76 52.37 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.781 0.8 . . . . 0.0 111.804 176.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.408 ' HB2' ' CH2' ' A' ' 392' ' ' TRP . 20.2 m-80 -136.05 171.26 14.72 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.818 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 1.017 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -156.91 143.93 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.826 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 174.133 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 383' ' ' ILE . . . . . 0.786 HD11 ' HE3' ' A' ' 374' ' ' MET . 45.1 mt -95.3 127.95 46.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.147 -177.072 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 384' ' ' TYR . . . . . 0.41 ' O ' ' HG2' ' A' ' 343' ' ' ARG . 0.2 OUTLIER -103.31 92.32 4.45 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.097 170.56 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 385' ' ' VAL . . . . . 0.572 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 15.6 t -87.86 82.9 2.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 178.401 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 57.81 -111.32 2.93 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.415 -0.898 . . . . 0.0 111.777 -173.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 387' ' ' ASP . . . . . 0.44 ' HB2' ' HD3' ' A' ' 309' ' ' LYS . 32.1 t70 -77.03 -24.84 52.07 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.884 0.373 . . . . 0.0 111.306 175.258 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 388' ' ' LEU . . . . . 0.808 HD13 ' HD1' ' A' ' 312' ' ' PHE . 3.6 mp -71.43 156.46 39.43 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.403 -179.041 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 389' ' ' ASN . . . . . 0.7 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 7.7 p30 -169.49 153.56 5.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.196 178.221 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 390' ' ' HIS . . . . . 0.546 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 56.7 t-80 -175.88 117.7 0.15 Allowed 'General case' 0 N--CA 1.469 0.503 0 O-C-N 123.283 0.365 . . . . 0.0 110.486 177.13 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 391' ' ' GLN . . . . . 1.017 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 4.1 tt0 -73.4 154.94 39.81 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.103 0.478 . . . . 0.0 112.114 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 392' ' ' TRP . . . . . 0.512 ' HE1' ' HB3' ' A' ' 394' ' ' GLN . 0.1 OUTLIER -160.76 151.4 18.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.804 176.558 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -113.91 131.85 56.14 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 177.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.87 HE22 ' HA ' ' A' ' 378' ' ' PRO . 0.0 OUTLIER -111.72 136.13 51.39 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.753 0.311 . . . . 0.0 110.542 -177.131 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.487 ' O ' ' HB3' ' A' ' 378' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.922 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.462 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 303' ' ' THR . . . . . 0.535 ' O ' HG23 ' A' ' 335' ' ' THR . 4.3 t . . . . . 0 CA--C 1.535 0.402 0 CA-C-O 120.787 0.327 . . . . 0.0 111.218 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 304' ' ' TYR . . . . . 0.489 ' HB3' ' NE ' ' A' ' 336' ' ' ARG . 0.8 OUTLIER -59.35 133.27 55.95 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.965 0.412 . . . . 0.0 110.002 178.814 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.528 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 12.8 t 174.46 -170.68 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -175.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 18.5 t -65.46 116.25 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 170.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 307' ' ' CYS . . . . . 0.486 ' HB3' ' CE2' ' A' ' 332' ' ' PHE . 0.0 OUTLIER -67.65 139.26 56.8 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -173.134 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 308' ' ' ASP . . . . . 0.642 ' OD2' HG22 ' A' ' 310' ' ' THR . 15.8 t70 -59.45 118.03 5.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.064 -176.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.455 ' HD2' ' N ' ' A' ' 310' ' ' THR . 0.0 OUTLIER -48.2 -15.87 0.08 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -168.781 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.642 HG22 ' OD2' ' A' ' 308' ' ' ASP . 9.2 t -99.35 -10.93 21.69 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 118.663 0.665 . . . . 0.0 110.82 -175.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.554 ' HE2' ' CE1' ' A' ' 332' ' ' PHE . 24.5 mtpt -83.67 51.99 2.15 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.487 0.661 . . . . 0.0 110.579 -178.34 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.519 ' HZ ' ' HG3' ' A' ' 364' ' ' MET . 11.3 m-85 -141.7 151.89 43.38 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.675 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 313' ' ' THR . . . . . 0.4 ' C ' HD21 ' A' ' 388' ' ' LEU . 18.7 p -142.49 152.52 42.78 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.559 -1.2 . . . . 0.0 109.296 178.162 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 65.7 m95 -82.23 95.39 7.53 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.132 0.491 . . . . 0.0 110.804 178.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.792 ' HA ' ' HE3' ' A' ' 315' ' ' LYS . 0.4 OUTLIER -65.3 -46.47 80.24 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 167.56 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 8.0 ttm180 -150.09 126.71 10.92 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.883 173.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 317' ' ' ALA . . . . . 0.486 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -72.94 160.91 81.76 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-O 119.218 -0.42 . . . . 0.0 110.162 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 318' ' ' PRO . . . . . 0.545 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 2.7 Cg_endo -43.55 114.35 0.49 Allowed 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 122.653 2.236 . . . . 0.0 112.492 -176.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 15.8 m -133.78 136.37 44.48 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.438 -174.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -63.66 125.8 25.48 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -176.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 321' ' ' SER . . . . . 0.528 ' HB3' HG13 ' A' ' 327' ' ' VAL . 93.7 p -56.17 -48.79 75.66 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.782 -171.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 133.69 -10.44 4.91 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 36.8 t-80 -128.03 61.34 1.44 Allowed 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.346 0.593 . . . . 0.0 109.74 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 52.76 35.62 19.1 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 114.921 -1.036 . . . . 0.0 113.547 177.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 325' ' ' THR . . . . . 0.676 ' HA ' ' HG3' ' A' ' 375' ' ' GLN . 3.7 p -148.48 -175.12 4.8 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 177.134 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.832 HG23 ' HG2' ' A' ' 375' ' ' GLN . 0.2 OUTLIER -130.88 145.91 34.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.34 0.59 . . . . 0.0 111.032 -177.327 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 327' ' ' VAL . . . . . 0.668 HG12 ' HG3' ' A' ' 373' ' ' GLU . 16.9 m -123.44 150.48 27.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.97 175.618 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 328' ' ' MET . . . . . 0.532 ' SD ' ' HB ' ' A' ' 372' ' ' ILE . 0.1 OUTLIER -139.65 149.54 43.86 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 175.229 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.732 ' HG2' ' HG2' ' A' ' 315' ' ' LYS . 4.6 tt0 -125.3 121.63 34.54 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -177.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.444 ' HB ' ' HD1' ' A' ' 312' ' ' PHE . 4.2 m -126.65 145.03 34.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.718 -174.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 331' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -111.67 131.82 10.49 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 119.915 -1.136 . . . . 0.0 112.381 179.422 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 332' ' ' PHE . . . . . 0.975 ' H ' ' HA2' ' A' ' 368' ' ' GLY . 4.1 t80 -133.87 136.71 44.53 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.011 -0.736 . . . . 0.0 109.011 176.143 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 19.9 m -129.78 62.36 1.55 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -171.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -164.26 -84.28 0.05 OUTLIER Glycine 0 CA--C 1.52 0.348 0 C-N-CA 119.25 -1.452 . . . . 0.0 113.877 163.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 335' ' ' THR . . . . . 0.95 ' HB ' ' HZ ' ' A' ' 332' ' ' PHE . 35.3 m -50.59 135.82 22.31 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.328 -0.936 . . . . 0.0 109.89 179.085 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.891 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 17.8 ptt180 -72.69 179.98 0.96 Allowed Pre-proline 0 CA--C 1.523 -0.078 0 CA-C-O 117.783 -1.103 . . . . 0.0 108.923 -178.288 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.891 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -25.96 101.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.366 1.474 0 C-N-CA 123.653 2.902 . . . . 0.0 112.905 178.631 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 338' ' ' CYS . . . . . 0.563 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 29.0 p -113.88 -175.71 2.74 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 113.81 -1.541 . . . . 0.0 109.465 -165.197 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -108.74 96.97 6.7 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 340' ' ' ILE . . . . . 0.752 ' HB ' ' SD ' ' A' ' 364' ' ' MET . 15.7 tt -73.8 131.23 82.07 Favored Pre-proline 0 C--N 1.325 -0.472 0 C-N-CA 119.604 -0.838 . . . . 0.0 111.449 -169.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -81.58 79.28 3.25 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 121.67 1.58 . . . . 0.0 111.156 172.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.669 HG22 HG23 ' A' ' 340' ' ' ILE . 2.5 m -101.62 116.09 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 CA-C-O 121.756 0.789 . . . . 0.0 110.313 177.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.541 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 25.6 ptt180 -133.8 177.85 7.4 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.761 -1.108 . . . . 0.0 108.162 178.197 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 344' ' ' ALA . . . . . 0.493 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -149.95 147.16 27.55 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.579 176.355 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.617 HG22 HD12 ' A' ' 382' ' ' ILE . 5.8 m -118.38 143.03 30.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 177.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.26 121.88 15.81 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 177.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 347' ' ' HIS . . . . . 0.529 ' O ' HG23 ' A' ' 349' ' ' VAL . 41.3 t-80 43.9 61.85 2.16 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 124.277 0.986 . . . . 0.0 112.54 173.094 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 348' ' ' GLY . . . . . 0.564 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 46.9 38.05 9.94 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 114.733 0.653 . . . . 0.0 114.733 -175.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 349' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 347' ' ' HIS . 58.5 t -138.34 102.88 8.0 Favored Pre-proline 0 C--O 1.235 0.305 0 CA-C-N 117.859 0.829 . . . . 0.0 108.91 178.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 350' ' ' PRO . . . . . 0.468 ' HA ' ' HB ' ' A' ' 345' ' ' VAL . 15.0 Cg_exo -72.6 63.53 3.78 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.848 2.366 . . . . 0.0 112.837 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -100.05 -56.23 2.42 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 7.6 p -125.05 133.1 70.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.278 174.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 353' ' ' ASN . . . . . 0.484 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 41.8 t30 -64.42 116.57 6.24 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.942 176.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.602 ' HB ' ' HG ' ' A' ' 376' ' ' LEU . 27.4 m -98.53 3.81 10.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.348 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 355' ' ' ALA . . . . . 0.493 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -74.14 84.58 1.84 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.278 0.561 . . . . 0.0 111.026 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 356' ' ' MET . . . . . 0.5 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 22.7 ttt -98.78 98.43 9.54 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 173.559 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.66 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 57.6 mt -83.06 147.39 28.16 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.655 -161.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.718 ' HB ' ' CB ' ' A' ' 373' ' ' GLU . 4.4 mm -88.68 -19.95 7.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 178.039 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 20.6 m -133.75 92.94 21.83 Favored Pre-proline 0 N--CA 1.445 -0.682 0 CA-C-N 113.605 -1.634 . . . . 0.0 108.339 171.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -88.51 25.77 0.61 Allowed 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 123.024 2.483 . . . . 0.0 114.074 -170.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 361' ' ' ASN . . . . . 0.498 ' N ' ' HD3' ' A' ' 362' ' ' PRO . 40.9 m-80 -149.65 57.6 2.85 Favored Pre-proline 0 C--N 1.314 -0.953 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.864 176.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 362' ' ' PRO . . . . . 0.515 ' HB3' HG23 ' A' ' 372' ' ' ILE . 4.9 Cg_endo -75.52 111.44 3.3 Favored 'Trans proline' 0 C--O 1.247 0.951 0 C-N-CA 121.447 1.432 . . . . 0.0 112.932 179.042 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 363' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 338' ' ' CYS . 15.8 p -96.68 125.54 41.22 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 114.924 -1.034 . . . . 0.0 111.59 167.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 364' ' ' MET . . . . . 0.814 ' HB3' ' CA ' ' A' ' 369' ' ' GLY . 0.0 OUTLIER -112.4 143.65 43.17 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.073 -1.421 . . . . 0.0 111.241 -176.089 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.468 ' HG2' ' HG3' ' A' ' 337' ' ' PRO . 41.9 mt-10 -103.6 172.36 6.85 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.953 0.882 . . . . 0.0 112.156 -171.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 28.4 p30 -51.48 -6.29 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 113.167 -1.833 . . . . 0.0 113.569 172.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -115.71 -3.38 12.27 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.23 0.538 . . . . 0.0 110.26 -176.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 368' ' ' GLY . . . . . 0.975 ' HA2' ' H ' ' A' ' 332' ' ' PHE . . . 123.98 161.45 11.13 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.426 -176.333 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 369' ' ' GLY . . . . . 0.814 ' CA ' ' HB3' ' A' ' 364' ' ' MET . . . -76.41 -32.15 52.35 Favored Glycine 0 CA--C 1.498 -1.007 0 C-N-CA 120.37 -0.919 . . . . 0.0 113.163 177.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 370' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 87.6 -132.42 11.18 Favored Glycine 0 N--CA 1.438 -1.18 0 C-N-CA 120.03 -1.081 . . . . 0.0 111.002 -172.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -103.13 136.7 42.44 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.155 0.502 . . . . 0.0 111.4 -176.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 372' ' ' ILE . . . . . 0.532 ' HB ' ' SD ' ' A' ' 328' ' ' MET . 0.1 OUTLIER -128.07 165.18 27.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.584 175.752 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.718 ' CB ' ' HB ' ' A' ' 358' ' ' ILE . 11.3 mp0 -128.79 130.36 46.9 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.153 0.502 . . . . 0.0 110.637 -177.083 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 374' ' ' MET . . . . . 0.676 ' HG2' HD11 ' A' ' 383' ' ' ILE . 0.0 OUTLIER -137.8 166.86 22.96 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.026 179.722 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 375' ' ' GLN . . . . . 0.832 ' HG2' HG23 ' A' ' 326' ' ' VAL . 0.0 OUTLIER -173.54 176.15 2.84 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.425 0.631 . . . . 0.0 110.809 168.153 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 376' ' ' LEU . . . . . 0.799 HD22 ' HD2' ' A' ' 377' ' ' PRO . 2.6 tm? -168.0 128.97 1.15 Allowed Pre-proline 0 C--N 1.317 -0.834 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 175.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 377' ' ' PRO . . . . . 0.799 ' HD2' HD22 ' A' ' 376' ' ' LEU . 34.0 Cg_exo -26.73 130.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 124.22 3.28 . . . . 0.0 113.161 -178.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -35.46 133.51 0.23 Allowed 'Trans proline' 0 C--N 1.361 1.2 0 C-N-CA 124.373 3.382 . . . . 0.0 113.0 -167.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 151.0 -174.45 30.27 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 -160.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 380' ' ' ASP . . . . . 0.66 ' HB3' ' CD2' ' A' ' 393' ' ' PHE . 4.4 p30 -98.41 125.25 43.5 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 117.787 0.794 . . . . 0.0 111.984 -173.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.635 HD22 ' HG2' ' A' ' 394' ' ' GLN . 33.1 m-80 -139.76 153.56 47.19 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.514 -176.141 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 0.981 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -144.5 140.3 23.97 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.872 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.676 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 383' ' ' ILE . . . . . 0.676 HD11 ' HG2' ' A' ' 374' ' ' MET . 37.3 mt -98.94 130.44 47.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.938 -175.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 384' ' ' TYR . . . . . 0.55 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.2 OUTLIER -106.71 92.0 3.92 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.006 174.058 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 385' ' ' VAL . . . . . 0.434 ' O ' ' HB2' ' A' ' 388' ' ' LEU . 9.5 t -87.02 87.71 2.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 64.57 -112.6 5.14 Favored Glycine 0 N--CA 1.442 -0.942 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -169.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -83.95 -16.81 42.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.72 0.295 . . . . 0.0 111.289 174.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 388' ' ' LEU . . . . . 0.55 ' O ' ' HA ' ' A' ' 384' ' ' TYR . 1.2 mp -68.51 151.52 46.68 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.348 -179.134 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 389' ' ' ASN . . . . . 0.571 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 29.0 p30 -159.36 151.35 20.75 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.679 177.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 390' ' ' HIS . . . . . 0.545 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 8.7 t60 -172.26 116.1 0.34 Allowed 'General case' 0 C--O 1.239 0.504 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.481 175.421 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 391' ' ' GLN . . . . . 0.981 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 4.1 tt0 -76.87 153.75 34.45 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.803 -177.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 392' ' ' TRP . . . . . 0.563 ' HD1' ' NE2' ' A' ' 394' ' ' GLN . 38.8 t-105 -167.08 153.34 8.14 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.948 178.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 393' ' ' PHE . . . . . 0.66 ' CD2' ' HB3' ' A' ' 380' ' ' ASP . 29.2 m-85 -106.75 110.92 23.22 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 176.415 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.635 ' HG2' HD22 ' A' ' 381' ' ' ASN . 33.7 mm-40 -75.76 107.55 8.01 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -169.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 9.7 ptmm? . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.466 -177.444 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 303' ' ' THR . . . . . 0.621 HG23 HG23 ' A' ' 335' ' ' THR . 14.9 t . . . . . 0 CA--C 1.535 0.372 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -66.78 120.83 14.19 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.058 -177.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.615 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 9.4 t 173.55 -167.03 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.519 -170.277 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 37.2 t -64.91 113.07 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 169.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 307' ' ' CYS . . . . . 0.423 ' SG ' ' HE2' ' A' ' 332' ' ' PHE . 0.0 OUTLIER -68.36 142.59 55.42 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.953 0.406 . . . . 0.0 110.712 -171.332 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 308' ' ' ASP . . . . . 0.856 ' HB3' ' HG3' ' A' ' 311' ' ' LYS . 6.6 t70 -60.87 126.3 26.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.442 -173.237 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.454 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 17.6 pttm -38.45 -29.62 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 125.849 1.659 . . . . 0.0 114.841 -178.64 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 12.3 t -108.72 4.31 23.62 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 121.723 -0.611 . . . . 0.0 112.029 -169.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.856 ' HG3' ' HB3' ' A' ' 308' ' ' ASP . 27.8 mtpp -83.8 -28.79 27.86 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -173.661 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.618 ' HE2' ' O ' ' A' ' 385' ' ' VAL . 0.1 OUTLIER -85.01 175.71 8.88 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.621 0.724 . . . . 0.0 112.159 -176.163 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 5.2 t -153.2 159.45 42.66 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.329 -1.305 . . . . 0.0 109.476 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 314' ' ' TRP . . . . . 0.474 ' CH2' ' HD3' ' A' ' 318' ' ' PRO . 52.5 m95 -81.99 95.9 7.55 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-O 121.161 0.505 . . . . 0.0 110.518 -179.121 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.615 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 65.4 tttm -65.82 -43.18 89.36 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 168.248 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.436 HH11 ' HD2' ' A' ' 316' ' ' ARG . 44.8 ttm105 -149.28 125.31 10.65 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.846 172.168 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 317' ' ' ALA . . . . . 0.538 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -71.02 164.09 59.73 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.309 -179.064 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 318' ' ' PRO . . . . . 0.592 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 2.1 Cg_endo -45.59 108.66 0.15 Allowed 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 122.56 2.174 . . . . 0.0 112.03 -179.409 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 30.1 m -120.5 124.29 45.04 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.647 -174.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 320' ' ' ASP . . . . . 0.557 ' HA ' HG13 ' A' ' 326' ' ' VAL . 11.4 t70 -53.57 121.62 8.13 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 177.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 60.2 p -61.21 -43.69 98.47 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.236 0.541 . . . . 0.0 109.794 -172.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 116.8 -8.79 16.6 Favored Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 109.911 -1.275 . . . . 0.0 109.911 178.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -127.1 62.37 1.34 Allowed 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 114.541 -0.83 . . . . 0.0 109.823 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 29.5 t70 64.43 17.99 11.1 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.577 171.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 325' ' ' THR . . . . . 0.526 ' HA ' ' HG2' ' A' ' 375' ' ' GLN . 17.8 p -149.45 -174.58 4.71 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 121.828 -0.545 . . . . 0.0 110.285 -176.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.557 HG13 ' HA ' ' A' ' 320' ' ' ASP . 0.6 OUTLIER -135.56 146.07 30.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.202 0.525 . . . . 0.0 111.095 -177.707 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 327' ' ' VAL . . . . . 0.619 HG12 ' HG2' ' A' ' 373' ' ' GLU . 19.8 m -124.33 153.74 31.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.645 177.485 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 328' ' ' MET . . . . . 0.843 ' SD ' ' HB ' ' A' ' 372' ' ' ILE . 0.0 OUTLIER -145.48 157.84 43.94 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 174.977 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.615 ' HG2' ' HD3' ' A' ' 315' ' ' LYS . 8.0 tt0 -136.21 128.19 29.5 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 120.588 -0.445 . . . . 0.0 109.898 -178.01 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.68 HG22 HD11 ' A' ' 372' ' ' ILE . 1.5 m -129.63 147.09 33.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -173.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -120.89 134.96 10.49 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.533 -176.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 332' ' ' PHE . . . . . 0.862 ' H ' ' HA2' ' A' ' 368' ' ' GLY . 0.9 OUTLIER -110.69 152.2 26.82 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.099 0.476 . . . . 0.0 110.67 178.748 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 17.5 m -88.8 -36.64 15.96 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -172.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -146.12 -39.23 0.05 OUTLIER Glycine 0 C--N 1.333 0.394 0 C-N-CA 118.983 -1.58 . . . . 0.0 114.313 -176.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 335' ' ' THR . . . . . 0.621 HG23 HG23 ' A' ' 303' ' ' THR . 22.8 m -53.5 129.53 32.75 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.906 0.384 . . . . 0.0 110.727 -177.281 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.895 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 7.2 ptm180 -87.58 -176.38 0.71 Allowed Pre-proline 0 N--CA 1.455 -0.2 0 CA-C-O 117.268 -1.348 . . . . 0.0 107.857 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.895 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 37.4 Cg_exo -26.28 97.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 123.482 2.788 . . . . 0.0 113.862 -179.328 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 338' ' ' CYS . . . . . 0.615 ' HB2' ' O ' ' A' ' 305' ' ' THR . 30.0 p -117.55 -176.23 2.98 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.965 -173.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 11.7 mpt_? -111.95 108.39 17.72 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 -177.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 340' ' ' ILE . . . . . 0.8 ' HB ' ' SD ' ' A' ' 364' ' ' MET . 15.0 tt -73.1 131.77 83.16 Favored Pre-proline 0 C--O 1.236 0.37 0 C-N-CA 119.527 -0.869 . . . . 0.0 111.964 -170.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -87.46 78.72 1.62 Allowed 'Trans proline' 0 N--CA 1.447 -1.21 0 C-N-CA 122.069 1.846 . . . . 0.0 110.976 168.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.798 HG22 HG23 ' A' ' 340' ' ' ILE . 2.5 m -103.51 124.62 57.86 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.872 0 CA-C-O 121.686 0.755 . . . . 0.0 110.613 177.451 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.4 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 28.4 ptt180 -141.11 177.48 8.04 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 173.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 344' ' ' ALA . . . . . 0.523 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -147.18 147.89 30.97 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 120.314 -0.555 . . . . 0.0 110.336 176.048 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.489 HG22 HD12 ' A' ' 382' ' ' ILE . 10.6 m -118.54 145.86 23.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.23 116.37 5.93 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 176.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 347' ' ' HIS . . . . . 0.665 ' HB3' ' CB ' ' A' ' 380' ' ' ASP . 7.9 p-80 34.7 71.47 0.11 Allowed 'General case' 0 N--CA 1.476 0.846 0 O-C-N 124.498 1.124 . . . . 0.0 113.651 176.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 348' ' ' GLY . . . . . 0.8 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 51.88 34.96 38.64 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 115.109 0.804 . . . . 0.0 115.109 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 349' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 347' ' ' HIS . 49.9 t -139.65 101.26 7.31 Favored Pre-proline 0 C--O 1.234 0.282 0 CA-C-N 118.531 1.166 . . . . 0.0 108.327 177.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 350' ' ' PRO . . . . . 0.442 ' HA ' ' HB ' ' A' ' 345' ' ' VAL . 12.1 Cg_exo -75.76 61.9 6.35 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.847 2.365 . . . . 0.0 113.097 -179.135 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -101.02 -56.41 2.33 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 5.5 p -119.4 128.72 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.895 173.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 353' ' ' ASN . . . . . 0.523 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 31.8 t30 -64.64 116.56 6.35 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.549 176.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.464 ' HB ' ' HG ' ' A' ' 376' ' ' LEU . 16.7 m -92.28 -1.22 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.701 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 355' ' ' ALA . . . . . 0.435 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -76.14 89.12 3.05 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.222 0.534 . . . . 0.0 112.009 -176.336 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.73 103.08 13.82 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 170.082 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.554 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 53.8 mt -86.47 121.99 29.8 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.53 -161.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.68 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 2.5 mm -63.48 -23.79 34.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.506 174.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 16.7 m -128.14 92.02 42.87 Favored Pre-proline 0 N--CA 1.45 -0.475 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.23 169.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -88.82 24.14 0.7 Allowed 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 123.105 2.537 . . . . 0.0 113.47 -171.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 361' ' ' ASN . . . . . 0.572 ' N ' ' HD3' ' A' ' 362' ' ' PRO . 28.3 p-10 -145.23 50.92 1.2 Allowed Pre-proline 0 C--N 1.313 -1.012 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.305 178.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 362' ' ' PRO . . . . . 0.585 ' HB3' HG23 ' A' ' 372' ' ' ILE . 5.7 Cg_endo -75.2 108.2 2.66 Favored 'Trans proline' 0 C--O 1.249 1.063 0 C-N-CA 121.648 1.566 . . . . 0.0 113.323 -177.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 363' ' ' THR . . . . . 0.511 ' HA ' ' HE2' ' A' ' 364' ' ' MET . 2.0 p -92.11 167.02 12.36 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 114.693 -1.139 . . . . 0.0 112.011 166.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 364' ' ' MET . . . . . 0.8 ' SD ' ' HB ' ' A' ' 340' ' ' ILE . 0.2 OUTLIER -144.42 149.81 36.67 Favored 'General case' 0 CA--C 1.496 -1.129 0 CA-C-N 113.716 -1.584 . . . . 0.0 111.188 -172.46 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.441 ' HG2' ' HD3' ' A' ' 337' ' ' PRO . 55.8 mt-10 -120.5 177.96 4.85 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-O 122.144 0.974 . . . . 0.0 111.999 -179.377 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -49.16 -5.59 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 112.533 -2.122 . . . . 0.0 113.597 174.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -118.29 -10.11 10.29 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 121.647 -0.658 . . . . 0.0 110.342 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 368' ' ' GLY . . . . . 0.862 ' HA2' ' H ' ' A' ' 332' ' ' PHE . . . 129.33 176.97 14.64 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 121.186 -0.531 . . . . 0.0 111.778 -174.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 369' ' ' GLY . . . . . 0.504 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -76.8 -34.04 44.54 Favored Glycine 0 C--N 1.334 0.448 0 CA-C-N 117.686 0.743 . . . . 0.0 113.06 178.355 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 94.39 -50.61 2.11 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.298 -0.953 . . . . 0.0 113.521 179.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -166.36 144.38 5.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 117.08 0.44 . . . . 0.0 111.423 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 372' ' ' ILE . . . . . 0.843 ' HB ' ' SD ' ' A' ' 328' ' ' MET . 0.3 OUTLIER -138.28 158.58 32.06 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 169.474 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.68 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 52.0 mt-10 -133.29 129.79 38.06 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.79 0.329 . . . . 0.0 110.326 178.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 374' ' ' MET . . . . . 0.64 ' HG2' HD11 ' A' ' 383' ' ' ILE . 4.9 ppp? -136.83 162.72 32.45 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -179.009 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 375' ' ' GLN . . . . . 0.622 ' HB3' HD11 ' A' ' 358' ' ' ILE . 3.4 tp60 172.52 177.81 0.09 Allowed 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 171.507 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 376' ' ' LEU . . . . . 0.63 HD11 HD21 ' A' ' 381' ' ' ASN . 0.0 OUTLIER -168.5 178.37 1.06 Allowed Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 173.822 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 377' ' ' PRO . . . . . 0.461 ' HD2' ' HB2' ' A' ' 376' ' ' LEU . 92.0 Cg_exo -44.66 125.4 6.26 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 CA-C-N 121.131 1.44 . . . . 0.0 111.176 169.532 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -36.79 147.08 0.08 OUTLIER 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 124.593 3.529 . . . . 0.0 113.943 -173.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 153.87 -174.44 32.4 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -164.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 380' ' ' ASP . . . . . 0.665 ' CB ' ' HB3' ' A' ' 347' ' ' HIS . 4.4 m-20 -93.0 124.76 37.2 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 117.558 0.679 . . . . 0.0 109.373 -178.292 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.63 HD21 HD11 ' A' ' 376' ' ' LEU . 0.6 OUTLIER -120.38 168.56 11.17 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.942 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 1.027 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -160.63 136.74 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 165.662 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 383' ' ' ILE . . . . . 0.64 HD11 ' HG2' ' A' ' 374' ' ' MET . 37.3 mt -95.37 130.01 44.71 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 C-N-CA 119.383 -0.927 . . . . 0.0 109.489 -174.231 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 384' ' ' TYR . . . . . 0.565 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.3 OUTLIER -107.65 90.9 3.44 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 114.352 -1.295 . . . . 0.0 108.114 173.237 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 385' ' ' VAL . . . . . 0.618 ' O ' ' HE2' ' A' ' 312' ' ' PHE . 10.6 t -84.43 91.25 2.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 175.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 61.02 -112.01 4.31 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.171 -171.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -90.05 -13.51 35.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.853 0.358 . . . . 0.0 111.354 176.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 388' ' ' LEU . . . . . 0.565 ' O ' ' HA ' ' A' ' 384' ' ' TYR . 1.6 mp -67.8 146.44 53.7 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 175.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 389' ' ' ASN . . . . . 0.578 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 30.2 p30 -155.58 152.25 28.55 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.042 178.203 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 390' ' ' HIS . . . . . 0.592 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 44.6 t-80 -173.62 119.43 0.3 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.783 174.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 391' ' ' GLN . . . . . 1.027 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 24.9 tm0? -82.91 153.04 25.28 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.617 0.722 . . . . 0.0 112.023 -178.235 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 392' ' ' TRP . . . . . 0.494 ' HD1' ' OE1' ' A' ' 394' ' ' GLN . 8.3 t-105 -173.16 137.79 0.71 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 113.977 -1.465 . . . . 0.0 107.753 176.395 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 393' ' ' PHE . . . . . 0.56 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 30.8 p90 -100.18 129.77 46.24 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -176.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.499 ' HG3' ' OE1' ' A' ' 375' ' ' GLN . 3.3 mm100 -89.61 110.45 21.32 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -172.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.594 ' HE2' ' HA ' ' A' ' 395' ' ' LYS . 0.6 OUTLIER . . . . . 0 C--O 1.246 0.904 0 CA-C-O 118.109 -0.948 . . . . 0.0 109.623 -173.203 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 303' ' ' THR . . . . . 0.628 HG23 HG23 ' A' ' 335' ' ' THR . 5.7 t . . . . . 0 CA--C 1.539 0.542 0 CA-C-O 121.445 0.641 . . . . 0.0 111.723 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 304' ' ' TYR . . . . . 0.533 ' HB3' ' HD3' ' A' ' 336' ' ' ARG . 39.4 p90 -69.87 128.65 37.12 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 175.21 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.508 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 7.3 t 175.86 -170.72 0.06 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -172.485 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 16.5 t -75.92 106.87 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 107.354 -1.351 . . . . 0.0 107.354 170.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -69.9 155.62 40.29 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.786 0.803 . . . . 0.0 113.031 -168.029 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 308' ' ' ASP . . . . . 0.657 ' OD2' HG22 ' A' ' 310' ' ' THR . 23.1 t70 -67.2 122.23 17.38 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.765 178.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.492 ' HB2' ' N ' ' A' ' 387' ' ' ASP . 31.7 pttt -40.66 -32.86 0.23 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 113.506 -1.679 . . . . 0.0 115.499 -173.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.657 HG22 ' OD2' ' A' ' 308' ' ' ASP . 10.0 t -105.77 16.42 25.29 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.882 0.849 . . . . 0.0 110.735 -165.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.533 ' HE3' ' OG1' ' A' ' 335' ' ' THR . 17.4 mtmm -99.46 47.63 0.95 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.626 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 1.039 ' HZ ' HD12 ' A' ' 340' ' ' ILE . 6.1 m-85 -139.98 160.58 39.6 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.65 -171.045 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 313' ' ' THR . . . . . 0.408 ' C ' HD21 ' A' ' 388' ' ' LEU . 69.5 p -134.59 150.35 50.7 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.849 175.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 314' ' ' TRP . . . . . 0.557 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 28.0 m-90 -78.01 92.55 4.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.248 0.546 . . . . 0.0 109.761 174.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.478 ' HB3' ' C ' ' A' ' 329' ' ' GLU . 28.5 tptp -68.93 -49.67 56.0 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 170.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 17.0 ttm180 -151.91 125.63 8.99 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.742 175.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 317' ' ' ALA . . . . . 0.403 ' HB1' ' CG ' ' A' ' 390' ' ' HIS . . . -76.53 157.8 81.95 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-O 119.106 -0.474 . . . . 0.0 110.419 -176.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 318' ' ' PRO . . . . . 0.88 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 80.3 Cg_exo -37.56 111.76 0.1 Allowed 'Trans proline' 0 C--N 1.363 1.339 0 C-N-CA 123.187 2.592 . . . . 0.0 113.537 -178.122 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 16.4 m -134.86 138.52 44.25 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.7 -173.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -58.01 126.45 27.5 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.929 0.395 . . . . 0.0 110.075 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 321' ' ' SER . . . . . 0.512 ' HB3' HG13 ' A' ' 327' ' ' VAL . 92.4 p -59.44 -44.32 92.96 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.51 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 131.58 -13.32 5.37 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.139 176.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 323' ' ' HIS . . . . . 0.453 ' O ' ' HB2' ' A' ' 324' ' ' ASP . 95.0 m-70 -114.27 20.51 15.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.588 0.233 . . . . 0.0 110.67 -179.067 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 324' ' ' ASP . . . . . 0.453 ' HB2' ' O ' ' A' ' 323' ' ' HIS . 10.6 m-20 84.76 43.99 0.02 OUTLIER 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.148 172.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 325' ' ' THR . . . . . 0.486 ' HB ' HG13 ' A' ' 358' ' ' ILE . 5.5 p -151.85 172.68 15.82 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 174.292 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.73 HG21 ' HZ2' ' A' ' 392' ' ' TRP . 0.2 OUTLIER -123.66 141.89 42.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 119.945 1.248 . . . . 0.0 111.784 -173.04 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 327' ' ' VAL . . . . . 0.814 HG12 ' HG2' ' A' ' 373' ' ' GLU . 17.8 m -120.86 155.55 24.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.676 176.321 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 328' ' ' MET . . . . . 0.608 ' HE3' ' HD3' ' A' ' 318' ' ' PRO . 6.6 ptm -146.54 157.93 43.81 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.815 -1.179 . . . . 0.0 107.815 172.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.587 ' HA ' ' O ' ' A' ' 370' ' ' GLY . 16.2 tt0 -128.42 129.39 46.09 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -175.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.586 HG11 HG21 ' A' ' 385' ' ' VAL . 7.5 m -129.68 149.67 33.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -175.561 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -109.13 178.22 20.61 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 175.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 332' ' ' PHE . . . . . 0.528 ' HB2' ' SD ' ' A' ' 364' ' ' MET . 0.1 OUTLIER -138.56 158.19 44.72 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 117.939 0.869 . . . . 0.0 113.239 -177.211 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 9.7 t -65.54 -70.92 0.21 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.313 -1.312 . . . . 0.0 112.271 171.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -166.73 -22.68 0.02 OUTLIER Glycine 0 CA--C 1.53 1.022 0 C-N-CA 119.04 -1.552 . . . . 0.0 115.475 -176.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 335' ' ' THR . . . . . 0.628 HG23 HG23 ' A' ' 303' ' ' THR . 29.3 m -51.06 131.22 27.08 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 117.136 0.468 . . . . 0.0 109.781 174.349 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.772 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 1.3 ptm180 -69.23 177.36 1.22 Allowed Pre-proline 0 CA--C 1.518 -0.285 0 CA-C-O 118.456 -0.783 . . . . 0.0 109.198 -172.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.772 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.2 OUTLIER -28.28 105.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.358 1.064 0 C-N-CA 123.253 2.635 . . . . 0.0 112.864 175.22 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 338' ' ' CYS . . . . . 0.809 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 31.6 p -125.47 155.29 40.74 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.275 -1.33 . . . . 0.0 107.615 -174.428 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -68.29 116.99 9.5 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.369 171.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 340' ' ' ILE . . . . . 1.039 HD12 ' HZ ' ' A' ' 312' ' ' PHE . 33.8 mm -79.0 118.87 74.95 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.614 -174.584 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -75.72 79.87 2.73 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.01 1.806 . . . . 0.0 110.804 176.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.833 HG13 HG22 ' A' ' 340' ' ' ILE . 2.5 m -103.87 118.76 51.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.612 0.72 . . . . 0.0 110.098 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -135.72 177.88 7.48 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 176.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 344' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -146.67 146.46 30.38 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.495 178.002 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 17.3 m -119.48 142.65 33.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.4 115.45 5.12 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.561 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 347' ' ' HIS . . . . . 0.524 ' O ' HG23 ' A' ' 349' ' ' VAL . 63.8 t60 41.49 68.05 0.49 Allowed 'General case' 0 N--CA 1.471 0.6 0 O-C-N 124.571 1.169 . . . . 0.0 111.593 176.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 348' ' ' GLY . . . . . 0.634 ' H ' ' CG2' ' A' ' 382' ' ' ILE . . . 46.01 39.39 8.98 Favored Glycine 0 C--N 1.333 0.39 0 N-CA-C 115.385 0.914 . . . . 0.0 115.385 -177.255 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 349' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 347' ' ' HIS . 59.8 t -138.88 101.8 7.77 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 118.47 1.135 . . . . 0.0 108.53 178.4 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -75.14 64.47 6.17 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 122.893 2.396 . . . . 0.0 113.104 -178.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -100.72 -55.84 2.48 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 176.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 4.9 p -123.5 130.96 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.634 173.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 353' ' ' ASN . . . . . 0.485 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 33.1 t30 -66.13 121.16 14.54 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.801 176.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.655 ' HB ' ' HG ' ' A' ' 376' ' ' LEU . 26.6 m -101.01 4.11 10.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.733 -178.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 355' ' ' ALA . . . . . 0.471 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -72.01 87.36 1.04 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.132 0.492 . . . . 0.0 112.199 -177.581 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 356' ' ' MET . . . . . 0.579 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 37.0 ttm -97.81 100.54 11.91 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 169.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.673 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 26.4 mt -85.63 122.9 30.39 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.591 -164.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.695 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 3.7 mm -61.1 -30.49 47.83 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 CA-C-N 115.313 -0.858 . . . . 0.0 108.943 173.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 18.8 m -135.48 97.13 13.23 Favored Pre-proline 0 N--CA 1.451 -0.393 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.404 175.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -90.79 37.32 0.32 Allowed 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 123.356 2.704 . . . . 0.0 113.706 -174.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -140.2 61.88 18.69 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.202 176.203 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 362' ' ' PRO . . . . . 0.76 ' HB3' HG23 ' A' ' 372' ' ' ILE . 93.9 Cg_endo -84.77 143.06 9.37 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.115 1.877 . . . . 0.0 112.016 176.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 18.4 p -142.47 134.05 26.64 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -178.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 364' ' ' MET . . . . . 0.809 ' HG2' ' SG ' ' A' ' 338' ' ' CYS . 16.3 ptt? -95.38 121.51 37.13 Favored 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 176.45 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.503 ' HG2' ' HG3' ' A' ' 337' ' ' PRO . 37.9 mt-10 -116.75 -167.54 1.31 Allowed 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 113.778 -1.555 . . . . 0.0 109.369 -170.493 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -56.68 -6.04 0.28 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -177.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -122.3 1.31 9.64 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.591 -0.693 . . . . 0.0 110.781 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 368' ' ' GLY . . . . . 0.507 ' HA2' ' CD1' ' A' ' 332' ' ' PHE . . . 112.61 174.92 19.47 Favored Glycine 0 CA--C 1.516 0.119 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -178.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 369' ' ' GLY . . . . . 0.795 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -51.91 -40.65 50.49 Favored Glycine 0 C--N 1.335 0.489 0 CA-C-N 117.541 0.671 . . . . 0.0 113.627 174.601 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 370' ' ' GLY . . . . . 0.587 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 83.24 -127.09 7.82 Favored Glycine 0 N--CA 1.439 -1.141 0 C-N-CA 120.259 -0.972 . . . . 0.0 111.572 -178.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -102.08 139.41 37.74 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.384 0.612 . . . . 0.0 112.017 -173.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 372' ' ' ILE . . . . . 0.76 HG23 ' HB3' ' A' ' 362' ' ' PRO . 0.5 OUTLIER -131.78 155.5 41.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.093 175.751 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.814 ' HG2' HG12 ' A' ' 327' ' ' VAL . 40.8 mt-10 -133.37 128.39 35.52 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.467 -178.027 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 374' ' ' MET . . . . . 0.673 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 0.1 OUTLIER -147.72 165.84 29.26 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.392 -173.937 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 375' ' ' GLN . . . . . 0.579 ' O ' ' HB3' ' A' ' 356' ' ' MET . 1.7 tp60 179.55 175.08 0.76 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 175.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 376' ' ' LEU . . . . . 0.745 HD22 ' HD2' ' A' ' 377' ' ' PRO . 2.1 tm? -166.69 143.13 3.89 Favored Pre-proline 0 N--CA 1.445 -0.691 0 N-CA-C 104.373 -2.455 . . . . 0.0 104.373 -176.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 377' ' ' PRO . . . . . 0.745 ' HD2' HD22 ' A' ' 376' ' ' LEU . 46.5 Cg_exo -36.53 134.27 0.33 Allowed 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.569 2.179 . . . . 0.0 112.638 174.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.54 ' HA ' ' OE1' ' A' ' 394' ' ' GLN . 57.1 Cg_exo -33.86 135.82 0.11 Allowed 'Trans proline' 0 C--N 1.365 1.404 0 C-N-CA 124.875 3.717 . . . . 0.0 114.205 -172.548 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 153.15 -168.71 31.98 Favored Glycine 0 N--CA 1.441 -1.01 0 N-CA-C 110.256 -1.137 . . . . 0.0 110.256 -166.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.88 130.85 48.45 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 117.103 0.451 . . . . 0.0 110.701 179.258 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.655 HD21 HG21 ' A' ' 354' ' ' VAL . 11.4 m120 -136.5 169.97 16.82 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.152 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 1.123 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -157.22 143.97 9.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 173.008 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 383' ' ' ILE . . . . . 0.851 HD12 ' HG3' ' A' ' 318' ' ' PRO . 21.2 mt -100.22 132.89 44.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.558 -176.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 384' ' ' TYR . . . . . 0.526 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 14.6 m-85 -104.71 97.48 7.37 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.183 169.619 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 385' ' ' VAL . . . . . 0.586 HG21 HG11 ' A' ' 330' ' ' VAL . 9.7 t -83.84 82.9 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 173.668 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 63.59 -109.05 2.5 Favored Glycine 0 N--CA 1.434 -1.493 0 C-N-CA 120.39 -0.91 . . . . 0.0 111.223 -166.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 387' ' ' ASP . . . . . 0.492 ' N ' ' HB2' ' A' ' 309' ' ' LYS . 6.9 t70 -93.5 -11.48 31.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.624 0.25 . . . . 0.0 110.894 177.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 388' ' ' LEU . . . . . 0.557 ' HG ' ' CE2' ' A' ' 314' ' ' TRP . 1.0 OUTLIER -69.07 151.17 46.78 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 174.981 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 389' ' ' ASN . . . . . 0.554 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 8.2 p30 -156.63 152.38 27.1 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 121.061 -0.256 . . . . 0.0 110.476 -178.201 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 390' ' ' HIS . . . . . 0.88 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 4.9 t-80 -174.11 116.39 0.22 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.485 171.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 391' ' ' GLN . . . . . 1.123 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 14.6 tt0 -79.53 154.72 28.61 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.44 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 392' ' ' TRP . . . . . 0.73 ' HZ2' HG21 ' A' ' 326' ' ' VAL . 0.6 OUTLIER -163.8 152.36 13.55 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 114.955 -1.02 . . . . 0.0 108.282 179.691 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -110.52 125.58 53.48 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.54 ' OE1' ' HA ' ' A' ' 378' ' ' PRO . 2.2 pp0? -104.46 119.99 40.23 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 -178.355 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? . . . . . 0 C--N 1.315 -0.926 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.118 -168.521 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 303' ' ' THR . . . . . 0.496 ' O ' HG23 ' A' ' 335' ' ' THR . 5.3 t . . . . . 0 CA--C 1.538 0.489 0 CA-C-O 121.394 0.616 . . . . 0.0 111.198 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 304' ' ' TYR . . . . . 0.548 ' HB3' ' NE ' ' A' ' 336' ' ' ARG . 0.9 OUTLIER -69.37 132.85 47.04 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 121.727 -0.608 . . . . 0.0 109.421 174.383 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.539 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 12.9 t 172.38 -169.24 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -177.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 38.6 t -64.16 110.97 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 170.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -69.22 140.69 54.55 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 -171.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 308' ' ' ASP . . . . . 0.613 ' OD1' HG22 ' A' ' 310' ' ' THR . 11.2 t70 -61.89 131.06 48.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.452 0.644 . . . . 0.0 111.376 -171.567 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.473 ' HA ' ' HA3' ' A' ' 386' ' ' GLY . 23.4 pttm -37.95 -38.13 0.29 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 113.245 -1.798 . . . . 0.0 114.523 -178.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.613 HG22 ' OD1' ' A' ' 308' ' ' ASP . 13.9 t -98.9 -8.32 25.81 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.067 0.461 . . . . 0.0 111.574 -166.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.505 ' HZ3' ' HB3' ' A' ' 311' ' ' LYS . 6.3 mtpm? -74.71 -22.16 58.99 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.319 -175.542 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.698 ' HD2' ' HB ' ' A' ' 330' ' ' VAL . 49.3 m-85 -70.85 169.26 15.06 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-O 121.934 0.874 . . . . 0.0 112.915 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 313' ' ' THR . . . . . 0.456 HG22 ' O ' ' A' ' 331' ' ' GLY . 11.6 t -151.64 153.25 34.08 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.46 169.298 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 20.1 m95 -78.11 96.77 5.23 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.143 0.496 . . . . 0.0 111.487 -177.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.593 ' HD3' ' HB3' ' A' ' 329' ' ' GLU . 50.9 tttp -65.94 -46.93 76.38 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 168.618 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.792 ' HB3' ' HB2' ' A' ' 329' ' ' GLU . 70.9 ttt180 -153.35 97.29 2.14 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.09 175.413 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -44.68 154.88 0.4 Allowed Pre-proline 0 N--CA 1.476 0.845 0 C-N-CA 123.634 0.774 . . . . 0.0 112.583 175.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 318' ' ' PRO . . . . . 0.526 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 3.2 Cg_exo -38.67 112.27 0.13 Allowed 'Trans proline' 0 C--N 1.367 1.516 0 C-N-CA 123.676 2.917 . . . . 0.0 113.626 -174.601 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 32.8 m -127.19 132.44 50.48 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.548 -1.206 . . . . 0.0 109.655 -177.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -59.45 118.45 6.03 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 321' ' ' SER . . . . . 0.54 ' HB3' HG13 ' A' ' 327' ' ' VAL . 88.9 p -52.41 -55.68 20.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.536 0.684 . . . . 0.0 111.038 -168.548 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 136.4 -18.17 3.71 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 109.266 -1.533 . . . . 0.0 109.266 -175.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -104.61 43.58 1.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.714 -0.743 . . . . 0.0 109.217 178.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 49.72 49.2 20.49 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.411 -177.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 325' ' ' THR . . . . . 0.623 ' HA ' HE21 ' A' ' 375' ' ' GLN . 1.7 p -155.89 -168.38 2.76 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.536 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.596 ' HB ' ' HG3' ' A' ' 374' ' ' MET . 0.3 OUTLIER -127.19 145.48 34.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 118.89 0.768 . . . . 0.0 111.653 -179.627 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 327' ' ' VAL . . . . . 0.7 HG12 ' HG3' ' A' ' 373' ' ' GLU . 11.5 m -119.45 152.43 21.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.846 170.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 328' ' ' MET . . . . . 0.57 ' SD ' HD13 ' A' ' 383' ' ' ILE . 0.0 OUTLIER -140.09 142.86 36.06 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 175.989 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.792 ' HB2' ' HB3' ' A' ' 316' ' ' ARG . 6.4 mt-10 -122.48 128.55 50.98 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.12 0.486 . . . . 0.0 109.954 179.414 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.698 ' HB ' ' HD2' ' A' ' 312' ' ' PHE . 0.9 OUTLIER -130.05 146.07 34.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.906 -175.825 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 331' ' ' GLY . . . . . 0.456 ' O ' HG22 ' A' ' 313' ' ' THR . . . -125.6 140.73 12.43 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.043 -178.355 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 332' ' ' PHE . . . . . 0.762 ' CD1' ' HA2' ' A' ' 368' ' ' GLY . 0.4 OUTLIER -111.45 176.64 4.94 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -178.246 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 333' ' ' SER . . . . . 0.449 ' OG ' ' HE2' ' A' ' 311' ' ' LYS . 4.7 p -100.98 -66.66 0.9 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 114.161 -1.381 . . . . 0.0 113.351 172.271 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -122.05 -43.68 0.39 Allowed Glycine 0 CA--C 1.535 1.315 0 N-CA-C 116.511 1.364 . . . . 0.0 116.511 -167.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 335' ' ' THR . . . . . 0.496 HG23 ' O ' ' A' ' 303' ' ' THR . 33.9 m -52.4 123.04 9.91 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 117.374 0.587 . . . . 0.0 111.404 -176.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.855 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 12.5 ptt180 -75.2 -176.27 0.54 Allowed Pre-proline 0 CA--C 1.529 0.137 0 CA-C-O 117.726 -1.13 . . . . 0.0 109.018 -176.228 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.855 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -27.27 98.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.371 1.745 0 C-N-CA 123.549 2.833 . . . . 0.0 113.253 177.197 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 338' ' ' CYS . . . . . 0.782 ' SG ' ' HE2' ' A' ' 364' ' ' MET . 14.9 p -114.89 -175.63 2.73 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 113.787 -1.551 . . . . 0.0 110.336 -168.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -108.64 101.51 10.65 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 178.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 340' ' ' ILE . . . . . 0.843 HG22 HG22 ' A' ' 342' ' ' VAL . 39.3 mt -72.37 118.05 64.15 Favored Pre-proline 0 C--O 1.236 0.362 0 C-N-CA 120.328 -0.549 . . . . 0.0 111.253 -169.276 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -79.88 78.11 3.82 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 122.21 1.94 . . . . 0.0 111.065 176.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.865 HG13 HG13 ' A' ' 385' ' ' VAL . 0.0 OUTLIER -103.77 115.82 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.235 174.642 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 37.5 ptt180 -129.46 174.28 9.79 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 177.013 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 344' ' ' ALA . . . . . 0.508 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -146.89 145.44 29.83 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.441 177.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.403 HG22 HD12 ' A' ' 382' ' ' ILE . 13.3 m -117.35 145.39 23.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.269 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.25 115.25 4.85 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.592 175.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 347' ' ' HIS . . . . . 0.663 ' HB3' ' CB ' ' A' ' 380' ' ' ASP . 11.6 p80 32.47 74.46 0.05 Allowed 'General case' 0 N--CA 1.476 0.861 0 O-C-N 124.745 1.278 . . . . 0.0 113.159 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 348' ' ' GLY . . . . . 0.84 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 47.51 41.46 17.96 Favored Glycine 0 C--N 1.331 0.301 0 N-CA-C 115.396 0.918 . . . . 0.0 115.396 -178.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 58.6 t -142.8 102.12 5.37 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 118.396 1.098 . . . . 0.0 108.181 176.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -78.02 53.64 4.54 Favored 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 123.072 2.514 . . . . 0.0 113.248 -176.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -102.73 -4.89 24.36 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 122.009 0.909 . . . . 0.0 108.996 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 2.4 p -170.09 104.96 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.668 -164.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 353' ' ' ASN . . . . . 0.508 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 56.5 t30 -64.12 108.92 1.67 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.994 177.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.534 ' HB ' ' HG ' ' A' ' 376' ' ' LEU . 28.0 m -91.6 3.75 7.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.995 179.187 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 355' ' ' ALA . . . . . 0.461 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -79.0 84.25 5.03 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.402 0.62 . . . . 0.0 111.275 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 3.0 tmm? -96.04 103.26 15.14 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 170.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.528 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 27.7 mt -86.65 115.28 24.01 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.881 -163.27 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.737 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 3.4 mm -58.57 -24.91 26.67 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.05 177.572 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 29.9 m -134.03 90.76 25.62 Favored Pre-proline 0 N--CA 1.445 -0.694 0 CA-C-N 114.446 -1.252 . . . . 0.0 108.37 173.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -84.19 34.58 0.52 Allowed 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 123.094 2.529 . . . . 0.0 113.151 -172.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -140.01 61.75 19.03 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.205 178.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 362' ' ' PRO . . . . . 0.758 ' HB3' HG23 ' A' ' 372' ' ' ILE . 41.5 Cg_endo -80.92 137.46 11.03 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.299 1.999 . . . . 0.0 111.83 178.196 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.87 141.37 30.27 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.015 -173.337 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 364' ' ' MET . . . . . 0.782 ' HE2' ' SG ' ' A' ' 338' ' ' CYS . 30.3 mtm -97.04 125.09 41.23 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 176.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -117.38 -167.42 1.31 Allowed 'General case' 0 C--N 1.313 -0.996 0 O-C-N 124.705 1.253 . . . . 0.0 108.889 177.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 28.0 p-10 -46.27 -32.81 3.3 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 -176.162 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -100.48 3.63 43.08 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 121.72 -0.613 . . . . 0.0 111.392 -176.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 368' ' ' GLY . . . . . 0.762 ' HA2' ' CD1' ' A' ' 332' ' ' PHE . . . 113.44 -179.48 18.96 Favored Glycine 0 N--CA 1.451 -0.341 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -179.249 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 369' ' ' GLY . . . . . 0.694 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -50.26 -37.69 31.84 Favored Glycine 0 CA--C 1.505 -0.562 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.869 171.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 370' ' ' GLY . . . . . 0.589 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 78.88 -128.1 8.41 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 120.302 -0.952 . . . . 0.0 111.318 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -103.47 141.39 36.06 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.355 0.598 . . . . 0.0 111.984 -175.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 372' ' ' ILE . . . . . 0.758 HG23 ' HB3' ' A' ' 362' ' ' PRO . 0.5 OUTLIER -136.81 159.73 37.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.35 175.803 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.737 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 2.5 mp0 -125.54 128.52 48.09 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.187 0.518 . . . . 0.0 110.913 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 374' ' ' MET . . . . . 0.596 ' HG3' ' HB ' ' A' ' 326' ' ' VAL . 1.9 ptm -130.45 167.49 18.53 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.946 -1.025 . . . . 0.0 108.475 179.529 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 375' ' ' GLN . . . . . 0.623 HE21 ' HA ' ' A' ' 325' ' ' THR . 5.9 tp-100 -179.67 171.67 1.18 Allowed 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 164.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 376' ' ' LEU . . . . . 0.869 HD22 ' HD2' ' A' ' 377' ' ' PRO . 2.5 tm? -165.89 137.64 3.12 Favored Pre-proline 0 C--N 1.311 -1.097 0 N-CA-C 104.015 -2.587 . . . . 0.0 104.015 -178.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 377' ' ' PRO . . . . . 0.869 ' HD2' HD22 ' A' ' 376' ' ' LEU . 31.0 Cg_exo -26.92 119.6 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.544 2.829 . . . . 0.0 112.495 177.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -37.09 139.02 0.22 Allowed 'Trans proline' 0 C--N 1.359 1.122 0 C-N-CA 124.286 3.324 . . . . 0.0 113.071 -169.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 153.66 -164.55 31.21 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -157.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 380' ' ' ASP . . . . . 0.663 ' CB ' ' HB3' ' A' ' 347' ' ' HIS . 8.8 m-20 -96.59 121.63 38.63 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 118.103 0.951 . . . . 0.0 110.741 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.653 ' HB2' HE21 ' A' ' 394' ' ' GLN . 9.6 m120 -125.95 163.8 22.2 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 1.0 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -156.94 139.62 6.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 171.685 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 383' ' ' ILE . . . . . 0.677 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 40.9 mt -98.65 129.85 48.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.092 -174.367 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 384' ' ' TYR . . . . . 0.671 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.9 OUTLIER -108.89 92.63 4.13 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.437 -1.256 . . . . 0.0 109.207 172.862 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 385' ' ' VAL . . . . . 0.865 HG13 HG13 ' A' ' 342' ' ' VAL . 3.5 t -85.47 85.52 2.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 176.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 386' ' ' GLY . . . . . 0.473 ' HA3' ' HA ' ' A' ' 309' ' ' LYS . . . 66.17 -112.38 4.88 Favored Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 120.356 -0.926 . . . . 0.0 110.919 -168.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -85.94 -17.04 36.53 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.867 0.365 . . . . 0.0 110.93 175.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 388' ' ' LEU . . . . . 0.671 ' O ' ' HA ' ' A' ' 384' ' ' TYR . 1.3 mp -65.33 147.07 54.08 Favored 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.118 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 389' ' ' ASN . . . . . 0.677 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 8.2 p30 -159.7 151.02 19.74 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.714 -0.221 . . . . 0.0 110.745 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 390' ' ' HIS . . . . . 0.526 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 11.5 t-80 -172.95 115.65 0.28 Allowed 'General case' 0 C--N 1.328 -0.353 0 O-C-N 123.517 0.511 . . . . 0.0 110.119 176.345 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 391' ' ' GLN . . . . . 1.0 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 25.3 tm0? -83.0 154.22 24.58 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.249 0.547 . . . . 0.0 111.76 -177.637 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 392' ' ' TRP . . . . . 0.518 ' HD1' ' NE2' ' A' ' 394' ' ' GLN . 23.8 t-105 -169.93 150.5 3.87 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.891 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 393' ' ' PHE . . . . . 0.541 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 9.1 p90 -104.83 109.67 21.73 Favored 'General case' 0 C--N 1.317 -0.843 0 O-C-N 121.411 -0.805 . . . . 0.0 108.863 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.653 HE21 ' HB2' ' A' ' 381' ' ' ASN . 27.2 mm-40 -78.47 123.53 27.15 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -165.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt . . . . . 0 C--O 1.249 1.028 0 CA-C-O 117.918 -1.039 . . . . 0.0 110.802 -179.384 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 303' ' ' THR . . . . . 0.425 ' O ' HG23 ' A' ' 335' ' ' THR . 9.1 t . . . . . 0 CA--C 1.536 0.428 0 CA-C-O 121.266 0.555 . . . . 0.0 111.914 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 304' ' ' TYR . . . . . 0.509 ' HB2' ' O ' ' A' ' 337' ' ' PRO . 5.5 p90 -65.06 131.17 45.85 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 174.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.59 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 12.0 t 175.57 -167.98 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -170.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.409 ' HA ' ' HB2' ' A' ' 339' ' ' ARG . 8.4 t -75.67 105.64 4.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 168.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 307' ' ' CYS . . . . . 0.531 ' HB3' HG21 ' A' ' 335' ' ' THR . 0.1 OUTLIER -70.49 156.35 39.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.918 0.866 . . . . 0.0 113.315 -167.206 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 308' ' ' ASP . . . . . 0.578 ' OD2' HG22 ' A' ' 310' ' ' THR . 26.2 t70 -70.07 130.35 41.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.046 -1.433 . . . . 0.0 111.801 -175.245 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -38.76 -28.78 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 115.982 1.845 . . . . 0.0 115.982 -174.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 310' ' ' THR . . . . . 0.578 HG22 ' OD2' ' A' ' 308' ' ' ASP . 12.7 t -108.19 0.75 21.67 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 119.323 0.965 . . . . 0.0 112.283 -169.134 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.418 ' HE3' ' HB3' ' A' ' 311' ' ' LYS . 27.7 mtpp -88.46 43.26 1.12 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -171.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.493 ' HD2' HD13 ' A' ' 388' ' ' LEU . 0.0 OUTLIER -152.48 177.89 10.14 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.655 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 8.9 t -152.89 160.48 43.06 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.191 177.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -64.33 125.35 24.31 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.49 ' HB3' ' C ' ' A' ' 329' ' ' GLU . 19.9 ttmm -104.43 -45.58 4.62 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 170.029 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 45.7 ttm105 -149.78 125.65 10.5 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 114.737 -1.119 . . . . 0.0 109.078 170.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 317' ' ' ALA . . . . . 0.496 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -71.53 161.39 78.74 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-O 119.202 -0.428 . . . . 0.0 110.048 -179.225 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 318' ' ' PRO . . . . . 0.517 ' HB3' ' CD1' ' A' ' 383' ' ' ILE . 3.5 Cg_exo -44.5 113.21 0.42 Allowed 'Trans proline' 0 C--N 1.358 1.058 0 C-N-CA 122.384 2.056 . . . . 0.0 112.548 -177.107 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 19.6 m -129.42 138.63 51.58 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.695 -174.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -59.22 127.82 34.05 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.731 0.3 . . . . 0.0 110.706 175.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 321' ' ' SER . . . . . 0.592 ' HB3' HG13 ' A' ' 327' ' ' VAL . 67.3 p -79.14 6.01 10.67 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.551 0.74 . . . . 0.0 111.973 -174.043 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 84.86 -20.76 13.64 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.4 -0.905 . . . . 0.0 113.559 -172.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 86.8 t60 -98.01 7.03 46.97 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 117.388 0.594 . . . . 0.0 110.751 -177.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 36.2 t70 71.85 53.49 0.2 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 122.582 1.182 . . . . 0.0 108.806 -176.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 325' ' ' THR . . . . . 0.864 ' HA ' ' HG3' ' A' ' 375' ' ' GLN . 5.0 p -155.82 161.98 40.54 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.67 HG23 ' HG2' ' A' ' 375' ' ' GLN . 0.2 OUTLIER -110.71 138.48 38.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 119.628 1.104 . . . . 0.0 111.807 -173.552 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 327' ' ' VAL . . . . . 0.695 HG12 ' HG2' ' A' ' 373' ' ' GLU . 15.8 m -114.78 161.08 13.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.736 173.375 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 328' ' ' MET . . . . . 0.51 ' SD ' HG13 ' A' ' 330' ' ' VAL . 0.0 OUTLIER -149.31 152.06 35.23 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 178.272 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.49 ' C ' ' HB3' ' A' ' 315' ' ' LYS . 9.9 tt0 -137.02 135.88 37.96 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -176.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.61 HG23 ' HA3' ' A' ' 369' ' ' GLY . 1.7 m -133.64 161.12 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -176.583 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 331' ' ' GLY . . . . . 0.756 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -127.49 134.14 8.17 Favored Glycine 0 CA--C 1.522 0.529 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.03 176.197 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 332' ' ' PHE . . . . . 0.495 ' HD1' ' H ' ' A' ' 332' ' ' PHE . 0.1 OUTLIER -90.34 160.47 16.1 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -174.84 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 11.4 p -101.1 4.42 42.15 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.43 -1.259 . . . . 0.0 114.297 173.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 166.55 -46.57 0.26 Allowed Glycine 0 CA--C 1.525 0.679 0 C-N-CA 118.292 -1.909 . . . . 0.0 115.764 173.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 335' ' ' THR . . . . . 0.666 ' HB ' ' CE ' ' A' ' 364' ' ' MET . 41.0 m -54.74 122.54 10.93 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.584 0.192 . . . . 0.0 110.527 -178.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.819 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 16.5 ptt180 -79.2 179.54 1.76 Allowed Pre-proline 0 C--O 1.227 -0.121 0 CA-C-O 117.417 -1.277 . . . . 0.0 108.336 -175.365 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.819 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.9 OUTLIER -26.12 100.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.37 1.703 0 C-N-CA 123.578 2.852 . . . . 0.0 113.695 -175.143 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 338' ' ' CYS . . . . . 0.903 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 32.1 p -132.32 153.36 50.8 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.256 -170.539 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 339' ' ' ARG . . . . . 0.409 ' HB2' ' HA ' ' A' ' 306' ' ' VAL . 22.2 mmm180 -67.96 114.1 6.22 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.863 173.086 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 340' ' ' ILE . . . . . 0.632 HD11 ' HB2' ' A' ' 362' ' ' PRO . 28.9 pt -93.64 119.16 67.41 Favored Pre-proline 0 C--N 1.321 -0.666 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.196 -177.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.68 82.67 0.72 Allowed 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.787 2.325 . . . . 0.0 111.943 -178.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.844 HG11 HD13 ' A' ' 372' ' ' ILE . 34.5 m -102.59 124.71 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-O 122.135 0.969 . . . . 0.0 110.645 -178.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.504 ' HG3' ' HB2' ' A' ' 384' ' ' TYR . 30.0 ptt180 -137.28 178.76 6.84 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 114.527 -1.215 . . . . 0.0 107.961 177.686 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 344' ' ' ALA . . . . . 0.468 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -149.12 146.21 27.58 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.815 174.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 13.0 m -120.16 147.8 23.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -71.27 119.86 16.02 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 178.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 347' ' ' HIS . . . . . 0.658 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 3.8 t60 46.79 62.07 2.52 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 124.284 0.99 . . . . 0.0 111.377 174.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 348' ' ' GLY . . . . . 0.707 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 42.14 44.61 4.87 Favored Glycine 0 C--N 1.332 0.357 0 N-CA-C 114.564 0.586 . . . . 0.0 114.564 -173.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 349' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 347' ' ' HIS . 96.8 t -141.57 102.32 5.98 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -73.02 67.35 4.08 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.767 2.311 . . . . 0.0 112.5 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -100.51 -57.19 2.16 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 5.4 p -124.57 132.76 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.574 171.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 353' ' ' ASN . . . . . 0.468 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 50.6 t30 -61.83 109.71 1.32 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.13 175.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.422 ' O ' ' HB2' ' A' ' 376' ' ' LEU . 20.6 m -86.36 3.82 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.091 178.501 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 355' ' ' ALA . . . . . 0.458 ' HB1' HD21 ' A' ' 357' ' ' LEU . . . -79.98 82.22 6.1 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.104 -0.639 . . . . 0.0 110.999 178.362 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.67 99.16 10.79 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 169.574 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.693 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 34.6 mt -80.16 139.25 36.88 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.261 -0.882 . . . . 0.0 111.488 -159.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.914 HD11 ' HB2' ' A' ' 375' ' ' GLN . 3.0 mm -80.53 -21.85 11.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 3.4 m -139.55 94.83 9.21 Favored Pre-proline 0 N--CA 1.448 -0.567 0 CA-C-N 113.578 -1.646 . . . . 0.0 108.185 171.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -83.74 35.75 0.57 Allowed 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 123.494 2.796 . . . . 0.0 113.263 -173.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -141.72 60.04 10.74 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.714 176.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 362' ' ' PRO . . . . . 0.879 ' HB3' HG23 ' A' ' 372' ' ' ILE . 66.0 Cg_endo -79.47 145.74 18.85 Favored 'Trans proline' 0 C--O 1.241 0.656 0 C-N-CA 122.564 2.176 . . . . 0.0 112.618 -176.302 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 363' ' ' THR . . . . . 0.474 ' O ' ' HA2' ' A' ' 369' ' ' GLY . 0.8 OUTLIER -144.72 168.31 20.5 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.598 -174.421 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 364' ' ' MET . . . . . 0.903 ' HG2' ' SG ' ' A' ' 338' ' ' CYS . 13.7 ptt? -132.16 129.63 40.07 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.4 172.335 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 365' ' ' GLU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 337' ' ' PRO . 21.8 mt-10 -113.08 -164.99 0.95 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.216 -1.357 . . . . 0.0 110.929 -167.536 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -56.55 -5.59 0.23 Allowed 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -125.29 2.83 7.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.462 0.648 . . . . 0.0 110.603 177.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 368' ' ' GLY . . . . . 0.756 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . 104.02 -174.81 22.66 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 -176.441 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 369' ' ' GLY . . . . . 0.61 ' HA3' HG23 ' A' ' 330' ' ' VAL . . . -64.82 107.59 1.94 Allowed Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 172.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -75.77 -29.54 59.18 Favored Glycine 0 C--N 1.312 -0.799 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.609 -169.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -166.27 143.51 5.21 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.057 0.456 . . . . 0.0 111.249 175.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 372' ' ' ILE . . . . . 0.879 HG23 ' HB3' ' A' ' 362' ' ' PRO . 1.1 mt -135.15 150.22 29.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.002 170.427 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.765 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 43.3 mt-10 -130.8 127.7 39.22 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.226 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 374' ' ' MET . . . . . 0.693 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 0.2 OUTLIER -141.73 160.27 40.52 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.219 -175.215 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 375' ' ' GLN . . . . . 0.914 ' HB2' HD11 ' A' ' 358' ' ' ILE . 0.0 OUTLIER -175.23 173.7 2.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.283 0.563 . . . . 0.0 111.653 172.717 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 376' ' ' LEU . . . . . 0.749 HD22 ' HD2' ' A' ' 377' ' ' PRO . 1.8 tm? -168.57 138.81 2.0 Allowed Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 105.11 -2.181 . . . . 0.0 105.11 -178.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 377' ' ' PRO . . . . . 0.749 ' HD2' HD22 ' A' ' 376' ' ' LEU . 51.9 Cg_exo -34.3 135.22 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.951 2.434 . . . . 0.0 112.528 174.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 378' ' ' PRO . . . . . 0.509 ' HA ' ' OE1' ' A' ' 394' ' ' GLN . 3.0 Cg_exo -35.59 138.61 0.14 Allowed 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 125.162 3.908 . . . . 0.0 113.63 -171.116 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 155.46 -160.98 30.25 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 -162.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 380' ' ' ASP . . . . . 0.658 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 21.8 m-20 -105.14 128.28 53.3 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 118.252 1.026 . . . . 0.0 110.527 174.622 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.584 HD22 ' CB ' ' A' ' 376' ' ' LEU . 7.0 m-20 -126.32 138.48 53.59 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 1.071 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -141.12 135.25 32.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 177.9 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 383' ' ' ILE . . . . . 0.643 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 20.9 mt -98.9 132.31 44.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 C-N-CA 119.786 -0.766 . . . . 0.0 110.281 -171.238 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 384' ' ' TYR . . . . . 0.504 ' HB2' ' HG3' ' A' ' 343' ' ' ARG . 5.7 m-85 -102.76 131.15 49.81 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 168.372 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 385' ' ' VAL . . . . . 0.643 HG13 HG12 ' A' ' 342' ' ' VAL . 12.6 t -119.71 84.67 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 178.263 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 59.1 -109.13 1.91 Allowed Glycine 0 N--CA 1.434 -1.468 0 C-N-CA 120.363 -0.922 . . . . 0.0 111.002 -164.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -84.9 -20.27 31.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.566 0.183 . . . . 0.0 111.487 176.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 388' ' ' LEU . . . . . 0.493 HD13 ' HD2' ' A' ' 312' ' ' PHE . 0.7 OUTLIER -67.0 154.99 39.81 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.71 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 389' ' ' ASN . . . . . 0.643 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 7.9 p30 -164.96 160.31 19.0 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.231 175.003 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 390' ' ' HIS . . . . . 0.434 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 23.2 t-80 -173.65 117.17 0.26 Allowed 'General case' 0 C--O 1.238 0.487 0 O-C-N 123.51 0.506 . . . . 0.0 110.285 173.016 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 391' ' ' GLN . . . . . 1.071 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 2.5 mt-30 -65.28 146.08 55.39 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 392' ' ' TRP . . . . . . . . . . . . . 50.4 t-105 -149.72 147.83 28.52 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.894 176.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -110.91 115.6 29.78 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 173.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.509 ' OE1' ' HA ' ' A' ' 378' ' ' PRO . 2.7 pp0? -100.45 126.53 46.86 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 121.699 -0.626 . . . . 0.0 109.656 -176.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm . . . . . 0 C--N 1.313 -1.017 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.855 -179.37 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 303' ' ' THR . . . . . 0.504 ' O ' HG22 ' A' ' 305' ' ' THR . 10.3 t . . . . . 0 CA--C 1.533 0.31 0 CA-C-O 121.029 0.442 . . . . 0.0 111.744 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 304' ' ' TYR . . . . . 0.453 ' HB3' ' HG2' ' A' ' 336' ' ' ARG . 31.4 p90 -63.28 129.84 41.99 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 120.903 0.382 . . . . 0.0 110.412 -175.261 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.504 HG22 ' O ' ' A' ' 303' ' ' THR . 12.4 t 171.88 -166.88 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -167.54 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 42.2 t -63.91 112.36 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 170.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 307' ' ' CYS . . . . . 0.463 ' HB2' ' CE2' ' A' ' 332' ' ' PHE . 0.0 OUTLIER -67.99 147.05 52.95 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.13 0.491 . . . . 0.0 111.63 -170.07 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -57.07 109.17 0.61 Allowed 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.014 176.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 309' ' ' LYS . . . . . 0.492 ' HB2' ' N ' ' A' ' 387' ' ' ASP . 26.8 pttt -41.47 -27.12 0.08 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 113.892 -1.504 . . . . 0.0 114.716 -175.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 10.0 t -102.87 17.92 22.8 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.616 0.722 . . . . 0.0 110.428 -170.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 311' ' ' LYS . . . . . 0.621 ' HB2' ' CE2' ' A' ' 332' ' ' PHE . 25.2 mtpp -98.72 -14.39 19.8 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.406 178.361 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 312' ' ' PHE . . . . . 0.459 ' HB2' HD13 ' A' ' 388' ' ' LEU . 97.4 m-85 -75.05 162.32 28.66 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.11 177.509 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 313' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 331' ' ' GLY . 8.9 t -141.67 154.9 45.64 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.038 176.351 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 314' ' ' TRP . . . . . 0.412 ' H ' ' HE3' ' A' ' 314' ' ' TRP . 7.8 m-90 -75.65 92.6 2.97 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.639 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 315' ' ' LYS . . . . . 0.524 ' HB3' ' O ' ' A' ' 329' ' ' GLU . 24.0 tptm -73.74 -56.51 4.89 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 171.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.415 ' NH2' HG21 ' A' ' 319' ' ' THR . 58.2 ttt180 -147.11 125.3 12.17 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 317' ' ' ALA . . . . . 0.432 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -68.69 160.07 78.86 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 119.136 -0.459 . . . . 0.0 109.956 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 318' ' ' PRO . . . . . 0.473 ' HD3' ' CD2' ' A' ' 390' ' ' HIS . 3.9 Cg_exo -41.87 115.78 0.48 Allowed 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 122.823 2.348 . . . . 0.0 112.091 -178.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 319' ' ' THR . . . . . 0.415 HG21 ' NH2' ' A' ' 316' ' ' ARG . 21.5 m -128.68 132.96 48.08 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.246 -174.107 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -62.99 114.86 3.93 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -177.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 321' ' ' SER . . . . . 0.539 ' HB3' HG13 ' A' ' 327' ' ' VAL . 69.9 p -55.81 -46.34 78.06 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 123.543 0.527 . . . . 0.0 110.711 -163.141 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 126.67 -16.2 6.58 Favored Glycine 0 N--CA 1.442 -0.938 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 -179.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -110.62 52.24 0.74 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 57.88 36.29 26.17 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.646 178.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 325' ' ' THR . . . . . 0.478 ' HB ' HG13 ' A' ' 358' ' ' ILE . 3.1 p -157.13 -167.78 2.43 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -178.128 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 326' ' ' VAL . . . . . 0.997 HG23 ' HG2' ' A' ' 375' ' ' GLN . 3.6 t -131.83 148.45 32.37 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-O 121.318 0.58 . . . . 0.0 112.028 -178.443 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 327' ' ' VAL . . . . . 0.846 HG12 ' HG2' ' A' ' 373' ' ' GLU . 15.6 m -128.23 151.22 34.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.478 174.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 328' ' ' MET . . . . . 0.516 ' HG2' ' HE1' ' A' ' 374' ' ' MET . 0.6 OUTLIER -137.34 154.86 49.96 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 169.489 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.584 ' HG3' ' O ' ' A' ' 370' ' ' GLY . 14.0 tt0 -123.75 129.44 51.07 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 120.214 -0.594 . . . . 0.0 109.627 -177.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 330' ' ' VAL . . . . . 0.501 HG11 HG11 ' A' ' 385' ' ' VAL . 3.6 m -124.38 145.05 32.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.115 -178.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 331' ' ' GLY . . . . . 0.427 ' O ' HG22 ' A' ' 313' ' ' THR . . . -112.95 133.2 11.17 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 119.963 -1.113 . . . . 0.0 111.964 179.135 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 332' ' ' PHE . . . . . 0.621 ' CE2' ' HB2' ' A' ' 311' ' ' LYS . 2.6 t80 -141.25 143.14 33.97 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 30.7 p -147.34 49.26 1.1 Allowed 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -171.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -145.48 -80.99 0.04 OUTLIER Glycine 0 C--O 1.23 -0.135 0 C-N-CA 119.78 -1.2 . . . . 0.0 112.03 167.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 335' ' ' THR . . . . . 0.614 ' HB ' ' CZ ' ' A' ' 332' ' ' PHE . 56.1 m -50.82 126.71 16.61 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 172.16 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 336' ' ' ARG . . . . . 0.583 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 0.0 OUTLIER -81.6 -177.84 1.04 Allowed Pre-proline 0 CA--C 1.533 0.324 0 CA-C-O 117.183 -1.389 . . . . 0.0 107.948 -172.19 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 337' ' ' PRO . . . . . 0.933 ' HA ' ' O ' ' A' ' 364' ' ' MET . 6.6 Cg_exo -23.39 101.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 123.91 3.073 . . . . 0.0 114.197 -172.064 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 338' ' ' CYS . . . . . 0.569 ' H ' ' HG3' ' A' ' 364' ' ' MET . 13.6 p -116.39 -176.85 3.04 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 113.898 -1.501 . . . . 0.0 111.38 -165.423 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -111.0 101.11 9.69 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.391 -1.336 . . . . 0.0 107.391 -178.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 340' ' ' ILE . . . . . 0.849 HG22 HG13 ' A' ' 342' ' ' VAL . 22.4 mt -76.32 117.28 63.16 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.464 -170.386 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -82.44 82.12 2.32 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.875 2.383 . . . . 0.0 112.235 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 342' ' ' VAL . . . . . 0.849 HG13 HG22 ' A' ' 340' ' ' ILE . 16.4 m -102.16 159.36 4.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.225 0.536 . . . . 0.0 110.2 179.165 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 343' ' ' ARG . . . . . 0.44 ' CG ' ' HB2' ' A' ' 384' ' ' TYR . 15.7 ptt-85 -169.3 175.63 5.51 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 179.623 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 344' ' ' ALA . . . . . 0.615 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -150.06 149.78 30.79 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.55 178.227 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 345' ' ' VAL . . . . . 0.467 ' HB ' ' HA ' ' A' ' 350' ' ' PRO . 5.1 m -121.84 147.97 25.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 175.263 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -67.17 120.97 14.62 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 176.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 347' ' ' HIS . . . . . 0.607 ' HB2' ' CB ' ' A' ' 380' ' ' ASP . 22.7 t60 38.46 69.86 0.24 Allowed 'General case' 0 N--CA 1.479 0.988 0 O-C-N 124.427 1.079 . . . . 0.0 112.435 175.353 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 348' ' ' GLY . . . . . 0.812 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 44.45 37.41 4.82 Favored Glycine 0 CA--C 1.52 0.378 0 N-CA-C 115.175 0.83 . . . . 0.0 115.175 -177.543 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 349' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 347' ' ' HIS . 60.7 t -139.94 102.25 6.97 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 118.257 1.029 . . . . 0.0 108.566 178.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 350' ' ' PRO . . . . . 0.467 ' HA ' ' HB ' ' A' ' 345' ' ' VAL . 19.2 Cg_exo -71.1 67.36 2.54 Favored 'Trans proline' 0 N--CA 1.465 -0.181 0 C-N-CA 122.801 2.334 . . . . 0.0 112.676 177.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -100.62 -56.87 2.23 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 174.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.7 132.93 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 115.166 -0.924 . . . . 0.0 110.886 173.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 353' ' ' ASN . . . . . 0.615 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 31.6 t30 -63.15 111.11 2.08 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.588 173.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 354' ' ' VAL . . . . . 0.561 HG12 HD22 ' A' ' 376' ' ' LEU . 30.0 m -90.62 4.2 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.317 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 355' ' ' ALA . . . . . 0.48 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -76.81 82.47 3.4 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.238 0.542 . . . . 0.0 111.094 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 356' ' ' MET . . . . . 0.612 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 21.5 ttt -95.97 99.57 11.33 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 170.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 357' ' ' LEU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 47.2 mt -88.84 123.06 32.87 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.709 -161.159 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 358' ' ' ILE . . . . . 0.797 HD11 ' HB2' ' A' ' 375' ' ' GLN . 1.5 mm -67.83 -25.38 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 171.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 54.1 m -122.88 86.07 50.34 Favored Pre-proline 0 N--CA 1.451 -0.375 0 CA-C-N 114.323 -1.308 . . . . 0.0 108.683 170.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -82.84 26.13 0.65 Allowed 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 123.043 2.496 . . . . 0.0 113.022 -172.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 46.5 m-20 -155.83 68.75 5.05 Favored Pre-proline 0 C--N 1.318 -0.804 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.696 178.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 362' ' ' PRO . . . . . 0.824 ' HB3' HG23 ' A' ' 372' ' ' ILE . 49.7 Cg_endo -73.28 151.56 48.87 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 121.745 1.63 . . . . 0.0 111.269 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 363' ' ' THR . . . . . 0.561 HG22 ' O ' ' A' ' 338' ' ' CYS . 0.0 OUTLIER -145.4 169.71 17.77 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -173.065 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 364' ' ' MET . . . . . 0.933 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 3.3 ppp? -127.24 142.97 51.34 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 176.105 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -135.09 -165.01 1.61 Allowed 'General case' 0 C--N 1.319 -0.76 0 O-C-N 124.999 1.437 . . . . 0.0 109.729 178.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -45.27 -28.69 0.85 Allowed 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -174.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -109.32 3.29 21.44 Favored 'General case' 0 C--O 1.234 0.239 0 O-C-N 121.513 -0.742 . . . . 0.0 111.852 -177.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 109.23 -171.79 15.62 Favored Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 -179.028 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 369' ' ' GLY . . . . . 0.552 ' HA2' ' O ' ' A' ' 363' ' ' THR . . . -45.26 -45.9 10.73 Favored Glycine 0 C--N 1.339 0.704 0 CA-C-N 117.067 0.433 . . . . 0.0 113.126 172.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 370' ' ' GLY . . . . . 0.584 ' O ' ' HG3' ' A' ' 329' ' ' GLU . . . 83.93 -54.58 4.96 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.606 -0.807 . . . . 0.0 113.256 175.058 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -165.16 142.17 5.83 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.266 0.555 . . . . 0.0 111.527 177.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 372' ' ' ILE . . . . . 0.824 HG23 ' HB3' ' A' ' 362' ' ' PRO . 1.1 mt -131.23 150.16 34.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 170.463 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 373' ' ' GLU . . . . . 0.846 ' HG2' HG12 ' A' ' 327' ' ' VAL . 32.5 mt-10 -123.45 126.49 46.86 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.199 178.36 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 374' ' ' MET . . . . . 0.525 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 1.0 OUTLIER -137.26 161.37 36.4 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.452 -176.806 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 375' ' ' GLN . . . . . 0.997 ' HG2' HG23 ' A' ' 326' ' ' VAL . 0.0 OUTLIER -170.51 174.88 4.93 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.782 0.801 . . . . 0.0 111.183 170.722 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 376' ' ' LEU . . . . . 0.567 HD12 ' HD2' ' A' ' 377' ' ' PRO . 35.6 tp -169.02 123.87 0.73 Allowed Pre-proline 0 N--CA 1.438 -1.034 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 171.048 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 377' ' ' PRO . . . . . 0.567 ' HD2' HD12 ' A' ' 376' ' ' LEU . 45.2 Cg_exo -27.88 129.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 123.766 2.977 . . . . 0.0 112.101 -177.085 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -33.77 134.47 0.12 Allowed 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 124.499 3.466 . . . . 0.0 113.961 -161.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 158.51 -178.44 34.74 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -160.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 380' ' ' ASP . . . . . 0.75 ' HA ' ' HA ' ' A' ' 393' ' ' PHE . 3.9 m-20 -90.42 120.06 31.22 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 118.064 0.932 . . . . 0.0 111.155 -174.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 381' ' ' ASN . . . . . 0.559 HD22 ' HB3' ' A' ' 376' ' ' LEU . 2.6 m-20 -121.28 163.47 18.52 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 176.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 382' ' ' ILE . . . . . 1.04 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -159.62 138.02 2.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 168.573 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 383' ' ' ILE . . . . . 0.407 ' HB ' ' CD2' ' A' ' 390' ' ' HIS . 12.8 mt -103.41 135.94 38.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 121.028 0.442 . . . . 0.0 110.286 -171.581 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 384' ' ' TYR . . . . . 0.44 ' HB2' ' CG ' ' A' ' 343' ' ' ARG . 50.9 m-85 -100.17 136.74 39.6 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 164.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 385' ' ' VAL . . . . . 0.725 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 10.9 t -120.73 77.77 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 177.064 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 386' ' ' GLY . . . . . 0.424 ' HA3' ' HB2' ' A' ' 309' ' ' LYS . . . 59.73 -106.05 0.89 Allowed Glycine 0 N--CA 1.431 -1.685 0 C-N-CA 120.134 -1.031 . . . . 0.0 111.155 -163.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 387' ' ' ASP . . . . . 0.492 ' N ' ' HB2' ' A' ' 309' ' ' LYS . 10.6 t70 -81.32 -17.42 49.3 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 388' ' ' LEU . . . . . 0.725 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 2.4 mp -70.47 154.36 41.97 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.871 0.367 . . . . 0.0 111.195 178.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 389' ' ' ASN . . . . . 0.438 ' HB3' ' CE2' ' A' ' 384' ' ' TYR . 24.2 p30 -155.93 145.22 20.77 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.384 173.533 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 390' ' ' HIS . . . . . 0.473 ' CD2' ' HD3' ' A' ' 318' ' ' PRO . 0.2 OUTLIER -170.42 106.81 0.31 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.798 -0.183 . . . . 0.0 111.307 -173.743 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 391' ' ' GLN . . . . . 1.04 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 21.2 tm0? -87.87 153.98 20.89 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.212 0.53 . . . . 0.0 112.422 -174.355 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 392' ' ' TRP . . . . . . . . . . . . . 5.5 t-105 -178.0 116.28 0.08 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.143 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 393' ' ' PHE . . . . . 0.75 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 18.4 p90 -66.69 124.7 23.61 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.295 170.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.402 ' HG3' ' OE1' ' A' ' 375' ' ' GLN . 5.3 mm100 -80.81 108.79 14.77 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 -175.465 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 53.2 tptt . . . . . 0 C--O 1.247 0.957 0 CA-C-O 118.795 -0.622 . . . . 0.0 109.985 -174.499 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . 0.455 ' O ' HG23 ' A' ' 303' ' ' THR . 8.8 t . . . . . 0 CA--C 1.537 0.455 0 CA-C-O 121.697 0.761 . . . . 0.0 111.734 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . 0.571 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 13.9 p90 -70.12 117.0 11.14 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.465 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 11.0 t 172.22 -166.83 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -168.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 39.1 t -64.5 109.55 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 171.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . 0.436 ' HB3' HG21 ' A' ' 335' ' ' THR . 0.4 OUTLIER -72.6 144.6 47.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.199 -173.788 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . 0.663 ' OD1' HG22 ' A' ' 310' ' ' THR . 16.4 t70 -70.9 127.2 31.78 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.546 0.689 . . . . 0.0 110.711 -177.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.522 ' HD3' ' HB2' ' A' ' 387' ' ' ASP . 0.0 OUTLIER -44.85 -18.52 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 116.123 1.897 . . . . 0.0 116.123 -173.465 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.663 HG22 ' OD1' ' A' ' 308' ' ' ASP . 10.9 t -108.29 5.68 25.84 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 119.761 1.164 . . . . 0.0 111.725 -171.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . 0.452 ' HE3' ' HB3' ' A' ' 311' ' ' LYS . 25.3 mtpp -86.26 -25.77 25.35 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -171.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.507 ' HA ' ' O ' ' A' ' 331' ' ' GLY . 0.0 OUTLIER -83.14 174.74 10.53 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.664 0.745 . . . . 0.0 111.269 178.369 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . 0.408 ' C ' HD21 ' A' ' 388' ' ' LEU . 32.0 p -139.33 156.87 46.73 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.867 -177.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . 0.671 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 26.8 m-90 -76.39 92.34 3.36 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.547 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 84.8 tttt -77.67 -52.04 9.63 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 119.909 -0.716 . . . . 0.0 109.09 170.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.554 ' HB3' ' HB3' ' A' ' 329' ' ' GLU . 9.2 ttp180 -143.66 121.15 11.72 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 172.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . 0.503 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -72.49 162.49 73.74 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.993 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . 0.631 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 5.7 Cg_exo -42.31 115.48 0.5 Allowed 'Trans proline' 0 C--N 1.358 1.072 0 C-N-CA 122.586 2.191 . . . . 0.0 112.846 -177.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 45.6 m -131.08 136.95 48.87 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.532 -174.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -60.12 116.88 4.51 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . 0.6 ' HB3' HG13 ' A' ' 327' ' ' VAL . 97.3 p -52.28 -53.57 42.34 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.185 0.517 . . . . 0.0 111.37 -167.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 141.88 -26.44 2.36 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.62 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 17.1 t60 -99.24 12.23 36.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.032 0.444 . . . . 0.0 110.039 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 24.6 t70 86.86 53.74 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.878 175.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . 0.408 ' HB ' HG13 ' A' ' 358' ' ' ILE . 0.9 OUTLIER -158.58 -167.48 2.16 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 113.67 -1.605 . . . . 0.0 106.906 176.423 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.729 ' HB ' ' HG3' ' A' ' 374' ' ' MET . 0.6 OUTLIER -125.72 145.89 32.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 119.704 1.138 . . . . 0.0 111.64 -178.689 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' VAL . . . . . 0.772 HG12 ' HG2' ' A' ' 373' ' ' GLU . 13.6 m -123.56 152.58 28.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.751 172.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' MET . . . . . 0.655 ' SD ' ' HB ' ' A' ' 372' ' ' ILE . 0.1 OUTLIER -142.4 149.69 39.68 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 173.152 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.554 ' HB3' ' HB3' ' A' ' 316' ' ' ARG . 46.6 tt0 -129.43 125.14 35.82 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.071 -175.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.506 HG11 HG11 ' A' ' 385' ' ' VAL . 2.8 m -129.97 146.84 33.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -174.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -118.03 137.96 13.52 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.573 -176.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -89.43 156.33 18.75 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.894 0.854 . . . . 0.0 112.957 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 2.3 p -94.79 -19.56 20.23 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.496 -1.229 . . . . 0.0 113.813 171.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -176.23 -37.22 0.05 OUTLIER Glycine 0 CA--C 1.525 0.717 0 C-N-CA 118.979 -1.582 . . . . 0.0 114.991 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' THR . . . . . 0.707 ' HB ' ' SD ' ' A' ' 364' ' ' MET . 90.7 m -53.36 127.21 23.97 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.682 0.277 . . . . 0.0 111.192 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.571 ' HG3' ' HB3' ' A' ' 304' ' ' TYR . 2.0 ptm180 -91.69 179.67 1.34 Allowed Pre-proline 0 CA--C 1.534 0.333 0 CA-C-O 117.248 -1.358 . . . . 0.0 107.914 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.575 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.2 OUTLIER -23.99 96.96 0.01 OUTLIER 'Trans proline' 0 C--N 1.375 1.935 0 C-N-CA 124.098 3.199 . . . . 0.0 114.501 -168.256 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 338' ' ' CYS . . . . . 0.771 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 2.2 p -111.17 -177.61 3.25 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 113.928 -1.487 . . . . 0.0 109.94 -172.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -109.93 99.84 8.9 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 176.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . 0.724 HG22 HG13 ' A' ' 342' ' ' VAL . 43.7 mt -74.42 118.78 72.65 Favored Pre-proline 0 C--N 1.327 -0.412 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.181 -168.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -76.89 80.53 2.82 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.373 2.049 . . . . 0.0 111.238 176.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.724 HG13 HG22 ' A' ' 340' ' ' ILE . 1.4 m -102.16 111.77 33.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 114.849 -1.068 . . . . 0.0 110.106 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -127.14 174.63 8.76 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 178.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 344' ' ' ALA . . . . . 0.476 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -146.53 145.63 30.21 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.474 176.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.436 HG22 HD12 ' A' ' 382' ' ' ILE . 11.5 m -117.72 145.46 23.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 177.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -66.51 119.2 11.25 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.375 175.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 347' ' ' HIS . . . . . 0.547 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 20.7 t60 40.72 66.61 0.61 Allowed 'General case' 0 N--CA 1.474 0.775 0 O-C-N 124.491 1.119 . . . . 0.0 111.95 175.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . 0.589 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 47.32 34.17 8.57 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 115.271 0.869 . . . . 0.0 115.271 -178.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 347' ' ' HIS . 63.7 t -135.7 102.81 10.27 Favored Pre-proline 0 C--O 1.233 0.235 0 CA-C-N 118.371 1.086 . . . . 0.0 108.685 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -74.54 62.35 5.42 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.866 2.377 . . . . 0.0 112.837 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -100.15 -56.26 2.41 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.5 p -120.65 128.9 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-N 115.113 -0.948 . . . . 0.0 110.36 173.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . 0.466 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 33.0 t30 -64.49 119.63 10.78 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.526 175.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.467 ' O ' ' HB2' ' A' ' 376' ' ' LEU . 29.1 m -98.32 6.22 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.94 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 355' ' ' ALA . . . . . 0.476 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -77.55 84.99 3.92 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.474 0.654 . . . . 0.0 111.142 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 356' ' ' MET . . . . . 0.579 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 21.4 ttt -99.3 100.11 11.15 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 106.16 -1.792 . . . . 0.0 106.16 171.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.622 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 47.1 mt -86.21 121.95 29.52 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.416 -160.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.725 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 3.2 mm -64.43 -28.98 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 108.137 -1.061 . . . . 0.0 108.137 174.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 86.4 m -123.46 84.52 52.64 Favored Pre-proline 0 N--CA 1.45 -0.438 0 CA-C-N 114.27 -1.332 . . . . 0.0 108.459 172.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -85.33 27.66 0.59 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.06 2.507 . . . . 0.0 114.287 -169.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 35.7 m-20 -149.2 66.31 8.48 Favored Pre-proline 0 C--N 1.315 -0.922 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.123 177.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . 0.828 ' HB3' HG23 ' A' ' 372' ' ' ILE . 75.9 Cg_endo -81.43 149.08 16.64 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.183 1.922 . . . . 0.0 112.666 178.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 363' ' ' THR . . . . . 0.478 HG22 ' O ' ' A' ' 338' ' ' CYS . 2.6 p -143.75 147.59 34.41 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.615 -174.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 364' ' ' MET . . . . . 0.771 ' HG2' ' SG ' ' A' ' 338' ' ' CYS . 10.3 ptp . . . . . 0 CA--C 1.497 -1.06 0 C-N-CA 119.444 -0.902 . . . . 0.0 108.911 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . 0.612 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -50.35 -42.01 41.32 Favored Glycine 0 CA--C 1.504 -0.611 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.04 172.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . 0.547 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 82.33 -130.42 9.69 Favored Glycine 0 N--CA 1.436 -1.34 0 C-N-CA 120.11 -1.043 . . . . 0.0 110.76 -177.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -103.3 138.16 40.45 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.323 0.582 . . . . 0.0 111.25 -175.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 372' ' ' ILE . . . . . 0.828 HG23 ' HB3' ' A' ' 362' ' ' PRO . 0.1 OUTLIER -130.48 165.23 31.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.41 -0.814 . . . . 0.0 108.999 175.921 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . 0.772 ' HG2' HG12 ' A' ' 327' ' ' VAL . 43.2 mt-10 -132.96 128.69 37.0 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.096 0.474 . . . . 0.0 110.483 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . 0.729 ' HG3' ' HB ' ' A' ' 326' ' ' VAL . 0.0 OUTLIER -133.95 165.67 24.48 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -178.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 375' ' ' GLN . . . . . 0.848 HE21 ' H ' ' A' ' 376' ' ' LEU . 14.2 tp60 -177.67 172.83 1.7 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.155 -0.684 . . . . 0.0 109.155 169.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 376' ' ' LEU . . . . . 0.848 ' H ' HE21 ' A' ' 375' ' ' GLN . 2.5 tm? -165.81 133.89 2.38 Favored Pre-proline 0 C--N 1.309 -1.163 0 N-CA-C 103.753 -2.684 . . . . 0.0 103.753 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 377' ' ' PRO . . . . . 0.776 ' HD2' HD22 ' A' ' 376' ' ' LEU . 34.6 Cg_exo -28.07 126.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.479 2.786 . . . . 0.0 112.586 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -35.12 134.03 0.18 Allowed 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 124.574 3.516 . . . . 0.0 113.358 -167.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 157.1 -170.62 34.38 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -162.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . 0.713 ' HA ' ' HA ' ' A' ' 393' ' ' PHE . 2.9 m-20 -89.85 120.02 30.73 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 117.509 0.654 . . . . 0.0 110.515 -177.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -125.28 166.78 15.9 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 176.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 0.955 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -160.57 139.83 3.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 169.694 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . 0.713 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 40.8 mt -99.64 125.06 53.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 C-N-CA 119.367 -0.933 . . . . 0.0 109.539 -175.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -101.07 92.36 4.97 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.29 171.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . 0.506 HG11 HG11 ' A' ' 330' ' ' VAL . 11.7 t -84.9 85.62 2.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 60.63 -112.57 4.71 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.508 -0.853 . . . . 0.0 111.329 -170.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 387' ' ' ASP . . . . . 0.522 ' HB2' ' HD3' ' A' ' 309' ' ' LYS . 3.5 t70 -83.18 -18.13 40.43 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.091 0.472 . . . . 0.0 110.512 177.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.671 ' HG ' ' CE2' ' A' ' 314' ' ' TRP . 3.4 mp -72.06 156.58 39.05 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.894 177.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . 0.713 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 7.7 p30 -168.96 158.17 8.49 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.316 177.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . 0.631 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 37.5 t-80 -174.83 116.93 0.18 Allowed 'General case' 0 C--O 1.237 0.431 0 O-C-N 123.419 0.45 . . . . 0.0 110.011 175.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 391' ' ' GLN . . . . . 0.955 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 8.2 tt0 -77.6 153.27 33.4 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.019 0.438 . . . . 0.0 112.073 -179.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 392' ' ' TRP . . . . . 0.401 ' CD1' ' NE2' ' A' ' 394' ' ' GLN . 23.9 t-105 -179.49 115.27 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.873 178.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . 0.713 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 12.3 p90 -68.21 121.05 15.39 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.21 0.529 . . . . 0.0 110.249 172.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 0.633 ' HG3' HE22 ' A' ' 375' ' ' GLN . 4.2 mm100 -84.27 119.09 24.64 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -172.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 4.1 mmmp? . . . . . 0 C--O 1.246 0.919 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.393 -176.894 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . 0.423 ' O ' HG23 ' A' ' 303' ' ' THR . 6.4 t . . . . . 0 CA--C 1.538 0.497 0 CA-C-O 121.602 0.715 . . . . 0.0 111.181 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . 0.541 ' HB3' ' NE ' ' A' ' 336' ' ' ARG . 33.5 p90 -76.75 126.46 31.03 Favored 'General case' 0 CA--C 1.516 -0.358 0 O-C-N 121.806 -0.558 . . . . 0.0 109.729 176.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.517 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 10.0 t -179.9 -173.91 0.25 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.245 -174.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.09 111.54 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 167.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.67 144.25 51.12 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.377 -169.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . 0.491 ' OD2' HG22 ' A' ' 310' ' ' THR . 34.0 t70 -67.56 119.96 13.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.322 0.582 . . . . 0.0 110.448 -178.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.651 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -46.12 -12.17 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 -172.631 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.491 HG22 ' OD2' ' A' ' 308' ' ' ASP . 8.1 t -107.2 -0.67 22.52 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 119.079 0.854 . . . . 0.0 111.319 -175.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -83.85 -25.11 30.57 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -173.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.651 ' CZ ' ' HA ' ' A' ' 309' ' ' LYS . 0.1 OUTLIER -83.22 174.68 10.55 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.759 0.79 . . . . 0.0 111.155 176.882 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . 0.401 ' C ' HD21 ' A' ' 388' ' ' LEU . 14.7 t -149.78 159.67 44.16 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.542 -1.208 . . . . 0.0 108.769 -179.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . 0.436 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 29.0 m-90 -69.17 117.64 11.07 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 121.353 0.597 . . . . 0.0 110.28 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.964 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 59.4 tttm -97.47 -47.81 5.53 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 173.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 41.1 ttp-105 -154.61 130.03 9.8 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.955 168.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . 0.561 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -66.13 166.0 18.96 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.993 -178.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . 0.567 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 3.6 Cg_exo -44.3 116.27 0.99 Allowed 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.559 2.173 . . . . 0.0 112.368 178.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 55.0 m -128.7 132.18 48.0 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.466 -174.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.94 125.35 23.23 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 175.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . 0.438 ' C ' ' H ' ' A' ' 323' ' ' HIS . 59.5 p -70.24 5.6 1.64 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 123.423 0.689 . . . . 0.0 112.489 -168.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 74.56 -25.58 1.12 Allowed Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.319 -169.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . 0.438 ' H ' ' C ' ' A' ' 321' ' ' SER . 2.2 t-160 -106.42 46.46 0.92 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.114 0.483 . . . . 0.0 109.98 -178.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 50.34 43.66 26.65 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 114.96 -1.018 . . . . 0.0 113.533 177.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . 0.665 ' HA ' ' HG3' ' A' ' 375' ' ' GLN . 2.1 p -150.84 -168.12 3.01 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 174.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.823 ' HB ' ' HG2' ' A' ' 374' ' ' MET . 0.2 OUTLIER -129.3 144.73 37.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 118.979 0.809 . . . . 0.0 111.019 179.707 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' VAL . . . . . 0.654 HG12 ' HG2' ' A' ' 373' ' ' GLU . 15.0 m -128.39 143.86 39.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.024 174.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' MET . . . . . 0.435 ' CG ' HD12 ' A' ' 372' ' ' ILE . 0.0 OUTLIER -135.04 149.46 50.13 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 178.297 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.964 ' HG2' ' HD3' ' A' ' 315' ' ' LYS . 7.7 tt0 -131.12 131.07 43.88 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 120.657 -0.417 . . . . 0.0 109.994 -173.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.672 HG23 ' HA3' ' A' ' 369' ' ' GLY . 0.0 OUTLIER -126.81 161.29 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -178.18 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . 0.555 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -127.69 137.8 10.05 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.729 175.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . 0.931 ' H ' ' HA2' ' A' ' 368' ' ' GLY . 0.2 OUTLIER -89.96 155.6 19.0 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.541 0.686 . . . . 0.0 111.807 179.185 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 2.6 p -95.84 -13.99 23.58 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 171.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -176.44 -40.72 0.05 OUTLIER Glycine 0 CA--C 1.528 0.859 0 C-N-CA 118.961 -1.59 . . . . 0.0 115.19 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' THR . . . . . 0.567 ' HB ' ' SD ' ' A' ' 364' ' ' MET . 82.8 m -52.78 132.84 37.11 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.823 0.344 . . . . 0.0 111.533 -177.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.865 HH21 ' HB2' ' A' ' 337' ' ' PRO . 0.2 OUTLIER -87.87 177.4 2.7 Favored Pre-proline 0 C--N 1.338 0.077 0 CA-C-O 117.389 -1.291 . . . . 0.0 107.875 -179.143 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.865 ' HB2' HH21 ' A' ' 336' ' ' ARG . 1.0 OUTLIER -26.64 98.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.367 1.535 0 C-N-CA 123.723 2.949 . . . . 0.0 114.138 -174.432 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 338' ' ' CYS . . . . . 0.757 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 6.5 p -111.48 -176.19 2.88 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 113.559 -1.655 . . . . 0.0 110.376 -171.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -111.54 98.9 7.77 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 174.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . 0.773 ' HB ' ' HG2' ' A' ' 362' ' ' PRO . 68.5 mt -74.49 119.59 77.33 Favored Pre-proline 0 C--N 1.328 -0.338 0 O-C-N 123.416 0.448 . . . . 0.0 110.906 -171.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.2 82.32 2.4 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.928 2.419 . . . . 0.0 112.162 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.706 HG13 HG22 ' A' ' 340' ' ' ILE . 9.9 m -99.04 151.65 4.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.382 178.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 -162.34 171.34 17.37 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 176.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 344' ' ' ALA . . . . . 0.544 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -145.97 144.67 30.27 Favored 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.008 176.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.553 ' HB ' ' HA ' ' A' ' 350' ' ' PRO . 4.9 m -116.27 143.83 25.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 176.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.405 ' HB2' ' CG1' ' A' ' 354' ' ' VAL . . . -63.6 123.23 18.29 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 176.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 347' ' ' HIS . . . . . 0.519 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 37.2 t-80 42.52 62.97 1.55 Allowed 'General case' 0 N--CA 1.473 0.711 0 O-C-N 124.268 0.98 . . . . 0.0 112.749 170.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . 0.54 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 50.75 29.72 19.55 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 115.25 0.86 . . . . 0.0 115.25 -177.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 347' ' ' HIS . 50.6 t -136.2 103.08 9.74 Favored Pre-proline 0 C--O 1.234 0.247 0 CA-C-N 118.267 1.033 . . . . 0.0 109.784 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 350' ' ' PRO . . . . . 0.553 ' HA ' ' HB ' ' A' ' 345' ' ' VAL . 17.1 Cg_exo -71.98 62.62 3.24 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 123.095 2.53 . . . . 0.0 112.884 178.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -100.12 -56.05 2.47 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 178.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 4.6 p -124.64 133.4 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.451 174.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 34.0 t30 -64.85 117.35 7.43 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.89 177.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.576 HG12 HD22 ' A' ' 376' ' ' LEU . 27.9 m -99.79 7.54 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.917 179.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 355' ' ' ALA . . . . . 0.544 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -78.62 82.94 4.83 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.029 0.443 . . . . 0.0 110.568 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 356' ' ' MET . . . . . 0.614 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 22.4 ttt -97.46 51.96 1.1 Allowed 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 175.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.842 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 11.7 mt -24.53 111.59 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 112.901 -1.954 . . . . 0.0 115.226 170.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.82 HD11 ' HB2' ' A' ' 375' ' ' GLN . 3.9 mm -60.36 -22.89 26.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 113.352 -1.749 . . . . 0.0 108.48 168.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 55.1 m -139.23 90.34 11.82 Favored Pre-proline 0 N--CA 1.451 -0.419 0 CA-C-N 114.265 -1.334 . . . . 0.0 108.648 177.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 360' ' ' PRO . . . . . 0.475 ' HA ' HD12 ' A' ' 357' ' ' LEU . 92.6 Cg_endo -82.17 45.34 1.91 Allowed 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 123.27 2.647 . . . . 0.0 114.445 -170.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -174.58 80.44 0.34 Allowed Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 120.958 0.408 . . . . 0.0 110.375 176.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . 0.773 ' HG2' ' HB ' ' A' ' 340' ' ' ILE . 95.3 Cg_endo -82.65 112.39 2.13 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.702 2.268 . . . . 0.0 111.932 176.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 4.0 p -90.81 142.19 28.02 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.764 0.792 . . . . 0.0 112.5 173.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 364' ' ' MET . . . . . 0.827 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 5.2 ptp . . . . . 0 CA--C 1.504 -0.827 0 CA-C-N 114.067 -1.424 . . . . 0.0 109.457 178.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . 0.931 ' HA2' ' H ' ' A' ' 332' ' ' PHE . . . . . . . . 0 CA--C 1.504 -0.637 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . 0.672 ' HA3' HG23 ' A' ' 330' ' ' VAL . . . -104.37 3.27 43.37 Favored Glycine 0 C--N 1.317 -0.505 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 175.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 73.15 -93.38 0.68 Allowed Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 114.96 -0.62 . . . . 0.0 113.575 175.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -152.29 133.49 14.34 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.411 -0.395 . . . . 0.0 111.084 -170.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 372' ' ' ILE . . . . . 0.627 HG23 ' HB3' ' A' ' 362' ' ' PRO . 0.7 OUTLIER -129.63 135.38 61.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 173.392 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . 0.654 ' HG2' HG12 ' A' ' 327' ' ' VAL . 40.9 mt-10 -122.43 126.72 48.53 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . 0.842 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 0.1 OUTLIER -134.47 165.5 25.02 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 123.505 0.722 . . . . 0.0 110.718 -175.692 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 375' ' ' GLN . . . . . 0.837 ' HA ' HE21 ' A' ' 375' ' ' GLN . 0.0 OUTLIER -173.5 -173.81 0.93 Allowed 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.545 0.688 . . . . 0.0 111.668 162.835 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 376' ' ' LEU . . . . . 0.962 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 10.5 tp -166.15 166.97 9.04 Favored Pre-proline 0 N--CA 1.443 -0.79 0 N-CA-C 104.481 -2.415 . . . . 0.0 104.481 171.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 377' ' ' PRO . . . . . 0.962 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 2.9 Cg_endo -43.48 133.81 7.0 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 121.58 1.52 . . . . 0.0 110.684 167.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_exo -37.8 140.04 0.29 Allowed 'Trans proline' 0 C--N 1.358 1.077 0 C-N-CA 123.85 3.033 . . . . 0.0 112.371 -177.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 148.61 -169.45 29.16 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.122 -1.037 . . . . 0.0 110.565 -160.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . 0.519 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 2.2 m-20 -98.72 128.52 45.0 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 117.583 0.692 . . . . 0.0 111.29 -175.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -127.07 168.73 14.21 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 176.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 1.034 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -161.04 138.6 2.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 168.835 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . 0.743 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 17.3 mt -104.62 130.29 55.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 C-N-CA 119.928 -0.709 . . . . 0.0 109.418 -172.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 384' ' ' TYR . . . . . 0.536 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 3.5 m-85 -101.57 98.56 8.86 Favored 'General case' 0 N--CA 1.441 -0.884 0 O-C-N 124.318 1.011 . . . . 0.0 108.572 169.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . 0.61 HG11 HG11 ' A' ' 330' ' ' VAL . 25.9 t -86.63 84.71 2.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 175.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 62.15 -112.06 4.52 Favored Glycine 0 N--CA 1.439 -1.132 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 -169.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 387' ' ' ASP . . . . . 0.53 ' HB2' ' HD3' ' A' ' 309' ' ' LYS . 0.7 OUTLIER -85.03 -15.26 44.71 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.781 0.324 . . . . 0.0 110.947 177.426 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.536 ' O ' ' HA ' ' A' ' 384' ' ' TYR . 3.3 mp -70.34 155.07 41.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.023 177.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . 0.743 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 6.4 p30 -167.12 157.01 10.97 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.808 -0.178 . . . . 0.0 110.898 175.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . 0.567 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 33.0 t-80 -175.03 123.19 0.24 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.852 175.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 391' ' ' GLN . . . . . 1.034 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 25.3 tt0 -78.52 153.61 31.15 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.066 0.46 . . . . 0.0 111.585 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 392' ' ' TRP . . . . . 0.491 ' N ' ' HG2' ' A' ' 391' ' ' GLN . 10.7 t-105 -166.36 145.87 5.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.605 174.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . 0.507 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 13.5 p90 -103.3 118.79 37.58 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 0.811 ' HG3' HE22 ' A' ' 375' ' ' GLN . 3.0 mm100 -83.14 112.96 20.3 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -168.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 31.2 mtmm . . . . . 0 C--O 1.248 1.026 0 O-C-N 124.225 0.953 . . . . 0.0 111.462 -179.9 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . 0.605 HG23 HG23 ' A' ' 335' ' ' THR . 8.9 t . . . . . 0 CA--C 1.539 0.527 0 CA-C-O 121.575 0.702 . . . . 0.0 111.232 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . 0.408 ' O ' ' HB ' ' A' ' 305' ' ' THR . 14.2 p90 -63.54 119.11 9.18 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 174.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.419 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 12.1 t 174.9 -168.33 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -172.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 36.4 t -65.22 106.95 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 169.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . 0.596 ' HB3' HG21 ' A' ' 335' ' ' THR . 0.5 OUTLIER -69.91 140.86 53.16 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.264 -167.892 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . 0.609 ' OD1' HG22 ' A' ' 310' ' ' THR . 14.0 t70 -63.41 132.68 52.23 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.953 -174.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.566 ' HD2' ' N ' ' A' ' 310' ' ' THR . 0.0 OUTLIER -41.5 -20.36 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 116.104 1.89 . . . . 0.0 116.104 -175.428 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.609 HG22 ' OD1' ' A' ' 308' ' ' ASP . 6.7 t -108.31 2.54 22.68 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 119.134 0.879 . . . . 0.0 112.196 -174.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . 0.426 ' HG2' ' HB3' ' A' ' 308' ' ' ASP . 24.9 mmmt -74.01 -33.14 63.68 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -173.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.951 ' HD1' HD13 ' A' ' 388' ' ' LEU . 0.0 OUTLIER -86.08 175.18 8.69 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 122.006 0.908 . . . . 0.0 111.672 -175.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 11.1 t -144.3 155.45 43.83 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 113.871 -1.513 . . . . 0.0 107.755 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 16.4 m-90 -75.69 93.11 3.04 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.237 0.541 . . . . 0.0 109.598 178.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.452 ' HB3' ' C ' ' A' ' 329' ' ' GLU . 25.1 tptp -65.95 -43.82 86.84 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 170.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 24.8 ttt180 -152.83 130.79 11.78 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.142 170.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . 0.445 ' HB1' ' CD2' ' A' ' 390' ' ' HIS . . . -69.5 159.04 85.26 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.649 -178.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . 0.781 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 78.7 Cg_exo -39.71 112.7 0.16 Allowed 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 122.65 2.234 . . . . 0.0 112.742 178.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 19.0 m -131.89 135.33 46.57 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.166 -173.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -57.38 124.13 17.86 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . 0.433 ' HB3' HG13 ' A' ' 327' ' ' VAL . 84.5 p -62.16 -47.84 82.73 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.448 0.642 . . . . 0.0 110.014 -174.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 123.64 -14.62 8.09 Favored Glycine 0 N--CA 1.443 -0.892 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -111.86 53.09 0.73 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.284 0.564 . . . . 0.0 109.884 178.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 22.9 t70 57.28 33.94 24.04 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 114.746 -1.116 . . . . 0.0 112.464 177.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . 0.557 ' HB ' HG13 ' A' ' 358' ' ' ILE . 10.0 p -152.5 -172.55 4.27 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -132.12 145.45 34.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.338 0.59 . . . . 0.0 111.377 -177.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' VAL . . . . . 0.724 HG12 ' HG2' ' A' ' 373' ' ' GLU . 15.8 m -127.11 155.94 38.34 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.895 176.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 5.0 ptm -142.09 159.43 42.24 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 167.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.552 ' HG3' ' O ' ' A' ' 370' ' ' GLY . 9.7 tt0 -124.45 129.39 50.57 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -176.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.594 HG23 ' HA3' ' A' ' 369' ' ' GLY . 3.1 m -125.55 146.19 31.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.88 -179.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . 0.727 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -124.47 140.42 12.55 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.116 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . 0.572 ' HD1' ' HA2' ' A' ' 368' ' ' GLY . 7.9 p90 -89.3 146.67 24.56 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.96 0.886 . . . . 0.0 111.69 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 28.2 t -86.84 -28.6 22.8 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.114 -1.403 . . . . 0.0 111.961 172.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -159.23 -44.58 0.02 OUTLIER Glycine 0 C--N 1.336 0.56 0 C-N-CA 119.605 -1.283 . . . . 0.0 113.917 -179.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' THR . . . . . 0.605 HG23 HG23 ' A' ' 303' ' ' THR . 27.1 m -52.69 124.55 14.12 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 123.795 0.35 . . . . 0.0 110.949 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.59 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 33.3 ptt85 -87.29 -177.38 0.88 Allowed Pre-proline 0 CA--C 1.532 0.285 0 CA-C-O 117.089 -1.434 . . . . 0.0 108.37 -174.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.775 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.1 OUTLIER -26.63 96.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 123.751 2.967 . . . . 0.0 114.151 -176.449 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 338' ' ' CYS . . . . . 0.482 ' SG ' ' HG3' ' A' ' 364' ' ' MET . 12.1 p -112.42 -176.83 3.01 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 113.515 -1.675 . . . . 0.0 110.074 -171.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 11.2 mpt_? -112.21 103.08 11.22 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 178.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . 0.832 HG22 HG13 ' A' ' 342' ' ' VAL . 29.7 mt -74.17 119.99 79.14 Favored Pre-proline 0 C--N 1.324 -0.508 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.486 -167.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.65 81.26 2.67 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.853 2.368 . . . . 0.0 111.561 177.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.832 HG13 HG22 ' A' ' 340' ' ' ILE . 4.6 m -102.41 155.38 5.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-O 121.747 0.784 . . . . 0.0 110.887 -178.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.467 ' HE ' ' HB3' ' A' ' 384' ' ' TYR . 22.4 ptt180 -166.31 174.94 8.63 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 344' ' ' ALA . . . . . 0.529 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -150.9 145.0 25.35 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.849 -0.74 . . . . 0.0 110.893 177.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.439 ' O ' HG23 ' A' ' 382' ' ' ILE . 9.2 m -119.88 147.16 23.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -70.12 122.86 20.26 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 176.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 347' ' ' HIS . . . . . 0.523 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 47.2 t60 43.96 60.43 2.73 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 124.149 0.906 . . . . 0.0 111.413 174.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . 0.689 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 44.09 46.04 7.93 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 114.637 0.615 . . . . 0.0 114.637 -174.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 347' ' ' HIS . 73.5 t -141.64 102.5 5.93 Favored Pre-proline 0 C--N 1.33 -0.251 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -76.15 49.7 2.64 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.603 2.202 . . . . 0.0 112.625 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -102.11 -5.54 24.36 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 2.6 p -169.8 106.31 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 114.561 -1.199 . . . . 0.0 110.055 -167.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . 0.465 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 38.1 t30 -64.74 111.78 2.93 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.688 178.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.505 ' HA ' HD22 ' A' ' 376' ' ' LEU . 31.5 m -91.2 -0.59 9.55 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.212 177.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 355' ' ' ALA . . . . . 0.529 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -74.25 84.55 1.89 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.213 0.53 . . . . 0.0 111.462 -176.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 356' ' ' MET . . . . . 0.658 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 47.6 ttp -97.9 101.14 12.56 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 168.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.521 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 27.6 mt -85.35 119.33 25.6 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.192 -163.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.765 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 2.5 mm -61.79 -28.98 45.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.506 175.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 22.4 m -130.14 90.08 43.2 Favored Pre-proline 0 N--CA 1.443 -0.8 0 CA-C-N 114.3 -1.318 . . . . 0.0 108.539 173.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -83.87 36.86 0.61 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.142 2.561 . . . . 0.0 113.055 -173.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -153.35 71.56 6.88 Favored Pre-proline 0 C--N 1.317 -0.83 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.257 175.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . 0.621 ' HB2' HD12 ' A' ' 340' ' ' ILE . 94.7 Cg_endo -81.43 145.02 14.68 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.568 2.179 . . . . 0.0 111.387 176.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 363' ' ' THR . . . . . 0.451 ' O ' ' HA2' ' A' ' 369' ' ' GLY . 0.5 OUTLIER -144.26 140.19 29.08 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 -173.008 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 364' ' ' MET . . . . . 0.775 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 41.4 mtm . . . . . 0 CA--C 1.492 -1.286 0 C-N-CA 119.398 -0.921 . . . . 0.0 109.198 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . 0.727 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . . . . . . 0 N--CA 1.449 -0.49 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . 0.635 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -46.84 -25.79 2.49 Favored Glycine 0 CA--C 1.522 0.504 0 CA-C-N 117.7 0.75 . . . . 0.0 114.517 174.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . 0.552 ' O ' ' HG3' ' A' ' 329' ' ' GLU . . . 77.35 -57.82 3.7 Favored Glycine 0 C--O 1.228 -0.228 0 C-N-CA 120.867 -0.682 . . . . 0.0 113.034 176.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -165.87 147.06 6.9 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.126 0.489 . . . . 0.0 111.431 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 372' ' ' ILE . . . . . 0.747 HD13 HG11 ' A' ' 342' ' ' VAL . 1.3 mt -131.6 140.03 49.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.448 170.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . 0.765 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 40.8 mt-10 -119.44 123.7 44.71 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.428 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . 0.558 ' HG2' HD11 ' A' ' 383' ' ' ILE . 0.0 OUTLIER -138.63 164.38 29.64 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.817 -176.866 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 375' ' ' GLN . . . . . 1.011 ' HA ' HE21 ' A' ' 375' ' ' GLN . 0.0 OUTLIER 177.54 175.0 0.47 Allowed 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 173.585 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 376' ' ' LEU . . . . . 0.983 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 8.9 tp -166.88 173.59 3.05 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 177.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 377' ' ' PRO . . . . . 0.983 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 75.2 Cg_exo -41.08 127.61 2.8 Favored 'Trans proline' 0 C--N 1.348 0.5 0 CA-C-N 121.465 1.559 . . . . 0.0 111.225 166.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -41.67 148.16 0.34 Allowed 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 123.826 3.017 . . . . 0.0 112.568 -177.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 142.31 -163.75 27.06 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 119.763 -1.208 . . . . 0.0 111.07 -162.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . 0.62 ' C ' HD22 ' A' ' 381' ' ' ASN . 4.8 m-20 -89.44 115.87 27.2 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 117.32 0.56 . . . . 0.0 111.163 -176.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.62 HD22 ' C ' ' A' ' 380' ' ' ASP . 0.8 OUTLIER -126.62 147.55 49.89 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.039 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 0.99 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -148.71 137.73 15.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 176.609 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . 0.668 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 28.2 mt -99.49 132.69 44.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.206 -173.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 384' ' ' TYR . . . . . 0.619 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 1.8 m-85 -106.13 99.91 9.48 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.177 -1.374 . . . . 0.0 109.071 170.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . 0.773 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 2.8 t -84.83 86.61 2.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 174.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 60.42 -106.36 1.03 Allowed Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 120.003 -1.094 . . . . 0.0 110.718 -169.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 387' ' ' ASP . . . . . 0.448 ' HB2' ' HB2' ' A' ' 309' ' ' LYS . 17.8 t70 -89.97 -14.36 34.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.502 0.192 . . . . 0.0 111.325 176.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.951 HD13 ' HD1' ' A' ' 312' ' ' PHE . 3.0 mp -67.67 153.82 42.85 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 176.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . 0.668 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 30.5 p-10 -163.75 154.42 15.78 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.017 176.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . 0.781 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 9.2 t60 -173.41 116.38 0.26 Allowed 'General case' 0 C--O 1.241 0.633 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 174.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 391' ' ' GLN . . . . . 0.99 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 8.6 tt0 -80.59 153.67 27.89 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.973 -177.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 392' ' ' TRP . . . . . 0.496 ' HD1' ' OE1' ' A' ' 394' ' ' GLN . 32.0 t-105 -166.09 153.15 9.77 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.964 -1.017 . . . . 0.0 109.208 -176.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -110.11 118.06 35.38 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 0.933 ' HG3' HE22 ' A' ' 375' ' ' GLN . 4.0 mm100 -80.33 104.11 10.66 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -173.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.153 -0.927 . . . . 0.0 111.293 -174.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . 0.458 ' O ' HG23 ' A' ' 303' ' ' THR . 10.2 t . . . . . 0 CA--C 1.536 0.416 0 CA-C-O 121.89 0.852 . . . . 0.0 111.374 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . 0.554 ' HB3' ' NE ' ' A' ' 336' ' ' ARG . 17.2 p90 -67.06 130.77 44.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.814 174.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.527 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 14.8 t 173.1 -169.17 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -175.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 41.3 t -66.43 112.42 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 169.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.0 140.41 57.71 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -172.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . 0.584 ' OD1' HG22 ' A' ' 310' ' ' THR . 12.5 t70 -62.24 130.92 47.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.538 0.685 . . . . 0.0 111.46 -170.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 18.3 pttm -38.47 -29.71 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 113.175 -1.829 . . . . 0.0 115.066 -177.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.584 HG22 ' OD1' ' A' ' 308' ' ' ASP . 12.0 t -108.37 0.28 21.07 Favored 'General case' 0 N--CA 1.443 -0.817 0 O-C-N 121.685 -0.634 . . . . 0.0 112.425 -170.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -84.87 -29.18 25.48 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -173.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.456 ' HA ' ' O ' ' A' ' 331' ' ' GLY . 0.1 OUTLIER -81.1 173.76 12.25 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.639 0.733 . . . . 0.0 111.012 -179.75 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 6.4 t -147.49 159.02 44.2 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.004 -178.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . 0.454 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 25.3 m-90 -71.03 122.02 19.28 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 178.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.713 ' HD3' ' HB3' ' A' ' 329' ' ' GLU . 70.8 tttt -102.52 -42.92 5.79 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 173.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.821 ' HB3' ' HB2' ' A' ' 329' ' ' GLU . 19.8 ttm-85 -149.39 128.15 12.5 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.85 169.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -71.52 158.73 87.32 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . 0.519 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 3.3 Cg_exo -43.01 111.15 0.2 Allowed 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 122.65 2.233 . . . . 0.0 112.487 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 32.2 m -129.26 131.27 46.98 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.624 -174.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -59.34 125.32 23.14 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . 0.413 ' HB3' HG13 ' A' ' 327' ' ' VAL . 86.6 p -58.79 -45.08 90.67 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.832 -173.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 136.7 -3.52 3.52 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.363 176.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 6.3 t-80 -143.7 70.68 1.31 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.052 0.453 . . . . 0.0 110.304 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 58.31 30.14 19.11 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.01 -0.995 . . . . 0.0 113.666 175.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . 0.617 ' HA ' ' CG ' ' A' ' 375' ' ' GLN . 11.1 p -153.48 179.2 9.02 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.816 HG23 ' HG2' ' A' ' 375' ' ' GLN . 0.5 OUTLIER -134.03 144.76 34.57 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.404 0 CA-C-O 121.106 0.479 . . . . 0.0 111.142 -172.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' VAL . . . . . 0.796 HG12 ' HG3' ' A' ' 373' ' ' GLU . 14.1 m -118.86 155.52 21.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.662 175.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 328' ' ' MET . . . . . 0.619 ' HG3' HG13 ' A' ' 372' ' ' ILE . 0.0 OUTLIER -143.56 153.42 42.55 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 176.71 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.821 ' HB2' ' HB3' ' A' ' 316' ' ' ARG . 8.9 mt-10 -134.7 133.43 39.99 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.003 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.592 HG23 ' HA3' ' A' ' 369' ' ' GLY . 2.4 m -132.81 159.05 43.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.004 0.431 . . . . 0.0 111.853 -179.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . 0.488 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -129.27 136.21 8.86 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.19 -1.005 . . . . 0.0 112.582 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . 0.419 ' HD1' ' CA ' ' A' ' 368' ' ' GLY . 2.1 p90 -90.31 154.45 19.7 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.682 0.753 . . . . 0.0 111.807 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 27.6 p -119.1 30.69 7.02 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.528 -1.214 . . . . 0.0 112.515 173.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 164.65 -51.29 0.29 Allowed Glycine 0 C--O 1.225 -0.465 0 C-N-CA 119.388 -1.387 . . . . 0.0 114.122 169.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' THR . . . . . . . . . . . . . 2.8 m -55.79 124.47 17.63 Favored 'General case' 0 C--N 1.317 -0.827 0 O-C-N 123.695 0.291 . . . . 0.0 111.5 -178.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.722 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 5.5 ppt_? -80.66 -178.63 1.2 Allowed Pre-proline 0 N--CA 1.462 0.132 0 CA-C-O 116.921 -1.514 . . . . 0.0 107.843 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.868 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.7 OUTLIER -24.35 96.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 123.566 2.844 . . . . 0.0 113.733 -179.083 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 338' ' ' CYS . . . . . 0.598 ' SG ' ' HB2' ' A' ' 364' ' ' MET . 18.3 p -117.76 -176.8 3.11 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.091 -1.868 . . . . 0.0 109.927 -168.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -110.35 103.76 12.46 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -178.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . 0.736 HG12 ' HG3' ' A' ' 364' ' ' MET . 55.4 mt -72.2 121.15 83.93 Favored Pre-proline 0 C--N 1.328 -0.364 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.48 -171.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 341' ' ' PRO . . . . . 0.424 ' O ' ' HA ' ' A' ' 385' ' ' VAL . 74.2 Cg_endo -79.83 77.9 3.9 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 121.556 1.504 . . . . 0.0 110.947 174.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.754 HG13 HG13 ' A' ' 385' ' ' VAL . 0.0 OUTLIER -105.08 117.66 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-O 122.238 1.018 . . . . 0.0 110.555 175.628 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.486 ' HG3' ' HB2' ' A' ' 384' ' ' TYR . 25.9 ptt180 -130.49 179.34 5.99 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 113.575 -1.648 . . . . 0.0 106.983 177.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 344' ' ' ALA . . . . . 0.518 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -149.29 147.66 28.62 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.963 175.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.447 HG22 HD12 ' A' ' 382' ' ' ILE . 10.5 m -119.52 141.7 38.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 176.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.53 116.68 7.05 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 347' ' ' HIS . . . . . 0.576 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 57.9 t-80 44.67 65.89 0.98 Allowed 'General case' 0 N--CA 1.472 0.626 0 O-C-N 124.345 1.028 . . . . 0.0 111.447 175.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . 0.52 ' H ' ' CG2' ' A' ' 382' ' ' ILE . . . 42.97 41.14 4.47 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 115.096 0.799 . . . . 0.0 115.096 -175.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 347' ' ' HIS . 87.6 t -140.5 102.49 6.58 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 118.112 0.956 . . . . 0.0 108.661 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -74.63 66.25 5.68 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 122.99 2.46 . . . . 0.0 113.376 -178.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -100.47 -57.79 2.04 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 174.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 5.9 p -116.98 130.69 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.641 174.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . 0.518 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 38.1 t30 -62.92 108.26 1.16 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.423 171.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.432 HG23 ' CB ' ' A' ' 344' ' ' ALA . 20.4 m -88.96 5.28 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.0 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 355' ' ' ALA . . . . . 0.45 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -77.46 82.03 3.92 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.317 0.58 . . . . 0.0 110.436 177.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 356' ' ' MET . . . . . 0.535 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 39.1 ttm -98.03 99.83 11.12 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 172.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.672 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 46.4 mt -85.15 146.71 26.98 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.38 -159.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.751 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 2.4 mm -90.81 -21.7 6.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 176.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 97.5 m -127.1 84.83 62.47 Favored Pre-proline 0 N--CA 1.446 -0.655 0 CA-C-N 113.216 -1.811 . . . . 0.0 108.257 172.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -80.62 27.6 0.56 Allowed 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.798 2.332 . . . . 0.0 112.758 -175.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -147.66 61.66 6.35 Favored Pre-proline 0 C--N 1.315 -0.901 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.512 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . 0.466 ' HB2' HD12 ' A' ' 340' ' ' ILE . 90.2 Cg_endo -85.11 102.39 0.78 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.124 1.883 . . . . 0.0 112.066 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 363' ' ' THR . . . . . 0.436 HG22 ' O ' ' A' ' 338' ' ' CYS . 1.3 p -93.04 168.87 10.84 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 122.05 0.929 . . . . 0.0 113.273 171.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 364' ' ' MET . . . . . 0.868 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 43.9 mtt . . . . . 0 CA--C 1.499 -0.989 0 CA-C-N 113.819 -1.537 . . . . 0.0 109.324 174.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . 0.488 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . . . . . . 0 N--CA 1.452 -0.271 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . 0.592 ' HA3' HG23 ' A' ' 330' ' ' VAL . . . -70.62 95.65 0.54 Allowed Glycine 0 CA--C 1.507 -0.425 0 C-N-CA 120.081 -1.057 . . . . 0.0 110.78 168.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -70.94 -27.17 72.67 Favored Glycine 0 C--N 1.313 -0.71 0 CA-C-N 115.166 -0.517 . . . . 0.0 112.939 -166.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -164.44 136.71 4.71 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.942 0.401 . . . . 0.0 110.685 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 372' ' ' ILE . . . . . 0.619 HG13 ' HG3' ' A' ' 328' ' ' MET . 0.4 OUTLIER -127.31 145.4 34.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 173.005 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . 0.796 ' HG3' HG12 ' A' ' 327' ' ' VAL . 3.8 mp0 -127.38 127.09 43.63 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 175.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . 0.7 ' HG2' HD11 ' A' ' 383' ' ' ILE . 4.3 ppp? -138.3 166.83 23.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.926 -175.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 375' ' ' GLN . . . . . 0.816 ' HG2' HG23 ' A' ' 326' ' ' VAL . 0.0 OUTLIER -173.9 175.32 2.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.194 0.521 . . . . 0.0 110.59 165.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 376' ' ' LEU . . . . . 0.74 HD22 ' HD2' ' A' ' 377' ' ' PRO . 2.2 tm? -167.79 129.42 1.22 Allowed Pre-proline 0 C--N 1.315 -0.903 0 N-CA-C 105.11 -2.181 . . . . 0.0 105.11 176.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 377' ' ' PRO . . . . . 0.74 ' HD2' HD22 ' A' ' 376' ' ' LEU . 58.7 Cg_exo -24.97 125.79 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 124.503 3.469 . . . . 0.0 112.874 -179.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -35.51 134.42 0.22 Allowed 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 124.82 3.68 . . . . 0.0 113.019 -165.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 157.7 -171.79 34.88 Favored Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -159.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . 0.576 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 5.7 m-20 -97.07 127.46 43.06 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 117.494 0.647 . . . . 0.0 110.342 -178.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.587 HD22 ' HG2' ' A' ' 394' ' ' GLN . 25.5 m-80 -131.09 168.56 17.21 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 1.021 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -158.87 140.18 4.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 169.775 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . 0.7 HD11 ' HG2' ' A' ' 374' ' ' MET . 44.3 mt -99.82 130.44 48.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 C-N-CA 119.656 -0.818 . . . . 0.0 109.473 -175.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 384' ' ' TYR . . . . . 0.486 ' HB2' ' HG3' ' A' ' 343' ' ' ARG . 2.5 m-85 -100.95 136.6 40.55 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 169.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . 0.754 HG13 HG13 ' A' ' 342' ' ' VAL . 6.1 t -126.67 85.47 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 176.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 66.56 -109.75 3.09 Favored Glycine 0 N--CA 1.435 -1.432 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 -166.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -95.47 -7.52 37.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.856 0.328 . . . . 0.0 111.883 172.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.492 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 1.4 mp -66.05 150.07 49.27 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 173.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . 0.54 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 7.7 p30 -166.05 154.78 11.22 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 121.275 -0.17 . . . . 0.0 110.669 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . 0.519 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 3.9 t60 -173.49 116.34 0.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.145 176.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 391' ' ' GLN . . . . . 1.021 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 6.3 tt0 -77.64 153.85 32.78 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.209 0.528 . . . . 0.0 112.364 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 392' ' ' TRP . . . . . 0.446 ' HD1' ' OE1' ' A' ' 394' ' ' GLN . 17.1 t-105 -169.53 147.71 3.61 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.054 176.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . 0.523 ' HB2' ' HE3' ' A' ' 395' ' ' LYS . 5.9 p90 -102.27 114.9 29.46 Favored 'General case' 0 C--N 1.313 -0.987 0 O-C-N 121.408 -0.807 . . . . 0.0 109.023 -178.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 0.762 ' HG3' HE22 ' A' ' 375' ' ' GLN . 2.8 mm100 -83.23 107.17 15.59 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -171.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.523 ' HE3' ' HB2' ' A' ' 393' ' ' PHE . 33.7 mmtp . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.022 -0.989 . . . . 0.0 109.965 -172.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 2.4 t . . . . . 0 CA--C 1.534 0.362 0 CA-C-O 121.306 0.574 . . . . 0.0 111.753 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . 0.525 ' HB3' ' NE ' ' A' ' 336' ' ' ARG . 21.7 p90 -63.11 124.27 20.72 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.931 0.396 . . . . 0.0 110.563 172.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.596 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 9.7 t -179.85 -176.75 0.36 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -176.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 47.8 t -64.21 112.69 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 166.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . 0.691 ' HB2' ' CZ ' ' A' ' 332' ' ' PHE . 0.0 OUTLIER -68.16 138.55 55.76 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.032 0.444 . . . . 0.0 110.456 -171.088 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . 0.588 ' OD2' HG22 ' A' ' 310' ' ' THR . 14.7 t70 -61.32 133.12 55.51 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.01 -171.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.432 ' O ' ' CE1' ' A' ' 312' ' ' PHE . 22.1 pttp -38.59 -28.94 0.03 OUTLIER 'General case' 0 C--O 1.22 -0.5 0 CA-C-N 113.097 -1.865 . . . . 0.0 114.973 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.588 HG22 ' OD2' ' A' ' 308' ' ' ASP . 13.5 t -109.05 10.4 26.13 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 119.286 0.948 . . . . 0.0 113.192 -169.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . 0.5 ' HB2' ' CE2' ' A' ' 332' ' ' PHE . 28.6 mtpp -96.02 -19.76 19.22 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 -174.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.846 ' HD1' HD13 ' A' ' 388' ' ' LEU . 0.3 OUTLIER -86.43 173.0 9.95 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.937 0.875 . . . . 0.0 111.882 177.124 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 8.9 t -153.34 162.11 41.63 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 113.981 -1.463 . . . . 0.0 109.131 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 14.5 m-90 -76.17 95.47 3.69 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 120.884 0.373 . . . . 0.0 110.38 -177.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.562 ' HB3' ' HB3' ' A' ' 329' ' ' GLU . 59.4 tttm -65.68 -46.62 78.39 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 165.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.62 ' HB3' ' HB2' ' A' ' 329' ' ' GLU . 40.7 ttt180 -153.09 128.32 9.81 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 114.45 -1.25 . . . . 0.0 108.864 169.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . 0.516 ' HB1' ' CG ' ' A' ' 390' ' ' HIS . . . -74.45 160.93 80.09 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-O 118.757 -0.64 . . . . 0.0 109.871 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 85.5 Cg_exo -36.87 108.87 0.06 OUTLIER 'Trans proline' 0 C--N 1.362 1.282 0 C-N-CA 123.149 2.566 . . . . 0.0 113.36 -178.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 18.6 m -127.44 132.86 49.99 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.944 -175.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . 0.571 ' HB2' ' CZ2' ' A' ' 392' ' ' TRP . 13.5 t70 -55.61 124.95 19.06 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 60.0 p -62.98 -46.73 86.32 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.411 0.624 . . . . 0.0 110.116 -173.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 122.8 -7.94 9.38 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -124.47 56.79 1.27 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.141 -0.529 . . . . 0.0 110.703 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . 0.587 ' HA ' ' HD3' ' A' ' 395' ' ' LYS . 21.5 m-20 56.87 31.19 19.22 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.458 176.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . 0.54 ' HB ' HG13 ' A' ' 358' ' ' ILE . 15.7 p -150.67 -179.26 7.1 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -178.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 1.3 t -129.57 144.42 38.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.178 0.513 . . . . 0.0 110.973 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 327' ' ' VAL . . . . . 0.641 HG12 ' HG2' ' A' ' 373' ' ' GLU . 16.7 m -120.06 154.48 23.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.336 176.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 328' ' ' MET . . . . . 0.536 ' SD ' HG13 ' A' ' 330' ' ' VAL . 0.0 OUTLIER -143.15 147.07 34.35 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 176.722 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.62 ' HB2' ' HB3' ' A' ' 316' ' ' ARG . 9.0 mt-10 -130.32 128.13 40.88 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 121.076 0.465 . . . . 0.0 110.957 -176.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.536 HG13 ' SD ' ' A' ' 328' ' ' MET . 0.0 OUTLIER -128.35 149.8 33.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.928 -175.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . 0.662 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -128.72 141.78 12.9 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.503 -0.856 . . . . 0.0 113.094 -179.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . 0.721 ' HE1' ' HD2' ' A' ' 312' ' ' PHE . 3.5 m-85 -112.81 178.03 4.43 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.358 0.663 . . . . 0.0 111.041 174.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 50.7 m -136.03 4.41 2.98 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 170.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -145.68 -62.93 0.01 OUTLIER Glycine 0 C--N 1.34 0.767 0 C-N-CA 119.029 -1.558 . . . . 0.0 114.768 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' THR . . . . . 0.441 HG22 ' HB3' ' A' ' 338' ' ' CYS . 13.9 m -53.95 132.46 42.16 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.122 0.487 . . . . 0.0 111.11 -175.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.882 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 2.8 ptm180 -82.29 -176.76 0.83 Allowed Pre-proline 0 C--O 1.226 -0.133 0 CA-C-O 117.981 -1.009 . . . . 0.0 108.952 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.882 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.4 OUTLIER -31.7 98.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 123.264 2.643 . . . . 0.0 112.802 174.172 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 338' ' ' CYS . . . . . 0.596 ' HB2' ' O ' ' A' ' 305' ' ' THR . 26.3 p -119.91 -174.25 2.72 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 113.522 -1.672 . . . . 0.0 109.578 -170.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -108.96 107.12 17.37 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -178.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . 0.884 HD12 ' HB2' ' A' ' 362' ' ' PRO . 32.9 mt -73.26 120.12 79.37 Favored Pre-proline 0 C--N 1.329 -0.313 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.963 -173.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -77.11 80.36 2.89 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.187 1.925 . . . . 0.0 111.202 175.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.698 HG13 HG22 ' A' ' 340' ' ' ILE . 11.7 m -97.41 146.3 7.89 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.662 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.091 178.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.453 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 24.4 ptt180 -163.82 171.98 14.72 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 172.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 344' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -147.97 143.66 27.46 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.797 177.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.416 ' HB ' ' HA ' ' A' ' 350' ' ' PRO . 6.2 m -115.96 144.39 23.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -63.23 117.13 6.14 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.279 -0.418 . . . . 0.0 112.014 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 347' ' ' HIS . . . . . 0.729 ' HB3' ' HB2' ' A' ' 380' ' ' ASP . 11.6 p80 30.37 75.5 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 O-C-N 124.721 1.263 . . . . 0.0 113.671 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . 0.768 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 53.64 28.44 37.83 Favored Glycine 0 CA--C 1.519 0.337 0 N-CA-C 115.69 1.036 . . . . 0.0 115.69 178.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 347' ' ' HIS . 46.9 t -137.15 101.79 9.2 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 118.948 1.374 . . . . 0.0 108.731 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 350' ' ' PRO . . . . . 0.416 ' HA ' ' HB ' ' A' ' 345' ' ' VAL . 15.2 Cg_exo -73.06 66.51 4.17 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 123.112 2.542 . . . . 0.0 112.865 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -99.87 -55.39 2.66 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.282 -1.006 . . . . 0.0 108.282 177.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 4.7 p -130.1 136.2 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.215 174.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . 0.478 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 52.1 t30 -63.18 117.82 7.07 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.187 177.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 30.5 m -95.25 5.1 8.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.844 176.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 355' ' ' ALA . . . . . 0.4 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -77.47 84.16 3.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.235 0.541 . . . . 0.0 111.405 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.94 102.9 14.77 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 170.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.571 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 32.3 mt -83.45 117.93 23.4 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.41 -162.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.697 HD11 ' HB3' ' A' ' 375' ' ' GLN . 4.4 mm -59.54 -29.12 41.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.358 173.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 12.6 m -131.91 94.12 25.55 Favored Pre-proline 0 N--CA 1.446 -0.672 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.573 172.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -81.83 34.6 0.55 Allowed 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 123.522 2.815 . . . . 0.0 112.899 -173.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -151.63 70.68 8.11 Favored Pre-proline 0 C--N 1.316 -0.889 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.98 177.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . 0.983 ' HB3' HG23 ' A' ' 372' ' ' ILE . 60.3 Cg_endo -80.88 141.02 13.1 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.313 2.008 . . . . 0.0 111.314 175.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 363' ' ' THR . . . . . 0.611 ' O ' ' HA2' ' A' ' 369' ' ' GLY . 1.0 OUTLIER -143.66 143.25 31.36 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -174.11 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 364' ' ' MET . . . . . 0.807 ' HA ' ' HA2' ' A' ' 369' ' ' GLY . 5.2 mmt . . . . . 0 CA--C 1.5 -0.954 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . 0.662 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . . . . . . 0 N--CA 1.453 -0.207 0 N-CA-C 112.257 -0.337 . . . . 0.0 112.257 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . 0.807 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -68.07 -24.99 74.58 Favored Glycine 0 C--N 1.333 0.368 0 N-CA-C 114.132 0.413 . . . . 0.0 114.132 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . 0.591 ' O ' ' HG2' ' A' ' 329' ' ' GLU . . . 85.37 -58.15 4.91 Favored Glycine 0 C--N 1.318 -0.417 0 C-N-CA 120.143 -1.027 . . . . 0.0 113.313 178.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -165.87 145.84 6.45 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.14 0.495 . . . . 0.0 112.173 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 372' ' ' ILE . . . . . 0.983 HG23 ' HB3' ' A' ' 362' ' ' PRO . 0.7 OUTLIER -136.13 156.25 36.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.451 171.441 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . 0.641 ' HG2' HG12 ' A' ' 327' ' ' VAL . 42.5 mt-10 -134.4 126.54 29.77 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -178.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . 0.571 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 2.9 mtt -142.65 165.03 28.49 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -176.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 375' ' ' GLN . . . . . 0.863 ' HA ' HE21 ' A' ' 375' ' ' GLN . 0.0 OUTLIER -178.62 173.45 1.3 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.784 0.326 . . . . 0.0 110.296 176.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 376' ' ' LEU . . . . . 0.722 HD22 ' HD2' ' A' ' 377' ' ' PRO . 2.0 tm? -165.62 139.62 3.79 Favored Pre-proline 0 C--N 1.318 -0.785 0 N-CA-C 104.44 -2.43 . . . . 0.0 104.44 -177.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 377' ' ' PRO . . . . . 0.722 ' HD2' HD22 ' A' ' 376' ' ' LEU . 37.8 Cg_exo -33.89 129.63 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.761 2.307 . . . . 0.0 112.299 175.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.758 ' HA ' HE22 ' A' ' 394' ' ' GLN . 75.8 Cg_exo -34.03 138.85 0.08 OUTLIER 'Trans proline' 0 C--N 1.362 1.243 0 C-N-CA 124.926 3.75 . . . . 0.0 113.932 -170.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 155.32 -158.38 28.38 Favored Glycine 0 N--CA 1.441 -0.975 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 -163.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . 0.729 ' HB2' ' HB3' ' A' ' 347' ' ' HIS . 8.9 m-20 -109.32 132.79 53.8 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 118.149 0.974 . . . . 0.0 111.522 175.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -126.25 168.7 13.73 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 176.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 1.053 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -160.05 138.49 2.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 168.048 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . 0.614 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 57.6 mt -99.16 128.81 50.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 C-N-CA 120.074 -0.65 . . . . 0.0 109.926 -173.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 384' ' ' TYR . . . . . 0.453 ' O ' ' HG2' ' A' ' 343' ' ' ARG . 0.2 OUTLIER -104.26 99.57 9.29 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 114.302 -1.317 . . . . 0.0 108.791 170.771 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . 0.499 ' O ' ' HB2' ' A' ' 388' ' ' LEU . 11.5 t -94.77 88.21 2.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 174.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 67.82 -116.99 8.24 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.123 -1.037 . . . . 0.0 110.851 -174.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -92.43 -4.26 53.98 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 117.783 0.792 . . . . 0.0 111.684 171.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.846 HD13 ' HD1' ' A' ' 312' ' ' PHE . 2.5 mp -71.15 150.79 45.05 Favored 'General case' 0 CA--C 1.522 -0.113 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 172.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . 0.614 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 7.3 p30 -164.44 152.22 12.11 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.651 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . 0.948 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 30.5 t60 -175.56 119.5 0.17 Allowed 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.493 0.495 . . . . 0.0 110.4 176.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 391' ' ' GLN . . . . . 1.053 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 15.0 tt0 -78.03 153.24 32.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.404 0.621 . . . . 0.0 112.582 -179.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 392' ' ' TRP . . . . . 0.571 ' CZ2' ' HB2' ' A' ' 320' ' ' ASP . 52.7 t-105 -153.49 143.59 22.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.884 178.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -104.48 110.03 22.14 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 176.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 0.758 HE22 ' HA ' ' A' ' 378' ' ' PRO . 0.0 OUTLIER -101.23 134.34 44.43 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 121.822 -0.549 . . . . 0.0 111.617 -164.847 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.587 ' HD3' ' HA ' ' A' ' 324' ' ' ASP . 13.2 mmmm . . . . . 0 C--O 1.245 0.824 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.794 -178.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 7.5 t . . . . . 0 CA--C 1.537 0.446 0 CA-C-O 121.12 0.486 . . . . 0.0 111.799 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . 0.636 ' HB2' ' O ' ' A' ' 337' ' ' PRO . 39.7 p90 -67.1 129.59 40.38 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.467 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 12.4 t 173.02 -167.18 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -170.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 7.8 p -62.09 112.17 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 172.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -73.54 137.75 44.56 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.175 -173.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . 0.738 ' OD1' HG22 ' A' ' 310' ' ' THR . 9.4 t70 -60.36 119.9 8.84 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.034 177.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.506 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 29.0 pttt -42.09 -22.45 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 115.961 1.837 . . . . 0.0 115.961 -175.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.738 HG22 ' OD1' ' A' ' 308' ' ' ASP . 6.2 t -107.54 12.44 27.73 Favored 'General case' 0 C--N 1.314 -0.959 0 O-C-N 121.331 -0.856 . . . . 0.0 111.206 -170.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . 0.459 ' HE3' ' OG1' ' A' ' 335' ' ' THR . 19.9 mtmm -96.37 -22.94 16.87 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -174.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.539 ' HA ' ' O ' ' A' ' 331' ' ' GLY . 0.1 OUTLIER -85.86 174.62 9.17 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.517 0.675 . . . . 0.0 110.957 176.678 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 13.2 t -147.83 158.46 44.04 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.34 -177.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . 0.496 ' HZ3' ' HB2' ' A' ' 328' ' ' MET . 19.2 m95 -79.44 95.61 5.83 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-O 121.018 0.437 . . . . 0.0 110.775 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.555 ' HG2' ' OE1' ' A' ' 329' ' ' GLU . 4.3 ttpp -69.91 -43.49 71.6 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 169.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 3.8 ttm180 -153.04 101.85 2.6 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.634 174.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -41.49 154.77 0.23 Allowed Pre-proline 0 N--CA 1.476 0.83 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 171.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . 0.461 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 3.8 Cg_exo -38.17 114.17 0.16 Allowed 'Trans proline' 0 C--N 1.366 1.493 0 C-N-CA 123.777 2.985 . . . . 0.0 113.228 -176.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 16.9 m -134.38 137.39 44.07 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.32 -174.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -59.17 131.32 50.67 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -177.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . 0.641 ' HB3' HG13 ' A' ' 327' ' ' VAL . 51.5 p -80.34 5.86 13.66 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 122.149 -0.344 . . . . 0.0 111.6 -175.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 74.0 -22.34 1.22 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.105 -175.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . 0.411 ' H ' ' C ' ' A' ' 321' ' ' SER . 94.7 m-70 -102.33 47.77 0.89 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.381 0.61 . . . . 0.0 110.328 -177.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . 0.431 ' O ' HG23 ' A' ' 325' ' ' THR . 4.9 t70 55.94 39.18 30.59 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 114.403 -1.272 . . . . 0.0 111.659 174.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . 0.431 HG23 ' O ' ' A' ' 324' ' ' ASP . 4.0 p -160.29 -171.59 3.24 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.766 ' HB ' ' SD ' ' A' ' 374' ' ' MET . 0.3 OUTLIER -132.57 146.2 33.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.546 0.689 . . . . 0.0 111.558 -175.125 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 327' ' ' VAL . . . . . 0.677 HG12 ' HG2' ' A' ' 373' ' ' GLU . 14.9 m -122.61 157.81 27.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.276 175.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 328' ' ' MET . . . . . 0.631 ' SD ' HD13 ' A' ' 383' ' ' ILE . 0.0 OUTLIER -135.62 146.67 48.14 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 173.223 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.555 ' OE1' ' HG2' ' A' ' 315' ' ' LYS . 9.5 tt0 -120.67 122.4 40.39 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -177.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 2.7 m -128.76 151.56 35.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.521 0.201 . . . . 0.0 111.301 -176.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . 0.826 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -126.84 139.4 11.22 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.478 -177.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . 0.434 ' H ' ' HA2' ' A' ' 368' ' ' GLY . 0.8 OUTLIER -89.37 152.88 21.27 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.367 0.603 . . . . 0.0 111.858 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 8.7 t -107.39 2.12 24.15 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 174.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -173.38 -63.6 0.05 OUTLIER Glycine 0 C--N 1.341 0.834 0 C-N-CA 118.676 -1.726 . . . . 0.0 115.144 175.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 335' ' ' THR . . . . . 0.459 ' OG1' ' HE3' ' A' ' 311' ' ' LYS . 51.5 m -52.46 134.13 34.96 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 123.805 0.356 . . . . 0.0 111.251 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.644 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 16.1 ptt180 -90.62 -175.95 0.58 Allowed Pre-proline 0 CA--C 1.536 0.429 0 CA-C-O 117.212 -1.375 . . . . 0.0 108.624 -175.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.7 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.1 OUTLIER -24.07 96.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 124.061 3.174 . . . . 0.0 114.65 -170.869 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 338' ' ' CYS . . . . . 0.734 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 3.9 p -109.95 -176.05 2.9 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 113.719 -1.582 . . . . 0.0 110.32 -169.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -112.16 96.3 5.95 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 177.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . 0.762 HG22 HG13 ' A' ' 342' ' ' VAL . 61.9 mt -78.18 118.86 74.79 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.302 -169.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -79.65 82.46 2.49 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.837 2.358 . . . . 0.0 111.903 177.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.762 HG13 HG22 ' A' ' 340' ' ' ILE . 4.2 m -100.94 123.68 54.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.504 0.669 . . . . 0.0 110.669 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -132.07 173.97 10.67 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 176.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 344' ' ' ALA . . . . . 0.542 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -144.96 140.97 28.6 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.718 175.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.521 HG22 HD12 ' A' ' 382' ' ' ILE . 10.6 m -114.62 140.59 34.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.423 ' HB2' ' CG1' ' A' ' 354' ' ' VAL . . . -67.62 121.4 15.81 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 347' ' ' HIS . . . . . 0.574 ' O ' HG23 ' A' ' 349' ' ' VAL . 6.9 t60 46.62 59.79 3.7 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 124.336 1.022 . . . . 0.0 111.038 174.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . 0.473 ' H ' ' CG2' ' A' ' 382' ' ' ILE . . . 45.86 39.16 8.4 Favored Glycine 0 C--N 1.335 0.515 0 N-CA-C 115.097 0.799 . . . . 0.0 115.097 -174.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 347' ' ' HIS . 58.9 t -137.35 102.19 8.94 Favored Pre-proline 0 C--O 1.235 0.301 0 CA-C-N 118.219 1.009 . . . . 0.0 108.949 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -75.82 61.38 6.28 Favored 'Trans proline' 0 N--CA 1.464 -0.209 0 C-N-CA 122.802 2.334 . . . . 0.0 113.245 -178.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -100.51 -56.76 2.26 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 175.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 2.3 p -117.48 127.49 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.535 174.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -63.38 112.08 2.57 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.774 175.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.654 HG12 ' HG ' ' A' ' 376' ' ' LEU . 4.2 m -92.68 9.02 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.713 177.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 355' ' ' ALA . . . . . 0.542 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -79.17 82.97 5.28 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.147 0.498 . . . . 0.0 111.041 176.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 5.4 tmm? -92.92 100.5 12.95 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 169.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 22.2 mt -86.89 117.87 25.9 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.072 -163.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.73 ' HB ' ' CB ' ' A' ' 373' ' ' GLU . 2.7 mm -61.46 -25.03 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.632 175.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 19.5 m -138.91 93.72 10.41 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.828 173.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -88.61 41.1 0.57 Allowed 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 123.275 2.65 . . . . 0.0 114.063 -171.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -161.83 72.48 2.41 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-O 121.235 0.54 . . . . 0.0 109.779 175.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . 0.872 ' HB3' HG23 ' A' ' 372' ' ' ILE . 87.8 Cg_endo -82.58 108.57 1.71 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.79 2.327 . . . . 0.0 112.302 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 16.8 p -89.78 144.28 26.1 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.671 0.748 . . . . 0.0 112.326 171.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 364' ' ' MET . . . . . 0.734 ' HG2' ' SG ' ' A' ' 338' ' ' CYS . 5.7 ptp . . . . . 0 CA--C 1.499 -0.981 0 CA-C-N 114.387 -1.279 . . . . 0.0 108.153 174.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . 0.826 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . . . . . . 0 N--CA 1.444 -0.817 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -48.23 -34.31 12.47 Favored Glycine 0 CA--C 1.519 0.313 0 CA-C-N 117.725 0.763 . . . . 0.0 113.303 172.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . 0.49 ' O ' ' HG3' ' A' ' 329' ' ' GLU . . . 81.53 -58.17 4.88 Favored Glycine 0 C--O 1.227 -0.314 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.584 176.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -165.19 137.82 4.42 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.043 0.449 . . . . 0.0 111.125 178.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 372' ' ' ILE . . . . . 0.872 HG23 ' HB3' ' A' ' 362' ' ' PRO . 0.9 OUTLIER -134.4 159.1 42.12 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 172.846 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . 0.73 ' CB ' ' HB ' ' A' ' 358' ' ' ILE . 36.5 mt-10 -128.21 125.92 39.94 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.581 -177.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . 0.766 ' SD ' ' HB ' ' A' ' 326' ' ' VAL . 0.0 OUTLIER -136.43 160.37 38.97 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -179.083 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 375' ' ' GLN . . . . . 0.9 ' HA ' HE21 ' A' ' 375' ' ' GLN . 0.0 OUTLIER -177.91 170.11 1.93 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.918 0.39 . . . . 0.0 110.208 172.592 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 376' ' ' LEU . . . . . 0.75 HD22 ' HD2' ' A' ' 377' ' ' PRO . 2.3 tm? -166.93 131.81 1.66 Allowed Pre-proline 0 N--CA 1.439 -0.991 0 N-CA-C 104.537 -2.394 . . . . 0.0 104.537 -178.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 377' ' ' PRO . . . . . 0.75 ' HD2' HD22 ' A' ' 376' ' ' LEU . 35.7 Cg_exo -28.95 131.0 0.04 OUTLIER 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 123.788 2.992 . . . . 0.0 112.811 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -35.56 138.21 0.15 Allowed 'Trans proline' 0 C--N 1.359 1.106 0 C-N-CA 124.658 3.572 . . . . 0.0 113.582 -166.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 151.87 -165.07 30.56 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 -160.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . 0.471 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 15.8 m-20 -99.7 128.78 45.8 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 117.925 0.862 . . . . 0.0 111.23 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.433 HD21 ' HB3' ' A' ' 376' ' ' LEU . 9.5 m120 -128.43 159.79 34.3 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 174.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 1.024 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -150.55 139.1 14.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 170.313 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . 0.668 HD11 ' SD ' ' A' ' 374' ' ' MET . 31.5 mt -99.51 127.02 52.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.44 -176.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 384' ' ' TYR . . . . . 0.444 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.2 OUTLIER -104.41 92.54 4.37 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.226 174.017 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . 0.529 ' O ' ' HB2' ' A' ' 388' ' ' LEU . 20.3 t -85.13 86.19 2.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 178.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 60.46 -112.57 4.66 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.287 -0.959 . . . . 0.0 111.341 -170.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 387' ' ' ASP . . . . . 0.408 ' N ' ' HB2' ' A' ' 309' ' ' LYS . 4.9 t70 -82.86 -17.05 45.23 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.008 0.432 . . . . 0.0 110.793 176.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.529 ' HB2' ' O ' ' A' ' 385' ' ' VAL . 2.3 mp -69.38 151.83 45.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.209 177.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . 0.657 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 7.6 p30 -165.37 153.34 11.24 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.575 176.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . 0.461 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 35.5 t-80 -173.74 113.74 0.21 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.323 177.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 391' ' ' GLN . . . . . 1.024 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 13.6 tt0 -73.65 154.62 39.64 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.293 177.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 392' ' ' TRP . . . . . 0.553 ' HD1' ' OE1' ' A' ' 394' ' ' GLN . 17.8 t-105 -166.63 150.99 7.41 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.77 177.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -105.33 115.89 31.03 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 0.775 ' HG3' HE22 ' A' ' 375' ' ' GLN . 3.5 mm100 -84.4 113.96 21.55 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -170.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 1.7 ptmm? . . . . . 0 C--O 1.251 1.172 0 CA-C-O 118.442 -0.79 . . . . 0.0 110.818 -178.252 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . 0.54 HG23 HG23 ' A' ' 335' ' ' THR . 10.4 t . . . . . 0 CA--C 1.539 0.543 0 CA-C-O 121.949 0.881 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -69.84 116.38 10.16 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 175.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.587 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 13.0 t 177.38 -172.32 0.1 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -172.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 56.2 t -65.81 110.59 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 169.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . 1.009 ' HB3' HG21 ' A' ' 335' ' ' THR . 0.0 OUTLIER -68.37 135.83 52.41 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.966 0.413 . . . . 0.0 110.43 -169.886 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . 0.603 ' OD1' HG22 ' A' ' 310' ' ' THR . 17.1 t70 -64.32 126.16 26.91 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.31 -174.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.501 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -47.9 -17.74 0.13 Allowed 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 -168.85 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.603 HG22 ' OD1' ' A' ' 308' ' ' ASP . 11.8 t -108.92 3.28 22.12 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 119.88 1.218 . . . . 0.0 111.999 -173.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -78.51 -30.91 47.41 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -173.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.504 ' HE1' ' HB2' ' A' ' 307' ' ' CYS . 0.0 OUTLIER -79.77 176.32 9.82 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-O 122.198 0.999 . . . . 0.0 111.821 -173.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 8.8 t -148.66 156.93 43.06 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 113.487 -1.688 . . . . 0.0 107.995 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 27.6 m-90 -68.66 121.19 15.93 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.409 ' HB3' ' C ' ' A' ' 329' ' ' GLU . 54.4 tptt -103.13 -41.94 5.93 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 173.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -154.83 130.62 10.03 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.308 170.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -69.31 162.09 68.71 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.631 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . 0.737 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 53.8 Cg_exo -46.13 111.39 0.34 Allowed 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 122.311 2.007 . . . . 0.0 112.087 177.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . 0.457 ' C ' HG13 ' A' ' 326' ' ' VAL . 17.2 m -130.08 132.7 46.27 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.655 -172.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -54.99 124.74 17.72 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 178.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . 0.502 ' C ' ' H ' ' A' ' 323' ' ' HIS . 23.8 p -75.71 0.96 15.96 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.756 0.422 . . . . 0.0 111.848 -170.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 72.57 -26.91 0.73 Allowed Glycine 0 C--N 1.331 0.29 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.453 -169.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . 0.502 ' H ' ' C ' ' A' ' 321' ' ' SER . 30.4 t60 -95.87 44.6 1.08 Allowed 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 121.087 0.47 . . . . 0.0 109.789 -175.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 17.5 t70 59.12 31.51 21.35 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.001 175.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . 0.848 ' HA ' ' HG3' ' A' ' 375' ' ' GLN . 4.6 p -152.05 -171.88 4.06 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -178.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.457 HG13 ' C ' ' A' ' 319' ' ' THR . 48.2 t -137.71 129.17 39.65 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.611 0 CA-C-N 118.466 0.575 . . . . 0.0 111.085 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 327' ' ' VAL . . . . . 0.527 HG12 ' HG2' ' A' ' 373' ' ' GLU . 12.5 m -107.46 163.07 5.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.524 -178.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 328' ' ' MET . . . . . 0.549 ' SD ' HG13 ' A' ' 330' ' ' VAL . 0.0 OUTLIER -145.65 154.61 42.3 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 174.433 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.428 ' HG3' ' O ' ' A' ' 370' ' ' GLY . 16.5 tt0 -133.28 130.53 39.07 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.387 -175.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.549 HG13 ' SD ' ' A' ' 328' ' ' MET . 0.2 OUTLIER -130.01 153.31 38.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.839 -178.277 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . 0.414 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -121.18 137.12 11.62 Favored Glycine 0 CA--C 1.522 0.484 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.852 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . 0.458 ' HD2' ' N ' ' A' ' 335' ' ' THR . 1.3 p90 -88.05 155.85 19.6 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.673 0.749 . . . . 0.0 112.768 -178.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 28.3 p -115.69 20.93 14.32 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.76 -1.109 . . . . 0.0 112.764 169.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 164.24 -14.11 0.09 OUTLIER Glycine 0 N--CA 1.465 0.588 0 C-N-CA 120.112 -1.042 . . . . 0.0 113.846 173.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 335' ' ' THR . . . . . 1.009 HG21 ' HB3' ' A' ' 307' ' ' CYS . 0.2 OUTLIER -85.99 118.42 25.46 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 179.656 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 336' ' ' ARG . 4.8 ptp180 -100.22 178.94 1.12 Allowed Pre-proline 0 N--CA 1.451 -0.421 0 CA-C-O 116.549 -1.691 . . . . 0.0 106.475 174.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.57 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.1 OUTLIER -23.26 91.04 0.0 OUTLIER 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 123.736 2.957 . . . . 0.0 114.387 -164.047 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 338' ' ' CYS . . . . . 0.587 ' HB2' ' O ' ' A' ' 305' ' ' THR . 14.2 p -115.41 -176.74 2.98 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 112.68 -2.055 . . . . 0.0 109.303 -170.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? -111.4 101.8 10.23 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . 0.763 HG22 HG13 ' A' ' 342' ' ' VAL . 59.1 mt -72.95 118.78 71.32 Favored Pre-proline 0 C--N 1.325 -0.488 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.515 -170.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -74.18 79.24 2.44 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 121.969 1.78 . . . . 0.0 110.644 175.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.763 HG13 HG22 ' A' ' 340' ' ' ILE . 1.1 m -103.13 122.91 56.18 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.86 0 CA-C-O 121.874 0.845 . . . . 0.0 111.076 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.518 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 15.4 ptt180 -135.62 176.77 8.37 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 114.046 -1.434 . . . . 0.0 108.029 175.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 344' ' ' ALA . . . . . 0.503 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -148.66 144.31 27.07 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.554 175.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.436 ' O ' HG23 ' A' ' 382' ' ' ILE . 11.6 m -117.09 144.9 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 176.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -68.66 116.08 8.77 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 178.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 347' ' ' HIS . . . . . 0.627 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 12.2 t60 40.64 67.68 0.49 Allowed 'General case' 0 N--CA 1.478 0.96 0 O-C-N 124.399 1.062 . . . . 0.0 111.519 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . 0.76 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 40.96 48.19 4.21 Favored Glycine 0 C--N 1.332 0.353 0 N-CA-C 115.206 0.842 . . . . 0.0 115.206 -174.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . 0.699 HG12 ' HG2' ' A' ' 351' ' ' GLU . 61.8 t -141.43 101.5 6.12 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 118.173 0.986 . . . . 0.0 108.457 176.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -80.53 72.3 6.6 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 123.131 2.554 . . . . 0.0 113.679 -176.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . 0.699 ' HG2' HG12 ' A' ' 349' ' ' VAL . 4.8 mm-40 -99.52 -58.04 2.02 Favored 'General case' 0 CA--C 1.502 -0.9 0 CA-C-O 122.6 1.191 . . . . 0.0 107.937 171.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . 0.455 HG12 ' HB2' ' A' ' 351' ' ' GLU . 1.1 p -125.47 127.17 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 112.644 -2.071 . . . . 0.0 110.127 -177.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -62.64 114.44 3.58 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.998 178.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.646 ' HB ' ' OD1' ' A' ' 381' ' ' ASN . 3.5 m -94.05 6.62 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.131 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 355' ' ' ALA . . . . . 0.503 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -74.67 83.13 2.08 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.886 0.374 . . . . 0.0 111.33 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 356' ' ' MET . . . . . 0.634 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 37.0 ttm -94.9 98.31 10.62 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 171.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.639 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 42.8 mt -87.46 123.92 32.89 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.802 -162.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.776 HD11 ' HB2' ' A' ' 375' ' ' GLN . 2.3 mm -62.88 -23.6 33.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.526 173.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 8.3 m -132.38 92.18 28.92 Favored Pre-proline 0 N--CA 1.447 -0.582 0 CA-C-N 114.499 -1.228 . . . . 0.0 108.547 170.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -86.41 28.77 0.53 Allowed 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.133 2.555 . . . . 0.0 112.466 -175.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -156.9 65.66 3.75 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 114.77 -1.104 . . . . 0.0 109.217 177.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . 0.712 ' HB2' HD12 ' A' ' 340' ' ' ILE . 87.2 Cg_endo -86.03 114.6 1.36 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.5 2.134 . . . . 0.0 111.991 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 363' ' ' THR . . . . . 0.407 HG22 ' O ' ' A' ' 338' ' ' CYS . 15.1 p -92.64 147.08 23.17 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 171.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 364' ' ' MET . . . . . 0.749 ' HA ' ' HA2' ' A' ' 369' ' ' GLY . 46.6 mtt . . . . . 0 CA--C 1.499 -1.009 0 CA-C-N 113.936 -1.484 . . . . 0.0 108.449 172.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . 0.414 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . 0.749 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -46.64 -40.89 12.17 Favored Glycine 0 CA--C 1.519 0.305 0 CA-C-N 117.588 0.694 . . . . 0.0 113.476 173.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . 0.428 ' O ' ' HG3' ' A' ' 329' ' ' GLU . . . 83.28 -51.17 4.53 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.152 177.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -166.01 143.79 5.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.921 0.391 . . . . 0.0 111.616 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 372' ' ' ILE . . . . . 0.627 HD13 HG11 ' A' ' 342' ' ' VAL . 0.9 OUTLIER -134.71 151.46 31.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 170.398 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . 0.66 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 44.5 mt-10 -128.75 126.86 40.87 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.815 0.34 . . . . 0.0 110.355 -178.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . 0.821 ' HG2' HD11 ' A' ' 383' ' ' ILE . 4.2 ppp? -137.3 165.1 26.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.589 -178.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 375' ' ' GLN . . . . . 0.848 ' HG3' ' HA ' ' A' ' 325' ' ' THR . 0.3 OUTLIER -177.32 -179.9 0.91 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.303 0.573 . . . . 0.0 111.692 168.954 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 376' ' ' LEU . . . . . 0.701 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 13.1 tp -167.96 155.0 7.68 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 178.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 377' ' ' PRO . . . . . 0.701 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 82.8 Cg_exo -45.53 131.67 12.49 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 121.287 1.325 . . . . 0.0 110.046 167.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.553 ' HA ' ' NE2' ' A' ' 394' ' ' GLN . 4.0 Cg_exo -35.07 141.12 0.09 OUTLIER 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 125.103 3.869 . . . . 0.0 113.979 -171.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 152.64 -167.37 31.49 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 -163.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . 0.627 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 5.0 m-20 -99.4 124.31 44.43 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 117.548 0.674 . . . . 0.0 111.395 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.646 ' OD1' ' HB ' ' A' ' 354' ' ' VAL . 15.9 m-80 -134.19 141.64 47.12 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 0.963 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -142.58 137.05 28.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -179.837 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . 0.821 HD11 ' HG2' ' A' ' 374' ' ' MET . 47.6 mt -98.25 127.83 50.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.751 -172.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 384' ' ' TYR . . . . . 0.518 ' O ' ' HG2' ' A' ' 343' ' ' ARG . 0.3 OUTLIER -104.98 91.42 3.8 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.197 173.469 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 9.3 t -83.34 90.27 2.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 61.45 -113.26 5.52 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.461 -0.876 . . . . 0.0 111.027 -170.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -88.11 -16.36 33.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.759 0.314 . . . . 0.0 110.883 175.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.437 HD13 ' HD2' ' A' ' 312' ' ' PHE . 0.9 OUTLIER -69.51 155.69 40.07 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.191 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . 0.64 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 28.2 p-10 -165.98 157.3 13.66 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.778 177.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . 0.737 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 6.8 t60 -174.55 120.98 0.25 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.202 174.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 391' ' ' GLN . . . . . 0.963 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 21.3 tt0 -75.35 149.51 38.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.438 0.637 . . . . 0.0 112.115 -177.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 392' ' ' TRP . . . . . . . . . . . . . 70.5 t-105 -146.12 143.35 29.27 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.426 177.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . 0.685 ' HD2' ' HE2' ' A' ' 395' ' ' LYS . 12.3 p90 -104.15 107.38 18.26 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 173.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 0.712 ' HG2' HE22 ' A' ' 375' ' ' GLN . 0.0 OUTLIER -94.33 123.05 37.49 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.805 0.812 . . . . 0.0 110.972 -170.836 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.685 ' HE2' ' HD2' ' A' ' 393' ' ' PHE . 48.6 mttm . . . . . 0 C--O 1.245 0.834 0 CA-C-N 114.464 -1.244 . . . . 0.0 108.911 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . 0.475 ' O ' HG23 ' A' ' 335' ' ' THR . 5.2 t . . . . . 0 CA--C 1.538 0.505 0 CA-C-O 121.486 0.66 . . . . 0.0 111.001 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -65.98 124.67 23.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.151 0.501 . . . . 0.0 110.023 177.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.501 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 14.3 t 175.79 -170.58 0.06 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.113 -171.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 61.3 t -63.64 108.86 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 168.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.56 142.14 55.29 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.747 0.308 . . . . 0.0 110.567 -169.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . 0.689 ' OD1' HG22 ' A' ' 310' ' ' THR . 16.1 t70 -64.46 131.91 48.48 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.813 0.816 . . . . 0.0 112.004 -170.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -37.72 -30.65 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 112.975 -1.921 . . . . 0.0 115.222 -177.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.689 HG22 ' OD1' ' A' ' 308' ' ' ASP . 11.6 t -105.19 -1.85 24.89 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 118.747 0.703 . . . . 0.0 112.376 -169.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 27.0 mmmt -70.13 -35.05 73.79 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.284 0.564 . . . . 0.0 110.908 -178.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.635 ' HB3' ' HE1' ' A' ' 364' ' ' MET . 0.1 OUTLIER -90.47 177.64 6.32 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 122.296 1.046 . . . . 0.0 112.544 -174.553 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 14.2 t -161.8 168.86 22.41 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 113.534 -1.666 . . . . 0.0 108.978 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . 0.4 ' CE3' ' HA ' ' A' ' 317' ' ' ALA . 92.9 m95 -83.91 96.72 8.91 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 121.371 0.605 . . . . 0.0 110.648 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.684 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 56.7 tttm -66.61 -40.13 88.69 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 167.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 61.4 ttt180 -158.9 131.79 7.05 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.333 168.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . 0.471 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -74.87 163.66 66.69 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.059 -176.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . 0.471 ' HD2' ' HB1' ' A' ' 317' ' ' ALA . 4.9 Cg_exo -37.64 116.05 0.19 Allowed 'Trans proline' 0 C--N 1.362 1.239 0 C-N-CA 123.58 2.853 . . . . 0.0 113.364 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 28.8 m -132.9 138.36 46.95 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.424 -176.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . 0.432 ' OD2' ' HZ2' ' A' ' 392' ' ' TRP . 45.5 m-20 -61.13 132.83 55.0 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -178.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . 0.449 ' HB3' HG13 ' A' ' 327' ' ' VAL . 60.3 p -71.52 1.58 6.3 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 122.492 0.317 . . . . 0.0 111.466 -174.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 70.52 -22.06 0.54 Allowed Glycine 0 CA--C 1.521 0.452 0 C-N-CA 121.438 -0.411 . . . . 0.0 113.642 -170.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . 0.6 ' O ' ' HB3' ' A' ' 324' ' ' ASP . 93.5 m-70 -77.67 -41.74 37.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.993 0.396 . . . . 0.0 111.7 -172.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . 0.6 ' HB3' ' O ' ' A' ' 323' ' ' HIS . 4.5 p-10 144.37 13.89 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.721 0 O-C-N 124.354 1.034 . . . . 0.0 109.89 -163.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . 0.455 ' HA ' ' HG2' ' A' ' 375' ' ' GLN . 6.5 p -150.13 -170.23 3.59 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -170.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 373' ' ' GLU . 1.4 t -130.04 148.71 33.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.173 0.511 . . . . 0.0 111.03 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 327' ' ' VAL . . . . . 0.694 HG12 ' HG2' ' A' ' 373' ' ' GLU . 19.1 m -128.7 157.42 41.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.982 178.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 328' ' ' MET . . . . . 0.649 ' HE2' HD12 ' A' ' 372' ' ' ILE . 23.1 ptt? -140.89 156.3 46.13 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 170.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.684 ' HG2' ' HD3' ' A' ' 315' ' ' LYS . 22.8 tt0 -121.8 119.12 30.75 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 19.5 m -122.97 142.23 40.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 120.676 0.274 . . . . 0.0 110.792 -175.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . 0.537 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -125.49 138.28 10.82 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.247 -0.978 . . . . 0.0 113.199 -173.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . 0.848 ' HE2' ' HB ' ' A' ' 335' ' ' THR . 0.0 OUTLIER -147.61 163.13 37.56 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 176.114 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 15.1 m -151.96 44.48 0.74 Allowed 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -174.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -139.34 -65.82 0.04 OUTLIER Glycine 0 C--N 1.331 0.258 0 C-N-CA 119.369 -1.396 . . . . 0.0 112.126 169.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 335' ' ' THR . . . . . 0.848 ' HB ' ' HE2' ' A' ' 332' ' ' PHE . 28.6 m -52.9 140.56 24.21 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.234 -0.983 . . . . 0.0 109.236 172.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.635 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 21.9 ptt180 -87.91 178.37 2.18 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 117.592 -1.194 . . . . 0.0 108.725 176.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.635 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 2.2 Cg_exo -27.65 104.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.372 1.776 0 C-N-CA 123.573 2.849 . . . . 0.0 113.58 -178.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 338' ' ' CYS . . . . . 0.584 ' SG ' ' HB2' ' A' ' 364' ' ' MET . 22.2 p -116.74 -174.3 2.55 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 113.882 -1.508 . . . . 0.0 110.286 -167.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 -111.71 101.6 9.96 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . 0.496 HG12 HG13 ' A' ' 342' ' ' VAL . 13.4 tt -77.61 121.93 85.05 Favored Pre-proline 0 C--N 1.325 -0.47 0 C-N-CA 119.118 -1.033 . . . . 0.0 110.849 -167.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -78.16 80.55 2.96 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.252 1.968 . . . . 0.0 111.954 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.604 HG12 HG13 ' A' ' 385' ' ' VAL . 30.2 m -106.07 153.31 7.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.355 -178.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.513 ' HG3' ' HB2' ' A' ' 384' ' ' TYR . 40.3 ptt180 -168.33 174.99 6.65 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -179.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 344' ' ' ALA . . . . . 0.549 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -149.81 144.36 25.95 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.931 -0.708 . . . . 0.0 110.885 177.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.547 ' HB ' ' HA ' ' A' ' 350' ' ' PRO . 4.6 m -116.72 147.09 20.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -69.53 125.59 27.17 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 176.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 347' ' ' HIS . . . . . 0.526 ' O ' HG23 ' A' ' 349' ' ' VAL . 5.0 t60 43.88 60.17 2.82 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 124.422 1.077 . . . . 0.0 111.665 172.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . 0.617 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 43.02 42.79 5.26 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 115.046 0.778 . . . . 0.0 115.046 -174.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 347' ' ' HIS . 75.5 t -139.98 101.8 7.0 Favored Pre-proline 0 C--N 1.331 -0.227 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 350' ' ' PRO . . . . . 0.547 ' HA ' ' HB ' ' A' ' 345' ' ' VAL . 12.5 Cg_exo -75.41 54.8 3.95 Favored 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 122.913 2.408 . . . . 0.0 113.834 -176.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -100.15 -56.35 2.39 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 176.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.7 p -112.28 123.69 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.854 172.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . 0.549 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 6.1 t30 -65.8 122.25 16.89 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.371 174.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.459 HG21 ' HA ' ' A' ' 381' ' ' ASN . 29.1 m -97.56 4.51 9.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.143 176.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 355' ' ' ALA . . . . . 0.529 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -76.93 83.95 3.48 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.893 -179.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 356' ' ' MET . . . . . 0.683 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 53.3 ttp -95.36 99.87 11.73 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 169.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.437 ' CD2' ' HB3' ' A' ' 374' ' ' MET . 36.5 mt -85.34 116.49 23.7 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.768 -162.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.752 ' HB ' ' CB ' ' A' ' 373' ' ' GLU . 1.7 mm -64.6 -24.36 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 174.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 72.3 m -118.61 85.15 26.23 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 114.294 -1.321 . . . . 0.0 108.257 169.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 360' ' ' PRO . . . . . 0.411 ' HA ' ' HB2' ' A' ' 357' ' ' LEU . 75.0 Cg_endo -84.3 26.04 0.67 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.115 2.543 . . . . 0.0 114.448 -167.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -166.52 68.34 1.04 Allowed Pre-proline 0 C--N 1.311 -1.093 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.587 173.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . 0.655 ' HB3' HG23 ' A' ' 372' ' ' ILE . 58.6 Cg_endo -82.54 169.05 14.08 Favored 'Trans proline' 0 C--O 1.246 0.889 0 C-N-CA 122.542 2.161 . . . . 0.0 113.317 -178.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 4.2 p -143.7 -176.53 5.01 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.087 -168.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 364' ' ' MET . . . . . 0.8 ' HA ' ' HA2' ' A' ' 369' ' ' GLY . 42.4 mtp . . . . . 0 C--N 1.312 -1.026 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 172.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . 0.571 ' HA2' ' HD1' ' A' ' 332' ' ' PHE . . . . . . . . 0 N--CA 1.447 -0.573 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . 0.8 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -54.61 -47.19 71.57 Favored Glycine 0 CA--C 1.505 -0.548 0 C-N-CA 121.371 -0.442 . . . . 0.0 113.391 177.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . 0.62 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 90.12 -134.61 12.44 Favored Glycine 0 N--CA 1.438 -1.194 0 C-N-CA 119.943 -1.122 . . . . 0.0 110.917 -172.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -103.16 140.61 37.12 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.513 0.673 . . . . 0.0 111.697 -177.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 372' ' ' ILE . . . . . 0.655 HG23 ' HB3' ' A' ' 362' ' ' PRO . 1.5 mt -128.25 161.31 36.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.044 176.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . 0.752 ' CB ' ' HB ' ' A' ' 358' ' ' ILE . 38.8 mt-10 -124.49 128.54 49.14 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.484 0.659 . . . . 0.0 110.97 -179.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . 0.447 ' O ' ' HB2' ' A' ' 375' ' ' GLN . 0.1 OUTLIER -140.32 157.31 45.76 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.38 -1.282 . . . . 0.0 108.188 -179.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 375' ' ' GLN . . . . . 0.912 ' HA ' HE21 ' A' ' 375' ' ' GLN . 0.0 OUTLIER 179.83 175.45 0.78 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 118.224 0.465 . . . . 0.0 109.803 179.124 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 376' ' ' LEU . . . . . 1.013 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 11.2 tp -166.69 164.45 10.38 Favored Pre-proline 0 N--CA 1.446 -0.63 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 176.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 377' ' ' PRO . . . . . 1.013 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 80.0 Cg_exo -43.63 133.92 7.39 Favored 'Trans proline' 0 CA--C 1.533 0.433 0 C-N-CA 121.38 1.387 . . . . 0.0 111.3 169.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.555 ' HA ' HE22 ' A' ' 394' ' ' GLN . 4.7 Cg_exo -35.47 144.22 0.08 OUTLIER 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 125.177 3.918 . . . . 0.0 114.223 -175.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 151.17 -159.69 28.31 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -164.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . 0.46 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 7.5 m-20 -104.7 131.55 52.01 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 118.013 0.906 . . . . 0.0 110.939 175.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.459 ' HA ' HG21 ' A' ' 354' ' ' VAL . 10.0 m120 -128.5 145.53 51.08 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 177.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 1.018 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -143.91 136.97 23.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 176.634 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . 0.644 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 13.4 mt -100.72 131.71 47.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.326 -173.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 384' ' ' TYR . . . . . 0.513 ' HB2' ' HG3' ' A' ' 343' ' ' ARG . 5.0 m-85 -99.91 133.72 43.86 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 114.51 -1.223 . . . . 0.0 108.163 167.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . 0.84 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 4.5 t -124.21 82.05 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 177.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 59.91 -108.57 1.79 Allowed Glycine 0 N--CA 1.434 -1.455 0 C-N-CA 119.837 -1.173 . . . . 0.0 110.848 -167.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -83.12 -15.51 50.47 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 175.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.84 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 4.1 mp -69.68 155.77 40.0 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.477 0.179 . . . . 0.0 110.625 177.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . 0.644 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 4.9 p-10 -171.41 152.25 3.24 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.426 174.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . 0.423 ' O ' HG12 ' A' ' 382' ' ' ILE . 6.5 t60 -173.91 120.45 0.29 Allowed 'General case' 0 C--O 1.237 0.421 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 177.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 391' ' ' GLN . . . . . 1.018 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 7.5 tt0 -76.35 152.94 36.18 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.294 0.568 . . . . 0.0 112.496 -175.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 392' ' ' TRP . . . . . 0.432 ' HZ2' ' OD2' ' A' ' 320' ' ' ASP . 59.0 t-105 -150.2 148.82 29.38 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.397 177.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -111.64 114.03 26.8 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 173.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 0.555 HE22 ' HA ' ' A' ' 378' ' ' PRO . 0.0 OUTLIER -103.01 127.31 50.3 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.334 0.588 . . . . 0.0 110.069 -172.885 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.648 ' H ' ' HD3' ' A' ' 395' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.021 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.514 -174.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . 0.446 ' O ' HG22 ' A' ' 305' ' ' THR . 10.0 t . . . . . 0 CA--C 1.535 0.378 0 CA-C-O 121.471 0.653 . . . . 0.0 111.437 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . 0.478 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 43.7 p90 -64.03 120.87 12.85 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 172.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.619 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 14.2 t 170.75 -166.75 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -170.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 19.2 t -65.32 110.58 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 171.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . 0.412 ' HB3' HG21 ' A' ' 335' ' ' THR . 0.1 OUTLIER -68.79 141.33 55.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.007 0.432 . . . . 0.0 110.955 -173.698 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . 0.609 ' OD1' HG22 ' A' ' 310' ' ' THR . 9.4 t70 -60.82 123.02 16.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.944 -177.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 34.7 pttt -45.28 -17.53 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 115.4 1.629 . . . . 0.0 115.4 -177.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.609 HG22 ' OD1' ' A' ' 308' ' ' ASP . 10.6 t -109.63 9.08 25.14 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 120.212 1.369 . . . . 0.0 112.252 -174.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . 0.447 ' HG3' ' HB3' ' A' ' 308' ' ' ASP . 26.2 mtpp -90.42 -27.03 19.56 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -174.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.839 ' HD1' HD13 ' A' ' 388' ' ' LEU . 0.4 OUTLIER -85.91 173.55 9.89 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.887 0.851 . . . . 0.0 112.443 -175.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 11.2 t -153.6 158.91 41.87 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.203 -1.362 . . . . 0.0 109.101 -178.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 16.4 m95 -79.79 95.53 6.04 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 120.981 0.42 . . . . 0.0 111.376 -176.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.499 ' HB3' ' C ' ' A' ' 329' ' ' GLU . 31.8 tptt -63.37 -49.64 73.06 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 167.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.404 ' HB3' ' HB2' ' A' ' 329' ' ' GLU . 3.8 ttm180 -154.73 131.55 10.77 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.211 -0.904 . . . . 0.0 108.918 175.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -75.07 159.31 82.99 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-O 119.051 -0.499 . . . . 0.0 110.908 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -34.27 113.24 0.08 OUTLIER 'Trans proline' 0 C--N 1.365 1.397 0 C-N-CA 123.78 2.987 . . . . 0.0 113.545 177.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 21.0 m -130.89 137.15 49.2 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.932 -175.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -58.82 128.18 35.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.664 -0.244 . . . . 0.0 110.36 -179.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 60.5 p -74.68 3.98 7.0 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.026 0.53 . . . . 0.0 111.85 -173.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 70.61 -18.79 0.74 Allowed Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.238 -0.506 . . . . 0.0 114.08 -172.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . 0.445 ' O ' ' CB ' ' A' ' 324' ' ' ASP . 11.5 m170 -92.01 -13.75 30.5 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 117.579 0.69 . . . . 0.0 112.791 -174.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . 0.445 ' CB ' ' O ' ' A' ' 323' ' ' HIS . 29.9 t70 108.0 35.39 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 O-C-N 125.329 1.643 . . . . 0.0 109.033 -175.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . 0.572 ' HA ' ' CG ' ' A' ' 375' ' ' GLN . 3.3 p -150.97 -173.77 4.59 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.697 HG23 ' HG2' ' A' ' 375' ' ' GLN . 0.6 OUTLIER -130.04 143.74 40.13 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.589 0 CA-C-N 118.776 0.716 . . . . 0.0 111.511 -177.33 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 327' ' ' VAL . . . . . 0.835 HG12 ' HG2' ' A' ' 373' ' ' GLU . 19.2 m -123.28 146.2 29.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.466 176.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 328' ' ' MET . . . . . 0.63 ' SD ' HG21 ' A' ' 383' ' ' ILE . 6.1 ptp -130.61 153.5 48.85 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 174.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.499 ' C ' ' HB3' ' A' ' 315' ' ' LYS . 3.8 tt0 -125.75 126.27 44.31 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.541 HG23 ' HA3' ' A' ' 369' ' ' GLY . 10.7 m -125.58 159.05 33.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.351 -176.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . 0.528 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -130.8 135.59 8.35 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 118.843 -1.646 . . . . 0.0 114.482 178.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . 1.011 ' H ' ' HA2' ' A' ' 368' ' ' GLY . 36.2 m-85 -112.52 171.49 7.49 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.442 0.697 . . . . 0.0 110.074 170.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 34.7 m -130.58 -15.17 3.58 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 174.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -123.82 -66.42 0.2 Allowed Glycine 0 C--O 1.224 -0.484 0 C-N-CA 119.766 -1.207 . . . . 0.0 113.659 -175.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 335' ' ' THR . . . . . 0.412 HG21 ' HB3' ' A' ' 307' ' ' CYS . 12.8 m -54.16 129.01 33.32 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 123.747 0.322 . . . . 0.0 111.202 -176.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.669 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 6.4 ptm180 -88.7 179.45 1.63 Allowed Pre-proline 0 CA--C 1.532 0.269 0 CA-C-O 117.442 -1.266 . . . . 0.0 108.123 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.669 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -26.89 99.41 0.02 OUTLIER 'Trans proline' 0 C--N 1.372 1.816 0 C-N-CA 123.888 3.059 . . . . 0.0 114.155 -175.574 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 338' ' ' CYS . . . . . 0.619 ' HB2' ' O ' ' A' ' 305' ' ' THR . 19.2 p -115.61 -175.61 2.75 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 113.583 -1.644 . . . . 0.0 109.302 -169.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -106.54 96.34 6.38 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . 0.856 HD12 ' HD2' ' A' ' 341' ' ' PRO . 9.3 tp -75.54 120.05 79.88 Favored Pre-proline 0 C--N 1.325 -0.457 0 C-N-CA 119.011 -1.076 . . . . 0.0 110.924 -168.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 341' ' ' PRO . . . . . 0.856 ' HD2' HD12 ' A' ' 340' ' ' ILE . 53.5 Cg_endo -72.87 79.45 1.96 Allowed 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 121.92 1.746 . . . . 0.0 111.216 175.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.69 HG13 HG13 ' A' ' 340' ' ' ILE . 2.5 m -103.85 109.64 27.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.273 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.612 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 18.9 ptt180 -127.45 175.64 8.07 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 344' ' ' ALA . . . . . 0.559 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -147.42 145.87 29.38 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.407 176.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.475 HG22 HD12 ' A' ' 382' ' ' ILE . 10.4 m -115.63 143.34 25.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 176.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -62.05 115.85 4.44 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.326 176.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 347' ' ' HIS . . . . . 0.762 ' HB3' ' HB2' ' A' ' 380' ' ' ASP . 13.6 p80 33.62 73.17 0.07 Allowed 'General case' 0 N--CA 1.472 0.664 0 O-C-N 124.618 1.199 . . . . 0.0 113.822 177.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . 0.734 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 53.18 31.59 41.76 Favored Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 115.324 0.89 . . . . 0.0 115.324 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 49.8 t -139.49 102.88 7.16 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 118.584 1.192 . . . . 0.0 109.011 178.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -71.88 62.55 3.15 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.966 2.444 . . . . 0.0 112.778 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -100.87 -55.98 2.44 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 177.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.2 p -121.54 131.43 73.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.434 174.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . 0.433 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 43.4 t30 -64.19 113.04 3.3 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.551 174.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.401 ' CG1' HD22 ' A' ' 376' ' ' LEU . 27.5 m -97.25 5.16 9.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.05 -178.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 355' ' ' ALA . . . . . 0.559 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -76.38 86.25 3.15 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.027 0.441 . . . . 0.0 111.272 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.96 100.58 12.08 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 171.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.587 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 23.8 mt -85.57 120.17 26.72 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.931 -164.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.712 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 2.1 mm -65.86 -25.9 37.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 173.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 50.4 m -120.68 82.27 33.9 Favored Pre-proline 0 N--CA 1.446 -0.652 0 CA-C-N 114.41 -1.268 . . . . 0.0 108.153 170.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -85.86 21.0 1.14 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.088 2.525 . . . . 0.0 113.785 -169.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 361' ' ' ASN . . . . . 0.55 ' N ' ' HD3' ' A' ' 362' ' ' PRO . 15.8 m120 -145.77 52.88 1.66 Allowed Pre-proline 0 C--N 1.312 -1.054 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.348 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . 0.55 ' HD3' ' N ' ' A' ' 361' ' ' ASN . 11.0 Cg_endo -78.81 147.11 21.38 Favored 'Trans proline' 0 C--O 1.251 1.161 0 C-N-CA 121.635 1.557 . . . . 0.0 113.142 -177.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 6.3 p -139.99 116.85 10.97 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.664 -169.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 364' ' ' MET . . . . . 0.774 ' HG3' HD13 ' A' ' 340' ' ' ILE . 11.3 mmt . . . . . 0 C--N 1.311 -1.094 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.96 -170.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . 1.011 ' HA2' ' H ' ' A' ' 332' ' ' PHE . . . . . . . . 0 N--CA 1.448 -0.516 0 N-CA-C 114.535 0.574 . . . . 0.0 114.535 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . 0.541 ' HA3' HG23 ' A' ' 330' ' ' VAL . . . -177.18 93.47 0.09 OUTLIER Glycine 0 C--N 1.312 -0.759 0 N-CA-C 107.652 -2.179 . . . . 0.0 107.652 -171.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . 0.442 ' O ' ' HG3' ' A' ' 329' ' ' GLU . . . -74.31 -43.24 32.28 Favored Glycine 0 C--N 1.304 -1.248 0 C-N-CA 120.826 -0.702 . . . . 0.0 114.639 -155.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -166.2 136.6 3.42 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 120.966 0.413 . . . . 0.0 110.754 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 372' ' ' ILE . . . . . 0.62 ' O ' ' HA ' ' A' ' 327' ' ' VAL . 0.9 OUTLIER -136.67 135.52 48.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.947 176.771 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . 0.835 ' HG2' HG12 ' A' ' 327' ' ' VAL . 25.8 mt-10 -110.98 131.22 55.23 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.703 -176.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . 0.649 ' HG2' HD11 ' A' ' 383' ' ' ILE . 0.0 OUTLIER -137.17 165.1 26.9 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.794 -1.093 . . . . 0.0 108.627 178.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 375' ' ' GLN . . . . . 1.026 ' HA ' HE21 ' A' ' 375' ' ' GLN . 0.0 OUTLIER -176.14 -175.95 0.75 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.807 0.813 . . . . 0.0 110.813 169.309 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 376' ' ' LEU . . . . . 0.957 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 14.5 tp -166.21 162.9 12.09 Favored Pre-proline 0 N--CA 1.437 -1.081 0 N-CA-C 103.806 -2.664 . . . . 0.0 103.806 173.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 377' ' ' PRO . . . . . 0.957 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 66.6 Cg_exo -39.65 130.99 1.84 Allowed 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 121.356 1.37 . . . . 0.0 110.705 167.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -37.2 141.32 0.18 Allowed 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 124.201 3.267 . . . . 0.0 112.694 -176.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 149.43 -174.86 28.86 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -163.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . 0.762 ' HB2' ' HB3' ' A' ' 347' ' ' HIS . 6.1 m-20 -94.41 125.92 39.35 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 117.501 0.65 . . . . 0.0 110.167 -175.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.647 HD22 ' HG2' ' A' ' 394' ' ' GLN . 28.4 m-80 -137.29 170.24 16.43 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 1.023 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -160.55 143.98 4.82 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 175.426 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . 0.688 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 44.2 mt -101.48 128.82 53.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.31 -175.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 384' ' ' TYR . . . . . 0.612 ' O ' ' HG2' ' A' ' 343' ' ' ARG . 0.7 OUTLIER -104.06 92.07 4.22 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.971 171.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . 0.478 ' O ' ' HB2' ' A' ' 388' ' ' LEU . 15.2 t -84.0 89.45 2.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 178.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . 0.752 ' HA3' ' HZ ' ' A' ' 312' ' ' PHE . . . 61.05 -116.52 9.46 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.1 -1.048 . . . . 0.0 111.136 -172.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -78.49 -20.76 50.12 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.848 0.356 . . . . 0.0 111.366 174.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.839 HD13 ' HD1' ' A' ' 312' ' ' PHE . 2.4 mp -70.26 155.12 41.1 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.37 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . 0.688 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 7.0 p30 -167.8 152.73 6.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.886 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -173.48 118.55 0.29 Allowed 'General case' 0 C--O 1.24 0.554 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 177.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 391' ' ' GLN . . . . . 1.023 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 15.5 tt0 -80.93 153.32 27.61 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.894 0.878 . . . . 0.0 112.081 -176.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 392' ' ' TRP . . . . . 0.451 ' CD1' ' NE2' ' A' ' 394' ' ' GLN . 6.0 t-105 -172.31 150.99 2.45 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.47 -178.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . 0.501 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 21.3 p90 -102.34 119.12 38.28 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 121.214 -0.929 . . . . 0.0 108.807 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 0.75 ' HG3' HE22 ' A' ' 375' ' ' GLN . 3.4 mm100 -85.98 127.28 34.6 Favored 'General case' 0 C--O 1.238 0.469 0 O-C-N 121.909 -0.495 . . . . 0.0 109.878 -167.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm . . . . . 0 C--O 1.246 0.897 0 O-C-N 124.348 1.03 . . . . 0.0 110.651 175.793 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . 0.611 HG23 HG23 ' A' ' 335' ' ' THR . 5.8 t . . . . . 0 CA--C 1.537 0.48 0 CA-C-O 121.344 0.592 . . . . 0.0 111.764 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -68.11 122.87 19.18 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 175.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.498 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 7.4 t 178.54 -167.89 0.07 Allowed 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -171.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 30.8 t -69.78 113.65 5.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 167.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . 0.502 ' SG ' HG21 ' A' ' 335' ' ' THR . 0.1 OUTLIER -66.6 147.27 53.5 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.842 0.83 . . . . 0.0 112.135 -169.864 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . 0.51 ' OD1' HG22 ' A' ' 310' ' ' THR . 12.1 t70 -66.58 128.21 35.35 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.163 -1.381 . . . . 0.0 110.145 177.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.415 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -44.64 -13.13 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 115.775 1.769 . . . . 0.0 115.775 -176.406 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.51 HG22 ' OD1' ' A' ' 308' ' ' ASP . 12.0 t -108.96 -2.37 18.32 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 119.775 1.17 . . . . 0.0 113.086 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . 0.676 ' HE2' ' OG1' ' A' ' 335' ' ' THR . 31.2 mmmt -65.69 -35.68 81.45 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -173.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.586 ' HA ' ' O ' ' A' ' 331' ' ' GLY . 0.1 OUTLIER -86.01 174.25 9.34 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 122.086 0.946 . . . . 0.0 112.405 -175.129 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . 0.42 ' C ' HD21 ' A' ' 388' ' ' LEU . 12.6 t -151.98 161.47 42.58 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 113.65 -1.614 . . . . 0.0 109.459 -177.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . 0.546 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 28.8 m-90 -77.32 124.19 27.53 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 121.295 0.569 . . . . 0.0 110.034 -178.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.61 ' HB3' ' HB3' ' A' ' 329' ' ' GLU . 63.0 tttt -108.04 -41.95 4.8 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 172.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.643 ' HB3' ' HB2' ' A' ' 329' ' ' GLU . 3.9 ttm180 -151.16 130.02 12.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.762 171.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -70.25 157.74 89.19 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.453 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . 0.628 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 1.6 Cg_endo -45.66 118.44 2.23 Favored 'Trans proline' 0 C--N 1.359 1.118 0 C-N-CA 122.541 2.161 . . . . 0.0 112.27 -178.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 47.5 m -134.96 145.16 47.87 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.243 -174.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -60.07 134.5 57.11 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . 0.49 ' HB3' HG13 ' A' ' 327' ' ' VAL . 79.9 p -76.92 1.04 18.77 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -173.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 73.1 -20.47 1.14 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.833 -169.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . 0.427 ' H ' ' C ' ' A' ' 321' ' ' SER . 96.6 m-70 -112.2 50.15 0.87 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.111 0.482 . . . . 0.0 110.369 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 9.5 t70 54.03 38.22 28.5 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.835 174.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . 0.449 ' HB ' HG13 ' A' ' 358' ' ' ILE . 2.6 p -150.86 -168.47 3.11 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 175.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.569 HG13 HE22 ' A' ' 394' ' ' GLN . 0.4 OUTLIER -129.13 141.25 47.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 118.245 0.475 . . . . 0.0 110.873 -178.782 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 327' ' ' VAL . . . . . 0.828 HG12 ' HG2' ' A' ' 373' ' ' GLU . 17.6 m -121.35 149.16 24.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.682 177.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 328' ' ' MET . . . . . 0.686 ' SD ' ' HB ' ' A' ' 372' ' ' ILE . 0.1 OUTLIER -141.94 150.73 41.82 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 176.194 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.643 ' HB2' ' HB3' ' A' ' 316' ' ' ARG . 9.9 mt-10 -124.94 128.86 49.27 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 120.825 0.345 . . . . 0.0 110.2 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.484 HG23 ' HA3' ' A' ' 369' ' ' GLY . 1.8 m -131.78 152.66 37.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.854 -178.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . 0.586 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -113.86 178.15 18.21 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-O 119.475 -0.625 . . . . 0.0 112.536 -178.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . 0.709 ' HB2' ' SD ' ' A' ' 364' ' ' MET . 0.5 OUTLIER -128.77 142.83 50.86 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 117.467 0.633 . . . . 0.0 111.158 -178.409 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 5.3 p -87.57 -17.64 31.53 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 173.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 177.09 -39.61 0.1 OUTLIER Glycine 0 C--N 1.338 0.641 0 C-N-CA 117.943 -2.075 . . . . 0.0 116.045 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 335' ' ' THR . . . . . 0.676 ' OG1' ' HE2' ' A' ' 311' ' ' LYS . 81.2 m -52.91 131.78 36.27 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.833 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 1.4 ptp180 -79.24 -179.98 1.59 Allowed Pre-proline 0 N--CA 1.449 -0.495 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -177.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.833 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 1.3 Cg_exo -27.56 100.88 0.02 OUTLIER 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 123.269 2.646 . . . . 0.0 113.742 178.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 338' ' ' CYS . . . . . 0.918 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 26.3 p -130.54 150.39 51.76 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.402 -176.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -67.17 123.93 21.67 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.444 170.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . 0.426 HG12 HG13 ' A' ' 342' ' ' VAL . 19.2 tt -94.64 117.73 66.93 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.155 -176.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -70.37 82.29 0.89 Allowed 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.513 2.142 . . . . 0.0 112.042 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.668 HG12 HG13 ' A' ' 385' ' ' VAL . 11.4 m -102.31 115.4 44.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.468 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.4 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 36.1 ptt180 -130.34 178.13 6.82 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 344' ' ' ALA . . . . . 0.469 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -151.21 148.85 28.73 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.89 177.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.414 ' O ' HG23 ' A' ' 382' ' ' ILE . 14.7 m -121.57 146.86 25.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -70.17 119.19 13.99 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 177.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 347' ' ' HIS . . . . . 0.661 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 68.8 t60 47.36 57.5 5.77 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 124.172 0.92 . . . . 0.0 111.457 174.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . 0.619 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 44.83 44.22 8.58 Favored Glycine 0 CA--C 1.521 0.413 0 N-CA-C 114.671 0.628 . . . . 0.0 114.671 -172.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 347' ' ' HIS . 57.4 t -139.82 102.23 7.05 Favored Pre-proline 0 C--O 1.234 0.271 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -76.36 64.19 7.18 Favored 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 123.06 2.507 . . . . 0.0 113.847 -175.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -100.52 -57.09 2.18 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 174.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 4.3 p -115.55 125.94 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.676 174.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . 0.462 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 39.5 t30 -62.89 108.89 1.29 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.57 174.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.509 ' HA ' HD22 ' A' ' 376' ' ' LEU . 27.6 m -86.81 0.97 6.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.078 -179.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 355' ' ' ALA . . . . . 0.469 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -76.88 84.32 3.45 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 121.476 0.655 . . . . 0.0 110.468 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 356' ' ' MET . . . . . 0.676 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 11.9 tpt -98.96 103.62 15.59 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 170.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.546 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 42.4 mt -86.2 119.64 26.7 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.177 -161.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.699 ' HB ' ' CB ' ' A' ' 373' ' ' GLU . 3.0 mm -64.77 -27.18 41.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 173.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 89.8 m -122.06 84.53 45.4 Favored Pre-proline 0 N--CA 1.449 -0.52 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.572 171.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -85.39 28.07 0.58 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.119 2.546 . . . . 0.0 113.65 -171.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 361' ' ' ASN . . . . . 0.443 ' N ' ' HD3' ' A' ' 362' ' ' PRO . 2.4 p-10 -148.59 55.0 1.91 Allowed Pre-proline 0 C--N 1.313 -0.99 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.488 177.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . 0.774 ' HB3' HG23 ' A' ' 372' ' ' ILE . 73.5 Cg_endo -85.08 162.53 11.61 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 121.884 1.723 . . . . 0.0 113.041 -179.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 363' ' ' THR . . . . . 0.669 ' O ' ' HA2' ' A' ' 369' ' ' GLY . 1.2 p -145.2 -172.7 3.92 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.89 -172.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 364' ' ' MET . . . . . 0.918 ' HG2' ' SG ' ' A' ' 338' ' ' CYS . 9.3 ptp . . . . . 0 C--N 1.316 -0.876 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 162.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . 0.473 ' HA2' ' HB3' ' A' ' 332' ' ' PHE . . . . . . . . 0 N--CA 1.449 -0.468 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . 0.669 ' HA2' ' O ' ' A' ' 363' ' ' THR . . . -47.53 -54.0 11.61 Favored Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.921 -0.657 . . . . 0.0 113.303 172.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . 0.596 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 89.26 -126.97 8.46 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.441 -0.885 . . . . 0.0 111.447 -176.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -101.76 131.74 47.89 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.708 0.29 . . . . 0.0 111.213 -175.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 372' ' ' ILE . . . . . 0.774 HG23 ' HB3' ' A' ' 362' ' ' PRO . 0.2 OUTLIER -131.03 166.1 29.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 173.698 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . 0.828 ' HG2' HG12 ' A' ' 327' ' ' VAL . 24.1 mt-10 -133.97 132.64 40.4 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.363 0.601 . . . . 0.0 111.349 177.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . 0.589 ' HG2' HD11 ' A' ' 383' ' ' ILE . 0.0 OUTLIER -135.08 166.17 23.69 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 177.245 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 375' ' ' GLN . . . . . 0.924 HE22 ' HG3' ' A' ' 394' ' ' GLN . 0.0 OUTLIER 175.93 176.0 0.26 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.345 0.521 . . . . 0.0 109.694 170.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 376' ' ' LEU . . . . . 1.002 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 9.4 tp -166.18 175.36 2.32 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 103.498 -2.779 . . . . 0.0 103.498 177.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 377' ' ' PRO . . . . . 1.002 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 58.2 Cg_exo -40.87 130.36 2.83 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 CA-C-N 121.789 1.675 . . . . 0.0 111.882 167.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.473 ' HD2' ' HA ' ' A' ' 377' ' ' PRO . 5.1 Cg_exo -41.05 146.98 0.31 Allowed 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 124.018 3.145 . . . . 0.0 112.207 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 145.34 -168.39 27.21 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.18 -1.01 . . . . 0.0 110.83 -163.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . 0.661 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 3.1 m-20 -88.35 119.81 29.13 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 117.134 0.467 . . . . 0.0 110.026 -178.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.428 HD22 ' HG2' ' A' ' 394' ' ' GLN . 26.2 m-80 -132.99 144.64 50.23 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 1.044 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -143.86 137.04 24.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.218 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . 0.698 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 44.1 mt -97.96 127.7 50.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.506 -175.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 384' ' ' TYR . . . . . 0.523 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.2 OUTLIER -104.64 91.73 3.99 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 114.322 -1.308 . . . . 0.0 108.426 173.475 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . 0.668 HG13 HG12 ' A' ' 342' ' ' VAL . 17.7 t -84.23 89.44 2.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 64.23 -110.35 3.39 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 120.278 -0.963 . . . . 0.0 110.725 -170.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -94.22 -9.13 37.22 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.867 0.334 . . . . 0.0 111.366 172.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.583 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 3.1 mp -66.75 153.35 43.51 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 174.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . 0.698 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 9.0 p30 -164.06 156.51 17.28 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.927 177.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . 0.628 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 23.4 t-80 -174.75 117.83 0.19 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.924 172.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 391' ' ' GLN . . . . . 1.044 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 0.6 OUTLIER -79.08 154.35 29.47 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.11 0.481 . . . . 0.0 110.978 -179.958 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 392' ' ' TRP . . . . . 0.499 ' HD1' ' OE1' ' A' ' 394' ' ' GLN . 6.6 t-105 -166.73 150.93 7.21 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.111 -0.95 . . . . 0.0 108.51 -178.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -105.93 119.67 39.77 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 0.924 ' HG3' HE22 ' A' ' 375' ' ' GLN . 3.8 mm100 -85.67 113.22 21.71 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -173.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.753 ' H ' ' HD3' ' A' ' 395' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.131 -0.938 . . . . 0.0 111.285 -178.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . 0.403 HG23 ' O ' ' A' ' 303' ' ' THR . 4.5 t . . . . . 0 N--CA 1.445 -0.696 0 CA-C-O 121.532 0.682 . . . . 0.0 110.664 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . 0.615 ' HB3' ' HE ' ' A' ' 336' ' ' ARG . 5.2 p90 -74.46 127.31 32.74 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 171.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' A' ' 304' ' ' TYR . 11.6 t 172.82 -169.83 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -173.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 37.2 t -66.78 112.83 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 169.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . 0.459 ' HB3' HG21 ' A' ' 335' ' ' THR . 0.1 OUTLIER -67.81 141.02 56.63 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.436 -171.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . 0.561 ' HB3' ' HG3' ' A' ' 311' ' ' LYS . 10.4 t0 -59.33 124.45 20.05 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.044 -176.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -40.7 -29.85 0.1 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.101 -1.408 . . . . 0.0 114.418 -177.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 11.4 t -107.08 1.41 24.22 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.348 0.594 . . . . 0.0 111.123 -170.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . 0.561 ' HG3' ' HB3' ' A' ' 308' ' ' ASP . 49.2 mtpt -90.36 43.85 1.17 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.534 0.683 . . . . 0.0 110.079 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.691 ' HB3' HD13 ' A' ' 388' ' ' LEU . 0.3 OUTLIER -140.7 157.14 45.87 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.635 -168.464 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 15.0 p -144.72 152.83 40.98 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.967 175.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . 0.61 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 20.1 m-90 -79.94 94.51 5.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.97 0.414 . . . . 0.0 110.231 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 18.8 tttm -71.24 -42.59 68.66 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.167 173.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 41.0 ttm105 -154.99 98.56 2.04 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.105 173.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -41.91 152.07 0.31 Allowed Pre-proline 0 N--CA 1.472 0.662 0 C-N-CA 123.695 0.798 . . . . 0.0 112.441 174.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . 0.483 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 1.0 OUTLIER -44.24 117.11 1.21 Allowed 'Trans proline' 0 C--N 1.365 1.443 0 C-N-CA 123.083 2.522 . . . . 0.0 113.099 -174.292 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 10.1 m -133.41 144.15 49.35 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.004 -174.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -59.1 129.64 43.11 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.625 0.25 . . . . 0.0 110.566 177.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . 0.734 ' HB3' HG13 ' A' ' 327' ' ' VAL . 59.6 p -77.96 6.73 7.17 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.513 0.725 . . . . 0.0 111.771 -174.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 81.7 -16.75 18.27 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.649 -0.786 . . . . 0.0 113.039 -170.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 20.7 m80 -98.34 7.61 45.98 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 117.19 0.495 . . . . 0.0 111.217 -177.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 72.33 49.66 0.21 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.947 0.88 . . . . 0.0 109.233 -177.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . 0.567 ' HB ' HG13 ' A' ' 358' ' ' ILE . 4.5 p -157.99 163.92 37.31 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 -177.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -111.0 132.63 58.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 119.755 1.161 . . . . 0.0 112.619 -172.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 327' ' ' VAL . . . . . 0.847 HG12 ' HG2' ' A' ' 373' ' ' GLU . 15.4 m -115.2 163.98 11.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.878 174.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 10.1 ptm -153.33 152.25 30.9 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 172.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -114.1 135.31 54.16 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.571 HG23 ' HA3' ' A' ' 369' ' ' GLY . 3.1 m -132.94 146.66 32.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 C-N-CA 120.366 -0.534 . . . . 0.0 112.275 -178.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . 0.592 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -118.66 134.6 10.97 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.241 -0.98 . . . . 0.0 112.062 -179.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . 0.763 ' HB3' ' SD ' ' A' ' 364' ' ' MET . 0.1 OUTLIER -89.56 157.65 17.97 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -177.112 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 36.0 t -71.11 -33.36 70.08 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 112.658 -2.064 . . . . 0.0 112.29 169.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 168.62 -17.89 0.07 OUTLIER Glycine 0 CA--C 1.526 0.776 0 C-N-CA 119.62 -1.276 . . . . 0.0 114.689 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 335' ' ' THR . . . . . 0.488 ' O ' ' HD2' ' A' ' 332' ' ' PHE . 25.8 m -54.62 120.09 6.21 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.699 0.25 . . . . 0.0 110.889 176.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.694 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 9.2 ptt180 -75.46 -176.53 0.58 Allowed Pre-proline 0 N--CA 1.467 0.38 0 CA-C-O 117.62 -1.181 . . . . 0.0 108.85 -172.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.83 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.1 OUTLIER -26.67 95.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 123.693 2.929 . . . . 0.0 113.379 177.072 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 338' ' ' CYS . . . . . 0.69 ' SG ' ' HE2' ' A' ' 364' ' ' MET . 13.7 p -115.7 -175.44 2.72 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 113.656 -1.611 . . . . 0.0 110.89 -167.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -110.61 100.42 9.21 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . 0.901 HG22 HG13 ' A' ' 342' ' ' VAL . 24.8 mt -74.8 116.53 54.59 Favored Pre-proline 0 C--N 1.324 -0.531 0 C-N-CA 120.057 -0.657 . . . . 0.0 110.836 -169.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.76 81.65 2.71 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.47 2.114 . . . . 0.0 110.992 177.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.901 HG13 HG22 ' A' ' 340' ' ' ILE . 4.1 m -103.26 134.09 45.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.989 0.899 . . . . 0.0 111.459 -178.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.657 ' HG3' ' HB2' ' A' ' 384' ' ' TYR . 20.8 ptt180 -140.51 176.93 8.38 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 113.899 -1.5 . . . . 0.0 107.734 174.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 344' ' ' ALA . . . . . 0.599 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -144.57 144.99 31.58 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 120.546 -0.462 . . . . 0.0 109.903 172.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.511 HG22 HD12 ' A' ' 382' ' ' ILE . 11.6 m -119.07 144.98 25.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.1 119.19 10.36 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 177.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 347' ' ' HIS . . . . . 0.755 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 25.5 t-80 46.92 63.84 1.78 Allowed 'General case' 0 N--CA 1.468 0.461 0 O-C-N 124.337 1.023 . . . . 0.0 112.015 170.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . 0.559 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 43.19 42.01 5.17 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 114.926 0.73 . . . . 0.0 114.926 -174.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 347' ' ' HIS . 65.3 t -142.38 103.23 5.52 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 117.792 0.796 . . . . 0.0 108.928 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 350' ' ' PRO . . . . . 0.435 ' HA ' ' HB ' ' A' ' 345' ' ' VAL . 16.1 Cg_exo -72.26 51.8 1.8 Allowed 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.872 2.381 . . . . 0.0 113.073 178.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -103.06 -7.59 21.25 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -178.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 2.4 p -170.72 110.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.065 -169.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . 0.528 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 50.7 t30 -65.25 108.87 2.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.247 177.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.486 ' CG1' HD22 ' A' ' 376' ' ' LEU . 27.7 m -91.13 0.88 8.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.438 178.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 355' ' ' ALA . . . . . 0.599 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -74.44 83.3 1.96 Allowed 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.098 0.475 . . . . 0.0 111.459 -176.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 356' ' ' MET . . . . . 0.546 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 35.4 ttm -95.36 98.64 10.72 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 168.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.691 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 18.8 mt -80.32 141.65 35.25 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.323 -162.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.761 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 4.2 mm -80.45 -25.28 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 178.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 7.9 m -140.34 97.94 7.5 Favored Pre-proline 0 N--CA 1.445 -0.71 0 CA-C-N 113.513 -1.676 . . . . 0.0 108.797 175.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -85.83 34.42 0.48 Allowed 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.968 2.445 . . . . 0.0 112.808 -175.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -142.8 64.23 14.81 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.434 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . 0.535 ' HG3' ' CG2' ' A' ' 342' ' ' VAL . 90.2 Cg_endo -80.9 143.17 14.38 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.355 2.037 . . . . 0.0 111.481 178.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 363' ' ' THR . . . . . 0.51 HG23 ' O ' ' A' ' 338' ' ' CYS . 0.8 OUTLIER -143.47 148.94 36.83 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -174.611 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 364' ' ' MET . . . . . 0.83 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 37.1 mtm . . . . . 0 CA--C 1.495 -1.147 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . 0.592 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . 0.571 ' HA3' HG23 ' A' ' 330' ' ' VAL . . . -64.15 108.31 2.2 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 170.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -71.5 -31.2 65.8 Favored Glycine 0 C--N 1.313 -0.699 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.907 -169.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -164.74 141.68 6.15 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.051 0.453 . . . . 0.0 110.813 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 372' ' ' ILE . . . . . 0.844 HD13 HG11 ' A' ' 342' ' ' VAL . 1.7 mt -133.61 144.57 35.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 171.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . 0.847 ' HG2' HG12 ' A' ' 327' ' ' VAL . 40.0 mt-10 -129.24 125.05 36.03 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.494 -0.482 . . . . 0.0 109.981 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . 0.691 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 0.0 OUTLIER -140.31 161.45 37.65 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.008 -175.54 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 375' ' ' GLN . . . . . 0.845 HE22 ' HG2' ' A' ' 394' ' ' GLN . 7.3 tp60 -178.52 175.28 1.14 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 174.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 376' ' ' LEU . . . . . 0.838 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 10.8 tp -166.56 157.05 10.81 Favored Pre-proline 0 N--CA 1.444 -0.77 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 377' ' ' PRO . . . . . 0.838 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 82.7 Cg_exo -42.39 132.08 4.99 Favored 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 121.828 1.685 . . . . 0.0 111.008 168.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.778 ' HA ' HE22 ' A' ' 394' ' ' GLN . 5.8 Cg_exo -35.74 139.84 0.13 Allowed 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 124.935 3.757 . . . . 0.0 113.75 -173.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 154.72 -165.08 31.94 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -162.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . 0.755 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 11.8 m-20 -102.91 129.08 49.5 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 117.881 0.841 . . . . 0.0 110.634 177.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -125.71 166.4 16.84 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 176.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 0.98 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -159.66 140.59 4.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 168.886 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . 0.488 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 24.3 mt -96.76 135.39 31.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.919 -175.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 384' ' ' TYR . . . . . 0.657 ' HB2' ' HG3' ' A' ' 343' ' ' ARG . 3.4 m-85 -105.11 129.34 53.54 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 167.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 6.1 t -117.56 82.22 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 65.51 -108.8 2.53 Favored Glycine 0 N--CA 1.431 -1.646 0 C-N-CA 120.001 -1.095 . . . . 0.0 110.51 -161.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -93.77 -10.71 33.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.652 0.226 . . . . 0.0 111.543 176.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.691 HD13 ' HB3' ' A' ' 312' ' ' PHE . 1.1 tp -65.22 146.87 54.39 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . 0.488 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 27.5 p-10 -157.07 147.71 21.45 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.595 0.236 . . . . 0.0 111.077 178.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . 0.483 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 5.3 t60 -172.62 122.33 0.43 Allowed 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.724 176.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 391' ' ' GLN . . . . . 0.98 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 7.9 tt0 -79.2 151.37 31.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.333 0.587 . . . . 0.0 112.367 -173.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 392' ' ' TRP . . . . . . . . . . . . . 43.6 t-105 -148.48 132.54 17.25 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.792 -1.094 . . . . 0.0 109.31 177.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -99.45 109.18 21.77 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 0.845 ' HG2' HE22 ' A' ' 375' ' ' GLN . 0.0 OUTLIER -97.8 127.19 43.57 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.303 0.573 . . . . 0.0 110.502 -170.05 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.777 -178.382 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . 0.532 HG23 HG23 ' A' ' 335' ' ' THR . 7.1 t . . . . . 0 N--CA 1.451 -0.407 0 CA-C-O 121.159 0.504 . . . . 0.0 111.691 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . 0.722 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 30.9 p90 -67.09 119.65 12.37 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.307 -0.557 . . . . 0.0 109.794 175.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.443 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 12.3 t 176.23 -167.67 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -171.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 23.1 t -64.73 108.21 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 169.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.71 140.8 51.52 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.732 -169.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . 0.591 ' OD2' HG22 ' A' ' 310' ' ' THR . 20.3 t70 -66.85 128.34 35.94 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.442 0.639 . . . . 0.0 111.567 -176.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.56 ' HD3' ' HB2' ' A' ' 387' ' ' ASP . 0.0 OUTLIER -42.48 -22.44 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 115.954 1.835 . . . . 0.0 115.954 -173.867 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.591 HG22 ' OD2' ' A' ' 308' ' ' ASP . 11.7 t -105.54 -3.81 21.96 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 118.976 0.807 . . . . 0.0 111.62 -170.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . 0.407 ' HB3' ' HE2' ' A' ' 311' ' ' LYS . 10.4 mmmm -67.97 -24.74 65.18 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.873 -177.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.671 ' HE1' ' H ' ' A' ' 369' ' ' GLY . 2.1 m-85 -81.16 173.04 12.93 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 122.01 0.91 . . . . 0.0 113.313 -176.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . 0.528 HG22 ' O ' ' A' ' 331' ' ' GLY . 14.2 t -148.58 155.21 40.8 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 113.878 -1.51 . . . . 0.0 108.718 177.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 11.6 m-90 -79.23 93.8 5.31 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.17 0.51 . . . . 0.0 110.115 -178.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.577 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 59.6 tttm -76.97 -55.09 5.76 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.186 172.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -142.04 126.21 17.45 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 176.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -69.12 158.04 87.64 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-O 119.14 -0.457 . . . . 0.0 110.286 178.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . 0.537 ' HG3' HD12 ' A' ' 383' ' ' ILE . 87.2 Cg_exo -40.16 117.66 0.47 Allowed 'Trans proline' 0 C--N 1.36 1.152 0 C-N-CA 122.458 2.105 . . . . 0.0 111.997 174.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 13.6 m -136.13 140.56 43.76 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.801 -174.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . 0.409 ' HA ' ' O ' ' A' ' 325' ' ' THR . 7.0 t70 -55.53 126.95 27.47 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.147 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . 0.512 ' HB3' HG13 ' A' ' 327' ' ' VAL . 33.5 p -87.1 10.9 15.23 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.644 0.259 . . . . 0.0 111.447 -172.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 85.6 -31.37 3.91 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.53 -173.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 58.7 m-70 -87.06 28.31 0.93 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.82 0.31 . . . . 0.0 111.61 -176.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 48.65 50.62 16.9 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.877 0.846 . . . . 0.0 109.884 -172.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . 0.532 ' HB ' HG13 ' A' ' 358' ' ' ILE . 11.6 p -154.34 177.14 11.48 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 -175.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -123.16 142.5 39.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 119.536 1.062 . . . . 0.0 112.18 -174.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 327' ' ' VAL . . . . . 0.636 HG12 ' HG2' ' A' ' 373' ' ' GLU . 3.7 m -124.77 147.65 29.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.897 172.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 328' ' ' MET . . . . . 0.573 ' CE ' HD12 ' A' ' 372' ' ' ILE . 16.5 ptt? -130.84 156.58 44.78 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 173.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.621 ' HA ' ' O ' ' A' ' 370' ' ' GLY . 7.9 tt0 -124.19 125.91 45.23 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.581 HG11 HG21 ' A' ' 385' ' ' VAL . 15.7 m -126.5 143.58 39.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.416 -174.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . 0.587 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -122.74 135.97 10.41 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.692 -176.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . 0.512 ' HD1' ' H ' ' A' ' 332' ' ' PHE . 0.2 OUTLIER -90.62 155.74 18.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 122.058 0.933 . . . . 0.0 113.122 -177.374 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 30.4 t -78.72 -37.52 41.26 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 113.862 -1.517 . . . . 0.0 112.948 171.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -173.69 -25.75 0.03 OUTLIER Glycine 0 CA--C 1.526 0.727 0 C-N-CA 118.651 -1.737 . . . . 0.0 115.405 -178.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 335' ' ' THR . . . . . 0.701 ' HB ' ' SD ' ' A' ' 364' ' ' MET . 25.9 m -52.7 127.27 22.57 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.699 0.285 . . . . 0.0 110.385 176.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.75 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 2.2 ptm180 -87.72 -179.26 1.28 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 117.378 -1.296 . . . . 0.0 108.491 -174.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.75 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -26.46 98.35 0.02 OUTLIER 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 123.862 3.041 . . . . 0.0 114.115 -175.137 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 338' ' ' CYS . . . . . 0.769 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 1.8 p -109.84 -176.55 3.03 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 113.6 -1.636 . . . . 0.0 110.136 -171.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 339' ' ' ARG . 3.5 mpt_? -109.4 100.51 9.59 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 175.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . 0.889 HG22 HG13 ' A' ' 342' ' ' VAL . 29.9 mt -74.82 114.38 33.98 Favored Pre-proline 0 C--N 1.329 -0.315 0 C-N-CA 120.069 -0.653 . . . . 0.0 111.307 -167.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -79.51 81.46 2.78 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.499 2.132 . . . . 0.0 111.309 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.889 HG13 HG22 ' A' ' 340' ' ' ILE . 4.1 m -103.08 128.33 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-O 121.508 0.671 . . . . 0.0 110.651 -178.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -140.74 175.77 9.34 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 174.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 344' ' ' ALA . . . . . 0.554 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -147.89 149.82 32.97 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.064 -0.654 . . . . 0.0 111.334 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 11.0 m -118.86 146.62 23.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 176.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.425 ' HB2' ' CG1' ' A' ' 354' ' ' VAL . . . -70.11 117.73 12.05 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 177.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 347' ' ' HIS . . . . . 0.903 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 15.3 t-80 48.31 62.18 2.65 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 124.166 0.916 . . . . 0.0 112.007 173.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . 0.772 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 43.35 40.08 4.54 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.963 -0.637 . . . . 0.0 114.507 -173.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 347' ' ' HIS . 94.9 t -138.13 101.58 8.43 Favored Pre-proline 0 C--O 1.235 0.319 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -72.04 68.88 3.17 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.593 2.196 . . . . 0.0 112.357 178.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -99.85 -56.35 2.41 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 176.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 5.3 p -128.88 136.9 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.264 172.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . 0.554 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 35.0 t30 -62.18 110.58 1.66 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.905 174.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.516 ' CG1' HD22 ' A' ' 376' ' ' LEU . 27.7 m -88.36 3.04 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.346 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -75.14 82.29 2.31 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.312 0.577 . . . . 0.0 110.771 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 356' ' ' MET . . . . . 0.554 ' HB2' ' O ' ' A' ' 375' ' ' GLN . 62.5 mtt -98.19 99.67 10.92 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 168.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.631 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 34.5 mt -82.1 141.48 33.1 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.052 -162.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.719 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 4.1 mm -83.64 -21.53 8.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 178.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 6.6 m -141.39 96.97 6.89 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 113.828 -1.533 . . . . 0.0 108.673 171.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 360' ' ' PRO . . . . . 0.457 ' HA ' HD12 ' A' ' 357' ' ' LEU . 91.5 Cg_endo -89.05 39.89 0.48 Allowed 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 123.136 2.557 . . . . 0.0 114.259 -170.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 361' ' ' ASN . . . . . 0.58 HD22 ' N ' ' A' ' 361' ' ' ASN . 0.0 OUTLIER -156.85 72.78 4.7 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-O 121.406 0.622 . . . . 0.0 111.234 176.689 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . 0.746 ' HG2' ' HB ' ' A' ' 340' ' ' ILE . 83.2 Cg_endo -85.08 154.31 11.11 Favored 'Trans proline' 0 C--O 1.243 0.731 0 C-N-CA 122.788 2.325 . . . . 0.0 113.029 176.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 1.8 p -143.98 141.12 30.0 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.054 -176.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 364' ' ' MET . . . . . 0.769 ' HG2' ' SG ' ' A' ' 338' ' ' CYS . 10.7 ptp . . . . . 0 CA--C 1.5 -0.98 0 C-N-CA 119.578 -0.849 . . . . 0.0 108.785 178.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . 0.587 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . . . . . . 0 N--CA 1.451 -0.359 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . 0.767 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -57.98 -32.46 66.64 Favored Glycine 0 CA--C 1.506 -0.53 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.835 173.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . 0.621 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 82.78 -131.36 10.32 Favored Glycine 0 N--CA 1.435 -1.379 0 C-N-CA 120.029 -1.081 . . . . 0.0 111.081 -177.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -103.46 137.66 41.25 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.336 0.589 . . . . 0.0 111.558 -175.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 372' ' ' ILE . . . . . 0.679 HG23 ' HB3' ' A' ' 362' ' ' PRO . 0.8 OUTLIER -130.41 150.33 34.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.366 176.73 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . 0.719 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 38.4 mt-10 -116.62 127.08 54.13 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.513 -175.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . 0.87 ' HG2' HD11 ' A' ' 383' ' ' ILE . 4.1 ppp? -139.38 160.51 39.67 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 375' ' ' GLN . . . . . 0.915 ' HA ' HE21 ' A' ' 375' ' ' GLN . 0.0 OUTLIER -176.44 174.54 1.91 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.95 0.405 . . . . 0.0 110.89 174.346 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 376' ' ' LEU . . . . . 0.874 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 6.6 tp -165.17 158.74 14.18 Favored Pre-proline 0 N--CA 1.445 -0.676 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 377' ' ' PRO . . . . . 0.874 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 66.4 Cg_exo -40.97 129.34 2.89 Favored 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 121.77 1.647 . . . . 0.0 111.259 167.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.627 ' HA ' HE22 ' A' ' 394' ' ' GLN . 2.7 Cg_exo -35.8 140.75 0.12 Allowed 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 124.948 3.765 . . . . 0.0 113.502 -174.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 151.45 -161.77 29.31 Favored Glycine 0 N--CA 1.442 -0.935 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -162.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . 0.903 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 5.3 m-20 -101.86 129.42 48.09 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 117.918 0.859 . . . . 0.0 110.877 177.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.427 ' HB3' ' HE3' ' A' ' 374' ' ' MET . 9.7 m120 -128.66 146.25 50.92 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 176.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 1.052 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -149.61 138.17 14.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 177.773 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . 0.87 HD11 ' HG2' ' A' ' 374' ' ' MET . 43.9 mt -101.63 135.66 37.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.693 -171.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -105.12 96.68 6.7 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.549 -1.205 . . . . 0.0 108.795 169.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . 0.581 HG21 HG11 ' A' ' 330' ' ' VAL . 2.3 t -80.36 79.2 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.778 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 174.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 65.93 -104.45 1.02 Allowed Glycine 0 N--CA 1.43 -1.753 0 C-N-CA 119.388 -1.387 . . . . 0.0 110.16 -163.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 387' ' ' ASP . . . . . 0.56 ' HB2' ' HD3' ' A' ' 309' ' ' LYS . 35.9 t70 -98.63 -12.15 21.39 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 175.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.69 107.91 4.76 Favored 'General case' 0 CA--C 1.511 -0.537 0 O-C-N 121.771 -0.581 . . . . 0.0 109.773 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . 0.452 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 5.8 p30 -114.17 144.05 43.82 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 -176.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . 0.404 ' CE1' ' HD3' ' A' ' 318' ' ' PRO . 0.3 OUTLIER -169.42 108.61 0.43 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.09 0.472 . . . . 0.0 111.286 -177.31 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 391' ' ' GLN . . . . . 1.052 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 19.6 tt0 -78.01 154.16 31.73 Favored 'General case' 0 C--N 1.345 0.407 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -172.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 392' ' ' TRP . . . . . . . . . . . . . 39.7 t-105 -154.71 148.43 25.43 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.321 177.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -107.25 119.16 38.64 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 173.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 0.649 ' HG2' HE22 ' A' ' 375' ' ' GLN . 0.0 OUTLIER -108.86 136.76 47.88 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.456 0.646 . . . . 0.0 111.857 -169.745 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 19.8 tptp . . . . . 0 C--O 1.247 0.936 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.988 175.528 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . 0.534 ' O ' HG23 ' A' ' 335' ' ' THR . 6.1 t . . . . . 0 CA--C 1.536 0.441 0 CA-C-O 120.908 0.385 . . . . 0.0 111.613 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . 0.438 ' O ' ' HB ' ' A' ' 305' ' ' THR . 5.3 p90 -59.38 132.47 54.11 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.077 177.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.47 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 15.2 t 172.5 -167.68 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -172.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 64.7 t -62.19 114.23 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 171.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . 0.616 ' HB3' ' HE1' ' A' ' 364' ' ' MET . 0.1 OUTLIER -69.03 135.18 50.46 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.146 0.498 . . . . 0.0 111.753 -172.193 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . 0.451 ' HB3' ' NZ ' ' A' ' 311' ' ' LYS . 22.4 t70 -55.29 111.58 0.9 Allowed 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.475 175.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.555 ' HD3' ' HB2' ' A' ' 387' ' ' ASP . 0.0 OUTLIER -40.77 -24.36 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 115.845 1.795 . . . . 0.0 115.845 -169.189 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.531 ' N ' ' HD2' ' A' ' 309' ' ' LYS . 11.7 t -98.71 -4.14 34.27 Favored 'General case' 0 C--N 1.314 -0.96 0 O-C-N 121.677 -0.639 . . . . 0.0 111.773 -171.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . 0.676 ' HE3' ' H ' ' A' ' 335' ' ' THR . 29.0 mtmm -84.87 48.56 1.57 Allowed 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 120.936 0.398 . . . . 0.0 111.081 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.533 ' CD1' ' HB ' ' A' ' 330' ' ' VAL . 4.9 m-85 -139.65 153.82 47.4 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.662 -178.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 22.7 p -138.18 149.19 45.6 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.17 177.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 8.4 m-90 -67.7 116.12 8.04 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.471 0.653 . . . . 0.0 110.217 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.458 ' HB3' ' C ' ' A' ' 329' ' ' GLU . 53.2 tptt -96.69 -57.45 2.29 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 172.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 316' ' ' ARG . 27.2 ttm-85 -139.04 114.81 9.99 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.631 -1.168 . . . . 0.0 108.298 172.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . 0.489 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -68.21 160.8 73.3 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -178.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . 0.619 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 3.8 Cg_exo -43.06 110.96 0.19 Allowed 'Trans proline' 0 C--N 1.358 1.058 0 C-N-CA 122.237 1.958 . . . . 0.0 112.875 -175.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 31.1 m -127.07 128.76 46.77 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.266 -174.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -55.69 120.35 7.14 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . 0.489 ' HA ' HG22 ' A' ' 327' ' ' VAL . 82.9 p -47.74 -54.26 12.74 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.205 0.602 . . . . 0.0 111.053 -169.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 141.47 -17.04 2.67 Favored Glycine 0 N--CA 1.443 -0.86 0 CA-C-N 114.909 -1.042 . . . . 0.0 111.532 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . 0.56 ' O ' ' HB2' ' A' ' 324' ' ' ASP . 7.1 t-80 -122.73 23.94 9.29 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 120.722 0.296 . . . . 0.0 110.585 -179.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . 0.56 ' HB2' ' O ' ' A' ' 323' ' ' HIS . 5.6 m-20 92.69 45.94 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.122 0.969 . . . . 0.0 111.751 169.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . 0.676 ' HA ' ' HG2' ' A' ' 375' ' ' GLN . 1.8 p -154.55 -167.1 2.51 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 174.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.956 HG21 ' HZ2' ' A' ' 392' ' ' TRP . 3.0 t -134.38 142.13 41.64 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.395 0 CA-C-N 119.477 1.035 . . . . 0.0 111.855 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 327' ' ' VAL . . . . . 0.804 HG12 ' HG2' ' A' ' 373' ' ' GLU . 17.4 m -119.02 156.32 21.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.882 174.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.02 150.48 34.03 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.458 ' C ' ' HB3' ' A' ' 315' ' ' LYS . 24.5 tt0 -132.99 132.5 41.97 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -175.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.696 HG11 HG11 ' A' ' 385' ' ' VAL . 0.0 OUTLIER -130.02 150.82 35.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -176.17 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . 0.52 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -120.72 134.52 10.31 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.052 176.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -103.83 174.65 5.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.142 0.471 . . . . 0.0 111.092 -179.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 30.2 m -148.66 49.37 1.01 Allowed 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 170.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -177.05 -88.35 0.07 OUTLIER Glycine 0 C--N 1.339 0.703 0 C-N-CA 119.794 -1.193 . . . . 0.0 113.925 168.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 335' ' ' THR . . . . . 0.676 ' H ' ' HE3' ' A' ' 311' ' ' LYS . 50.3 m -51.3 130.62 27.23 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 114.701 -0.75 . . . . 0.0 110.324 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.802 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 8.1 ptm180 -79.1 -176.01 0.65 Allowed Pre-proline 0 CA--C 1.533 0.322 0 CA-C-O 117.633 -1.175 . . . . 0.0 108.986 -174.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.802 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -24.79 103.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 123.955 3.103 . . . . 0.0 114.045 -177.479 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 338' ' ' CYS . . . . . 0.723 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 8.9 p -111.42 -174.95 2.58 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 113.587 -1.642 . . . . 0.0 111.023 -168.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -107.89 96.51 6.43 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 177.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . 0.849 HG22 HG13 ' A' ' 342' ' ' VAL . 27.3 mt -74.08 120.41 81.2 Favored Pre-proline 0 C--N 1.327 -0.387 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.185 -166.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -81.25 80.69 2.9 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 122.295 1.996 . . . . 0.0 111.057 175.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.849 HG13 HG22 ' A' ' 340' ' ' ILE . 6.7 m -100.13 123.5 53.02 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.024 0 CA-C-O 121.986 0.898 . . . . 0.0 109.837 176.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.516 ' HG3' ' HB2' ' A' ' 384' ' ' TYR . 24.3 ptt180 -132.94 173.05 11.81 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.324 -1.307 . . . . 0.0 107.748 176.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 344' ' ' ALA . . . . . 0.553 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -143.27 141.09 30.92 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 173.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 17.5 m -115.83 145.27 21.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -63.91 115.83 5.24 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.005 177.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 347' ' ' HIS . . . . . 0.595 ' HB3' ' CB ' ' A' ' 380' ' ' ASP . 23.8 p80 35.79 71.11 0.13 Allowed 'General case' 0 N--CA 1.475 0.793 0 O-C-N 124.53 1.144 . . . . 0.0 112.601 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . 0.826 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 41.99 47.15 5.23 Favored Glycine 0 C--N 1.333 0.403 0 N-CA-C 115.191 0.836 . . . . 0.0 115.191 -175.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 347' ' ' HIS . 90.1 t -142.61 102.49 5.44 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 176.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -75.95 66.1 6.84 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.865 2.377 . . . . 0.0 112.781 -178.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -100.99 -55.97 2.43 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 177.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 7.4 p -124.96 133.18 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.45 171.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -64.82 112.49 3.28 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.333 177.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.529 ' HB ' HD22 ' A' ' 376' ' ' LEU . 32.7 m -89.98 1.8 7.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.917 178.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 355' ' ' ALA . . . . . 0.553 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -74.44 84.11 1.98 Allowed 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.181 0.515 . . . . 0.0 110.558 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 356' ' ' MET . . . . . 0.625 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 58.6 ttp -94.0 99.95 12.17 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 172.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.587 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 19.9 mt -85.34 115.45 23.1 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.494 -161.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.595 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 3.1 mm -59.18 -26.65 34.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.045 174.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 34.5 m -137.53 90.73 14.6 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.701 174.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -83.6 38.93 0.75 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.416 2.744 . . . . 0.0 113.461 -172.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -147.57 69.37 11.29 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.689 177.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . 0.784 ' HB3' HG23 ' A' ' 372' ' ' ILE . 63.0 Cg_endo -79.59 143.58 17.04 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.234 1.956 . . . . 0.0 111.825 176.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 363' ' ' THR . . . . . 0.416 ' O ' ' HA2' ' A' ' 369' ' ' GLY . 1.3 p -143.64 133.76 24.32 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.45 -173.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 364' ' ' MET . . . . . 0.723 ' HG2' ' SG ' ' A' ' 338' ' ' CYS . 19.2 ptt? . . . . . 0 CA--C 1.501 -0.928 0 C-N-CA 119.095 -1.042 . . . . 0.0 109.195 177.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . 0.52 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . . . . . . 0 N--CA 1.448 -0.543 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . 0.587 ' HA3' HG23 ' A' ' 330' ' ' VAL . . . -65.42 103.8 0.87 Allowed Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.736 -0.945 . . . . 0.0 110.736 170.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . 0.425 ' O ' ' HG3' ' A' ' 329' ' ' GLU . . . -72.41 -32.7 62.01 Favored Glycine 0 C--N 1.317 -0.514 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.518 -167.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -164.29 138.65 5.54 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 123.823 0.366 . . . . 0.0 110.458 179.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 372' ' ' ILE . . . . . 0.784 HG23 ' HB3' ' A' ' 362' ' ' PRO . 0.3 OUTLIER -137.63 156.14 31.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 171.063 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . 0.804 ' HG2' HG12 ' A' ' 327' ' ' VAL . 43.1 mt-10 -134.62 125.53 27.36 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -178.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . 0.587 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 2.4 mtt -142.94 164.51 29.89 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -174.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 375' ' ' GLN . . . . . 0.835 ' HA ' HE21 ' A' ' 375' ' ' GLN . 0.0 OUTLIER 177.97 179.08 0.32 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.132 0.423 . . . . 0.0 110.929 175.653 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 376' ' ' LEU . . . . . 0.916 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 14.2 tp -165.95 160.74 13.09 Favored Pre-proline 0 N--CA 1.446 -0.64 0 N-CA-C 104.867 -2.271 . . . . 0.0 104.867 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 377' ' ' PRO . . . . . 0.916 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 81.2 Cg_exo -44.54 131.09 9.6 Favored 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 121.502 1.468 . . . . 0.0 111.328 169.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.775 ' HA ' HE22 ' A' ' 394' ' ' GLN . 2.8 Cg_exo -37.03 138.86 0.22 Allowed 'Trans proline' 0 C--N 1.36 1.176 0 C-N-CA 124.607 3.538 . . . . 0.0 112.911 -175.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 152.66 -163.81 30.5 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 -162.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . 0.595 ' CB ' ' HB3' ' A' ' 347' ' ' HIS . 17.6 m-20 -98.86 122.59 42.29 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 117.468 0.634 . . . . 0.0 111.5 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.563 ' HB2' ' CH2' ' A' ' 392' ' ' TRP . 6.1 m120 -124.83 175.17 7.45 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 171.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 1.019 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -163.19 141.42 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 167.304 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . 0.653 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 45.9 mt -101.71 132.23 48.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 C-N-CA 119.674 -0.81 . . . . 0.0 110.456 -174.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 384' ' ' TYR . . . . . 0.555 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 1.9 m-85 -102.33 128.89 48.7 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.483 -1.235 . . . . 0.0 107.782 168.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . 0.696 HG11 HG11 ' A' ' 330' ' ' VAL . 15.2 t -118.48 77.15 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 63.16 -110.49 3.4 Favored Glycine 0 N--CA 1.43 -1.716 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.842 -161.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 387' ' ' ASP . . . . . 0.555 ' HB2' ' HD3' ' A' ' 309' ' ' LYS . 34.1 t70 -81.15 -20.31 41.6 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 177.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.555 ' O ' ' HA ' ' A' ' 384' ' ' TYR . 1.2 mp -68.54 153.03 44.55 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.909 -0.317 . . . . 0.0 110.254 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . 0.653 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 5.0 p-10 -160.24 155.26 24.59 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.08 177.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . 0.619 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 31.6 t60 -171.46 112.12 0.34 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.816 175.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 391' ' ' GLN . . . . . 1.019 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 15.3 tt0 -75.93 149.33 37.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.788 -178.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 392' ' ' TRP . . . . . 0.956 ' HZ2' HG21 ' A' ' 326' ' ' VAL . 0.1 OUTLIER -168.18 151.32 5.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.049 0.452 . . . . 0.0 110.142 -179.111 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -101.05 118.87 37.84 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 178.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 0.775 HE22 ' HA ' ' A' ' 378' ' ' PRO . 0.0 OUTLIER -95.64 131.81 41.48 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.308 -170.27 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.473 ' HD2' ' HA ' ' A' ' 395' ' ' LYS . 21.7 tptp . . . . . 0 C--O 1.252 1.223 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.281 178.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . 0.63 HG23 HG23 ' A' ' 335' ' ' THR . 5.2 t . . . . . 0 CA--C 1.536 0.412 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . 0.546 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 25.9 p90 -64.21 127.85 33.22 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 175.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.408 HG23 ' O ' ' A' ' 306' ' ' VAL . 14.3 t 178.45 -167.13 0.06 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -170.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.408 ' O ' HG23 ' A' ' 305' ' ' THR . 34.3 t -65.06 114.34 2.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 165.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.37 139.0 57.17 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.346 0.593 . . . . 0.0 110.414 -170.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . 0.487 ' HB3' ' HG2' ' A' ' 311' ' ' LYS . 5.4 t70 -60.94 126.71 28.36 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.609 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.547 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -44.02 -13.61 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 -175.38 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.413 ' N ' ' HD2' ' A' ' 309' ' ' LYS . 12.5 t -108.07 0.46 21.73 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 119.39 0.996 . . . . 0.0 111.8 -176.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . 0.487 ' HG2' ' HB3' ' A' ' 308' ' ' ASP . 29.6 mmmt -72.68 -33.06 66.26 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -175.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.808 ' HD1' HD13 ' A' ' 388' ' ' LEU . 0.6 OUTLIER -90.95 175.67 6.88 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 122.29 1.043 . . . . 0.0 112.798 -174.77 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 8.7 t -153.98 162.27 41.34 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 113.285 -1.78 . . . . 0.0 109.697 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . 0.638 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 24.0 m-90 -77.75 92.88 4.22 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -178.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -71.57 -43.04 67.03 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 171.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -154.02 124.4 7.0 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 171.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . 0.507 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -70.7 163.59 62.74 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 119.139 -0.458 . . . . 0.0 109.99 -177.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . 0.546 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 2.4 Cg_endo -46.19 113.5 0.63 Allowed 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 122.067 1.845 . . . . 0.0 112.281 -179.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 21.7 m -129.5 133.96 47.53 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.881 -172.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . 0.431 ' HA ' HG13 ' A' ' 326' ' ' VAL . 28.4 t70 -55.84 123.14 13.24 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -178.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . 0.446 ' HB3' HG13 ' A' ' 327' ' ' VAL . 81.0 p -62.66 -47.78 82.18 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 121.339 0.59 . . . . 0.0 109.883 -174.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 120.27 -15.0 10.11 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -109.05 49.2 0.83 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.774 0.797 . . . . 0.0 108.974 177.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 50.67 41.12 25.52 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 114.647 -1.161 . . . . 0.0 112.597 -178.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . 0.584 ' HA ' ' HG3' ' A' ' 375' ' ' GLN . 6.2 p -150.39 -173.42 4.45 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 175.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.893 HG23 ' HG2' ' A' ' 375' ' ' GLN . 1.5 t -133.75 146.0 32.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.94 -178.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 327' ' ' VAL . . . . . 0.761 HG12 ' HG2' ' A' ' 373' ' ' GLU . 20.6 m -123.6 155.86 30.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.774 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 328' ' ' MET . . . . . 0.492 ' CG ' HD12 ' A' ' 372' ' ' ILE . 0.0 OUTLIER -143.63 154.21 43.31 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 173.934 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -132.58 130.65 40.57 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.704 HG21 HD13 ' A' ' 340' ' ' ILE . 0.0 OUTLIER -118.54 162.21 16.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -179.231 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . 0.802 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -118.55 172.65 14.57 Favored Glycine 0 C--O 1.227 -0.341 0 C-N-CA 119.712 -1.232 . . . . 0.0 112.531 172.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . 0.794 ' HD1' ' HA2' ' A' ' 368' ' ' GLY . 0.9 OUTLIER -127.84 135.78 50.52 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 179.726 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 29.0 m -85.82 -21.01 28.32 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 176.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -171.53 -50.37 0.04 OUTLIER Glycine 0 C--N 1.335 0.518 0 C-N-CA 118.357 -1.878 . . . . 0.0 115.054 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 335' ' ' THR . . . . . 0.63 HG23 HG23 ' A' ' 303' ' ' THR . 65.8 m -49.59 129.74 19.69 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 123.892 0.407 . . . . 0.0 110.115 -178.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.639 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 1.0 OUTLIER -82.37 176.45 3.81 Favored Pre-proline 0 N--CA 1.451 -0.416 0 CA-C-O 117.366 -1.302 . . . . 0.0 107.631 -172.413 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.716 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.1 OUTLIER -25.25 98.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.363 1.342 0 C-N-CA 123.727 2.951 . . . . 0.0 114.053 -173.323 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 338' ' ' CYS . . . . . 0.704 ' SG ' ' HB2' ' A' ' 364' ' ' MET . 6.5 p -129.7 139.54 51.32 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 113.971 -1.468 . . . . 0.0 108.444 -171.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -65.6 124.54 22.64 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.395 -0.522 . . . . 0.0 109.706 177.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . 0.704 HD13 HG21 ' A' ' 330' ' ' VAL . 18.6 tt -98.45 118.72 62.94 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.273 -177.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.7 95.23 0.71 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.949 2.432 . . . . 0.0 112.336 -177.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.75 HG11 HD13 ' A' ' 372' ' ' ILE . 15.4 m -110.07 122.53 64.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.643 0.735 . . . . 0.0 110.812 179.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 14.6 ptt180 -133.5 -178.25 4.91 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 173.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 344' ' ' ALA . . . . . 0.5 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -147.03 147.81 31.04 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.629 177.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.592 HG22 HD12 ' A' ' 382' ' ' ILE . 4.8 m -118.94 142.47 33.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 177.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.469 ' HB2' HG11 ' A' ' 354' ' ' VAL . . . -65.48 127.67 32.78 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 177.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 347' ' ' HIS . . . . . 0.591 ' O ' HG23 ' A' ' 349' ' ' VAL . 35.2 t60 41.44 60.38 2.13 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 124.204 0.94 . . . . 0.0 112.038 174.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . 0.51 ' H ' ' CG2' ' A' ' 382' ' ' ILE . . . 44.85 38.62 5.85 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 115.035 0.774 . . . . 0.0 115.035 -175.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 347' ' ' HIS . 58.4 t -135.85 103.15 10.04 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 117.917 0.859 . . . . 0.0 108.863 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 350' ' ' PRO . . . . . 0.49 ' HA ' ' HB ' ' A' ' 345' ' ' VAL . 15.4 Cg_exo -72.65 62.12 3.71 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.861 2.374 . . . . 0.0 112.936 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -100.4 -55.2 2.67 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 7.7 p -124.83 133.76 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.456 174.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . 0.5 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 37.4 t30 -66.72 116.14 7.31 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.482 176.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.63 ' HB ' HD22 ' A' ' 376' ' ' LEU . 27.5 m -101.06 5.92 10.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.292 -176.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 355' ' ' ALA . . . . . 0.435 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -74.82 87.03 2.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.194 0.521 . . . . 0.0 112.027 -177.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.1 99.45 11.43 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 170.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 43.1 mt -87.37 121.82 30.32 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.607 -164.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.918 HD11 ' HB2' ' A' ' 375' ' ' GLN . 2.8 mm -63.25 -29.77 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.565 175.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 27.6 m -133.81 91.42 25.07 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.467 173.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -85.01 39.9 0.78 Allowed 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 123.518 2.812 . . . . 0.0 113.801 -170.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -158.4 70.74 3.86 Favored Pre-proline 0 C--N 1.319 -0.76 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.288 176.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . 0.478 ' HG3' HG21 ' A' ' 342' ' ' VAL . 97.8 Cg_endo -84.31 147.99 11.5 Favored 'Trans proline' 0 C--O 1.247 0.94 0 C-N-CA 122.17 1.913 . . . . 0.0 111.759 173.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 4.6 m -143.07 150.95 40.22 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -174.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 364' ' ' MET . . . . . 0.716 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 60.3 mtp . . . . . 0 C--N 1.307 -1.254 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.584 -176.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . 0.802 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . . . . . . 0 CA--C 1.494 -1.255 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . 0.584 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -109.17 5.55 31.96 Favored Glycine 0 C--N 1.307 -1.07 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 168.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 75.44 -84.06 0.87 Allowed Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 114.693 -0.754 . . . . 0.0 113.949 174.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -166.81 141.52 4.1 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.222 -0.489 . . . . 0.0 110.596 -173.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 372' ' ' ILE . . . . . 0.75 HD13 HG11 ' A' ' 342' ' ' VAL . 0.7 OUTLIER -136.72 145.4 30.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.113 175.395 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . 0.761 ' HG2' HG12 ' A' ' 327' ' ' VAL . 43.5 mt-10 -127.71 125.68 40.46 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 177.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . 0.786 ' HE3' HD11 ' A' ' 383' ' ' ILE . 0.0 OUTLIER -139.18 156.07 47.38 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.286 -174.227 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 375' ' ' GLN . . . . . 0.918 ' HB2' HD11 ' A' ' 358' ' ' ILE . 0.0 OUTLIER -168.94 175.82 5.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.422 0.629 . . . . 0.0 112.337 175.798 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 376' ' ' LEU . . . . . 0.63 HD22 ' HB ' ' A' ' 354' ' ' VAL . 16.4 tp -168.18 145.09 3.38 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 174.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 377' ' ' PRO . . . . . 0.605 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 80.8 Cg_exo -40.93 140.92 1.04 Allowed 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.266 1.977 . . . . 0.0 112.165 177.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.87 ' HA ' HE22 ' A' ' 394' ' ' GLN . 4.4 Cg_exo -35.46 139.65 0.12 Allowed 'Trans proline' 0 C--N 1.357 1.008 1 C-N-CA 125.488 4.125 . . . . 0.0 114.106 -169.437 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 149.74 -163.09 29.29 Favored Glycine 0 N--CA 1.442 -0.916 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -166.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . 0.555 ' OD1' ' HB2' ' A' ' 347' ' ' HIS . 1.5 p30 -113.2 136.76 52.37 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.781 0.8 . . . . 0.0 111.804 176.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.408 ' HB2' ' CH2' ' A' ' 392' ' ' TRP . 20.2 m-80 -136.05 171.26 14.72 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.818 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 1.017 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -156.91 143.93 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.826 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 174.133 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . 0.786 HD11 ' HE3' ' A' ' 374' ' ' MET . 45.1 mt -95.3 127.95 46.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.147 -177.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 384' ' ' TYR . . . . . 0.41 ' O ' ' HG2' ' A' ' 343' ' ' ARG . 0.2 OUTLIER -103.31 92.32 4.45 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.097 170.56 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . 0.572 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 15.6 t -87.86 82.9 2.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 178.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 57.81 -111.32 2.93 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.415 -0.898 . . . . 0.0 111.777 -173.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 387' ' ' ASP . . . . . 0.44 ' HB2' ' HD3' ' A' ' 309' ' ' LYS . 32.1 t70 -77.03 -24.84 52.07 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.884 0.373 . . . . 0.0 111.306 175.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.808 HD13 ' HD1' ' A' ' 312' ' ' PHE . 3.6 mp -71.43 156.46 39.43 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.403 -179.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . 0.7 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 7.7 p30 -169.49 153.56 5.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.196 178.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . 0.546 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 56.7 t-80 -175.88 117.7 0.15 Allowed 'General case' 0 N--CA 1.469 0.503 0 O-C-N 123.283 0.365 . . . . 0.0 110.486 177.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 391' ' ' GLN . . . . . 1.017 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 4.1 tt0 -73.4 154.94 39.81 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.103 0.478 . . . . 0.0 112.114 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 392' ' ' TRP . . . . . 0.512 ' HE1' ' HB3' ' A' ' 394' ' ' GLN . 0.1 OUTLIER -160.76 151.4 18.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.804 176.558 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -113.91 131.85 56.14 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 177.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 0.897 ' HG2' HE22 ' A' ' 375' ' ' GLN . 0.0 OUTLIER -111.72 136.13 51.39 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.753 0.311 . . . . 0.0 110.542 -177.131 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.487 ' O ' ' HB3' ' A' ' 378' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.922 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.462 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . 0.535 ' O ' HG23 ' A' ' 335' ' ' THR . 4.3 t . . . . . 0 CA--C 1.535 0.402 0 CA-C-O 120.787 0.327 . . . . 0.0 111.218 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . 0.489 ' HB3' ' NE ' ' A' ' 336' ' ' ARG . 0.8 OUTLIER -59.35 133.27 55.95 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.965 0.412 . . . . 0.0 110.002 178.814 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.528 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 12.8 t 174.46 -170.68 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -175.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 18.5 t -65.46 116.25 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 170.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . 0.486 ' HB3' ' CE2' ' A' ' 332' ' ' PHE . 0.0 OUTLIER -67.65 139.26 56.8 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -173.134 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . 0.642 ' OD2' HG22 ' A' ' 310' ' ' THR . 15.8 t70 -59.45 118.03 5.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.064 -176.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.455 ' HD2' ' N ' ' A' ' 310' ' ' THR . 0.0 OUTLIER -48.2 -15.87 0.08 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -168.781 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.642 HG22 ' OD2' ' A' ' 308' ' ' ASP . 9.2 t -99.35 -10.93 21.69 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 118.663 0.665 . . . . 0.0 110.82 -175.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . 0.554 ' HE2' ' CE1' ' A' ' 332' ' ' PHE . 24.5 mtpt -83.67 51.99 2.15 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.487 0.661 . . . . 0.0 110.579 -178.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.519 ' HZ ' ' HG3' ' A' ' 364' ' ' MET . 11.3 m-85 -141.7 151.89 43.38 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.675 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . 0.4 ' C ' HD21 ' A' ' 388' ' ' LEU . 18.7 p -142.49 152.52 42.78 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.559 -1.2 . . . . 0.0 109.296 178.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 65.7 m95 -82.23 95.39 7.53 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.132 0.491 . . . . 0.0 110.804 178.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.792 ' HA ' ' HE3' ' A' ' 315' ' ' LYS . 0.4 OUTLIER -65.3 -46.47 80.24 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 167.56 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 8.0 ttm180 -150.09 126.71 10.92 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.883 173.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . 0.486 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -72.94 160.91 81.76 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-O 119.218 -0.42 . . . . 0.0 110.162 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . 0.545 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 2.7 Cg_endo -43.55 114.35 0.49 Allowed 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 122.653 2.236 . . . . 0.0 112.492 -176.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 15.8 m -133.78 136.37 44.48 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.438 -174.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -63.66 125.8 25.48 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -176.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . 0.528 ' HB3' HG13 ' A' ' 327' ' ' VAL . 93.7 p -56.17 -48.79 75.66 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.782 -171.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 133.69 -10.44 4.91 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 36.8 t-80 -128.03 61.34 1.44 Allowed 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.346 0.593 . . . . 0.0 109.74 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 52.76 35.62 19.1 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 114.921 -1.036 . . . . 0.0 113.547 177.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . 0.676 ' HA ' ' HG3' ' A' ' 375' ' ' GLN . 3.7 p -148.48 -175.12 4.8 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 177.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.832 HG23 ' HG2' ' A' ' 375' ' ' GLN . 0.2 OUTLIER -130.88 145.91 34.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.34 0.59 . . . . 0.0 111.032 -177.327 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 327' ' ' VAL . . . . . 0.668 HG12 ' HG3' ' A' ' 373' ' ' GLU . 16.9 m -123.44 150.48 27.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.97 175.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 328' ' ' MET . . . . . 0.532 ' SD ' ' HB ' ' A' ' 372' ' ' ILE . 0.1 OUTLIER -139.65 149.54 43.86 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 175.229 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.732 ' HG2' ' HG2' ' A' ' 315' ' ' LYS . 4.6 tt0 -125.3 121.63 34.54 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -177.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.444 ' HB ' ' HD1' ' A' ' 312' ' ' PHE . 4.2 m -126.65 145.03 34.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.718 -174.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -111.67 131.82 10.49 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 119.915 -1.136 . . . . 0.0 112.381 179.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . 0.975 ' H ' ' HA2' ' A' ' 368' ' ' GLY . 4.1 t80 -133.87 136.71 44.53 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.011 -0.736 . . . . 0.0 109.011 176.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 19.9 m -129.78 62.36 1.55 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -171.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -164.26 -84.28 0.05 OUTLIER Glycine 0 CA--C 1.52 0.348 0 C-N-CA 119.25 -1.452 . . . . 0.0 113.877 163.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 335' ' ' THR . . . . . 0.95 ' HB ' ' HZ ' ' A' ' 332' ' ' PHE . 35.3 m -50.59 135.82 22.31 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.328 -0.936 . . . . 0.0 109.89 179.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.891 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 17.8 ptt180 -72.69 179.98 0.96 Allowed Pre-proline 0 CA--C 1.523 -0.078 0 CA-C-O 117.783 -1.103 . . . . 0.0 108.923 -178.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.891 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -25.96 101.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.366 1.474 0 C-N-CA 123.653 2.902 . . . . 0.0 112.905 178.631 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 338' ' ' CYS . . . . . 0.563 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 29.0 p -113.88 -175.71 2.74 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 113.81 -1.541 . . . . 0.0 109.465 -165.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -108.74 96.97 6.7 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . 0.752 ' HB ' ' SD ' ' A' ' 364' ' ' MET . 15.7 tt -73.8 131.23 82.07 Favored Pre-proline 0 C--N 1.325 -0.472 0 C-N-CA 119.604 -0.838 . . . . 0.0 111.449 -169.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -81.58 79.28 3.25 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 121.67 1.58 . . . . 0.0 111.156 172.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.669 HG22 HG23 ' A' ' 340' ' ' ILE . 2.5 m -101.62 116.09 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 CA-C-O 121.756 0.789 . . . . 0.0 110.313 177.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.541 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 25.6 ptt180 -133.8 177.85 7.4 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.761 -1.108 . . . . 0.0 108.162 178.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 344' ' ' ALA . . . . . 0.493 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -149.95 147.16 27.55 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.579 176.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.617 HG22 HD12 ' A' ' 382' ' ' ILE . 5.8 m -118.38 143.03 30.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 177.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.26 121.88 15.81 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 177.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 347' ' ' HIS . . . . . 0.529 ' O ' HG23 ' A' ' 349' ' ' VAL . 41.3 t-80 43.9 61.85 2.16 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 124.277 0.986 . . . . 0.0 112.54 173.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . 0.564 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 46.9 38.05 9.94 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 114.733 0.653 . . . . 0.0 114.733 -175.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 347' ' ' HIS . 58.5 t -138.34 102.88 8.0 Favored Pre-proline 0 C--O 1.235 0.305 0 CA-C-N 117.859 0.829 . . . . 0.0 108.91 178.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 350' ' ' PRO . . . . . 0.468 ' HA ' ' HB ' ' A' ' 345' ' ' VAL . 15.0 Cg_exo -72.6 63.53 3.78 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.848 2.366 . . . . 0.0 112.837 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -100.05 -56.23 2.42 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 7.6 p -125.05 133.1 70.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.278 174.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . 0.484 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 41.8 t30 -64.42 116.57 6.24 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.942 176.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.602 ' HB ' ' HG ' ' A' ' 376' ' ' LEU . 27.4 m -98.53 3.81 10.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.348 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 355' ' ' ALA . . . . . 0.493 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -74.14 84.58 1.84 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.278 0.561 . . . . 0.0 111.026 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 356' ' ' MET . . . . . 0.5 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 22.7 ttt -98.78 98.43 9.54 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 173.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.66 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 57.6 mt -83.06 147.39 28.16 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.655 -161.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.718 ' HB ' ' CB ' ' A' ' 373' ' ' GLU . 4.4 mm -88.68 -19.95 7.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 178.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 20.6 m -133.75 92.94 21.83 Favored Pre-proline 0 N--CA 1.445 -0.682 0 CA-C-N 113.605 -1.634 . . . . 0.0 108.339 171.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -88.51 25.77 0.61 Allowed 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 123.024 2.483 . . . . 0.0 114.074 -170.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 361' ' ' ASN . . . . . 0.498 ' N ' ' HD3' ' A' ' 362' ' ' PRO . 40.9 m-80 -149.65 57.6 2.85 Favored Pre-proline 0 C--N 1.314 -0.953 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.864 176.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . 0.515 ' HB3' HG23 ' A' ' 372' ' ' ILE . 4.9 Cg_endo -75.52 111.44 3.3 Favored 'Trans proline' 0 C--O 1.247 0.951 0 C-N-CA 121.447 1.432 . . . . 0.0 112.932 179.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 363' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 338' ' ' CYS . 15.8 p -96.68 125.54 41.22 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 114.924 -1.034 . . . . 0.0 111.59 167.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 364' ' ' MET . . . . . 0.814 ' HB3' ' CA ' ' A' ' 369' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.319 -0.734 0 CA-C-N 114.073 -1.421 . . . . 0.0 111.241 -176.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . 0.975 ' HA2' ' H ' ' A' ' 332' ' ' PHE . . . . . . . . 0 N--CA 1.449 -0.442 0 N-CA-C 111.426 -0.67 . . . . 0.0 111.426 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . 0.814 ' CA ' ' HB3' ' A' ' 364' ' ' MET . . . -76.41 -32.15 52.35 Favored Glycine 0 CA--C 1.498 -1.007 0 C-N-CA 120.37 -0.919 . . . . 0.0 113.163 177.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 87.6 -132.42 11.18 Favored Glycine 0 N--CA 1.438 -1.18 0 C-N-CA 120.03 -1.081 . . . . 0.0 111.002 -172.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -103.13 136.7 42.44 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.155 0.502 . . . . 0.0 111.4 -176.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 372' ' ' ILE . . . . . 0.532 ' HB ' ' SD ' ' A' ' 328' ' ' MET . 0.1 OUTLIER -128.07 165.18 27.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.584 175.752 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . 0.718 ' CB ' ' HB ' ' A' ' 358' ' ' ILE . 11.3 mp0 -128.79 130.36 46.9 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.153 0.502 . . . . 0.0 110.637 -177.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . 0.676 ' HG2' HD11 ' A' ' 383' ' ' ILE . 0.0 OUTLIER -137.8 166.86 22.96 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.026 179.722 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 375' ' ' GLN . . . . . 0.832 ' HG2' HG23 ' A' ' 326' ' ' VAL . 0.0 OUTLIER -173.54 176.15 2.84 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.425 0.631 . . . . 0.0 110.809 168.153 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 376' ' ' LEU . . . . . 0.799 HD22 ' HD2' ' A' ' 377' ' ' PRO . 2.6 tm? -168.0 128.97 1.15 Allowed Pre-proline 0 C--N 1.317 -0.834 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 175.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 377' ' ' PRO . . . . . 0.799 ' HD2' HD22 ' A' ' 376' ' ' LEU . 34.0 Cg_exo -26.73 130.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 124.22 3.28 . . . . 0.0 113.161 -178.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -35.46 133.51 0.23 Allowed 'Trans proline' 0 C--N 1.361 1.2 0 C-N-CA 124.373 3.382 . . . . 0.0 113.0 -167.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 151.0 -174.45 30.27 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 -160.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . 0.66 ' HB3' ' CD2' ' A' ' 393' ' ' PHE . 4.4 p30 -98.41 125.25 43.5 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 117.787 0.794 . . . . 0.0 111.984 -173.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.635 HD22 ' HG2' ' A' ' 394' ' ' GLN . 33.1 m-80 -139.76 153.56 47.19 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.514 -176.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 0.981 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -144.5 140.3 23.97 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.872 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.676 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . 0.676 HD11 ' HG2' ' A' ' 374' ' ' MET . 37.3 mt -98.94 130.44 47.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.938 -175.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 384' ' ' TYR . . . . . 0.55 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.2 OUTLIER -106.71 92.0 3.92 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.006 174.058 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . 0.434 ' O ' ' HB2' ' A' ' 388' ' ' LEU . 9.5 t -87.02 87.71 2.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 64.57 -112.6 5.14 Favored Glycine 0 N--CA 1.442 -0.942 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -169.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -83.95 -16.81 42.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.72 0.295 . . . . 0.0 111.289 174.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.55 ' O ' ' HA ' ' A' ' 384' ' ' TYR . 1.2 mp -68.51 151.52 46.68 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.348 -179.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . 0.571 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 29.0 p30 -159.36 151.35 20.75 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.679 177.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . 0.545 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 8.7 t60 -172.26 116.1 0.34 Allowed 'General case' 0 C--O 1.239 0.504 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.481 175.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 391' ' ' GLN . . . . . 0.981 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 4.1 tt0 -76.87 153.75 34.45 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.803 -177.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 392' ' ' TRP . . . . . 0.455 ' HD1' ' CD ' ' A' ' 394' ' ' GLN . 38.8 t-105 -167.08 153.34 8.14 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.948 178.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . 0.66 ' CD2' ' HB3' ' A' ' 380' ' ' ASP . 29.2 m-85 -106.75 110.92 23.22 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 176.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 0.635 ' HG2' HD22 ' A' ' 381' ' ' ASN . 5.3 mm100 -75.76 107.55 8.01 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -169.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 9.7 ptmm? . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.466 -177.444 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . 0.621 HG23 HG23 ' A' ' 335' ' ' THR . 14.9 t . . . . . 0 CA--C 1.535 0.372 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -66.78 120.83 14.19 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.058 -177.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.615 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 9.4 t 173.55 -167.03 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.519 -170.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 37.2 t -64.91 113.07 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 169.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . 0.423 ' SG ' ' HE2' ' A' ' 332' ' ' PHE . 0.0 OUTLIER -68.36 142.59 55.42 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.953 0.406 . . . . 0.0 110.712 -171.332 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . 0.856 ' HB3' ' HG3' ' A' ' 311' ' ' LYS . 6.6 t70 -60.87 126.3 26.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.442 -173.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.454 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 17.6 pttm -38.45 -29.62 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 125.849 1.659 . . . . 0.0 114.841 -178.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 12.3 t -108.72 4.31 23.62 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 121.723 -0.611 . . . . 0.0 112.029 -169.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . 0.856 ' HG3' ' HB3' ' A' ' 308' ' ' ASP . 27.8 mtpp -83.8 -28.79 27.86 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -173.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.618 ' HE2' ' O ' ' A' ' 385' ' ' VAL . 0.1 OUTLIER -85.01 175.71 8.88 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.621 0.724 . . . . 0.0 112.159 -176.163 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 5.2 t -153.2 159.45 42.66 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.329 -1.305 . . . . 0.0 109.476 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . 0.474 ' CH2' ' HD3' ' A' ' 318' ' ' PRO . 52.5 m95 -81.99 95.9 7.55 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-O 121.161 0.505 . . . . 0.0 110.518 -179.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.615 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 65.4 tttm -65.82 -43.18 89.36 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 168.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.436 HH11 ' HD2' ' A' ' 316' ' ' ARG . 44.8 ttm105 -149.28 125.31 10.65 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.846 172.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . 0.538 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -71.02 164.09 59.73 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.309 -179.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . 0.592 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 2.1 Cg_endo -45.59 108.66 0.15 Allowed 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 122.56 2.174 . . . . 0.0 112.03 -179.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 30.1 m -120.5 124.29 45.04 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.647 -174.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . 0.557 ' HA ' HG13 ' A' ' 326' ' ' VAL . 11.4 t70 -53.57 121.62 8.13 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 177.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 60.2 p -61.21 -43.69 98.47 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.236 0.541 . . . . 0.0 109.794 -172.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 116.8 -8.79 16.6 Favored Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 109.911 -1.275 . . . . 0.0 109.911 178.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -127.1 62.37 1.34 Allowed 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 114.541 -0.83 . . . . 0.0 109.823 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 29.5 t70 64.43 17.99 11.1 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.577 171.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . 0.526 ' HA ' ' HG2' ' A' ' 375' ' ' GLN . 17.8 p -149.45 -174.58 4.71 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 121.828 -0.545 . . . . 0.0 110.285 -176.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.557 HG13 ' HA ' ' A' ' 320' ' ' ASP . 0.6 OUTLIER -135.56 146.07 30.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.202 0.525 . . . . 0.0 111.095 -177.707 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 327' ' ' VAL . . . . . 0.619 HG12 ' HG2' ' A' ' 373' ' ' GLU . 19.8 m -124.33 153.74 31.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.645 177.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 328' ' ' MET . . . . . 0.843 ' SD ' ' HB ' ' A' ' 372' ' ' ILE . 0.0 OUTLIER -145.48 157.84 43.94 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 174.977 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.615 ' HG2' ' HD3' ' A' ' 315' ' ' LYS . 8.0 tt0 -136.21 128.19 29.5 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 120.588 -0.445 . . . . 0.0 109.898 -178.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.68 HG22 HD11 ' A' ' 372' ' ' ILE . 1.5 m -129.63 147.09 33.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -173.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -120.89 134.96 10.49 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.533 -176.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . 0.862 ' H ' ' HA2' ' A' ' 368' ' ' GLY . 0.9 OUTLIER -110.69 152.2 26.82 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.099 0.476 . . . . 0.0 110.67 178.748 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 17.5 m -88.8 -36.64 15.96 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -172.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -146.12 -39.23 0.05 OUTLIER Glycine 0 C--N 1.333 0.394 0 C-N-CA 118.983 -1.58 . . . . 0.0 114.313 -176.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 335' ' ' THR . . . . . 0.621 HG23 HG23 ' A' ' 303' ' ' THR . 22.8 m -53.5 129.53 32.75 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.906 0.384 . . . . 0.0 110.727 -177.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.895 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 7.2 ptm180 -87.58 -176.38 0.71 Allowed Pre-proline 0 N--CA 1.455 -0.2 0 CA-C-O 117.268 -1.348 . . . . 0.0 107.857 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.895 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 37.4 Cg_exo -26.28 97.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 123.482 2.788 . . . . 0.0 113.862 -179.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 338' ' ' CYS . . . . . 0.615 ' HB2' ' O ' ' A' ' 305' ' ' THR . 30.0 p -117.55 -176.23 2.98 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.965 -173.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 11.7 mpt_? -111.95 108.39 17.72 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 -177.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . 0.8 ' HB ' ' SD ' ' A' ' 364' ' ' MET . 15.0 tt -73.1 131.77 83.16 Favored Pre-proline 0 C--O 1.236 0.37 0 C-N-CA 119.527 -0.869 . . . . 0.0 111.964 -170.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -87.46 78.72 1.62 Allowed 'Trans proline' 0 N--CA 1.447 -1.21 0 C-N-CA 122.069 1.846 . . . . 0.0 110.976 168.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.798 HG22 HG23 ' A' ' 340' ' ' ILE . 2.5 m -103.51 124.62 57.86 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.872 0 CA-C-O 121.686 0.755 . . . . 0.0 110.613 177.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.4 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 28.4 ptt180 -141.11 177.48 8.04 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 173.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 344' ' ' ALA . . . . . 0.523 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -147.18 147.89 30.97 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 120.314 -0.555 . . . . 0.0 110.336 176.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.489 HG22 HD12 ' A' ' 382' ' ' ILE . 10.6 m -118.54 145.86 23.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.23 116.37 5.93 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 176.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 347' ' ' HIS . . . . . 0.665 ' HB3' ' CB ' ' A' ' 380' ' ' ASP . 7.9 p-80 34.7 71.47 0.11 Allowed 'General case' 0 N--CA 1.476 0.846 0 O-C-N 124.498 1.124 . . . . 0.0 113.651 176.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . 0.8 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 51.88 34.96 38.64 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 115.109 0.804 . . . . 0.0 115.109 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 347' ' ' HIS . 49.9 t -139.65 101.26 7.31 Favored Pre-proline 0 C--O 1.234 0.282 0 CA-C-N 118.531 1.166 . . . . 0.0 108.327 177.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 350' ' ' PRO . . . . . 0.442 ' HA ' ' HB ' ' A' ' 345' ' ' VAL . 12.1 Cg_exo -75.76 61.9 6.35 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.847 2.365 . . . . 0.0 113.097 -179.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -101.02 -56.41 2.33 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 5.5 p -119.4 128.72 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.895 173.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . 0.523 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 31.8 t30 -64.64 116.56 6.35 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.549 176.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.464 ' HB ' ' HG ' ' A' ' 376' ' ' LEU . 16.7 m -92.28 -1.22 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.701 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 355' ' ' ALA . . . . . 0.435 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -76.14 89.12 3.05 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.222 0.534 . . . . 0.0 112.009 -176.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.73 103.08 13.82 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 170.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.554 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 53.8 mt -86.47 121.99 29.8 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.53 -161.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.68 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 2.5 mm -63.48 -23.79 34.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.506 174.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 16.7 m -128.14 92.02 42.87 Favored Pre-proline 0 N--CA 1.45 -0.475 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.23 169.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -88.82 24.14 0.7 Allowed 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 123.105 2.537 . . . . 0.0 113.47 -171.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 361' ' ' ASN . . . . . 0.572 ' N ' ' HD3' ' A' ' 362' ' ' PRO . 28.3 p-10 -145.23 50.92 1.2 Allowed Pre-proline 0 C--N 1.313 -1.012 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.305 178.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . 0.585 ' HB3' HG23 ' A' ' 372' ' ' ILE . 5.7 Cg_endo -75.2 108.2 2.66 Favored 'Trans proline' 0 C--O 1.249 1.063 0 C-N-CA 121.648 1.566 . . . . 0.0 113.323 -177.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 363' ' ' THR . . . . . 0.511 ' HA ' ' HE2' ' A' ' 364' ' ' MET . 2.0 p -92.11 167.02 12.36 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 114.693 -1.139 . . . . 0.0 112.011 166.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 364' ' ' MET . . . . . 0.8 ' SD ' ' HB ' ' A' ' 340' ' ' ILE . 0.2 OUTLIER . . . . . 0 CA--C 1.496 -1.129 0 CA-C-N 113.716 -1.584 . . . . 0.0 111.188 -172.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . 0.862 ' HA2' ' H ' ' A' ' 332' ' ' PHE . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 111.778 -0.529 . . . . 0.0 111.778 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . 0.504 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -76.8 -34.04 44.54 Favored Glycine 0 C--N 1.334 0.448 0 CA-C-N 117.686 0.743 . . . . 0.0 113.06 178.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 94.39 -50.61 2.11 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.298 -0.953 . . . . 0.0 113.521 179.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -166.36 144.38 5.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 117.08 0.44 . . . . 0.0 111.423 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 372' ' ' ILE . . . . . 0.843 ' HB ' ' SD ' ' A' ' 328' ' ' MET . 0.3 OUTLIER -138.28 158.58 32.06 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 169.474 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . 0.68 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 52.0 mt-10 -133.29 129.79 38.06 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.79 0.329 . . . . 0.0 110.326 178.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . 0.64 ' HG2' HD11 ' A' ' 383' ' ' ILE . 4.9 ppp? -136.83 162.72 32.45 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -179.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 375' ' ' GLN . . . . . 1.065 ' HA ' HE21 ' A' ' 375' ' ' GLN . 0.0 OUTLIER 172.52 177.81 0.09 Allowed 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 171.507 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 376' ' ' LEU . . . . . 0.63 HD11 HD21 ' A' ' 381' ' ' ASN . 0.0 OUTLIER -168.5 178.37 1.06 Allowed Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 173.822 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 377' ' ' PRO . . . . . 0.461 ' HD2' ' HB2' ' A' ' 376' ' ' LEU . 92.0 Cg_exo -44.66 125.4 6.26 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 CA-C-N 121.131 1.44 . . . . 0.0 111.176 169.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -36.79 147.08 0.08 OUTLIER 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 124.593 3.529 . . . . 0.0 113.943 -173.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 153.87 -174.44 32.4 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -164.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . 0.665 ' CB ' ' HB3' ' A' ' 347' ' ' HIS . 4.4 m-20 -93.0 124.76 37.2 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 117.558 0.679 . . . . 0.0 109.373 -178.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.63 HD21 HD11 ' A' ' 376' ' ' LEU . 0.6 OUTLIER -120.38 168.56 11.17 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.942 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 1.027 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -160.63 136.74 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 165.662 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . 0.64 HD11 ' HG2' ' A' ' 374' ' ' MET . 37.3 mt -95.37 130.01 44.71 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 C-N-CA 119.383 -0.927 . . . . 0.0 109.489 -174.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 384' ' ' TYR . . . . . 0.565 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.3 OUTLIER -107.65 90.9 3.44 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 114.352 -1.295 . . . . 0.0 108.114 173.237 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . 0.618 ' O ' ' HE2' ' A' ' 312' ' ' PHE . 10.6 t -84.43 91.25 2.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 175.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 61.02 -112.01 4.31 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.171 -171.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -90.05 -13.51 35.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.853 0.358 . . . . 0.0 111.354 176.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.565 ' O ' ' HA ' ' A' ' 384' ' ' TYR . 1.6 mp -67.8 146.44 53.7 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 175.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . 0.578 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 30.2 p30 -155.58 152.25 28.55 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.042 178.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . 0.592 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 13.0 t60 -173.62 119.43 0.3 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.783 174.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 391' ' ' GLN . . . . . 1.027 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 0.8 OUTLIER -82.91 153.04 25.28 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.617 0.722 . . . . 0.0 112.023 -178.235 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 392' ' ' TRP . . . . . 0.494 ' HD1' ' OE1' ' A' ' 394' ' ' GLN . 8.3 t-105 -173.16 137.79 0.71 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 113.977 -1.465 . . . . 0.0 107.753 176.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . 0.56 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 30.8 p90 -100.18 129.77 46.24 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -176.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 1.043 ' HG3' HE22 ' A' ' 375' ' ' GLN . 3.3 mm100 -89.61 110.45 21.32 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -172.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.594 ' HE2' ' HA ' ' A' ' 395' ' ' LYS . 0.6 OUTLIER . . . . . 0 C--O 1.246 0.904 0 CA-C-O 118.109 -0.948 . . . . 0.0 109.623 -173.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . 0.628 HG23 HG23 ' A' ' 335' ' ' THR . 5.7 t . . . . . 0 CA--C 1.539 0.542 0 CA-C-O 121.445 0.641 . . . . 0.0 111.723 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . 0.533 ' HB3' ' HD3' ' A' ' 336' ' ' ARG . 39.4 p90 -69.87 128.65 37.12 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 175.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.508 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 7.3 t 175.86 -170.72 0.06 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -172.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 16.5 t -75.92 106.87 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 107.354 -1.351 . . . . 0.0 107.354 170.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -69.9 155.62 40.29 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.786 0.803 . . . . 0.0 113.031 -168.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . 0.657 ' OD2' HG22 ' A' ' 310' ' ' THR . 23.1 t70 -67.2 122.23 17.38 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.765 178.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.492 ' HB2' ' N ' ' A' ' 387' ' ' ASP . 31.7 pttt -40.66 -32.86 0.23 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 113.506 -1.679 . . . . 0.0 115.499 -173.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.657 HG22 ' OD2' ' A' ' 308' ' ' ASP . 10.0 t -105.77 16.42 25.29 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.882 0.849 . . . . 0.0 110.735 -165.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . 0.533 ' HE3' ' OG1' ' A' ' 335' ' ' THR . 17.4 mtmm -99.46 47.63 0.95 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.626 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 1.039 ' HZ ' HD12 ' A' ' 340' ' ' ILE . 6.1 m-85 -139.98 160.58 39.6 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.65 -171.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . 0.408 ' C ' HD21 ' A' ' 388' ' ' LEU . 69.5 p -134.59 150.35 50.7 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.849 175.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . 0.557 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 28.0 m-90 -78.01 92.55 4.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.248 0.546 . . . . 0.0 109.761 174.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.478 ' HB3' ' C ' ' A' ' 329' ' ' GLU . 28.5 tptp -68.93 -49.67 56.0 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 170.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 17.0 ttm180 -151.91 125.63 8.99 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.742 175.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . 0.403 ' HB1' ' CG ' ' A' ' 390' ' ' HIS . . . -76.53 157.8 81.95 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-O 119.106 -0.474 . . . . 0.0 110.419 -176.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . 0.88 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 80.3 Cg_exo -37.56 111.76 0.1 Allowed 'Trans proline' 0 C--N 1.363 1.339 0 C-N-CA 123.187 2.592 . . . . 0.0 113.537 -178.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 16.4 m -134.86 138.52 44.25 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.7 -173.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -58.01 126.45 27.5 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.929 0.395 . . . . 0.0 110.075 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . 0.512 ' HB3' HG13 ' A' ' 327' ' ' VAL . 92.4 p -59.44 -44.32 92.96 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.51 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 131.58 -13.32 5.37 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.139 176.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . 0.453 ' O ' ' HB2' ' A' ' 324' ' ' ASP . 95.0 m-70 -114.27 20.51 15.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.588 0.233 . . . . 0.0 110.67 -179.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . 0.453 ' HB2' ' O ' ' A' ' 323' ' ' HIS . 10.6 m-20 84.76 43.99 0.02 OUTLIER 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.148 172.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . 0.486 ' HB ' HG13 ' A' ' 358' ' ' ILE . 5.5 p -151.85 172.68 15.82 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 174.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.73 HG21 ' HZ2' ' A' ' 392' ' ' TRP . 0.2 OUTLIER -123.66 141.89 42.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 119.945 1.248 . . . . 0.0 111.784 -173.04 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 327' ' ' VAL . . . . . 0.814 HG12 ' HG2' ' A' ' 373' ' ' GLU . 17.8 m -120.86 155.55 24.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.676 176.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 328' ' ' MET . . . . . 0.608 ' HE3' ' HD3' ' A' ' 318' ' ' PRO . 6.6 ptm -146.54 157.93 43.81 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.815 -1.179 . . . . 0.0 107.815 172.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.587 ' HA ' ' O ' ' A' ' 370' ' ' GLY . 16.2 tt0 -128.42 129.39 46.09 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -175.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.586 HG11 HG21 ' A' ' 385' ' ' VAL . 7.5 m -129.68 149.67 33.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -175.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -109.13 178.22 20.61 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 175.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . 0.528 ' HB2' ' SD ' ' A' ' 364' ' ' MET . 0.1 OUTLIER -138.56 158.19 44.72 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 117.939 0.869 . . . . 0.0 113.239 -177.211 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 9.7 t -65.54 -70.92 0.21 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.313 -1.312 . . . . 0.0 112.271 171.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -166.73 -22.68 0.02 OUTLIER Glycine 0 CA--C 1.53 1.022 0 C-N-CA 119.04 -1.552 . . . . 0.0 115.475 -176.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 335' ' ' THR . . . . . 0.628 HG23 HG23 ' A' ' 303' ' ' THR . 29.3 m -51.06 131.22 27.08 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 117.136 0.468 . . . . 0.0 109.781 174.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.772 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 1.3 ptm180 -69.23 177.36 1.22 Allowed Pre-proline 0 CA--C 1.518 -0.285 0 CA-C-O 118.456 -0.783 . . . . 0.0 109.198 -172.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.772 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.2 OUTLIER -28.28 105.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.358 1.064 0 C-N-CA 123.253 2.635 . . . . 0.0 112.864 175.22 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 338' ' ' CYS . . . . . 0.809 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 31.6 p -125.47 155.29 40.74 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.275 -1.33 . . . . 0.0 107.615 -174.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -68.29 116.99 9.5 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.369 171.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . 1.039 HD12 ' HZ ' ' A' ' 312' ' ' PHE . 33.8 mm -79.0 118.87 74.95 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.614 -174.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -75.72 79.87 2.73 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.01 1.806 . . . . 0.0 110.804 176.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.833 HG13 HG22 ' A' ' 340' ' ' ILE . 2.5 m -103.87 118.76 51.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.612 0.72 . . . . 0.0 110.098 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -135.72 177.88 7.48 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 176.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 344' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -146.67 146.46 30.38 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.495 178.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 17.3 m -119.48 142.65 33.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.4 115.45 5.12 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.561 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 347' ' ' HIS . . . . . 0.524 ' O ' HG23 ' A' ' 349' ' ' VAL . 63.8 t60 41.49 68.05 0.49 Allowed 'General case' 0 N--CA 1.471 0.6 0 O-C-N 124.571 1.169 . . . . 0.0 111.593 176.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . 0.634 ' H ' ' CG2' ' A' ' 382' ' ' ILE . . . 46.01 39.39 8.98 Favored Glycine 0 C--N 1.333 0.39 0 N-CA-C 115.385 0.914 . . . . 0.0 115.385 -177.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 347' ' ' HIS . 59.8 t -138.88 101.8 7.77 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 118.47 1.135 . . . . 0.0 108.53 178.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -75.14 64.47 6.17 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 122.893 2.396 . . . . 0.0 113.104 -178.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -100.72 -55.84 2.48 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 176.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 4.9 p -123.5 130.96 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.634 173.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . 0.485 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 33.1 t30 -66.13 121.16 14.54 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.801 176.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.655 ' HB ' ' HG ' ' A' ' 376' ' ' LEU . 26.6 m -101.01 4.11 10.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.733 -178.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 355' ' ' ALA . . . . . 0.471 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -72.01 87.36 1.04 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.132 0.492 . . . . 0.0 112.199 -177.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 356' ' ' MET . . . . . 0.579 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 37.0 ttm -97.81 100.54 11.91 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 169.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.673 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 26.4 mt -85.63 122.9 30.39 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.591 -164.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.695 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 3.7 mm -61.1 -30.49 47.83 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 CA-C-N 115.313 -0.858 . . . . 0.0 108.943 173.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 18.8 m -135.48 97.13 13.23 Favored Pre-proline 0 N--CA 1.451 -0.393 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.404 175.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -90.79 37.32 0.32 Allowed 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 123.356 2.704 . . . . 0.0 113.706 -174.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -140.2 61.88 18.69 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.202 176.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . 0.76 ' HB3' HG23 ' A' ' 372' ' ' ILE . 93.9 Cg_endo -84.77 143.06 9.37 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.115 1.877 . . . . 0.0 112.016 176.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 18.4 p -142.47 134.05 26.64 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -178.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 364' ' ' MET . . . . . 0.809 ' HG2' ' SG ' ' A' ' 338' ' ' CYS . 16.3 ptt? . . . . . 0 CA--C 1.49 -1.337 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 176.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . 0.507 ' HA2' ' CD1' ' A' ' 332' ' ' PHE . . . . . . . . 0 CA--C 1.516 0.119 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . 0.795 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -51.91 -40.65 50.49 Favored Glycine 0 C--N 1.335 0.489 0 CA-C-N 117.541 0.671 . . . . 0.0 113.627 174.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . 0.587 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 83.24 -127.09 7.82 Favored Glycine 0 N--CA 1.439 -1.141 0 C-N-CA 120.259 -0.972 . . . . 0.0 111.572 -178.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -102.08 139.41 37.74 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.384 0.612 . . . . 0.0 112.017 -173.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 372' ' ' ILE . . . . . 0.76 HG23 ' HB3' ' A' ' 362' ' ' PRO . 0.5 OUTLIER -131.78 155.5 41.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.093 175.751 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . 0.814 ' HG2' HG12 ' A' ' 327' ' ' VAL . 40.8 mt-10 -133.37 128.39 35.52 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.467 -178.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . 0.673 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 0.1 OUTLIER -147.72 165.84 29.26 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.392 -173.937 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 375' ' ' GLN . . . . . 1.027 HE22 ' HG2' ' A' ' 394' ' ' GLN . 0.0 OUTLIER 179.55 175.08 0.76 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 175.874 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 376' ' ' LEU . . . . . 0.745 HD22 ' HD2' ' A' ' 377' ' ' PRO . 2.1 tm? -166.69 143.13 3.89 Favored Pre-proline 0 N--CA 1.445 -0.691 0 N-CA-C 104.373 -2.455 . . . . 0.0 104.373 -176.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 377' ' ' PRO . . . . . 0.745 ' HD2' HD22 ' A' ' 376' ' ' LEU . 46.5 Cg_exo -36.53 134.27 0.33 Allowed 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.569 2.179 . . . . 0.0 112.638 174.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.753 ' HA ' HE22 ' A' ' 394' ' ' GLN . 57.1 Cg_exo -33.86 135.82 0.11 Allowed 'Trans proline' 0 C--N 1.365 1.404 0 C-N-CA 124.875 3.717 . . . . 0.0 114.205 -172.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 153.15 -168.71 31.98 Favored Glycine 0 N--CA 1.441 -1.01 0 N-CA-C 110.256 -1.137 . . . . 0.0 110.256 -166.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.88 130.85 48.45 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 117.103 0.451 . . . . 0.0 110.701 179.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 -136.5 169.97 16.82 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 1.123 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -157.22 143.97 9.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 173.008 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . 0.851 HD12 ' HG3' ' A' ' 318' ' ' PRO . 21.2 mt -100.22 132.89 44.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.558 -176.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 384' ' ' TYR . . . . . 0.526 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 14.6 m-85 -104.71 97.48 7.37 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.183 169.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . 0.586 HG21 HG11 ' A' ' 330' ' ' VAL . 9.7 t -83.84 82.9 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 173.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 63.59 -109.05 2.5 Favored Glycine 0 N--CA 1.434 -1.493 0 C-N-CA 120.39 -0.91 . . . . 0.0 111.223 -166.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 387' ' ' ASP . . . . . 0.492 ' N ' ' HB2' ' A' ' 309' ' ' LYS . 6.9 t70 -93.5 -11.48 31.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.624 0.25 . . . . 0.0 110.894 177.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.557 ' HG ' ' CE2' ' A' ' 314' ' ' TRP . 1.0 OUTLIER -69.07 151.17 46.78 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 174.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . 0.554 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 8.2 p30 -156.63 152.38 27.1 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 121.061 -0.256 . . . . 0.0 110.476 -178.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . 0.88 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 4.9 t-80 -174.11 116.39 0.22 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.485 171.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 391' ' ' GLN . . . . . 1.123 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 14.6 tt0 -79.53 154.72 28.61 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.44 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 392' ' ' TRP . . . . . 0.73 ' HZ2' HG21 ' A' ' 326' ' ' VAL . 0.6 OUTLIER -163.8 152.36 13.55 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 114.955 -1.02 . . . . 0.0 108.282 179.691 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -110.52 125.58 53.48 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 1.027 ' HG2' HE22 ' A' ' 375' ' ' GLN . 0.0 OUTLIER -104.46 119.99 40.23 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 -178.355 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? . . . . . 0 C--N 1.315 -0.926 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.118 -168.521 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . 0.496 ' O ' HG23 ' A' ' 335' ' ' THR . 5.3 t . . . . . 0 CA--C 1.538 0.489 0 CA-C-O 121.394 0.616 . . . . 0.0 111.198 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . 0.548 ' HB3' ' NE ' ' A' ' 336' ' ' ARG . 0.9 OUTLIER -69.37 132.85 47.04 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 121.727 -0.608 . . . . 0.0 109.421 174.383 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.539 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 12.9 t 172.38 -169.24 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -177.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 38.6 t -64.16 110.97 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 170.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -69.22 140.69 54.55 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 -171.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . 0.613 ' OD1' HG22 ' A' ' 310' ' ' THR . 11.2 t70 -61.89 131.06 48.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.452 0.644 . . . . 0.0 111.376 -171.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.473 ' HA ' ' HA3' ' A' ' 386' ' ' GLY . 23.4 pttm -37.95 -38.13 0.29 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 113.245 -1.798 . . . . 0.0 114.523 -178.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.613 HG22 ' OD1' ' A' ' 308' ' ' ASP . 13.9 t -98.9 -8.32 25.81 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.067 0.461 . . . . 0.0 111.574 -166.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . 0.505 ' HZ3' ' HB3' ' A' ' 311' ' ' LYS . 6.3 mtpm? -74.71 -22.16 58.99 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.319 -175.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.698 ' HD2' ' HB ' ' A' ' 330' ' ' VAL . 49.3 m-85 -70.85 169.26 15.06 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-O 121.934 0.874 . . . . 0.0 112.915 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . 0.456 HG22 ' O ' ' A' ' 331' ' ' GLY . 11.6 t -151.64 153.25 34.08 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.46 169.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 20.1 m95 -78.11 96.77 5.23 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.143 0.496 . . . . 0.0 111.487 -177.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.593 ' HD3' ' HB3' ' A' ' 329' ' ' GLU . 50.9 tttp -65.94 -46.93 76.38 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 168.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.792 ' HB3' ' HB2' ' A' ' 329' ' ' GLU . 70.9 ttt180 -153.35 97.29 2.14 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.09 175.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -44.68 154.88 0.4 Allowed Pre-proline 0 N--CA 1.476 0.845 0 C-N-CA 123.634 0.774 . . . . 0.0 112.583 175.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . 0.526 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 3.2 Cg_exo -38.67 112.27 0.13 Allowed 'Trans proline' 0 C--N 1.367 1.516 0 C-N-CA 123.676 2.917 . . . . 0.0 113.626 -174.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 32.8 m -127.19 132.44 50.48 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.548 -1.206 . . . . 0.0 109.655 -177.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -59.45 118.45 6.03 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . 0.54 ' HB3' HG13 ' A' ' 327' ' ' VAL . 88.9 p -52.41 -55.68 20.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.536 0.684 . . . . 0.0 111.038 -168.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 136.4 -18.17 3.71 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 109.266 -1.533 . . . . 0.0 109.266 -175.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -104.61 43.58 1.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.714 -0.743 . . . . 0.0 109.217 178.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 49.72 49.2 20.49 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.411 -177.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 1.7 p -155.89 -168.38 2.76 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.596 ' HB ' ' HG3' ' A' ' 374' ' ' MET . 0.3 OUTLIER -127.19 145.48 34.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 118.89 0.768 . . . . 0.0 111.653 -179.627 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 327' ' ' VAL . . . . . 0.7 HG12 ' HG3' ' A' ' 373' ' ' GLU . 11.5 m -119.45 152.43 21.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.846 170.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 328' ' ' MET . . . . . 0.57 ' SD ' HD13 ' A' ' 383' ' ' ILE . 0.0 OUTLIER -140.09 142.86 36.06 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 175.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.792 ' HB2' ' HB3' ' A' ' 316' ' ' ARG . 6.4 mt-10 -122.48 128.55 50.98 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.12 0.486 . . . . 0.0 109.954 179.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.698 ' HB ' ' HD2' ' A' ' 312' ' ' PHE . 0.9 OUTLIER -130.05 146.07 34.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.906 -175.825 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . 0.456 ' O ' HG22 ' A' ' 313' ' ' THR . . . -125.6 140.73 12.43 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.043 -178.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . 0.762 ' CD1' ' HA2' ' A' ' 368' ' ' GLY . 0.4 OUTLIER -111.45 176.64 4.94 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -178.246 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . 0.449 ' OG ' ' HE2' ' A' ' 311' ' ' LYS . 4.7 p -100.98 -66.66 0.9 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 114.161 -1.381 . . . . 0.0 113.351 172.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -122.05 -43.68 0.39 Allowed Glycine 0 CA--C 1.535 1.315 0 N-CA-C 116.511 1.364 . . . . 0.0 116.511 -167.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 335' ' ' THR . . . . . 0.496 HG23 ' O ' ' A' ' 303' ' ' THR . 33.9 m -52.4 123.04 9.91 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 117.374 0.587 . . . . 0.0 111.404 -176.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.855 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 12.5 ptt180 -75.2 -176.27 0.54 Allowed Pre-proline 0 CA--C 1.529 0.137 0 CA-C-O 117.726 -1.13 . . . . 0.0 109.018 -176.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.855 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -27.27 98.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.371 1.745 0 C-N-CA 123.549 2.833 . . . . 0.0 113.253 177.197 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 338' ' ' CYS . . . . . 0.782 ' SG ' ' HE2' ' A' ' 364' ' ' MET . 14.9 p -114.89 -175.63 2.73 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 113.787 -1.551 . . . . 0.0 110.336 -168.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -108.64 101.51 10.65 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 178.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . 0.843 HG22 HG22 ' A' ' 342' ' ' VAL . 39.3 mt -72.37 118.05 64.15 Favored Pre-proline 0 C--O 1.236 0.362 0 C-N-CA 120.328 -0.549 . . . . 0.0 111.253 -169.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -79.88 78.11 3.82 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 122.21 1.94 . . . . 0.0 111.065 176.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.865 HG13 HG13 ' A' ' 385' ' ' VAL . 0.0 OUTLIER -103.77 115.82 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.235 174.642 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 37.5 ptt180 -129.46 174.28 9.79 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 177.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 344' ' ' ALA . . . . . 0.508 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -146.89 145.44 29.83 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.441 177.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.403 HG22 HD12 ' A' ' 382' ' ' ILE . 13.3 m -117.35 145.39 23.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.25 115.25 4.85 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.592 175.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 347' ' ' HIS . . . . . 0.663 ' HB3' ' CB ' ' A' ' 380' ' ' ASP . 11.6 p80 32.47 74.46 0.05 Allowed 'General case' 0 N--CA 1.476 0.861 0 O-C-N 124.745 1.278 . . . . 0.0 113.159 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . 0.84 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 47.51 41.46 17.96 Favored Glycine 0 C--N 1.331 0.301 0 N-CA-C 115.396 0.918 . . . . 0.0 115.396 -178.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 58.6 t -142.8 102.12 5.37 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 118.396 1.098 . . . . 0.0 108.181 176.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -78.02 53.64 4.54 Favored 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 123.072 2.514 . . . . 0.0 113.248 -176.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -102.73 -4.89 24.36 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 122.009 0.909 . . . . 0.0 108.996 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 2.4 p -170.09 104.96 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.668 -164.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . 0.508 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 56.5 t30 -64.12 108.92 1.67 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.994 177.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.534 ' HB ' ' HG ' ' A' ' 376' ' ' LEU . 28.0 m -91.6 3.75 7.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.995 179.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 355' ' ' ALA . . . . . 0.461 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -79.0 84.25 5.03 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.402 0.62 . . . . 0.0 111.275 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 3.0 tmm? -96.04 103.26 15.14 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 170.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.528 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 27.7 mt -86.65 115.28 24.01 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.881 -163.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.737 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 3.4 mm -58.57 -24.91 26.67 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.05 177.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 29.9 m -134.03 90.76 25.62 Favored Pre-proline 0 N--CA 1.445 -0.694 0 CA-C-N 114.446 -1.252 . . . . 0.0 108.37 173.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -84.19 34.58 0.52 Allowed 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 123.094 2.529 . . . . 0.0 113.151 -172.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -140.01 61.75 19.03 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.205 178.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . 0.758 ' HB3' HG23 ' A' ' 372' ' ' ILE . 41.5 Cg_endo -80.92 137.46 11.03 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.299 1.999 . . . . 0.0 111.83 178.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.87 141.37 30.27 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.015 -173.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 364' ' ' MET . . . . . 0.782 ' HE2' ' SG ' ' A' ' 338' ' ' CYS . 30.3 mtm . . . . . 0 CA--C 1.492 -1.288 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 176.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . 0.762 ' HA2' ' CD1' ' A' ' 332' ' ' PHE . . . . . . . . 0 N--CA 1.451 -0.341 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . 0.694 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -50.26 -37.69 31.84 Favored Glycine 0 CA--C 1.505 -0.562 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.869 171.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . 0.589 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 78.88 -128.1 8.41 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 120.302 -0.952 . . . . 0.0 111.318 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -103.47 141.39 36.06 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.355 0.598 . . . . 0.0 111.984 -175.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 372' ' ' ILE . . . . . 0.758 HG23 ' HB3' ' A' ' 362' ' ' PRO . 0.5 OUTLIER -136.81 159.73 37.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.35 175.803 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . 0.737 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 2.5 mp0 -125.54 128.52 48.09 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.187 0.518 . . . . 0.0 110.913 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . 0.596 ' HG3' ' HB ' ' A' ' 326' ' ' VAL . 1.9 ptm -130.45 167.49 18.53 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.946 -1.025 . . . . 0.0 108.475 179.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 375' ' ' GLN . . . . . 0.8 HE21 ' H ' ' A' ' 376' ' ' LEU . 13.2 tp60 -179.67 171.67 1.18 Allowed 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 164.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 376' ' ' LEU . . . . . 0.869 HD22 ' HD2' ' A' ' 377' ' ' PRO . 2.5 tm? -165.89 137.64 3.12 Favored Pre-proline 0 C--N 1.311 -1.097 0 N-CA-C 104.015 -2.587 . . . . 0.0 104.015 -178.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 377' ' ' PRO . . . . . 0.869 ' HD2' HD22 ' A' ' 376' ' ' LEU . 31.0 Cg_exo -26.92 119.6 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.544 2.829 . . . . 0.0 112.495 177.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -37.09 139.02 0.22 Allowed 'Trans proline' 0 C--N 1.359 1.122 0 C-N-CA 124.286 3.324 . . . . 0.0 113.071 -169.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 153.66 -164.55 31.21 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -157.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . 0.663 ' CB ' ' HB3' ' A' ' 347' ' ' HIS . 8.8 m-20 -96.59 121.63 38.63 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 118.103 0.951 . . . . 0.0 110.741 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -125.95 163.8 22.2 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 1.0 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -156.94 139.62 6.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 171.685 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . 0.677 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 40.9 mt -98.65 129.85 48.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.092 -174.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 384' ' ' TYR . . . . . 0.671 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.9 OUTLIER -108.89 92.63 4.13 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.437 -1.256 . . . . 0.0 109.207 172.862 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . 0.865 HG13 HG13 ' A' ' 342' ' ' VAL . 3.5 t -85.47 85.52 2.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 176.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . 0.473 ' HA3' ' HA ' ' A' ' 309' ' ' LYS . . . 66.17 -112.38 4.88 Favored Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 120.356 -0.926 . . . . 0.0 110.919 -168.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -85.94 -17.04 36.53 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.867 0.365 . . . . 0.0 110.93 175.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.671 ' O ' ' HA ' ' A' ' 384' ' ' TYR . 1.3 mp -65.33 147.07 54.08 Favored 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . 0.677 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 8.2 p30 -159.7 151.02 19.74 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.714 -0.221 . . . . 0.0 110.745 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . 0.526 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 11.5 t-80 -172.95 115.65 0.28 Allowed 'General case' 0 C--N 1.328 -0.353 0 O-C-N 123.517 0.511 . . . . 0.0 110.119 176.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 391' ' ' GLN . . . . . 1.0 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 0.8 OUTLIER -83.0 154.22 24.58 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.249 0.547 . . . . 0.0 111.76 -177.637 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 392' ' ' TRP . . . . . 0.432 ' HD1' ' CD ' ' A' ' 394' ' ' GLN . 23.8 t-105 -169.93 150.5 3.87 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.891 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . 0.541 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 9.1 p90 -104.83 109.67 21.73 Favored 'General case' 0 C--N 1.317 -0.843 0 O-C-N 121.411 -0.805 . . . . 0.0 108.863 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 0.646 ' HG3' HE22 ' A' ' 375' ' ' GLN . 4.0 mm100 -78.47 123.53 27.15 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -165.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt . . . . . 0 C--O 1.249 1.028 0 CA-C-O 117.918 -1.039 . . . . 0.0 110.802 -179.384 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . 0.425 ' O ' HG23 ' A' ' 335' ' ' THR . 9.1 t . . . . . 0 CA--C 1.536 0.428 0 CA-C-O 121.266 0.555 . . . . 0.0 111.914 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . 0.509 ' HB2' ' O ' ' A' ' 337' ' ' PRO . 5.5 p90 -65.06 131.17 45.85 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 174.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.59 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 12.0 t 175.57 -167.98 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -170.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.409 ' HA ' ' HB2' ' A' ' 339' ' ' ARG . 8.4 t -75.67 105.64 4.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 168.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . 0.531 ' HB3' HG21 ' A' ' 335' ' ' THR . 0.1 OUTLIER -70.49 156.35 39.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.918 0.866 . . . . 0.0 113.315 -167.206 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . 0.578 ' OD2' HG22 ' A' ' 310' ' ' THR . 26.2 t70 -70.07 130.35 41.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.046 -1.433 . . . . 0.0 111.801 -175.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -38.76 -28.78 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 115.982 1.845 . . . . 0.0 115.982 -174.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . 0.578 HG22 ' OD2' ' A' ' 308' ' ' ASP . 12.7 t -108.19 0.75 21.67 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 119.323 0.965 . . . . 0.0 112.283 -169.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . 0.418 ' HE3' ' HB3' ' A' ' 311' ' ' LYS . 27.7 mtpp -88.46 43.26 1.12 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -171.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.493 ' HD2' HD13 ' A' ' 388' ' ' LEU . 0.0 OUTLIER -152.48 177.89 10.14 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.655 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 8.9 t -152.89 160.48 43.06 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.191 177.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -64.33 125.35 24.31 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.49 ' HB3' ' C ' ' A' ' 329' ' ' GLU . 19.9 ttmm -104.43 -45.58 4.62 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 170.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 45.7 ttm105 -149.78 125.65 10.5 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 114.737 -1.119 . . . . 0.0 109.078 170.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . 0.496 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -71.53 161.39 78.74 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-O 119.202 -0.428 . . . . 0.0 110.048 -179.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . 0.517 ' HB3' ' CD1' ' A' ' 383' ' ' ILE . 3.5 Cg_exo -44.5 113.21 0.42 Allowed 'Trans proline' 0 C--N 1.358 1.058 0 C-N-CA 122.384 2.056 . . . . 0.0 112.548 -177.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 19.6 m -129.42 138.63 51.58 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.695 -174.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -59.22 127.82 34.05 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.731 0.3 . . . . 0.0 110.706 175.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . 0.592 ' HB3' HG13 ' A' ' 327' ' ' VAL . 67.3 p -79.14 6.01 10.67 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.551 0.74 . . . . 0.0 111.973 -174.043 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 84.86 -20.76 13.64 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.4 -0.905 . . . . 0.0 113.559 -172.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 86.8 t60 -98.01 7.03 46.97 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 117.388 0.594 . . . . 0.0 110.751 -177.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 36.2 t70 71.85 53.49 0.2 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 122.582 1.182 . . . . 0.0 108.806 -176.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . 0.864 ' HA ' ' HG3' ' A' ' 375' ' ' GLN . 5.0 p -155.82 161.98 40.54 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.67 HG23 ' HG2' ' A' ' 375' ' ' GLN . 0.2 OUTLIER -110.71 138.48 38.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 119.628 1.104 . . . . 0.0 111.807 -173.552 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 327' ' ' VAL . . . . . 0.695 HG12 ' HG2' ' A' ' 373' ' ' GLU . 15.8 m -114.78 161.08 13.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.736 173.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 328' ' ' MET . . . . . 0.51 ' SD ' HG13 ' A' ' 330' ' ' VAL . 0.0 OUTLIER -149.31 152.06 35.23 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 178.272 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.49 ' C ' ' HB3' ' A' ' 315' ' ' LYS . 9.9 tt0 -137.02 135.88 37.96 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -176.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.61 HG23 ' HA3' ' A' ' 369' ' ' GLY . 1.7 m -133.64 161.12 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -176.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . 0.756 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -127.49 134.14 8.17 Favored Glycine 0 CA--C 1.522 0.529 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.03 176.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . 0.495 ' HD1' ' H ' ' A' ' 332' ' ' PHE . 0.1 OUTLIER -90.34 160.47 16.1 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -174.84 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 11.4 p -101.1 4.42 42.15 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.43 -1.259 . . . . 0.0 114.297 173.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 166.55 -46.57 0.26 Allowed Glycine 0 CA--C 1.525 0.679 0 C-N-CA 118.292 -1.909 . . . . 0.0 115.764 173.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 335' ' ' THR . . . . . 0.666 ' HB ' ' CE ' ' A' ' 364' ' ' MET . 41.0 m -54.74 122.54 10.93 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.584 0.192 . . . . 0.0 110.527 -178.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.819 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 16.5 ptt180 -79.2 179.54 1.76 Allowed Pre-proline 0 C--O 1.227 -0.121 0 CA-C-O 117.417 -1.277 . . . . 0.0 108.336 -175.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.819 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.9 OUTLIER -26.12 100.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.37 1.703 0 C-N-CA 123.578 2.852 . . . . 0.0 113.695 -175.143 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 338' ' ' CYS . . . . . 0.903 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 32.1 p -132.32 153.36 50.8 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.256 -170.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . 0.409 ' HB2' ' HA ' ' A' ' 306' ' ' VAL . 22.2 mmm180 -67.96 114.1 6.22 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.863 173.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . 0.632 HD11 ' HB2' ' A' ' 362' ' ' PRO . 28.9 pt -93.64 119.16 67.41 Favored Pre-proline 0 C--N 1.321 -0.666 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.196 -177.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.68 82.67 0.72 Allowed 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.787 2.325 . . . . 0.0 111.943 -178.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.844 HG11 HD13 ' A' ' 372' ' ' ILE . 34.5 m -102.59 124.71 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-O 122.135 0.969 . . . . 0.0 110.645 -178.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.504 ' HG3' ' HB2' ' A' ' 384' ' ' TYR . 30.0 ptt180 -137.28 178.76 6.84 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 114.527 -1.215 . . . . 0.0 107.961 177.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 344' ' ' ALA . . . . . 0.468 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -149.12 146.21 27.58 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.815 174.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 13.0 m -120.16 147.8 23.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -71.27 119.86 16.02 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 178.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 347' ' ' HIS . . . . . 0.658 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 3.8 t60 46.79 62.07 2.52 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 124.284 0.99 . . . . 0.0 111.377 174.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . 0.707 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 42.14 44.61 4.87 Favored Glycine 0 C--N 1.332 0.357 0 N-CA-C 114.564 0.586 . . . . 0.0 114.564 -173.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 347' ' ' HIS . 96.8 t -141.57 102.32 5.98 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -73.02 67.35 4.08 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.767 2.311 . . . . 0.0 112.5 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -100.51 -57.19 2.16 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 5.4 p -124.57 132.76 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.574 171.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . 0.468 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 50.6 t30 -61.83 109.71 1.32 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.13 175.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.422 ' O ' ' HB2' ' A' ' 376' ' ' LEU . 20.6 m -86.36 3.82 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.091 178.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 355' ' ' ALA . . . . . 0.458 ' HB1' HD21 ' A' ' 357' ' ' LEU . . . -79.98 82.22 6.1 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.104 -0.639 . . . . 0.0 110.999 178.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.67 99.16 10.79 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 169.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.693 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 34.6 mt -80.16 139.25 36.88 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.261 -0.882 . . . . 0.0 111.488 -159.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.914 HD11 ' HB2' ' A' ' 375' ' ' GLN . 3.0 mm -80.53 -21.85 11.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 3.4 m -139.55 94.83 9.21 Favored Pre-proline 0 N--CA 1.448 -0.567 0 CA-C-N 113.578 -1.646 . . . . 0.0 108.185 171.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -83.74 35.75 0.57 Allowed 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 123.494 2.796 . . . . 0.0 113.263 -173.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -141.72 60.04 10.74 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.714 176.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . 0.879 ' HB3' HG23 ' A' ' 372' ' ' ILE . 66.0 Cg_endo -79.47 145.74 18.85 Favored 'Trans proline' 0 C--O 1.241 0.656 0 C-N-CA 122.564 2.176 . . . . 0.0 112.618 -176.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 363' ' ' THR . . . . . 0.474 ' O ' ' HA2' ' A' ' 369' ' ' GLY . 0.8 OUTLIER -144.72 168.31 20.5 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.598 -174.421 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 364' ' ' MET . . . . . 0.903 ' HG2' ' SG ' ' A' ' 338' ' ' CYS . 13.7 ptt? . . . . . 0 C--N 1.313 -1.009 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.4 172.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . 0.756 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . . . . . . 0 N--CA 1.45 -0.433 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . 0.61 ' HA3' HG23 ' A' ' 330' ' ' VAL . . . -64.82 107.59 1.94 Allowed Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 172.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -75.77 -29.54 59.18 Favored Glycine 0 C--N 1.312 -0.799 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.609 -169.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -166.27 143.51 5.21 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.057 0.456 . . . . 0.0 111.249 175.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 372' ' ' ILE . . . . . 0.879 HG23 ' HB3' ' A' ' 362' ' ' PRO . 1.1 mt -135.15 150.22 29.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.002 170.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . 0.765 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 43.3 mt-10 -130.8 127.7 39.22 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.226 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . 0.693 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 0.2 OUTLIER -141.73 160.27 40.52 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.219 -175.215 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 375' ' ' GLN . . . . . 0.914 ' HB2' HD11 ' A' ' 358' ' ' ILE . 0.0 OUTLIER -175.23 173.7 2.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.283 0.563 . . . . 0.0 111.653 172.717 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 376' ' ' LEU . . . . . 0.749 HD22 ' HD2' ' A' ' 377' ' ' PRO . 1.8 tm? -168.57 138.81 2.0 Allowed Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 105.11 -2.181 . . . . 0.0 105.11 -178.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 377' ' ' PRO . . . . . 0.749 ' HD2' HD22 ' A' ' 376' ' ' LEU . 51.9 Cg_exo -34.3 135.22 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.951 2.434 . . . . 0.0 112.528 174.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . 0.778 ' HA ' HE22 ' A' ' 394' ' ' GLN . 3.0 Cg_exo -35.59 138.61 0.14 Allowed 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 125.162 3.908 . . . . 0.0 113.63 -171.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 155.46 -160.98 30.25 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 -162.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . 0.658 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 21.8 m-20 -105.14 128.28 53.3 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 118.252 1.026 . . . . 0.0 110.527 174.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.588 HD22 ' C ' ' A' ' 380' ' ' ASP . 0.9 OUTLIER -126.32 138.48 53.59 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.226 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 1.071 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -141.12 135.25 32.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 177.9 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . 0.643 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 20.9 mt -98.9 132.31 44.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 C-N-CA 119.786 -0.766 . . . . 0.0 110.281 -171.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 384' ' ' TYR . . . . . 0.504 ' HB2' ' HG3' ' A' ' 343' ' ' ARG . 5.7 m-85 -102.76 131.15 49.81 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 168.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . 0.643 HG13 HG12 ' A' ' 342' ' ' VAL . 12.6 t -119.71 84.67 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 178.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 59.1 -109.13 1.91 Allowed Glycine 0 N--CA 1.434 -1.468 0 C-N-CA 120.363 -0.922 . . . . 0.0 111.002 -164.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -84.9 -20.27 31.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.566 0.183 . . . . 0.0 111.487 176.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.493 HD13 ' HD2' ' A' ' 312' ' ' PHE . 0.7 OUTLIER -67.0 154.99 39.81 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.71 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . 0.643 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 7.9 p30 -164.96 160.31 19.0 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.231 175.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . 0.434 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 26.6 t60 -173.65 117.17 0.26 Allowed 'General case' 0 C--O 1.238 0.487 0 O-C-N 123.51 0.506 . . . . 0.0 110.285 173.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 391' ' ' GLN . . . . . 1.071 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 2.5 mt-30 -65.28 146.08 55.39 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 392' ' ' TRP . . . . . . . . . . . . . 50.4 t-105 -149.72 147.83 28.52 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.894 176.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -110.91 115.6 29.78 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 173.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 0.778 HE22 ' HA ' ' A' ' 378' ' ' PRO . 0.0 OUTLIER -100.45 126.53 46.86 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 121.699 -0.626 . . . . 0.0 109.656 -176.78 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm . . . . . 0 C--N 1.313 -1.017 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.855 -179.37 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . 0.504 ' O ' HG22 ' A' ' 305' ' ' THR . 10.3 t . . . . . 0 CA--C 1.533 0.31 0 CA-C-O 121.029 0.442 . . . . 0.0 111.744 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 304' ' ' TYR . . . . . 0.453 ' HB3' ' HG2' ' A' ' 336' ' ' ARG . 31.4 p90 -63.28 129.84 41.99 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 120.903 0.382 . . . . 0.0 110.412 -175.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.504 HG22 ' O ' ' A' ' 303' ' ' THR . 12.4 t 171.88 -166.88 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -167.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 42.2 t -63.91 112.36 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 170.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 307' ' ' CYS . . . . . 0.463 ' HB2' ' CE2' ' A' ' 332' ' ' PHE . 0.0 OUTLIER -67.99 147.05 52.95 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.13 0.491 . . . . 0.0 111.63 -170.07 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -57.07 109.17 0.61 Allowed 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.014 176.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 309' ' ' LYS . . . . . 0.492 ' HB2' ' N ' ' A' ' 387' ' ' ASP . 26.8 pttt -41.47 -27.12 0.08 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 113.892 -1.504 . . . . 0.0 114.716 -175.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 10.0 t -102.87 17.92 22.8 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.616 0.722 . . . . 0.0 110.428 -170.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 311' ' ' LYS . . . . . 0.621 ' HB2' ' CE2' ' A' ' 332' ' ' PHE . 25.2 mtpp -98.72 -14.39 19.8 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.406 178.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 312' ' ' PHE . . . . . 0.459 ' HB2' HD13 ' A' ' 388' ' ' LEU . 97.4 m-85 -75.05 162.32 28.66 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.11 177.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 313' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 331' ' ' GLY . 8.9 t -141.67 154.9 45.64 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.038 176.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 314' ' ' TRP . . . . . 0.412 ' H ' ' HE3' ' A' ' 314' ' ' TRP . 7.8 m-90 -75.65 92.6 2.97 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 315' ' ' LYS . . . . . 0.524 ' HB3' ' O ' ' A' ' 329' ' ' GLU . 24.0 tptm -73.74 -56.51 4.89 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 171.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.415 ' NH2' HG21 ' A' ' 319' ' ' THR . 58.2 ttt180 -147.11 125.3 12.17 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . 0.432 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -68.69 160.07 78.86 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 119.136 -0.459 . . . . 0.0 109.956 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 318' ' ' PRO . . . . . 0.473 ' HD3' ' CD2' ' A' ' 390' ' ' HIS . 3.9 Cg_exo -41.87 115.78 0.48 Allowed 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 122.823 2.348 . . . . 0.0 112.091 -178.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 319' ' ' THR . . . . . 0.415 HG21 ' NH2' ' A' ' 316' ' ' ARG . 21.5 m -128.68 132.96 48.08 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.246 -174.107 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -62.99 114.86 3.93 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -177.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 321' ' ' SER . . . . . 0.539 ' HB3' HG13 ' A' ' 327' ' ' VAL . 69.9 p -55.81 -46.34 78.06 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 123.543 0.527 . . . . 0.0 110.711 -163.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 126.67 -16.2 6.58 Favored Glycine 0 N--CA 1.442 -0.938 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 -179.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -110.62 52.24 0.74 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 57.88 36.29 26.17 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.646 178.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 325' ' ' THR . . . . . 0.478 ' HB ' HG13 ' A' ' 358' ' ' ILE . 3.1 p -157.13 -167.78 2.43 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -178.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 326' ' ' VAL . . . . . 0.997 HG23 ' HG2' ' A' ' 375' ' ' GLN . 3.6 t -131.83 148.45 32.37 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-O 121.318 0.58 . . . . 0.0 112.028 -178.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 327' ' ' VAL . . . . . 0.846 HG12 ' HG2' ' A' ' 373' ' ' GLU . 15.6 m -128.23 151.22 34.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.478 174.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 328' ' ' MET . . . . . 0.516 ' HG2' ' HE1' ' A' ' 374' ' ' MET . 0.6 OUTLIER -137.34 154.86 49.96 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 169.489 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 329' ' ' GLU . . . . . 0.584 ' HG3' ' O ' ' A' ' 370' ' ' GLY . 14.0 tt0 -123.75 129.44 51.07 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 120.214 -0.594 . . . . 0.0 109.627 -177.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 330' ' ' VAL . . . . . 0.501 HG11 HG11 ' A' ' 385' ' ' VAL . 3.6 m -124.38 145.05 32.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.115 -178.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 331' ' ' GLY . . . . . 0.427 ' O ' HG22 ' A' ' 313' ' ' THR . . . -112.95 133.2 11.17 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 119.963 -1.113 . . . . 0.0 111.964 179.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 332' ' ' PHE . . . . . 0.621 ' CE2' ' HB2' ' A' ' 311' ' ' LYS . 2.6 t80 -141.25 143.14 33.97 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 30.7 p -147.34 49.26 1.1 Allowed 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -171.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -145.48 -80.99 0.04 OUTLIER Glycine 0 C--O 1.23 -0.135 0 C-N-CA 119.78 -1.2 . . . . 0.0 112.03 167.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 335' ' ' THR . . . . . 0.614 ' HB ' ' CZ ' ' A' ' 332' ' ' PHE . 56.1 m -50.82 126.71 16.61 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 172.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 336' ' ' ARG . . . . . 0.583 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 0.0 OUTLIER -81.6 -177.84 1.04 Allowed Pre-proline 0 CA--C 1.533 0.324 0 CA-C-O 117.183 -1.389 . . . . 0.0 107.948 -172.19 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 337' ' ' PRO . . . . . 0.933 ' HA ' ' O ' ' A' ' 364' ' ' MET . 6.6 Cg_exo -23.39 101.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 123.91 3.073 . . . . 0.0 114.197 -172.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 338' ' ' CYS . . . . . 0.569 ' H ' ' HG3' ' A' ' 364' ' ' MET . 13.6 p -116.39 -176.85 3.04 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 113.898 -1.501 . . . . 0.0 111.38 -165.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -111.0 101.11 9.69 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.391 -1.336 . . . . 0.0 107.391 -178.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 340' ' ' ILE . . . . . 0.849 HG22 HG13 ' A' ' 342' ' ' VAL . 22.4 mt -76.32 117.28 63.16 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.464 -170.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -82.44 82.12 2.32 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.875 2.383 . . . . 0.0 112.235 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 342' ' ' VAL . . . . . 0.849 HG13 HG22 ' A' ' 340' ' ' ILE . 16.4 m -102.16 159.36 4.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.225 0.536 . . . . 0.0 110.2 179.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 343' ' ' ARG . . . . . 0.44 ' CG ' ' HB2' ' A' ' 384' ' ' TYR . 15.7 ptt-85 -169.3 175.63 5.51 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 179.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 344' ' ' ALA . . . . . 0.615 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -150.06 149.78 30.79 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.55 178.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 345' ' ' VAL . . . . . 0.467 ' HB ' ' HA ' ' A' ' 350' ' ' PRO . 5.1 m -121.84 147.97 25.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 175.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -67.17 120.97 14.62 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 176.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 347' ' ' HIS . . . . . 0.607 ' HB2' ' CB ' ' A' ' 380' ' ' ASP . 22.7 t60 38.46 69.86 0.24 Allowed 'General case' 0 N--CA 1.479 0.988 0 O-C-N 124.427 1.079 . . . . 0.0 112.435 175.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 348' ' ' GLY . . . . . 0.812 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 44.45 37.41 4.82 Favored Glycine 0 CA--C 1.52 0.378 0 N-CA-C 115.175 0.83 . . . . 0.0 115.175 -177.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 349' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 347' ' ' HIS . 60.7 t -139.94 102.25 6.97 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 118.257 1.029 . . . . 0.0 108.566 178.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 350' ' ' PRO . . . . . 0.467 ' HA ' ' HB ' ' A' ' 345' ' ' VAL . 19.2 Cg_exo -71.1 67.36 2.54 Favored 'Trans proline' 0 N--CA 1.465 -0.181 0 C-N-CA 122.801 2.334 . . . . 0.0 112.676 177.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -100.62 -56.87 2.23 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 174.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.7 132.93 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 115.166 -0.924 . . . . 0.0 110.886 173.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 353' ' ' ASN . . . . . 0.615 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 31.6 t30 -63.15 111.11 2.08 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.588 173.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 354' ' ' VAL . . . . . 0.561 HG12 HD22 ' A' ' 376' ' ' LEU . 30.0 m -90.62 4.2 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.317 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 355' ' ' ALA . . . . . 0.48 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -76.81 82.47 3.4 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.238 0.542 . . . . 0.0 111.094 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 356' ' ' MET . . . . . 0.612 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 21.5 ttt -95.97 99.57 11.33 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 170.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 357' ' ' LEU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 47.2 mt -88.84 123.06 32.87 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.709 -161.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 358' ' ' ILE . . . . . 0.797 HD11 ' HB2' ' A' ' 375' ' ' GLN . 1.5 mm -67.83 -25.38 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 171.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 54.1 m -122.88 86.07 50.34 Favored Pre-proline 0 N--CA 1.451 -0.375 0 CA-C-N 114.323 -1.308 . . . . 0.0 108.683 170.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -82.84 26.13 0.65 Allowed 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 123.043 2.496 . . . . 0.0 113.022 -172.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 46.5 m-20 -155.83 68.75 5.05 Favored Pre-proline 0 C--N 1.318 -0.804 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.696 178.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 362' ' ' PRO . . . . . 0.824 ' HB3' HG23 ' A' ' 372' ' ' ILE . 49.7 Cg_endo -73.28 151.56 48.87 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 121.745 1.63 . . . . 0.0 111.269 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 363' ' ' THR . . . . . 0.561 HG22 ' O ' ' A' ' 338' ' ' CYS . 0.0 OUTLIER -145.4 169.71 17.77 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -173.065 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 364' ' ' MET . . . . . 0.933 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 3.3 ppp? . . . . . 0 CA--C 1.494 -1.181 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 176.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.263 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 369' ' ' GLY . . . . . 0.552 ' HA2' ' O ' ' A' ' 363' ' ' THR . . . -45.26 -45.9 10.73 Favored Glycine 0 C--N 1.339 0.704 0 CA-C-N 117.067 0.433 . . . . 0.0 113.126 172.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 370' ' ' GLY . . . . . 0.584 ' O ' ' HG3' ' A' ' 329' ' ' GLU . . . 83.93 -54.58 4.96 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.606 -0.807 . . . . 0.0 113.256 175.058 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -165.16 142.17 5.83 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.266 0.555 . . . . 0.0 111.527 177.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 372' ' ' ILE . . . . . 0.824 HG23 ' HB3' ' A' ' 362' ' ' PRO . 1.1 mt -131.23 150.16 34.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 170.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 373' ' ' GLU . . . . . 0.846 ' HG2' HG12 ' A' ' 327' ' ' VAL . 32.5 mt-10 -123.45 126.49 46.86 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.199 178.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 374' ' ' MET . . . . . 0.525 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 1.0 OUTLIER -137.26 161.37 36.4 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.452 -176.806 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 375' ' ' GLN . . . . . 0.997 ' HG2' HG23 ' A' ' 326' ' ' VAL . 0.0 OUTLIER -170.51 174.88 4.93 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.782 0.801 . . . . 0.0 111.183 170.722 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 376' ' ' LEU . . . . . 0.567 HD12 ' HD2' ' A' ' 377' ' ' PRO . 35.6 tp -169.02 123.87 0.73 Allowed Pre-proline 0 N--CA 1.438 -1.034 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 171.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 377' ' ' PRO . . . . . 0.567 ' HD2' HD12 ' A' ' 376' ' ' LEU . 45.2 Cg_exo -27.88 129.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 123.766 2.977 . . . . 0.0 112.101 -177.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -33.77 134.47 0.12 Allowed 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 124.499 3.466 . . . . 0.0 113.961 -161.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 158.51 -178.44 34.74 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -160.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 380' ' ' ASP . . . . . 0.75 ' HA ' ' HA ' ' A' ' 393' ' ' PHE . 3.9 m-20 -90.42 120.06 31.22 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 118.064 0.932 . . . . 0.0 111.155 -174.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 381' ' ' ASN . . . . . 0.483 HD22 ' C ' ' A' ' 380' ' ' ASP . 0.7 OUTLIER -121.28 163.47 18.52 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 176.91 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 382' ' ' ILE . . . . . 1.04 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -159.62 138.02 2.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 168.573 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 383' ' ' ILE . . . . . 0.407 ' HB ' ' CD2' ' A' ' 390' ' ' HIS . 12.8 mt -103.41 135.94 38.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 121.028 0.442 . . . . 0.0 110.286 -171.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 384' ' ' TYR . . . . . 0.44 ' HB2' ' CG ' ' A' ' 343' ' ' ARG . 50.9 m-85 -100.17 136.74 39.6 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 164.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 385' ' ' VAL . . . . . 0.725 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 10.9 t -120.73 77.77 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 177.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 386' ' ' GLY . . . . . 0.424 ' HA3' ' HB2' ' A' ' 309' ' ' LYS . . . 59.73 -106.05 0.89 Allowed Glycine 0 N--CA 1.431 -1.685 0 C-N-CA 120.134 -1.031 . . . . 0.0 111.155 -163.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 387' ' ' ASP . . . . . 0.492 ' N ' ' HB2' ' A' ' 309' ' ' LYS . 10.6 t70 -81.32 -17.42 49.3 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 388' ' ' LEU . . . . . 0.725 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 2.4 mp -70.47 154.36 41.97 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.871 0.367 . . . . 0.0 111.195 178.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 389' ' ' ASN . . . . . 0.438 ' HB3' ' CE2' ' A' ' 384' ' ' TYR . 24.2 p30 -155.93 145.22 20.77 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.384 173.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 390' ' ' HIS . . . . . 0.473 ' CD2' ' HD3' ' A' ' 318' ' ' PRO . 0.2 OUTLIER -170.42 106.81 0.31 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.798 -0.183 . . . . 0.0 111.307 -173.743 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 391' ' ' GLN . . . . . 1.04 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 0.6 OUTLIER -87.87 153.98 20.89 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.212 0.53 . . . . 0.0 112.422 -174.355 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 392' ' ' TRP . . . . . . . . . . . . . 5.5 t-105 -178.0 116.28 0.08 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.143 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 393' ' ' PHE . . . . . 0.75 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 18.4 p90 -66.69 124.7 23.61 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.295 170.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 394' ' ' GLN . . . . . 0.56 ' HG3' ' NE2' ' A' ' 375' ' ' GLN . 5.3 mm100 -80.81 108.79 14.77 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 -175.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 53.2 tptt . . . . . 0 C--O 1.247 0.957 0 CA-C-O 118.795 -0.622 . . . . 0.0 109.985 -174.499 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . 0.455 ' O ' HG23 ' A' ' 303' ' ' THR . 8.8 t . . . . . 0 CA--C 1.537 0.455 0 CA-C-O 121.697 0.761 . . . . 0.0 111.734 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . 0.571 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 13.9 p90 -70.12 117.0 11.14 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 175.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.465 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 11.0 t 172.22 -166.83 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -168.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 39.1 t -64.5 109.55 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 171.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . 0.436 ' HB3' HG21 ' A' ' 335' ' ' THR . 0.4 OUTLIER -72.6 144.6 47.8 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.199 -173.788 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . 0.663 ' OD1' HG22 ' A' ' 310' ' ' THR . 16.4 t70 -70.9 127.2 31.78 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.546 0.689 . . . . 0.0 110.711 -177.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.522 ' HD3' ' HB2' ' A' ' 387' ' ' ASP . 0.0 OUTLIER -44.85 -18.52 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 116.123 1.897 . . . . 0.0 116.123 -173.465 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.663 HG22 ' OD1' ' A' ' 308' ' ' ASP . 10.9 t -108.29 5.68 25.84 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 119.761 1.164 . . . . 0.0 111.725 -171.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.452 ' HE3' ' HB3' ' A' ' 311' ' ' LYS . 25.3 mtpp -86.26 -25.77 25.35 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.13 0.789 . . . . 0.0 113.13 -171.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.507 ' HA ' ' O ' ' A' ' 331' ' ' GLY . 0.0 OUTLIER -83.14 174.74 10.53 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.664 0.745 . . . . 0.0 111.269 178.369 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . 0.408 ' C ' HD21 ' A' ' 388' ' ' LEU . 32.0 p -139.33 156.87 46.73 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.867 -177.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . 0.671 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 26.8 m-90 -76.39 92.34 3.36 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.547 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 84.8 tttt -77.67 -52.04 9.63 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 119.909 -0.716 . . . . 0.0 109.09 170.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.554 ' HB3' ' HB3' ' A' ' 329' ' ' GLU . 9.2 ttp180 -143.66 121.15 11.72 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 172.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . 0.503 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -72.49 162.49 73.74 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.993 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . 0.631 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 5.7 Cg_exo -42.31 115.48 0.5 Allowed 'Trans proline' 0 C--N 1.358 1.072 0 C-N-CA 122.586 2.191 . . . . 0.0 112.846 -177.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 45.6 m -131.08 136.95 48.87 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.532 -174.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -60.12 116.88 4.51 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . 0.6 ' HB3' HG13 ' A' ' 327' ' ' VAL . 97.3 p -52.28 -53.57 42.34 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.185 0.517 . . . . 0.0 111.37 -167.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 141.88 -26.44 2.36 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.62 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 17.1 t60 -99.24 12.23 36.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.032 0.444 . . . . 0.0 110.039 -178.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 24.6 t70 86.86 53.74 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.878 175.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . 0.408 ' HB ' HG13 ' A' ' 358' ' ' ILE . 0.9 OUTLIER -158.58 -167.48 2.16 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 113.67 -1.605 . . . . 0.0 106.906 176.423 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.729 ' HB ' ' HG3' ' A' ' 374' ' ' MET . 0.6 OUTLIER -125.72 145.89 32.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 119.704 1.138 . . . . 0.0 111.64 -178.689 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' VAL . . . . . 0.772 HG12 ' HG2' ' A' ' 373' ' ' GLU . 13.6 m -123.56 152.58 28.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 114.925 -1.034 . . . . 0.0 110.751 172.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' MET . . . . . 0.655 ' SD ' ' HB ' ' A' ' 372' ' ' ILE . 0.1 OUTLIER -142.4 149.69 39.68 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 107.748 -1.205 . . . . 0.0 107.748 173.152 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.554 ' HB3' ' HB3' ' A' ' 316' ' ' ARG . 46.6 tt0 -129.43 125.14 35.82 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.071 -175.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.506 HG11 HG11 ' A' ' 385' ' ' VAL . 2.8 m -129.97 146.84 33.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -174.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . 0.507 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -118.03 137.96 13.52 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.573 -176.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -89.43 156.33 18.75 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.894 0.854 . . . . 0.0 112.957 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 2.3 p -94.79 -19.56 20.23 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.496 -1.229 . . . . 0.0 113.813 171.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -176.23 -37.22 0.05 OUTLIER Glycine 0 CA--C 1.525 0.717 0 C-N-CA 118.979 -1.582 . . . . 0.0 114.991 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' THR . . . . . 0.707 ' HB ' ' SD ' ' A' ' 364' ' ' MET . 90.7 m -53.36 127.21 23.97 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.682 0.277 . . . . 0.0 111.192 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.571 ' HG3' ' HB3' ' A' ' 304' ' ' TYR . 2.0 ptm180 -91.69 179.67 1.34 Allowed Pre-proline 0 CA--C 1.534 0.333 0 CA-C-O 117.248 -1.358 . . . . 0.0 107.914 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.575 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.2 OUTLIER -23.99 96.96 0.01 OUTLIER 'Trans proline' 0 C--N 1.375 1.935 0 C-N-CA 124.098 3.199 . . . . 0.0 114.501 -168.256 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' CYS . . . . . 0.771 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 2.2 p -111.17 -177.61 3.25 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 113.928 -1.487 . . . . 0.0 109.94 -172.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 9.7 mpt_? -109.93 99.84 8.9 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 176.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . 0.724 HG22 HG13 ' A' ' 342' ' ' VAL . 43.7 mt -74.42 118.78 72.65 Favored Pre-proline 0 C--N 1.327 -0.412 0 C-N-CA 120.443 -0.503 . . . . 0.0 111.181 -168.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -76.89 80.53 2.82 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.373 2.049 . . . . 0.0 111.238 176.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.724 HG13 HG22 ' A' ' 340' ' ' ILE . 1.4 m -102.16 111.77 33.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 114.849 -1.068 . . . . 0.0 110.106 178.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -127.14 174.63 8.76 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 178.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' ALA . . . . . 0.476 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -146.53 145.63 30.21 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.474 176.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.436 HG22 HD12 ' A' ' 382' ' ' ILE . 11.5 m -117.72 145.46 23.55 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 108.704 -0.851 . . . . 0.0 108.704 177.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -66.51 119.2 11.25 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.375 175.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . 0.547 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 20.7 t60 40.72 66.61 0.61 Allowed 'General case' 0 N--CA 1.474 0.775 0 O-C-N 124.491 1.119 . . . . 0.0 111.95 175.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . 0.589 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 47.32 34.17 8.57 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 115.271 0.869 . . . . 0.0 115.271 -178.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . 0.547 HG23 ' O ' ' A' ' 347' ' ' HIS . 63.7 t -135.7 102.81 10.27 Favored Pre-proline 0 C--O 1.233 0.235 0 CA-C-N 118.371 1.086 . . . . 0.0 108.685 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_exo -74.54 62.35 5.42 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.866 2.377 . . . . 0.0 112.837 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -100.15 -56.26 2.41 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.5 p -120.65 128.9 76.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 CA-C-N 115.113 -0.948 . . . . 0.0 110.36 173.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . 0.466 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 33.0 t30 -64.49 119.63 10.78 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.526 175.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.467 ' O ' ' HB2' ' A' ' 376' ' ' LEU . 29.1 m -98.32 6.22 9.06 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.399 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.94 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . 0.476 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -77.55 84.99 3.92 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.474 0.654 . . . . 0.0 111.142 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' MET . . . . . 0.579 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 21.4 ttt -99.3 100.11 11.15 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 106.16 -1.792 . . . . 0.0 106.16 171.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.622 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 47.1 mt -86.21 121.95 29.52 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.416 -160.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.725 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 3.2 mm -64.43 -28.98 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 N-CA-C 108.137 -1.061 . . . . 0.0 108.137 174.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 86.4 m -123.46 84.52 52.64 Favored Pre-proline 0 N--CA 1.45 -0.438 0 CA-C-N 114.27 -1.332 . . . . 0.0 108.459 172.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -85.33 27.66 0.59 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.06 2.507 . . . . 0.0 114.287 -169.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 35.7 m-20 -149.2 66.31 8.48 Favored Pre-proline 0 C--N 1.315 -0.922 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.123 177.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . 0.828 ' HB3' HG23 ' A' ' 372' ' ' ILE . 75.9 Cg_endo -81.43 149.08 16.64 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.183 1.922 . . . . 0.0 112.666 178.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' THR . . . . . 0.478 HG22 ' O ' ' A' ' 338' ' ' CYS . 2.6 p -143.75 147.59 34.41 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.227 -0.897 . . . . 0.0 108.615 -174.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' MET . . . . . 0.771 ' HG2' ' SG ' ' A' ' 338' ' ' CYS . 10.3 ptp -102.59 129.69 49.23 Favored 'General case' 0 CA--C 1.497 -1.06 0 C-N-CA 119.444 -0.902 . . . . 0.0 108.911 177.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -120.42 -166.13 1.28 Allowed 'General case' 0 C--N 1.321 -0.648 0 O-C-N 124.87 1.356 . . . . 0.0 111.412 -172.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . 0.577 HD22 ' N ' ' A' ' 366' ' ' ASN . 0.0 OUTLIER -56.7 -12.95 2.1 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -178.11 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -120.24 3.14 10.88 Favored 'General case' 0 C--N 1.332 -0.19 0 O-C-N 121.57 -0.706 . . . . 0.0 110.926 176.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 112.65 -179.75 19.36 Favored Glycine 0 N--CA 1.451 -0.347 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . 0.612 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -50.35 -42.01 41.32 Favored Glycine 0 CA--C 1.504 -0.611 0 C-N-CA 120.949 -0.643 . . . . 0.0 113.04 172.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . 0.547 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 82.33 -130.42 9.69 Favored Glycine 0 N--CA 1.436 -1.34 0 C-N-CA 120.11 -1.043 . . . . 0.0 110.76 -177.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 36.8 p90 -103.3 138.16 40.45 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.323 0.582 . . . . 0.0 111.25 -175.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 372' ' ' ILE . . . . . 0.828 HG23 ' HB3' ' A' ' 362' ' ' PRO . 0.1 OUTLIER -130.48 165.23 31.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.41 -0.814 . . . . 0.0 108.999 175.921 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.772 ' HG2' HG12 ' A' ' 327' ' ' VAL . 43.2 mt-10 -132.96 128.69 37.0 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.096 0.474 . . . . 0.0 110.483 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . 0.729 ' HG3' ' HB ' ' A' ' 326' ' ' VAL . 0.0 OUTLIER -133.95 165.67 24.48 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -178.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 375' ' ' GLN . . . . . 0.848 HE21 ' H ' ' A' ' 376' ' ' LEU . 14.2 tp60 -177.67 172.83 1.7 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.155 -0.684 . . . . 0.0 109.155 169.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' LEU . . . . . 0.848 ' H ' HE21 ' A' ' 375' ' ' GLN . 2.5 tm? -165.81 133.89 2.38 Favored Pre-proline 0 C--N 1.309 -1.163 0 N-CA-C 103.753 -2.684 . . . . 0.0 103.753 179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' PRO . . . . . 0.776 ' HD2' HD22 ' A' ' 376' ' ' LEU . 34.6 Cg_exo -28.07 126.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 123.479 2.786 . . . . 0.0 112.586 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -35.12 134.03 0.18 Allowed 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 124.574 3.516 . . . . 0.0 113.358 -167.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 157.1 -170.62 34.38 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 -162.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . 0.713 ' HA ' ' HA ' ' A' ' 393' ' ' PHE . 2.9 m-20 -89.85 120.02 30.73 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 117.509 0.654 . . . . 0.0 110.515 -177.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -125.28 166.78 15.9 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 176.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 0.955 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -160.57 139.83 3.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 169.694 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . 0.713 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 40.8 mt -99.64 125.06 53.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 C-N-CA 119.367 -0.933 . . . . 0.0 109.539 -175.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -101.07 92.36 4.97 Favored 'General case' 0 N--CA 1.442 -0.842 0 CA-C-N 114.94 -1.027 . . . . 0.0 108.29 171.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . 0.506 HG11 HG11 ' A' ' 330' ' ' VAL . 11.7 t -84.9 85.62 2.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 60.63 -112.57 4.71 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.508 -0.853 . . . . 0.0 111.329 -170.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' ASP . . . . . 0.522 ' HB2' ' HD3' ' A' ' 309' ' ' LYS . 3.5 t70 -83.18 -18.13 40.43 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.091 0.472 . . . . 0.0 110.512 177.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.671 ' HG ' ' CE2' ' A' ' 314' ' ' TRP . 3.4 mp -72.06 156.58 39.05 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.894 177.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . 0.713 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 7.7 p30 -168.96 158.17 8.49 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.316 177.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . 0.631 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 37.5 t-80 -174.83 116.93 0.18 Allowed 'General case' 0 C--O 1.237 0.431 0 O-C-N 123.419 0.45 . . . . 0.0 110.011 175.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' GLN . . . . . 0.955 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 8.2 tt0 -77.6 153.27 33.4 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.019 0.438 . . . . 0.0 112.073 -179.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' TRP . . . . . 0.401 ' CD1' ' NE2' ' A' ' 394' ' ' GLN . 23.9 t-105 -179.49 115.27 0.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.873 178.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . 0.713 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 12.3 p90 -68.21 121.05 15.39 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.21 0.529 . . . . 0.0 110.249 172.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.633 ' HG3' HE22 ' A' ' 375' ' ' GLN . 4.2 mm100 -84.27 119.09 24.64 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -172.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 4.1 mmmp? . . . . . 0 C--O 1.246 0.919 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.393 -176.894 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . 0.423 ' O ' HG23 ' A' ' 303' ' ' THR . 6.4 t . . . . . 0 CA--C 1.538 0.497 0 CA-C-O 121.602 0.715 . . . . 0.0 111.181 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . 0.541 ' HB3' ' NE ' ' A' ' 336' ' ' ARG . 33.5 p90 -76.75 126.46 31.03 Favored 'General case' 0 CA--C 1.516 -0.358 0 O-C-N 121.806 -0.558 . . . . 0.0 109.729 176.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.517 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 10.0 t -179.9 -173.91 0.25 Allowed 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.245 -174.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.09 111.54 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 167.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.67 144.25 51.12 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.377 -169.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . 0.491 ' OD2' HG22 ' A' ' 310' ' ' THR . 34.0 t70 -67.56 119.96 13.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.322 0.582 . . . . 0.0 110.448 -178.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.651 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -46.12 -12.17 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 -172.631 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.491 HG22 ' OD2' ' A' ' 308' ' ' ASP . 8.1 t -107.2 -0.67 22.52 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 119.079 0.854 . . . . 0.0 111.319 -175.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -83.85 -25.11 30.57 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -173.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.651 ' CZ ' ' HA ' ' A' ' 309' ' ' LYS . 0.1 OUTLIER -83.22 174.68 10.55 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.759 0.79 . . . . 0.0 111.155 176.882 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . 0.401 ' C ' HD21 ' A' ' 388' ' ' LEU . 14.7 t -149.78 159.67 44.16 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.542 -1.208 . . . . 0.0 108.769 -179.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . 0.436 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 29.0 m-90 -69.17 117.64 11.07 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 121.353 0.597 . . . . 0.0 110.28 -179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.964 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 59.4 tttm -97.47 -47.81 5.53 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 173.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 41.1 ttp-105 -154.61 130.03 9.8 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.955 168.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . 0.561 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -66.13 166.0 18.96 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.993 -178.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . 0.567 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 3.6 Cg_exo -44.3 116.27 0.99 Allowed 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.559 2.173 . . . . 0.0 112.368 178.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 55.0 m -128.7 132.18 48.0 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.466 -174.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.94 125.35 23.23 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 175.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . 0.438 ' C ' ' H ' ' A' ' 323' ' ' HIS . 59.5 p -70.24 5.6 1.64 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 123.423 0.689 . . . . 0.0 112.489 -168.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 74.56 -25.58 1.12 Allowed Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.319 -169.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . 0.438 ' H ' ' C ' ' A' ' 321' ' ' SER . 2.2 t-160 -106.42 46.46 0.92 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.114 0.483 . . . . 0.0 109.98 -178.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 50.34 43.66 26.65 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 114.96 -1.018 . . . . 0.0 113.533 177.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . 0.665 ' HA ' ' HG3' ' A' ' 375' ' ' GLN . 2.1 p -150.84 -168.12 3.01 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 174.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.823 ' HB ' ' HG2' ' A' ' 374' ' ' MET . 0.2 OUTLIER -129.3 144.73 37.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 118.979 0.809 . . . . 0.0 111.019 179.707 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' VAL . . . . . 0.654 HG12 ' HG2' ' A' ' 373' ' ' GLU . 15.0 m -128.39 143.86 39.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.024 174.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' MET . . . . . 0.435 ' CG ' HD12 ' A' ' 372' ' ' ILE . 0.0 OUTLIER -135.04 149.46 50.13 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 178.297 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.964 ' HG2' ' HD3' ' A' ' 315' ' ' LYS . 7.7 tt0 -131.12 131.07 43.88 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 120.657 -0.417 . . . . 0.0 109.994 -173.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.672 HG23 ' HA3' ' A' ' 369' ' ' GLY . 0.0 OUTLIER -126.81 161.29 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -178.18 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . 0.555 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -127.69 137.8 10.05 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.729 175.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . 0.931 ' H ' ' HA2' ' A' ' 368' ' ' GLY . 0.2 OUTLIER -89.96 155.6 19.0 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.541 0.686 . . . . 0.0 111.807 179.185 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 2.6 p -95.84 -13.99 23.58 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 171.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -176.44 -40.72 0.05 OUTLIER Glycine 0 CA--C 1.528 0.859 0 C-N-CA 118.961 -1.59 . . . . 0.0 115.19 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' THR . . . . . 0.567 ' HB ' ' SD ' ' A' ' 364' ' ' MET . 82.8 m -52.78 132.84 37.11 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.823 0.344 . . . . 0.0 111.533 -177.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.865 HH21 ' HB2' ' A' ' 337' ' ' PRO . 0.2 OUTLIER -87.87 177.4 2.7 Favored Pre-proline 0 C--N 1.338 0.077 0 CA-C-O 117.389 -1.291 . . . . 0.0 107.875 -179.143 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.865 ' HB2' HH21 ' A' ' 336' ' ' ARG . 1.0 OUTLIER -26.64 98.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.367 1.535 0 C-N-CA 123.723 2.949 . . . . 0.0 114.138 -174.432 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' CYS . . . . . 0.757 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 6.5 p -111.48 -176.19 2.88 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 113.559 -1.655 . . . . 0.0 110.376 -171.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -111.54 98.9 7.77 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 174.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . 0.773 ' HB ' ' HG2' ' A' ' 362' ' ' PRO . 68.5 mt -74.49 119.59 77.33 Favored Pre-proline 0 C--N 1.328 -0.338 0 O-C-N 123.416 0.448 . . . . 0.0 110.906 -171.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.2 82.32 2.4 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.928 2.419 . . . . 0.0 112.162 178.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.706 HG13 HG22 ' A' ' 340' ' ' ILE . 9.9 m -99.04 151.65 4.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.382 178.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 17.3 ptt180 -162.34 171.34 17.37 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 176.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' ALA . . . . . 0.544 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -145.97 144.67 30.27 Favored 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.008 176.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.553 ' HB ' ' HA ' ' A' ' 350' ' ' PRO . 4.9 m -116.27 143.83 25.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 176.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.405 ' HB2' ' CG1' ' A' ' 354' ' ' VAL . . . -63.6 123.23 18.29 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 176.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . 0.519 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 37.2 t-80 42.52 62.97 1.55 Allowed 'General case' 0 N--CA 1.473 0.711 0 O-C-N 124.268 0.98 . . . . 0.0 112.749 170.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . 0.54 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 50.75 29.72 19.55 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 115.25 0.86 . . . . 0.0 115.25 -177.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 347' ' ' HIS . 50.6 t -136.2 103.08 9.74 Favored Pre-proline 0 C--O 1.234 0.247 0 CA-C-N 118.267 1.033 . . . . 0.0 109.784 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . 0.553 ' HA ' ' HB ' ' A' ' 345' ' ' VAL . 17.1 Cg_exo -71.98 62.62 3.24 Favored 'Trans proline' 0 C--O 1.234 0.316 0 C-N-CA 123.095 2.53 . . . . 0.0 112.884 178.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -100.12 -56.05 2.47 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 178.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 4.6 p -124.64 133.4 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.67 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.451 174.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . 0.415 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 34.0 t30 -64.85 117.35 7.43 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.891 -1.049 . . . . 0.0 110.89 177.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.576 HG12 HD22 ' A' ' 376' ' ' LEU . 27.9 m -99.79 7.54 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.46 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.917 179.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . 0.544 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -78.62 82.94 4.83 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-O 121.029 0.443 . . . . 0.0 110.568 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' MET . . . . . 0.614 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 22.4 ttt -97.46 51.96 1.1 Allowed 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 175.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.842 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 11.7 mt -24.53 111.59 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 112.901 -1.954 . . . . 0.0 115.226 170.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.82 HD11 ' HB2' ' A' ' 375' ' ' GLN . 3.9 mm -60.36 -22.89 26.4 Favored 'Isoleucine or valine' 0 C--O 1.232 0.169 0 CA-C-N 113.352 -1.749 . . . . 0.0 108.48 168.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 55.1 m -139.23 90.34 11.82 Favored Pre-proline 0 N--CA 1.451 -0.419 0 CA-C-N 114.265 -1.334 . . . . 0.0 108.648 177.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' PRO . . . . . 0.475 ' HA ' HD12 ' A' ' 357' ' ' LEU . 92.6 Cg_endo -82.17 45.34 1.91 Allowed 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 123.27 2.647 . . . . 0.0 114.445 -170.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -174.58 80.44 0.34 Allowed Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 120.958 0.408 . . . . 0.0 110.375 176.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . 0.773 ' HG2' ' HB ' ' A' ' 340' ' ' ILE . 95.3 Cg_endo -82.65 112.39 2.13 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.702 2.268 . . . . 0.0 111.932 176.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 4.0 p -90.81 142.19 28.02 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.764 0.792 . . . . 0.0 112.5 173.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' MET . . . . . 0.827 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 5.2 ptp -96.44 143.97 26.98 Favored 'General case' 0 CA--C 1.504 -0.827 0 CA-C-N 114.067 -1.424 . . . . 0.0 109.457 178.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -141.21 -168.13 2.55 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.64 1.213 . . . . 0.0 110.821 -174.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . 0.599 HD22 ' N ' ' A' ' 367' ' ' ASN . 0.2 OUTLIER -60.22 -4.6 0.85 Allowed 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -176.699 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' ASN . . . . . 0.599 ' N ' HD22 ' A' ' 366' ' ' ASN . 10.0 p30 -113.15 -11.38 13.3 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.198 0.523 . . . . 0.0 110.618 -174.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . 0.931 ' HA2' ' H ' ' A' ' 332' ' ' PHE . . . 138.48 -132.05 5.63 Favored Glycine 0 CA--C 1.504 -0.637 0 N-CA-C 110.826 -0.91 . . . . 0.0 110.826 -175.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . 0.672 ' HA3' HG23 ' A' ' 330' ' ' VAL . . . -104.37 3.27 43.37 Favored Glycine 0 C--N 1.317 -0.505 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 175.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 73.15 -93.38 0.68 Allowed Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 114.96 -0.62 . . . . 0.0 113.575 175.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -152.29 133.49 14.34 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.411 -0.395 . . . . 0.0 111.084 -170.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 372' ' ' ILE . . . . . 0.627 HG23 ' HB3' ' A' ' 362' ' ' PRO . 0.7 OUTLIER -129.63 135.38 61.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 173.392 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.654 ' HG2' HG12 ' A' ' 327' ' ' VAL . 40.9 mt-10 -122.43 126.72 48.53 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . 0.842 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 0.1 OUTLIER -134.47 165.5 25.02 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 123.505 0.722 . . . . 0.0 110.718 -175.692 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 375' ' ' GLN . . . . . 0.837 ' HA ' HE21 ' A' ' 375' ' ' GLN . 0.0 OUTLIER -173.5 -173.81 0.93 Allowed 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.545 0.688 . . . . 0.0 111.668 162.835 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' LEU . . . . . 0.962 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 10.5 tp -166.15 166.97 9.04 Favored Pre-proline 0 N--CA 1.443 -0.79 0 N-CA-C 104.481 -2.415 . . . . 0.0 104.481 171.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' PRO . . . . . 0.962 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 2.9 Cg_endo -43.48 133.81 7.0 Favored 'Trans proline' 0 CA--C 1.534 0.48 0 C-N-CA 121.58 1.52 . . . . 0.0 110.684 167.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_exo -37.8 140.04 0.29 Allowed 'Trans proline' 0 C--N 1.358 1.077 0 C-N-CA 123.85 3.033 . . . . 0.0 112.371 -177.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 148.61 -169.45 29.16 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.122 -1.037 . . . . 0.0 110.565 -160.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . 0.519 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 2.2 m-20 -98.72 128.52 45.0 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 117.583 0.692 . . . . 0.0 111.29 -175.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -127.07 168.73 14.21 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 176.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 1.034 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -161.04 138.6 2.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 168.835 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . 0.743 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 17.3 mt -104.62 130.29 55.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 C-N-CA 119.928 -0.709 . . . . 0.0 109.418 -172.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' TYR . . . . . 0.536 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 3.5 m-85 -101.57 98.56 8.86 Favored 'General case' 0 N--CA 1.441 -0.884 0 O-C-N 124.318 1.011 . . . . 0.0 108.572 169.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . 0.61 HG11 HG11 ' A' ' 330' ' ' VAL . 25.9 t -86.63 84.71 2.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 175.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 62.15 -112.06 4.52 Favored Glycine 0 N--CA 1.439 -1.132 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 -169.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' ASP . . . . . 0.53 ' HB2' ' HD3' ' A' ' 309' ' ' LYS . 0.7 OUTLIER -85.03 -15.26 44.71 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.781 0.324 . . . . 0.0 110.947 177.426 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.536 ' O ' ' HA ' ' A' ' 384' ' ' TYR . 3.3 mp -70.34 155.07 41.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.023 177.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . 0.743 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 6.4 p30 -167.12 157.01 10.97 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.808 -0.178 . . . . 0.0 110.898 175.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . 0.567 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 33.0 t-80 -175.03 123.19 0.24 Allowed 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.852 175.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' GLN . . . . . 1.034 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 25.3 tt0 -78.52 153.61 31.15 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.066 0.46 . . . . 0.0 111.585 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' TRP . . . . . 0.491 ' N ' ' HG2' ' A' ' 391' ' ' GLN . 10.7 t-105 -166.36 145.87 5.91 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.981 -1.009 . . . . 0.0 108.605 174.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . 0.507 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 13.5 p90 -103.3 118.79 37.58 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.811 ' HG3' HE22 ' A' ' 375' ' ' GLN . 3.0 mm100 -83.14 112.96 20.3 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -168.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 31.2 mtmm . . . . . 0 C--O 1.248 1.026 0 O-C-N 124.225 0.953 . . . . 0.0 111.462 -179.9 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . 0.605 HG23 HG23 ' A' ' 335' ' ' THR . 8.9 t . . . . . 0 CA--C 1.539 0.527 0 CA-C-O 121.575 0.702 . . . . 0.0 111.232 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . 0.408 ' O ' ' HB ' ' A' ' 305' ' ' THR . 14.2 p90 -63.54 119.11 9.18 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 174.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.419 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 12.1 t 174.9 -168.33 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -172.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 36.4 t -65.22 106.95 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 169.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . 0.596 ' HB3' HG21 ' A' ' 335' ' ' THR . 0.5 OUTLIER -69.91 140.86 53.16 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.264 -167.892 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . 0.609 ' OD1' HG22 ' A' ' 310' ' ' THR . 14.0 t70 -63.41 132.68 52.23 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.953 -174.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.566 ' HD2' ' N ' ' A' ' 310' ' ' THR . 0.0 OUTLIER -41.5 -20.36 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 116.104 1.89 . . . . 0.0 116.104 -175.428 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.609 HG22 ' OD1' ' A' ' 308' ' ' ASP . 6.7 t -108.31 2.54 22.68 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 119.134 0.879 . . . . 0.0 112.196 -174.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.426 ' HG2' ' HB3' ' A' ' 308' ' ' ASP . 24.9 mmmt -74.01 -33.14 63.68 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -173.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.951 ' HD1' HD13 ' A' ' 388' ' ' LEU . 0.0 OUTLIER -86.08 175.18 8.69 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 122.006 0.908 . . . . 0.0 111.672 -175.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 11.1 t -144.3 155.45 43.83 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 113.871 -1.513 . . . . 0.0 107.755 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 16.4 m-90 -75.69 93.11 3.04 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.237 0.541 . . . . 0.0 109.598 178.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.452 ' HB3' ' C ' ' A' ' 329' ' ' GLU . 25.1 tptp -65.95 -43.82 86.84 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 170.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 24.8 ttt180 -152.83 130.79 11.78 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.142 170.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . 0.445 ' HB1' ' CD2' ' A' ' 390' ' ' HIS . . . -69.5 159.04 85.26 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.649 -178.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . 0.781 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 78.7 Cg_exo -39.71 112.7 0.16 Allowed 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 122.65 2.234 . . . . 0.0 112.742 178.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 19.0 m -131.89 135.33 46.57 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.812 -1.085 . . . . 0.0 110.166 -173.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 60.1 m-20 -57.38 124.13 17.86 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . 0.433 ' HB3' HG13 ' A' ' 327' ' ' VAL . 84.5 p -62.16 -47.84 82.73 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.448 0.642 . . . . 0.0 110.014 -174.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 123.64 -14.62 8.09 Favored Glycine 0 N--CA 1.443 -0.892 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -111.86 53.09 0.73 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.284 0.564 . . . . 0.0 109.884 178.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 22.9 t70 57.28 33.94 24.04 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 114.746 -1.116 . . . . 0.0 112.464 177.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . 0.557 ' HB ' HG13 ' A' ' 358' ' ' ILE . 10.0 p -152.5 -172.55 4.27 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -179.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -132.12 145.45 34.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.338 0.59 . . . . 0.0 111.377 -177.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' VAL . . . . . 0.724 HG12 ' HG2' ' A' ' 373' ' ' GLU . 15.8 m -127.11 155.94 38.34 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.895 176.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 5.0 ptm -142.09 159.43 42.24 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 167.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.552 ' HG3' ' O ' ' A' ' 370' ' ' GLY . 9.7 tt0 -124.45 129.39 50.57 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 -176.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.594 HG23 ' HA3' ' A' ' 369' ' ' GLY . 3.1 m -125.55 146.19 31.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.88 -179.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . 0.727 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -124.47 140.42 12.55 Favored Glycine 0 CA--C 1.523 0.571 0 C-N-CA 120.936 -0.649 . . . . 0.0 112.116 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . 0.572 ' HD1' ' HA2' ' A' ' 368' ' ' GLY . 7.9 p90 -89.3 146.67 24.56 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.96 0.886 . . . . 0.0 111.69 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 28.2 t -86.84 -28.6 22.8 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.114 -1.403 . . . . 0.0 111.961 172.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -159.23 -44.58 0.02 OUTLIER Glycine 0 C--N 1.336 0.56 0 C-N-CA 119.605 -1.283 . . . . 0.0 113.917 -179.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' THR . . . . . 0.605 HG23 HG23 ' A' ' 303' ' ' THR . 27.1 m -52.69 124.55 14.12 Favored 'General case' 0 C--N 1.322 -0.595 0 O-C-N 123.795 0.35 . . . . 0.0 110.949 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.59 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 33.3 ptt85 -87.29 -177.38 0.88 Allowed Pre-proline 0 CA--C 1.532 0.285 0 CA-C-O 117.089 -1.434 . . . . 0.0 108.37 -174.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.775 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.1 OUTLIER -26.63 96.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.377 2.053 0 C-N-CA 123.751 2.967 . . . . 0.0 114.151 -176.449 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' CYS . . . . . 0.482 ' SG ' ' HG3' ' A' ' 364' ' ' MET . 12.1 p -112.42 -176.83 3.01 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 113.515 -1.675 . . . . 0.0 110.074 -171.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 11.2 mpt_? -112.21 103.08 11.22 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 178.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . 0.832 HG22 HG13 ' A' ' 342' ' ' VAL . 29.7 mt -74.17 119.99 79.14 Favored Pre-proline 0 C--N 1.324 -0.508 0 C-N-CA 120.365 -0.534 . . . . 0.0 111.486 -167.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.65 81.26 2.67 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.853 2.368 . . . . 0.0 111.561 177.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.832 HG13 HG22 ' A' ' 340' ' ' ILE . 4.6 m -102.41 155.38 5.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-O 121.747 0.784 . . . . 0.0 110.887 -178.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.467 ' HE ' ' HB3' ' A' ' 384' ' ' TYR . 22.4 ptt180 -166.31 174.94 8.63 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' ALA . . . . . 0.529 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -150.9 145.0 25.35 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.849 -0.74 . . . . 0.0 110.893 177.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.439 ' O ' HG23 ' A' ' 382' ' ' ILE . 9.2 m -119.88 147.16 23.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -70.12 122.86 20.26 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 176.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . 0.523 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 47.2 t60 43.96 60.43 2.73 Favored 'General case' 0 N--CA 1.474 0.775 0 O-C-N 124.149 0.906 . . . . 0.0 111.413 174.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . 0.689 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 44.09 46.04 7.93 Favored Glycine 0 C--N 1.333 0.415 0 N-CA-C 114.637 0.615 . . . . 0.0 114.637 -174.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 347' ' ' HIS . 73.5 t -141.64 102.5 5.93 Favored Pre-proline 0 C--N 1.33 -0.251 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -76.15 49.7 2.64 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.603 2.202 . . . . 0.0 112.625 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -102.11 -5.54 24.36 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 2.6 p -169.8 106.31 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 114.561 -1.199 . . . . 0.0 110.055 -167.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . 0.465 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 38.1 t30 -64.74 111.78 2.93 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.688 178.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.505 ' HA ' HD22 ' A' ' 376' ' ' LEU . 31.5 m -91.2 -0.59 9.55 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.212 177.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . 0.529 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -74.25 84.55 1.89 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.213 0.53 . . . . 0.0 111.462 -176.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' MET . . . . . 0.658 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 47.6 ttp -97.9 101.14 12.56 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 106.201 -1.778 . . . . 0.0 106.201 168.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.521 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 27.6 mt -85.35 119.33 25.6 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.192 -163.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.765 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 2.5 mm -61.79 -28.98 45.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.506 175.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 22.4 m -130.14 90.08 43.2 Favored Pre-proline 0 N--CA 1.443 -0.8 0 CA-C-N 114.3 -1.318 . . . . 0.0 108.539 173.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -83.87 36.86 0.61 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.142 2.561 . . . . 0.0 113.055 -173.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -153.35 71.56 6.88 Favored Pre-proline 0 C--N 1.317 -0.83 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.257 175.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . 0.621 ' HB2' HD12 ' A' ' 340' ' ' ILE . 94.7 Cg_endo -81.43 145.02 14.68 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.568 2.179 . . . . 0.0 111.387 176.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' THR . . . . . 0.451 ' O ' ' HA2' ' A' ' 369' ' ' GLY . 0.5 OUTLIER -144.26 140.19 29.08 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 -173.008 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' MET . . . . . 0.775 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 41.4 mtm -95.47 110.05 22.16 Favored 'General case' 0 CA--C 1.492 -1.286 0 C-N-CA 119.398 -0.921 . . . . 0.0 109.198 178.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -97.96 -167.33 1.5 Allowed 'General case' 0 C--N 1.312 -1.04 0 O-C-N 124.77 1.294 . . . . 0.0 110.437 -175.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . 0.56 HD22 ' N ' ' A' ' 367' ' ' ASN . 0.3 OUTLIER -54.05 -7.82 0.15 Allowed 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -179.433 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' ASN . . . . . 0.56 ' N ' HD22 ' A' ' 366' ' ' ASN . 9.7 p30 -124.09 -1.64 8.23 Favored 'General case' 0 N--CA 1.465 0.314 0 O-C-N 121.655 -0.653 . . . . 0.0 110.98 -178.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . 0.727 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . 116.66 -176.63 16.39 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -172.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . 0.635 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -46.84 -25.79 2.49 Favored Glycine 0 CA--C 1.522 0.504 0 CA-C-N 117.7 0.75 . . . . 0.0 114.517 174.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . 0.552 ' O ' ' HG3' ' A' ' 329' ' ' GLU . . . 77.35 -57.82 3.7 Favored Glycine 0 C--O 1.228 -0.228 0 C-N-CA 120.867 -0.682 . . . . 0.0 113.034 176.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -165.87 147.06 6.9 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.126 0.489 . . . . 0.0 111.431 177.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 372' ' ' ILE . . . . . 0.747 HD13 HG11 ' A' ' 342' ' ' VAL . 1.3 mt -131.6 140.03 49.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.448 170.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.765 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 40.8 mt-10 -119.44 123.7 44.71 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.428 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . 0.558 ' HG2' HD11 ' A' ' 383' ' ' ILE . 0.0 OUTLIER -138.63 164.38 29.64 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.396 -0.82 . . . . 0.0 108.817 -176.866 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 375' ' ' GLN . . . . . 1.011 ' HA ' HE21 ' A' ' 375' ' ' GLN . 0.0 OUTLIER 177.54 175.0 0.47 Allowed 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 173.585 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' LEU . . . . . 0.983 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 8.9 tp -166.88 173.59 3.05 Favored Pre-proline 0 C--N 1.32 -0.697 0 N-CA-C 104.21 -2.515 . . . . 0.0 104.21 177.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' PRO . . . . . 0.983 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 75.2 Cg_exo -41.08 127.61 2.8 Favored 'Trans proline' 0 C--N 1.348 0.5 0 CA-C-N 121.465 1.559 . . . . 0.0 111.225 166.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -41.67 148.16 0.34 Allowed 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 123.826 3.017 . . . . 0.0 112.568 -177.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 142.31 -163.75 27.06 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 119.763 -1.208 . . . . 0.0 111.07 -162.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . 0.62 ' C ' HD22 ' A' ' 381' ' ' ASN . 4.8 m-20 -89.44 115.87 27.2 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 117.32 0.56 . . . . 0.0 111.163 -176.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.62 HD22 ' C ' ' A' ' 380' ' ' ASP . 0.8 OUTLIER -126.62 147.55 49.89 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 177.039 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 0.99 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -148.71 137.73 15.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.022 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 176.609 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . 0.668 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 28.2 mt -99.49 132.69 44.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.206 -173.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' TYR . . . . . 0.619 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 1.8 m-85 -106.13 99.91 9.48 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.177 -1.374 . . . . 0.0 109.071 170.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . 0.773 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 2.8 t -84.83 86.61 2.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 174.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 60.42 -106.36 1.03 Allowed Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 120.003 -1.094 . . . . 0.0 110.718 -169.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' ASP . . . . . 0.448 ' HB2' ' HB2' ' A' ' 309' ' ' LYS . 17.8 t70 -89.97 -14.36 34.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.502 0.192 . . . . 0.0 111.325 176.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.951 HD13 ' HD1' ' A' ' 312' ' ' PHE . 3.0 mp -67.67 153.82 42.85 Favored 'General case' 0 CA--C 1.511 -0.546 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 176.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . 0.668 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 30.5 p-10 -163.75 154.42 15.78 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.017 176.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . 0.781 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 9.2 t60 -173.41 116.38 0.26 Allowed 'General case' 0 C--O 1.241 0.633 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 174.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' GLN . . . . . 0.99 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 8.6 tt0 -80.59 153.67 27.89 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.973 -177.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' TRP . . . . . 0.496 ' HD1' ' OE1' ' A' ' 394' ' ' GLN . 32.0 t-105 -166.09 153.15 9.77 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.964 -1.017 . . . . 0.0 109.208 -176.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -110.11 118.06 35.38 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.933 ' HG3' HE22 ' A' ' 375' ' ' GLN . 4.0 mm100 -80.33 104.11 10.66 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -173.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.153 -0.927 . . . . 0.0 111.293 -174.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . 0.458 ' O ' HG23 ' A' ' 303' ' ' THR . 10.2 t . . . . . 0 CA--C 1.536 0.416 0 CA-C-O 121.89 0.852 . . . . 0.0 111.374 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . 0.554 ' HB3' ' NE ' ' A' ' 336' ' ' ARG . 17.2 p90 -67.06 130.77 44.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.814 174.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.527 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 14.8 t 173.1 -169.17 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -175.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 41.3 t -66.43 112.42 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 169.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.0 140.41 57.71 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -172.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . 0.584 ' OD1' HG22 ' A' ' 310' ' ' THR . 12.5 t70 -62.24 130.92 47.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.538 0.685 . . . . 0.0 111.46 -170.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 18.3 pttm -38.47 -29.71 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 113.175 -1.829 . . . . 0.0 115.066 -177.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.584 HG22 ' OD1' ' A' ' 308' ' ' ASP . 12.0 t -108.37 0.28 21.07 Favored 'General case' 0 N--CA 1.443 -0.817 0 O-C-N 121.685 -0.634 . . . . 0.0 112.425 -170.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 26.1 mtpp -84.87 -29.18 25.48 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -173.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.456 ' HA ' ' O ' ' A' ' 331' ' ' GLY . 0.1 OUTLIER -81.1 173.76 12.25 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.639 0.733 . . . . 0.0 111.012 -179.75 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 6.4 t -147.49 159.02 44.2 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.004 -178.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . 0.454 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 25.3 m-90 -71.03 122.02 19.28 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 178.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.713 ' HD3' ' HB3' ' A' ' 329' ' ' GLU . 70.8 tttt -102.52 -42.92 5.79 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 173.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.821 ' HB3' ' HB2' ' A' ' 329' ' ' GLU . 19.8 ttm-85 -149.39 128.15 12.5 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.73 -1.123 . . . . 0.0 108.85 169.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -71.52 158.73 87.32 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . 0.519 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 3.3 Cg_exo -43.01 111.15 0.2 Allowed 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 122.65 2.233 . . . . 0.0 112.487 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 32.2 m -129.26 131.27 46.98 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.624 -174.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -59.34 125.32 23.14 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . 0.413 ' HB3' HG13 ' A' ' 327' ' ' VAL . 86.6 p -58.79 -45.08 90.67 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.832 -173.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 136.7 -3.52 3.52 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.363 176.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 6.3 t-80 -143.7 70.68 1.31 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.052 0.453 . . . . 0.0 110.304 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 58.31 30.14 19.11 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 115.01 -0.995 . . . . 0.0 113.666 175.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . 0.617 ' HA ' ' CG ' ' A' ' 375' ' ' GLN . 11.1 p -153.48 179.2 9.02 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.816 HG23 ' HG2' ' A' ' 375' ' ' GLN . 0.5 OUTLIER -134.03 144.76 34.57 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.404 0 CA-C-O 121.106 0.479 . . . . 0.0 111.142 -172.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' VAL . . . . . 0.796 HG12 ' HG3' ' A' ' 373' ' ' GLU . 14.1 m -118.86 155.52 21.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.662 175.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' MET . . . . . 0.619 ' HG3' HG13 ' A' ' 372' ' ' ILE . 0.0 OUTLIER -143.56 153.42 42.55 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 176.71 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.821 ' HB2' ' HB3' ' A' ' 316' ' ' ARG . 8.9 mt-10 -134.7 133.43 39.99 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.003 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.592 HG23 ' HA3' ' A' ' 369' ' ' GLY . 2.4 m -132.81 159.05 43.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.004 0.431 . . . . 0.0 111.853 -179.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . 0.488 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -129.27 136.21 8.86 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.19 -1.005 . . . . 0.0 112.582 178.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . 0.419 ' HD1' ' CA ' ' A' ' 368' ' ' GLY . 2.1 p90 -90.31 154.45 19.7 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.682 0.753 . . . . 0.0 111.807 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 27.6 p -119.1 30.69 7.02 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.528 -1.214 . . . . 0.0 112.515 173.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 164.65 -51.29 0.29 Allowed Glycine 0 C--O 1.225 -0.465 0 C-N-CA 119.388 -1.387 . . . . 0.0 114.122 169.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' THR . . . . . . . . . . . . . 2.8 m -55.79 124.47 17.63 Favored 'General case' 0 C--N 1.317 -0.827 0 O-C-N 123.695 0.291 . . . . 0.0 111.5 -178.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.722 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 5.5 ppt_? -80.66 -178.63 1.2 Allowed Pre-proline 0 N--CA 1.462 0.132 0 CA-C-O 116.921 -1.514 . . . . 0.0 107.843 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.868 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.7 OUTLIER -24.35 96.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 123.566 2.844 . . . . 0.0 113.733 -179.083 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' CYS . . . . . 0.598 ' SG ' ' HB2' ' A' ' 364' ' ' MET . 18.3 p -117.76 -176.8 3.11 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.091 -1.868 . . . . 0.0 109.927 -168.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -110.35 103.76 12.46 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -178.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . 0.736 HG12 ' HG3' ' A' ' 364' ' ' MET . 55.4 mt -72.2 121.15 83.93 Favored Pre-proline 0 C--N 1.328 -0.364 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.48 -171.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . 0.424 ' O ' ' HA ' ' A' ' 385' ' ' VAL . 74.2 Cg_endo -79.83 77.9 3.9 Favored 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 121.556 1.504 . . . . 0.0 110.947 174.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.754 HG13 HG13 ' A' ' 385' ' ' VAL . 0.0 OUTLIER -105.08 117.66 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 CA-C-O 122.238 1.018 . . . . 0.0 110.555 175.628 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.486 ' HG3' ' HB2' ' A' ' 384' ' ' TYR . 25.9 ptt180 -130.49 179.34 5.99 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 113.575 -1.648 . . . . 0.0 106.983 177.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' ALA . . . . . 0.518 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -149.29 147.66 28.62 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.864 -0.734 . . . . 0.0 110.963 175.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.447 HG22 HD12 ' A' ' 382' ' ' ILE . 10.5 m -119.52 141.7 38.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 176.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.53 116.68 7.05 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . 0.576 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 57.9 t-80 44.67 65.89 0.98 Allowed 'General case' 0 N--CA 1.472 0.626 0 O-C-N 124.345 1.028 . . . . 0.0 111.447 175.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . 0.52 ' H ' ' CG2' ' A' ' 382' ' ' ILE . . . 42.97 41.14 4.47 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 115.096 0.799 . . . . 0.0 115.096 -175.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 347' ' ' HIS . 87.6 t -140.5 102.49 6.58 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 118.112 0.956 . . . . 0.0 108.661 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -74.63 66.25 5.68 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 122.99 2.46 . . . . 0.0 113.376 -178.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -100.47 -57.79 2.04 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 174.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 5.9 p -116.98 130.69 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.641 174.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . 0.518 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 38.1 t30 -62.92 108.26 1.16 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.423 171.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.432 HG23 ' CB ' ' A' ' 344' ' ' ALA . 20.4 m -88.96 5.28 4.6 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.0 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . 0.45 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -77.46 82.03 3.92 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.317 0.58 . . . . 0.0 110.436 177.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' MET . . . . . 0.535 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 39.1 ttm -98.03 99.83 11.12 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 172.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.672 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 46.4 mt -85.15 146.71 26.98 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.38 -159.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.751 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 2.4 mm -90.81 -21.7 6.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 176.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 97.5 m -127.1 84.83 62.47 Favored Pre-proline 0 N--CA 1.446 -0.655 0 CA-C-N 113.216 -1.811 . . . . 0.0 108.257 172.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -80.62 27.6 0.56 Allowed 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.798 2.332 . . . . 0.0 112.758 -175.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -147.66 61.66 6.35 Favored Pre-proline 0 C--N 1.315 -0.901 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.512 178.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . 0.466 ' HB2' HD12 ' A' ' 340' ' ' ILE . 90.2 Cg_endo -85.11 102.39 0.78 Allowed 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 122.124 1.883 . . . . 0.0 112.066 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' THR . . . . . 0.436 HG22 ' O ' ' A' ' 338' ' ' CYS . 1.3 p -93.04 168.87 10.84 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 122.05 0.929 . . . . 0.0 113.273 171.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' MET . . . . . 0.868 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 43.9 mtt -115.63 128.03 55.64 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-N 113.819 -1.537 . . . . 0.0 109.324 174.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.539 ' CD ' ' HG3' ' A' ' 337' ' ' PRO . 53.9 mm-40 -121.71 -163.29 1.04 Allowed 'General case' 0 C--N 1.313 -0.993 0 O-C-N 124.275 0.984 . . . . 0.0 109.83 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . 0.602 HD22 ' N ' ' A' ' 366' ' ' ASN . 0.1 OUTLIER -40.39 -28.03 0.06 Allowed 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -178.655 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -111.84 7.87 20.28 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 121.4 -0.813 . . . . 0.0 112.247 -177.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . 0.488 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . 99.07 -164.49 20.5 Favored Glycine 0 N--CA 1.452 -0.271 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 -177.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . 0.592 ' HA3' HG23 ' A' ' 330' ' ' VAL . . . -70.62 95.65 0.54 Allowed Glycine 0 CA--C 1.507 -0.425 0 C-N-CA 120.081 -1.057 . . . . 0.0 110.78 168.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -70.94 -27.17 72.67 Favored Glycine 0 C--N 1.313 -0.71 0 CA-C-N 115.166 -0.517 . . . . 0.0 112.939 -166.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -164.44 136.71 4.71 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.942 0.401 . . . . 0.0 110.685 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 372' ' ' ILE . . . . . 0.619 HG13 ' HG3' ' A' ' 328' ' ' MET . 0.4 OUTLIER -127.31 145.4 34.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 173.005 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.796 ' HG3' HG12 ' A' ' 327' ' ' VAL . 3.8 mp0 -127.38 127.09 43.63 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 175.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . 0.7 ' HG2' HD11 ' A' ' 383' ' ' ILE . 4.3 ppp? -138.3 166.83 23.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.926 -175.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 375' ' ' GLN . . . . . 0.816 ' HG2' HG23 ' A' ' 326' ' ' VAL . 0.0 OUTLIER -173.9 175.32 2.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.194 0.521 . . . . 0.0 110.59 165.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' LEU . . . . . 0.74 HD22 ' HD2' ' A' ' 377' ' ' PRO . 2.2 tm? -167.79 129.42 1.22 Allowed Pre-proline 0 C--N 1.315 -0.903 0 N-CA-C 105.11 -2.181 . . . . 0.0 105.11 176.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' PRO . . . . . 0.74 ' HD2' HD22 ' A' ' 376' ' ' LEU . 58.7 Cg_exo -24.97 125.79 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 124.503 3.469 . . . . 0.0 112.874 -179.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -35.51 134.42 0.22 Allowed 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 124.82 3.68 . . . . 0.0 113.019 -165.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 157.7 -171.79 34.88 Favored Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 -159.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . 0.576 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 5.7 m-20 -97.07 127.46 43.06 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 117.494 0.647 . . . . 0.0 110.342 -178.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.587 HD22 ' HG2' ' A' ' 394' ' ' GLN . 25.5 m-80 -131.09 168.56 17.21 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 1.021 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -158.87 140.18 4.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 169.775 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . 0.7 HD11 ' HG2' ' A' ' 374' ' ' MET . 44.3 mt -99.82 130.44 48.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 C-N-CA 119.656 -0.818 . . . . 0.0 109.473 -175.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' TYR . . . . . 0.486 ' HB2' ' HG3' ' A' ' 343' ' ' ARG . 2.5 m-85 -100.95 136.6 40.55 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 169.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . 0.754 HG13 HG13 ' A' ' 342' ' ' VAL . 6.1 t -126.67 85.47 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 176.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 66.56 -109.75 3.09 Favored Glycine 0 N--CA 1.435 -1.432 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 -166.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -95.47 -7.52 37.93 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.856 0.328 . . . . 0.0 111.883 172.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.492 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 1.4 mp -66.05 150.07 49.27 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 173.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . 0.54 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 7.7 p30 -166.05 154.78 11.22 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 121.275 -0.17 . . . . 0.0 110.669 179.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . 0.519 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 3.9 t60 -173.49 116.34 0.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.145 176.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' GLN . . . . . 1.021 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 6.3 tt0 -77.64 153.85 32.78 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.209 0.528 . . . . 0.0 112.364 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' TRP . . . . . 0.446 ' HD1' ' OE1' ' A' ' 394' ' ' GLN . 17.1 t-105 -169.53 147.71 3.61 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.783 -1.099 . . . . 0.0 109.054 176.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . 0.523 ' HB2' ' HE3' ' A' ' 395' ' ' LYS . 5.9 p90 -102.27 114.9 29.46 Favored 'General case' 0 C--N 1.313 -0.987 0 O-C-N 121.408 -0.807 . . . . 0.0 109.023 -178.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.762 ' HG3' HE22 ' A' ' 375' ' ' GLN . 2.8 mm100 -83.23 107.17 15.59 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -171.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.523 ' HE3' ' HB2' ' A' ' 393' ' ' PHE . 33.7 mmtp . . . . . 0 C--O 1.25 1.111 0 CA-C-O 118.022 -0.989 . . . . 0.0 109.965 -172.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 2.4 t . . . . . 0 CA--C 1.534 0.362 0 CA-C-O 121.306 0.574 . . . . 0.0 111.753 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . 0.525 ' HB3' ' NE ' ' A' ' 336' ' ' ARG . 21.7 p90 -63.11 124.27 20.72 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.931 0.396 . . . . 0.0 110.563 172.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.596 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 9.7 t -179.85 -176.75 0.36 Allowed 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -176.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 47.8 t -64.21 112.69 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.004 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 166.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . 0.691 ' HB2' ' CZ ' ' A' ' 332' ' ' PHE . 0.0 OUTLIER -68.16 138.55 55.76 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.032 0.444 . . . . 0.0 110.456 -171.088 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . 0.588 ' OD2' HG22 ' A' ' 310' ' ' THR . 14.7 t70 -61.32 133.12 55.51 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.01 -171.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.432 ' O ' ' CE1' ' A' ' 312' ' ' PHE . 22.1 pttp -38.59 -28.94 0.03 OUTLIER 'General case' 0 C--O 1.22 -0.5 0 CA-C-N 113.097 -1.865 . . . . 0.0 114.973 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.588 HG22 ' OD2' ' A' ' 308' ' ' ASP . 13.5 t -109.05 10.4 26.13 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 119.286 0.948 . . . . 0.0 113.192 -169.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.5 ' HB2' ' CE2' ' A' ' 332' ' ' PHE . 28.6 mtpp -96.02 -19.76 19.22 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 -174.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.846 ' HD1' HD13 ' A' ' 388' ' ' LEU . 0.3 OUTLIER -86.43 173.0 9.95 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.937 0.875 . . . . 0.0 111.882 177.124 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 8.9 t -153.34 162.11 41.63 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 113.981 -1.463 . . . . 0.0 109.131 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 14.5 m-90 -76.17 95.47 3.69 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 120.884 0.373 . . . . 0.0 110.38 -177.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.562 ' HB3' ' HB3' ' A' ' 329' ' ' GLU . 59.4 tttm -65.68 -46.62 78.39 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 165.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.62 ' HB3' ' HB2' ' A' ' 329' ' ' GLU . 40.7 ttt180 -153.09 128.32 9.81 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 114.45 -1.25 . . . . 0.0 108.864 169.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . 0.516 ' HB1' ' CG ' ' A' ' 390' ' ' HIS . . . -74.45 160.93 80.09 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-O 118.757 -0.64 . . . . 0.0 109.871 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . 0.948 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 85.5 Cg_exo -36.87 108.87 0.06 OUTLIER 'Trans proline' 0 C--N 1.362 1.282 0 C-N-CA 123.149 2.566 . . . . 0.0 113.36 -178.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 18.6 m -127.44 132.86 49.99 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.944 -175.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . 0.571 ' HB2' ' CZ2' ' A' ' 392' ' ' TRP . 13.5 t70 -55.61 124.95 19.06 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 177.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 60.0 p -62.98 -46.73 86.32 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 121.411 0.624 . . . . 0.0 110.116 -173.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 122.8 -7.94 9.38 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -124.47 56.79 1.27 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.141 -0.529 . . . . 0.0 110.703 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . 0.587 ' HA ' ' HD3' ' A' ' 395' ' ' LYS . 21.5 m-20 56.87 31.19 19.22 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.458 176.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . 0.54 ' HB ' HG13 ' A' ' 358' ' ' ILE . 15.7 p -150.67 -179.26 7.1 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -178.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 1.3 t -129.57 144.42 38.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.178 0.513 . . . . 0.0 110.973 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' VAL . . . . . 0.641 HG12 ' HG2' ' A' ' 373' ' ' GLU . 16.7 m -120.06 154.48 23.04 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.336 176.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' MET . . . . . 0.536 ' SD ' HG13 ' A' ' 330' ' ' VAL . 0.0 OUTLIER -143.15 147.07 34.35 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 176.722 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.62 ' HB2' ' HB3' ' A' ' 316' ' ' ARG . 9.0 mt-10 -130.32 128.13 40.88 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 121.076 0.465 . . . . 0.0 110.957 -176.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.536 HG13 ' SD ' ' A' ' 328' ' ' MET . 0.0 OUTLIER -128.35 149.8 33.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.928 -175.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . 0.662 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -128.72 141.78 12.9 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.503 -0.856 . . . . 0.0 113.094 -179.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . 0.721 ' HE1' ' HD2' ' A' ' 312' ' ' PHE . 3.5 m-85 -112.81 178.03 4.43 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.358 0.663 . . . . 0.0 111.041 174.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 50.7 m -136.03 4.41 2.98 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 170.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -145.68 -62.93 0.01 OUTLIER Glycine 0 C--N 1.34 0.767 0 C-N-CA 119.029 -1.558 . . . . 0.0 114.768 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' THR . . . . . 0.441 HG22 ' HB3' ' A' ' 338' ' ' CYS . 13.9 m -53.95 132.46 42.16 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.122 0.487 . . . . 0.0 111.11 -175.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.882 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 2.8 ptm180 -82.29 -176.76 0.83 Allowed Pre-proline 0 C--O 1.226 -0.133 0 CA-C-O 117.981 -1.009 . . . . 0.0 108.952 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.882 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.4 OUTLIER -31.7 98.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 123.264 2.643 . . . . 0.0 112.802 174.172 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' CYS . . . . . 0.596 ' HB2' ' O ' ' A' ' 305' ' ' THR . 26.3 p -119.91 -174.25 2.72 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 113.522 -1.672 . . . . 0.0 109.578 -170.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -108.96 107.12 17.37 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -178.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . 0.884 HD12 ' HB2' ' A' ' 362' ' ' PRO . 32.9 mt -73.26 120.12 79.37 Favored Pre-proline 0 C--N 1.329 -0.313 0 C-N-CA 120.12 -0.632 . . . . 0.0 110.963 -173.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -77.11 80.36 2.89 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.187 1.925 . . . . 0.0 111.202 175.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.698 HG13 HG22 ' A' ' 340' ' ' ILE . 11.7 m -97.41 146.3 7.89 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.662 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.091 178.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.453 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 24.4 ptt180 -163.82 171.98 14.72 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 172.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -147.97 143.66 27.46 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.797 177.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.416 ' HB ' ' HA ' ' A' ' 350' ' ' PRO . 6.2 m -115.96 144.39 23.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 177.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -63.23 117.13 6.14 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 116.279 -0.418 . . . . 0.0 112.014 177.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . 0.729 ' HB3' ' HB2' ' A' ' 380' ' ' ASP . 11.6 p80 30.37 75.5 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.892 0 O-C-N 124.721 1.263 . . . . 0.0 113.671 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . 0.768 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 53.64 28.44 37.83 Favored Glycine 0 CA--C 1.519 0.337 0 N-CA-C 115.69 1.036 . . . . 0.0 115.69 178.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 347' ' ' HIS . 46.9 t -137.15 101.79 9.2 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 118.948 1.374 . . . . 0.0 108.731 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . 0.416 ' HA ' ' HB ' ' A' ' 345' ' ' VAL . 15.2 Cg_exo -73.06 66.51 4.17 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 123.112 2.542 . . . . 0.0 112.865 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -99.87 -55.39 2.66 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.282 -1.006 . . . . 0.0 108.282 177.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 4.7 p -130.1 136.2 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.215 174.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . 0.478 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 52.1 t30 -63.18 117.82 7.07 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.187 177.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . . . . . . . . . 30.5 m -95.25 5.1 8.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.844 176.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . 0.4 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -77.47 84.16 3.87 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.235 0.541 . . . . 0.0 111.405 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.94 102.9 14.77 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 170.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.571 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 32.3 mt -83.45 117.93 23.4 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.41 -162.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.697 HD11 ' HB3' ' A' ' 375' ' ' GLN . 4.4 mm -59.54 -29.12 41.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.358 173.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 12.6 m -131.91 94.12 25.55 Favored Pre-proline 0 N--CA 1.446 -0.672 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.573 172.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -81.83 34.6 0.55 Allowed 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 123.522 2.815 . . . . 0.0 112.899 -173.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -151.63 70.68 8.11 Favored Pre-proline 0 C--N 1.316 -0.889 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.98 177.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . 0.983 ' HB3' HG23 ' A' ' 372' ' ' ILE . 60.3 Cg_endo -80.88 141.02 13.1 Favored 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 122.313 2.008 . . . . 0.0 111.314 175.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' THR . . . . . 0.611 ' O ' ' HA2' ' A' ' 369' ' ' GLY . 1.0 OUTLIER -143.66 143.25 31.36 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -174.11 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' MET . . . . . 0.807 ' HA ' ' HA2' ' A' ' 369' ' ' GLY . 5.2 mmt -110.87 142.18 43.27 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -178.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.496 ' HG2' ' HG3' ' A' ' 337' ' ' PRO . 27.2 mt-10 -125.64 -168.5 1.85 Allowed 'General case' 0 C--N 1.318 -0.772 0 O-C-N 123.398 0.436 . . . . 0.0 110.953 175.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . 0.461 HD22 ' N ' ' A' ' 366' ' ' ASN . 0.1 OUTLIER -43.25 -31.85 0.68 Allowed 'General case' 0 N--CA 1.472 0.626 0 O-C-N 124.232 0.958 . . . . 0.0 113.221 -179.037 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -111.03 -1.46 16.28 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -177.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . 0.662 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . 124.81 178.66 15.41 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.257 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . 0.807 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -68.07 -24.99 74.58 Favored Glycine 0 C--N 1.333 0.368 0 N-CA-C 114.132 0.413 . . . . 0.0 114.132 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . 0.591 ' O ' ' HG2' ' A' ' 329' ' ' GLU . . . 85.37 -58.15 4.91 Favored Glycine 0 C--N 1.318 -0.417 0 C-N-CA 120.143 -1.027 . . . . 0.0 113.313 178.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 35.0 p90 -165.87 145.84 6.45 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.14 0.495 . . . . 0.0 112.173 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 372' ' ' ILE . . . . . 0.983 HG23 ' HB3' ' A' ' 362' ' ' PRO . 0.7 OUTLIER -136.13 156.25 36.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.451 171.441 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.641 ' HG2' HG12 ' A' ' 327' ' ' VAL . 42.5 mt-10 -134.4 126.54 29.77 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -178.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . 0.571 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 2.9 mtt -142.65 165.03 28.49 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -176.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 375' ' ' GLN . . . . . 0.863 ' HA ' HE21 ' A' ' 375' ' ' GLN . 0.0 OUTLIER -178.62 173.45 1.3 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.784 0.326 . . . . 0.0 110.296 176.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 376' ' ' LEU . . . . . 0.722 HD22 ' HD2' ' A' ' 377' ' ' PRO . 2.0 tm? -165.62 139.62 3.79 Favored Pre-proline 0 C--N 1.318 -0.785 0 N-CA-C 104.44 -2.43 . . . . 0.0 104.44 -177.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 377' ' ' PRO . . . . . 0.722 ' HD2' HD22 ' A' ' 376' ' ' LEU . 37.8 Cg_exo -33.89 129.63 0.16 Allowed 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.761 2.307 . . . . 0.0 112.299 175.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.758 ' HA ' HE22 ' A' ' 394' ' ' GLN . 75.8 Cg_exo -34.03 138.85 0.08 OUTLIER 'Trans proline' 0 C--N 1.362 1.243 0 C-N-CA 124.926 3.75 . . . . 0.0 113.932 -170.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 155.32 -158.38 28.38 Favored Glycine 0 N--CA 1.441 -0.975 0 N-CA-C 109.112 -1.595 . . . . 0.0 109.112 -163.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . 0.729 ' HB2' ' HB3' ' A' ' 347' ' ' HIS . 8.9 m-20 -109.32 132.79 53.8 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 118.149 0.974 . . . . 0.0 111.522 175.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -126.25 168.7 13.73 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 176.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 1.053 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -160.05 138.49 2.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 168.048 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . 0.614 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 57.6 mt -99.16 128.81 50.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 C-N-CA 120.074 -0.65 . . . . 0.0 109.926 -173.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' TYR . . . . . 0.453 ' O ' ' HG2' ' A' ' 343' ' ' ARG . 0.2 OUTLIER -104.26 99.57 9.29 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 114.302 -1.317 . . . . 0.0 108.791 170.771 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . 0.499 ' O ' ' HB2' ' A' ' 388' ' ' LEU . 11.5 t -94.77 88.21 2.17 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.123 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 174.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 67.82 -116.99 8.24 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.123 -1.037 . . . . 0.0 110.851 -174.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -92.43 -4.26 53.98 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 117.783 0.792 . . . . 0.0 111.684 171.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.846 HD13 ' HD1' ' A' ' 312' ' ' PHE . 2.5 mp -71.15 150.79 45.05 Favored 'General case' 0 CA--C 1.522 -0.113 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 172.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . 0.614 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 7.3 p30 -164.44 152.22 12.11 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.651 -179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . 0.948 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 30.5 t60 -175.56 119.5 0.17 Allowed 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.493 0.495 . . . . 0.0 110.4 176.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' GLN . . . . . 1.053 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 15.0 tt0 -78.03 153.24 32.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.404 0.621 . . . . 0.0 112.582 -179.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' TRP . . . . . 0.571 ' CZ2' ' HB2' ' A' ' 320' ' ' ASP . 52.7 t-105 -153.49 143.59 22.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.884 178.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 14.1 p90 -104.48 110.03 22.14 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 176.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.758 HE22 ' HA ' ' A' ' 378' ' ' PRO . 0.0 OUTLIER -101.23 134.34 44.43 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 121.822 -0.549 . . . . 0.0 111.617 -164.847 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.587 ' HD3' ' HA ' ' A' ' 324' ' ' ASP . 13.2 mmmm . . . . . 0 C--O 1.245 0.824 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.794 -178.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 7.5 t . . . . . 0 CA--C 1.537 0.446 0 CA-C-O 121.12 0.486 . . . . 0.0 111.799 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . 0.636 ' HB2' ' O ' ' A' ' 337' ' ' PRO . 39.7 p90 -67.1 129.59 40.38 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.467 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 12.4 t 173.02 -167.18 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -170.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 7.8 p -62.09 112.17 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 172.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -73.54 137.75 44.56 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.175 -173.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . 0.738 ' OD1' HG22 ' A' ' 310' ' ' THR . 9.4 t70 -60.36 119.9 8.84 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.034 177.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.506 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 29.0 pttt -42.09 -22.45 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 115.961 1.837 . . . . 0.0 115.961 -175.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.738 HG22 ' OD1' ' A' ' 308' ' ' ASP . 6.2 t -107.54 12.44 27.73 Favored 'General case' 0 C--N 1.314 -0.959 0 O-C-N 121.331 -0.856 . . . . 0.0 111.206 -170.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.459 ' HE3' ' OG1' ' A' ' 335' ' ' THR . 19.9 mtmm -96.37 -22.94 16.87 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -174.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.539 ' HA ' ' O ' ' A' ' 331' ' ' GLY . 0.1 OUTLIER -85.86 174.62 9.17 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.517 0.675 . . . . 0.0 110.957 176.678 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 13.2 t -147.83 158.46 44.04 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.791 -1.095 . . . . 0.0 109.34 -177.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . 0.496 ' HZ3' ' HB2' ' A' ' 328' ' ' MET . 19.2 m95 -79.44 95.61 5.83 Favored 'General case' 0 CA--C 1.51 -0.584 0 CA-C-O 121.018 0.437 . . . . 0.0 110.775 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.555 ' HG2' ' OE1' ' A' ' 329' ' ' GLU . 4.3 ttpp -69.91 -43.49 71.6 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 169.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 3.8 ttm180 -153.04 101.85 2.6 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.634 174.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -41.49 154.77 0.23 Allowed Pre-proline 0 N--CA 1.476 0.83 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 171.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . 0.461 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 3.8 Cg_exo -38.17 114.17 0.16 Allowed 'Trans proline' 0 C--N 1.366 1.493 0 C-N-CA 123.777 2.985 . . . . 0.0 113.228 -176.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 16.9 m -134.38 137.39 44.07 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.32 -174.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -59.17 131.32 50.67 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -177.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . 0.641 ' HB3' HG13 ' A' ' 327' ' ' VAL . 51.5 p -80.34 5.86 13.66 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 122.149 -0.344 . . . . 0.0 111.6 -175.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 74.0 -22.34 1.22 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.986 -0.626 . . . . 0.0 113.105 -175.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . 0.411 ' H ' ' C ' ' A' ' 321' ' ' SER . 94.7 m-70 -102.33 47.77 0.89 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.381 0.61 . . . . 0.0 110.328 -177.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . 0.431 ' O ' HG23 ' A' ' 325' ' ' THR . 4.9 t70 55.94 39.18 30.59 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 114.403 -1.272 . . . . 0.0 111.659 174.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . 0.431 HG23 ' O ' ' A' ' 324' ' ' ASP . 4.0 p -160.29 -171.59 3.24 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 -179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.766 ' HB ' ' SD ' ' A' ' 374' ' ' MET . 0.3 OUTLIER -132.57 146.2 33.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.546 0.689 . . . . 0.0 111.558 -175.125 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' VAL . . . . . 0.677 HG12 ' HG2' ' A' ' 373' ' ' GLU . 14.9 m -122.61 157.81 27.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.276 175.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' MET . . . . . 0.631 ' SD ' HD13 ' A' ' 383' ' ' ILE . 0.0 OUTLIER -135.62 146.67 48.14 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 173.223 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.555 ' OE1' ' HG2' ' A' ' 315' ' ' LYS . 9.5 tt0 -120.67 122.4 40.39 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -177.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 2.7 m -128.76 151.56 35.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.521 0.201 . . . . 0.0 111.301 -176.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . 0.826 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -126.84 139.4 11.22 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.478 -177.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . 0.434 ' H ' ' HA2' ' A' ' 368' ' ' GLY . 0.8 OUTLIER -89.37 152.88 21.27 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.367 0.603 . . . . 0.0 111.858 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 8.7 t -107.39 2.12 24.15 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 174.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -173.38 -63.6 0.05 OUTLIER Glycine 0 C--N 1.341 0.834 0 C-N-CA 118.676 -1.726 . . . . 0.0 115.144 175.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' THR . . . . . 0.459 ' OG1' ' HE3' ' A' ' 311' ' ' LYS . 51.5 m -52.46 134.13 34.96 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 123.805 0.356 . . . . 0.0 111.251 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.644 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 16.1 ptt180 -90.62 -175.95 0.58 Allowed Pre-proline 0 CA--C 1.536 0.429 0 CA-C-O 117.212 -1.375 . . . . 0.0 108.624 -175.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.7 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.1 OUTLIER -24.07 96.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 124.061 3.174 . . . . 0.0 114.65 -170.869 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' CYS . . . . . 0.734 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 3.9 p -109.95 -176.05 2.9 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 113.719 -1.582 . . . . 0.0 110.32 -169.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -112.16 96.3 5.95 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 177.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . 0.762 HG22 HG13 ' A' ' 342' ' ' VAL . 61.9 mt -78.18 118.86 74.79 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.302 -169.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -79.65 82.46 2.49 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.837 2.358 . . . . 0.0 111.903 177.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.762 HG13 HG22 ' A' ' 340' ' ' ILE . 4.2 m -100.94 123.68 54.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.504 0.669 . . . . 0.0 110.669 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 25.3 ptt180 -132.07 173.97 10.67 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 176.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' ALA . . . . . 0.542 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -144.96 140.97 28.6 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.718 175.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.521 HG22 HD12 ' A' ' 382' ' ' ILE . 10.6 m -114.62 140.59 34.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.423 ' HB2' ' CG1' ' A' ' 354' ' ' VAL . . . -67.62 121.4 15.81 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 112.674 0.62 . . . . 0.0 112.674 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . 0.574 ' O ' HG23 ' A' ' 349' ' ' VAL . 6.9 t60 46.62 59.79 3.7 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 124.336 1.022 . . . . 0.0 111.038 174.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . 0.473 ' H ' ' CG2' ' A' ' 382' ' ' ILE . . . 45.86 39.16 8.4 Favored Glycine 0 C--N 1.335 0.515 0 N-CA-C 115.097 0.799 . . . . 0.0 115.097 -174.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 347' ' ' HIS . 58.9 t -137.35 102.19 8.94 Favored Pre-proline 0 C--O 1.235 0.301 0 CA-C-N 118.219 1.009 . . . . 0.0 108.949 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -75.82 61.38 6.28 Favored 'Trans proline' 0 N--CA 1.464 -0.209 0 C-N-CA 122.802 2.334 . . . . 0.0 113.245 -178.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -100.51 -56.76 2.26 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 175.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 2.3 p -117.48 127.49 74.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.535 174.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 55.9 t30 -63.38 112.08 2.57 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.774 175.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.654 HG12 ' HG ' ' A' ' 376' ' ' LEU . 4.2 m -92.68 9.02 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.713 177.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . 0.542 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -79.17 82.97 5.28 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.147 0.498 . . . . 0.0 111.041 176.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 5.4 tmm? -92.92 100.5 12.95 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 169.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 22.2 mt -86.89 117.87 25.9 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.072 -163.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.73 ' HB ' ' CB ' ' A' ' 373' ' ' GLU . 2.7 mm -61.46 -25.03 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.375 0 CA-C-N 114.824 -1.08 . . . . 0.0 108.632 175.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 19.5 m -138.91 93.72 10.41 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 114.591 -1.186 . . . . 0.0 108.828 173.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -88.61 41.1 0.57 Allowed 'Trans proline' 0 N--CA 1.462 -0.347 0 C-N-CA 123.275 2.65 . . . . 0.0 114.063 -171.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -161.83 72.48 2.41 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-O 121.235 0.54 . . . . 0.0 109.779 175.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . 0.872 ' HB3' HG23 ' A' ' 372' ' ' ILE . 87.8 Cg_endo -82.58 108.57 1.71 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.79 2.327 . . . . 0.0 112.302 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 16.8 p -89.78 144.28 26.1 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.671 0.748 . . . . 0.0 112.326 171.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' MET . . . . . 0.734 ' HG2' ' SG ' ' A' ' 338' ' ' CYS . 5.7 ptp -93.94 125.39 38.54 Favored 'General case' 0 CA--C 1.499 -0.981 0 CA-C-N 114.387 -1.279 . . . . 0.0 108.153 174.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.485 ' HG2' ' HG3' ' A' ' 337' ' ' PRO . 33.6 mt-10 -126.52 -163.39 1.23 Allowed 'General case' 0 C--N 1.315 -0.921 0 O-C-N 124.511 1.132 . . . . 0.0 110.344 -172.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -48.37 -23.95 1.08 Allowed 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 -171.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -112.32 -1.98 14.95 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 118.828 0.74 . . . . 0.0 110.967 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . 0.826 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . 115.11 -168.21 12.51 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -172.275 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -48.23 -34.31 12.47 Favored Glycine 0 CA--C 1.519 0.313 0 CA-C-N 117.725 0.763 . . . . 0.0 113.303 172.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . 0.49 ' O ' ' HG3' ' A' ' 329' ' ' GLU . . . 81.53 -58.17 4.88 Favored Glycine 0 C--O 1.227 -0.314 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.584 176.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -165.19 137.82 4.42 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.043 0.449 . . . . 0.0 111.125 178.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 372' ' ' ILE . . . . . 0.872 HG23 ' HB3' ' A' ' 362' ' ' PRO . 0.9 OUTLIER -134.4 159.1 42.12 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.721 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 172.846 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.73 ' CB ' ' HB ' ' A' ' 358' ' ' ILE . 36.5 mt-10 -128.21 125.92 39.94 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.581 -177.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . 0.766 ' SD ' ' HB ' ' A' ' 326' ' ' VAL . 0.0 OUTLIER -136.43 160.37 38.97 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -179.083 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 375' ' ' GLN . . . . . 0.9 ' HA ' HE21 ' A' ' 375' ' ' GLN . 0.0 OUTLIER -177.91 170.11 1.93 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.918 0.39 . . . . 0.0 110.208 172.592 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 376' ' ' LEU . . . . . 0.75 HD22 ' HD2' ' A' ' 377' ' ' PRO . 2.3 tm? -166.93 131.81 1.66 Allowed Pre-proline 0 N--CA 1.439 -0.991 0 N-CA-C 104.537 -2.394 . . . . 0.0 104.537 -178.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 377' ' ' PRO . . . . . 0.75 ' HD2' HD22 ' A' ' 376' ' ' LEU . 35.7 Cg_exo -28.95 131.0 0.04 OUTLIER 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 123.788 2.992 . . . . 0.0 112.811 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -35.56 138.21 0.15 Allowed 'Trans proline' 0 C--N 1.359 1.106 0 C-N-CA 124.658 3.572 . . . . 0.0 113.582 -166.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 151.87 -165.07 30.56 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.174 -1.17 . . . . 0.0 110.174 -160.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . 0.471 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 15.8 m-20 -99.7 128.78 45.8 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 117.925 0.862 . . . . 0.0 111.23 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.433 HD21 ' HB3' ' A' ' 376' ' ' LEU . 9.5 m120 -128.43 159.79 34.3 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 174.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 1.024 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -150.55 139.1 14.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.24 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 170.313 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . 0.668 HD11 ' SD ' ' A' ' 374' ' ' MET . 31.5 mt -99.51 127.02 52.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.44 -176.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' TYR . . . . . 0.444 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.2 OUTLIER -104.41 92.54 4.37 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 114.719 -1.128 . . . . 0.0 108.226 174.017 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . 0.529 ' O ' ' HB2' ' A' ' 388' ' ' LEU . 20.3 t -85.13 86.19 2.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 178.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 60.46 -112.57 4.66 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.287 -0.959 . . . . 0.0 111.341 -170.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' ASP . . . . . 0.408 ' N ' ' HB2' ' A' ' 309' ' ' LYS . 4.9 t70 -82.86 -17.05 45.23 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.008 0.432 . . . . 0.0 110.793 176.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.529 ' HB2' ' O ' ' A' ' 385' ' ' VAL . 2.3 mp -69.38 151.83 45.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.209 177.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . 0.657 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 7.6 p30 -165.37 153.34 11.24 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.575 176.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . 0.461 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 35.5 t-80 -173.74 113.74 0.21 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.323 177.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' GLN . . . . . 1.024 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 13.6 tt0 -73.65 154.62 39.64 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.293 177.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' TRP . . . . . 0.553 ' HD1' ' OE1' ' A' ' 394' ' ' GLN . 17.8 t-105 -166.63 150.99 7.41 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.77 177.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -105.33 115.89 31.03 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.775 ' HG3' HE22 ' A' ' 375' ' ' GLN . 3.5 mm100 -84.4 113.96 21.55 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -170.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 1.7 ptmm? . . . . . 0 C--O 1.251 1.172 0 CA-C-O 118.442 -0.79 . . . . 0.0 110.818 -178.252 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . 0.54 HG23 HG23 ' A' ' 335' ' ' THR . 10.4 t . . . . . 0 CA--C 1.539 0.543 0 CA-C-O 121.949 0.881 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -69.84 116.38 10.16 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 175.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.587 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 13.0 t 177.38 -172.32 0.1 Allowed 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -172.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 56.2 t -65.81 110.59 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 169.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . 1.009 ' HB3' HG21 ' A' ' 335' ' ' THR . 0.0 OUTLIER -68.37 135.83 52.41 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.966 0.413 . . . . 0.0 110.43 -169.886 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . 0.603 ' OD1' HG22 ' A' ' 310' ' ' THR . 17.1 t70 -64.32 126.16 26.91 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.31 -174.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.501 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -47.9 -17.74 0.13 Allowed 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 -168.85 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.603 HG22 ' OD1' ' A' ' 308' ' ' ASP . 11.8 t -108.92 3.28 22.12 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 119.88 1.218 . . . . 0.0 111.999 -173.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 23.8 mtpp -78.51 -30.91 47.41 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -173.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.504 ' HE1' ' HB2' ' A' ' 307' ' ' CYS . 0.0 OUTLIER -79.77 176.32 9.82 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-O 122.198 0.999 . . . . 0.0 111.821 -173.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 8.8 t -148.66 156.93 43.06 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 113.487 -1.688 . . . . 0.0 107.995 178.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 27.6 m-90 -68.66 121.19 15.93 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.409 ' HB3' ' C ' ' A' ' 329' ' ' GLU . 54.4 tptt -103.13 -41.94 5.93 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 173.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 41.6 ttp180 -154.83 130.62 10.03 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.308 170.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -69.31 162.09 68.71 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.631 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . 0.737 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 53.8 Cg_exo -46.13 111.39 0.34 Allowed 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 122.311 2.007 . . . . 0.0 112.087 177.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . 0.457 ' C ' HG13 ' A' ' 326' ' ' VAL . 17.2 m -130.08 132.7 46.27 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.655 -172.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -54.99 124.74 17.72 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 178.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . 0.502 ' C ' ' H ' ' A' ' 323' ' ' HIS . 23.8 p -75.71 0.96 15.96 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.756 0.422 . . . . 0.0 111.848 -170.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 72.57 -26.91 0.73 Allowed Glycine 0 C--N 1.331 0.29 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.453 -169.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . 0.502 ' H ' ' C ' ' A' ' 321' ' ' SER . 30.4 t60 -95.87 44.6 1.08 Allowed 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 121.087 0.47 . . . . 0.0 109.789 -175.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 17.5 t70 59.12 31.51 21.35 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.001 175.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . 0.848 ' HA ' ' HG3' ' A' ' 375' ' ' GLN . 4.6 p -152.05 -171.88 4.06 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -178.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.457 HG13 ' C ' ' A' ' 319' ' ' THR . 48.2 t -137.71 129.17 39.65 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.611 0 CA-C-N 118.466 0.575 . . . . 0.0 111.085 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' VAL . . . . . 0.527 HG12 ' HG2' ' A' ' 373' ' ' GLU . 12.5 m -107.46 163.07 5.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.524 -178.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' MET . . . . . 0.549 ' SD ' HG13 ' A' ' 330' ' ' VAL . 0.0 OUTLIER -145.65 154.61 42.3 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 174.433 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.428 ' HG3' ' O ' ' A' ' 370' ' ' GLY . 16.5 tt0 -133.28 130.53 39.07 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.387 -175.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.549 HG13 ' SD ' ' A' ' 328' ' ' MET . 0.2 OUTLIER -130.01 153.31 38.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.839 -178.277 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . 0.414 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -121.18 137.12 11.62 Favored Glycine 0 CA--C 1.522 0.484 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.852 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . 0.458 ' HD2' ' N ' ' A' ' 335' ' ' THR . 1.3 p90 -88.05 155.85 19.6 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.673 0.749 . . . . 0.0 112.768 -178.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 28.3 p -115.69 20.93 14.32 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.76 -1.109 . . . . 0.0 112.764 169.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 164.24 -14.11 0.09 OUTLIER Glycine 0 N--CA 1.465 0.588 0 C-N-CA 120.112 -1.042 . . . . 0.0 113.846 173.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' THR . . . . . 1.009 HG21 ' HB3' ' A' ' 307' ' ' CYS . 0.2 OUTLIER -85.99 118.42 25.46 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 179.656 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 336' ' ' ARG . 4.8 ptp180 -100.22 178.94 1.12 Allowed Pre-proline 0 N--CA 1.451 -0.421 0 CA-C-O 116.549 -1.691 . . . . 0.0 106.475 174.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.57 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.1 OUTLIER -23.26 91.04 0.0 OUTLIER 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 123.736 2.957 . . . . 0.0 114.387 -164.047 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' CYS . . . . . 0.587 ' HB2' ' O ' ' A' ' 305' ' ' THR . 14.2 p -115.41 -176.74 2.98 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 112.68 -2.055 . . . . 0.0 109.303 -170.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? -111.4 101.8 10.23 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . 0.763 HG22 HG13 ' A' ' 342' ' ' VAL . 59.1 mt -72.95 118.78 71.32 Favored Pre-proline 0 C--N 1.325 -0.488 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.515 -170.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -74.18 79.24 2.44 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 121.969 1.78 . . . . 0.0 110.644 175.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.763 HG13 HG22 ' A' ' 340' ' ' ILE . 1.1 m -103.13 122.91 56.18 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.86 0 CA-C-O 121.874 0.845 . . . . 0.0 111.076 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.518 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 15.4 ptt180 -135.62 176.77 8.37 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 114.046 -1.434 . . . . 0.0 108.029 175.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' ALA . . . . . 0.503 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -148.66 144.31 27.07 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.554 175.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.436 ' O ' HG23 ' A' ' 382' ' ' ILE . 11.6 m -117.09 144.9 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 176.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -68.66 116.08 8.77 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 178.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . 0.627 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 12.2 t60 40.64 67.68 0.49 Allowed 'General case' 0 N--CA 1.478 0.96 0 O-C-N 124.399 1.062 . . . . 0.0 111.519 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . 0.76 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 40.96 48.19 4.21 Favored Glycine 0 C--N 1.332 0.353 0 N-CA-C 115.206 0.842 . . . . 0.0 115.206 -174.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . 0.699 HG12 ' HG2' ' A' ' 351' ' ' GLU . 61.8 t -141.43 101.5 6.12 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 118.173 0.986 . . . . 0.0 108.457 176.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -80.53 72.3 6.6 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 123.131 2.554 . . . . 0.0 113.679 -176.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . 0.699 ' HG2' HG12 ' A' ' 349' ' ' VAL . 4.8 mm-40 -99.52 -58.04 2.02 Favored 'General case' 0 CA--C 1.502 -0.9 0 CA-C-O 122.6 1.191 . . . . 0.0 107.937 171.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . 0.455 HG12 ' HB2' ' A' ' 351' ' ' GLU . 1.1 p -125.47 127.17 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 CA-C-N 112.644 -2.071 . . . . 0.0 110.127 -177.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -62.64 114.44 3.58 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.998 178.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.646 ' HB ' ' OD1' ' A' ' 381' ' ' ASN . 3.5 m -94.05 6.62 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.426 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.131 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . 0.503 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -74.67 83.13 2.08 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.886 0.374 . . . . 0.0 111.33 179.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 356' ' ' MET . . . . . 0.634 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 37.0 ttm -94.9 98.31 10.62 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 171.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.639 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 42.8 mt -87.46 123.92 32.89 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.802 -162.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.776 HD11 ' HB2' ' A' ' 375' ' ' GLN . 2.3 mm -62.88 -23.6 33.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.526 173.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 8.3 m -132.38 92.18 28.92 Favored Pre-proline 0 N--CA 1.447 -0.582 0 CA-C-N 114.499 -1.228 . . . . 0.0 108.547 170.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -86.41 28.77 0.53 Allowed 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.133 2.555 . . . . 0.0 112.466 -175.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -156.9 65.66 3.75 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 114.77 -1.104 . . . . 0.0 109.217 177.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . 0.712 ' HB2' HD12 ' A' ' 340' ' ' ILE . 87.2 Cg_endo -86.03 114.6 1.36 Allowed 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.5 2.134 . . . . 0.0 111.991 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' THR . . . . . 0.407 HG22 ' O ' ' A' ' 338' ' ' CYS . 15.1 p -92.64 147.08 23.17 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 171.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' MET . . . . . 0.749 ' HA ' ' HA2' ' A' ' 369' ' ' GLY . 46.6 mtt -95.78 134.42 38.75 Favored 'General case' 0 CA--C 1.499 -1.009 0 CA-C-N 113.936 -1.484 . . . . 0.0 108.449 172.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.549 ' HA ' ' HD3' ' A' ' 337' ' ' PRO . 45.9 mt-10 -117.16 -167.66 1.34 Allowed 'General case' 0 C--N 1.32 -0.676 0 O-C-N 123.939 0.774 . . . . 0.0 111.22 -176.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . 0.538 HD22 ' N ' ' A' ' 367' ' ' ASN . 0.2 OUTLIER -59.39 -6.83 1.11 Allowed 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 179.631 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' ASN . . . . . 0.538 ' N ' HD22 ' A' ' 366' ' ' ASN . 7.6 p30 -113.49 -2.08 13.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.362 0.601 . . . . 0.0 109.906 178.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . 0.414 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . 109.98 -176.6 19.32 Favored Glycine 0 N--CA 1.451 -0.356 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -172.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . 0.749 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -46.64 -40.89 12.17 Favored Glycine 0 CA--C 1.519 0.305 0 CA-C-N 117.588 0.694 . . . . 0.0 113.476 173.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . 0.428 ' O ' ' HG3' ' A' ' 329' ' ' GLU . . . 83.28 -51.17 4.53 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.152 177.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -166.01 143.79 5.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.921 0.391 . . . . 0.0 111.616 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 372' ' ' ILE . . . . . 0.627 HD13 HG11 ' A' ' 342' ' ' VAL . 0.9 OUTLIER -134.71 151.46 31.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 170.398 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.66 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 44.5 mt-10 -128.75 126.86 40.87 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.815 0.34 . . . . 0.0 110.355 -178.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . 0.821 ' HG2' HD11 ' A' ' 383' ' ' ILE . 4.2 ppp? -137.3 165.1 26.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.589 -178.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 375' ' ' GLN . . . . . 0.848 ' HG3' ' HA ' ' A' ' 325' ' ' THR . 0.3 OUTLIER -177.32 -179.9 0.91 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.303 0.573 . . . . 0.0 111.692 168.954 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 376' ' ' LEU . . . . . 0.701 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 13.1 tp -167.96 155.0 7.68 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 178.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 377' ' ' PRO . . . . . 0.701 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 82.8 Cg_exo -45.53 131.67 12.49 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 121.287 1.325 . . . . 0.0 110.046 167.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.553 ' HA ' ' NE2' ' A' ' 394' ' ' GLN . 4.0 Cg_exo -35.07 141.12 0.09 OUTLIER 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 125.103 3.869 . . . . 0.0 113.979 -171.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 152.64 -167.37 31.49 Favored Glycine 0 N--CA 1.446 -0.693 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 -163.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . 0.627 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 5.0 m-20 -99.4 124.31 44.43 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 117.548 0.674 . . . . 0.0 111.395 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.646 ' OD1' ' HB ' ' A' ' 354' ' ' VAL . 15.9 m-80 -134.19 141.64 47.12 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 0.963 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -142.58 137.05 28.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -179.837 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . 0.821 HD11 ' HG2' ' A' ' 374' ' ' MET . 47.6 mt -98.25 127.83 50.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 C-N-CA 119.887 -0.725 . . . . 0.0 109.751 -172.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' TYR . . . . . 0.518 ' O ' ' HG2' ' A' ' 343' ' ' ARG . 0.3 OUTLIER -104.98 91.42 3.8 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.197 173.469 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 9.3 t -83.34 90.27 2.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 61.45 -113.26 5.52 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.461 -0.876 . . . . 0.0 111.027 -170.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -88.11 -16.36 33.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.759 0.314 . . . . 0.0 110.883 175.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.437 HD13 ' HD2' ' A' ' 312' ' ' PHE . 0.9 OUTLIER -69.51 155.69 40.07 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.191 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . 0.64 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 28.2 p-10 -165.98 157.3 13.66 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.778 177.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . 0.737 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 6.8 t60 -174.55 120.98 0.25 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.202 174.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' GLN . . . . . 0.963 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 21.3 tt0 -75.35 149.51 38.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.438 0.637 . . . . 0.0 112.115 -177.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' TRP . . . . . . . . . . . . . 70.5 t-105 -146.12 143.35 29.27 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.426 177.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . 0.685 ' HD2' ' HE2' ' A' ' 395' ' ' LYS . 12.3 p90 -104.15 107.38 18.26 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 107.969 -1.122 . . . . 0.0 107.969 173.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.712 ' HG2' HE22 ' A' ' 375' ' ' GLN . 0.0 OUTLIER -94.33 123.05 37.49 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.805 0.812 . . . . 0.0 110.972 -170.836 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.685 ' HE2' ' HD2' ' A' ' 393' ' ' PHE . 48.6 mttm . . . . . 0 C--O 1.245 0.834 0 CA-C-N 114.464 -1.244 . . . . 0.0 108.911 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . 0.475 ' O ' HG23 ' A' ' 335' ' ' THR . 5.2 t . . . . . 0 CA--C 1.538 0.505 0 CA-C-O 121.486 0.66 . . . . 0.0 111.001 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -65.98 124.67 23.16 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.151 0.501 . . . . 0.0 110.023 177.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.501 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 14.3 t 175.79 -170.58 0.06 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.113 -171.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 61.3 t -63.64 108.86 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 168.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.56 142.14 55.29 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.747 0.308 . . . . 0.0 110.567 -169.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . 0.689 ' OD1' HG22 ' A' ' 310' ' ' THR . 16.1 t70 -64.46 131.91 48.48 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.813 0.816 . . . . 0.0 112.004 -170.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -37.72 -30.65 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 112.975 -1.921 . . . . 0.0 115.222 -177.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.689 HG22 ' OD1' ' A' ' 308' ' ' ASP . 11.6 t -105.19 -1.85 24.89 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 118.747 0.703 . . . . 0.0 112.376 -169.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . . . . . . . . . 27.0 mmmt -70.13 -35.05 73.79 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.284 0.564 . . . . 0.0 110.908 -178.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.635 ' HB3' ' HE1' ' A' ' 364' ' ' MET . 0.1 OUTLIER -90.47 177.64 6.32 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 122.296 1.046 . . . . 0.0 112.544 -174.553 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 14.2 t -161.8 168.86 22.41 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 113.534 -1.666 . . . . 0.0 108.978 -179.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . 0.4 ' CE3' ' HA ' ' A' ' 317' ' ' ALA . 92.9 m95 -83.91 96.72 8.91 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 121.371 0.605 . . . . 0.0 110.648 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.684 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 56.7 tttm -66.61 -40.13 88.69 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 167.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 61.4 ttt180 -158.9 131.79 7.05 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.333 168.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . 0.471 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -74.87 163.66 66.69 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.059 -176.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . 0.471 ' HD2' ' HB1' ' A' ' 317' ' ' ALA . 4.9 Cg_exo -37.64 116.05 0.19 Allowed 'Trans proline' 0 C--N 1.362 1.239 0 C-N-CA 123.58 2.853 . . . . 0.0 113.364 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 28.8 m -132.9 138.36 46.95 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.424 -176.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . 0.432 ' OD2' ' HZ2' ' A' ' 392' ' ' TRP . 45.5 m-20 -61.13 132.83 55.0 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -178.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . 0.449 ' HB3' HG13 ' A' ' 327' ' ' VAL . 60.3 p -71.52 1.58 6.3 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 122.492 0.317 . . . . 0.0 111.466 -174.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 70.52 -22.06 0.54 Allowed Glycine 0 CA--C 1.521 0.452 0 C-N-CA 121.438 -0.411 . . . . 0.0 113.642 -170.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . 0.6 ' O ' ' HB3' ' A' ' 324' ' ' ASP . 93.5 m-70 -77.67 -41.74 37.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.993 0.396 . . . . 0.0 111.7 -172.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . 0.6 ' HB3' ' O ' ' A' ' 323' ' ' HIS . 4.5 p-10 144.37 13.89 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.721 0 O-C-N 124.354 1.034 . . . . 0.0 109.89 -163.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . 0.455 ' HA ' ' HG2' ' A' ' 375' ' ' GLN . 6.5 p -150.13 -170.23 3.59 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -170.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 373' ' ' GLU . 1.4 t -130.04 148.71 33.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.173 0.511 . . . . 0.0 111.03 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' VAL . . . . . 0.694 HG12 ' HG2' ' A' ' 373' ' ' GLU . 19.1 m -128.7 157.42 41.36 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.982 178.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' MET . . . . . 0.649 ' HE2' HD12 ' A' ' 372' ' ' ILE . 23.1 ptt? -140.89 156.3 46.13 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 170.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.684 ' HG2' ' HD3' ' A' ' 315' ' ' LYS . 22.8 tt0 -121.8 119.12 30.75 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . . . . . . . . . 19.5 m -122.97 142.23 40.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 120.676 0.274 . . . . 0.0 110.792 -175.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . 0.537 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -125.49 138.28 10.82 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 120.247 -0.978 . . . . 0.0 113.199 -173.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . 0.848 ' HE2' ' HB ' ' A' ' 335' ' ' THR . 0.0 OUTLIER -147.61 163.13 37.56 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 176.114 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 15.1 m -151.96 44.48 0.74 Allowed 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 -174.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -139.34 -65.82 0.04 OUTLIER Glycine 0 C--N 1.331 0.258 0 C-N-CA 119.369 -1.396 . . . . 0.0 112.126 169.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' THR . . . . . 0.848 ' HB ' ' HE2' ' A' ' 332' ' ' PHE . 28.6 m -52.9 140.56 24.21 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.234 -0.983 . . . . 0.0 109.236 172.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.635 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 21.9 ptt180 -87.91 178.37 2.18 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 117.592 -1.194 . . . . 0.0 108.725 176.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.635 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 2.2 Cg_exo -27.65 104.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.372 1.776 0 C-N-CA 123.573 2.849 . . . . 0.0 113.58 -178.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' CYS . . . . . 0.584 ' SG ' ' HB2' ' A' ' 364' ' ' MET . 22.2 p -116.74 -174.3 2.55 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 113.882 -1.508 . . . . 0.0 110.286 -167.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 -111.71 101.6 9.96 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . 0.496 HG12 HG13 ' A' ' 342' ' ' VAL . 13.4 tt -77.61 121.93 85.05 Favored Pre-proline 0 C--N 1.325 -0.47 0 C-N-CA 119.118 -1.033 . . . . 0.0 110.849 -167.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -78.16 80.55 2.96 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.252 1.968 . . . . 0.0 111.954 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.604 HG12 HG13 ' A' ' 385' ' ' VAL . 30.2 m -106.07 153.31 7.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.355 -178.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.513 ' HG3' ' HB2' ' A' ' 384' ' ' TYR . 40.3 ptt180 -168.33 174.99 6.65 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -179.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' ALA . . . . . 0.549 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -149.81 144.36 25.95 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.931 -0.708 . . . . 0.0 110.885 177.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.547 ' HB ' ' HA ' ' A' ' 350' ' ' PRO . 4.6 m -116.72 147.09 20.33 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -69.53 125.59 27.17 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 176.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . 0.526 ' O ' HG23 ' A' ' 349' ' ' VAL . 5.0 t60 43.88 60.17 2.82 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 124.422 1.077 . . . . 0.0 111.665 172.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . 0.617 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 43.02 42.79 5.26 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 115.046 0.778 . . . . 0.0 115.046 -174.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 347' ' ' HIS . 75.5 t -139.98 101.8 7.0 Favored Pre-proline 0 C--N 1.331 -0.227 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . 0.547 ' HA ' ' HB ' ' A' ' 345' ' ' VAL . 12.5 Cg_exo -75.41 54.8 3.95 Favored 'Trans proline' 0 C--O 1.233 0.247 0 C-N-CA 122.913 2.408 . . . . 0.0 113.834 -176.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -100.15 -56.35 2.39 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 176.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.7 p -112.28 123.69 68.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.854 172.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . 0.549 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 6.1 t30 -65.8 122.25 16.89 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.371 174.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.459 HG21 ' HA ' ' A' ' 381' ' ' ASN . 29.1 m -97.56 4.51 9.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.143 176.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . 0.529 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -76.93 83.95 3.48 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.893 -179.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 356' ' ' MET . . . . . 0.683 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 53.3 ttp -95.36 99.87 11.73 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 169.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.437 ' CD2' ' HB3' ' A' ' 374' ' ' MET . 36.5 mt -85.34 116.49 23.7 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.768 -162.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.752 ' HB ' ' CB ' ' A' ' 373' ' ' GLU . 1.7 mm -64.6 -24.36 35.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 174.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 72.3 m -118.61 85.15 26.23 Favored Pre-proline 0 N--CA 1.45 -0.47 0 CA-C-N 114.294 -1.321 . . . . 0.0 108.257 169.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' PRO . . . . . 0.411 ' HA ' ' HB2' ' A' ' 357' ' ' LEU . 75.0 Cg_endo -84.3 26.04 0.67 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.115 2.543 . . . . 0.0 114.448 -167.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -166.52 68.34 1.04 Allowed Pre-proline 0 C--N 1.311 -1.093 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.587 173.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . 0.655 ' HB3' HG23 ' A' ' 372' ' ' ILE . 58.6 Cg_endo -82.54 169.05 14.08 Favored 'Trans proline' 0 C--O 1.246 0.889 0 C-N-CA 122.542 2.161 . . . . 0.0 113.317 -178.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 4.2 p -143.7 -176.53 5.01 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.087 -168.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' MET . . . . . 0.8 ' HA ' ' HA2' ' A' ' 369' ' ' GLY . 42.4 mtp -144.83 127.61 16.28 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 172.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.456 ' O ' ' HE1' ' A' ' 332' ' ' PHE . 48.4 mt-10 -117.52 -169.62 1.7 Allowed 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.295 -172.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . 0.679 HD22 ' N ' ' A' ' 367' ' ' ASN . 0.2 OUTLIER -58.78 -21.99 57.19 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -171.676 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' ASN . . . . . 0.679 ' N ' HD22 ' A' ' 366' ' ' ASN . 26.8 m120 -101.11 -4.41 27.38 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.564 -0.71 . . . . 0.0 110.729 176.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . 0.571 ' HA2' ' HD1' ' A' ' 332' ' ' PHE . . . 116.94 172.9 16.45 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -173.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . 0.8 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -54.61 -47.19 71.57 Favored Glycine 0 CA--C 1.505 -0.548 0 C-N-CA 121.371 -0.442 . . . . 0.0 113.391 177.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . 0.62 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 90.12 -134.61 12.44 Favored Glycine 0 N--CA 1.438 -1.194 0 C-N-CA 119.943 -1.122 . . . . 0.0 110.917 -172.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 44.7 p90 -103.16 140.61 37.12 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.513 0.673 . . . . 0.0 111.697 -177.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 372' ' ' ILE . . . . . 0.655 HG23 ' HB3' ' A' ' 362' ' ' PRO . 1.5 mt -128.25 161.31 36.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.044 176.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.752 ' CB ' ' HB ' ' A' ' 358' ' ' ILE . 38.8 mt-10 -124.49 128.54 49.14 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.484 0.659 . . . . 0.0 110.97 -179.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . 0.447 ' O ' ' HB2' ' A' ' 375' ' ' GLN . 0.1 OUTLIER -140.32 157.31 45.76 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.38 -1.282 . . . . 0.0 108.188 -179.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 375' ' ' GLN . . . . . 0.912 ' HA ' HE21 ' A' ' 375' ' ' GLN . 0.0 OUTLIER 179.83 175.45 0.78 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 118.224 0.465 . . . . 0.0 109.803 179.124 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 376' ' ' LEU . . . . . 1.013 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 11.2 tp -166.69 164.45 10.38 Favored Pre-proline 0 N--CA 1.446 -0.63 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 176.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 377' ' ' PRO . . . . . 1.013 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 80.0 Cg_exo -43.63 133.92 7.39 Favored 'Trans proline' 0 CA--C 1.533 0.433 0 C-N-CA 121.38 1.387 . . . . 0.0 111.3 169.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.555 ' HA ' HE22 ' A' ' 394' ' ' GLN . 4.7 Cg_exo -35.47 144.22 0.08 OUTLIER 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 125.177 3.918 . . . . 0.0 114.223 -175.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 151.17 -159.69 28.31 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -164.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . 0.46 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 7.5 m-20 -104.7 131.55 52.01 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 118.013 0.906 . . . . 0.0 110.939 175.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.459 ' HA ' HG21 ' A' ' 354' ' ' VAL . 10.0 m120 -128.5 145.53 51.08 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 177.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 1.018 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -143.91 136.97 23.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 176.634 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . 0.644 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 13.4 mt -100.72 131.71 47.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.326 -173.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' TYR . . . . . 0.513 ' HB2' ' HG3' ' A' ' 343' ' ' ARG . 5.0 m-85 -99.91 133.72 43.86 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 114.51 -1.223 . . . . 0.0 108.163 167.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . 0.84 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 4.5 t -124.21 82.05 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 177.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 59.91 -108.57 1.79 Allowed Glycine 0 N--CA 1.434 -1.455 0 C-N-CA 119.837 -1.173 . . . . 0.0 110.848 -167.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -83.12 -15.51 50.47 Favored 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 175.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.84 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 4.1 mp -69.68 155.77 40.0 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 120.477 0.179 . . . . 0.0 110.625 177.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . 0.644 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 4.9 p-10 -171.41 152.25 3.24 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.426 174.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . 0.423 ' O ' HG12 ' A' ' 382' ' ' ILE . 6.5 t60 -173.91 120.45 0.29 Allowed 'General case' 0 C--O 1.237 0.421 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 177.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' GLN . . . . . 1.018 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 7.5 tt0 -76.35 152.94 36.18 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 121.294 0.568 . . . . 0.0 112.496 -175.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' TRP . . . . . 0.432 ' HZ2' ' OD2' ' A' ' 320' ' ' ASP . 59.0 t-105 -150.2 148.82 29.38 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.397 177.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 15.0 p90 -111.64 114.03 26.8 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 173.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.555 HE22 ' HA ' ' A' ' 378' ' ' PRO . 0.0 OUTLIER -103.01 127.31 50.3 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.334 0.588 . . . . 0.0 110.069 -172.885 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.648 ' H ' ' HD3' ' A' ' 395' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.021 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.514 -174.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . 0.446 ' O ' HG22 ' A' ' 305' ' ' THR . 10.0 t . . . . . 0 CA--C 1.535 0.378 0 CA-C-O 121.471 0.653 . . . . 0.0 111.437 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . 0.478 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 43.7 p90 -64.03 120.87 12.85 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 172.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.619 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 14.2 t 170.75 -166.75 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -170.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 19.2 t -65.32 110.58 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 171.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . 0.412 ' HB3' HG21 ' A' ' 335' ' ' THR . 0.1 OUTLIER -68.79 141.33 55.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.007 0.432 . . . . 0.0 110.955 -173.698 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . 0.609 ' OD1' HG22 ' A' ' 310' ' ' THR . 9.4 t70 -60.82 123.02 16.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.944 -177.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 34.7 pttt -45.28 -17.53 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 115.4 1.629 . . . . 0.0 115.4 -177.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.609 HG22 ' OD1' ' A' ' 308' ' ' ASP . 10.6 t -109.63 9.08 25.14 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 120.212 1.369 . . . . 0.0 112.252 -174.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.447 ' HG3' ' HB3' ' A' ' 308' ' ' ASP . 26.2 mtpp -90.42 -27.03 19.56 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -174.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.839 ' HD1' HD13 ' A' ' 388' ' ' LEU . 0.4 OUTLIER -85.91 173.55 9.89 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.887 0.851 . . . . 0.0 112.443 -175.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 11.2 t -153.6 158.91 41.87 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.203 -1.362 . . . . 0.0 109.101 -178.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 16.4 m95 -79.79 95.53 6.04 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 120.981 0.42 . . . . 0.0 111.376 -176.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.499 ' HB3' ' C ' ' A' ' 329' ' ' GLU . 31.8 tptt -63.37 -49.64 73.06 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 167.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.404 ' HB3' ' HB2' ' A' ' 329' ' ' GLU . 3.8 ttm180 -154.73 131.55 10.77 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.211 -0.904 . . . . 0.0 108.918 175.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -75.07 159.31 82.99 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-O 119.051 -0.499 . . . . 0.0 110.908 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -34.27 113.24 0.08 OUTLIER 'Trans proline' 0 C--N 1.365 1.397 0 C-N-CA 123.78 2.987 . . . . 0.0 113.545 177.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 21.0 m -130.89 137.15 49.2 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.932 -175.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -58.82 128.18 35.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.664 -0.244 . . . . 0.0 110.36 -179.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 60.5 p -74.68 3.98 7.0 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.026 0.53 . . . . 0.0 111.85 -173.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 70.61 -18.79 0.74 Allowed Glycine 0 CA--C 1.523 0.582 0 C-N-CA 121.238 -0.506 . . . . 0.0 114.08 -172.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . 0.445 ' O ' ' CB ' ' A' ' 324' ' ' ASP . 11.5 m170 -92.01 -13.75 30.5 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 117.579 0.69 . . . . 0.0 112.791 -174.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . 0.445 ' CB ' ' O ' ' A' ' 323' ' ' HIS . 29.9 t70 108.0 35.39 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.34 0 O-C-N 125.329 1.643 . . . . 0.0 109.033 -175.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . 0.572 ' HA ' ' CG ' ' A' ' 375' ' ' GLN . 3.3 p -150.97 -173.77 4.59 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.697 HG23 ' HG2' ' A' ' 375' ' ' GLN . 0.6 OUTLIER -130.04 143.74 40.13 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.589 0 CA-C-N 118.776 0.716 . . . . 0.0 111.511 -177.33 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' VAL . . . . . 0.835 HG12 ' HG2' ' A' ' 373' ' ' GLU . 19.2 m -123.28 146.2 29.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.466 176.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' MET . . . . . 0.63 ' SD ' HG21 ' A' ' 383' ' ' ILE . 6.1 ptp -130.61 153.5 48.85 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 174.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.499 ' C ' ' HB3' ' A' ' 315' ' ' LYS . 3.8 tt0 -125.75 126.27 44.31 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.541 HG23 ' HA3' ' A' ' 369' ' ' GLY . 10.7 m -125.58 159.05 33.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.351 -176.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . 0.528 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -130.8 135.59 8.35 Favored Glycine 0 CA--C 1.524 0.656 0 C-N-CA 118.843 -1.646 . . . . 0.0 114.482 178.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . 1.011 ' H ' ' HA2' ' A' ' 368' ' ' GLY . 36.2 m-85 -112.52 171.49 7.49 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 123.442 0.697 . . . . 0.0 110.074 170.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 34.7 m -130.58 -15.17 3.58 Favored 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 174.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -123.82 -66.42 0.2 Allowed Glycine 0 C--O 1.224 -0.484 0 C-N-CA 119.766 -1.207 . . . . 0.0 113.659 -175.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' THR . . . . . 0.412 HG21 ' HB3' ' A' ' 307' ' ' CYS . 12.8 m -54.16 129.01 33.32 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 123.747 0.322 . . . . 0.0 111.202 -176.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.669 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 6.4 ptm180 -88.7 179.45 1.63 Allowed Pre-proline 0 CA--C 1.532 0.269 0 CA-C-O 117.442 -1.266 . . . . 0.0 108.123 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.669 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -26.89 99.41 0.02 OUTLIER 'Trans proline' 0 C--N 1.372 1.816 0 C-N-CA 123.888 3.059 . . . . 0.0 114.155 -175.574 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' CYS . . . . . 0.619 ' HB2' ' O ' ' A' ' 305' ' ' THR . 19.2 p -115.61 -175.61 2.75 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 113.583 -1.644 . . . . 0.0 109.302 -169.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 7.0 mpt_? -106.54 96.34 6.38 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . 0.856 HD12 ' HD2' ' A' ' 341' ' ' PRO . 9.3 tp -75.54 120.05 79.88 Favored Pre-proline 0 C--N 1.325 -0.457 0 C-N-CA 119.011 -1.076 . . . . 0.0 110.924 -168.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . 0.856 ' HD2' HD12 ' A' ' 340' ' ' ILE . 53.5 Cg_endo -72.87 79.45 1.96 Allowed 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 121.92 1.746 . . . . 0.0 111.216 175.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.69 HG13 HG13 ' A' ' 340' ' ' ILE . 2.5 m -103.85 109.64 27.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.273 178.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.612 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 18.9 ptt180 -127.45 175.64 8.07 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' ALA . . . . . 0.559 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -147.42 145.87 29.38 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 120.169 -0.612 . . . . 0.0 110.407 176.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.475 HG22 HD12 ' A' ' 382' ' ' ILE . 10.4 m -115.63 143.34 25.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 176.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -62.05 115.85 4.44 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 116.109 -0.496 . . . . 0.0 112.326 176.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . 0.762 ' HB3' ' HB2' ' A' ' 380' ' ' ASP . 13.6 p80 33.62 73.17 0.07 Allowed 'General case' 0 N--CA 1.472 0.664 0 O-C-N 124.618 1.199 . . . . 0.0 113.822 177.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . 0.734 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 53.18 31.59 41.76 Favored Glycine 0 N--CA 1.45 -0.408 0 N-CA-C 115.324 0.89 . . . . 0.0 115.324 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 49.8 t -139.49 102.88 7.16 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 118.584 1.192 . . . . 0.0 109.011 178.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -71.88 62.55 3.15 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.966 2.444 . . . . 0.0 112.778 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -100.87 -55.98 2.44 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 177.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 3.2 p -121.54 131.43 73.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.434 174.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . 0.433 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 43.4 t30 -64.19 113.04 3.3 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.551 174.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.401 ' CG1' HD22 ' A' ' 376' ' ' LEU . 27.5 m -97.25 5.16 9.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.05 -178.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . 0.559 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -76.38 86.25 3.15 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.027 0.441 . . . . 0.0 111.272 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.96 100.58 12.08 Favored 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 171.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.587 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 23.8 mt -85.57 120.17 26.72 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.931 -164.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.712 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 2.1 mm -65.86 -25.9 37.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 173.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 50.4 m -120.68 82.27 33.9 Favored Pre-proline 0 N--CA 1.446 -0.652 0 CA-C-N 114.41 -1.268 . . . . 0.0 108.153 170.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -85.86 21.0 1.14 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.088 2.525 . . . . 0.0 113.785 -169.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . 0.55 ' N ' ' HD3' ' A' ' 362' ' ' PRO . 15.8 m120 -145.77 52.88 1.66 Allowed Pre-proline 0 C--N 1.312 -1.054 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.348 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . 0.55 ' HD3' ' N ' ' A' ' 361' ' ' ASN . 11.0 Cg_endo -78.81 147.11 21.38 Favored 'Trans proline' 0 C--O 1.251 1.161 0 C-N-CA 121.635 1.557 . . . . 0.0 113.142 -177.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 6.3 p -139.99 116.85 10.97 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.664 -169.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' MET . . . . . 0.774 ' HG3' HD13 ' A' ' 340' ' ' ILE . 11.3 mmt -98.15 147.24 24.77 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.96 -170.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.535 ' HG2' ' HD3' ' A' ' 337' ' ' PRO . 40.9 mt-10 -125.5 177.9 5.94 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 122.108 0.956 . . . . 0.0 112.604 -172.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . 0.582 HD22 ' N ' ' A' ' 367' ' ' ASN . 0.2 OUTLIER -60.16 -4.7 0.85 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 113.407 -1.724 . . . . 0.0 111.621 173.567 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' ASN . . . . . 0.582 ' N ' HD22 ' A' ' 366' ' ' ASN . 25.5 p30 -112.45 -5.29 14.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.858 0.361 . . . . 0.0 110.152 -175.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . 1.011 ' HA2' ' H ' ' A' ' 332' ' ' PHE . . . 134.73 -119.69 2.23 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.272 -0.966 . . . . 0.0 114.535 177.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . 0.541 ' HA3' HG23 ' A' ' 330' ' ' VAL . . . -177.18 93.47 0.09 OUTLIER Glycine 0 C--N 1.312 -0.759 0 N-CA-C 107.652 -2.179 . . . . 0.0 107.652 -171.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . 0.442 ' O ' ' HG3' ' A' ' 329' ' ' GLU . . . -74.31 -43.24 32.28 Favored Glycine 0 C--N 1.304 -1.248 0 C-N-CA 120.826 -0.702 . . . . 0.0 114.639 -155.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -166.2 136.6 3.42 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 120.966 0.413 . . . . 0.0 110.754 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 372' ' ' ILE . . . . . 0.62 ' O ' ' HA ' ' A' ' 327' ' ' VAL . 0.9 OUTLIER -136.67 135.52 48.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.947 176.771 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.835 ' HG2' HG12 ' A' ' 327' ' ' VAL . 25.8 mt-10 -110.98 131.22 55.23 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.703 -176.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . 0.649 ' HG2' HD11 ' A' ' 383' ' ' ILE . 0.0 OUTLIER -137.17 165.1 26.9 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 114.794 -1.093 . . . . 0.0 108.627 178.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 375' ' ' GLN . . . . . 1.026 ' HA ' HE21 ' A' ' 375' ' ' GLN . 0.0 OUTLIER -176.14 -175.95 0.75 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.807 0.813 . . . . 0.0 110.813 169.309 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 376' ' ' LEU . . . . . 0.957 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 14.5 tp -166.21 162.9 12.09 Favored Pre-proline 0 N--CA 1.437 -1.081 0 N-CA-C 103.806 -2.664 . . . . 0.0 103.806 173.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 377' ' ' PRO . . . . . 0.957 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 66.6 Cg_exo -39.65 130.99 1.84 Allowed 'Trans proline' 0 CA--C 1.534 0.498 0 C-N-CA 121.356 1.37 . . . . 0.0 110.705 167.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -37.2 141.32 0.18 Allowed 'Trans proline' 0 C--N 1.355 0.906 0 C-N-CA 124.201 3.267 . . . . 0.0 112.694 -176.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 149.43 -174.86 28.86 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 110.663 -0.975 . . . . 0.0 110.663 -163.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . 0.762 ' HB2' ' HB3' ' A' ' 347' ' ' HIS . 6.1 m-20 -94.41 125.92 39.35 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 117.501 0.65 . . . . 0.0 110.167 -175.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.647 HD22 ' HG2' ' A' ' 394' ' ' GLN . 28.4 m-80 -137.29 170.24 16.43 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -178.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 1.023 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -160.55 143.98 4.82 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 175.426 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . 0.688 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 44.2 mt -101.48 128.82 53.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.31 -175.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' TYR . . . . . 0.612 ' O ' ' HG2' ' A' ' 343' ' ' ARG . 0.7 OUTLIER -104.06 92.07 4.22 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.971 171.935 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . 0.478 ' O ' ' HB2' ' A' ' 388' ' ' LEU . 15.2 t -84.0 89.45 2.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 178.242 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . 0.752 ' HA3' ' HZ ' ' A' ' 312' ' ' PHE . . . 61.05 -116.52 9.46 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.1 -1.048 . . . . 0.0 111.136 -172.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -78.49 -20.76 50.12 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.848 0.356 . . . . 0.0 111.366 174.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.839 HD13 ' HD1' ' A' ' 312' ' ' PHE . 2.4 mp -70.26 155.12 41.1 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.37 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . 0.688 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 7.0 p30 -167.8 152.73 6.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.886 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -173.48 118.55 0.29 Allowed 'General case' 0 C--O 1.24 0.554 0 N-CA-C 110.423 -0.214 . . . . 0.0 110.423 177.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' GLN . . . . . 1.023 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 15.5 tt0 -80.93 153.32 27.61 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.894 0.878 . . . . 0.0 112.081 -176.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' TRP . . . . . 0.451 ' CD1' ' NE2' ' A' ' 394' ' ' GLN . 6.0 t-105 -172.31 150.99 2.45 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.47 -178.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . 0.501 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 21.3 p90 -102.34 119.12 38.28 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 121.214 -0.929 . . . . 0.0 108.807 179.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.75 ' HG3' HE22 ' A' ' 375' ' ' GLN . 3.4 mm100 -85.98 127.28 34.6 Favored 'General case' 0 C--O 1.238 0.469 0 O-C-N 121.909 -0.495 . . . . 0.0 109.878 -167.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm . . . . . 0 C--O 1.246 0.897 0 O-C-N 124.348 1.03 . . . . 0.0 110.651 175.793 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . 0.611 HG23 HG23 ' A' ' 335' ' ' THR . 5.8 t . . . . . 0 CA--C 1.537 0.48 0 CA-C-O 121.344 0.592 . . . . 0.0 111.764 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -68.11 122.87 19.18 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 175.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.498 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 7.4 t 178.54 -167.89 0.07 Allowed 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -171.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 30.8 t -69.78 113.65 5.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 167.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . 0.502 ' SG ' HG21 ' A' ' 335' ' ' THR . 0.1 OUTLIER -66.6 147.27 53.5 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.842 0.83 . . . . 0.0 112.135 -169.864 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . 0.51 ' OD1' HG22 ' A' ' 310' ' ' THR . 12.1 t70 -66.58 128.21 35.35 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.163 -1.381 . . . . 0.0 110.145 177.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.415 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -44.64 -13.13 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 115.775 1.769 . . . . 0.0 115.775 -176.406 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.51 HG22 ' OD1' ' A' ' 308' ' ' ASP . 12.0 t -108.96 -2.37 18.32 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 119.775 1.17 . . . . 0.0 113.086 -178.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.676 ' HE2' ' OG1' ' A' ' 335' ' ' THR . 31.2 mmmt -65.69 -35.68 81.45 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -173.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.586 ' HA ' ' O ' ' A' ' 331' ' ' GLY . 0.1 OUTLIER -86.01 174.25 9.34 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 122.086 0.946 . . . . 0.0 112.405 -175.129 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . 0.42 ' C ' HD21 ' A' ' 388' ' ' LEU . 12.6 t -151.98 161.47 42.58 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 113.65 -1.614 . . . . 0.0 109.459 -177.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . 0.546 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 28.8 m-90 -77.32 124.19 27.53 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-O 121.295 0.569 . . . . 0.0 110.034 -178.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.61 ' HB3' ' HB3' ' A' ' 329' ' ' GLU . 63.0 tttt -108.04 -41.95 4.8 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 172.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.643 ' HB3' ' HB2' ' A' ' 329' ' ' GLU . 3.9 ttm180 -151.16 130.02 12.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.105 -0.952 . . . . 0.0 108.762 171.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -70.25 157.74 89.19 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.453 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . 0.628 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 1.6 Cg_endo -45.66 118.44 2.23 Favored 'Trans proline' 0 C--N 1.359 1.118 0 C-N-CA 122.541 2.161 . . . . 0.0 112.27 -178.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 47.5 m -134.96 145.16 47.87 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.243 -174.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -60.07 134.5 57.11 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . 0.49 ' HB3' HG13 ' A' ' 327' ' ' VAL . 79.9 p -76.92 1.04 18.77 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -173.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 73.1 -20.47 1.14 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.833 -169.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . 0.427 ' H ' ' C ' ' A' ' 321' ' ' SER . 96.6 m-70 -112.2 50.15 0.87 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.111 0.482 . . . . 0.0 110.369 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 9.5 t70 54.03 38.22 28.5 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.835 174.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . 0.449 ' HB ' HG13 ' A' ' 358' ' ' ILE . 2.6 p -150.86 -168.47 3.11 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 175.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.569 HG13 HE22 ' A' ' 394' ' ' GLN . 0.4 OUTLIER -129.13 141.25 47.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 118.245 0.475 . . . . 0.0 110.873 -178.782 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' VAL . . . . . 0.828 HG12 ' HG2' ' A' ' 373' ' ' GLU . 17.6 m -121.35 149.16 24.41 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.682 177.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' MET . . . . . 0.686 ' SD ' ' HB ' ' A' ' 372' ' ' ILE . 0.1 OUTLIER -141.94 150.73 41.82 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 176.194 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.643 ' HB2' ' HB3' ' A' ' 316' ' ' ARG . 9.9 mt-10 -124.94 128.86 49.27 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-O 120.825 0.345 . . . . 0.0 110.2 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.484 HG23 ' HA3' ' A' ' 369' ' ' GLY . 1.8 m -131.78 152.66 37.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.854 -178.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . 0.586 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -113.86 178.15 18.21 Favored Glycine 0 CA--C 1.525 0.704 0 CA-C-O 119.475 -0.625 . . . . 0.0 112.536 -178.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . 0.709 ' HB2' ' SD ' ' A' ' 364' ' ' MET . 0.5 OUTLIER -128.77 142.83 50.86 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 117.467 0.633 . . . . 0.0 111.158 -178.409 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 5.3 p -87.57 -17.64 31.53 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 173.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 177.09 -39.61 0.1 OUTLIER Glycine 0 C--N 1.338 0.641 0 C-N-CA 117.943 -2.075 . . . . 0.0 116.045 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' THR . . . . . 0.676 ' OG1' ' HE2' ' A' ' 311' ' ' LYS . 81.2 m -52.91 131.78 36.27 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 -179.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.833 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 1.4 ptp180 -79.24 -179.98 1.59 Allowed Pre-proline 0 N--CA 1.449 -0.495 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -177.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.833 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 1.3 Cg_exo -27.56 100.88 0.02 OUTLIER 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 123.269 2.646 . . . . 0.0 113.742 178.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' CYS . . . . . 0.918 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 26.3 p -130.54 150.39 51.76 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.402 -176.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -67.17 123.93 21.67 Favored 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.444 170.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . 0.426 HG12 HG13 ' A' ' 342' ' ' VAL . 19.2 tt -94.64 117.73 66.93 Favored Pre-proline 0 C--N 1.315 -0.921 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.155 -176.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -70.37 82.29 0.89 Allowed 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.513 2.142 . . . . 0.0 112.042 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.668 HG12 HG13 ' A' ' 385' ' ' VAL . 11.4 m -102.31 115.4 44.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.468 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.4 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 36.1 ptt180 -130.34 178.13 6.82 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' ALA . . . . . 0.469 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -151.21 148.85 28.73 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.89 177.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.414 ' O ' HG23 ' A' ' 382' ' ' ILE . 14.7 m -121.57 146.86 25.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 177.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -70.17 119.19 13.99 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 177.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . 0.661 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 68.8 t60 47.36 57.5 5.77 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 124.172 0.92 . . . . 0.0 111.457 174.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . 0.619 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 44.83 44.22 8.58 Favored Glycine 0 CA--C 1.521 0.413 0 N-CA-C 114.671 0.628 . . . . 0.0 114.671 -172.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 347' ' ' HIS . 57.4 t -139.82 102.23 7.05 Favored Pre-proline 0 C--O 1.234 0.271 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -76.36 64.19 7.18 Favored 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 123.06 2.507 . . . . 0.0 113.847 -175.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -100.52 -57.09 2.18 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 174.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 4.3 p -115.55 125.94 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.676 174.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . 0.462 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 39.5 t30 -62.89 108.89 1.29 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.57 174.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.509 ' HA ' HD22 ' A' ' 376' ' ' LEU . 27.6 m -86.81 0.97 6.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.078 -179.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . 0.469 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -76.88 84.32 3.45 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-O 121.476 0.655 . . . . 0.0 110.468 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 356' ' ' MET . . . . . 0.676 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 11.9 tpt -98.96 103.62 15.59 Favored 'General case' 0 N--CA 1.43 -1.433 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 170.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.546 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 42.4 mt -86.2 119.64 26.7 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.177 -161.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.699 ' HB ' ' CB ' ' A' ' 373' ' ' GLU . 3.0 mm -64.77 -27.18 41.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 173.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 89.8 m -122.06 84.53 45.4 Favored Pre-proline 0 N--CA 1.449 -0.52 0 CA-C-N 114.346 -1.297 . . . . 0.0 108.572 171.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -85.39 28.07 0.58 Allowed 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 123.119 2.546 . . . . 0.0 113.65 -171.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . 0.443 ' N ' ' HD3' ' A' ' 362' ' ' PRO . 2.4 p-10 -148.59 55.0 1.91 Allowed Pre-proline 0 C--N 1.313 -0.99 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.488 177.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . 0.774 ' HB3' HG23 ' A' ' 372' ' ' ILE . 73.5 Cg_endo -85.08 162.53 11.61 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 121.884 1.723 . . . . 0.0 113.041 -179.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' THR . . . . . 0.669 ' O ' ' HA2' ' A' ' 369' ' ' GLY . 1.2 p -145.2 -172.7 3.92 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.141 -0.936 . . . . 0.0 109.89 -172.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' MET . . . . . 0.918 ' HG2' ' SG ' ' A' ' 338' ' ' CYS . 9.3 ptp -131.91 134.44 45.68 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.305 -1.369 . . . . 0.0 107.305 162.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -124.42 -164.51 1.27 Allowed 'General case' 0 C--N 1.319 -0.731 0 O-C-N 124.647 1.217 . . . . 0.0 110.164 -170.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -55.64 -10.58 0.71 Allowed 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -177.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 12.5 p-10 -126.76 1.03 6.73 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.909 0.385 . . . . 0.0 110.913 -175.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . 0.473 ' HA2' ' HB3' ' A' ' 332' ' ' PHE . . . 108.14 -178.5 21.36 Favored Glycine 0 N--CA 1.449 -0.468 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 -177.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . 0.669 ' HA2' ' O ' ' A' ' 363' ' ' THR . . . -47.53 -54.0 11.61 Favored Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.921 -0.657 . . . . 0.0 113.303 172.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . 0.596 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 89.26 -126.97 8.46 Favored Glycine 0 N--CA 1.441 -0.994 0 C-N-CA 120.441 -0.885 . . . . 0.0 111.447 -176.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -101.76 131.74 47.89 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.708 0.29 . . . . 0.0 111.213 -175.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 372' ' ' ILE . . . . . 0.774 HG23 ' HB3' ' A' ' 362' ' ' PRO . 0.2 OUTLIER -131.03 166.1 29.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 173.698 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.828 ' HG2' HG12 ' A' ' 327' ' ' VAL . 24.1 mt-10 -133.97 132.64 40.4 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.363 0.601 . . . . 0.0 111.349 177.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . 0.589 ' HG2' HD11 ' A' ' 383' ' ' ILE . 0.0 OUTLIER -135.08 166.17 23.69 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 177.245 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 375' ' ' GLN . . . . . 0.924 HE22 ' HG3' ' A' ' 394' ' ' GLN . 0.0 OUTLIER 175.93 176.0 0.26 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.345 0.521 . . . . 0.0 109.694 170.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 376' ' ' LEU . . . . . 1.002 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 9.4 tp -166.18 175.36 2.32 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 103.498 -2.779 . . . . 0.0 103.498 177.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 377' ' ' PRO . . . . . 1.002 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 58.2 Cg_exo -40.87 130.36 2.83 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 CA-C-N 121.789 1.675 . . . . 0.0 111.882 167.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.473 ' HD2' ' HA ' ' A' ' 377' ' ' PRO . 5.1 Cg_exo -41.05 146.98 0.31 Allowed 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 124.018 3.145 . . . . 0.0 112.207 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 145.34 -168.39 27.21 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.18 -1.01 . . . . 0.0 110.83 -163.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . 0.661 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 3.1 m-20 -88.35 119.81 29.13 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 117.134 0.467 . . . . 0.0 110.026 -178.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.428 HD22 ' HG2' ' A' ' 394' ' ' GLN . 26.2 m-80 -132.99 144.64 50.23 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 1.044 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -143.86 137.04 24.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.218 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . 0.698 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 44.1 mt -97.96 127.7 50.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.506 -175.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' TYR . . . . . 0.523 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.2 OUTLIER -104.64 91.73 3.99 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 114.322 -1.308 . . . . 0.0 108.426 173.475 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . 0.668 HG13 HG12 ' A' ' 342' ' ' VAL . 17.7 t -84.23 89.44 2.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 64.23 -110.35 3.39 Favored Glycine 0 N--CA 1.442 -0.911 0 C-N-CA 120.278 -0.963 . . . . 0.0 110.725 -170.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -94.22 -9.13 37.22 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 116.867 0.334 . . . . 0.0 111.366 172.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.583 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 3.1 mp -66.75 153.35 43.51 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 174.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . 0.698 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 9.0 p30 -164.06 156.51 17.28 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.927 177.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . 0.628 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 23.4 t-80 -174.75 117.83 0.19 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.924 172.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' GLN . . . . . 1.044 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 0.6 OUTLIER -79.08 154.35 29.47 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.11 0.481 . . . . 0.0 110.978 -179.958 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' TRP . . . . . 0.499 ' HD1' ' OE1' ' A' ' 394' ' ' GLN . 6.6 t-105 -166.73 150.93 7.21 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.111 -0.95 . . . . 0.0 108.51 -178.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 24.2 p90 -105.93 119.67 39.77 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.924 ' HG3' HE22 ' A' ' 375' ' ' GLN . 3.8 mm100 -85.67 113.22 21.71 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -173.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.753 ' H ' ' HD3' ' A' ' 395' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.131 -0.938 . . . . 0.0 111.285 -178.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . 0.403 HG23 ' O ' ' A' ' 303' ' ' THR . 4.5 t . . . . . 0 N--CA 1.445 -0.696 0 CA-C-O 121.532 0.682 . . . . 0.0 110.664 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . 0.615 ' HB3' ' HE ' ' A' ' 336' ' ' ARG . 5.2 p90 -74.46 127.31 32.74 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 171.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' A' ' 304' ' ' TYR . 11.6 t 172.82 -169.83 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -173.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 37.2 t -66.78 112.83 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 107.242 -1.392 . . . . 0.0 107.242 169.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . 0.459 ' HB3' HG21 ' A' ' 335' ' ' THR . 0.1 OUTLIER -67.81 141.02 56.63 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.436 -171.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . 0.561 ' HB3' ' HG3' ' A' ' 311' ' ' LYS . 10.4 t0 -59.33 124.45 20.05 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.044 -176.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 54.4 pttt -40.7 -29.85 0.1 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.101 -1.408 . . . . 0.0 114.418 -177.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 11.4 t -107.08 1.41 24.22 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.348 0.594 . . . . 0.0 111.123 -170.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.561 ' HG3' ' HB3' ' A' ' 308' ' ' ASP . 49.2 mtpt -90.36 43.85 1.17 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.534 0.683 . . . . 0.0 110.079 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.691 ' HB3' HD13 ' A' ' 388' ' ' LEU . 0.3 OUTLIER -140.7 157.14 45.87 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.635 -168.464 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 15.0 p -144.72 152.83 40.98 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.967 175.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . 0.61 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 20.1 m-90 -79.94 94.51 5.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.97 0.414 . . . . 0.0 110.231 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 18.8 tttm -71.24 -42.59 68.66 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.167 173.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 41.0 ttm105 -154.99 98.56 2.04 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.105 173.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -41.91 152.07 0.31 Allowed Pre-proline 0 N--CA 1.472 0.662 0 C-N-CA 123.695 0.798 . . . . 0.0 112.441 174.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . 0.483 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 1.0 OUTLIER -44.24 117.11 1.21 Allowed 'Trans proline' 0 C--N 1.365 1.443 0 C-N-CA 123.083 2.522 . . . . 0.0 113.099 -174.292 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 10.1 m -133.41 144.15 49.35 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.71 -1.132 . . . . 0.0 110.004 -174.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -59.1 129.64 43.11 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.625 0.25 . . . . 0.0 110.566 177.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . 0.734 ' HB3' HG13 ' A' ' 327' ' ' VAL . 59.6 p -77.96 6.73 7.17 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.513 0.725 . . . . 0.0 111.771 -174.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 81.7 -16.75 18.27 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.649 -0.786 . . . . 0.0 113.039 -170.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 20.7 m80 -98.34 7.61 45.98 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 117.19 0.495 . . . . 0.0 111.217 -177.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 72.33 49.66 0.21 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 121.947 0.88 . . . . 0.0 109.233 -177.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . 0.567 ' HB ' HG13 ' A' ' 358' ' ' ILE . 4.5 p -157.99 163.92 37.31 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 105.563 -2.014 . . . . 0.0 105.563 -177.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -111.0 132.63 58.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 CA-C-N 119.755 1.161 . . . . 0.0 112.619 -172.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 327' ' ' VAL . . . . . 0.847 HG12 ' HG2' ' A' ' 373' ' ' GLU . 15.4 m -115.2 163.98 11.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.878 174.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 10.1 ptm -153.33 152.25 30.9 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 172.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -114.1 135.31 54.16 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.571 HG23 ' HA3' ' A' ' 369' ' ' GLY . 3.1 m -132.94 146.66 32.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 C-N-CA 120.366 -0.534 . . . . 0.0 112.275 -178.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . 0.592 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -118.66 134.6 10.97 Favored Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.241 -0.98 . . . . 0.0 112.062 -179.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . 0.763 ' HB3' ' SD ' ' A' ' 364' ' ' MET . 0.1 OUTLIER -89.56 157.65 17.97 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -177.112 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 36.0 t -71.11 -33.36 70.08 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 112.658 -2.064 . . . . 0.0 112.29 169.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 168.62 -17.89 0.07 OUTLIER Glycine 0 CA--C 1.526 0.776 0 C-N-CA 119.62 -1.276 . . . . 0.0 114.689 -179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 335' ' ' THR . . . . . 0.488 ' O ' ' HD2' ' A' ' 332' ' ' PHE . 25.8 m -54.62 120.09 6.21 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 116.699 0.25 . . . . 0.0 110.889 176.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.694 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 9.2 ptt180 -75.46 -176.53 0.58 Allowed Pre-proline 0 N--CA 1.467 0.38 0 CA-C-O 117.62 -1.181 . . . . 0.0 108.85 -172.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.83 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.1 OUTLIER -26.67 95.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 123.693 2.929 . . . . 0.0 113.379 177.072 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 338' ' ' CYS . . . . . 0.69 ' SG ' ' HE2' ' A' ' 364' ' ' MET . 13.7 p -115.7 -175.44 2.72 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 113.656 -1.611 . . . . 0.0 110.89 -167.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 8.0 mpt_? -110.61 100.42 9.21 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . 0.901 HG22 HG13 ' A' ' 342' ' ' VAL . 24.8 mt -74.8 116.53 54.59 Favored Pre-proline 0 C--N 1.324 -0.531 0 C-N-CA 120.057 -0.657 . . . . 0.0 110.836 -169.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -79.76 81.65 2.71 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.47 2.114 . . . . 0.0 110.992 177.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.901 HG13 HG22 ' A' ' 340' ' ' ILE . 4.1 m -103.26 134.09 45.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.989 0.899 . . . . 0.0 111.459 -178.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.657 ' HG3' ' HB2' ' A' ' 384' ' ' TYR . 20.8 ptt180 -140.51 176.93 8.38 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 113.899 -1.5 . . . . 0.0 107.734 174.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 344' ' ' ALA . . . . . 0.599 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -144.57 144.99 31.58 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 120.546 -0.462 . . . . 0.0 109.903 172.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.511 HG22 HD12 ' A' ' 382' ' ' ILE . 11.6 m -119.07 144.98 25.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.1 119.19 10.36 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 177.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . 0.755 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 25.5 t-80 46.92 63.84 1.78 Allowed 'General case' 0 N--CA 1.468 0.461 0 O-C-N 124.337 1.023 . . . . 0.0 112.015 170.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . 0.559 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 43.19 42.01 5.17 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 114.926 0.73 . . . . 0.0 114.926 -174.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 347' ' ' HIS . 65.3 t -142.38 103.23 5.52 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 117.792 0.796 . . . . 0.0 108.928 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . 0.435 ' HA ' ' HB ' ' A' ' 345' ' ' VAL . 16.1 Cg_exo -72.26 51.8 1.8 Allowed 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.872 2.381 . . . . 0.0 113.073 178.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -103.06 -7.59 21.25 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -178.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 2.4 p -170.72 110.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.065 -169.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . 0.528 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 50.7 t30 -65.25 108.87 2.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.247 177.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.486 ' CG1' HD22 ' A' ' 376' ' ' LEU . 27.7 m -91.13 0.88 8.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.438 178.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . 0.599 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -74.44 83.3 1.96 Allowed 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.098 0.475 . . . . 0.0 111.459 -176.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 356' ' ' MET . . . . . 0.546 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 35.4 ttm -95.36 98.64 10.72 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 168.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.691 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 18.8 mt -80.32 141.65 35.25 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.323 -162.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.761 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 4.2 mm -80.45 -25.28 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 178.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 7.9 m -140.34 97.94 7.5 Favored Pre-proline 0 N--CA 1.445 -0.71 0 CA-C-N 113.513 -1.676 . . . . 0.0 108.797 175.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -85.83 34.42 0.48 Allowed 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.968 2.445 . . . . 0.0 112.808 -175.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -142.8 64.23 14.81 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.434 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . 0.535 ' HG3' ' CG2' ' A' ' 342' ' ' VAL . 90.2 Cg_endo -80.9 143.17 14.38 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.355 2.037 . . . . 0.0 111.481 178.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 363' ' ' THR . . . . . 0.51 HG23 ' O ' ' A' ' 338' ' ' CYS . 0.8 OUTLIER -143.47 148.94 36.83 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -174.611 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 364' ' ' MET . . . . . 0.83 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 37.1 mtm -101.2 141.21 34.41 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 177.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -134.84 -166.11 1.77 Allowed 'General case' 0 C--N 1.322 -0.627 0 O-C-N 125.095 1.497 . . . . 0.0 110.529 -177.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . 0.481 HD22 ' N ' ' A' ' 366' ' ' ASN . 0.1 OUTLIER -41.91 -27.36 0.12 Allowed 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -179.781 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -111.81 -1.26 15.63 Favored 'General case' 0 N--CA 1.468 0.451 0 O-C-N 121.718 -0.614 . . . . 0.0 111.416 -177.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . 0.592 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . 112.31 -165.14 12.04 Favored Glycine 0 N--CA 1.451 -0.317 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -173.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . 0.571 ' HA3' HG23 ' A' ' 330' ' ' VAL . . . -64.15 108.31 2.2 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 170.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -71.5 -31.2 65.8 Favored Glycine 0 C--N 1.313 -0.699 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.907 -169.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -164.74 141.68 6.15 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.051 0.453 . . . . 0.0 110.813 179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 372' ' ' ILE . . . . . 0.844 HD13 HG11 ' A' ' 342' ' ' VAL . 1.7 mt -133.61 144.57 35.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 171.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.847 ' HG2' HG12 ' A' ' 327' ' ' VAL . 40.0 mt-10 -129.24 125.05 36.03 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 120.494 -0.482 . . . . 0.0 109.981 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . 0.691 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 0.0 OUTLIER -140.31 161.45 37.65 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.008 -175.54 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 375' ' ' GLN . . . . . 0.845 HE22 ' HG2' ' A' ' 394' ' ' GLN . 7.3 tp60 -178.52 175.28 1.14 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 174.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 376' ' ' LEU . . . . . 0.838 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 10.8 tp -166.56 157.05 10.81 Favored Pre-proline 0 N--CA 1.444 -0.77 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 -179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 377' ' ' PRO . . . . . 0.838 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 82.7 Cg_exo -42.39 132.08 4.99 Favored 'Trans proline' 0 CA--C 1.532 0.409 0 C-N-CA 121.828 1.685 . . . . 0.0 111.008 168.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.778 ' HA ' HE22 ' A' ' 394' ' ' GLN . 5.8 Cg_exo -35.74 139.84 0.13 Allowed 'Trans proline' 0 C--N 1.356 0.959 0 C-N-CA 124.935 3.757 . . . . 0.0 113.75 -173.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 154.72 -165.08 31.94 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -162.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . 0.755 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 11.8 m-20 -102.91 129.08 49.5 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 117.881 0.841 . . . . 0.0 110.634 177.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -125.71 166.4 16.84 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 176.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 0.98 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -159.66 140.59 4.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 168.886 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . 0.488 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 24.3 mt -96.76 135.39 31.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.919 -175.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 384' ' ' TYR . . . . . 0.657 ' HB2' ' HG3' ' A' ' 343' ' ' ARG . 3.4 m-85 -105.11 129.34 53.54 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 167.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . . . . . . . . . 6.1 t -117.56 82.22 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 65.51 -108.8 2.53 Favored Glycine 0 N--CA 1.431 -1.646 0 C-N-CA 120.001 -1.095 . . . . 0.0 110.51 -161.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -93.77 -10.71 33.29 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.652 0.226 . . . . 0.0 111.543 176.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.691 HD13 ' HB3' ' A' ' 312' ' ' PHE . 1.1 tp -65.22 146.87 54.39 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 176.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . 0.488 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 27.5 p-10 -157.07 147.71 21.45 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 120.595 0.236 . . . . 0.0 111.077 178.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . 0.483 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 5.3 t60 -172.62 122.33 0.43 Allowed 'General case' 0 C--O 1.236 0.393 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.724 176.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 391' ' ' GLN . . . . . 0.98 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 7.9 tt0 -79.2 151.37 31.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.333 0.587 . . . . 0.0 112.367 -173.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 392' ' ' TRP . . . . . . . . . . . . . 43.6 t-105 -148.48 132.54 17.25 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.792 -1.094 . . . . 0.0 109.31 177.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -99.45 109.18 21.77 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.845 ' HG2' HE22 ' A' ' 375' ' ' GLN . 0.0 OUTLIER -97.8 127.19 43.57 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.303 0.573 . . . . 0.0 110.502 -170.05 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.777 -178.382 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . 0.532 HG23 HG23 ' A' ' 335' ' ' THR . 7.1 t . . . . . 0 N--CA 1.451 -0.407 0 CA-C-O 121.159 0.504 . . . . 0.0 111.691 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . 0.722 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 30.9 p90 -67.09 119.65 12.37 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.307 -0.557 . . . . 0.0 109.794 175.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.443 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 12.3 t 176.23 -167.67 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -171.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 23.1 t -64.73 108.21 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 169.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -70.71 140.8 51.52 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.732 -169.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . 0.591 ' OD2' HG22 ' A' ' 310' ' ' THR . 20.3 t70 -66.85 128.34 35.94 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.442 0.639 . . . . 0.0 111.567 -176.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.56 ' HD3' ' HB2' ' A' ' 387' ' ' ASP . 0.0 OUTLIER -42.48 -22.44 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 115.954 1.835 . . . . 0.0 115.954 -173.867 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.591 HG22 ' OD2' ' A' ' 308' ' ' ASP . 11.7 t -105.54 -3.81 21.96 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 118.976 0.807 . . . . 0.0 111.62 -170.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.407 ' HB3' ' HE2' ' A' ' 311' ' ' LYS . 10.4 mmmm -67.97 -24.74 65.18 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.873 -177.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.671 ' HE1' ' H ' ' A' ' 369' ' ' GLY . 2.1 m-85 -81.16 173.04 12.93 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 122.01 0.91 . . . . 0.0 113.313 -176.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . 0.528 HG22 ' O ' ' A' ' 331' ' ' GLY . 14.2 t -148.58 155.21 40.8 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 113.878 -1.51 . . . . 0.0 108.718 177.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 11.6 m-90 -79.23 93.8 5.31 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.17 0.51 . . . . 0.0 110.115 -178.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.577 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 59.6 tttm -76.97 -55.09 5.76 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.186 172.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 54.6 ttt180 -142.04 126.21 17.45 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 176.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -69.12 158.04 87.64 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-O 119.14 -0.457 . . . . 0.0 110.286 178.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . 0.537 ' HG3' HD12 ' A' ' 383' ' ' ILE . 87.2 Cg_exo -40.16 117.66 0.47 Allowed 'Trans proline' 0 C--N 1.36 1.152 0 C-N-CA 122.458 2.105 . . . . 0.0 111.997 174.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 13.6 m -136.13 140.56 43.76 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.801 -174.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . 0.409 ' HA ' ' O ' ' A' ' 325' ' ' THR . 7.0 t70 -55.53 126.95 27.47 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.147 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . 0.512 ' HB3' HG13 ' A' ' 327' ' ' VAL . 33.5 p -87.1 10.9 15.23 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-O 120.644 0.259 . . . . 0.0 111.447 -172.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 85.6 -31.37 3.91 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.53 -173.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 58.7 m-70 -87.06 28.31 0.93 Allowed 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 116.82 0.31 . . . . 0.0 111.61 -176.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 48.65 50.62 16.9 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.877 0.846 . . . . 0.0 109.884 -172.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . 0.532 ' HB ' HG13 ' A' ' 358' ' ' ILE . 11.6 p -154.34 177.14 11.48 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 -175.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -123.16 142.5 39.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 119.536 1.062 . . . . 0.0 112.18 -174.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 327' ' ' VAL . . . . . 0.636 HG12 ' HG2' ' A' ' 373' ' ' GLU . 3.7 m -124.77 147.65 29.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 114.766 -1.106 . . . . 0.0 109.897 172.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 328' ' ' MET . . . . . 0.573 ' CE ' HD12 ' A' ' 372' ' ' ILE . 16.5 ptt? -130.84 156.58 44.78 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 173.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.621 ' HA ' ' O ' ' A' ' 370' ' ' GLY . 7.9 tt0 -124.19 125.91 45.23 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.581 HG11 HG21 ' A' ' 385' ' ' VAL . 15.7 m -126.5 143.58 39.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.416 -174.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . 0.587 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -122.74 135.97 10.41 Favored Glycine 0 C--N 1.335 0.49 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.692 -176.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . 0.512 ' HD1' ' H ' ' A' ' 332' ' ' PHE . 0.2 OUTLIER -90.62 155.74 18.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 122.058 0.933 . . . . 0.0 113.122 -177.374 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 30.4 t -78.72 -37.52 41.26 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 113.862 -1.517 . . . . 0.0 112.948 171.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -173.69 -25.75 0.03 OUTLIER Glycine 0 CA--C 1.526 0.727 0 C-N-CA 118.651 -1.737 . . . . 0.0 115.405 -178.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 335' ' ' THR . . . . . 0.701 ' HB ' ' SD ' ' A' ' 364' ' ' MET . 25.9 m -52.7 127.27 22.57 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.699 0.285 . . . . 0.0 110.385 176.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.75 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 2.2 ptm180 -87.72 -179.26 1.28 Allowed Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 117.378 -1.296 . . . . 0.0 108.491 -174.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.75 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -26.46 98.35 0.02 OUTLIER 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 123.862 3.041 . . . . 0.0 114.115 -175.137 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 338' ' ' CYS . . . . . 0.769 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 1.8 p -109.84 -176.55 3.03 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 113.6 -1.636 . . . . 0.0 110.136 -171.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 339' ' ' ARG . 3.5 mpt_? -109.4 100.51 9.59 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 175.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . 0.889 HG22 HG13 ' A' ' 342' ' ' VAL . 29.9 mt -74.82 114.38 33.98 Favored Pre-proline 0 C--N 1.329 -0.315 0 C-N-CA 120.069 -0.653 . . . . 0.0 111.307 -167.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -79.51 81.46 2.78 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 122.499 2.132 . . . . 0.0 111.309 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.889 HG13 HG22 ' A' ' 340' ' ' ILE . 4.1 m -103.08 128.33 56.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-O 121.508 0.671 . . . . 0.0 110.651 -178.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -140.74 175.77 9.34 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.74 -1.208 . . . . 0.0 107.74 174.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 344' ' ' ALA . . . . . 0.554 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -147.89 149.82 32.97 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 120.064 -0.654 . . . . 0.0 111.334 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 11.0 m -118.86 146.62 23.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 176.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.425 ' HB2' ' CG1' ' A' ' 354' ' ' VAL . . . -70.11 117.73 12.05 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 177.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . 0.903 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 15.3 t-80 48.31 62.18 2.65 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 124.166 0.916 . . . . 0.0 112.007 173.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . 0.772 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 43.35 40.08 4.54 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.963 -0.637 . . . . 0.0 114.507 -173.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . 0.612 HG23 ' O ' ' A' ' 347' ' ' HIS . 94.9 t -138.13 101.58 8.43 Favored Pre-proline 0 C--O 1.235 0.319 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -72.04 68.88 3.17 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.593 2.196 . . . . 0.0 112.357 178.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -99.85 -56.35 2.41 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 176.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 5.3 p -128.88 136.9 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.264 172.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . 0.554 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 35.0 t30 -62.18 110.58 1.66 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.905 174.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.516 ' CG1' HD22 ' A' ' 376' ' ' LEU . 27.7 m -88.36 3.04 5.66 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.346 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . . . . . . . . . . . -75.14 82.29 2.31 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 121.312 0.577 . . . . 0.0 110.771 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 356' ' ' MET . . . . . 0.554 ' HB2' ' O ' ' A' ' 375' ' ' GLN . 62.5 mtt -98.19 99.67 10.92 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 168.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.631 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 34.5 mt -82.1 141.48 33.1 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.052 -162.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.719 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 4.1 mm -83.64 -21.53 8.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 178.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 6.6 m -141.39 96.97 6.89 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 113.828 -1.533 . . . . 0.0 108.673 171.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 360' ' ' PRO . . . . . 0.457 ' HA ' HD12 ' A' ' 357' ' ' LEU . 91.5 Cg_endo -89.05 39.89 0.48 Allowed 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 123.136 2.557 . . . . 0.0 114.259 -170.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . 0.58 HD22 ' N ' ' A' ' 361' ' ' ASN . 0.0 OUTLIER -156.85 72.78 4.7 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-O 121.406 0.622 . . . . 0.0 111.234 176.689 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . 0.746 ' HG2' ' HB ' ' A' ' 340' ' ' ILE . 83.2 Cg_endo -85.08 154.31 11.11 Favored 'Trans proline' 0 C--O 1.243 0.731 0 C-N-CA 122.788 2.325 . . . . 0.0 113.029 176.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 1.8 p -143.98 141.12 30.0 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.054 -176.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 364' ' ' MET . . . . . 0.769 ' HG2' ' SG ' ' A' ' 338' ' ' CYS . 10.7 ptp -94.83 130.87 41.22 Favored 'General case' 0 CA--C 1.5 -0.98 0 C-N-CA 119.578 -0.849 . . . . 0.0 108.785 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -126.82 -166.76 1.63 Allowed 'General case' 0 C--N 1.322 -0.616 0 O-C-N 124.824 1.327 . . . . 0.0 111.777 -171.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . 0.533 HD22 ' N ' ' A' ' 366' ' ' ASN . 0.1 OUTLIER -42.99 -30.95 0.46 Allowed 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -178.328 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -116.66 3.11 13.05 Favored 'General case' 0 C--N 1.328 -0.333 0 O-C-N 121.846 -0.534 . . . . 0.0 112.188 -175.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . 0.587 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . 122.87 -176.88 16.59 Favored Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -177.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . 0.767 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -57.98 -32.46 66.64 Favored Glycine 0 CA--C 1.506 -0.53 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.835 173.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . 0.621 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 82.78 -131.36 10.32 Favored Glycine 0 N--CA 1.435 -1.379 0 C-N-CA 120.029 -1.081 . . . . 0.0 111.081 -177.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -103.46 137.66 41.25 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.336 0.589 . . . . 0.0 111.558 -175.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 372' ' ' ILE . . . . . 0.679 HG23 ' HB3' ' A' ' 362' ' ' PRO . 0.8 OUTLIER -130.41 150.33 34.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.366 176.73 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.719 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 38.4 mt-10 -116.62 127.08 54.13 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 120.412 -0.515 . . . . 0.0 110.513 -175.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . 0.87 ' HG2' HD11 ' A' ' 383' ' ' ILE . 4.1 ppp? -139.38 160.51 39.67 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -179.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 375' ' ' GLN . . . . . 0.915 ' HA ' HE21 ' A' ' 375' ' ' GLN . 0.0 OUTLIER -176.44 174.54 1.91 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.95 0.405 . . . . 0.0 110.89 174.346 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 376' ' ' LEU . . . . . 0.874 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 6.6 tp -165.17 158.74 14.18 Favored Pre-proline 0 N--CA 1.445 -0.676 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 377' ' ' PRO . . . . . 0.874 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 66.4 Cg_exo -40.97 129.34 2.89 Favored 'Trans proline' 0 CA--C 1.532 0.411 0 C-N-CA 121.77 1.647 . . . . 0.0 111.259 167.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.627 ' HA ' HE22 ' A' ' 394' ' ' GLN . 2.7 Cg_exo -35.8 140.75 0.12 Allowed 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 124.948 3.765 . . . . 0.0 113.502 -174.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 151.45 -161.77 29.31 Favored Glycine 0 N--CA 1.442 -0.935 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -162.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . 0.903 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 5.3 m-20 -101.86 129.42 48.09 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 117.918 0.859 . . . . 0.0 110.877 177.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.427 ' HB3' ' HE3' ' A' ' 374' ' ' MET . 9.7 m120 -128.66 146.25 50.92 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 176.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 1.052 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -149.61 138.17 14.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 177.773 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . 0.87 HD11 ' HG2' ' A' ' 374' ' ' MET . 43.9 mt -101.63 135.66 37.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.693 -171.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 384' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -105.12 96.68 6.7 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.549 -1.205 . . . . 0.0 108.795 169.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . 0.581 HG21 HG11 ' A' ' 330' ' ' VAL . 2.3 t -80.36 79.2 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.778 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 174.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 65.93 -104.45 1.02 Allowed Glycine 0 N--CA 1.43 -1.753 0 C-N-CA 119.388 -1.387 . . . . 0.0 110.16 -163.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 387' ' ' ASP . . . . . 0.56 ' HB2' ' HD3' ' A' ' 309' ' ' LYS . 35.9 t70 -98.63 -12.15 21.39 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 175.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.69 107.91 4.76 Favored 'General case' 0 CA--C 1.511 -0.537 0 O-C-N 121.771 -0.581 . . . . 0.0 109.773 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . 0.452 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 5.8 p30 -114.17 144.05 43.82 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 -176.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . 0.404 ' CE1' ' HD3' ' A' ' 318' ' ' PRO . 0.3 OUTLIER -169.42 108.61 0.43 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.09 0.472 . . . . 0.0 111.286 -177.31 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 391' ' ' GLN . . . . . 1.052 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 19.6 tt0 -78.01 154.16 31.73 Favored 'General case' 0 C--N 1.345 0.407 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -172.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 392' ' ' TRP . . . . . . . . . . . . . 39.7 t-105 -154.71 148.43 25.43 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.321 177.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -107.25 119.16 38.64 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 173.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.649 ' HG2' HE22 ' A' ' 375' ' ' GLN . 0.0 OUTLIER -108.86 136.76 47.88 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.456 0.646 . . . . 0.0 111.857 -169.745 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 19.8 tptp . . . . . 0 C--O 1.247 0.936 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.988 175.528 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . 0.534 ' O ' HG23 ' A' ' 335' ' ' THR . 6.1 t . . . . . 0 CA--C 1.536 0.441 0 CA-C-O 120.908 0.385 . . . . 0.0 111.613 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . 0.438 ' O ' ' HB ' ' A' ' 305' ' ' THR . 5.3 p90 -59.38 132.47 54.11 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 120.462 -0.495 . . . . 0.0 110.077 177.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.47 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 15.2 t 172.5 -167.68 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 -172.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 64.7 t -62.19 114.23 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 171.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . 0.616 ' HB3' ' HE1' ' A' ' 364' ' ' MET . 0.1 OUTLIER -69.03 135.18 50.46 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.146 0.498 . . . . 0.0 111.753 -172.193 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . 0.451 ' HB3' ' NZ ' ' A' ' 311' ' ' LYS . 22.4 t70 -55.29 111.58 0.9 Allowed 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.475 175.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.555 ' HD3' ' HB2' ' A' ' 387' ' ' ASP . 0.0 OUTLIER -40.77 -24.36 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 115.845 1.795 . . . . 0.0 115.845 -169.189 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.531 ' N ' ' HD2' ' A' ' 309' ' ' LYS . 11.7 t -98.71 -4.14 34.27 Favored 'General case' 0 C--N 1.314 -0.96 0 O-C-N 121.677 -0.639 . . . . 0.0 111.773 -171.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.676 ' HE3' ' H ' ' A' ' 335' ' ' THR . 29.0 mtmm -84.87 48.56 1.57 Allowed 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 120.936 0.398 . . . . 0.0 111.081 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.533 ' CD1' ' HB ' ' A' ' 330' ' ' VAL . 4.9 m-85 -139.65 153.82 47.4 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.662 -178.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 22.7 p -138.18 149.19 45.6 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.17 177.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 8.4 m-90 -67.7 116.12 8.04 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.471 0.653 . . . . 0.0 110.217 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.458 ' HB3' ' C ' ' A' ' 329' ' ' GLU . 53.2 tptt -96.69 -57.45 2.29 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 106.755 -1.572 . . . . 0.0 106.755 172.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 316' ' ' ARG . 27.2 ttm-85 -139.04 114.81 9.99 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.631 -1.168 . . . . 0.0 108.298 172.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . 0.489 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -68.21 160.8 73.3 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -178.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . 0.619 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 3.8 Cg_exo -43.06 110.96 0.19 Allowed 'Trans proline' 0 C--N 1.358 1.058 0 C-N-CA 122.237 1.958 . . . . 0.0 112.875 -175.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 31.1 m -127.07 128.76 46.77 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.266 -174.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -55.69 120.35 7.14 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . 0.489 ' HA ' HG22 ' A' ' 327' ' ' VAL . 82.9 p -47.74 -54.26 12.74 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 123.205 0.602 . . . . 0.0 111.053 -169.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 141.47 -17.04 2.67 Favored Glycine 0 N--CA 1.443 -0.86 0 CA-C-N 114.909 -1.042 . . . . 0.0 111.532 -179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . 0.56 ' O ' ' HB2' ' A' ' 324' ' ' ASP . 7.1 t-80 -122.73 23.94 9.29 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 120.722 0.296 . . . . 0.0 110.585 -179.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . 0.56 ' HB2' ' O ' ' A' ' 323' ' ' HIS . 5.6 m-20 92.69 45.94 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.122 0.969 . . . . 0.0 111.751 169.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . 0.676 ' HA ' ' HG2' ' A' ' 375' ' ' GLN . 1.8 p -154.55 -167.1 2.51 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 174.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.956 HG21 ' HZ2' ' A' ' 392' ' ' TRP . 3.0 t -134.38 142.13 41.64 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.395 0 CA-C-N 119.477 1.035 . . . . 0.0 111.855 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 327' ' ' VAL . . . . . 0.804 HG12 ' HG2' ' A' ' 373' ' ' GLU . 17.4 m -119.02 156.32 21.11 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.882 174.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 328' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.02 150.48 34.03 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 177.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.458 ' C ' ' HB3' ' A' ' 315' ' ' LYS . 24.5 tt0 -132.99 132.5 41.97 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -175.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.696 HG11 HG11 ' A' ' 385' ' ' VAL . 0.0 OUTLIER -130.02 150.82 35.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -176.17 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . 0.52 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -120.72 134.52 10.31 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.404 -0.903 . . . . 0.0 112.052 176.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -103.83 174.65 5.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.142 0.471 . . . . 0.0 111.092 -179.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 30.2 m -148.66 49.37 1.01 Allowed 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 170.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -177.05 -88.35 0.07 OUTLIER Glycine 0 C--N 1.339 0.703 0 C-N-CA 119.794 -1.193 . . . . 0.0 113.925 168.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 335' ' ' THR . . . . . 0.676 ' H ' ' HE3' ' A' ' 311' ' ' LYS . 50.3 m -51.3 130.62 27.23 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 114.701 -0.75 . . . . 0.0 110.324 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.802 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 8.1 ptm180 -79.1 -176.01 0.65 Allowed Pre-proline 0 CA--C 1.533 0.322 0 CA-C-O 117.633 -1.175 . . . . 0.0 108.986 -174.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.802 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -24.79 103.14 0.02 OUTLIER 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 123.955 3.103 . . . . 0.0 114.045 -177.479 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 338' ' ' CYS . . . . . 0.723 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 8.9 p -111.42 -174.95 2.58 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 113.587 -1.642 . . . . 0.0 111.023 -168.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -107.89 96.51 6.43 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 106.702 -1.592 . . . . 0.0 106.702 177.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . 0.849 HG22 HG13 ' A' ' 342' ' ' VAL . 27.3 mt -74.08 120.41 81.2 Favored Pre-proline 0 C--N 1.327 -0.387 0 C-N-CA 120.203 -0.599 . . . . 0.0 111.185 -166.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -81.25 80.69 2.9 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 122.295 1.996 . . . . 0.0 111.057 175.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.849 HG13 HG22 ' A' ' 340' ' ' ILE . 6.7 m -100.13 123.5 53.02 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.024 0 CA-C-O 121.986 0.898 . . . . 0.0 109.837 176.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.516 ' HG3' ' HB2' ' A' ' 384' ' ' TYR . 24.3 ptt180 -132.94 173.05 11.81 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 114.324 -1.307 . . . . 0.0 107.748 176.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 344' ' ' ALA . . . . . 0.553 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -143.27 141.09 30.92 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 173.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 17.5 m -115.83 145.27 21.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.12 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -63.91 115.83 5.24 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.005 177.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . 0.595 ' HB3' ' CB ' ' A' ' 380' ' ' ASP . 23.8 p80 35.79 71.11 0.13 Allowed 'General case' 0 N--CA 1.475 0.793 0 O-C-N 124.53 1.144 . . . . 0.0 112.601 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . 0.826 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 41.99 47.15 5.23 Favored Glycine 0 C--N 1.333 0.403 0 N-CA-C 115.191 0.836 . . . . 0.0 115.191 -175.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 347' ' ' HIS . 90.1 t -142.61 102.49 5.44 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 176.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -75.95 66.1 6.84 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.865 2.377 . . . . 0.0 112.781 -178.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -100.99 -55.97 2.43 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 177.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 7.4 p -124.96 133.18 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.45 171.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . . . . . . . . . 49.8 t30 -64.82 112.49 3.28 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.333 177.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.529 ' HB ' HD22 ' A' ' 376' ' ' LEU . 32.7 m -89.98 1.8 7.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.917 178.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . 0.553 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -74.44 84.11 1.98 Allowed 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.181 0.515 . . . . 0.0 110.558 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 356' ' ' MET . . . . . 0.625 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 58.6 ttp -94.0 99.95 12.17 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 172.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.587 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 19.9 mt -85.34 115.45 23.1 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.494 -161.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.595 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 3.1 mm -59.18 -26.65 34.09 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.045 174.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 34.5 m -137.53 90.73 14.6 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.701 174.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -83.6 38.93 0.75 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.416 2.744 . . . . 0.0 113.461 -172.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -147.57 69.37 11.29 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.689 177.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . 0.784 ' HB3' HG23 ' A' ' 372' ' ' ILE . 63.0 Cg_endo -79.59 143.58 17.04 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.234 1.956 . . . . 0.0 111.825 176.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 363' ' ' THR . . . . . 0.416 ' O ' ' HA2' ' A' ' 369' ' ' GLY . 1.3 p -143.64 133.76 24.32 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.45 -173.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 364' ' ' MET . . . . . 0.723 ' HG2' ' SG ' ' A' ' 338' ' ' CYS . 19.2 ptt? -98.72 111.95 24.17 Favored 'General case' 0 CA--C 1.501 -0.928 0 C-N-CA 119.095 -1.042 . . . . 0.0 109.195 177.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.466 ' CD ' ' HG3' ' A' ' 337' ' ' PRO . 67.1 mm-40 -103.13 -163.74 1.02 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 113.029 -1.896 . . . . 0.0 109.947 -173.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -48.31 -22.84 0.75 Allowed 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 -179.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -111.12 -2.58 15.78 Favored 'General case' 0 N--CA 1.463 0.182 0 O-C-N 121.795 -0.566 . . . . 0.0 111.273 -178.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . 0.52 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . 107.73 -167.19 13.38 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -172.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . 0.587 ' HA3' HG23 ' A' ' 330' ' ' VAL . . . -65.42 103.8 0.87 Allowed Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 110.736 -0.945 . . . . 0.0 110.736 170.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . 0.425 ' O ' ' HG3' ' A' ' 329' ' ' GLU . . . -72.41 -32.7 62.01 Favored Glycine 0 C--N 1.317 -0.514 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.518 -167.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -164.29 138.65 5.54 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 123.823 0.366 . . . . 0.0 110.458 179.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 372' ' ' ILE . . . . . 0.784 HG23 ' HB3' ' A' ' 362' ' ' PRO . 0.3 OUTLIER -137.63 156.14 31.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 171.063 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.804 ' HG2' HG12 ' A' ' 327' ' ' VAL . 43.1 mt-10 -134.62 125.53 27.36 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -178.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . 0.587 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 2.4 mtt -142.94 164.51 29.89 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -174.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 375' ' ' GLN . . . . . 0.835 ' HA ' HE21 ' A' ' 375' ' ' GLN . 0.0 OUTLIER 177.97 179.08 0.32 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 118.132 0.423 . . . . 0.0 110.929 175.653 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 376' ' ' LEU . . . . . 0.916 ' HG ' ' HD2' ' A' ' 377' ' ' PRO . 14.2 tp -165.95 160.74 13.09 Favored Pre-proline 0 N--CA 1.446 -0.64 0 N-CA-C 104.867 -2.271 . . . . 0.0 104.867 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 377' ' ' PRO . . . . . 0.916 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 81.2 Cg_exo -44.54 131.09 9.6 Favored 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 121.502 1.468 . . . . 0.0 111.328 169.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.775 ' HA ' HE22 ' A' ' 394' ' ' GLN . 2.8 Cg_exo -37.03 138.86 0.22 Allowed 'Trans proline' 0 C--N 1.36 1.176 0 C-N-CA 124.607 3.538 . . . . 0.0 112.911 -175.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 152.66 -163.81 30.5 Favored Glycine 0 N--CA 1.447 -0.595 0 N-CA-C 110.712 -0.955 . . . . 0.0 110.712 -162.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . 0.595 ' CB ' ' HB3' ' A' ' 347' ' ' HIS . 17.6 m-20 -98.86 122.59 42.29 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 117.468 0.634 . . . . 0.0 111.5 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.563 ' HB2' ' CH2' ' A' ' 392' ' ' TRP . 6.1 m120 -124.83 175.17 7.45 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 171.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 1.019 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -163.19 141.42 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 N-CA-C 107.721 -1.215 . . . . 0.0 107.721 167.304 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . 0.653 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 45.9 mt -101.71 132.23 48.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 C-N-CA 119.674 -0.81 . . . . 0.0 110.456 -174.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 384' ' ' TYR . . . . . 0.555 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 1.9 m-85 -102.33 128.89 48.7 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 114.483 -1.235 . . . . 0.0 107.782 168.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . 0.696 HG11 HG11 ' A' ' 330' ' ' VAL . 15.2 t -118.48 77.15 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 63.16 -110.49 3.4 Favored Glycine 0 N--CA 1.43 -1.716 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.842 -161.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 387' ' ' ASP . . . . . 0.555 ' HB2' ' HD3' ' A' ' 309' ' ' LYS . 34.1 t70 -81.15 -20.31 41.6 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 177.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.555 ' O ' ' HA ' ' A' ' 384' ' ' TYR . 1.2 mp -68.54 153.03 44.55 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.909 -0.317 . . . . 0.0 110.254 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . 0.653 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 5.0 p-10 -160.24 155.26 24.59 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.08 177.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . 0.619 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 31.6 t60 -171.46 112.12 0.34 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.816 175.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 391' ' ' GLN . . . . . 1.019 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 15.3 tt0 -75.93 149.33 37.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.788 -178.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 392' ' ' TRP . . . . . 0.956 ' HZ2' HG21 ' A' ' 326' ' ' VAL . 0.1 OUTLIER -168.18 151.32 5.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.049 0.452 . . . . 0.0 110.142 -179.111 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -101.05 118.87 37.84 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 178.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.775 HE22 ' HA ' ' A' ' 378' ' ' PRO . 0.0 OUTLIER -95.64 131.81 41.48 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.308 -170.27 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.473 ' HD2' ' HA ' ' A' ' 395' ' ' LYS . 21.7 tptp . . . . . 0 C--O 1.252 1.223 0 CA-C-N 114.184 -1.371 . . . . 0.0 110.281 178.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . 0.63 HG23 HG23 ' A' ' 335' ' ' THR . 5.2 t . . . . . 0 CA--C 1.536 0.412 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . 0.546 ' HB3' ' HG3' ' A' ' 336' ' ' ARG . 25.9 p90 -64.21 127.85 33.22 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 175.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.408 HG23 ' O ' ' A' ' 306' ' ' VAL . 14.3 t 178.45 -167.13 0.06 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -170.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.408 ' O ' HG23 ' A' ' 305' ' ' THR . 34.3 t -65.06 114.34 2.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 165.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -67.37 139.0 57.17 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.346 0.593 . . . . 0.0 110.414 -170.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . 0.487 ' HB3' ' HG2' ' A' ' 311' ' ' LYS . 5.4 t70 -60.94 126.71 28.36 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.609 -179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.547 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 0.0 OUTLIER -44.02 -13.61 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 -175.38 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.413 ' N ' ' HD2' ' A' ' 309' ' ' LYS . 12.5 t -108.07 0.46 21.73 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 119.39 0.996 . . . . 0.0 111.8 -176.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.487 ' HG2' ' HB3' ' A' ' 308' ' ' ASP . 29.6 mmmt -72.68 -33.06 66.26 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -175.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.808 ' HD1' HD13 ' A' ' 388' ' ' LEU . 0.6 OUTLIER -90.95 175.67 6.88 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 122.29 1.043 . . . . 0.0 112.798 -174.77 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 8.7 t -153.98 162.27 41.34 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 113.285 -1.78 . . . . 0.0 109.697 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . 0.638 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 24.0 m-90 -77.75 92.88 4.22 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -178.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -71.57 -43.04 67.03 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 171.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -154.02 124.4 7.0 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 171.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . 0.507 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -70.7 163.59 62.74 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 119.139 -0.458 . . . . 0.0 109.99 -177.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . 0.546 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 2.4 Cg_endo -46.19 113.5 0.63 Allowed 'Trans proline' 0 C--N 1.356 0.965 0 C-N-CA 122.067 1.845 . . . . 0.0 112.281 -179.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 21.7 m -129.5 133.96 47.53 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.629 -1.169 . . . . 0.0 109.881 -172.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . 0.431 ' HA ' HG13 ' A' ' 326' ' ' VAL . 28.4 t70 -55.84 123.14 13.24 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -178.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . 0.446 ' HB3' HG13 ' A' ' 327' ' ' VAL . 81.0 p -62.66 -47.78 82.18 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 121.339 0.59 . . . . 0.0 109.883 -174.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 120.27 -15.0 10.11 Favored Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -109.05 49.2 0.83 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.774 0.797 . . . . 0.0 108.974 177.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 50.67 41.12 25.52 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 114.647 -1.161 . . . . 0.0 112.597 -178.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . 0.584 ' HA ' ' HG3' ' A' ' 375' ' ' GLN . 6.2 p -150.39 -173.42 4.45 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 175.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.893 HG23 ' HG2' ' A' ' 375' ' ' GLN . 1.5 t -133.75 146.0 32.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 C-N-CA 120.349 -0.54 . . . . 0.0 110.94 -178.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 327' ' ' VAL . . . . . 0.761 HG12 ' HG2' ' A' ' 373' ' ' GLU . 20.6 m -123.6 155.86 30.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.774 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 328' ' ' MET . . . . . 0.492 ' CG ' HD12 ' A' ' 372' ' ' ILE . 0.0 OUTLIER -143.63 154.21 43.31 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 173.934 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -132.58 130.65 40.57 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.704 HG21 HD13 ' A' ' 340' ' ' ILE . 0.0 OUTLIER -118.54 162.21 16.83 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -179.231 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . 0.802 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -118.55 172.65 14.57 Favored Glycine 0 C--O 1.227 -0.341 0 C-N-CA 119.712 -1.232 . . . . 0.0 112.531 172.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . 0.794 ' HD1' ' HA2' ' A' ' 368' ' ' GLY . 0.9 OUTLIER -127.84 135.78 50.52 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 179.726 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 29.0 m -85.82 -21.01 28.32 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 176.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -171.53 -50.37 0.04 OUTLIER Glycine 0 C--N 1.335 0.518 0 C-N-CA 118.357 -1.878 . . . . 0.0 115.054 -179.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 335' ' ' THR . . . . . 0.63 HG23 HG23 ' A' ' 303' ' ' THR . 65.8 m -49.59 129.74 19.69 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 123.892 0.407 . . . . 0.0 110.115 -178.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.639 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 1.0 OUTLIER -82.37 176.45 3.81 Favored Pre-proline 0 N--CA 1.451 -0.416 0 CA-C-O 117.366 -1.302 . . . . 0.0 107.631 -172.413 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.716 ' HA ' ' O ' ' A' ' 364' ' ' MET . 0.1 OUTLIER -25.25 98.46 0.01 OUTLIER 'Trans proline' 0 C--N 1.363 1.342 0 C-N-CA 123.727 2.951 . . . . 0.0 114.053 -173.323 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 338' ' ' CYS . . . . . 0.704 ' SG ' ' HB2' ' A' ' 364' ' ' MET . 6.5 p -129.7 139.54 51.32 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 113.971 -1.468 . . . . 0.0 108.444 -171.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -65.6 124.54 22.64 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.395 -0.522 . . . . 0.0 109.706 177.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . 0.704 HD13 HG21 ' A' ' 330' ' ' VAL . 18.6 tt -98.45 118.72 62.94 Favored Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.273 -177.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.7 95.23 0.71 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.949 2.432 . . . . 0.0 112.336 -177.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.75 HG11 HD13 ' A' ' 372' ' ' ILE . 15.4 m -110.07 122.53 64.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.643 0.735 . . . . 0.0 110.812 179.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 14.6 ptt180 -133.5 -178.25 4.91 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 173.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 344' ' ' ALA . . . . . 0.5 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -147.03 147.81 31.04 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.629 177.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.592 HG22 HD12 ' A' ' 382' ' ' ILE . 4.8 m -118.94 142.47 33.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 177.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.469 ' HB2' HG11 ' A' ' 354' ' ' VAL . . . -65.48 127.67 32.78 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 113.148 0.795 . . . . 0.0 113.148 177.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . 0.591 ' O ' HG23 ' A' ' 349' ' ' VAL . 35.2 t60 41.44 60.38 2.13 Favored 'General case' 0 N--CA 1.475 0.805 0 O-C-N 124.204 0.94 . . . . 0.0 112.038 174.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . 0.51 ' H ' ' CG2' ' A' ' 382' ' ' ILE . . . 44.85 38.62 5.85 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 115.035 0.774 . . . . 0.0 115.035 -175.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 347' ' ' HIS . 58.4 t -135.85 103.15 10.04 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 117.917 0.859 . . . . 0.0 108.863 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . 0.49 ' HA ' ' HB ' ' A' ' 345' ' ' VAL . 15.4 Cg_exo -72.65 62.12 3.71 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.861 2.374 . . . . 0.0 112.936 -179.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -100.4 -55.2 2.67 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 7.7 p -124.83 133.76 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.456 174.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . 0.5 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 37.4 t30 -66.72 116.14 7.31 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.482 176.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.63 ' HB ' HD22 ' A' ' 376' ' ' LEU . 27.5 m -101.06 5.92 10.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.292 -176.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . 0.435 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -74.82 87.03 2.24 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.194 0.521 . . . . 0.0 112.027 -177.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.1 99.45 11.43 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 106.596 -1.631 . . . . 0.0 106.596 170.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 43.1 mt -87.37 121.82 30.32 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.607 -164.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.918 HD11 ' HB2' ' A' ' 375' ' ' GLN . 2.8 mm -63.25 -29.77 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.565 175.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 27.6 m -133.81 91.42 25.07 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.467 173.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -85.01 39.9 0.78 Allowed 'Trans proline' 0 N--CA 1.46 -0.461 0 C-N-CA 123.518 2.812 . . . . 0.0 113.801 -170.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -158.4 70.74 3.86 Favored Pre-proline 0 C--N 1.319 -0.76 0 C-N-CA 120.823 -0.351 . . . . 0.0 111.288 176.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . 0.478 ' HG3' HG21 ' A' ' 342' ' ' VAL . 97.8 Cg_endo -84.31 147.99 11.5 Favored 'Trans proline' 0 C--O 1.247 0.94 0 C-N-CA 122.17 1.913 . . . . 0.0 111.759 173.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 4.6 m -143.07 150.95 40.22 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -174.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 364' ' ' MET . . . . . 0.716 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 60.3 mtp -100.14 120.98 40.7 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.584 -176.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.474 ' HG2' ' HG3' ' A' ' 337' ' ' PRO . 57.8 mt-10 -145.26 -166.0 2.32 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.005 -1.452 . . . . 0.0 109.68 -165.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . 0.55 HD22 ' N ' ' A' ' 366' ' ' ASN . 0.1 OUTLIER -49.38 -9.38 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 63.8 m-80 -107.35 -14.72 14.81 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.475 1.034 . . . . 0.0 110.027 -179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . 0.802 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . 126.12 -105.42 0.79 Allowed Glycine 0 CA--C 1.494 -1.255 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -171.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . 0.584 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -109.17 5.55 31.96 Favored Glycine 0 C--N 1.307 -1.07 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 168.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 75.44 -84.06 0.87 Allowed Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 114.693 -0.754 . . . . 0.0 113.949 174.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -166.81 141.52 4.1 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.222 -0.489 . . . . 0.0 110.596 -173.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 372' ' ' ILE . . . . . 0.75 HD13 HG11 ' A' ' 342' ' ' VAL . 0.7 OUTLIER -136.72 145.4 30.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.113 175.395 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.761 ' HG2' HG12 ' A' ' 327' ' ' VAL . 43.5 mt-10 -127.71 125.68 40.46 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 177.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . 0.786 ' HE3' HD11 ' A' ' 383' ' ' ILE . 0.0 OUTLIER -139.18 156.07 47.38 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.286 -174.227 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 375' ' ' GLN . . . . . 0.918 ' HB2' HD11 ' A' ' 358' ' ' ILE . 0.0 OUTLIER -168.94 175.82 5.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.422 0.629 . . . . 0.0 112.337 175.798 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 376' ' ' LEU . . . . . 0.63 HD22 ' HB ' ' A' ' 354' ' ' VAL . 16.4 tp -168.18 145.09 3.38 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 174.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 377' ' ' PRO . . . . . 0.605 ' HD2' ' HG ' ' A' ' 376' ' ' LEU . 80.8 Cg_exo -40.93 140.92 1.04 Allowed 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.266 1.977 . . . . 0.0 112.165 177.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.87 ' HA ' HE22 ' A' ' 394' ' ' GLN . 4.4 Cg_exo -35.46 139.65 0.12 Allowed 'Trans proline' 0 C--N 1.357 1.008 1 C-N-CA 125.488 4.125 . . . . 0.0 114.106 -169.437 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 149.74 -163.09 29.29 Favored Glycine 0 N--CA 1.442 -0.916 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 -166.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . 0.555 ' OD1' ' HB2' ' A' ' 347' ' ' HIS . 1.5 p30 -113.2 136.76 52.37 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.781 0.8 . . . . 0.0 111.804 176.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.408 ' HB2' ' CH2' ' A' ' 392' ' ' TRP . 20.2 m-80 -136.05 171.26 14.72 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.818 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 1.017 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -156.91 143.93 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.826 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 174.133 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . 0.786 HD11 ' HE3' ' A' ' 374' ' ' MET . 45.1 mt -95.3 127.95 46.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 C-N-CA 120.109 -0.636 . . . . 0.0 110.147 -177.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 384' ' ' TYR . . . . . 0.41 ' O ' ' HG2' ' A' ' 343' ' ' ARG . 0.2 OUTLIER -103.31 92.32 4.45 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.097 170.56 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . 0.572 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 15.6 t -87.86 82.9 2.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 178.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 57.81 -111.32 2.93 Favored Glycine 0 CA--C 1.523 0.537 0 C-N-CA 120.415 -0.898 . . . . 0.0 111.777 -173.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 387' ' ' ASP . . . . . 0.44 ' HB2' ' HD3' ' A' ' 309' ' ' LYS . 32.1 t70 -77.03 -24.84 52.07 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.884 0.373 . . . . 0.0 111.306 175.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.808 HD13 ' HD1' ' A' ' 312' ' ' PHE . 3.6 mp -71.43 156.46 39.43 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.403 -179.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . 0.7 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 7.7 p30 -169.49 153.56 5.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.196 178.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . 0.546 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 56.7 t-80 -175.88 117.7 0.15 Allowed 'General case' 0 N--CA 1.469 0.503 0 O-C-N 123.283 0.365 . . . . 0.0 110.486 177.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 391' ' ' GLN . . . . . 1.017 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 4.1 tt0 -73.4 154.94 39.81 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.103 0.478 . . . . 0.0 112.114 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 392' ' ' TRP . . . . . 0.512 ' HE1' ' HB3' ' A' ' 394' ' ' GLN . 0.1 OUTLIER -160.76 151.4 18.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.198 -0.91 . . . . 0.0 108.804 176.558 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -113.91 131.85 56.14 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 177.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.897 ' HG2' HE22 ' A' ' 375' ' ' GLN . 0.0 OUTLIER -111.72 136.13 51.39 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.753 0.311 . . . . 0.0 110.542 -177.131 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.487 ' O ' ' HB3' ' A' ' 378' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.922 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.462 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . 0.535 ' O ' HG23 ' A' ' 335' ' ' THR . 4.3 t . . . . . 0 CA--C 1.535 0.402 0 CA-C-O 120.787 0.327 . . . . 0.0 111.218 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . 0.489 ' HB3' ' NE ' ' A' ' 336' ' ' ARG . 0.8 OUTLIER -59.35 133.27 55.95 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.965 0.412 . . . . 0.0 110.002 178.814 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.528 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 12.8 t 174.46 -170.68 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -175.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 18.5 t -65.46 116.25 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 170.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . 0.486 ' HB3' ' CE2' ' A' ' 332' ' ' PHE . 0.0 OUTLIER -67.65 139.26 56.8 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -173.134 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . 0.642 ' OD2' HG22 ' A' ' 310' ' ' THR . 15.8 t70 -59.45 118.03 5.55 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.064 -176.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.455 ' HD2' ' N ' ' A' ' 310' ' ' THR . 0.0 OUTLIER -48.2 -15.87 0.08 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 -168.781 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.642 HG22 ' OD2' ' A' ' 308' ' ' ASP . 9.2 t -99.35 -10.93 21.69 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 118.663 0.665 . . . . 0.0 110.82 -175.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.554 ' HE2' ' CE1' ' A' ' 332' ' ' PHE . 24.5 mtpt -83.67 51.99 2.15 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.487 0.661 . . . . 0.0 110.579 -178.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.519 ' HZ ' ' HG3' ' A' ' 364' ' ' MET . 11.3 m-85 -141.7 151.89 43.38 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.265 -0.879 . . . . 0.0 111.675 -179.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . 0.4 ' C ' HD21 ' A' ' 388' ' ' LEU . 18.7 p -142.49 152.52 42.78 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.559 -1.2 . . . . 0.0 109.296 178.162 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 65.7 m95 -82.23 95.39 7.53 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.132 0.491 . . . . 0.0 110.804 178.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.792 ' HA ' ' HE3' ' A' ' 315' ' ' LYS . 0.4 OUTLIER -65.3 -46.47 80.24 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 167.56 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 8.0 ttm180 -150.09 126.71 10.92 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 114.85 -1.068 . . . . 0.0 108.883 173.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . 0.486 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -72.94 160.91 81.76 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-O 119.218 -0.42 . . . . 0.0 110.162 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . 0.545 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 2.7 Cg_endo -43.55 114.35 0.49 Allowed 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 122.653 2.236 . . . . 0.0 112.492 -176.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 15.8 m -133.78 136.37 44.48 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.438 -174.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -63.66 125.8 25.48 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 -176.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . 0.528 ' HB3' HG13 ' A' ' 327' ' ' VAL . 93.7 p -56.17 -48.79 75.66 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.782 -171.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 133.69 -10.44 4.91 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 36.8 t-80 -128.03 61.34 1.44 Allowed 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 121.346 0.593 . . . . 0.0 109.74 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 52.76 35.62 19.1 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 114.921 -1.036 . . . . 0.0 113.547 177.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . 0.676 ' HA ' ' HG3' ' A' ' 375' ' ' GLN . 3.7 p -148.48 -175.12 4.8 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 177.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.832 HG23 ' HG2' ' A' ' 375' ' ' GLN . 0.2 OUTLIER -130.88 145.91 34.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.34 0.59 . . . . 0.0 111.032 -177.327 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 327' ' ' VAL . . . . . 0.668 HG12 ' HG3' ' A' ' 373' ' ' GLU . 16.9 m -123.44 150.48 27.63 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.97 175.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 328' ' ' MET . . . . . 0.532 ' SD ' ' HB ' ' A' ' 372' ' ' ILE . 0.1 OUTLIER -139.65 149.54 43.86 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 175.229 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.732 ' HG2' ' HG2' ' A' ' 315' ' ' LYS . 4.6 tt0 -125.3 121.63 34.54 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -177.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.444 ' HB ' ' HD1' ' A' ' 312' ' ' PHE . 4.2 m -126.65 145.03 34.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.718 -174.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 312' ' ' PHE . . . -111.67 131.82 10.49 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 119.915 -1.136 . . . . 0.0 112.381 179.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . 0.975 ' H ' ' HA2' ' A' ' 368' ' ' GLY . 4.1 t80 -133.87 136.71 44.53 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.011 -0.736 . . . . 0.0 109.011 176.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 19.9 m -129.78 62.36 1.55 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -171.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -164.26 -84.28 0.05 OUTLIER Glycine 0 CA--C 1.52 0.348 0 C-N-CA 119.25 -1.452 . . . . 0.0 113.877 163.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 335' ' ' THR . . . . . 0.95 ' HB ' ' HZ ' ' A' ' 332' ' ' PHE . 35.3 m -50.59 135.82 22.31 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 114.328 -0.936 . . . . 0.0 109.89 179.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.891 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 17.8 ptt180 -72.69 179.98 0.96 Allowed Pre-proline 0 CA--C 1.523 -0.078 0 CA-C-O 117.783 -1.103 . . . . 0.0 108.923 -178.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.891 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -25.96 101.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.366 1.474 0 C-N-CA 123.653 2.902 . . . . 0.0 112.905 178.631 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 338' ' ' CYS . . . . . 0.563 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 29.0 p -113.88 -175.71 2.74 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 113.81 -1.541 . . . . 0.0 109.465 -165.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? -108.74 96.97 6.7 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . 0.752 ' HB ' ' SD ' ' A' ' 364' ' ' MET . 15.7 tt -73.8 131.23 82.07 Favored Pre-proline 0 C--N 1.325 -0.472 0 C-N-CA 119.604 -0.838 . . . . 0.0 111.449 -169.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -81.58 79.28 3.25 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 121.67 1.58 . . . . 0.0 111.156 172.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.669 HG22 HG23 ' A' ' 340' ' ' ILE . 2.5 m -101.62 116.09 44.59 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.594 0 CA-C-O 121.756 0.789 . . . . 0.0 110.313 177.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.541 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 25.6 ptt180 -133.8 177.85 7.4 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.761 -1.108 . . . . 0.0 108.162 178.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 344' ' ' ALA . . . . . 0.493 ' N ' ' HB2' ' A' ' 355' ' ' ALA . . . -149.95 147.16 27.55 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.579 176.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.617 HG22 HD12 ' A' ' 382' ' ' ILE . 5.8 m -118.38 143.03 30.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 177.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.26 121.88 15.81 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 112.757 0.651 . . . . 0.0 112.757 177.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . 0.529 ' O ' HG23 ' A' ' 349' ' ' VAL . 41.3 t-80 43.9 61.85 2.16 Favored 'General case' 0 N--CA 1.472 0.648 0 O-C-N 124.277 0.986 . . . . 0.0 112.54 173.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . 0.564 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 46.9 38.05 9.94 Favored Glycine 0 CA--C 1.521 0.451 0 N-CA-C 114.733 0.653 . . . . 0.0 114.733 -175.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 347' ' ' HIS . 58.5 t -138.34 102.88 8.0 Favored Pre-proline 0 C--O 1.235 0.305 0 CA-C-N 117.859 0.829 . . . . 0.0 108.91 178.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . 0.468 ' HA ' ' HB ' ' A' ' 345' ' ' VAL . 15.0 Cg_exo -72.6 63.53 3.78 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.848 2.366 . . . . 0.0 112.837 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -100.05 -56.23 2.42 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 7.6 p -125.05 133.1 70.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 115.038 -0.983 . . . . 0.0 110.278 174.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . 0.484 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 41.8 t30 -64.42 116.57 6.24 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.942 176.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.602 ' HB ' ' HG ' ' A' ' 376' ' ' LEU . 27.4 m -98.53 3.81 10.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.348 179.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . 0.493 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -74.14 84.58 1.84 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.278 0.561 . . . . 0.0 111.026 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 356' ' ' MET . . . . . 0.5 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 22.7 ttt -98.78 98.43 9.54 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 173.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.66 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 57.6 mt -83.06 147.39 28.16 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.655 -161.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.718 ' HB ' ' CB ' ' A' ' 373' ' ' GLU . 4.4 mm -88.68 -19.95 7.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 178.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 20.6 m -133.75 92.94 21.83 Favored Pre-proline 0 N--CA 1.445 -0.682 0 CA-C-N 113.605 -1.634 . . . . 0.0 108.339 171.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -88.51 25.77 0.61 Allowed 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 123.024 2.483 . . . . 0.0 114.074 -170.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . 0.498 ' N ' ' HD3' ' A' ' 362' ' ' PRO . 40.9 m-80 -149.65 57.6 2.85 Favored Pre-proline 0 C--N 1.314 -0.953 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.864 176.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . 0.515 ' HB3' HG23 ' A' ' 372' ' ' ILE . 4.9 Cg_endo -75.52 111.44 3.3 Favored 'Trans proline' 0 C--O 1.247 0.951 0 C-N-CA 121.447 1.432 . . . . 0.0 112.932 179.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 363' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 338' ' ' CYS . 15.8 p -96.68 125.54 41.22 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 114.924 -1.034 . . . . 0.0 111.59 167.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 364' ' ' MET . . . . . 0.814 ' HB3' ' CA ' ' A' ' 369' ' ' GLY . 0.0 OUTLIER -112.4 143.65 43.17 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.073 -1.421 . . . . 0.0 111.241 -176.089 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.468 ' HG2' ' HG3' ' A' ' 337' ' ' PRO . 41.9 mt-10 -103.6 172.36 6.85 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-O 121.953 0.882 . . . . 0.0 112.156 -171.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . 0.59 HD22 ' N ' ' A' ' 367' ' ' ASN . 0.2 OUTLIER -51.48 -6.29 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 113.167 -1.833 . . . . 0.0 113.569 172.977 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 367' ' ' ASN . . . . . 0.59 ' N ' HD22 ' A' ' 366' ' ' ASN . 10.1 p30 -115.71 -3.38 12.27 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.23 0.538 . . . . 0.0 110.26 -176.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . 0.975 ' HA2' ' H ' ' A' ' 332' ' ' PHE . . . 123.98 161.45 11.13 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.426 -176.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . 0.814 ' CA ' ' HB3' ' A' ' 364' ' ' MET . . . -76.41 -32.15 52.35 Favored Glycine 0 CA--C 1.498 -1.007 0 C-N-CA 120.37 -0.919 . . . . 0.0 113.163 177.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 87.6 -132.42 11.18 Favored Glycine 0 N--CA 1.438 -1.18 0 C-N-CA 120.03 -1.081 . . . . 0.0 111.002 -172.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -103.13 136.7 42.44 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.155 0.502 . . . . 0.0 111.4 -176.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 372' ' ' ILE . . . . . 0.532 ' HB ' ' SD ' ' A' ' 328' ' ' MET . 0.1 OUTLIER -128.07 165.18 27.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.584 175.752 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.718 ' CB ' ' HB ' ' A' ' 358' ' ' ILE . 11.3 mp0 -128.79 130.36 46.9 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 121.153 0.502 . . . . 0.0 110.637 -177.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . 0.676 ' HG2' HD11 ' A' ' 383' ' ' ILE . 0.0 OUTLIER -137.8 166.86 22.96 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.026 179.722 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 375' ' ' GLN . . . . . 0.832 ' HG2' HG23 ' A' ' 326' ' ' VAL . 0.0 OUTLIER -173.54 176.15 2.84 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.425 0.631 . . . . 0.0 110.809 168.153 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 376' ' ' LEU . . . . . 0.799 HD22 ' HD2' ' A' ' 377' ' ' PRO . 2.6 tm? -168.0 128.97 1.15 Allowed Pre-proline 0 C--N 1.317 -0.834 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 175.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 377' ' ' PRO . . . . . 0.799 ' HD2' HD22 ' A' ' 376' ' ' LEU . 34.0 Cg_exo -26.73 130.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 124.22 3.28 . . . . 0.0 113.161 -178.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -35.46 133.51 0.23 Allowed 'Trans proline' 0 C--N 1.361 1.2 0 C-N-CA 124.373 3.382 . . . . 0.0 113.0 -167.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 151.0 -174.45 30.27 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 -160.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . 0.66 ' HB3' ' CD2' ' A' ' 393' ' ' PHE . 4.4 p30 -98.41 125.25 43.5 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 117.787 0.794 . . . . 0.0 111.984 -173.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.635 HD22 ' HG2' ' A' ' 394' ' ' GLN . 33.1 m-80 -139.76 153.56 47.19 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.514 -176.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 0.981 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -144.5 140.3 23.97 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.872 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.676 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . 0.676 HD11 ' HG2' ' A' ' 374' ' ' MET . 37.3 mt -98.94 130.44 47.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.938 -175.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 384' ' ' TYR . . . . . 0.55 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.2 OUTLIER -106.71 92.0 3.92 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.51 -1.223 . . . . 0.0 109.006 174.058 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . 0.434 ' O ' ' HB2' ' A' ' 388' ' ' LEU . 9.5 t -87.02 87.71 2.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -179.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 64.57 -112.6 5.14 Favored Glycine 0 N--CA 1.442 -0.942 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -169.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -83.95 -16.81 42.81 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.72 0.295 . . . . 0.0 111.289 174.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.55 ' O ' ' HA ' ' A' ' 384' ' ' TYR . 1.2 mp -68.51 151.52 46.68 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.348 -179.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . 0.571 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 29.0 p30 -159.36 151.35 20.75 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.679 177.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . 0.545 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 8.7 t60 -172.26 116.1 0.34 Allowed 'General case' 0 C--O 1.239 0.504 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.481 175.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 391' ' ' GLN . . . . . 0.981 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 4.1 tt0 -76.87 153.75 34.45 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.803 -177.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 392' ' ' TRP . . . . . 0.455 ' HD1' ' CD ' ' A' ' 394' ' ' GLN . 38.8 t-105 -167.08 153.34 8.14 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.948 178.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . 0.66 ' CD2' ' HB3' ' A' ' 380' ' ' ASP . 29.2 m-85 -106.75 110.92 23.22 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 176.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.635 ' HG2' HD22 ' A' ' 381' ' ' ASN . 5.3 mm100 -75.76 107.55 8.01 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -169.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 9.7 ptmm? . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.466 -177.444 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . 0.621 HG23 HG23 ' A' ' 335' ' ' THR . 14.9 t . . . . . 0 CA--C 1.535 0.372 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -66.78 120.83 14.19 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.058 -177.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.615 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 9.4 t 173.55 -167.03 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.15 -0.932 . . . . 0.0 108.519 -170.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 37.2 t -64.91 113.07 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 169.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . 0.423 ' SG ' ' HE2' ' A' ' 332' ' ' PHE . 0.0 OUTLIER -68.36 142.59 55.42 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.953 0.406 . . . . 0.0 110.712 -171.332 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . 0.856 ' HB3' ' HG3' ' A' ' 311' ' ' LYS . 6.6 t70 -60.87 126.3 26.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.442 -173.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.454 ' HA ' ' CZ ' ' A' ' 312' ' ' PHE . 17.6 pttm -38.45 -29.62 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 125.849 1.659 . . . . 0.0 114.841 -178.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 12.3 t -108.72 4.31 23.62 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 121.723 -0.611 . . . . 0.0 112.029 -169.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.856 ' HG3' ' HB3' ' A' ' 308' ' ' ASP . 27.8 mtpp -83.8 -28.79 27.86 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -173.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.618 ' HE2' ' O ' ' A' ' 385' ' ' VAL . 0.1 OUTLIER -85.01 175.71 8.88 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.621 0.724 . . . . 0.0 112.159 -176.163 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 5.2 t -153.2 159.45 42.66 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.329 -1.305 . . . . 0.0 109.476 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . 0.474 ' CH2' ' HD3' ' A' ' 318' ' ' PRO . 52.5 m95 -81.99 95.9 7.55 Favored 'General case' 0 CA--C 1.508 -0.661 0 CA-C-O 121.161 0.505 . . . . 0.0 110.518 -179.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.615 ' HD3' ' HG2' ' A' ' 329' ' ' GLU . 65.4 tttm -65.82 -43.18 89.36 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 168.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.436 HH11 ' HD2' ' A' ' 316' ' ' ARG . 44.8 ttm105 -149.28 125.31 10.65 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.846 172.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . 0.538 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -71.02 164.09 59.73 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.309 -179.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . 0.592 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 2.1 Cg_endo -45.59 108.66 0.15 Allowed 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 122.56 2.174 . . . . 0.0 112.03 -179.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 30.1 m -120.5 124.29 45.04 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.647 -174.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . 0.557 ' HA ' HG13 ' A' ' 326' ' ' VAL . 11.4 t70 -53.57 121.62 8.13 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 177.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 60.2 p -61.21 -43.69 98.47 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.236 0.541 . . . . 0.0 109.794 -172.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 116.8 -8.79 16.6 Favored Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 109.911 -1.275 . . . . 0.0 109.911 178.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -127.1 62.37 1.34 Allowed 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 114.541 -0.83 . . . . 0.0 109.823 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 29.5 t70 64.43 17.99 11.1 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.577 171.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . 0.526 ' HA ' ' HG2' ' A' ' 375' ' ' GLN . 17.8 p -149.45 -174.58 4.71 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 121.828 -0.545 . . . . 0.0 110.285 -176.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.557 HG13 ' HA ' ' A' ' 320' ' ' ASP . 0.6 OUTLIER -135.56 146.07 30.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.202 0.525 . . . . 0.0 111.095 -177.707 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 327' ' ' VAL . . . . . 0.619 HG12 ' HG2' ' A' ' 373' ' ' GLU . 19.8 m -124.33 153.74 31.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.645 177.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 328' ' ' MET . . . . . 0.843 ' SD ' ' HB ' ' A' ' 372' ' ' ILE . 0.0 OUTLIER -145.48 157.84 43.94 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 174.977 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.615 ' HG2' ' HD3' ' A' ' 315' ' ' LYS . 8.0 tt0 -136.21 128.19 29.5 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 120.588 -0.445 . . . . 0.0 109.898 -178.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.68 HG22 HD11 ' A' ' 372' ' ' ILE . 1.5 m -129.63 147.09 33.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -173.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -120.89 134.96 10.49 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.533 -176.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . 0.862 ' H ' ' HA2' ' A' ' 368' ' ' GLY . 0.9 OUTLIER -110.69 152.2 26.82 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.099 0.476 . . . . 0.0 110.67 178.748 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 17.5 m -88.8 -36.64 15.96 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -172.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -146.12 -39.23 0.05 OUTLIER Glycine 0 C--N 1.333 0.394 0 C-N-CA 118.983 -1.58 . . . . 0.0 114.313 -176.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 335' ' ' THR . . . . . 0.621 HG23 HG23 ' A' ' 303' ' ' THR . 22.8 m -53.5 129.53 32.75 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.906 0.384 . . . . 0.0 110.727 -177.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.895 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 7.2 ptm180 -87.58 -176.38 0.71 Allowed Pre-proline 0 N--CA 1.455 -0.2 0 CA-C-O 117.268 -1.348 . . . . 0.0 107.857 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.895 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 37.4 Cg_exo -26.28 97.25 0.01 OUTLIER 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 123.482 2.788 . . . . 0.0 113.862 -179.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 338' ' ' CYS . . . . . 0.615 ' HB2' ' O ' ' A' ' 305' ' ' THR . 30.0 p -117.55 -176.23 2.98 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.965 -173.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 11.7 mpt_? -111.95 108.39 17.72 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 -177.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . 0.8 ' HB ' ' SD ' ' A' ' 364' ' ' MET . 15.0 tt -73.1 131.77 83.16 Favored Pre-proline 0 C--O 1.236 0.37 0 C-N-CA 119.527 -0.869 . . . . 0.0 111.964 -170.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -87.46 78.72 1.62 Allowed 'Trans proline' 0 N--CA 1.447 -1.21 0 C-N-CA 122.069 1.846 . . . . 0.0 110.976 168.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.798 HG22 HG23 ' A' ' 340' ' ' ILE . 2.5 m -103.51 124.62 57.86 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.872 0 CA-C-O 121.686 0.755 . . . . 0.0 110.613 177.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.4 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 28.4 ptt180 -141.11 177.48 8.04 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 173.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 344' ' ' ALA . . . . . 0.523 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -147.18 147.89 30.97 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 120.314 -0.555 . . . . 0.0 110.336 176.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.489 HG22 HD12 ' A' ' 382' ' ' ILE . 10.6 m -118.54 145.86 23.94 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.23 116.37 5.93 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 176.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . 0.665 ' HB3' ' CB ' ' A' ' 380' ' ' ASP . 7.9 p-80 34.7 71.47 0.11 Allowed 'General case' 0 N--CA 1.476 0.846 0 O-C-N 124.498 1.124 . . . . 0.0 113.651 176.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . 0.8 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 51.88 34.96 38.64 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 115.109 0.804 . . . . 0.0 115.109 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 347' ' ' HIS . 49.9 t -139.65 101.26 7.31 Favored Pre-proline 0 C--O 1.234 0.282 0 CA-C-N 118.531 1.166 . . . . 0.0 108.327 177.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . 0.442 ' HA ' ' HB ' ' A' ' 345' ' ' VAL . 12.1 Cg_exo -75.76 61.9 6.35 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.847 2.365 . . . . 0.0 113.097 -179.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -101.02 -56.41 2.33 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 177.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 5.5 p -119.4 128.72 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.895 173.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . 0.523 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 31.8 t30 -64.64 116.56 6.35 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.549 176.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.464 ' HB ' ' HG ' ' A' ' 376' ' ' LEU . 16.7 m -92.28 -1.22 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.701 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . 0.435 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -76.14 89.12 3.05 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.222 0.534 . . . . 0.0 112.009 -176.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -101.73 103.08 13.82 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 106.245 -1.761 . . . . 0.0 106.245 170.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.554 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 53.8 mt -86.47 121.99 29.8 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.53 -161.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.68 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 2.5 mm -63.48 -23.79 34.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.145 -0.934 . . . . 0.0 108.506 174.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 16.7 m -128.14 92.02 42.87 Favored Pre-proline 0 N--CA 1.45 -0.475 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.23 169.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -88.82 24.14 0.7 Allowed 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 123.105 2.537 . . . . 0.0 113.47 -171.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . 0.572 ' N ' ' HD3' ' A' ' 362' ' ' PRO . 28.3 p-10 -145.23 50.92 1.2 Allowed Pre-proline 0 C--N 1.313 -1.012 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.305 178.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . 0.585 ' HB3' HG23 ' A' ' 372' ' ' ILE . 5.7 Cg_endo -75.2 108.2 2.66 Favored 'Trans proline' 0 C--O 1.249 1.063 0 C-N-CA 121.648 1.566 . . . . 0.0 113.323 -177.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 363' ' ' THR . . . . . 0.511 ' HA ' ' HE2' ' A' ' 364' ' ' MET . 2.0 p -92.11 167.02 12.36 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 114.693 -1.139 . . . . 0.0 112.011 166.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 364' ' ' MET . . . . . 0.8 ' SD ' ' HB ' ' A' ' 340' ' ' ILE . 0.2 OUTLIER -144.42 149.81 36.67 Favored 'General case' 0 CA--C 1.496 -1.129 0 CA-C-N 113.716 -1.584 . . . . 0.0 111.188 -172.46 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.441 ' HG2' ' HD3' ' A' ' 337' ' ' PRO . 55.8 mt-10 -120.5 177.96 4.85 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-O 122.144 0.974 . . . . 0.0 111.999 -179.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . 0.554 HD22 ' N ' ' A' ' 366' ' ' ASN . 0.1 OUTLIER -49.16 -5.59 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 112.533 -2.122 . . . . 0.0 113.597 174.717 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -118.29 -10.11 10.29 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 121.647 -0.658 . . . . 0.0 110.342 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . 0.862 ' HA2' ' H ' ' A' ' 332' ' ' PHE . . . 129.33 176.97 14.64 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 121.186 -0.531 . . . . 0.0 111.778 -174.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . 0.504 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -76.8 -34.04 44.54 Favored Glycine 0 C--N 1.334 0.448 0 CA-C-N 117.686 0.743 . . . . 0.0 113.06 178.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . 94.39 -50.61 2.11 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.298 -0.953 . . . . 0.0 113.521 179.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -166.36 144.38 5.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 117.08 0.44 . . . . 0.0 111.423 179.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 372' ' ' ILE . . . . . 0.843 ' HB ' ' SD ' ' A' ' 328' ' ' MET . 0.3 OUTLIER -138.28 158.58 32.06 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 169.474 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.68 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 52.0 mt-10 -133.29 129.79 38.06 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.79 0.329 . . . . 0.0 110.326 178.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . 0.64 ' HG2' HD11 ' A' ' 383' ' ' ILE . 4.9 ppp? -136.83 162.72 32.45 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -179.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 375' ' ' GLN . . . . . 1.065 ' HA ' HE21 ' A' ' 375' ' ' GLN . 0.0 OUTLIER 172.52 177.81 0.09 Allowed 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 171.507 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 376' ' ' LEU . . . . . 0.63 HD11 HD21 ' A' ' 381' ' ' ASN . 0.0 OUTLIER -168.5 178.37 1.06 Allowed Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 105.375 -2.083 . . . . 0.0 105.375 173.822 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 377' ' ' PRO . . . . . 0.461 ' HD2' ' HB2' ' A' ' 376' ' ' LEU . 92.0 Cg_exo -44.66 125.4 6.26 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 CA-C-N 121.131 1.44 . . . . 0.0 111.176 169.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -36.79 147.08 0.08 OUTLIER 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 124.593 3.529 . . . . 0.0 113.943 -173.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 153.87 -174.44 32.4 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -164.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . 0.665 ' CB ' ' HB3' ' A' ' 347' ' ' HIS . 4.4 m-20 -93.0 124.76 37.2 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 117.558 0.679 . . . . 0.0 109.373 -178.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.63 HD21 HD11 ' A' ' 376' ' ' LEU . 0.6 OUTLIER -120.38 168.56 11.17 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 178.942 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 1.027 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -160.63 136.74 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.195 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 165.662 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . 0.64 HD11 ' HG2' ' A' ' 374' ' ' MET . 37.3 mt -95.37 130.01 44.71 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 C-N-CA 119.383 -0.927 . . . . 0.0 109.489 -174.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 384' ' ' TYR . . . . . 0.565 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.3 OUTLIER -107.65 90.9 3.44 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 114.352 -1.295 . . . . 0.0 108.114 173.237 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . 0.618 ' O ' ' HE2' ' A' ' 312' ' ' PHE . 10.6 t -84.43 91.25 2.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 175.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 61.02 -112.01 4.31 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.171 -171.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -90.05 -13.51 35.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.853 0.358 . . . . 0.0 111.354 176.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.565 ' O ' ' HA ' ' A' ' 384' ' ' TYR . 1.6 mp -67.8 146.44 53.7 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 175.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . 0.578 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 30.2 p30 -155.58 152.25 28.55 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.042 178.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . 0.592 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 13.0 t60 -173.62 119.43 0.3 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.783 174.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 391' ' ' GLN . . . . . 1.027 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 0.8 OUTLIER -82.91 153.04 25.28 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.617 0.722 . . . . 0.0 112.023 -178.235 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 392' ' ' TRP . . . . . 0.494 ' HD1' ' OE1' ' A' ' 394' ' ' GLN . 8.3 t-105 -173.16 137.79 0.71 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 113.977 -1.465 . . . . 0.0 107.753 176.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . 0.56 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 30.8 p90 -100.18 129.77 46.24 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -176.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 1.043 ' HG3' HE22 ' A' ' 375' ' ' GLN . 3.3 mm100 -89.61 110.45 21.32 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -172.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.594 ' HE2' ' HA ' ' A' ' 395' ' ' LYS . 0.6 OUTLIER . . . . . 0 C--O 1.246 0.904 0 CA-C-O 118.109 -0.948 . . . . 0.0 109.623 -173.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . 0.628 HG23 HG23 ' A' ' 335' ' ' THR . 5.7 t . . . . . 0 CA--C 1.539 0.542 0 CA-C-O 121.445 0.641 . . . . 0.0 111.723 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . 0.533 ' HB3' ' HD3' ' A' ' 336' ' ' ARG . 39.4 p90 -69.87 128.65 37.12 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 175.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.508 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 7.3 t 175.86 -170.72 0.06 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -172.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 16.5 t -75.92 106.87 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 107.354 -1.351 . . . . 0.0 107.354 170.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -69.9 155.62 40.29 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.786 0.803 . . . . 0.0 113.031 -168.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . 0.657 ' OD2' HG22 ' A' ' 310' ' ' THR . 23.1 t70 -67.2 122.23 17.38 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.181 -1.372 . . . . 0.0 110.765 178.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.492 ' HB2' ' N ' ' A' ' 387' ' ' ASP . 31.7 pttt -40.66 -32.86 0.23 Allowed 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 113.506 -1.679 . . . . 0.0 115.499 -173.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.657 HG22 ' OD2' ' A' ' 308' ' ' ASP . 10.0 t -105.77 16.42 25.29 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.882 0.849 . . . . 0.0 110.735 -165.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.533 ' HE3' ' OG1' ' A' ' 335' ' ' THR . 17.4 mtmm -99.46 47.63 0.95 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.626 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 1.039 ' HZ ' HD12 ' A' ' 340' ' ' ILE . 6.1 m-85 -139.98 160.58 39.6 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.65 -171.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . 0.408 ' C ' HD21 ' A' ' 388' ' ' LEU . 69.5 p -134.59 150.35 50.7 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.849 175.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . 0.557 ' CE2' ' HG ' ' A' ' 388' ' ' LEU . 28.0 m-90 -78.01 92.55 4.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.248 0.546 . . . . 0.0 109.761 174.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.478 ' HB3' ' C ' ' A' ' 329' ' ' GLU . 28.5 tptp -68.93 -49.67 56.0 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 170.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 17.0 ttm180 -151.91 125.63 8.99 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.125 -0.943 . . . . 0.0 108.742 175.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . 0.403 ' HB1' ' CG ' ' A' ' 390' ' ' HIS . . . -76.53 157.8 81.95 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-O 119.106 -0.474 . . . . 0.0 110.419 -176.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . 0.88 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 80.3 Cg_exo -37.56 111.76 0.1 Allowed 'Trans proline' 0 C--N 1.363 1.339 0 C-N-CA 123.187 2.592 . . . . 0.0 113.537 -178.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 16.4 m -134.86 138.52 44.25 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.7 -173.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -58.01 126.45 27.5 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.929 0.395 . . . . 0.0 110.075 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . 0.512 ' HB3' HG13 ' A' ' 327' ' ' VAL . 92.4 p -59.44 -44.32 92.96 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.52 -0.763 . . . . 0.0 109.51 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 131.58 -13.32 5.37 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 114.865 -1.061 . . . . 0.0 111.139 176.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . 0.453 ' O ' ' HB2' ' A' ' 324' ' ' ASP . 95.0 m-70 -114.27 20.51 15.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.588 0.233 . . . . 0.0 110.67 -179.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . 0.453 ' HB2' ' O ' ' A' ' 323' ' ' HIS . 10.6 m-20 84.76 43.99 0.02 OUTLIER 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.148 172.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . 0.486 ' HB ' HG13 ' A' ' 358' ' ' ILE . 5.5 p -151.85 172.68 15.82 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 174.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.73 HG21 ' HZ2' ' A' ' 392' ' ' TRP . 0.2 OUTLIER -123.66 141.89 42.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 119.945 1.248 . . . . 0.0 111.784 -173.04 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 327' ' ' VAL . . . . . 0.814 HG12 ' HG2' ' A' ' 373' ' ' GLU . 17.8 m -120.86 155.55 24.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.267 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.676 176.321 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 328' ' ' MET . . . . . 0.608 ' HE3' ' HD3' ' A' ' 318' ' ' PRO . 6.6 ptm -146.54 157.93 43.81 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.815 -1.179 . . . . 0.0 107.815 172.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.587 ' HA ' ' O ' ' A' ' 370' ' ' GLY . 16.2 tt0 -128.42 129.39 46.09 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -175.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.586 HG11 HG21 ' A' ' 385' ' ' VAL . 7.5 m -129.68 149.67 33.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -175.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . . . . . . . . . . . -109.13 178.22 20.61 Favored Glycine 0 C--N 1.338 0.671 0 N-CA-C 111.617 -0.593 . . . . 0.0 111.617 175.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . 0.528 ' HB2' ' SD ' ' A' ' 364' ' ' MET . 0.1 OUTLIER -138.56 158.19 44.72 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 117.939 0.869 . . . . 0.0 113.239 -177.211 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 9.7 t -65.54 -70.92 0.21 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.313 -1.312 . . . . 0.0 112.271 171.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -166.73 -22.68 0.02 OUTLIER Glycine 0 CA--C 1.53 1.022 0 C-N-CA 119.04 -1.552 . . . . 0.0 115.475 -176.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 335' ' ' THR . . . . . 0.628 HG23 HG23 ' A' ' 303' ' ' THR . 29.3 m -51.06 131.22 27.08 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 117.136 0.468 . . . . 0.0 109.781 174.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.772 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 1.3 ptm180 -69.23 177.36 1.22 Allowed Pre-proline 0 CA--C 1.518 -0.285 0 CA-C-O 118.456 -0.783 . . . . 0.0 109.198 -172.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.772 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.2 OUTLIER -28.28 105.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.358 1.064 0 C-N-CA 123.253 2.635 . . . . 0.0 112.864 175.22 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 338' ' ' CYS . . . . . 0.809 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 31.6 p -125.47 155.29 40.74 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.275 -1.33 . . . . 0.0 107.615 -174.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -68.29 116.99 9.5 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.369 171.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . 1.039 HD12 ' HZ ' ' A' ' 312' ' ' PHE . 33.8 mm -79.0 118.87 74.95 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.614 -174.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -75.72 79.87 2.73 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.01 1.806 . . . . 0.0 110.804 176.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.833 HG13 HG22 ' A' ' 340' ' ' ILE . 2.5 m -103.87 118.76 51.51 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-O 121.612 0.72 . . . . 0.0 110.098 -179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -135.72 177.88 7.48 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 176.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 344' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -146.67 146.46 30.38 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.495 178.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 17.3 m -119.48 142.65 33.83 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.4 115.45 5.12 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.73 -0.668 . . . . 0.0 112.561 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . 0.524 ' O ' HG23 ' A' ' 349' ' ' VAL . 63.8 t60 41.49 68.05 0.49 Allowed 'General case' 0 N--CA 1.471 0.6 0 O-C-N 124.571 1.169 . . . . 0.0 111.593 176.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . 0.634 ' H ' ' CG2' ' A' ' 382' ' ' ILE . . . 46.01 39.39 8.98 Favored Glycine 0 C--N 1.333 0.39 0 N-CA-C 115.385 0.914 . . . . 0.0 115.385 -177.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 347' ' ' HIS . 59.8 t -138.88 101.8 7.77 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 118.47 1.135 . . . . 0.0 108.53 178.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -75.14 64.47 6.17 Favored 'Trans proline' 0 C--O 1.234 0.289 0 C-N-CA 122.893 2.396 . . . . 0.0 113.104 -178.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -100.72 -55.84 2.48 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 176.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 4.9 p -123.5 130.96 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.634 173.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . 0.485 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 33.1 t30 -66.13 121.16 14.54 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.801 176.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.655 ' HB ' ' HG ' ' A' ' 376' ' ' LEU . 26.6 m -101.01 4.11 10.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.733 -178.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . 0.471 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -72.01 87.36 1.04 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.132 0.492 . . . . 0.0 112.199 -177.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 356' ' ' MET . . . . . 0.579 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 37.0 ttm -97.81 100.54 11.91 Favored 'General case' 0 N--CA 1.444 -0.753 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 169.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.673 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 26.4 mt -85.63 122.9 30.39 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.591 -164.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.695 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 3.7 mm -61.1 -30.49 47.83 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 CA-C-N 115.313 -0.858 . . . . 0.0 108.943 173.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 18.8 m -135.48 97.13 13.23 Favored Pre-proline 0 N--CA 1.451 -0.393 0 CA-C-N 114.854 -1.066 . . . . 0.0 109.404 175.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -90.79 37.32 0.32 Allowed 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 123.356 2.704 . . . . 0.0 113.706 -174.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -140.2 61.88 18.69 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.202 176.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . 0.76 ' HB3' HG23 ' A' ' 372' ' ' ILE . 93.9 Cg_endo -84.77 143.06 9.37 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.115 1.877 . . . . 0.0 112.016 176.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 18.4 p -142.47 134.05 26.64 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -178.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 364' ' ' MET . . . . . 0.809 ' HG2' ' SG ' ' A' ' 338' ' ' CYS . 16.3 ptt? -95.38 121.51 37.13 Favored 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 176.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.503 ' HG2' ' HG3' ' A' ' 337' ' ' PRO . 37.9 mt-10 -116.75 -167.54 1.31 Allowed 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 113.778 -1.555 . . . . 0.0 109.369 -170.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . 0.464 HD22 ' N ' ' A' ' 367' ' ' ASN . 0.2 OUTLIER -56.68 -6.04 0.28 Allowed 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 -177.69 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 367' ' ' ASN . . . . . 0.464 ' N ' HD22 ' A' ' 366' ' ' ASN . 0.9 OUTLIER -122.3 1.31 9.64 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.591 -0.693 . . . . 0.0 110.781 179.212 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . 0.507 ' HA2' ' CD1' ' A' ' 332' ' ' PHE . . . 112.61 174.92 19.47 Favored Glycine 0 CA--C 1.516 0.119 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -178.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . 0.795 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -51.91 -40.65 50.49 Favored Glycine 0 C--N 1.335 0.489 0 CA-C-N 117.541 0.671 . . . . 0.0 113.627 174.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . 0.587 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 83.24 -127.09 7.82 Favored Glycine 0 N--CA 1.439 -1.141 0 C-N-CA 120.259 -0.972 . . . . 0.0 111.572 -178.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 39.6 p90 -102.08 139.41 37.74 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.384 0.612 . . . . 0.0 112.017 -173.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 372' ' ' ILE . . . . . 0.76 HG23 ' HB3' ' A' ' 362' ' ' PRO . 0.5 OUTLIER -131.78 155.5 41.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.093 175.751 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.814 ' HG2' HG12 ' A' ' 327' ' ' VAL . 40.8 mt-10 -133.37 128.39 35.52 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.833 -0.347 . . . . 0.0 110.467 -178.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . 0.673 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 0.1 OUTLIER -147.72 165.84 29.26 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.392 -173.937 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 375' ' ' GLN . . . . . 1.027 HE22 ' HG2' ' A' ' 394' ' ' GLN . 0.0 OUTLIER 179.55 175.08 0.76 Allowed 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.989 -0.375 . . . . 0.0 109.989 175.874 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 376' ' ' LEU . . . . . 0.745 HD22 ' HD2' ' A' ' 377' ' ' PRO . 2.1 tm? -166.69 143.13 3.89 Favored Pre-proline 0 N--CA 1.445 -0.691 0 N-CA-C 104.373 -2.455 . . . . 0.0 104.373 -176.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 377' ' ' PRO . . . . . 0.745 ' HD2' HD22 ' A' ' 376' ' ' LEU . 46.5 Cg_exo -36.53 134.27 0.33 Allowed 'Trans proline' 0 CA--C 1.536 0.589 0 C-N-CA 122.569 2.179 . . . . 0.0 112.638 174.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.753 ' HA ' HE22 ' A' ' 394' ' ' GLN . 57.1 Cg_exo -33.86 135.82 0.11 Allowed 'Trans proline' 0 C--N 1.365 1.404 0 C-N-CA 124.875 3.717 . . . . 0.0 114.205 -172.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 153.15 -168.71 31.98 Favored Glycine 0 N--CA 1.441 -1.01 0 N-CA-C 110.256 -1.137 . . . . 0.0 110.256 -166.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -101.88 130.85 48.45 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 117.103 0.451 . . . . 0.0 110.701 179.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 17.8 m-80 -136.5 169.97 16.82 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 1.123 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -157.22 143.97 9.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 173.008 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . 0.851 HD12 ' HG3' ' A' ' 318' ' ' PRO . 21.2 mt -100.22 132.89 44.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.558 -176.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 384' ' ' TYR . . . . . 0.526 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 14.6 m-85 -104.71 97.48 7.37 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.183 169.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . 0.586 HG21 HG11 ' A' ' 330' ' ' VAL . 9.7 t -83.84 82.9 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 173.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 63.59 -109.05 2.5 Favored Glycine 0 N--CA 1.434 -1.493 0 C-N-CA 120.39 -0.91 . . . . 0.0 111.223 -166.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 387' ' ' ASP . . . . . 0.492 ' N ' ' HB2' ' A' ' 309' ' ' LYS . 6.9 t70 -93.5 -11.48 31.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.624 0.25 . . . . 0.0 110.894 177.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.557 ' HG ' ' CE2' ' A' ' 314' ' ' TRP . 1.0 OUTLIER -69.07 151.17 46.78 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 174.981 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . 0.554 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 8.2 p30 -156.63 152.38 27.1 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 121.061 -0.256 . . . . 0.0 110.476 -178.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . 0.88 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 4.9 t-80 -174.11 116.39 0.22 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.485 171.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 391' ' ' GLN . . . . . 1.123 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 14.6 tt0 -79.53 154.72 28.61 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.44 -179.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 392' ' ' TRP . . . . . 0.73 ' HZ2' HG21 ' A' ' 326' ' ' VAL . 0.6 OUTLIER -163.8 152.36 13.55 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 114.955 -1.02 . . . . 0.0 108.282 179.691 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -110.52 125.58 53.48 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 1.027 ' HG2' HE22 ' A' ' 375' ' ' GLN . 0.0 OUTLIER -104.46 119.99 40.23 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 -178.355 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? . . . . . 0 C--N 1.315 -0.926 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.118 -168.521 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . 0.496 ' O ' HG23 ' A' ' 335' ' ' THR . 5.3 t . . . . . 0 CA--C 1.538 0.489 0 CA-C-O 121.394 0.616 . . . . 0.0 111.198 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . 0.548 ' HB3' ' NE ' ' A' ' 336' ' ' ARG . 0.9 OUTLIER -69.37 132.85 47.04 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 121.727 -0.608 . . . . 0.0 109.421 174.383 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.539 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 12.9 t 172.38 -169.24 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -177.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 38.6 t -64.16 110.97 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 170.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -69.22 140.69 54.55 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 -171.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . 0.613 ' OD1' HG22 ' A' ' 310' ' ' THR . 11.2 t70 -61.89 131.06 48.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.452 0.644 . . . . 0.0 111.376 -171.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.473 ' HA ' ' HA3' ' A' ' 386' ' ' GLY . 23.4 pttm -37.95 -38.13 0.29 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 113.245 -1.798 . . . . 0.0 114.523 -178.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.613 HG22 ' OD1' ' A' ' 308' ' ' ASP . 13.9 t -98.9 -8.32 25.81 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.067 0.461 . . . . 0.0 111.574 -166.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.505 ' HZ3' ' HB3' ' A' ' 311' ' ' LYS . 6.3 mtpm? -74.71 -22.16 58.99 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.081 -0.509 . . . . 0.0 112.319 -175.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.698 ' HD2' ' HB ' ' A' ' 330' ' ' VAL . 49.3 m-85 -70.85 169.26 15.06 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-O 121.934 0.874 . . . . 0.0 112.915 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . 0.456 HG22 ' O ' ' A' ' 331' ' ' GLY . 11.6 t -151.64 153.25 34.08 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.46 169.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 20.1 m95 -78.11 96.77 5.23 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.143 0.496 . . . . 0.0 111.487 -177.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.593 ' HD3' ' HB3' ' A' ' 329' ' ' GLU . 50.9 tttp -65.94 -46.93 76.38 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 168.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.792 ' HB3' ' HB2' ' A' ' 329' ' ' GLU . 70.9 ttt180 -153.35 97.29 2.14 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.09 175.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -44.68 154.88 0.4 Allowed Pre-proline 0 N--CA 1.476 0.845 0 C-N-CA 123.634 0.774 . . . . 0.0 112.583 175.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . 0.526 ' HD2' ' HB3' ' A' ' 390' ' ' HIS . 3.2 Cg_exo -38.67 112.27 0.13 Allowed 'Trans proline' 0 C--N 1.367 1.516 0 C-N-CA 123.676 2.917 . . . . 0.0 113.626 -174.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 32.8 m -127.19 132.44 50.48 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.548 -1.206 . . . . 0.0 109.655 -177.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -59.45 118.45 6.03 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . 0.54 ' HB3' HG13 ' A' ' 327' ' ' VAL . 88.9 p -52.41 -55.68 20.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.536 0.684 . . . . 0.0 111.038 -168.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 136.4 -18.17 3.71 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 109.266 -1.533 . . . . 0.0 109.266 -175.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -104.61 43.58 1.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.714 -0.743 . . . . 0.0 109.217 178.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 49.72 49.2 20.49 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.218 -0.901 . . . . 0.0 112.411 -177.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . . . . . . . . . 1.7 p -155.89 -168.38 2.76 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.596 ' HB ' ' HG3' ' A' ' 374' ' ' MET . 0.3 OUTLIER -127.19 145.48 34.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 118.89 0.768 . . . . 0.0 111.653 -179.627 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 327' ' ' VAL . . . . . 0.7 HG12 ' HG3' ' A' ' 373' ' ' GLU . 11.5 m -119.45 152.43 21.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.846 170.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 328' ' ' MET . . . . . 0.57 ' SD ' HD13 ' A' ' 383' ' ' ILE . 0.0 OUTLIER -140.09 142.86 36.06 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 107.313 -1.365 . . . . 0.0 107.313 175.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.792 ' HB2' ' HB3' ' A' ' 316' ' ' ARG . 6.4 mt-10 -122.48 128.55 50.98 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.12 0.486 . . . . 0.0 109.954 179.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.698 ' HB ' ' HD2' ' A' ' 312' ' ' PHE . 0.9 OUTLIER -130.05 146.07 34.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.906 -175.825 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . 0.456 ' O ' HG22 ' A' ' 313' ' ' THR . . . -125.6 140.73 12.43 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.043 -178.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . 0.762 ' CD1' ' HA2' ' A' ' 368' ' ' GLY . 0.4 OUTLIER -111.45 176.64 4.94 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -178.246 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . 0.449 ' OG ' ' HE2' ' A' ' 311' ' ' LYS . 4.7 p -100.98 -66.66 0.9 Allowed 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 114.161 -1.381 . . . . 0.0 113.351 172.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -122.05 -43.68 0.39 Allowed Glycine 0 CA--C 1.535 1.315 0 N-CA-C 116.511 1.364 . . . . 0.0 116.511 -167.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 335' ' ' THR . . . . . 0.496 HG23 ' O ' ' A' ' 303' ' ' THR . 33.9 m -52.4 123.04 9.91 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 117.374 0.587 . . . . 0.0 111.404 -176.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.855 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 12.5 ptt180 -75.2 -176.27 0.54 Allowed Pre-proline 0 CA--C 1.529 0.137 0 CA-C-O 117.726 -1.13 . . . . 0.0 109.018 -176.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.855 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.1 OUTLIER -27.27 98.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.371 1.745 0 C-N-CA 123.549 2.833 . . . . 0.0 113.253 177.197 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 338' ' ' CYS . . . . . 0.782 ' SG ' ' HE2' ' A' ' 364' ' ' MET . 14.9 p -114.89 -175.63 2.73 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 113.787 -1.551 . . . . 0.0 110.336 -168.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -108.64 101.51 10.65 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 178.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . 0.843 HG22 HG22 ' A' ' 342' ' ' VAL . 39.3 mt -72.37 118.05 64.15 Favored Pre-proline 0 C--O 1.236 0.362 0 C-N-CA 120.328 -0.549 . . . . 0.0 111.253 -169.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -79.88 78.11 3.82 Favored 'Trans proline' 0 N--CA 1.449 -1.103 0 C-N-CA 122.21 1.94 . . . . 0.0 111.065 176.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.865 HG13 HG13 ' A' ' 385' ' ' VAL . 0.0 OUTLIER -103.77 115.82 46.4 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.235 174.642 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' A' ' 384' ' ' TYR . 37.5 ptt180 -129.46 174.28 9.79 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 177.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 344' ' ' ALA . . . . . 0.508 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -146.89 145.44 29.83 Favored 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.441 177.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.403 HG22 HD12 ' A' ' 382' ' ' ILE . 13.3 m -117.35 145.39 23.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.25 115.25 4.85 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.592 175.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . 0.663 ' HB3' ' CB ' ' A' ' 380' ' ' ASP . 11.6 p80 32.47 74.46 0.05 Allowed 'General case' 0 N--CA 1.476 0.861 0 O-C-N 124.745 1.278 . . . . 0.0 113.159 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . 0.84 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 47.51 41.46 17.96 Favored Glycine 0 C--N 1.331 0.301 0 N-CA-C 115.396 0.918 . . . . 0.0 115.396 -178.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . . . . . . . . . 58.6 t -142.8 102.12 5.37 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 118.396 1.098 . . . . 0.0 108.181 176.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -78.02 53.64 4.54 Favored 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 123.072 2.514 . . . . 0.0 113.248 -176.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -102.73 -4.89 24.36 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 122.009 0.909 . . . . 0.0 108.996 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 2.4 p -170.09 104.96 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.668 -164.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . 0.508 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 56.5 t30 -64.12 108.92 1.67 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.994 177.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.534 ' HB ' ' HG ' ' A' ' 376' ' ' LEU . 28.0 m -91.6 3.75 7.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.995 179.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . 0.461 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -79.0 84.25 5.03 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.402 0.62 . . . . 0.0 111.275 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 3.0 tmm? -96.04 103.26 15.14 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 170.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.528 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 27.7 mt -86.65 115.28 24.01 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.881 -163.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.737 ' HB ' ' HB3' ' A' ' 373' ' ' GLU . 3.4 mm -58.57 -24.91 26.67 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 115.032 -0.985 . . . . 0.0 109.05 177.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 29.9 m -134.03 90.76 25.62 Favored Pre-proline 0 N--CA 1.445 -0.694 0 CA-C-N 114.446 -1.252 . . . . 0.0 108.37 173.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -84.19 34.58 0.52 Allowed 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 123.094 2.529 . . . . 0.0 113.151 -172.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -140.01 61.75 19.03 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.205 178.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . 0.758 ' HB3' HG23 ' A' ' 372' ' ' ILE . 41.5 Cg_endo -80.92 137.46 11.03 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.299 1.999 . . . . 0.0 111.83 178.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 363' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.87 141.37 30.27 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.015 -173.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 364' ' ' MET . . . . . 0.782 ' HE2' ' SG ' ' A' ' 338' ' ' CYS . 30.3 mtm -97.04 125.09 41.23 Favored 'General case' 0 CA--C 1.492 -1.288 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 176.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -117.38 -167.42 1.31 Allowed 'General case' 0 C--N 1.313 -0.996 0 O-C-N 124.705 1.253 . . . . 0.0 108.889 177.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . 0.515 HD22 ' N ' ' A' ' 366' ' ' ASN . 0.1 OUTLIER -46.27 -32.81 3.3 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 -176.162 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -100.48 3.63 43.08 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 121.72 -0.613 . . . . 0.0 111.392 -176.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . 0.762 ' HA2' ' CD1' ' A' ' 332' ' ' PHE . . . 113.44 -179.48 18.96 Favored Glycine 0 N--CA 1.451 -0.341 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -179.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . 0.694 ' HA2' ' HA ' ' A' ' 364' ' ' MET . . . -50.26 -37.69 31.84 Favored Glycine 0 CA--C 1.505 -0.562 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.869 171.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . 0.589 ' O ' ' HA ' ' A' ' 329' ' ' GLU . . . 78.88 -128.1 8.41 Favored Glycine 0 N--CA 1.437 -1.261 0 C-N-CA 120.302 -0.952 . . . . 0.0 111.318 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -103.47 141.39 36.06 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.355 0.598 . . . . 0.0 111.984 -175.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 372' ' ' ILE . . . . . 0.758 HG23 ' HB3' ' A' ' 362' ' ' PRO . 0.5 OUTLIER -136.81 159.73 37.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.35 175.803 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.737 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 2.5 mp0 -125.54 128.52 48.09 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.187 0.518 . . . . 0.0 110.913 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . 0.596 ' HG3' ' HB ' ' A' ' 326' ' ' VAL . 1.9 ptm -130.45 167.49 18.53 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.946 -1.025 . . . . 0.0 108.475 179.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 375' ' ' GLN . . . . . 0.8 HE21 ' H ' ' A' ' 376' ' ' LEU . 13.2 tp60 -179.67 171.67 1.18 Allowed 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 164.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 376' ' ' LEU . . . . . 0.869 HD22 ' HD2' ' A' ' 377' ' ' PRO . 2.5 tm? -165.89 137.64 3.12 Favored Pre-proline 0 C--N 1.311 -1.097 0 N-CA-C 104.015 -2.587 . . . . 0.0 104.015 -178.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 377' ' ' PRO . . . . . 0.869 ' HD2' HD22 ' A' ' 376' ' ' LEU . 31.0 Cg_exo -26.92 119.6 0.04 OUTLIER 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.544 2.829 . . . . 0.0 112.495 177.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_exo -37.09 139.02 0.22 Allowed 'Trans proline' 0 C--N 1.359 1.122 0 C-N-CA 124.286 3.324 . . . . 0.0 113.071 -169.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 153.66 -164.55 31.21 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 109.837 -1.305 . . . . 0.0 109.837 -157.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . 0.663 ' CB ' ' HB3' ' A' ' 347' ' ' HIS . 8.8 m-20 -96.59 121.63 38.63 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 118.103 0.951 . . . . 0.0 110.741 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -125.95 163.8 22.2 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 1.0 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -156.94 139.62 6.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 171.685 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . 0.677 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 40.9 mt -98.65 129.85 48.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.092 -174.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 384' ' ' TYR . . . . . 0.671 ' HA ' ' O ' ' A' ' 388' ' ' LEU . 0.9 OUTLIER -108.89 92.63 4.13 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.437 -1.256 . . . . 0.0 109.207 172.862 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . 0.865 HG13 HG13 ' A' ' 342' ' ' VAL . 3.5 t -85.47 85.52 2.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 176.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . 0.473 ' HA3' ' HA ' ' A' ' 309' ' ' LYS . . . 66.17 -112.38 4.88 Favored Glycine 0 N--CA 1.439 -1.123 0 C-N-CA 120.356 -0.926 . . . . 0.0 110.919 -168.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -85.94 -17.04 36.53 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.867 0.365 . . . . 0.0 110.93 175.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.671 ' O ' ' HA ' ' A' ' 384' ' ' TYR . 1.3 mp -65.33 147.07 54.08 Favored 'General case' 0 C--O 1.223 -0.338 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 179.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . 0.677 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 8.2 p30 -159.7 151.02 19.74 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.714 -0.221 . . . . 0.0 110.745 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . 0.526 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 11.5 t-80 -172.95 115.65 0.28 Allowed 'General case' 0 C--N 1.328 -0.353 0 O-C-N 123.517 0.511 . . . . 0.0 110.119 176.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 391' ' ' GLN . . . . . 1.0 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 0.8 OUTLIER -83.0 154.22 24.58 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.249 0.547 . . . . 0.0 111.76 -177.637 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 392' ' ' TRP . . . . . 0.432 ' HD1' ' CD ' ' A' ' 394' ' ' GLN . 23.8 t-105 -169.93 150.5 3.87 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.891 179.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . 0.541 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 9.1 p90 -104.83 109.67 21.73 Favored 'General case' 0 C--N 1.317 -0.843 0 O-C-N 121.411 -0.805 . . . . 0.0 108.863 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.646 ' HG3' HE22 ' A' ' 375' ' ' GLN . 4.0 mm100 -78.47 123.53 27.15 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -165.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt . . . . . 0 C--O 1.249 1.028 0 CA-C-O 117.918 -1.039 . . . . 0.0 110.802 -179.384 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . 0.425 ' O ' HG23 ' A' ' 335' ' ' THR . 9.1 t . . . . . 0 CA--C 1.536 0.428 0 CA-C-O 121.266 0.555 . . . . 0.0 111.914 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . 0.509 ' HB2' ' O ' ' A' ' 337' ' ' PRO . 5.5 p90 -65.06 131.17 45.85 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 174.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.59 ' O ' ' HB2' ' A' ' 338' ' ' CYS . 12.0 t 175.57 -167.98 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -170.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.409 ' HA ' ' HB2' ' A' ' 339' ' ' ARG . 8.4 t -75.67 105.64 4.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 168.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . 0.531 ' HB3' HG21 ' A' ' 335' ' ' THR . 0.1 OUTLIER -70.49 156.35 39.5 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.918 0.866 . . . . 0.0 113.315 -167.206 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . 0.578 ' OD2' HG22 ' A' ' 310' ' ' THR . 26.2 t70 -70.07 130.35 41.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.046 -1.433 . . . . 0.0 111.801 -175.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -38.76 -28.78 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 115.982 1.845 . . . . 0.0 115.982 -174.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . 0.578 HG22 ' OD2' ' A' ' 308' ' ' ASP . 12.7 t -108.19 0.75 21.67 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 119.323 0.965 . . . . 0.0 112.283 -169.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.418 ' HE3' ' HB3' ' A' ' 311' ' ' LYS . 27.7 mtpp -88.46 43.26 1.12 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.346 0.869 . . . . 0.0 113.346 -171.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.493 ' HD2' HD13 ' A' ' 388' ' ' LEU . 0.0 OUTLIER -152.48 177.89 10.14 Favored 'General case' 0 N--CA 1.429 -1.498 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.655 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . . . . . . . . . 8.9 t -152.89 160.48 43.06 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 114.562 -1.199 . . . . 0.0 108.191 177.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . . . . . . . . . 5.4 m-90 -64.33 125.35 24.31 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.49 ' HB3' ' C ' ' A' ' 329' ' ' GLU . 19.9 ttmm -104.43 -45.58 4.62 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 170.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 45.7 ttm105 -149.78 125.65 10.5 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 114.737 -1.119 . . . . 0.0 109.078 170.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . 0.496 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -71.53 161.39 78.74 Favored Pre-proline 0 C--N 1.323 -0.551 0 CA-C-O 119.202 -0.428 . . . . 0.0 110.048 -179.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . 0.517 ' HB3' ' CD1' ' A' ' 383' ' ' ILE . 3.5 Cg_exo -44.5 113.21 0.42 Allowed 'Trans proline' 0 C--N 1.358 1.058 0 C-N-CA 122.384 2.056 . . . . 0.0 112.548 -177.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . . . . . . . . . 19.6 m -129.42 138.63 51.58 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.695 -174.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -59.22 127.82 34.05 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.731 0.3 . . . . 0.0 110.706 175.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . 0.592 ' HB3' HG13 ' A' ' 327' ' ' VAL . 67.3 p -79.14 6.01 10.67 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.551 0.74 . . . . 0.0 111.973 -174.043 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 84.86 -20.76 13.64 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 120.4 -0.905 . . . . 0.0 113.559 -172.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 86.8 t60 -98.01 7.03 46.97 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 117.388 0.594 . . . . 0.0 110.751 -177.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 36.2 t70 71.85 53.49 0.2 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 122.582 1.182 . . . . 0.0 108.806 -176.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . 0.864 ' HA ' ' HG3' ' A' ' 375' ' ' GLN . 5.0 p -155.82 161.98 40.54 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.67 HG23 ' HG2' ' A' ' 375' ' ' GLN . 0.2 OUTLIER -110.71 138.48 38.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-N 119.628 1.104 . . . . 0.0 111.807 -173.552 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 327' ' ' VAL . . . . . 0.695 HG12 ' HG2' ' A' ' 373' ' ' GLU . 15.8 m -114.78 161.08 13.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.736 173.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 328' ' ' MET . . . . . 0.51 ' SD ' HG13 ' A' ' 330' ' ' VAL . 0.0 OUTLIER -149.31 152.06 35.23 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 178.272 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.49 ' C ' ' HB3' ' A' ' 315' ' ' LYS . 9.9 tt0 -137.02 135.88 37.96 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -176.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.61 HG23 ' HA3' ' A' ' 369' ' ' GLY . 1.7 m -133.64 161.12 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 112.601 0.593 . . . . 0.0 112.601 -176.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . 0.756 ' HA2' ' HA3' ' A' ' 368' ' ' GLY . . . -127.49 134.14 8.17 Favored Glycine 0 CA--C 1.522 0.529 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.03 176.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . 0.495 ' HD1' ' H ' ' A' ' 332' ' ' PHE . 0.1 OUTLIER -90.34 160.47 16.1 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -174.84 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 11.4 p -101.1 4.42 42.15 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.43 -1.259 . . . . 0.0 114.297 173.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . 166.55 -46.57 0.26 Allowed Glycine 0 CA--C 1.525 0.679 0 C-N-CA 118.292 -1.909 . . . . 0.0 115.764 173.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 335' ' ' THR . . . . . 0.666 ' HB ' ' CE ' ' A' ' 364' ' ' MET . 41.0 m -54.74 122.54 10.93 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.584 0.192 . . . . 0.0 110.527 -178.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.819 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 16.5 ptt180 -79.2 179.54 1.76 Allowed Pre-proline 0 C--O 1.227 -0.121 0 CA-C-O 117.417 -1.277 . . . . 0.0 108.336 -175.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.819 ' HD2' ' HB2' ' A' ' 336' ' ' ARG . 0.9 OUTLIER -26.12 100.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.37 1.703 0 C-N-CA 123.578 2.852 . . . . 0.0 113.695 -175.143 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 338' ' ' CYS . . . . . 0.903 ' SG ' ' HG2' ' A' ' 364' ' ' MET . 32.1 p -132.32 153.36 50.8 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.256 -170.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . 0.409 ' HB2' ' HA ' ' A' ' 306' ' ' VAL . 22.2 mmm180 -67.96 114.1 6.22 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.863 173.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . 0.632 HD11 ' HB2' ' A' ' 362' ' ' PRO . 28.9 pt -93.64 119.16 67.41 Favored Pre-proline 0 C--N 1.321 -0.666 0 C-N-CA 119.823 -0.751 . . . . 0.0 110.196 -177.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.68 82.67 0.72 Allowed 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.787 2.325 . . . . 0.0 111.943 -178.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.844 HG11 HD13 ' A' ' 372' ' ' ILE . 34.5 m -102.59 124.71 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-O 122.135 0.969 . . . . 0.0 110.645 -178.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.504 ' HG3' ' HB2' ' A' ' 384' ' ' TYR . 30.0 ptt180 -137.28 178.76 6.84 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-N 114.527 -1.215 . . . . 0.0 107.961 177.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 344' ' ' ALA . . . . . 0.468 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -149.12 146.21 27.58 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.815 174.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . . . . . . . . . 13.0 m -120.16 147.8 23.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -71.27 119.86 16.02 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 178.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . 0.658 ' HB2' ' HB2' ' A' ' 380' ' ' ASP . 3.8 t60 46.79 62.07 2.52 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 124.284 0.99 . . . . 0.0 111.377 174.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . 0.707 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 42.14 44.61 4.87 Favored Glycine 0 C--N 1.332 0.357 0 N-CA-C 114.564 0.586 . . . . 0.0 114.564 -173.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 347' ' ' HIS . 96.8 t -141.57 102.32 5.98 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -73.02 67.35 4.08 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.767 2.311 . . . . 0.0 112.5 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -100.51 -57.19 2.16 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 5.4 p -124.57 132.76 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.574 171.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . 0.468 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 50.6 t30 -61.83 109.71 1.32 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.13 175.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.422 ' O ' ' HB2' ' A' ' 376' ' ' LEU . 20.6 m -86.36 3.82 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.091 178.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . 0.458 ' HB1' HD21 ' A' ' 357' ' ' LEU . . . -79.98 82.22 6.1 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.104 -0.639 . . . . 0.0 110.999 178.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 356' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.67 99.16 10.79 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 169.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.693 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 34.6 mt -80.16 139.25 36.88 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.261 -0.882 . . . . 0.0 111.488 -159.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.914 HD11 ' HB2' ' A' ' 375' ' ' GLN . 3.0 mm -80.53 -21.85 11.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 3.4 m -139.55 94.83 9.21 Favored Pre-proline 0 N--CA 1.448 -0.567 0 CA-C-N 113.578 -1.646 . . . . 0.0 108.185 171.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -83.74 35.75 0.57 Allowed 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 123.494 2.796 . . . . 0.0 113.263 -173.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -141.72 60.04 10.74 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.714 176.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . 0.879 ' HB3' HG23 ' A' ' 372' ' ' ILE . 66.0 Cg_endo -79.47 145.74 18.85 Favored 'Trans proline' 0 C--O 1.241 0.656 0 C-N-CA 122.564 2.176 . . . . 0.0 112.618 -176.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 363' ' ' THR . . . . . 0.474 ' O ' ' HA2' ' A' ' 369' ' ' GLY . 0.8 OUTLIER -144.72 168.31 20.5 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.598 -174.421 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 364' ' ' MET . . . . . 0.903 ' HG2' ' SG ' ' A' ' 338' ' ' CYS . 13.7 ptt? -132.16 129.63 40.07 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.4 172.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 337' ' ' PRO . 21.8 mt-10 -113.08 -164.99 0.95 Allowed 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.216 -1.357 . . . . 0.0 110.929 -167.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . 0.442 HD22 ' N ' ' A' ' 366' ' ' ASN . 0.1 OUTLIER -56.55 -5.59 0.23 Allowed 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 178.355 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 367' ' ' ASN . . . . . 0.502 HD22 ' H ' ' A' ' 367' ' ' ASN . 0.1 OUTLIER -125.29 2.83 7.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.462 0.648 . . . . 0.0 110.603 177.611 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . 0.756 ' HA3' ' HA2' ' A' ' 331' ' ' GLY . . . 104.02 -174.81 22.66 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 -176.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . 0.61 ' HA3' HG23 ' A' ' 330' ' ' VAL . . . -64.82 107.59 1.94 Allowed Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 172.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . . . . . . . . . . . -75.77 -29.54 59.18 Favored Glycine 0 C--N 1.312 -0.799 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.609 -169.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -166.27 143.51 5.21 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.057 0.456 . . . . 0.0 111.249 175.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 372' ' ' ILE . . . . . 0.879 HG23 ' HB3' ' A' ' 362' ' ' PRO . 1.1 mt -135.15 150.22 29.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.002 170.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.765 ' HB3' ' HB ' ' A' ' 358' ' ' ILE . 43.3 mt-10 -130.8 127.7 39.22 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.226 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . 0.693 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 0.2 OUTLIER -141.73 160.27 40.52 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.219 -175.215 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 375' ' ' GLN . . . . . 0.914 ' HB2' HD11 ' A' ' 358' ' ' ILE . 0.0 OUTLIER -175.23 173.7 2.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.283 0.563 . . . . 0.0 111.653 172.717 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 376' ' ' LEU . . . . . 0.749 HD22 ' HD2' ' A' ' 377' ' ' PRO . 1.8 tm? -168.57 138.81 2.0 Allowed Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 105.11 -2.181 . . . . 0.0 105.11 -178.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 377' ' ' PRO . . . . . 0.749 ' HD2' HD22 ' A' ' 376' ' ' LEU . 51.9 Cg_exo -34.3 135.22 0.13 Allowed 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.951 2.434 . . . . 0.0 112.528 174.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . 0.778 ' HA ' HE22 ' A' ' 394' ' ' GLN . 3.0 Cg_exo -35.59 138.61 0.14 Allowed 'Trans proline' 0 C--N 1.36 1.153 0 C-N-CA 125.162 3.908 . . . . 0.0 113.63 -171.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 155.46 -160.98 30.25 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 -162.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . 0.658 ' HB2' ' HB2' ' A' ' 347' ' ' HIS . 21.8 m-20 -105.14 128.28 53.3 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 118.252 1.026 . . . . 0.0 110.527 174.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.588 HD22 ' C ' ' A' ' 380' ' ' ASP . 0.9 OUTLIER -126.32 138.48 53.59 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.226 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 1.071 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -141.12 135.25 32.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 177.9 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . 0.643 ' O ' ' HA ' ' A' ' 389' ' ' ASN . 20.9 mt -98.9 132.31 44.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 C-N-CA 119.786 -0.766 . . . . 0.0 110.281 -171.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 384' ' ' TYR . . . . . 0.504 ' HB2' ' HG3' ' A' ' 343' ' ' ARG . 5.7 m-85 -102.76 131.15 49.81 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 168.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . 0.643 HG13 HG12 ' A' ' 342' ' ' VAL . 12.6 t -119.71 84.67 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 178.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . . . . . . . . . . . 59.1 -109.13 1.91 Allowed Glycine 0 N--CA 1.434 -1.468 0 C-N-CA 120.363 -0.922 . . . . 0.0 111.002 -164.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 387' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -84.9 -20.27 31.01 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.566 0.183 . . . . 0.0 111.487 176.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.493 HD13 ' HD2' ' A' ' 312' ' ' PHE . 0.7 OUTLIER -67.0 154.99 39.81 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.71 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . 0.643 ' HA ' ' O ' ' A' ' 383' ' ' ILE . 7.9 p30 -164.96 160.31 19.0 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.231 175.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . 0.434 ' HB3' ' HD2' ' A' ' 318' ' ' PRO . 26.6 t60 -173.65 117.17 0.26 Allowed 'General case' 0 C--O 1.238 0.487 0 O-C-N 123.51 0.506 . . . . 0.0 110.285 173.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 391' ' ' GLN . . . . . 1.071 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 2.5 mt-30 -65.28 146.08 55.39 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 392' ' ' TRP . . . . . . . . . . . . . 50.4 t-105 -149.72 147.83 28.52 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 114.442 -1.254 . . . . 0.0 108.894 176.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -110.91 115.6 29.78 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 173.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.778 HE22 ' HA ' ' A' ' 378' ' ' PRO . 0.0 OUTLIER -100.45 126.53 46.86 Favored 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 121.699 -0.626 . . . . 0.0 109.656 -176.78 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm . . . . . 0 C--N 1.313 -1.017 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.855 -179.37 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . 0.504 ' O ' HG22 ' A' ' 305' ' ' THR . 10.3 t . . . . . 0 CA--C 1.533 0.31 0 CA-C-O 121.029 0.442 . . . . 0.0 111.744 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 304' ' ' TYR . . . . . 0.453 ' HB3' ' HG2' ' A' ' 336' ' ' ARG . 31.4 p90 -63.28 129.84 41.99 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 120.903 0.382 . . . . 0.0 110.412 -175.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.504 HG22 ' O ' ' A' ' 303' ' ' THR . 12.4 t 171.88 -166.88 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -167.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 42.2 t -63.91 112.36 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.667 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 170.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 307' ' ' CYS . . . . . 0.463 ' HB2' ' CE2' ' A' ' 332' ' ' PHE . 0.0 OUTLIER -67.99 147.05 52.95 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.13 0.491 . . . . 0.0 111.63 -170.07 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 308' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -57.07 109.17 0.61 Allowed 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.014 176.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 309' ' ' LYS . . . . . 0.492 ' HB2' ' N ' ' A' ' 387' ' ' ASP . 26.8 pttt -41.47 -27.12 0.08 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 113.892 -1.504 . . . . 0.0 114.716 -175.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 310' ' ' THR . . . . . . . . . . . . . 10.0 t -102.87 17.92 22.8 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 121.616 0.722 . . . . 0.0 110.428 -170.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 311' ' ' LYS . . . . . 0.621 ' HB2' ' CE2' ' A' ' 332' ' ' PHE . 25.2 mtpp -98.72 -14.39 19.8 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.406 178.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 312' ' ' PHE . . . . . 0.459 ' HB2' HD13 ' A' ' 388' ' ' LEU . 97.4 m-85 -75.05 162.32 28.66 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.11 177.509 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 313' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 331' ' ' GLY . 8.9 t -141.67 154.9 45.64 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.038 176.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 314' ' ' TRP . . . . . 0.412 ' H ' ' HE3' ' A' ' 314' ' ' TRP . 7.8 m-90 -75.65 92.6 2.97 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 315' ' ' LYS . . . . . 0.524 ' HB3' ' O ' ' A' ' 329' ' ' GLU . 24.0 tptm -73.74 -56.51 4.89 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 171.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.415 ' NH2' HG21 ' A' ' 319' ' ' THR . 58.2 ttt180 -147.11 125.3 12.17 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 176.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . 0.432 ' HB1' ' HD2' ' A' ' 318' ' ' PRO . . . -68.69 160.07 78.86 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 119.136 -0.459 . . . . 0.0 109.956 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . 0.473 ' HD3' ' CD2' ' A' ' 390' ' ' HIS . 3.9 Cg_exo -41.87 115.78 0.48 Allowed 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 122.823 2.348 . . . . 0.0 112.091 -178.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 319' ' ' THR . . . . . 0.415 HG21 ' NH2' ' A' ' 316' ' ' ARG . 21.5 m -128.68 132.96 48.08 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.246 -174.107 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 320' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -62.99 114.86 3.93 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -177.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . 0.539 ' HB3' HG13 ' A' ' 327' ' ' VAL . 69.9 p -55.81 -46.34 78.06 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 123.543 0.527 . . . . 0.0 110.711 -163.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 126.67 -16.2 6.58 Favored Glycine 0 N--CA 1.442 -0.938 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 -179.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -110.62 52.24 0.74 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 177.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 324' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 57.88 36.29 26.17 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.646 178.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . 0.478 ' HB ' HG13 ' A' ' 358' ' ' ILE . 3.1 p -157.13 -167.78 2.43 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -178.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 326' ' ' VAL . . . . . 0.997 HG23 ' HG2' ' A' ' 375' ' ' GLN . 3.6 t -131.83 148.45 32.37 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-O 121.318 0.58 . . . . 0.0 112.028 -178.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 327' ' ' VAL . . . . . 0.846 HG12 ' HG2' ' A' ' 373' ' ' GLU . 15.6 m -128.23 151.22 34.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.478 174.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 328' ' ' MET . . . . . 0.516 ' HG2' ' HE1' ' A' ' 374' ' ' MET . 0.6 OUTLIER -137.34 154.86 49.96 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 169.489 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.584 ' HG3' ' O ' ' A' ' 370' ' ' GLY . 14.0 tt0 -123.75 129.44 51.07 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 120.214 -0.594 . . . . 0.0 109.627 -177.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 330' ' ' VAL . . . . . 0.501 HG11 HG11 ' A' ' 385' ' ' VAL . 3.6 m -124.38 145.05 32.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.115 -178.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 331' ' ' GLY . . . . . 0.427 ' O ' HG22 ' A' ' 313' ' ' THR . . . -112.95 133.2 11.17 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 119.963 -1.113 . . . . 0.0 111.964 179.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 332' ' ' PHE . . . . . 0.621 ' CE2' ' HB2' ' A' ' 311' ' ' LYS . 2.6 t80 -141.25 143.14 33.97 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 30.7 p -147.34 49.26 1.1 Allowed 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -171.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 334' ' ' GLY . . . . . . . . . . . . . . . -145.48 -80.99 0.04 OUTLIER Glycine 0 C--O 1.23 -0.135 0 C-N-CA 119.78 -1.2 . . . . 0.0 112.03 167.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 335' ' ' THR . . . . . 0.614 ' HB ' ' CZ ' ' A' ' 332' ' ' PHE . 56.1 m -50.82 126.71 16.61 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 172.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 336' ' ' ARG . . . . . 0.583 ' HB2' ' HD2' ' A' ' 337' ' ' PRO . 0.0 OUTLIER -81.6 -177.84 1.04 Allowed Pre-proline 0 CA--C 1.533 0.324 0 CA-C-O 117.183 -1.389 . . . . 0.0 107.948 -172.19 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 337' ' ' PRO . . . . . 0.933 ' HA ' ' O ' ' A' ' 364' ' ' MET . 6.6 Cg_exo -23.39 101.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 123.91 3.073 . . . . 0.0 114.197 -172.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 338' ' ' CYS . . . . . 0.569 ' H ' ' HG3' ' A' ' 364' ' ' MET . 13.6 p -116.39 -176.85 3.04 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 113.898 -1.501 . . . . 0.0 111.38 -165.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 339' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -111.0 101.11 9.69 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.391 -1.336 . . . . 0.0 107.391 -178.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 340' ' ' ILE . . . . . 0.849 HG22 HG13 ' A' ' 342' ' ' VAL . 22.4 mt -76.32 117.28 63.16 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.464 -170.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 341' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -82.44 82.12 2.32 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.875 2.383 . . . . 0.0 112.235 179.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 342' ' ' VAL . . . . . 0.849 HG13 HG22 ' A' ' 340' ' ' ILE . 16.4 m -102.16 159.36 4.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.225 0.536 . . . . 0.0 110.2 179.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 343' ' ' ARG . . . . . 0.44 ' CG ' ' HB2' ' A' ' 384' ' ' TYR . 15.7 ptt-85 -169.3 175.63 5.51 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 179.623 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 344' ' ' ALA . . . . . 0.615 ' O ' ' HA ' ' A' ' 353' ' ' ASN . . . -150.06 149.78 30.79 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.633 -0.827 . . . . 0.0 111.55 178.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 345' ' ' VAL . . . . . 0.467 ' HB ' ' HA ' ' A' ' 350' ' ' PRO . 5.1 m -121.84 147.97 25.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 175.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -67.17 120.97 14.62 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 176.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 347' ' ' HIS . . . . . 0.607 ' HB2' ' CB ' ' A' ' 380' ' ' ASP . 22.7 t60 38.46 69.86 0.24 Allowed 'General case' 0 N--CA 1.479 0.988 0 O-C-N 124.427 1.079 . . . . 0.0 112.435 175.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . 0.812 ' H ' HG21 ' A' ' 382' ' ' ILE . . . 44.45 37.41 4.82 Favored Glycine 0 CA--C 1.52 0.378 0 N-CA-C 115.175 0.83 . . . . 0.0 115.175 -177.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 349' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 347' ' ' HIS . 60.7 t -139.94 102.25 6.97 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 118.257 1.029 . . . . 0.0 108.566 178.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 350' ' ' PRO . . . . . 0.467 ' HA ' ' HB ' ' A' ' 345' ' ' VAL . 19.2 Cg_exo -71.1 67.36 2.54 Favored 'Trans proline' 0 N--CA 1.465 -0.181 0 C-N-CA 122.801 2.334 . . . . 0.0 112.676 177.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 351' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -100.62 -56.87 2.23 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 174.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 352' ' ' VAL . . . . . . . . . . . . . 7.4 p -122.7 132.93 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 115.166 -0.924 . . . . 0.0 110.886 173.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 353' ' ' ASN . . . . . 0.615 ' HA ' ' O ' ' A' ' 344' ' ' ALA . 31.6 t30 -63.15 111.11 2.08 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.588 173.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 354' ' ' VAL . . . . . 0.561 HG12 HD22 ' A' ' 376' ' ' LEU . 30.0 m -90.62 4.2 6.29 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.317 -179.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 355' ' ' ALA . . . . . 0.48 ' HB2' ' N ' ' A' ' 344' ' ' ALA . . . -76.81 82.47 3.4 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-O 121.238 0.542 . . . . 0.0 111.094 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 356' ' ' MET . . . . . 0.612 ' HB3' ' O ' ' A' ' 375' ' ' GLN . 21.5 ttt -95.97 99.57 11.33 Favored 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 170.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 357' ' ' LEU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 374' ' ' MET . 47.2 mt -88.84 123.06 32.87 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.709 -161.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 358' ' ' ILE . . . . . 0.797 HD11 ' HB2' ' A' ' 375' ' ' GLN . 1.5 mm -67.83 -25.38 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 171.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 359' ' ' THR . . . . . . . . . . . . . 54.1 m -122.88 86.07 50.34 Favored Pre-proline 0 N--CA 1.451 -0.375 0 CA-C-N 114.323 -1.308 . . . . 0.0 108.683 170.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 360' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -82.84 26.13 0.65 Allowed 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 123.043 2.496 . . . . 0.0 113.022 -172.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 361' ' ' ASN . . . . . . . . . . . . . 46.5 m-20 -155.83 68.75 5.05 Favored Pre-proline 0 C--N 1.318 -0.804 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.696 178.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 362' ' ' PRO . . . . . 0.824 ' HB3' HG23 ' A' ' 372' ' ' ILE . 49.7 Cg_endo -73.28 151.56 48.87 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 121.745 1.63 . . . . 0.0 111.269 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 363' ' ' THR . . . . . 0.561 HG22 ' O ' ' A' ' 338' ' ' CYS . 0.0 OUTLIER -145.4 169.71 17.77 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 -173.065 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 364' ' ' MET . . . . . 0.933 ' O ' ' HA ' ' A' ' 337' ' ' PRO . 3.3 ppp? -127.24 142.97 51.34 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 176.105 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 365' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -135.09 -165.01 1.61 Allowed 'General case' 0 C--N 1.319 -0.76 0 O-C-N 124.999 1.437 . . . . 0.0 109.729 178.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 366' ' ' ASN . . . . . 0.477 HD22 ' N ' ' A' ' 366' ' ' ASN . 0.1 OUTLIER -45.27 -28.69 0.85 Allowed 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -174.091 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 367' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -109.32 3.29 21.44 Favored 'General case' 0 C--O 1.234 0.239 0 O-C-N 121.513 -0.742 . . . . 0.0 111.852 -177.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 368' ' ' GLY . . . . . . . . . . . . . . . 109.23 -171.79 15.62 Favored Glycine 0 N--CA 1.452 -0.263 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 -179.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 369' ' ' GLY . . . . . 0.552 ' HA2' ' O ' ' A' ' 363' ' ' THR . . . -45.26 -45.9 10.73 Favored Glycine 0 C--N 1.339 0.704 0 CA-C-N 117.067 0.433 . . . . 0.0 113.126 172.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 370' ' ' GLY . . . . . 0.584 ' O ' ' HG3' ' A' ' 329' ' ' GLU . . . 83.93 -54.58 4.96 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.606 -0.807 . . . . 0.0 113.256 175.058 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 371' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -165.16 142.17 5.83 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.266 0.555 . . . . 0.0 111.527 177.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 372' ' ' ILE . . . . . 0.824 HG23 ' HB3' ' A' ' 362' ' ' PRO . 1.1 mt -131.23 150.16 34.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 170.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 373' ' ' GLU . . . . . 0.846 ' HG2' HG12 ' A' ' 327' ' ' VAL . 32.5 mt-10 -123.45 126.49 46.86 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.199 178.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 374' ' ' MET . . . . . 0.525 ' HA ' ' HA ' ' A' ' 357' ' ' LEU . 1.0 OUTLIER -137.26 161.37 36.4 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.452 -176.806 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 375' ' ' GLN . . . . . 0.997 ' HG2' HG23 ' A' ' 326' ' ' VAL . 0.0 OUTLIER -170.51 174.88 4.93 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.782 0.801 . . . . 0.0 111.183 170.722 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 376' ' ' LEU . . . . . 0.567 HD12 ' HD2' ' A' ' 377' ' ' PRO . 35.6 tp -169.02 123.87 0.73 Allowed Pre-proline 0 N--CA 1.438 -1.034 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 171.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 377' ' ' PRO . . . . . 0.567 ' HD2' HD12 ' A' ' 376' ' ' LEU . 45.2 Cg_exo -27.88 129.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 123.766 2.977 . . . . 0.0 112.101 -177.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 378' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -33.77 134.47 0.12 Allowed 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 124.499 3.466 . . . . 0.0 113.961 -161.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 158.51 -178.44 34.74 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -160.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . 0.75 ' HA ' ' HA ' ' A' ' 393' ' ' PHE . 3.9 m-20 -90.42 120.06 31.22 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 118.064 0.932 . . . . 0.0 111.155 -174.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 381' ' ' ASN . . . . . 0.483 HD22 ' C ' ' A' ' 380' ' ' ASP . 0.7 OUTLIER -121.28 163.47 18.52 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 176.91 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 382' ' ' ILE . . . . . 1.04 ' HB ' ' HA ' ' A' ' 391' ' ' GLN . 0.0 OUTLIER -159.62 138.02 2.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 168.573 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 383' ' ' ILE . . . . . 0.407 ' HB ' ' CD2' ' A' ' 390' ' ' HIS . 12.8 mt -103.41 135.94 38.58 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 121.028 0.442 . . . . 0.0 110.286 -171.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 384' ' ' TYR . . . . . 0.44 ' HB2' ' CG ' ' A' ' 343' ' ' ARG . 50.9 m-85 -100.17 136.74 39.6 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 164.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 385' ' ' VAL . . . . . 0.725 ' HB ' ' HB2' ' A' ' 388' ' ' LEU . 10.9 t -120.73 77.77 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 177.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 386' ' ' GLY . . . . . 0.424 ' HA3' ' HB2' ' A' ' 309' ' ' LYS . . . 59.73 -106.05 0.89 Allowed Glycine 0 N--CA 1.431 -1.685 0 C-N-CA 120.134 -1.031 . . . . 0.0 111.155 -163.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 387' ' ' ASP . . . . . 0.492 ' N ' ' HB2' ' A' ' 309' ' ' LYS . 10.6 t70 -81.32 -17.42 49.3 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 179.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 388' ' ' LEU . . . . . 0.725 ' HB2' ' HB ' ' A' ' 385' ' ' VAL . 2.4 mp -70.47 154.36 41.97 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.871 0.367 . . . . 0.0 111.195 178.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 389' ' ' ASN . . . . . 0.438 ' HB3' ' CE2' ' A' ' 384' ' ' TYR . 24.2 p30 -155.93 145.22 20.77 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.384 173.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 390' ' ' HIS . . . . . 0.473 ' CD2' ' HD3' ' A' ' 318' ' ' PRO . 0.2 OUTLIER -170.42 106.81 0.31 Allowed 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.798 -0.183 . . . . 0.0 111.307 -173.743 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 391' ' ' GLN . . . . . 1.04 ' HA ' ' HB ' ' A' ' 382' ' ' ILE . 0.6 OUTLIER -87.87 153.98 20.89 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.212 0.53 . . . . 0.0 112.422 -174.355 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 392' ' ' TRP . . . . . . . . . . . . . 5.5 t-105 -178.0 116.28 0.08 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.143 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 393' ' ' PHE . . . . . 0.75 ' HA ' ' HA ' ' A' ' 380' ' ' ASP . 18.4 p90 -66.69 124.7 23.61 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.295 170.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.56 ' HG3' ' NE2' ' A' ' 375' ' ' GLN . 5.3 mm100 -80.81 108.79 14.77 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 -175.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 53.2 tptt . . . . . 0 C--O 1.247 0.957 0 CA-C-O 118.795 -0.622 . . . . 0.0 109.985 -174.499 . . . . . . . . 0 0 . 1 stop_ save_